Citrus Sinensis ID: 007160
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 615 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.819 | 0.677 | 0.45 | 1e-110 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.611 | 0.531 | 0.450 | 4e-90 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.554 | 0.447 | 0.481 | 1e-89 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.637 | 0.575 | 0.435 | 3e-88 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.521 | 0.703 | 0.513 | 2e-87 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.461 | 0.435 | 0.530 | 9e-83 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.588 | 0.705 | 0.452 | 4e-82 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.544 | 0.471 | 0.464 | 6e-82 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.517 | 0.441 | 0.501 | 2e-81 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.538 | 0.850 | 0.457 | 4e-81 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 399 bits (1024), Expect = e-110, Method: Compositional matrix adjust.
Identities = 243/540 (45%), Positives = 319/540 (59%), Gaps = 36/540 (6%)
Query: 35 LSPDSSDC---CKPDTVLKRASHGCHCVYPIKLDLVL--LNVSQNPNWNLFLEELASQLG 89
+SP S DC C C CV+P+K+ L+L S P N E+A+
Sbjct: 91 VSPSSHDCQQTCVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNELEIEVAAGTY 150
Query: 90 LRVSQIELINFYVLSLSQLNISMDIT-PHTGISFSASDASAINFSLTTHKVHFDSTLVGD 148
L SQ++++ S +Q +DI G F + A+ I KV + T+ GD
Sbjct: 151 LEQSQVKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKVPLNETVFGD 210
Query: 149 YKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNK--GKHSNLILIFGIGTG 206
Y++ + ++ P PS +P AP P ++++ +NK G I I +
Sbjct: 211 YEVTHISY--PGIPSSSPNGDVT-GDAPGGLPIPINATTFANKSQGIGFRTIAIIALSGF 267
Query: 207 LLITAIISVL-IICSCAFRGRKSKA-----SPKETAKPRTADAVTLGGSLPHPT------ 254
+LI ++ + II G+ S A +P +P +
Sbjct: 268 VLILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSARSSGSDSLMSSM 327
Query: 255 -----STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD 309
S + EL++AT+ F +LGEGGFGRV++G + DGT VA+K LT Q D
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD 387
Query: 310 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 369
+EF+ EVEMLSRLHHRNLVKL+G + L YELV NGS+ES LH LD
Sbjct: 388 REFIAEVEMLSRLHHRNLVKLIGI--CIEGRTRCLIYELVHNGSVESHLH-----EGTLD 440
Query: 370 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
W+ R+KIAL AARGLAYLHEDS P VIHRDFKASN+LLE++F KV+DFGLA++A EG +
Sbjct: 441 WDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-S 499
Query: 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489
++STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR+PVDMSQPSG+ENLVT
Sbjct: 500 QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVT 559
Query: 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
WARP+L +++ LE+L DP L G Y +D +V IA+ CV E + RP MGEVVQ+LK++
Sbjct: 560 WARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 184/408 (45%), Positives = 252/408 (61%), Gaps = 32/408 (7%)
Query: 166 PLASSPPMKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRG 225
P +++P PT R + +ST+N G + ++ + L++ + + + C
Sbjct: 249 PGSNNPSQNNPTLRPPLDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREK 308
Query: 226 RKSKASPKE-TAKPRTADAVT------LGGSLPHPTSTR----------------FLAYE 262
R S S + T P ++ A + + S P S R +YE
Sbjct: 309 RLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYE 368
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 322
EL +ATN F ++LGEGGFG V+KG+L DG VA+K+L GG QGD+EF EVE LSR+
Sbjct: 369 ELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRI 428
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
HHR+LV +VG+ S D + LL Y+ V N L LHG V LDW TR+KIA AAR
Sbjct: 429 HHRHLVSIVGHCISGD--RRLLIYDYVSNNDLYFHLHGEKSV---LDWATRVKIAAGAAR 483
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
GLAYLHED P +IHRD K+SNILLE+NF A+V+DFGLA+ A + T +++TRV+GTFGY
Sbjct: 484 GLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGY 542
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---DKD 499
+APEYA +G L KSDV+S+GVVLLEL+TGRKPVD SQP G E+LV WARP++ + +
Sbjct: 543 MAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETE 602
Query: 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ LADP+LGG Y + + R+ A ACV A +RP MG++V++ +
Sbjct: 603 EFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFE 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (847), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 184/382 (48%), Positives = 238/382 (62%), Gaps = 41/382 (10%)
Query: 198 ILIFGIGTGLLITAIISVLIICSCAFRGRKSKAS----------PKETAKPRTADAVT-- 245
++ IG L++ +I V++ C + RK + S P E++ PR+ A+
Sbjct: 330 VVGVSIGVALVLLTLIGVVV---CCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKT 386
Query: 246 ----------------LGGSLP--HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFK 287
L S P S +YEEL ATN F ++LGEGGFGRV+K
Sbjct: 387 QSSAPLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYK 446
Query: 288 GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347
GVL D VA+K+L GG QGD+EF EV+ +SR+HHRNL+ +VGY S + + LL Y+
Sbjct: 447 GVLPDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISEN--RRLLIYD 504
Query: 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL 407
VPN +L LH LDW TR+KIA AARGLAYLHED P +IHRD K+SNILL
Sbjct: 505 YVPNNNLYFHLHA--AGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILL 562
Query: 408 ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLL 467
ENNFHA V+DFGLAK A + T +++TRVMGTFGY+APEYA +G L KSDV+S+GVVLL
Sbjct: 563 ENNFHALVSDFGLAKLALDCNT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 621
Query: 468 ELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE---LADPRLGGKYPKEDFIRVCTI 524
EL+TGRKPVD SQP G E+LV WARP+L + EE LADP+LG Y + R+
Sbjct: 622 ELITGRKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEA 681
Query: 525 AAACVAPEANQRPTMGEVVQSL 546
AAAC+ A +RP M ++V++
Sbjct: 682 AAACIRHSATKRPRMSQIVRAF 703
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 194/445 (43%), Positives = 258/445 (57%), Gaps = 53/445 (11%)
Query: 172 PMKAPTHRAS-------PSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFR 224
P+ PT AS PSSS S G + I+ G+ GL+ +S+ ++ R
Sbjct: 207 PIAKPTGPASNNGNNTLPSSSPGKSEVG--TGGIVAIGVIVGLVF---LSLFVMGVWFTR 261
Query: 225 GRKSK---------ASPKETAKPRTADAVTLGGSLPHPTSTR------------------ 257
RK K P + P+ +D V P R
Sbjct: 262 KRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVS 321
Query: 258 ----FLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL 313
+ +Y+EL + T+ F ++LGEGGFG V+KGVLSDG VA+K+L GG QG++EF
Sbjct: 322 NQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFK 381
Query: 314 VEVEMLSRLHHRNLVKLVGYYSSRDSSQH-LLCYELVPNGSLESWLHGPLGVNCHLDWET 372
EVE++SR+HHR+LV LVGY S QH LL Y+ VPN +L LH P + WET
Sbjct: 382 AEVEIISRVHHRHLVTLVGYCISE---QHRLLVYDYVPNNTLHYHLHAP--GRPVMTWET 436
Query: 373 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-Y 431
R+++A AARG+AYLHED P +IHRD K+SNILL+N+F A VADFGLAK A E N +
Sbjct: 437 RVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTH 496
Query: 432 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491
+STRVMGTFGY+APEYA +G L K+DVYSYGV+LLEL+TGRKPVD SQP G E+LV WA
Sbjct: 497 VSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWA 556
Query: 492 RPILR---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548
RP+L + + +EL DPRLG + + R+ AAACV A +RP M +VV++L
Sbjct: 557 RPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDT 616
Query: 549 VQRVIECQDPTLTSSNNRANLRQSS 573
++ + + + + RQ S
Sbjct: 617 LEEATDITNGMRPGQSQVFDSRQQS 641
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 168/327 (51%), Positives = 214/327 (65%), Gaps = 6/327 (1%)
Query: 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVE 317
A+ EL AT NF P + LGEGGFGRV+KG L S G VA+K+L G QG++EFLVEV
Sbjct: 74 FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133
Query: 318 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 377
MLS LHH NLV L+GY + D Q LL YE +P GSLE LH LDW RMKIA
Sbjct: 134 MLSLLHHPNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIA 191
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
AA+GL +LH+ + P VI+RDFK+SNILL+ FH K++DFGLAK P G +++STRVM
Sbjct: 192 AGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVM 251
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
GT+GY APEYAMTG L VKSDVYS+GVV LEL+TGRK +D P G++NLV WARP+ D
Sbjct: 252 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFND 311
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 557
+ + +LADPRL G++P + +A+ C+ +A RP + +VV +L + + D
Sbjct: 312 RRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLAN--QAYD 369
Query: 558 PTLTSS-NNRANLRQSSTTFDSDGTSS 583
P+ S NR T + DG S
Sbjct: 370 PSKDDSRRNRDERGARLITRNDDGGGS 396
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 9e-83, Method: Compositional matrix adjust.
Identities = 155/292 (53%), Positives = 206/292 (70%), Gaps = 8/292 (2%)
Query: 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 318
YEEL ATN F A++LG+GGFG V KG+L G VA+K+L G QG++EF EVE+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
+SR+HHR+LV L+GY + Q LL YE VPN +LE LHG ++W TR+KIAL
Sbjct: 328 ISRVHHRHLVSLIGYCMA--GVQRLLVYEFVPNNNLEFHLHGK--GRPTMEWSTRLKIAL 383
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
+A+GL+YLHED P +IHRD KASNIL++ F AKVADFGLAK A + T ++STRVMG
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMG 442
Query: 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR-- 496
TFGY+APEYA +G L KSDV+S+GVVLLEL+TGR+PVD + ++LV WARP+L
Sbjct: 443 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRA 502
Query: 497 -DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
++ E LAD ++G +Y +E+ R+ AAACV A +RP M ++V++L+
Sbjct: 503 SEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 178/393 (45%), Positives = 239/393 (60%), Gaps = 31/393 (7%)
Query: 160 PAPSQAPLASSP--PMKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLI 217
P P +P P P P SP S S S + ++ IG G+ + +I
Sbjct: 91 PPPPASPSGQEPTTPTMTPGFSLSPPSPSRLS-----TGAVVGISIGGGVFVLTLI--FF 143
Query: 218 ICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASIL 277
+C R R KA P +G L ST Y EL ATN F A++L
Sbjct: 144 LCKKK-RPRDDKALP-----------APIGLVLGIHQST--FTYGELARATNKFSEANLL 189
Query: 278 GEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 337
GEGGFG V+KG+L++G VA+K+L G QG+KEF EV ++S++HHRNLV LVGY +
Sbjct: 190 GEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIA- 248
Query: 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 397
+Q LL YE VPN +LE LHG ++W R+KIA+ +++GL+YLHE+ P +IH
Sbjct: 249 -GAQRLLVYEFVPNNTLEFHLHGK--GRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIH 305
Query: 398 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS 457
RD KA+NIL++ F AKVADFGLAK A + T ++STRVMGTFGY+APEYA +G L KS
Sbjct: 306 RDIKAANILIDFKFEAKVADFGLAKIALDTNT-HVSTRVMGTFGYLAPEYAASGKLTEKS 364
Query: 458 DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL---RDKDRLEELADPRLGGKYP 514
DVYS+GVVLLEL+TGR+PVD + ++LV WARP+L ++ E LAD +L +Y
Sbjct: 365 DVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYD 424
Query: 515 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+E+ R+ AAACV A +RP M +VV+ L+
Sbjct: 425 REEMARMVACAAACVRYTARRRPRMDQVVRVLE 457
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (781), Expect = 6e-82, Method: Compositional matrix adjust.
Identities = 170/366 (46%), Positives = 227/366 (62%), Gaps = 31/366 (8%)
Query: 242 DAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRL 301
D+ +G H YEEL + T F +ILGEGGFG V+KG L+DG VA+K+L
Sbjct: 330 DSAVMGSGQTH------FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQL 383
Query: 302 TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG- 360
G QGD+EF EVE++SR+HHR+LV LVGY + S+ LL YE VPN +LE LHG
Sbjct: 384 KVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIA--DSERLLIYEYVPNQTLEHHLHGK 441
Query: 361 --PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418
P+ L+W R++IA+ +A+GLAYLHED P +IHRD K++NILL++ F A+VADF
Sbjct: 442 GRPV-----LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADF 496
Query: 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 478
GLAK +T ++STRVMGTFGY+APEYA +G L +SDV+S+GVVLLEL+TGRKPVD
Sbjct: 497 GLAKLNDSTQT-HVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555
Query: 479 SQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ 535
QP G+E+LV WARP+L + EL D RL Y + + R+ AAACV +
Sbjct: 556 YQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615
Query: 536 RPTMGEVVQSLKMVQRVIECQDPTLTS----------SNNRANLRQSSTTFDSDGTSSMF 585
RP M +VV++L + + + +N+ R+ + FD S M+
Sbjct: 616 RPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQYNNDTMKFRKMAFGFDDSSDSGMY 675
Query: 586 SSGPYS 591
SG YS
Sbjct: 676 -SGDYS 680
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 172/343 (50%), Positives = 224/343 (65%), Gaps = 25/343 (7%)
Query: 240 TADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIK 299
T D+ LG H +YEEL E T F +ILGEGGFG V+KG L DG VA+K
Sbjct: 346 TPDSAILGSGQTH------FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVK 399
Query: 300 RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH-LLCYELVPNGSLESWL 358
+L G QGD+EF EVE++SR+HHR+LV LVGY S QH LL YE V N +LE L
Sbjct: 400 QLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIS---DQHRLLIYEYVSNQTLEHHL 456
Query: 359 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418
HG G+ L+W R++IA+ +A+GLAYLHED P +IHRD K++NILL++ + A+VADF
Sbjct: 457 HG-KGLPV-LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADF 514
Query: 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 478
GLA+ +T ++STRVMGTFGY+APEYA +G L +SDV+S+GVVLLEL+TGRKPVD
Sbjct: 515 GLARLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQ 573
Query: 479 SQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ 535
+QP G+E+LV WARP+L + L EL D RL +Y + + R+ AAACV +
Sbjct: 574 TQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPK 633
Query: 536 RPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDS 578
RP M +VV R ++C + SN + Q STT+DS
Sbjct: 634 RPRMVQVV-------RALDCDGDSGDISNG-IKIGQ-STTYDS 667
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 4e-81, Method: Compositional matrix adjust.
Identities = 162/354 (45%), Positives = 226/354 (63%), Gaps = 23/354 (6%)
Query: 225 GRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGR 284
G K ++ + PRT + +L + + ELK AT NF P S++GEGGFG
Sbjct: 28 GSKGSSTASFSYMPRTEGEILQNANLKN------FSLSELKSATRNFRPDSVVGEGGFGC 81
Query: 285 VFKGVLSD----------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
VFKG + + G +A+KRL G QG +E+L E+ L +L H NLVKL+GY
Sbjct: 82 VFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGY- 140
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
+ LL YE + GSLE+ L L W TR+++AL AARGLA+LH ++QP
Sbjct: 141 -CLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQ 198
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 454
VI+RDFKASNILL++N++AK++DFGLA+ P G +++STRVMGT GY APEY TGHL
Sbjct: 199 VIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLS 258
Query: 455 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 514
VKSDVYS+GVVLLELL+GR+ +D +QP G+ NLV WARP L +K RL + DPRL G+Y
Sbjct: 259 VKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYS 318
Query: 515 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK--MVQRVI--ECQDPTLTSSN 564
+++ +A C++ +A RPTM E+V++++ +Q+ E Q+P ++ N
Sbjct: 319 LTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASKEQQNPQISIDN 372
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 615 | ||||||
| 147821305 | 707 | hypothetical protein VITISV_041991 [Viti | 1.0 | 0.869 | 0.816 | 0.0 | |
| 225437589 | 707 | PREDICTED: receptor-like serine/threonin | 1.0 | 0.869 | 0.815 | 0.0 | |
| 449484209 | 723 | PREDICTED: receptor-like serine/threonin | 1.0 | 0.850 | 0.813 | 0.0 | |
| 449469022 | 723 | PREDICTED: receptor-like serine/threonin | 1.0 | 0.850 | 0.813 | 0.0 | |
| 297814127 | 725 | kinase family protein [Arabidopsis lyrat | 0.998 | 0.846 | 0.784 | 0.0 | |
| 30679031 | 725 | protein kinase family protein [Arabidops | 0.998 | 0.846 | 0.780 | 0.0 | |
| 3912917 | 707 | putative NAK-like ser/thr protein kinase | 0.998 | 0.868 | 0.780 | 0.0 | |
| 356501859 | 695 | PREDICTED: receptor-like serine/threonin | 0.995 | 0.880 | 0.778 | 0.0 | |
| 356503938 | 720 | PREDICTED: receptor-like serine/threonin | 0.996 | 0.851 | 0.790 | 0.0 | |
| 255548425 | 711 | kinase, putative [Ricinus communis] gi|2 | 0.965 | 0.835 | 0.788 | 0.0 |
| >gi|147821305|emb|CAN74588.1| hypothetical protein VITISV_041991 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1045 bits (2703), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/622 (81%), Positives = 549/622 (88%), Gaps = 7/622 (1%)
Query: 1 MKRSALEPPSAGLA-----NISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHG 55
MKR L P GL +I+P Q + G +P GLA+PPLSP S+CC+PD VLK+ SHG
Sbjct: 86 MKRGGLVSPGTGLVPPHLEDIAPMQSNAGPIPVGLAQPPLSPSDSNCCEPDMVLKQRSHG 145
Query: 56 CHCVYPIKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDIT 115
CHCVYPIK+DLVLLNVSQNPNW LFLEELA+QLGLRVSQIELINFY+LSLS+LNISMDI
Sbjct: 146 CHCVYPIKVDLVLLNVSQNPNWKLFLEELATQLGLRVSQIELINFYLLSLSRLNISMDII 205
Query: 116 PHTGISFSASDASAINFSLTTHKVHFDSTLVG--DYKLLNFTWFEPPAPSQAPLASSPPM 173
PHTGISFSASDAS IN SL H VH D T VG DYKLLN TWF+PP PS APL ++ PM
Sbjct: 206 PHTGISFSASDASKINSSLAAHMVHLDPTSVGVGDYKLLNVTWFKPPVPSPAPLVATSPM 265
Query: 174 KAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPK 233
+AP ++ S S+S SNK KH NL+LI GI G+L AIISV+++ CA +K+K SP+
Sbjct: 266 EAPANQYSASTSHVDSNKRKHPNLVLILGIIAGILTVAIISVIMVSLCASCRKKTKPSPE 325
Query: 234 ETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG 293
E KP TAD V + GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG
Sbjct: 326 ENVKPSTADPVPVVGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG 385
Query: 294 TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 353
TAVAIKRLT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELVPNGS
Sbjct: 386 TAVAIKRLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVPNGS 445
Query: 354 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413
LE+WLHGPLGVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA
Sbjct: 446 LEAWLHGPLGVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 505
Query: 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
KVADFGLAK+APEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR
Sbjct: 506 KVADFGLAKKAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 565
Query: 474 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 533
+PV+MSQPSGQENLVTWARPILRDKDRLEELAD RL GKYPKEDF+RVCTIAAACVAPEA
Sbjct: 566 RPVEMSQPSGQENLVTWARPILRDKDRLEELADERLAGKYPKEDFVRVCTIAAACVAPEA 625
Query: 534 NQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGL 593
NQRPTMGEVVQSLKMVQRV+E QD LTSSN R NLRQSSTTF+SDGTSS+FSSGPYSGL
Sbjct: 626 NQRPTMGEVVQSLKMVQRVMEYQDSMLTSSNARPNLRQSSTTFESDGTSSIFSSGPYSGL 685
Query: 594 SAFDNENVSRTAVFSEDLHEGR 615
SAFDN+N+SRTAVFSEDLHEGR
Sbjct: 686 SAFDNDNISRTAVFSEDLHEGR 707
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225437589|ref|XP_002270928.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2 [Vitis vinifera] gi|297743991|emb|CBI36961.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1043 bits (2697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/622 (81%), Positives = 548/622 (88%), Gaps = 7/622 (1%)
Query: 1 MKRSALEPPSAGLA-----NISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHG 55
MKR L P GL +I+P Q + G +P GLA+PPLSP S+CC+PD VLK+ SHG
Sbjct: 86 MKRGGLVSPGTGLVPPHLEDIAPMQSNAGPIPVGLAQPPLSPSDSNCCEPDMVLKQGSHG 145
Query: 56 CHCVYPIKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDIT 115
CHCVYPIK+DLVLLNVSQNPNW LFLEELA+QLGLRVSQIELINFY+LSLS+LNISMDI
Sbjct: 146 CHCVYPIKVDLVLLNVSQNPNWKLFLEELATQLGLRVSQIELINFYLLSLSRLNISMDII 205
Query: 116 PHTGISFSASDASAINFSLTTHKVHFDSTLVG--DYKLLNFTWFEPPAPSQAPLASSPPM 173
PHTGISFSASDAS IN SL H VH D T VG DYKLLN TWF+PP PS APL ++ PM
Sbjct: 206 PHTGISFSASDASKINSSLAAHMVHLDPTSVGVGDYKLLNVTWFKPPVPSPAPLVATSPM 265
Query: 174 KAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPK 233
+AP ++ S S+S SNK KH NL+LI GI G+L AII V+++ CA +K+K SP+
Sbjct: 266 EAPANQYSASTSHVDSNKRKHPNLVLILGIIAGILTVAIICVIMVSLCASCRKKTKPSPE 325
Query: 234 ETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG 293
E KP TAD V + GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG
Sbjct: 326 ENVKPSTADPVPVVGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG 385
Query: 294 TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 353
TAVAIKRLT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELVPNGS
Sbjct: 386 TAVAIKRLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVPNGS 445
Query: 354 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413
LE+WLHGPLGVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA
Sbjct: 446 LEAWLHGPLGVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 505
Query: 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
KVADFGLAK+APEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR
Sbjct: 506 KVADFGLAKKAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 565
Query: 474 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 533
+PV+MSQPSGQENLVTWARPILRDKDRLEELAD RL GKYPKEDF+RVCTIAAACVAPEA
Sbjct: 566 RPVEMSQPSGQENLVTWARPILRDKDRLEELADERLAGKYPKEDFVRVCTIAAACVAPEA 625
Query: 534 NQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGL 593
NQRPTMGEVVQSLKMVQRV+E QD LTSSN R NLRQSSTTF+SDGTSS+FSSGPYSGL
Sbjct: 626 NQRPTMGEVVQSLKMVQRVMEYQDSMLTSSNARPNLRQSSTTFESDGTSSIFSSGPYSGL 685
Query: 594 SAFDNENVSRTAVFSEDLHEGR 615
SAFDN+N+SRTAVFSEDLHEGR
Sbjct: 686 SAFDNDNISRTAVFSEDLHEGR 707
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449484209|ref|XP_004156817.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2597), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/616 (81%), Positives = 542/616 (87%), Gaps = 1/616 (0%)
Query: 1 MKRSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRAS-HGCHCV 59
+ +S PP L NI+P Q + G +PSGLA+PPLSP ++DCCKPD VLKR S CHCV
Sbjct: 108 LMKSGSAPPDDRLENIAPIQSTAGAIPSGLAQPPLSPIAADCCKPDMVLKRGSGDDCHCV 167
Query: 60 YPIKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTG 119
YPIK+DL+LLN+SQNPNW LFLEELAS+LGLRVSQIELINFYVLSLS+LNISMD+TPHTG
Sbjct: 168 YPIKIDLLLLNISQNPNWKLFLEELASELGLRVSQIELINFYVLSLSRLNISMDVTPHTG 227
Query: 120 ISFSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHR 179
ISFSA+DASAIN SLT HKV D TLVGDY LLN TWF+PP PSQAP+AS+ P+ AP +
Sbjct: 228 ISFSAADASAINSSLTMHKVRLDPTLVGDYSLLNITWFKPPPPSQAPIASASPVAAPAYH 287
Query: 180 ASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPR 239
S+S ++ +KG HSNL L+ GIG G L AI+ VLIIC C K++A P T KPR
Sbjct: 288 FPASTSPNSPSKGHHSNLTLLLGIGAGFLFIAILFVLIICLCTSHFGKTEAPPLVTEKPR 347
Query: 240 TADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIK 299
D V + GS PHP+S RFL YEELKEATNNFE ASILGEGGFGRVFKGVLSDGTAVAIK
Sbjct: 348 VEDKVPVAGSFPHPSSMRFLTYEELKEATNNFEAASILGEGGFGRVFKGVLSDGTAVAIK 407
Query: 300 RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH 359
RLT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELV NGSLE+WLH
Sbjct: 408 RLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVANGSLEAWLH 467
Query: 360 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419
GPLGVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG
Sbjct: 468 GPLGVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 527
Query: 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 479
LAKQAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS
Sbjct: 528 LAKQAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 587
Query: 480 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539
QPSGQENLVTWARPILRDKDRLEELADP+LGGKYPKEDF+RVCTIAAACVAPEA QRPTM
Sbjct: 588 QPSGQENLVTWARPILRDKDRLEELADPQLGGKYPKEDFVRVCTIAAACVAPEAGQRPTM 647
Query: 540 GEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNE 599
GEVVQSLKMVQRV E QD + SSNNR NLRQSSTTF+SDG+SSMFSSGPYSGLSAFDN+
Sbjct: 648 GEVVQSLKMVQRVTEYQDSIVPSSNNRTNLRQSSTTFESDGSSSMFSSGPYSGLSAFDND 707
Query: 600 NVSRTAVFSEDLHEGR 615
NVSRTA+FSEDLHEGR
Sbjct: 708 NVSRTAIFSEDLHEGR 723
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469022|ref|XP_004152220.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/616 (81%), Positives = 542/616 (87%), Gaps = 1/616 (0%)
Query: 1 MKRSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRAS-HGCHCV 59
+ +S PP L NI+P Q + G +PSGLA+PPLSP ++DCCKPD VLKR S CHCV
Sbjct: 108 LMKSGSAPPDDRLENIAPIQSTAGAIPSGLAQPPLSPIAADCCKPDMVLKRGSGDDCHCV 167
Query: 60 YPIKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTG 119
YPIK+DL+LLN+SQNPNW LFLEELAS+LGLRVSQIELINFYVLSLS+LNISMD+TPHTG
Sbjct: 168 YPIKIDLLLLNISQNPNWKLFLEELASELGLRVSQIELINFYVLSLSRLNISMDVTPHTG 227
Query: 120 ISFSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHR 179
ISFSA+DASAIN SLT HKV D TLVGDY LLN TWF+PP PSQAP+AS+ P+ AP +
Sbjct: 228 ISFSAADASAINSSLTMHKVRLDPTLVGDYSLLNITWFKPPPPSQAPIASASPVAAPAYH 287
Query: 180 ASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPR 239
S+S ++ +KG HSNL L+ GIG G L AI+ VLIIC C K++A P T KPR
Sbjct: 288 FPASTSPNSPSKGHHSNLTLLLGIGAGFLFIAILFVLIICLCTSHCGKTEAPPLVTEKPR 347
Query: 240 TADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIK 299
D V + GS PHP+S RFL YEELKEATNNFE ASILGEGGFGRVFKGVLSDGTAVAIK
Sbjct: 348 VEDKVPVAGSFPHPSSMRFLTYEELKEATNNFEAASILGEGGFGRVFKGVLSDGTAVAIK 407
Query: 300 RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH 359
RLT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELV NGSLE+WLH
Sbjct: 408 RLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVANGSLEAWLH 467
Query: 360 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419
GPLGVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG
Sbjct: 468 GPLGVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 527
Query: 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 479
LAKQAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS
Sbjct: 528 LAKQAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 587
Query: 480 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539
QPSGQENLVTWARPILRDKDRLEELADP+LGGKYPKEDF+RVCTIAAACVAPEA QRPTM
Sbjct: 588 QPSGQENLVTWARPILRDKDRLEELADPQLGGKYPKEDFVRVCTIAAACVAPEAGQRPTM 647
Query: 540 GEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNE 599
GEVVQSLKMVQRV E QD + SSNNR NLRQSSTTF+SDG+SSMFSSGPYSGLSAFDN+
Sbjct: 648 GEVVQSLKMVQRVTEYQDSIVPSSNNRTNLRQSSTTFESDGSSSMFSSGPYSGLSAFDND 707
Query: 600 NVSRTAVFSEDLHEGR 615
NVSRTA+FSEDLHEGR
Sbjct: 708 NVSRTAIFSEDLHEGR 723
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814127|ref|XP_002874947.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297320784|gb|EFH51206.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2590), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/616 (78%), Positives = 536/616 (87%), Gaps = 2/616 (0%)
Query: 1 MKRSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVY 60
MK++A + P AGL +I+PAQ S +P L +PPLSP S+CCK D VLKR S GCHCVY
Sbjct: 111 MKKNA-QSPGAGLVDIAPAQSSNSALPDALTQPPLSPSISNCCKADMVLKRRSIGCHCVY 169
Query: 61 PIKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGI 120
PIKLD++LLNVS+ P+WN+FL E A+QLGL QIELINFYVLSLS++NISMDITPH+GI
Sbjct: 170 PIKLDILLLNVSETPSWNMFLNEFATQLGLLPHQIELINFYVLSLSRMNISMDITPHSGI 229
Query: 121 SFSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRA 180
SFSAS ASAIN SL +HK+ F TLVGDYKLLN TWFE PAPSQAPL +S P KAP+ +
Sbjct: 230 SFSASQASAINSSLISHKIQFSPTLVGDYKLLNLTWFEAPAPSQAPLVASSPHKAPSQGS 289
Query: 181 SPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRT 240
S S+S + K KH NLILIF I G+LI AII+VL+ICSCA R K+ KET KPR
Sbjct: 290 SASTSVRSPGKKKHPNLILIFAIAAGVLILAIITVLVICSCALREEKAPDPHKETVKPRN 349
Query: 241 ADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKR 300
DA ++GGSLPHP STRFL+YEELKEAT+NFE ASILGEGGFG+V++G+L+DGTAVAIK+
Sbjct: 350 LDAGSVGGSLPHPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKK 409
Query: 301 LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 360
LT GG QGDKEF VE++MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLE+WLHG
Sbjct: 410 LTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHG 469
Query: 361 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420
PLG+NC LDW+TRMKIALDAARGLAYLHEDSQP VIHRDFKASNILLENNF+AKVADFGL
Sbjct: 470 PLGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGL 529
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480
AKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ
Sbjct: 530 AKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 589
Query: 481 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540
PSGQENLVTW RPILRDKDRLEEL D RL GKYPKEDFIRVCTIAAACVAPEA+QRPTMG
Sbjct: 590 PSGQENLVTWTRPILRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMG 649
Query: 541 EVVQSLKMVQRVIECQDPTLTSSNN-RANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNE 599
EVVQSLKMVQRV+E QDP L +SN R N RQSS TF+S+ TSSMFSSGPYSGLSAFD+E
Sbjct: 650 EVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQSSATFESEVTSSMFSSGPYSGLSAFDHE 709
Query: 600 NVSRTAVFSEDLHEGR 615
N++RT VFSEDLHEGR
Sbjct: 710 NITRTTVFSEDLHEGR 725
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30679031|ref|NP_192110.2| protein kinase family protein [Arabidopsis thaliana] gi|21928159|gb|AAM78107.1| AT4g02010/T10M13_2 [Arabidopsis thaliana] gi|32815839|gb|AAP88328.1| At4g02010/T10M13_2 [Arabidopsis thaliana] gi|332656711|gb|AEE82111.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2581), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/616 (78%), Positives = 535/616 (86%), Gaps = 2/616 (0%)
Query: 1 MKRSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVY 60
MKR+A + P AGLA+I+PAQ S G +P L +PPLSP S+CCK D VLKR S GCHCVY
Sbjct: 111 MKRNA-QSPGAGLADIAPAQSSNGVLPDALTQPPLSPSISNCCKSDMVLKRRSIGCHCVY 169
Query: 61 PIKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGI 120
PIKLD++LLNVS+ P+WN+FL E A+QLGL QIELINFYVLSLS++NISMDITPH+GI
Sbjct: 170 PIKLDILLLNVSETPSWNMFLNEFATQLGLLPHQIELINFYVLSLSRMNISMDITPHSGI 229
Query: 121 SFSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRA 180
SFSAS ASAIN SL +HK+ F TLVGDYKLLN TWFE PAPSQAPL +S P KAP+ +
Sbjct: 230 SFSASQASAINSSLISHKIQFSPTLVGDYKLLNLTWFEAPAPSQAPLVASSPHKAPSQGS 289
Query: 181 SPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRT 240
S ++S + K +H NLILIF I G+LI AII+VL+ICS A R K+ KE KPR
Sbjct: 290 SATTSVRSPGKKRHPNLILIFSIAAGVLILAIITVLVICSRALREEKAPDPHKEAVKPRN 349
Query: 241 ADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKR 300
DA + GGSLPHP STRFL+YEELKEAT+NFE ASILGEGGFG+V++G+L+DGTAVAIK+
Sbjct: 350 LDAGSFGGSLPHPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKK 409
Query: 301 LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 360
LT GG QGDKEF VE++MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLE+WLHG
Sbjct: 410 LTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHG 469
Query: 361 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420
PLG+NC LDW+TRMKIALDAARGLAYLHEDSQP VIHRDFKASNILLENNF+AKVADFGL
Sbjct: 470 PLGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGL 529
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480
AKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ
Sbjct: 530 AKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 589
Query: 481 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540
PSGQENLVTW RP+LRDKDRLEEL D RL GKYPKEDFIRVCTIAAACVAPEA+QRPTMG
Sbjct: 590 PSGQENLVTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMG 649
Query: 541 EVVQSLKMVQRVIECQDPTLTSSNN-RANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNE 599
EVVQSLKMVQRV+E QDP L +SN R N RQSS TF+S+ TSSMFSSGPYSGLSAFD+E
Sbjct: 650 EVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQSSATFESEVTSSMFSSGPYSGLSAFDHE 709
Query: 600 NVSRTAVFSEDLHEGR 615
N++RT VFSEDLHEGR
Sbjct: 710 NITRTTVFSEDLHEGR 725
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3912917|gb|AAC78693.1| putative NAK-like ser/thr protein kinase [Arabidopsis thaliana] gi|7268585|emb|CAB80694.1| putative NAK-like ser/thr protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2579), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/616 (78%), Positives = 535/616 (86%), Gaps = 2/616 (0%)
Query: 1 MKRSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVY 60
MKR+A + P AGLA+I+PAQ S G +P L +PPLSP S+CCK D VLKR S GCHCVY
Sbjct: 93 MKRNA-QSPGAGLADIAPAQSSNGVLPDALTQPPLSPSISNCCKSDMVLKRRSIGCHCVY 151
Query: 61 PIKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGI 120
PIKLD++LLNVS+ P+WN+FL E A+QLGL QIELINFYVLSLS++NISMDITPH+GI
Sbjct: 152 PIKLDILLLNVSETPSWNMFLNEFATQLGLLPHQIELINFYVLSLSRMNISMDITPHSGI 211
Query: 121 SFSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRA 180
SFSAS ASAIN SL +HK+ F TLVGDYKLLN TWFE PAPSQAPL +S P KAP+ +
Sbjct: 212 SFSASQASAINSSLISHKIQFSPTLVGDYKLLNLTWFEAPAPSQAPLVASSPHKAPSQGS 271
Query: 181 SPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRT 240
S ++S + K +H NLILIF I G+LI AII+VL+ICS A R K+ KE KPR
Sbjct: 272 SATTSVRSPGKKRHPNLILIFSIAAGVLILAIITVLVICSRALREEKAPDPHKEAVKPRN 331
Query: 241 ADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKR 300
DA + GGSLPHP STRFL+YEELKEAT+NFE ASILGEGGFG+V++G+L+DGTAVAIK+
Sbjct: 332 LDAGSFGGSLPHPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKK 391
Query: 301 LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 360
LT GG QGDKEF VE++MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLE+WLHG
Sbjct: 392 LTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHG 451
Query: 361 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420
PLG+NC LDW+TRMKIALDAARGLAYLHEDSQP VIHRDFKASNILLENNF+AKVADFGL
Sbjct: 452 PLGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGL 511
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480
AKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ
Sbjct: 512 AKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 571
Query: 481 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540
PSGQENLVTW RP+LRDKDRLEEL D RL GKYPKEDFIRVCTIAAACVAPEA+QRPTMG
Sbjct: 572 PSGQENLVTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMG 631
Query: 541 EVVQSLKMVQRVIECQDPTLTSSNN-RANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNE 599
EVVQSLKMVQRV+E QDP L +SN R N RQSS TF+S+ TSSMFSSGPYSGLSAFD+E
Sbjct: 632 EVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQSSATFESEVTSSMFSSGPYSGLSAFDHE 691
Query: 600 NVSRTAVFSEDLHEGR 615
N++RT VFSEDLHEGR
Sbjct: 692 NITRTTVFSEDLHEGR 707
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501859|ref|XP_003519741.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 993 bits (2568), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/613 (77%), Positives = 523/613 (85%), Gaps = 1/613 (0%)
Query: 3 RSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVYPI 62
R L+PP +G NI+P +PS LA+PPLSP SDCCK D V KR S CHC YPI
Sbjct: 84 RGELQPPVSGFKNIAPMHPIADAIPSALAQPPLSPYVSDCCKQDMVWKRGSEVCHCAYPI 143
Query: 63 KLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGISF 122
KLDL+LLNVS+NP+ N FL LA+QL L+ +QIE+I FY+LSLS LNISMDITPH GISF
Sbjct: 144 KLDLLLLNVSENPDQNAFLNGLATQLELQTTQIEIIKFYLLSLSTLNISMDITPHKGISF 203
Query: 123 SASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASP 182
SA +A+ IN L HKV D VGDYK++N TWF+PP S AP S+ PMKAP RA
Sbjct: 204 SAEEAAKINSLLLLHKVQLDRRFVGDYKVINITWFKPPPHSPAPTISTSPMKAPQRRAPT 263
Query: 183 SSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTAD 242
++ SSTS++G+ SNL+LI GI TG+L +I+ VLI+C C R K+K P ET KPR
Sbjct: 264 ATLSSTSDRGRRSNLLLILGIVTGILFISIVCVLILCLCTMRP-KTKTPPTETEKPRIES 322
Query: 243 AVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT 302
AV+ GSLPHPTSTRF+AYEELKEATNNFEPAS+LGEGGFGRV+KGVL+DGTAVAIKRLT
Sbjct: 323 AVSAVGSLPHPTSTRFIAYEELKEATNNFEPASVLGEGGFGRVYKGVLNDGTAVAIKRLT 382
Query: 303 CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL 362
GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELVPNGSLE+WLHGPL
Sbjct: 383 SGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVPNGSLEAWLHGPL 442
Query: 363 GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422
G+NC LDW+TRMKIALDAARGLAY+HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK
Sbjct: 443 GINCPLDWDTRMKIALDAARGLAYMHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 502
Query: 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 482
QAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL GRKPVDMSQPS
Sbjct: 503 QAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLIGRKPVDMSQPS 562
Query: 483 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542
GQENLVTWARPILRDKD LEELADPRLGG+YPKEDF+RVCTIAAACVAPEA+QRP MGEV
Sbjct: 563 GQENLVTWARPILRDKDSLEELADPRLGGRYPKEDFVRVCTIAAACVAPEASQRPAMGEV 622
Query: 543 VQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVS 602
VQSLKMVQRV E DP L SSN R NLRQSSTT+DSDGTSSMFSSGPYSGLS FD N+S
Sbjct: 623 VQSLKMVQRVTESHDPVLASSNTRPNLRQSSTTYDSDGTSSMFSSGPYSGLSTFDYHNIS 682
Query: 603 RTAVFSEDLHEGR 615
RTAVFSEDLHEGR
Sbjct: 683 RTAVFSEDLHEGR 695
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503938|ref|XP_003520756.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2509), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/615 (79%), Positives = 533/615 (86%), Gaps = 2/615 (0%)
Query: 2 KRSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVYP 61
K+S ++PP + NI+P + PS LA+PPLSP +S+CCK D VLKR S CHC YP
Sbjct: 107 KKSEVKPPISVFKNIAPVHSTAAAGPSALAQPPLSPYASNCCKQDMVLKRGSKDCHCAYP 166
Query: 62 IKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGIS 121
IKLDL L NVSQNP+WN FLEELA+QLGLR +QIELINFYVLSLS LNISM+ITPH GIS
Sbjct: 167 IKLDLFLSNVSQNPSWNDFLEELATQLGLRNTQIELINFYVLSLSTLNISMNITPHKGIS 226
Query: 122 FSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRAS 181
FSA++ S IN SL+ HKV D LVG YKLLN TWFEPP PSQAP ++ P+ P H +
Sbjct: 227 FSANEVSRINSSLSMHKVQLDPGLVGGYKLLNLTWFEPPPPSQAPTLAASPVNTPLHHSP 286
Query: 182 PSSSSSTSNK-GKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRT 240
S+SSS+S K G+HSNL LI GI G++ AIISVLI C C F K+K P ET KPRT
Sbjct: 287 TSTSSSSSPKRGRHSNLFLILGIAIGIIFIAIISVLIFCLCTFLS-KAKTPPIETEKPRT 345
Query: 241 ADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKR 300
A++ GSLPHPTSTRF+AYEELKEATNNFEPAS+LGEGGFGRVFKGVL+DGT VAIKR
Sbjct: 346 ESAISTVGSLPHPTSTRFIAYEELKEATNNFEPASVLGEGGFGRVFKGVLNDGTHVAIKR 405
Query: 301 LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 360
LT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGY+S+RDSSQ++LCYELVPNGSLE+WLHG
Sbjct: 406 LTNGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYFSNRDSSQNVLCYELVPNGSLEAWLHG 465
Query: 361 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420
PLG+NC LDW+TRMKIALDAARGL+YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL
Sbjct: 466 PLGINCPLDWDTRMKIALDAARGLSYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 525
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480
AKQAPEGR+NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ
Sbjct: 526 AKQAPEGRSNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 585
Query: 481 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540
P+GQENLVTWARPILRDKDRLEE+ADPRLGGKYPKEDF+RVCTIAAACVA EANQRPTMG
Sbjct: 586 PTGQENLVTWARPILRDKDRLEEIADPRLGGKYPKEDFVRVCTIAAACVALEANQRPTMG 645
Query: 541 EVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNEN 600
EVVQSLKMVQRV E QD L SSN R NLRQSS+TF+ DGTSSMFSSGPYSGLSAFDN+N
Sbjct: 646 EVVQSLKMVQRVTEYQDSVLASSNARPNLRQSSSTFEFDGTSSMFSSGPYSGLSAFDNDN 705
Query: 601 VSRTAVFSEDLHEGR 615
+SRT VFSEDL EGR
Sbjct: 706 ISRTVVFSEDLCEGR 720
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548425|ref|XP_002515269.1| kinase, putative [Ricinus communis] gi|223545749|gb|EEF47253.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 963 bits (2489), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/615 (78%), Positives = 534/615 (86%), Gaps = 21/615 (3%)
Query: 1 MKRSALEPPSAGLANISPAQFSTGTVPSGLAEPPLSPDSSDCCKPDTVLKRASHGCHCVY 60
MK++AL PPS GL +I+P + S G +GLA+PPLSP SDCCKPD VLKR S+ CHCVY
Sbjct: 118 MKKNALVPPSVGLVDIAPTRSSEGANATGLAQPPLSPQISDCCKPDMVLKRGSNDCHCVY 177
Query: 61 PIKLDLVLLNVSQNPNWNLFLEELASQLGLRVSQIELINFYVLSLSQLNISMDITPHTGI 120
PIKLDL+L+NVSQNP+WN FL++LASQLGLRVSQIELINFYVLSLS+LNISMDITPHTGI
Sbjct: 178 PIKLDLLLVNVSQNPSWNKFLQDLASQLGLRVSQIELINFYVLSLSRLNISMDITPHTGI 237
Query: 121 SFSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRA 180
SFS SDAS IN SL HKVHFDS+LVGDY+LLN TWFEPPAPSQAP+A+S P++AP+H++
Sbjct: 238 SFSGSDASFINSSLALHKVHFDSSLVGDYRLLNLTWFEPPAPSQAPVAASSPVEAPSHQS 297
Query: 181 SPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRT 240
+ SSS STSN+GK SNLILI IG G++I A++++L+ICSCAFR K K SPKE+ KPRT
Sbjct: 298 ATSSSVSTSNRGKRSNLILILCIGAGIIIIAVVTMLVICSCAFREWKPKGSPKESVKPRT 357
Query: 241 ADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKR 300
DAV+ GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKR
Sbjct: 358 VDAVSAGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKR 417
Query: 301 LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 360
LT GGQQGDKEFLVEVEMLS L+ V D S
Sbjct: 418 LTNGGQQGDKEFLVEVEMLSSFTWTRLMGTVHVKGPNDLS-------------------- 457
Query: 361 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420
PLGVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL
Sbjct: 458 PLGVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 517
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480
AKQAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ
Sbjct: 518 AKQAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 577
Query: 481 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540
PSGQENLVTWARPILRDKDRLEELAD +L GKYPK+DF+RVCTIAAACVAPEANQRPTMG
Sbjct: 578 PSGQENLVTWARPILRDKDRLEELADTKLKGKYPKDDFVRVCTIAAACVAPEANQRPTMG 637
Query: 541 EVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNEN 600
EVVQSLKMVQR+ E QD ++++SN R N+RQSSTTF+SDGTSS+FSSGPYSGLSAFDN+N
Sbjct: 638 EVVQSLKMVQRITEYQD-SMSASNARPNMRQSSTTFESDGTSSIFSSGPYSGLSAFDNDN 696
Query: 601 VSRTAVFSEDLHEGR 615
+SRTAVFSEDLHEGR
Sbjct: 697 ISRTAVFSEDLHEGR 711
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 615 | ||||||
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.653 | 0.554 | 0.808 | 1.2e-234 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.492 | 0.272 | 0.616 | 5e-104 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.466 | 0.385 | 0.637 | 3.2e-102 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.465 | 0.375 | 0.571 | 6.4e-85 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.474 | 0.428 | 0.549 | 8.2e-85 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.508 | 0.442 | 0.523 | 3.5e-84 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.492 | 0.664 | 0.530 | 2.9e-80 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.458 | 0.435 | 0.537 | 2e-79 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.458 | 0.432 | 0.537 | 4.1e-79 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.536 | 0.643 | 0.497 | 5.4e-79 |
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1698 (602.8 bits), Expect = 1.2e-234, Sum P(2) = 1.2e-234
Identities = 326/403 (80%), Positives = 352/403 (87%)
Query: 214 SVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEP 273
+VL+ICS A R K+ KE KPR DA + GGSLPHP STRFL+YEELKEAT+NFE
Sbjct: 323 TVLVICSRALREEKAPDPHKEAVKPRNLDAGSFGGSLPHPASTRFLSYEELKEATSNFES 382
Query: 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 333
ASILGEGGFG+V++G+L+DGTAVAIK+LT GG QGDKEF VE++MLSRLHHRNLVKLVGY
Sbjct: 383 ASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGY 442
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
YSSRDSSQHLLCYELVPNGSLE+WLHGPLG+NC LDW+TRMKIALDAARGLAYLHEDSQP
Sbjct: 443 YSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRMKIALDAARGLAYLHEDSQP 502
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
VIHRDFKASNILLENNF+AKVADFGLAKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHL
Sbjct: 503 SVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHL 562
Query: 454 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 513
LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW RP+LRDKDRLEEL D RL GKY
Sbjct: 563 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRDKDRLEELVDSRLEGKY 622
Query: 514 PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN-RANLRQX 572
PKEDFIRVCTIAAACVAPEA+QRPTMGEVVQSLKMVQRV+E QDP L +SN R N RQ
Sbjct: 623 PKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQS 682
Query: 573 XXXXXXXXXXXXXXXXPYSGLSAFDNENVSRTAVFSEDLHEGR 615
PYSGLSAFD+EN++RT VFSEDLHEGR
Sbjct: 683 SATFESEVTSSMFSSGPYSGLSAFDHENITRTTVFSEDLHEGR 725
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 940 (336.0 bits), Expect = 5.0e-104, Sum P(3) = 5.0e-104
Identities = 190/308 (61%), Positives = 227/308 (73%)
Query: 251 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK 310
P S + E+ +ATNNF+ + +LGEGGFGRV++GV DGT VA+K L QQG +
Sbjct: 703 PFTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSR 762
Query: 311 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 370
EFL EVEMLSRLHHRNLV L+G D ++ L+ YEL+PNGS+ES LHG + LDW
Sbjct: 763 EFLAEVEMLSRLHHRNLVNLIGI-CIEDRNRSLV-YELIPNGSVESHLHGIDKASSPLDW 820
Query: 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430
+ R+KIAL AARGLAYLHEDS P VIHRDFK+SNILLEN+F KV+DFGLA+ A + N
Sbjct: 821 DARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDN 880
Query: 431 -YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489
++STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP GQENLV+
Sbjct: 881 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVS 940
Query: 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
W RP L + L + D LG + + +V IA+ CV PE + RP MGEVVQ+LK+V
Sbjct: 941 WTRPFLTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQALKLV 1000
Query: 550 QRVIECQD 557
EC +
Sbjct: 1001 SN--ECDE 1006
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.2e-102, Sum P(2) = 3.2e-102
Identities = 188/295 (63%), Positives = 227/295 (76%)
Query: 255 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 314
S + EL++AT+ F +LGEGGFGRV++G + DGT VA+K LT Q D+EF+
Sbjct: 333 SVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIA 392
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
EVEMLSRLHHRNLVKL+G + L YELV NGS+ES LH G LDW+ R+
Sbjct: 393 EVEMLSRLHHRNLVKLIGICI--EGRTRCLIYELVHNGSVESHLHE--GT---LDWDARL 445
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
KIAL AARGLAYLHEDS P VIHRDFKASN+LLE++F KV+DFGLA++A EG + ++ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHIST 504
Query: 435 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494
RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR+PVDMSQPSG+ENLVTWARP+
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564
Query: 495 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
L +++ LE+L DP L G Y +D +V IA+ CV E + RP MGEVVQ+LK++
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 6.4e-85, Sum P(2) = 6.4e-85
Identities = 168/294 (57%), Positives = 209/294 (71%)
Query: 255 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 314
S +YEEL ATN F ++LGEGGFGRV+KGVL D VA+K+L GG QGD+EF
Sbjct: 414 SRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKA 473
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
EV+ +SR+HHRNL+ +VGY S + + LL Y+ VPN +L LH G LDW TR+
Sbjct: 474 EVDTISRVHHRNLLSMVGYCISEN--RRLLIYDYVPNNNLYFHLHAA-GTP-GLDWATRV 529
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
KIA AARGLAYLHED P +IHRD K+SNILLENNFHA V+DFGLAK A + T +++T
Sbjct: 530 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNT-HITT 588
Query: 435 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494
RVMGTFGY+APEYA +G L KSDV+S+GVVLLEL+TGRKPVD SQP G E+LV WARP+
Sbjct: 589 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 648
Query: 495 LRDKDRLEE---LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545
L + EE LADP+LG Y + R+ AAAC+ A +RP M ++V++
Sbjct: 649 LSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRA 702
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 811 (290.5 bits), Expect = 8.2e-85, Sum P(2) = 8.2e-85
Identities = 166/302 (54%), Positives = 215/302 (71%)
Query: 258 FLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVE 317
+ +Y+EL + T+ F ++LGEGGFG V+KGVLSDG VA+K+L GG QG++EF EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 318 MLSRLHHRNLVKLVGYYSSRDSSQH-LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 376
++SR+HHR+LV LVGY S QH LL Y+ VPN +L LH P G + WETR+++
Sbjct: 386 IISRVHHRHLVTLVGYCISE---QHRLLVYDYVPNNTLHYHLHAP-GRPV-MTWETRVRV 440
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 435
A AARG+AYLHED P +IHRD K+SNILL+N+F A VADFGLAK A E N ++STR
Sbjct: 441 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTR 500
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495
VMGTFGY+APEYA +G L K+DVYSYGV+LLEL+TGRKPVD SQP G E+LV WARP+L
Sbjct: 501 VMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLL 560
Query: 496 R---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552
+ + +EL DPRLG + + R+ AAACV A +RP M +VV++L ++
Sbjct: 561 GQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEA 620
Query: 553 IE 554
+
Sbjct: 621 TD 622
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 820 (293.7 bits), Expect = 3.5e-84, Sum P(2) = 3.5e-84
Identities = 170/325 (52%), Positives = 224/325 (68%)
Query: 226 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 285
R ++P +K R+ + G L + S +YEEL +ATN F ++LGEGGFG V
Sbjct: 335 RMQSSAPVGASK-RSGSYQSQSGGLGN--SKALFSYEELVKATNGFSQENLLGEGGFGCV 391
Query: 286 FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345
+KG+L DG VA+K+L GG QGD+EF EVE LSR+HHR+LV +VG+ S D + LL
Sbjct: 392 YKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGD--RRLLI 449
Query: 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405
Y+ V N L LHG V LDW TR+KIA AARGLAYLHED P +IHRD K+SNI
Sbjct: 450 YDYVSNNDLYFHLHGEKSV---LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNI 506
Query: 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 465
LLE+NF A+V+DFGLA+ A + T +++TRV+GTFGY+APEYA +G L KSDV+S+GVV
Sbjct: 507 LLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVV 565
Query: 466 LLELLTGRKPVDMSQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVC 522
LLEL+TGRKPVD SQP G E+LV WARP++ + + + LADP+LGG Y + + R+
Sbjct: 566 LLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMI 625
Query: 523 TIAAACVAPEANQRPTMGEVVQSLK 547
A ACV A +RP MG++V++ +
Sbjct: 626 EAAGACVRHLATKRPRMGQIVRAFE 650
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 2.9e-80, P = 2.9e-80
Identities = 164/309 (53%), Positives = 209/309 (67%)
Query: 260 AYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEM 318
A+ EL AT NF P + LGEGGFGRV+KG L S G VA+K+L G QG++EFLVEV M
Sbjct: 75 AFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLM 134
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
LS LHH NLV L+GY + D Q LL YE +P GSLE LH LDW RMKIA
Sbjct: 135 LSLLHHPNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAA 192
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
AA+GL +LH+ + P VI+RDFK+SNILL+ FH K++DFGLAK P G +++STRVMG
Sbjct: 193 GAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMG 252
Query: 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498
T+GY APEYAMTG L VKSDVYS+GVV LEL+TGRK +D P G++NLV WARP+ D+
Sbjct: 253 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDR 312
Query: 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP 558
+ +LADPRL G++P + +A+ C+ +A RP + +VV +L + + DP
Sbjct: 313 RKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLAN--QAYDP 370
Query: 559 TLTSSN-NR 566
+ S NR
Sbjct: 371 SKDDSRRNR 379
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 764 (274.0 bits), Expect = 2.0e-79, Sum P(2) = 2.0e-79
Identities = 156/290 (53%), Positives = 206/290 (71%)
Query: 261 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLS 320
YEEL ATN F A++LG+GGFG V KGVL G VA+K+L G QG++EF EVE++S
Sbjct: 265 YEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEIIS 324
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 380
R+HHR+LV LVGY + ++ LL YE VPN +LE LHG G ++W TR+KIAL +
Sbjct: 325 RVHHRHLVSLVGYCIA--GAKRLLVYEFVPNNNLELHLHGE-G-RPTMEWSTRLKIALGS 380
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
A+GL+YLHED P +IHRD KASNIL++ F AKVADFGLAK A + T ++STRVMGTF
Sbjct: 381 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMGTF 439
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---D 497
GY+APEYA +G L KSDV+S+GVVLLEL+TGR+PVD + ++LV WARP+L +
Sbjct: 440 GYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASE 499
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ E LAD ++ Y +E+ R+ AAACV A +RP M ++V++L+
Sbjct: 500 QGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 549
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 775 (277.9 bits), Expect = 4.1e-79, Sum P(2) = 4.1e-79
Identities = 156/290 (53%), Positives = 207/290 (71%)
Query: 261 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLS 320
YEEL ATN F A++LG+GGFG V KG+L G VA+K+L G QG++EF EVE++S
Sbjct: 270 YEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIIS 329
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 380
R+HHR+LV L+GY + Q LL YE VPN +LE LHG G ++W TR+KIAL +
Sbjct: 330 RVHHRHLVSLIGYCMA--GVQRLLVYEFVPNNNLEFHLHGK-G-RPTMEWSTRLKIALGS 385
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
A+GL+YLHED P +IHRD KASNIL++ F AKVADFGLAK A + T ++STRVMGTF
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMGTF 444
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---D 497
GY+APEYA +G L KSDV+S+GVVLLEL+TGR+PVD + ++LV WARP+L +
Sbjct: 445 GYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASE 504
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ E LAD ++G +Y +E+ R+ AAACV A +RP M ++V++L+
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 5.4e-79, P = 5.4e-79
Identities = 169/340 (49%), Positives = 217/340 (63%)
Query: 227 KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 286
KS+ P E K TA G H + F + EL AT NF P +LGEGGFGRV+
Sbjct: 44 KSRRGP-EQKKELTAPKE---GPTAHIAAQTF-TFRELAAATKNFRPECLLGEGGFGRVY 98
Query: 287 KGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345
KG L + G VA+K+L G QG++EFLVEV MLS LHH NLV L+GY + D Q LL
Sbjct: 99 KGRLETTGQIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLV 156
Query: 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405
YE +P GSLE LH LDW TRM IA AA+GL YLH+ + P VI+RD K+SNI
Sbjct: 157 YEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 216
Query: 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 465
LL + +H K++DFGLAK P G ++STRVMGT+GY APEYAMTG L +KSDVYS+GVV
Sbjct: 217 LLGDGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 276
Query: 466 LLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIA 525
LEL+TGRK +D ++ G+ NLV WARP+ +D+ + ++ADP L G+YP + +A
Sbjct: 277 FLELITGRKAIDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVA 336
Query: 526 AACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN 565
A C+ +A RP +G+VV +L + + DP S N
Sbjct: 337 AMCLQEQAATRPLIGDVVTALTYLAS--QTFDPNAPSGQN 374
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 615 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-52
Identities = 85/279 (30%), Positives = 122/279 (43%), Gaps = 33/279 (11%)
Query: 275 SILGEGGFGRVFKGVLSD-----GTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLV 328
LGEG FG V+KG L VA+K L +Q +EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
KL+G + + E + G L S+L L + AL ARG+ YL
Sbjct: 65 KLLGV--CTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLE 119
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
S+ IHRD A N L+ N K++DFGL++ + Y ++APE
Sbjct: 120 --SKNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESL 175
Query: 449 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507
G KSDV+S+GV+L E+ T G +P G N L++ RL P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--LKNGYRL-----P 223
Query: 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
+ P + + C A + RPT E+V+ L
Sbjct: 224 Q-----PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 7e-52
Identities = 85/279 (30%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 275 SILGEGGFGRVFKGVLSDG-----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLV 328
LGEG FG V+KG L VA+K L +Q +EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
KL+G + ++ E +P G L +L L + AL ARG+ YL
Sbjct: 65 KLLGV--CTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLE 120
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
S+ IHRD A N L+ N K++DFGL++ + Y ++APE
Sbjct: 121 --SKNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESL 176
Query: 449 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507
G KSDV+S+GV+L E+ T G +P G N L+ RL + +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--LKKGYRLPKPPNC 229
Query: 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
P E + + C A + RPT E+V+ L
Sbjct: 230 ------PPELY----KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 2e-49
Identities = 89/282 (31%), Positives = 131/282 (46%), Gaps = 42/282 (14%)
Query: 277 LGEGGFGRVFKGVL-----SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGEG FG V+KG L T VA+K L G ++ +EFL E ++ +L H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+G + + E +P G L +L L + +++AL A+G+ YL
Sbjct: 67 LGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLE-- 119
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYA 448
S+ +HRD A N L+ N K++DFGL++ E +Y R G ++APE
Sbjct: 120 SKNF-VHRDLAARNCLVTENLVVKISDFGLSRDIYE--DDYYRKRGGGKLPIKWMAPESL 176
Query: 449 MTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLE--EL 504
G KSDV+S+GV+L E+ T G +P MS E ++ L D RL E
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----NEEVLEL----LEDGYRLPRPEN 228
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
L Y + C A + RPT E+V+ L
Sbjct: 229 CPDEL---Y---------ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-49
Identities = 73/197 (37%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLVKLVGYY 334
LGEGGFG V+ G VAIK + E L E+E+L +L+H N+VKL G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
+ L E GSL+ L L + ++I L GL YLH S
Sbjct: 61 EDENH--LYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLH--SNG- 112
Query: 395 VIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
+IHRD K NILL +N K+ADFGL+K L ++GT Y+APE +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 454 L-VKSDVYSYGVVLLEL 469
KSD++S GV+L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 84/278 (30%), Positives = 120/278 (43%), Gaps = 32/278 (11%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLV 328
+E LGEG FG+V+ G VAIK + + D+E L E+++L +L H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
+L + D + L E G L L L + L YLH
Sbjct: 61 RLYDVF--EDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLH 114
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
++HRD K NILL+ + H K+ADFGLA+Q L+T V GT Y+APE
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVL 168
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508
+ D++S GV+L ELLTG+ P G + L+ + I + K P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIGKPK-----PPFPP 218
Query: 509 LGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
E D IR + + +R T E +Q
Sbjct: 219 PEWDISPEAKDLIR------KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-46
Identities = 82/286 (28%), Positives = 123/286 (43%), Gaps = 39/286 (13%)
Query: 276 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 330
LGEG FG V+KG L T VA+K L + + K+FL E ++ +L H N+V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-----LDWETRMKIALDAARGLA 385
+G + + L E + G L +L V L + + A+ A+G+
Sbjct: 62 LGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
YL S+ V HRD A N L+ + K++DFGL++ + T ++AP
Sbjct: 120 YLA--SKKFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLE- 502
E G KSDV+S+GV+L E+ T G P +S LR RL
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGYRLPK 228
Query: 503 -ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
E L Y + +C + RPT E+V+ L+
Sbjct: 229 PEYCPDEL---Y---------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 92/287 (32%), Positives = 128/287 (44%), Gaps = 42/287 (14%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNL 327
+E LG G FG V+K G VA+K L + + D+ E+ +L RL H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
V+L+ + D L E G L +L L + KIAL RGL YL
Sbjct: 61 VRLIDAF--EDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYL 114
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE- 446
H + +IHRD K NILL+ N K+ADFGLAK+ + ++ +T V GT Y+APE
Sbjct: 115 HSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-TTFV-GTPWYMAPEV 169
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506
K DV+S GV+L ELLTG+ P IL + +
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPF-------------SGENILDQLQLIRRILG 216
Query: 507 PRLGGKYPKE--------DFIRVCTIAAACVAPEANQRPTMGEVVQS 545
P L PK D I+ C+ + ++RPT E++Q
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKK------CLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 276 ILGEGGFGRVFKGVLSD-GTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
+LG G FG V+ + D G +A+K L+ ++ + E+ +LS L H N+V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKI-ALDAARGLAYLHE 389
+ + + E V GSL S L G L E ++ GLAYLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-------EPVIRKYTRQILEGLAYLHS 119
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449
+ ++HRD K +NIL++++ K+ADFG AK+ + T + V GT ++APE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 450 TGHLLVKSDVYSYGVVLLELLTGRKP 475
+D++S G ++E+ TG+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 85/286 (29%), Positives = 120/286 (41%), Gaps = 27/286 (9%)
Query: 277 LGEGGFGRVFKG---VLSDGTA--VAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGEG FG+V L D T VA+K L G +Q +F E+E+L L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLH 388
G L E +P+GSL +L H ++ + + + +G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLG 126
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPE 446
IHRD A NIL+E+ K++DFGLAK PE + Y F Y APE
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
T SDV+S+GV L EL T G P + + RL EL
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 506 DPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
G + P+ V + C E RP+ +++ + +
Sbjct: 240 KE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 271 FEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
FE +G+GGFG V+K G VAIK + ++ ++ + E+++L + H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM-KIALDAARGLAYLH 388
G Y +D + E GSL+ L E+++ + + +GL YLH
Sbjct: 62 YYGSYLKKDELW--IVMEFCSGGSLKDLLKS----TNQTLTESQIAYVCKELLKGLEYLH 115
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
+ +IHRD KA+NILL ++ K+ DFGL+ Q + + ++GT ++APE
Sbjct: 116 SNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVI 169
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKP 475
K+D++S G+ +EL G+ P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-32
Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V++G+ ++ T VA+K L G K+FL E +++ +L H L++L Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQL--YAVC 70
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ EL+ GSL +L G G L + +A A G+AYL + I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YI 125
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 454
HRD A N+L+ N KVADFGLA+ E + R F + APE A+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKE---DIYEAREGAKFPIKWTAPEAALYNRFS 182
Query: 455 VKSDVYSYGVVLLELLT-GRKP 475
+KSDV+S+G++L E++T GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 95/313 (30%), Positives = 142/313 (45%), Gaps = 58/313 (18%)
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEV 316
LKE E +LG G FG V+KGV + +G VAIK L + +KE L E
Sbjct: 3 ILKET--ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 317 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETR 373
+++ + H ++V+L+G S SQ L +L+P G L ++ +G L+W +
Sbjct: 61 YVMASVDHPHVVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ 117
Query: 374 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433
+ A+G++YL E ++HRD A N+L++ H K+ DFGLAK Y +
Sbjct: 118 I------AKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA 168
Query: 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 492
++A E + KSDV+SYGV + EL+T G KP + P A
Sbjct: 169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP---------AV 218
Query: 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTI-----AAACVAPEANQRPTMGEVVQSL- 546
I D LE+ G + P+ +CTI C +A RPT E++
Sbjct: 219 EI---PDLLEK------GERLPQPP---ICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266
Query: 547 KMVQRVIECQDPT 559
KM +DP
Sbjct: 267 KM------ARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 74/213 (34%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRN 326
N++ ++G G FG V+KG+ L G VAIK+++ + + K + E+++L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 327 LVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL-DAAR 382
+VK Y S ++S L E NGSL + GP E+ + + + +
Sbjct: 61 IVK---YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-------ESLVAVYVYQVLQ 110
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
GLAYLHE VIHRD KA+NIL + K+ADFG+A + + + S V+GT +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+APE SD++S G ++ELLTG P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 88/351 (25%), Positives = 138/351 (39%), Gaps = 29/351 (8%)
Query: 270 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRL-HHR 325
++ LGEG FG V+ D VA+K L + KE FL E+++L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
N+VKL ++ +D L E V GSLE L + E I L
Sbjct: 59 NIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQILSALE 115
Query: 386 YLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRT----NYLSTRVMGTF 440
YLH +IHRD K NILL + K+ DFGLAK P+ + L + +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 441 GYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
GY+APE + + SD++S G+ L ELLTG P + + + T +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILELP 231
Query: 498 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555
L P K D ++ +A + R + + + ++
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLK------KLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285
Query: 556 QDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAV 606
D + + + + S + S +S SG +++ +
Sbjct: 286 SDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 72/195 (36%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V++G+ + VAIK L ++F EV+ L RL H++L+ L S
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ EL+ GSL ++L P G L + + +A A G+AYL E + I
Sbjct: 74 --GEPVYIITELMEKGSLLAFLRSPEGQV--LPVASLIDMACQVAEGMAYLEEQN---SI 126
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 456
HRD A NIL+ + KVADFGLA+ E YLS+ + + APE A G K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIPYKWTAPEAASHGTFSTK 184
Query: 457 SDVYSYGVVLLELLT 471
SDV+S+G++L E+ T
Sbjct: 185 SDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 83/277 (29%), Positives = 123/277 (44%), Gaps = 35/277 (12%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKE-FLVEVEMLSRLHHRNLVKLVGY 333
+G+G FG V+KGVL T VA+K TC K FL E E+L + H N+VKL+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK--TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
+ ELVP GSL ++L L + ++++LDAA G+ YL
Sbjct: 61 --CVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLE---SK 112
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
IHRD A N L+ N K++DFG++++ G + APE G
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 454 LVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512
+SDV+SYG++L E + G P G N T ++R+E G +
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPY-----PGMSNQQT--------RERIES------GYR 213
Query: 513 YPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 547
P + + C A + RP+ E+ L+
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 71/205 (34%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V+ G + T VA+K L G + FL E +++ +L H LV+L S
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 337 RDSSQHLLCY---ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
+ Y E + GSL +L G L + +A A G+AYL +
Sbjct: 73 EEP-----IYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESRN-- 123
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTG 451
IHRD A NIL+ N K+ADFGLA+ + + + R F + APE A G
Sbjct: 124 -YIHRDLAARNILVGENLVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPEAANYG 179
Query: 452 HLLVKSDVYSYGVVLLELLT-GRKP 475
+KSDV+S+G++L E++T GR P
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
+ +G+G FG V G G VA+K L FL E +++ L H NLV+L+G
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGV- 68
Query: 335 SSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
+ + E + GSL +L G + ++ ALD G+ YL E +
Sbjct: 69 -VLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFALDVCEGMEYLEEKN- 122
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 450
+HRD A N+L+ + AKV+DFGLAK+A +G+ + G + APE
Sbjct: 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-------GKLPVKWTAPEALRE 173
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKP 475
KSDV+S+G++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 74/241 (30%), Positives = 101/241 (41%), Gaps = 54/241 (22%)
Query: 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLV----------EVE 317
++F+ I+GEG F V AIK L DK L+ E E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKE 53
Query: 318 MLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRM 374
+L+RL H ++KL YY+ +D E PNG L ++ G L C TR
Sbjct: 54 VLTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-----TRF 106
Query: 375 KIA--LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------Q 423
A L A L YLH +IHRD K NILL+ + H K+ DFG AK
Sbjct: 107 YAAEILLA---LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 424 APEGRTNYLSTR---------VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK 474
TN S +GT YV+PE SD+++ G ++ ++LTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 475 P 475
P
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 96/282 (34%), Positives = 125/282 (44%), Gaps = 21/282 (7%)
Query: 277 LGEGGFGRVF---KGVLSDGTA--VAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGEG FG+V +DGT VA+K L GQQ + E+ +L L+H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
G S + L E VP GSL +L L+ + A G+AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 447
IHRD A N+LL+N+ K+ DFGLAK PEG Y R G F Y A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWY-AVEC 181
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507
SDV+S+GV L ELLT S P E ++ + + RL EL +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQM-TVVRLIELLER 239
Query: 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
+ PK V + C EA RPT ++ LK +
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 92/304 (30%), Positives = 131/304 (43%), Gaps = 56/304 (18%)
Query: 264 LKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 322
L + T FE ++GEG +G+V+K G VAIK + + ++E E +L +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 323 -HHRNLVKLVGYYSSRDSS----QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 377
+H N+ G + ++ Q L EL GS+ + G L E I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTR 435
+ RGLAYLHE+ VIHRD K NILL N K+ DFG++ Q + GR N
Sbjct: 120 RETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN----T 172
Query: 436 VMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVT 489
+GT ++APE +SDV+S G+ +EL G+ P+ DM P
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPM------- 224
Query: 490 WARP---ILRDKDRLEELADPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMG 540
R I R+ P L K P+ DFI C I QRP M
Sbjct: 225 --RALFKIPRNP-------PPTL--KSPENWSKKFNDFISECLIK------NYEQRPFME 267
Query: 541 EVVQ 544
E+++
Sbjct: 268 ELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRN 326
+FE + +G+G FG VFK V +D A+K+ L+ ++ +E + E +L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 327 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLD--WETRMKIALDAARG 383
+++ YY S L + E NG L L G D W ++I L G
Sbjct: 61 IIR---YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----G 113
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
LA+LH ++HRD K+ N+ L+ + K+ D G+AK + ++GT Y+
Sbjct: 114 LAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYL 168
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503
+PE KSDV++ GVVL E TG+ P D N I+R
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKIIRGV----- 217
Query: 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 537
P + Y ++ + + C+ + QRP
Sbjct: 218 --FPPVSQMYSQQ----LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 55/286 (19%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 333
+G+G FG+V+ SDG +K L+ ++ ++ L EV++L +L+H N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 334 YSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
+ + LC E G L + E + + L YLH
Sbjct: 68 FEEKGK----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE----- 446
++HRD K NI L +N K+ DFG++K + T V GT Y++PE
Sbjct: 124 ---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVV-GTPYYLSPELCQNK 178
Query: 447 -YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
Y KSD++S G VL EL T + P + + L ELA
Sbjct: 179 PYN------YKSDIWSLGCVLYELCTLKHPF--------------------EGENLLELA 212
Query: 506 DPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545
L G+YP + + + + + + +RP++ +++QS
Sbjct: 213 LKILKGQYPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-26
Identities = 75/199 (37%), Positives = 108/199 (54%), Gaps = 14/199 (7%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVG 332
+LG+G FG VFKG L D T VA+K TC Q+ +FL E +L + H N+VKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
+ R + ELVP G S+L L + +K ALDAA G+AYL +S+
Sbjct: 60 VCTQRQPI--YIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYL--ESK 112
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 452
C IHRD A N L+ N K++DFG+++Q +G + + + + APE G
Sbjct: 113 NC-IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGR 170
Query: 453 LLVKSDVYSYGVVLLELLT 471
+SDV+SYG++L E +
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHR 325
+E + +GEG +G+V+K G VA+K++ + + F + E+++L +L H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR--- 382
N+V+L +S+ + +E + + L L P +K +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-----------VKFTESQIKCYM 106
Query: 383 -----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEGRTNYLSTRV 436
GL YLH + ++HRD K SNIL+ N+ K+ADFGLA +Y + RV
Sbjct: 107 KQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRV 162
Query: 437 MGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGR 473
+ T Y PE LL+ + D++S G +L EL G+
Sbjct: 163 I-TLWYRPPE------LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 74/215 (34%), Positives = 108/215 (50%), Gaps = 16/215 (7%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V+ G + T VAIK L G + FL E ++ +L H LV+L Y+
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRL---YAV 69
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ E + NGSL +L P G+ L + +A A G+A++ + I
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNY---I 124
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 454
HRD +A+NIL+ K+ADFGLA+ N + R F + APE G
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 455 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 487
+KSDV+S+G++L E++T GR P M+ P +NL
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 86/280 (30%), Positives = 130/280 (46%), Gaps = 45/280 (16%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKL 330
LG G FG V++G+ L DG A+K ++ GQ+ K+ E+ +LS+L H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR---GLA 385
+G + R+ + ELVP GSL L +G I L + GL
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSF---------PEPVIRLYTRQILLGLE 116
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
YLH+ + +HRD K +NIL++ N K+ADFG+AKQ E + G+ ++AP
Sbjct: 117 YLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAP 170
Query: 446 EYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
E G + +D++S G +LE+ TG KP P Q V I R K+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATG-KP-----PWSQLEGVAAVFKIGRSKELPPIP 224
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
K DFI C+ + + RPT E+++
Sbjct: 225 DHLSDEAK----DFILK------CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 89/294 (30%), Positives = 128/294 (43%), Gaps = 37/294 (12%)
Query: 275 SILGEGGFGRVFK---GVLSDGTA--VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
LG+G FG V L D T VA+K+L + ++F E+E+L L H N+VK
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLH 388
G S L E +P GSL +L + LD + A +G+ YL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYL- 124
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAP 445
S+ V HRD NIL+E+ K+ DFGL K P+ + Y R G F Y AP
Sbjct: 125 -GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-AP 180
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT----GRKP----VDMSQPSGQENLVTWAR-PILR 496
E V SDV+S+GVVL EL T P + M Q ++ + +L+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240
Query: 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550
+ RL P G P E + I C + +QRP+ E+ ++ ++
Sbjct: 241 NNGRL-----PAPPG-CPAE----IYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 81/262 (30%), Positives = 114/262 (43%), Gaps = 21/262 (8%)
Query: 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRN 326
S LGEG G V K L + G A+K +T K+ L E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+VK G + SS + E GSL+S + + KIA +GL+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446
LH +IHRD K SNILL K+ DFG++ + N L+ GT Y+APE
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL----VNSLAGTFTGTSFYMAPE 173
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKPV--DMSQPSGQENLVTW--ARPILRDKDRLE 502
+ SDV+S G+ LLE+ R P + P G L+++ P KD
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD--- 230
Query: 503 ELADPRLGGKYPKE--DFIRVC 522
+P G K+ +E DFI+ C
Sbjct: 231 ---EPGNGIKWSEEFKDFIKQC 249
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 87/285 (30%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 277 LGEGGFGRVFKGV--LSDGT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLV 331
LG G FG V KGV + G VA+K L G KEFL E ++++L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 332 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH--LDWETRMKIALDAARGLAYLHE 389
G +L EL P G L +L + + A A G+AYL
Sbjct: 63 GVCKG---EPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES 113
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-----YVA 444
+HRD A N+LL N AK++DFG+++ G Y +T T G + A
Sbjct: 114 KH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENLVTWARPILRDKDRLE 502
PE G KSDV+SYGV L E + G KP +M G E +L +RL
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAE-----VIAMLESGERLP 218
Query: 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
P+E + +I +C RPT E+ + +
Sbjct: 219 R----------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 73/202 (36%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG+G FG V+ G + T VAIK L G + FL E +++ +L H LV+L Y+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 69
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ E + GSL +L G +G +L + +A A G+AY+ + +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 124
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 454
HRD +A+NIL+ N KVADFGLA+ + N + R F + APE A+ G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 455 VKSDVYSYGVVLLELLT-GRKP 475
+KSDV+S+G++L EL T GR P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 70/221 (31%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 277 LGEGGFGRVFKGVLS------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVK 329
LGEG FG+VF G D VA+K L K+F E E+L+ H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-------LGVNC-HLDWETRMKIALD 379
G + + ++ +E + +G L +L HGP L ++IA+
Sbjct: 73 FYGVCT--EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
A G+ YL SQ V HRD N L+ + K+ DFG+++ T+Y RV G
Sbjct: 131 IASGMVYL--ASQHFV-HRDLATRNCLVGYDLVVKIGDFGMSRDVYT--TDYY--RVGGH 183
Query: 440 ----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
++ PE M +SDV+S+GVVL E+ T G++P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V+ G + T VA+K L G + FL E +++ +L H LV+L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ E + GSL +L G L M A A G+AY+ + I
Sbjct: 73 EPI---YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYIERMN---YI 124
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 454
HRD +++NIL+ + K+ADFGLA+ + N + R F + APE A+ G
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 455 VKSDVYSYGVVLLELLT-GRKP 475
+KSDV+S+G++L EL+T GR P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 82/283 (28%), Positives = 122/283 (43%), Gaps = 43/283 (15%)
Query: 277 LGEGGFGRVFKGVLSDGTA----VAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLV 331
LG+G FG V +G S VA+K L +FL E ++ L H NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 332 GYYSSRDSSQHLLCYELVPNGSLESWLH----GPLGVNCHLDWETRMKIALDAARGLAYL 387
G ++ EL P GSL L G ++ D+ A+ A G+ YL
Sbjct: 63 GVV--LTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYL 113
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST---RVMGTFGYVA 444
S+ IHRD A NILL ++ K+ DFGL + P+ +Y+ +V F + A
Sbjct: 114 E--SKRF-IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503
PE T SDV+ +GV L E+ T G +P + SG + L + I ++ +RLE
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQIL----KKIDKEGERLER 222
Query: 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
P+ + + C A RPT + + L
Sbjct: 223 ----------PEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 86/273 (31%), Positives = 132/273 (48%), Gaps = 33/273 (12%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG+G FG V+ G + T VAIK L G + FL E +++ +L H LV L Y+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPL---YAV 69
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ E + GSL +L G +L + +A A G+AY+ + I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERMN---YI 124
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 454
HRD +A+NIL+ +N K+ADFGLA+ + N + R F + APE A+ G
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 455 VKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 513
+KSDV+S+G++L EL+T GR P G N R +L +R + P+ G
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPY-----PGMVN-----REVLEQVERGYRMPCPQ-GCPE 230
Query: 514 PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
+ +++C + ++RPT E +QS
Sbjct: 231 SLHELMKLCW------KKDPDERPTF-EYIQSF 256
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 58/296 (19%)
Query: 277 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 329
LG+G FG V++G+ T VAIK + ++ EFL E ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHL----DWETRMKIALDAARG 383
L+G S L+ EL+ G L+S+L P N + +++A + A G
Sbjct: 74 LLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY--------LSTR 435
+AYL +HRD A N ++ + K+ DFG+ + E T+Y L R
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 186
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTWARPI 494
M APE G KSDV+S+GVVL E+ T QP G N
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMATL-----AEQPYQGLSN-------- 227
Query: 495 LRDKDRLEELADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
EE+ + G + P+ ++ + C RPT E+V SLK
Sbjct: 228 -------EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 49/285 (17%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 333
+G G FG+V+ V L G +A+K R+ + KE E+++L L H NLVK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
R+ + + E G+LE L G LD L GLAYLH
Sbjct: 68 EVHRE--KVYIFMEYCSGGTLEELLEH--GRI--LDEHVIRVYTLQLLEGLAYLHSHG-- 119
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPE---YA 448
++HRD K +NI L++N K+ DFG A + T + GT Y+APE
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA---------RPILRDKD 499
+D++S G V+LE+ TG++P S +N + +P + D
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW-----SELDN--EFQIMFHVGAGHKPPIPDSL 231
Query: 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+L +DF+ C + + +RPT E++Q
Sbjct: 232 QLSPEG----------KDFLDRCLES------DPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 37/285 (12%)
Query: 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRN 326
++ E +LG+G G V+K G A+K++ G + K+ L E++ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 327 LVKLVG-YYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 383
+VK G +Y + S + E + GSL L G + IA +G
Sbjct: 61 VVKCYGAFYKEGEIS---IVLEYMDGGSLADLLKKVGKIPEPV------LAYIARQILKG 111
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
L YLH +IHRD K SN+L+ + K+ADFG++K + +GT Y+
Sbjct: 112 LDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYM 167
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503
+PE +D++S G+ LLE G+ P P GQ + + I
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFELMQAICDG------ 218
Query: 504 LADPRL-GGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS 545
P L ++ E DFI +AC+ + +RP+ E++Q
Sbjct: 219 -PPPSLPAEEFSPEFRDFI------SACLQKDPKKRPSAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 276 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 330
++G G FG V +G L VAIK L G + +FL E ++ + H N+++L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
G + S ++ E + NGSL+ +L G + + A G+ YL
Sbjct: 71 EGVVTK--SRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYL--- 122
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 450
S+ +HRD A NIL+ +N KV+DFGL+++ + Y + + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 479
SDV+S+G+V+ E+++ G +P DMS
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 81/265 (30%), Positives = 126/265 (47%), Gaps = 32/265 (12%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRN 326
++ E LG G G V K + G +A+K + + K+ L E+++L + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 327 LVKLVG-YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
+V G +Y++ D S +C E + GSL+ L G + KIA+ +GL
Sbjct: 61 IVGFYGAFYNNGDIS---ICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLT 114
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
YLHE + +IHRD K SNIL+ + K+ DFG++ Q N L+ +GT Y+AP
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFVGTSSYMAP 168
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
E VKSD++S G+ L+EL TGR P P + L+ +
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFELLQYIV 217
Query: 506 D---PRL-GGKYPKE--DFIRVCTI 524
+ PRL GK+ + DF+ +C I
Sbjct: 218 NEPPPRLPSGKFSPDFQDFVNLCLI 242
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 270 NFEPASILGEGGFGRVFKGVLSD-GTAVAIK---RLTCGGQQGDKEFLVEVEMLSRLHHR 325
+FE ++G+G FG+V D A+K + C + + L E +L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGL 384
LV L +YS +D L +L+ G L H L E ++K + L
Sbjct: 61 FLVNL--WYSFQDEENMYLVVDLLLGGDLR--YH--LSQKVKFS-EEQVKFWICEIVLAL 113
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
YLH +IHRD K NILL+ H + DF +A + L+T GT GY+A
Sbjct: 114 EYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMA 167
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
PE V D +S GV E L G++P
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 70/204 (34%), Positives = 110/204 (53%), Gaps = 21/204 (10%)
Query: 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
I+GEG FG V +G + G VA+K + C + FL E ++++LHH+NLV+L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 335 SSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
+ +++ EL+ G+L ++L G V+ ++ +LD A G+ YL
Sbjct: 69 --LHNGLYIV-MELMSKGNLVNFLRTRGRALVSV----IQLLQFSLDVAEGMEYLESKK- 120
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 452
++HRD A NIL+ + AKV+DFGLA+ G N +++ + APE
Sbjct: 121 --LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN---SKL--PVKWTAPEALKHKK 173
Query: 453 LLVKSDVYSYGVVLLELLT-GRKP 475
KSDV+SYGV+L E+ + GR P
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
+G G FG V+ G + VAIK + G +++F+ E +++ +L H LV+L G +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
R S L +E + +G L +L G ET + + LD G+AYL VI
Sbjct: 71 R--SPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESS---NVI 122
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 456
HRD A N L+ N KV+DFG+ + + + ST + +PE K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSK 181
Query: 457 SDVYSYGVVLLELLT-GRKPVD 477
SDV+S+GV++ E+ + G+ P +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 84/315 (26%), Positives = 128/315 (40%), Gaps = 70/315 (22%)
Query: 269 NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH 323
N +E ++GEG +G V K + G VAIK+ + D++ L EV++L +L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK--ESEDDEDVKKTALREVKVLRQLR 58
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
H N+V L + + + L +E V LE P G L + +
Sbjct: 59 HENIVNLKEAFRRKG--RLYLVFEYVERTLLELLEASPGG----LPPDAVRSYIWQLLQA 112
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR----TNYLSTRVMGT 439
+AY H + +IHRD K NIL+ + K+ DFG A+ T+Y++TR
Sbjct: 113 IAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---- 165
Query: 440 FGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV-----DMSQ------- 480
Y APE LLV DV++ G ++ ELL G P+ D+ Q
Sbjct: 166 -WYRAPE------LLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKC 217
Query: 481 -----PSGQENLVTWAR------PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACV 529
PS QE + R P + LE +YP + AC+
Sbjct: 218 LGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER--------RYPGKVSSPALDFLKACL 269
Query: 530 APEANQRPTMGEVVQ 544
+ +R T E++Q
Sbjct: 270 RMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 67/298 (22%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
+E +G G +G V+K ++ G VAIK + + E+ ML H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRMKIAL---DAARG 383
G Y RD + + E GSL+ GPL + ++IA + +G
Sbjct: 65 YFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPL---------SELQIAYVCRETLKG 113
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFG 441
LAYLHE IHRD K +NILL + K+ADFG++ Q T ++ R +GT
Sbjct: 114 LAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPY 166
Query: 442 YVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVD----------MSQPSGQENLV 488
++APE A G K D+++ G+ +EL + P+ +S+ +
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--- 223
Query: 489 TWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
P L+DK+ K+ DFI+ C + +RPT +++Q
Sbjct: 224 ----PKLKDKE------------KWSPVFHDFIKKCLTK------DPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 326
N E +GEG G V+K + G VAIK++ Q KE ++ E+ ++ H N
Sbjct: 22 KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPN 76
Query: 327 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL-HGPLGVNCHLDWETRMK-IALDAARG 383
+V Y D L + E + GSL + + +N E ++ + + +G
Sbjct: 77 IVDYYDSYLVGD---ELWVVMEYMDGGSLTDIITQNFVRMN-----EPQIAYVCREVLQG 128
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
L YLH SQ IHRD K+ NILL + K+ADFG A Q + ++ S V+GT ++
Sbjct: 129 LEYLH--SQNV-IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWM 183
Query: 444 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
APE Y K D++S G++ +E+ G P
Sbjct: 184 APEVIKRKDYGP------KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 78/279 (27%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
F+ LGEG +G V+K + G VAIK + +E + E+ +L + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 330 LVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
YY S + L + E GS+ + N L E I +GL YLH
Sbjct: 63 ---YYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
+ IHRD KA NILL AK+ADFG++ Q + T V+GT ++APE
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVI 171
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEELADP 507
K+D++S G+ +E+ G+ P P ++ P L DP
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS---------DP 222
Query: 508 RLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
K+ E DF++ C + + +RP+ +++Q
Sbjct: 223 ---EKWSPEFNDFVKKCLVK------DPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 7e-22
Identities = 83/266 (31%), Positives = 117/266 (43%), Gaps = 63/266 (23%)
Query: 277 LGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKEFLV---EVEM-------LSRLHH 324
LG+G FG+V V G A+K L K+ ++ EVE LSR++H
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINH 52
Query: 325 RNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMK-----I 376
+VKL +Y+ + L L E P G L S L G E R + I
Sbjct: 53 PFIVKL--HYAFQTEE-KLYLVLEYAPGGELFSHLSKEGRFS-------EERARFYAAEI 102
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
L L YLH +I+RD K NILL+ + H K+ DFGLAK+ + +T
Sbjct: 103 VL----ALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFC 154
Query: 437 MGTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494
GT Y+APE + G+ K+ D +S GV+L E+LTG+ P ++ + + I
Sbjct: 155 -GTPEYLAPEVLLGKGY--GKAVDWWSLGVLLYEMLTGKPPFY-----AEDRKEIYEK-I 205
Query: 495 LRDKDRLEELADPRLGGKYPKEDFIR 520
L+D R E P D I
Sbjct: 206 LKDPLRFPEFLSPEA------RDLIS 225
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 43/286 (15%)
Query: 270 NFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHRN 326
+F+ LG+G +G V+K LSD A+K + G Q ++E V E+ +L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 327 LVKLVGYY-SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
++ Y + D ++ + E P G L + + + +I + RGL
Sbjct: 61 II---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
LHE ++HRD K++NILL N K+ D G++K ++ +GT Y+AP
Sbjct: 118 ALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAP 170
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
E KSD++S G +L E+ T P + AR +++L
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARS-------MQDLR 210
Query: 506 DPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545
GKYP +D + + + RP +++ S
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 61/217 (28%), Positives = 114/217 (52%), Gaps = 30/217 (13%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRL----TCGGQQGDKEFLV------EVEMLSRLHH 324
++G+G +GRV+ + ++ G +A+K++ T G+ ++ + E+E L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 325 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL--DA 380
N+V+ +G+ ++ + L E VP GS+ S L +G +E ++
Sbjct: 68 LNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGR--------FEEQLVRFFTEQV 117
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
GLAYLH ++HRD KA N+L++ + K++DFG++K++ + N + + G+
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 441 GYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKP 475
++APE + K D++S G V+LE+ GR+P
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 44/289 (15%)
Query: 277 LGEGGFGRVFKGVLS--DGTA----VAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVK 329
LG G FG V++G+ DG A VA+K L +Q + +FL+E ++S+ +H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-CHLDWETRMKIALDAARGLAY 386
L+G S + + EL+ G L+S+L P L + + A D A+G Y
Sbjct: 74 LIGV--SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 387 LHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLST--RVMGTFG 441
L E+ IHRD A N LL AK+ADFG+A+ R +Y R M
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPIK 186
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500
++ PE + G K+DV+S+GV+L E+ + G P P +++
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----------------PGRTNQEV 230
Query: 501 LEELADPRLGGK--YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+E + GG+ PK V I C RP +++ ++
Sbjct: 231 MEFVT---GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 277 LGEGGFGRVFKGVL------SDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 328
LGEG FG+V+KG L T+VAIK L + EF E E++S L H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-EFRQEAELMSDLQHPNIV 71
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPL-GVNCHLDWETRMK---------I 376
L+G + + L +E + +G L +L + P V ET I
Sbjct: 72 CLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
A+ A G+ YL S +HRD A N L+ K++DFGL++ + ++
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 437 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ ++ PE + G +SD++S+GVVL E+ + G +P
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 277 LGEGGFGRVF------KGVLSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVK 329
LGEG FG+V +G + G VA+K L G + E+E+L L+H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389
G + + L E +P+GSL+ +L P N ++ + ++K A+ +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN-KINLKQQLKYAVQICKGMDYLGS 127
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTFGYVAPEY 447
+HRD A N+L+E+ K+ DFGL K + + F Y APE
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 448 AMTGHLLVKSDVYSYGVVLLELLT 471
+ + SDV+S+GV L ELLT
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 280 GGFGRVF---KGVLSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGY 333
G +GRVF K S G AIK + + L E ++LS+ +VKL Y
Sbjct: 4 GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--Y 59
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
YS + L E +P G L S L V LD + + L YLH +
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLEN---VGS-LDEDVARIYIAEIVLALEYLHSNG-- 113
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS------TRVMGTFGYVAPEY 447
+IHRD K NIL+++N H K+ DFGL+K R L+ R++GT Y+APE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 448 AMTGHLLVKS-----DVYSYGVVLLELLTGRKP 475
+L + D +S G +L E L G P
Sbjct: 173 -----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 86/306 (28%), Positives = 137/306 (44%), Gaps = 52/306 (16%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHR 325
+E ++GEG +G V K + G VAIK+ K + E+ ML +L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
NLV L+ + R + L +E V + L+ P G LD K RG+
Sbjct: 61 NLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIE 114
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAP-EGRTNYLSTRVMGTFGY 442
+ H + +IHRD K NIL+ + K+ DFG A+ AP E T+Y++TR Y
Sbjct: 115 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WY 166
Query: 443 VAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV-----DMSQ----PSGQEN 486
APE LLV D+++ G ++ E+LTG +P+ D+ Q N
Sbjct: 167 RAPE------LLVGDTKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGN 219
Query: 487 LVTWARPILRDKD------RLEELADPR-LGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539
L+ + I K+ RL E+ + L ++PK + V +A C+ + + RP+
Sbjct: 220 LIPRHQEIF-QKNPLFAGMRLPEVKEIEPLEKRFPKLSGL-VLDLAKQCLRIDPDDRPSS 277
Query: 540 GEVVQS 545
+++
Sbjct: 278 SQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V G VAIK + G D +F+ E +++ +L H NLV+L G +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ + E + NG L ++L G L E + + D + YL + I
Sbjct: 71 Q--RPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLESN---GFI 122
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGHL 453
HRD A N L+ + KV+DFGLA+ + + Y S+ GT + PE
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSS--QGTKFPVKWAPPEVFDYSRF 178
Query: 454 LVKSDVYSYGVVLLELLTGRK 474
KSDV+S+GV++ E+ + K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 74/222 (33%), Positives = 113/222 (50%), Gaps = 29/222 (13%)
Query: 269 NNFEPASILGEGGFGRVFKG-VLSDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-H 323
N+ + ++GEG FG+V K + DG + AIKR+ + D ++F E+E+L +L H
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-------GPLGVNCH-----LDWE 371
H N++ L+G R L E P+G+L +L P + L +
Sbjct: 67 HPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431
+ A D ARG+ YL SQ IHRD A NIL+ N+ AK+ADFGL++ G+ Y
Sbjct: 125 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 177
Query: 432 LSTRVMGTFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
+ + MG ++A E SDV+SYGV+L E+++
Sbjct: 178 VK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT-CGGQQGDKEFLV-----EVEMLSRL 322
+ LG G F ++ + GT +A+K++T ++E +V E+ +++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 380
+H ++++++G ++ + S L E + GS+ L G +
Sbjct: 61 NHPHIIRMLG--ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA------VIINYTEQL 112
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQ--APEGRTNYLSTRVM 437
RGL+YLHE+ +IHRD K +N+L+++ ++ADFG A + A +++
Sbjct: 113 LRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GT ++APE DV+S G V++E+ T + P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 27/280 (9%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYY 334
LG G G V K + GT +A K + G + K+ L E++++ H +V +Y
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM---HECRSPYIVSFY 69
Query: 335 SSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
+ + ++ +C E + GSL+ GP+ V E KIA+ GL YL+
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV------EILGKIAVAVVEGLTYLYNVH 123
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 451
+ ++HRD K SNIL+ + K+ DFG++ + N ++ +GT Y++PE G
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGEL----INSIADTFVGTSTYMSPERIQGG 177
Query: 452 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 511
VKSDV+S G+ ++EL G+ P S IL ++ + PRL
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG--ILDLLQQIVQEPPPRL-- 233
Query: 512 KYPKEDFIRVCT-IAAACVAPEANQRPTMGEVVQSLKMVQ 550
P DF AC+ + +RPT ++ +Q
Sbjct: 234 --PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 79/289 (27%), Positives = 117/289 (40%), Gaps = 41/289 (14%)
Query: 277 LGEGGFGRVFKG------VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGEG FG+VF D VA+K L K+F E E+L+ L H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGP----------LGVNCHLDWETRMKIAL 378
G D ++ +E + +G L +L HGP L + IA
Sbjct: 73 YGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
A G+ YL +HRD N L+ N K+ DFG+++ + M
Sbjct: 131 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 497
++ PE M +SDV+S+GV+L E+ T G++P + +T R + R
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER- 246
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
PR+ PKE V I C E QR + E+ + L
Sbjct: 247 ---------PRV---CPKE----VYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 76/224 (33%), Positives = 112/224 (50%), Gaps = 36/224 (16%)
Query: 276 ILGEGGFGRVFKG----VLSDGTA---VAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNL 327
LG G FG V++G +L G+ VA+K L G Q KEFL E ++S +H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--------PLGVNCHLDWETRMKIALD 379
VKL+G + ++ EL+ G L S+L PL L + + I LD
Sbjct: 62 VKLLGVCLLNEPQYIIM--ELMEGGDLLSYLRDARVERFGPPL-----LTLKELLDICLD 114
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHA----KVADFGLAKQAPEGRTNYLST 434
A+G YL E IHRD A N L+ E + A K+ DFGLA+ +++Y
Sbjct: 115 VAKGCVYL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRK 169
Query: 435 RVMGTFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
G ++APE + G +SDV+S+GV++ E+LT G++P
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 19/221 (8%)
Query: 261 YEELKEATNNFEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGG-QQGDKEFLV-EV 316
YE L+ +G+G FG V K V SDG + K + G + +K+ LV EV
Sbjct: 2 YEVLET----------IGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV 50
Query: 317 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 376
+L L H N+V+ R + + E G L + +++ E +I
Sbjct: 51 NILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110
Query: 377 ALDAARGLAYLH--EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
L H D V+HRD K +NI L+ N + K+ DFGLAK G + +
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAK 168
Query: 435 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+GT Y++PE KSD++S G ++ EL P
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 48/237 (20%)
Query: 267 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEMLS 320
++E LGEG FG V+K + G VA+K++ +K+ F L E+++L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILK 62
Query: 321 RLHHRNLVKLVGY---YSSRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHL---DWET 372
+L H N+V L+ + + Y + P + L L P + L +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKC 119
Query: 373 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------- 422
M L+ G+ YLHE+ ++HRD KA+NIL++N K+ADFGLA+
Sbjct: 120 YMLQLLE---GINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 423 -QAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGR 473
G Y T ++ T Y PE + T + D++ G V E+ T R
Sbjct: 174 GGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V+ G ++ T VA+K L G + FL E ++ L H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ + E + GSL +L G L + + A G+AY+ + I
Sbjct: 73 EEPI--YIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---YI 125
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 454
HRD +A+N+L+ + K+ADFGLA+ + N + R F + APE G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 455 VKSDVYSYGVVLLELLT-GRKP 475
+KSDV+S+G++L E++T G+ P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 43/225 (19%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 323
+E LGEG + V+K G VAIK++ G ++ K+ L E+++L L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLE------SWLHGPLGVNCHLDWETRMKIA 377
H N++ L+ + + + L +E + LE S + P + + M +
Sbjct: 61 HPNIIGLLDVFGHKSNIN--LVFEFME-TDLEKVIKDKSIVLTPADIKSY------MLMT 111
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
L RGL YLH + ++HRD K +N+L+ ++ K+ADFGLA+ + +V+
Sbjct: 112 L---RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV 164
Query: 438 GTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKP 475
T Y APE LL + D++S G + ELL R P
Sbjct: 165 -TRWYRAPE------LLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 94/332 (28%), Positives = 145/332 (43%), Gaps = 52/332 (15%)
Query: 257 RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAV----AIKRLT-CGGQQGDK 310
R L ELK +LG G FG V+KG+ + +G V AIK L G + +
Sbjct: 2 RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54
Query: 311 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 367
EF+ E +++ + H +LV+L+G S L +L+P+G L ++H +G
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLDYVHEHKDNIGSQLL 111
Query: 368 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427
L+W + A+G+ YL E ++HRD A N+L+++ H K+ DFGLA+
Sbjct: 112 LNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162
Query: 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 486
Y + ++A E +SDV+SYGV + EL+T G KP D
Sbjct: 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------G 214
Query: 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
+ T P L +K E L P + I V + C +A+ RP E+
Sbjct: 215 IPTREIPDLLEKG--ERLPQPPICT-------IDVYMVMVKCWMIDADSRPKFKELAAEF 265
Query: 547 KMVQR------VIECQDPTLTSSNNRANLRQS 572
+ R VI+ D S N + Q+
Sbjct: 266 SRMARDPQRYLVIQGDDRMKLPSPNDSKFFQN 297
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-20
Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 277 LGEGGFGRVFKGVL-SDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 333
+G G FG VF G L +D T VA+K R T K FL E +L + H N+V+L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
+ + + ELV G ++L GP L + +++ +AA G+ YL
Sbjct: 62 CTQKQPI--YIVMELVQGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK- 113
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 449
IHRD A N L+ K++DFG++++ +G Y ST M + APE
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEALN 169
Query: 450 TGHLLVKSDVYSYGVVLLE 468
G +SDV+S+G++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 27/214 (12%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRL---TCGGQQGDKEFLV---EVEMLSRLHHRNLVK 329
+LG+G +G V+ G+ + G +A+K++ T +KE+ EV++L L H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLG--VNCHLDWETRMKIALDAARGLA 385
+G + D + + E VP GS+ S L+ GPL V C K G+A
Sbjct: 67 YLG--TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC--------KYTKQILDGVA 116
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ----APEGRTNYLSTRVMGTFG 441
YLH + CV+HRD K +N++L N K+ DFG A++ G + + + GT
Sbjct: 117 YLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
++APE KSD++S G + E+ TG+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 73/236 (30%), Positives = 109/236 (46%), Gaps = 32/236 (13%)
Query: 277 LGEGGFGRVFK-GVLSDGTAVAIKRL-----TCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
LG GGFGRV V S A+K + GQQ + E E+L +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 331 VGYYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYL 387
+ +D +++ + E G L + L G ++ R IA YL
Sbjct: 59 YRTF--KDK-KYIYMLMEYCLGGELWTILRDRGLFD-----EYTARFYIAC-VVLAFEYL 109
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
H +I+RD K N+LL++N + K+ DFG AK+ G+ + T GT YVAPE
Sbjct: 110 HNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEI 163
Query: 448 AMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502
+ G+ D +S G++L ELLTGR P ++ + + IL+ +LE
Sbjct: 164 ILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDD---EDPMEIYND-ILKGNGKLE 214
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 24/216 (11%)
Query: 276 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 330
++G G FG VF+G+L AVAIK L G ++ ++FL E ++ + H N+++L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL--DAARGLAYLH 388
G + + ++ E + NG+L+ +L G ++ + + + A G+ YL
Sbjct: 72 EGVVTKFKPA--MIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLS 124
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAP 445
+ + +HRD A NIL+ +N KV+DFGL++ PEG Y ++ + AP
Sbjct: 125 DMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAP 179
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 479
E SDV+S+G+V+ E+++ G +P DMS
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 80/305 (26%), Positives = 133/305 (43%), Gaps = 46/305 (15%)
Query: 257 RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTA----VAIKRLT-CGGQQGDK 310
R L EL++ +LG G FG V KG+ + +G + VAIK + G+Q +
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 311 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 367
E + + L H +V+L+G + L +L P GSL + L
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 368 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427
L+W + A+G+ YL E ++HR+ A NILL+++ ++ADFG+A
Sbjct: 112 LNW------CVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
Query: 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 486
Y + ++A E + G +SDV+SYGV + E+++ G +P +P +
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
Query: 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
L+ ++ E LA P++ I V + C + N RPT E+
Sbjct: 223 LL----------EKGERLAQPQICT-------IDVYMVMVKCWMIDENVRPTFKELANEF 265
Query: 547 KMVQR 551
+ R
Sbjct: 266 TRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+G+G FG V G G VA+K + + FL E ++++L H NLV+L+G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+++ E + GSL +L G + L + +K +LD + YL ++
Sbjct: 70 EEKGGLYIVT-EYMAKGSLVDYLRSR-GRSV-LGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGR-TNYLSTRVMGTFGYVAPEYAMTGHLL 454
+HRD A N+L+ + AKV+DFGL K+A + T L + + APE
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 177
Query: 455 VKSDVYSYGVVLLELLT-GRKP 475
KSDV+S+G++L E+ + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 75/252 (29%), Positives = 110/252 (43%), Gaps = 25/252 (9%)
Query: 277 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGEG FG+VF D VA+K L K+F E E+L+ L H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGV-------NCHLDWETRMKIALDAA 381
G D ++ +E + +G L +L HGP V L + IA A
Sbjct: 73 YGVCVEGDPL--IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
G+ YL +HRD N L+ N K+ DFG+++ + M
Sbjct: 131 AGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENL--VTWARPILRDK 498
++ PE M +SDV+S GVVL E+ T G++P Q S E + +T R + R +
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSNNEVIECITQGRVLQRPR 245
Query: 499 DRLEELADPRLG 510
+E+ D LG
Sbjct: 246 TCPKEVYDLMLG 257
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 276 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 330
++G G FG V +G L VAIK L G ++ ++FL E ++ + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
G + S ++ E + NG+L+S+L G + ++ A G+ YL E
Sbjct: 71 EGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM 125
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 447
+ +HRD A NIL+ +N KV+DFGL++ + ++ T +G + APE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 448 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 479
SDV+SYG+V+ E+++ G +P DMS
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 84/285 (29%), Positives = 130/285 (45%), Gaps = 35/285 (12%)
Query: 276 ILGEGGFGRVFKGVLS--DGTA--VAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
ILGEG FG V +G LS DG+ VA+K +L +EFL E + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 330 LVGY-YSSRDSSQ---HLLCYELVPNGSLESWL-HGPLGVNC-HLDWETRMKIALDAARG 383
L+G + + + ++ + +G L S+L + LG L +T +K +D A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGY 442
+ YL S IHRD A N +L + VADFGL+K+ G Y R+ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVKW 181
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501
+A E KSDV+++GV + E+ T G+ P G EN + LR +RL
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY-----PGVENHEIYD--YLRHGNRL 234
Query: 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
K P++ + + +C + RPT ++ + L
Sbjct: 235 ----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 78/312 (25%), Positives = 130/312 (41%), Gaps = 52/312 (16%)
Query: 270 NFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL 322
N LGEG FG+V K + T VA+K L + ++ L E +L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-----GPLGVNCHLDWETR---- 373
+H +++KL G S LL E GSL S+L GP + + +
Sbjct: 61 NHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 374 -----------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422
+ A +RG+ YL E ++HRD A N+L+ K++DFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 481
E + ++ ++A E +SDV+S+GV+L E++T G P P
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 541
E L +L+ R+E P+ + + C E ++RPT +
Sbjct: 236 ---ERLFN----LLKTGYRMER----------PENCSEEMYNLMLTCWKQEPDKRPTFAD 278
Query: 542 VVQSLK--MVQR 551
+ + L+ MV+
Sbjct: 279 ISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 23/227 (10%)
Query: 270 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLH 323
++ P +LG+G FG + L D + V K LT ++ ++ L E+ +LS L
Sbjct: 1 HYIPIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57
Query: 324 HRNLVKLVGYYSSRDSSQHLLC-YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
H N++ YY+ LL E G+L + G + E +
Sbjct: 58 HPNII---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ--LFEEEMVLWYLFQIVS 112
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
++Y+H+ ++HRD K NI L K+ DFG++K G ++ V+GT Y
Sbjct: 113 AVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYY 167
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489
++PE KSD+++ G VL ELLT ++ D + P NLV
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 38/228 (16%)
Query: 275 SILGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKE-------FLVEVEMLSRLHH 324
+++G G FG V+ G+ S G +A+K+ L E+ +L L H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 325 RNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMK-IALDA 380
N+V+ Y S + HL + E VP GS+ + L +G ET ++
Sbjct: 66 ENIVQ---YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE-------ETLVRNFVRQI 115
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR----- 435
+GL YLH +IHRD K +NIL++N K++DFG++K+ N LST+
Sbjct: 116 LKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGAR 169
Query: 436 --VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQ 480
+ G+ ++APE K+D++S G +++E+LTG+ P D +Q
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 37/212 (17%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 333
+GEG +G V+K G VAIK++ + K L E+++L L+H N++KL+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 334 YSSRDSSQHLLC-------YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+ + +L+ Y+L+ + P + ++ +GLA+
Sbjct: 67 FRHKGDL-YLVFEFMDTDLYKLIKDRQR----GLPESLIKSYLYQL--------LQGLAF 113
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGR--TNYLSTRVMGTFGYV 443
H ++HRD K N+L+ K+ADFGLA+ R T+Y+ TR Y
Sbjct: 114 CHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYR 165
Query: 444 APE--YAMTGHLLVKSDVYSYGVVLLELLTGR 473
APE G+ D++S G + ELL+ R
Sbjct: 166 APELLLGDKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 322
N+ +LG+G FGRV+ D G +A+K++ + + V E+++L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALD 379
H +V+ YY + L + E +P GS++ L +G L TR K
Sbjct: 62 QHERIVQ---YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV-----TR-KYTRQ 112
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVM 437
G+ YLH + ++HRD K +NIL ++ + K+ DFG +K Q + + V
Sbjct: 113 ILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VT 168
Query: 438 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKP 475
GT +++PE ++G K+DV+S G ++E+LT + P
Sbjct: 169 GTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 277 LGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
LG+GGFG V + G A K+L ++G++ L E ++L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 333 YYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARGLAYL 387
+ ++D LC L+ G L+ + G G E R A GL +L
Sbjct: 61 AFETKDD----LCLVMTLMNGGDLKYHIYNVGEPGFP-----EARAIFYAAQIICGLEHL 111
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
H+ +++RD K N+LL+++ + +++D GLA + G+ GT GY+APE
Sbjct: 112 HQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEV 165
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKP 475
D ++ G L E++ GR P
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 72/234 (30%), Positives = 113/234 (48%), Gaps = 16/234 (6%)
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 322
ELK+ ++FE S LG G G V K + ++L + + + L L
Sbjct: 1 ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-IRELQVL 57
Query: 323 HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
H N +VG+Y + S + +C E + GSL+ L + E K+++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVL 113
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
RGLAYL E Q ++HRD K SNIL+ + K+ DFG++ Q + N +GT
Sbjct: 114 RGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRS 167
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495
Y++PE H V+SD++S G+ L+EL GR P+ P +E + RP++
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPVV 219
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 34/274 (12%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V G VAIK + G D EF+ E +++ +L H LV+L G +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ + E + NG L ++L +++ D G+AYL E Q I
Sbjct: 71 QRPI--YIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYL-ESKQ--FI 122
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGHL 453
HRD A N L+++ KV+DFGL++ + Y S+ +G+ + PE +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSS--VGSKFPVRWSPPEVLLYSKF 178
Query: 454 LVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512
KSDV+++GV++ E+ + G+ P + S V+ + R P L +
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----------PHLASE 228
Query: 513 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
+V I +C +A +RPT +++ S+
Sbjct: 229 -------KVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 45/222 (20%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-------FLVEVEMLSRL 322
+E LGEG +G V+K G VA+K++ + D E L E+ +L L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKEL 55
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM--KIALDA 380
H N+VKL+ + + +L+ E L+ +L + I
Sbjct: 56 KHPNIVKLLDVIHT-ERKLYLVF-EYCDM-DLKKYLD-----KRPGPLSPNLIKSIMYQL 107
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMG 438
RGLAY H ++HRD K NIL+ + K+ADFGLA+ P + V+
Sbjct: 108 LRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP---LRTYTHEVV- 160
Query: 439 TFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
T Y APE +L+ S YS V + E++TG+
Sbjct: 161 TLWYRAPE------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 88/333 (26%), Positives = 143/333 (42%), Gaps = 47/333 (14%)
Query: 264 LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 317
LKE F+ +LG G FG V+KG+ + +G VAIK L + +KE L E
Sbjct: 4 LKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 318 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 374
+++ + + ++ +L+G + S L +L+P G L ++ +G L+W
Sbjct: 62 VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 114
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
+ A+G+ YL E ++HRD A N+L++ H K+ DFGLAK Y +
Sbjct: 115 --CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 435 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 493
++A E + +SDV+SYGV + EL+T G KP D S +
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------- 222
Query: 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR-- 551
IL +RL + P I V I C +A+ RP E++ + R
Sbjct: 223 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272
Query: 552 ----VIECQDPTLTSSNNRANLRQSSTTFDSDG 580
VI+ + S +N ++ +
Sbjct: 273 QRYLVIQGDERMHLPSPTDSNFYRALMDEEDMD 305
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 79/294 (26%), Positives = 128/294 (43%), Gaps = 39/294 (13%)
Query: 264 LKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 322
L++ FE ++G G +G+V+KG + G AIK + G + ++E E+ ML +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKY 59
Query: 323 -HHRNLVKLVGYYSSRD----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 377
HHRN+ G + ++ Q L E GS+ + G +W I
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 117
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTR 435
+ RGL++LH+ VIHRD K N+LL N K+ DFG++ Q GR N
Sbjct: 118 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--- 171
Query: 436 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490
+GT ++APE KSD++S G+ +E+ G P+ P
Sbjct: 172 -IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------- 221
Query: 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+R + PRL K + F + +C+ +QRPT ++++
Sbjct: 222 ----MRALFLIPRNPAPRLKSKKWSKKFQ---SFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 334
+G+G FG V+K + VAIK + + + E + E++ LS+ + K YY
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK---YY 65
Query: 335 SS--RDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
S + S ++ E GS L G L D I + GL YLHE+
Sbjct: 66 GSFLKGSKLWII-MEYCGGGSCLDLLKPGKL------DETYIAFILREVLLGLEYLHEEG 118
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 451
IHRD KA+NILL K+ADFG++ Q + +T V GT ++APE
Sbjct: 119 ---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNTFV-GTPFWMAPEVIKQS 173
Query: 452 HLLVKSDVYSYGVVLLELLTGRKP 475
K+D++S G+ +EL G P
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVEVEMLS 320
+E +G G +G V V G VAIK+++ F L E+++L
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLR 54
Query: 321 RLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK-I 376
L H N++ L + S + + + EL +E+ LH + L + ++
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLT-DDHIQYF 108
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA------PEGRTN 430
RGL YLH + VIHRD K SNIL+ +N K+ DFGLA+ T
Sbjct: 109 LYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 431 YLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
Y+ TR Y APE ++ K+ D++S G + ELLT +
Sbjct: 166 YVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 334
+G G V+ + L + VAIKR+ Q + L EV+ +S+ +H N+VK YY
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK---YY 65
Query: 335 SSRDSSQHL-LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
+S L L + GSL + P G T +K L +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHSNG 122
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPEYAM 449
Q IHRD KA NILL + K+ADFG++ +G R +GT ++APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 450 TGH-LLVKSDVYSYGVVLLELLTGRKP 475
H K+D++S+G+ +EL TG P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 277 LGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVG 332
LG G FG V KGV VAIK L ++ + E + E E++ +L + +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
++ +L E+ G L +L G + +++ + G+ YL +
Sbjct: 63 VC---EAEALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN- 115
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 450
+HRD A N+LL N +AK++DFGL+K A +Y R G + + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKP 475
+SDV+SYG+ + E + G+KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 277 LGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGEG FG+VF D VA+K L + ++F E E+L+ L H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGP--------LGVNC-HLDWETRMKIALD 379
G + + L+ +E + +G L +L HGP V L + IA
Sbjct: 73 YGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
A G+ YL + +HRD N L+ K+ DFG+++ + R M
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 440 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
++ PE + +SD++S+GVVL E+ T G++P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 35/235 (14%)
Query: 269 NNFEPASILGEGGFGRVFK----GVLS--DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSR 321
NN E +G+G FGRVF+ G+L T VA+K L +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 322 LHHRNLVKLVGYYSS--------------------RDSSQHLLCYELVPNGSLESWLHGP 361
H N+VKL+G + R S C S P
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 362 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
L ++C ++ IA A G+AYL E +HRD N L+ N K+ADFGL+
Sbjct: 125 LPLSC----TEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ S ++ PE +SDV++YGVVL E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 277 LGEGGFGRVFKGVL-----SDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGE FG+++KG L VAIK L Q EF E +++ LHH N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLG--------VNCHLDWETRMKIA 377
+G + L +E + G L +L H +G V LD + IA
Sbjct: 73 LGVVTQEQPVCML--FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
+ A G+ YL S +H+D A NIL+ H K++D GL+++ + + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
++ PE M G SD++S+GVVL E+ + G +P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
+LG+G +G V+ LS +AIK + + + E+ + S L HRN+V+ +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 335 SSRDSSQHLLCY-ELVPNGSLESWLH---GPLGVNCHLDWETRMKI-ALDAARGLAYLHE 389
S + E VP GSL + L GPL N E + GL YLH+
Sbjct: 75 SENG---FFKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIIFYTKQILEGLKYLHD 126
Query: 390 DSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE- 446
+ ++HRD K N+L+ N + K++DFG +K+ N + GT Y+APE
Sbjct: 127 NQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEV 180
Query: 447 --YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQP 481
G+ +D++S G ++E+ TG+ P +++ +P
Sbjct: 181 IDKGPRGYG-APADIWSLGCTIVEMATGKPPFIELGEP 217
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 276 ILGEGGFGRVFKGVLS-DGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLVKL 330
++GEG FG+V + ++ DG + AIK L + D ++F E+E+L +L HH N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIAL 378
+G +R + E P G+L +L G L + ++ A
Sbjct: 69 LGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
D A G+ YL E IHRD A N+L+ N +K+ADFGL++ G Y+ + MG
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMG 178
Query: 439 TFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
++A E KSDV+S+GV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 8e-18
Identities = 71/235 (30%), Positives = 101/235 (42%), Gaps = 54/235 (22%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTA--VAIKRLTCGGQQGDKEFLV----------EV 316
++FE LG G FGRV V G+ A+K L K +V E
Sbjct: 1 DDFEFIKTLGTGSFGRVML-VRHKGSGKYYALKIL-------SKAKIVKLKQVEHVLNEK 52
Query: 317 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 376
+L + H LV L Y S +D S L E VP G L S L +
Sbjct: 53 RILQSIRHPFLVNL--YGSFQDDSNLYLVMEYVPGGELFSHL-----RKSG-------RF 98
Query: 377 ALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428
AR L YLH +++RD K N+LL+++ + K+ DFG AK+ +GR
Sbjct: 99 PEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGR 154
Query: 429 TNYLSTRVMGTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQP 481
T L GT Y+APE + G+ K+ D ++ G+++ E+L G P P
Sbjct: 155 TYTLC----GTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 46/305 (15%)
Query: 257 RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDK 310
R L ELK+ +LG G FG V+KG+ + DG VAIK L + +K
Sbjct: 2 RILKETELKKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 54
Query: 311 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 367
E L E +++ + + +L+G + S L +L+P G L ++ +G
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111
Query: 368 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427
L+W + A+G++YL E ++HRD A N+L+++ H K+ DFGLA+
Sbjct: 112 LNW------CVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162
Query: 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 486
T Y + ++A E + +SDV+SYGV + EL+T G KP D
Sbjct: 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP------ 216
Query: 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
AR I ++ E L P + I V I C ++ RP E+V
Sbjct: 217 ----AREIPDLLEKGERLPQPPICT-------IDVYMIMVKCWMIDSECRPRFRELVDEF 265
Query: 547 KMVQR 551
+ R
Sbjct: 266 SRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 55/286 (19%)
Query: 277 LGEGGFGRVFKGVLSD-GTAVAIKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
+G G FG V K + GT +A+KR+ ++ K L++++++ R + +V +Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR--SSDCPYIVKFY 69
Query: 335 ----SSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKIALDAARGLAYL 387
D +C EL+ + SL+ + ++ L + E KIA+ + L YL
Sbjct: 70 GALFREGDC---WICMELM-DISLDKFYKYVYEVL--KSVIPEEILGKIAVATVKALNYL 123
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
E+ + +IHRD K SNILL+ N + K+ DFG++ Q + + TR G Y+APE
Sbjct: 124 KEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPER 178
Query: 448 AMTGHLL---VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
V+SDV+S G+ L E+ TG+ P W D+L ++
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWNSVF----DQLTQV 223
Query: 505 AD---PRLGGKYPKE------DFIRVCTIAAACVAPEANQRPTMGE 541
P L +E +FI +C I + ++RP E
Sbjct: 224 VKGDPPILSNSEEREFSPSFVNFINLCLIK------DESKRPKYKE 263
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 42/215 (19%)
Query: 277 LGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 333
+GEG G VFK G VA+K++ +G + L E++ L H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL--- 64
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD-----WETR--MKIALDAARGLAY 386
D H + LV +E V + + + M++ L G+AY
Sbjct: 65 ---LDVFPHGSGFVLV----MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK---GVAY 114
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAP 445
+H + ++HRD K +N+L+ + K+ADFGLA+ + E Y S +V T Y AP
Sbjct: 115 MHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQV-ATRWYRAP 169
Query: 446 EYAMTGHLLVKS-------DVYSYGVVLLELLTGR 473
E LL + D+++ G + ELL G
Sbjct: 170 E------LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
E+ + +L H N+VKL+G R L +E + +L L L WE R
Sbjct: 733 EIADMGKLQHPNIVKLIG--LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
KIA+ A+ L +LH P V+ + I+++ + L ++S+
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842
Query: 435 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494
YVAPE T + KSD+Y +G++L+ELLTG+ P D ++ ++V WAR
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYC 895
Query: 495 LRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
D L+ DP + G + + + V +A C A + RP +V+++L+ R
Sbjct: 896 YSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 24/214 (11%)
Query: 271 FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 326
F +LG+GGFG V V + G A K+L ++G+ L E ++L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 327 LVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH--GPLGVNCHLDWETRMKI-ALDAA 381
+V L Y ++D+ LC L+ G L+ ++ G G E R A +
Sbjct: 62 VVSLAYAYETKDA----LCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEIC 112
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
GL LH++ +++RD K NILL+++ H +++D GLA PEG+T + RV GT G
Sbjct: 113 CGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
Y+APE D ++ G +L E++ G+ P
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 71/289 (24%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 270 NFEPASILGEGGFGRVFKGVLS------DGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRL 322
N + + LG G FG VF T V +K L + EF E++M +L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLGVNCHLDWETRMKIA 377
H+N+V+L+G R++ H + E G L+ +L L + ++ +
Sbjct: 66 SHKNVVRLLGL--CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
A G+ +L S +HRD A N L+ + KV+ L+K Y +
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNAL 179
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
++APE KSDV+S+GV++ E+ T + P L D
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-----LPFYG----------LSD 224
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
++ L L +L P+ R+ + C A RP+ E+V +L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 74/217 (34%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 271 FEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGD----KEFLVEVEMLSRLHHR 325
+E S +GEG +G VFK + G VAIK+ + D K L E+ ML +L H
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV--ESEDDPVIKKIALREIRMLKQLKHP 60
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
NLV L+ + R HL+ +E + L P GV HL KI + +
Sbjct: 61 NLVNLIEVFR-RKRKLHLV-FEYCDHTVLNELEKNPRGVPEHL----IKKIIWQTLQAVN 114
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGR-TNYLSTRVMGTFGY 442
+ H C IHRD K NIL+ K+ DFG A+ P T+Y++TR Y
Sbjct: 115 FCH--KHNC-IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WY 166
Query: 443 VAPEYAMTGHLLVKS-------DVYSYGVVLLELLTG 472
APE LLV DV++ G V ELLTG
Sbjct: 167 RAPE------LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 264 LKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 322
L++ FE ++G G +G+V+KG + G AIK + + ++E +E+ ML +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKY 69
Query: 323 -HHRNLVKLVGYYSSRDSSQH----LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 377
HHRN+ G + + H L E GS+ + G DW I
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--IC 127
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTR 435
+ RGLA+LH VIHRD K N+LL N K+ DFG++ Q GR N
Sbjct: 128 REILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--- 181
Query: 436 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKPV-DM 478
+GT ++APE +SD++S G+ +E+ G P+ DM
Sbjct: 182 -IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 269 NNFEPASILGEGGFGRVFKGV---LSDGTA---VAIKRLTCGGQQGDKEFLV-EVEMLSR 321
NN LG G FG+V + LS A VA+K L ++E L+ E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 322 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 380
L +H N+V L+G + L+ E G L ++L L E + +
Sbjct: 95 LGNHENIVNLLG--ACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQV 150
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL---STRVM 437
A+G+A+L S+ C IHRD A N+LL + K+ DFGLA+ +NY+ + R+
Sbjct: 151 AKGMAFL--ASKNC-IHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARL- 205
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
++APE +SDV+SYG++L E+ +
Sbjct: 206 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V+ + T VA+K + G + FL E ++ L H LVKL +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ E + GSL +L G L + + A G+A++ + + I
Sbjct: 73 EPI---YIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 124
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 454
HRD +A+NIL+ + K+ADFGLA+ + N + R F + APE G
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 455 VKSDVYSYGVVLLELLT-GRKPV-DMSQP 481
+KSDV+S+G++L+E++T GR P MS P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNP 210
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 70/215 (32%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 276 ILGEGGFGRVFKGVLS-DGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLVKL 330
++GEG FG+V K + DG + AIKR+ + D ++F E+E+L +L HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIAL 378
+G R L E P+G+L +L L + + A
Sbjct: 62 LGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
D ARG+ YL + IHRD A NIL+ N+ AK+ADFGL++ G+ Y+ + MG
Sbjct: 120 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMG 171
Query: 439 TFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
++A E SDV+SYGV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 334
+G+G FG VFKG+ + VAIK + + + E + E+ +LS+ + K G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQP 393
+D+ ++ L +L+ GPL ET++ L + +GL YLH + +
Sbjct: 72 L-KDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHSEKK- 122
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
IHRD KA+N+LL + K+ADFG+A Q + T +GT ++APE
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 454 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 513
K+D++S G+ +EL G P P L+ P P L G Y
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 225
Query: 514 --PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
P ++F+ AC+ E + RPT E+++
Sbjct: 226 SKPLKEFVE------ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 276 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNL 327
LGEG FG+V K + VA+K L + D + + E+EM+ + H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------MK 375
+ L+G +++ +++ E +G+L +L P G D +
Sbjct: 79 INLLGV-CTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 435
A ARG+ +L S+ C IHRD A N+L+ + K+ADFGLA+ +Y
Sbjct: 137 FAYQVARGMEFL--ASKKC-IHRDLAARNVLVTEDHVMKIADFGLARDIHH--IDYYRKT 191
Query: 436 VMGTFGY--VAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
G +APE +SDV+S+GV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 326
+ +E LG+G FG+V+K G A K + ++ ++F+VE+++LS H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKIAL---DA 380
+V L Y + L+ E G+L+S L L T +I
Sbjct: 64 IVGLYEAYFYENKLWILI--EFCDGGALDSIMLELERGL---------TEPQIRYVCRQM 112
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
L +LH VIHRD KA NILL + K+ADFG++ A T +GT
Sbjct: 113 LEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVS--AKNKSTLQKRDTFIGTP 167
Query: 441 GYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKP 475
++APE K+D++S G+ L+EL P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 39/283 (13%)
Query: 277 LGEGGFGRVFKGVLSDGTAVA---IKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVG 332
+G G FG+V G G + A +K L FL EV+ L+H N+++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDS 391
+S +LL E P G L+++L G V + ++A + A GL +LH+
Sbjct: 63 --QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEGRTNYLSTRVMGTFG--YVAPEYA 448
IH D N L + K+ D+GLA +Q PE +Y T+ ++APE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE---DYYITKDCHAVPLRWLAPELV 174
Query: 449 MTGH--LLV-----KSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500
LL KS+++S GV + EL T +P S ++ L + ++R++D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP--YPDLSDEQVL----KQVVREQDI 228
Query: 501 LEELADPRLGGKYPKEDFIRVCTIAAAC-VAPEANQRPTMGEV 542
+L P+L KY R + C + PE RPT EV
Sbjct: 229 --KLPKPQLDLKYSD----RWYEVMQFCWLDPE--TRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 77/305 (25%), Positives = 121/305 (39%), Gaps = 56/305 (18%)
Query: 277 LGEGGFGRV----------------FKGVLSDGTA-VAIKRLTCGG-QQGDKEFLVEVEM 318
LGEG FG V + +D VA+K L ++FL EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 319 LSRLHHRNLVKLVG-------------YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 365
LSRL N+ +L+G Y + D +Q L + +G +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS------ 126
Query: 366 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425
L + T + +A A G+ YL +HRD N L+ N+ K+ADFG+++
Sbjct: 127 --LSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVD-MSQPS 482
+ R ++A E + G KSDV+++GV L E+LT +P + ++
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 483 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542
EN A RD R L P PK+ + + C + RPT E+
Sbjct: 242 VIEN----AGHFFRDDGRQIYLPRPPN---CPKDIYELMLE----CWRRDEEDRPTFREI 290
Query: 543 VQSLK 547
L+
Sbjct: 291 HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 38/262 (14%)
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM---- 318
ELK+ ++FE S LG G G VFK V + + + R L+ +E+
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLIMARK-----------LIHLEIKPAI 46
Query: 319 -------LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDW 370
L LH N +VG+Y + S + +C E + GSL+ L +
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPE 102
Query: 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430
+ K+++ +GL YL E + ++HRD K SNIL+ + K+ DFG++ Q + N
Sbjct: 103 QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160
Query: 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490
+GT Y++PE H V+SD++S G+ L+E+ GR P+ P +E + +
Sbjct: 161 SF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI--PPPDAKELELMF 214
Query: 491 ARPILRDKDRLEELADPRLGGK 512
P+ D E PR G+
Sbjct: 215 GCPVEGDPAESETSPRPRPPGR 236
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 71/227 (31%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 277 LGEGGFGRVFKGVLSD-GTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
+G+GG+G+VF D G VA+KR+ + L E ++L+ LVKL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-- 66
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHED 390
Y+ +D L E VP G + L+ G L + + M A+DA L Y
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY---- 122
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---- 446
IHRD K N L++ + H K+ DFGL+K + V+G+ Y+APE
Sbjct: 123 -----IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRG 172
Query: 447 --YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTW 490
Y T D +S G +L E L G P S P+ ENL W
Sbjct: 173 KGYDFT------VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 18/211 (8%)
Query: 271 FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 326
F +LG+GGFG V V + G A KRL ++G+ L E ++L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 327 LVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
+V L Y ++D+ LC L + G L+ ++ +G N + E + A + GL
Sbjct: 62 VVNLAYAYETKDA----LCLVLTIMNGGDLKFHIYN-MG-NPGFEEERALFYAAEILCGL 115
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
LH ++ ++RD K NILL++ H +++D GLA + PEG + + RV GT GY+A
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMA 169
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
PE + D + G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 272 EPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 326
+GEG FG V++GV ++ AVA+K +E FL E ++ + H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLA 385
+VKL+G + + EL P G L S+L VN + LD + + + + LA
Sbjct: 69 IVKLIGVITENPV---WIVMELAPLGELRSYLQ----VNKYSLDLASLILYSYQLSTALA 121
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
YL S+ V HRD A N+L+ + K+ DFGL++ E + Y +++ ++AP
Sbjct: 122 YLE--SKRFV-HRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAP 177
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
E SDV+ +GV + E+L G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 51/257 (19%)
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGP-------LGVNCHLDW 370
L LH N +VG+Y + S + +C E + GSL+ L LG
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG------- 102
Query: 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430
KI++ RGL YL E + ++HRD K SNIL+ + K+ DFG++ Q +
Sbjct: 103 ----KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 152
Query: 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490
++ +GT Y++PE H V+SD++S G+ L+E+ GR P+ E +
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 491 ARPILRDKDRLE----------------ELAD-------PRLGGKYPKEDFIRVCTIAAA 527
K+ EL D P+L ++F
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF---QDFVDK 269
Query: 528 CVAPEANQRPTMGEVVQ 544
C+ +R + E+ +
Sbjct: 270 CLKKNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 277 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG G +G V++GV VA+K L + + EFL E ++ + H NLV+L+G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 71
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 392
+R+ +++ E + G+L +L C+ ++ + +A + + YL + +
Sbjct: 72 TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 124
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 452
IHRD A N L+ N KVADFGL++ G T + APE
Sbjct: 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 453 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQ 480
+KSDV+++GV+L E+ T G P +D+SQ
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 73/231 (31%), Positives = 114/231 (49%), Gaps = 35/231 (15%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-FLV----EVEM 318
K + F+ +GEG +G+V+K D G VA+K++ +KE F + E+++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKI 59
Query: 319 LSRLHHRNLVKLVGYYSS--------RDSSQHLLCYELVPN---GSLESWLHGPLGVNCH 367
L +L+HRN+V L + +D L +E + + G LES L V+
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFS 114
Query: 368 LDW-ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
D ++ MK L+ GL Y H+ + +HRD K SNILL N K+ADFGLA+
Sbjct: 115 EDHIKSFMKQLLE---GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 476
+ + +V+ T Y PE + + DV+S G +L EL T +KP+
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 18/211 (8%)
Query: 271 FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 326
F +LG+GGFG V V + G A K+L ++G+ L E +L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 327 LVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
+V L Y ++D+ LC L + G L+ ++ +G N D + + A + GL
Sbjct: 62 VVSLAYAYETKDA----LCLVLTIMNGGDLKFHIYN-MG-NPGFDEQRAIFYAAELCCGL 115
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
L + +++RD K NILL++ H +++D GLA Q PEG T + RV GT GY+A
Sbjct: 116 EDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMA 169
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
PE D + G ++ E++ G+ P
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 33/292 (11%)
Query: 271 FEPASILGEGGFGRVFKGVL--SDGT--AVAIKRLTCG--GQQGDKEFLVEVEMLSRLHH 324
F +LG+G FG V + L DG+ VA+K L +EFL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 325 RNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWL-HGPLGVN-CHLDWETRMKIAL 378
N++KL+G + L + + +G L ++L +G L +T ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
D A G+ YL S IHRD A N +L N VADFGL+K+ G
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 497
++A E SDV+++GV + E++T G+ P +G EN + I
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLI--- 229
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
RL K P + V + C +PE RP+ + L+++
Sbjct: 230 -------KGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVE--MLSR 321
+ +++E +G G +G V+K L G A+K + + GD L++ E M+
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKE 62
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALD 379
H N+V G Y SR+ + +C E GSL+ H GPL + + R +
Sbjct: 63 CKHCNIVAYFGSYLSRE--KLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----E 114
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VM 437
+GLAYLH + +HRD K +NILL +N K+ADFG+A + T ++ R +
Sbjct: 115 TLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI----TATIAKRKSFI 167
Query: 438 GTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPV 476
GT ++APE A G D+++ G+ +EL + P+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 72/240 (30%), Positives = 108/240 (45%), Gaps = 16/240 (6%)
Query: 252 HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK 310
P ++ L E L + T+ +E +G+G +G+V+K DG+ A+K L D+
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDE 63
Query: 311 EFLVEVEMLSRL-HHRNLVKLVGYYSSRD---SSQHLLCYELVPNGSLESWLHGPLGVNC 366
E E +L L +H N+VK G + D Q L EL GS+ + G L
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 367 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
LD I A GL +LH + +IHRD K +NILL K+ DFG++ Q
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQP 481
R ++ +GT ++APE + DV+S G+ +EL G P+ P
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 48/292 (16%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRN 326
++ E LG G +G V K + GT +A+KR+ Q K L+++++ R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-- 58
Query: 327 LVKLVGYYSS--RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
V +Y + R+ +C E++ + SL+ + + + KIA+ + L
Sbjct: 59 CPYTVTFYGALFREGDV-WICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS-TRVMGTFGYV 443
YLH + VIHRD K SN+L+ N K+ DFG++ + ++ T G Y+
Sbjct: 117 EYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL----VDSVAKTIDAGCKPYM 170
Query: 444 APEY----AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499
APE VKSDV+S G+ ++EL TGR P D +W P + K
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWKTPFQQLKQ 219
Query: 500 RLEELADPRLGGKYPKE-------DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+EE P+L P E DF+ C +RP E++Q
Sbjct: 220 VVEE-PSPQL----PAEKFSPEFQDFVNKCLKK------NYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 36/220 (16%)
Query: 271 FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 326
F +LG+GGFG V V + G A K+L ++G+ L E ++L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 327 LVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAAR 382
+V L Y ++D+ LC L+ G L+ ++ G G D E + A +
Sbjct: 62 VVSLAYAYETKDA----LCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITC 113
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
GL LH + +++RD K NILL++ H +++D GLA + PEG T + RV GT GY
Sbjct: 114 GLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGY 167
Query: 443 VAPEYAMTGHLLVKSDVYSY-------GVVLLELLTGRKP 475
+APE +VK++ Y++ G ++ E++ G+ P
Sbjct: 168 MAPE-------VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 280 GGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKEFL-VEVE---MLSRLHHRNLVKLVGY 333
G FG V+ K + G AIK L + V+ E M+ + + KL
Sbjct: 7 GAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL--- 62
Query: 334 YSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHED 390
Y S S +L L E + G S + G L DW + IA + G+ LH+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP----EDW-AKQYIA-EVVLGVEDLHQR 116
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 450
+IHRD K N+L++ H K+ DFGL+ R + + +GT Y+APE +
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILG 167
Query: 451 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481
SD +S G V+ E L G P P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 276 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 330
++G+G FG V+ G L D A+K L + ++FL E ++ H N++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------MKIALDAARG 383
+G + S ++ L HG L + ET + L A+G
Sbjct: 62 LGICLPSEGSPLVV---------LPYMKHGDL--RNFIRSETHNPTVKDLIGFGLQVAKG 110
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TRVMGT 439
+ YL +HRD A N +L+ +F KVADFGLA+ + Y S T
Sbjct: 111 MEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYD--KEYYSVHNHTGAKLP 165
Query: 440 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
++A E T KSDV+S+GV+L EL+T
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 84/304 (27%), Positives = 136/304 (44%), Gaps = 35/304 (11%)
Query: 253 PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQQGDK 310
P S + + ++ + ++ +E +G+G +G+VFK VL+ +G+ A+K L D+
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILD-PIHDIDE 59
Query: 311 EFLVEVEMLSRLH-HRNLVKLVGYYSSRD---SSQHLLCYELVPNGSLESWLHGPLGVNC 366
E E +L L H N+VK G Y +D Q L EL GS+ + G L
Sbjct: 60 EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119
Query: 367 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
++ I +A GL +LH + IHRD K +NILL K+ DFG++ Q
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQP 481
R ++ +GT ++APE L + DV+S G+ +EL G P+ P
Sbjct: 177 TRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
Query: 482 SGQENLVTWARPILR-DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540
R + + ++ L P L DFIR C+ + +RPT+
Sbjct: 235 ---------MRALFKIPRNPPPTLHQPELWSN-EFNDFIR------KCLTKDYEKRPTVS 278
Query: 541 EVVQ 544
+++Q
Sbjct: 279 DLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGY 333
++G G +G V++G + G VA+K + D + EV +LS+L + Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 334 YSSRDSSQHL-LCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL---DAARGLAYLH 388
Y S L + E GS+ + + GP+ I++ + L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY---------ISVIIREVLVALKYIH 118
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
+ VIHRD KA+NIL+ N + K+ DFG+A + + ST V GT ++APE
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV-GTPYWMAPEVI 173
Query: 449 MTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507
G K+D++S G+ + E+ TG P L+ ++P P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-------------P 220
Query: 508 RL-GGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS 545
RL Y K +F+ AAC+ E +R + E+++S
Sbjct: 221 RLEDNGYSKLLREFV------AACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 74/244 (30%), Positives = 119/244 (48%), Gaps = 34/244 (13%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV---EVEMLSRLHHR 325
+FE +G G +G V+K ++ G AIK + + ++F V E+ M+ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHS 66
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMK-IALDAAR 382
N+V G Y RD + +C E GSL+ H GPL E+++ ++ + +
Sbjct: 67 NIVAYFGSYLRRD--KLWICMEFCGGGSLQDIYHVTGPLS-------ESQIAYVSRETLQ 117
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTF 440
GL YLH + +HRD K +NILL +N H K+ADFG++ Q T ++ R +GT
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI----TATIAKRKSFIGTP 170
Query: 441 GYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---WARPI 494
++APE A G D+++ G+ +EL + P+ P L+T + P
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230
Query: 495 LRDK 498
L+DK
Sbjct: 231 LKDK 234
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 62/234 (26%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT-------CGGQQGDKEFLVEVEMLSR 321
++ S +GEG +G V G VAIK+++ C + L E+++L R
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC------QRTLREIKILRR 59
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM------- 374
H N++ + +++ S ES + V + ET +
Sbjct: 60 FKHENIIGI---------------LDIIRPPSFES-FNDVYIVQELM--ETDLYKLIKTQ 101
Query: 375 KIALDAA--------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-P 425
++ D RGL Y+H + V+HRD K SN+LL N K+ DFGLA+ A P
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158
Query: 426 EGR-----TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
E T Y++TR Y APE + K+ D++S G +L E+L+ R
Sbjct: 159 EHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 277 LGEGGFGRVFKGVLSDGT------AVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVK 329
LGE FG+V+KG L AVAIK L + +EF E M SRL H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLG-------VNCHLDWETRMKIA 377
L+G + + Y + L +L H +G V L+ + I
Sbjct: 73 LLGVVTKEQPLSMIFSY--CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
A G+ +L S V+H+D N+L+ + + K++D GL ++ L +
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+++PE M G + SD++SYGVVL E+ + G +P
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 77/274 (28%), Positives = 123/274 (44%), Gaps = 39/274 (14%)
Query: 277 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 334
+G+G FG V+KG+ + VAIK + + + E + E+ +LS+ + + G Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 335 SSRDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQ 392
++ + E + GS L GPL ET + L + +GL YLH + +
Sbjct: 72 LK--GTKLWIIMEYLGGGSALDLLKPGPLE-------ETYIATILREILKGLDYLHSERK 122
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 452
IHRD KA+N+LL K+ADFG+A Q + T +GT ++APE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 453 LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512
K+D++S G+ +EL G P P L+ P P L G+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQ 224
Query: 513 Y--PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
Y P ++F+ AC+ + RPT E+++
Sbjct: 225 YSKPFKEFVE------ACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 276 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 330
++G G FG V G L VAIK L G ++ ++FL E ++ + H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
G + S ++ E + NGSL+++L G + + A G+ YL +
Sbjct: 71 EGVVTK--SKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM 125
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEY 447
+HRD A NIL+ +N KV+DFGL++ PE Y + + APE
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTAPEA 180
Query: 448 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 479
SDV+SYG+V+ E+++ G +P +MS
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 32/282 (11%)
Query: 276 ILGEGGFGRVFKGVLSDGT-----AVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLVK 329
+L EG FGR+F G+L D V +K + + L E +L L H+N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLA 385
++ D + Y + G+L+ +L G L + + +A+ A G++
Sbjct: 73 ILH-VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
YLH+ VIH+D A N +++ K+ D L++ + L ++A
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
E + SDV+S+GV+L EL+T G+ P P + + L+D RL +
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY----LKDGYRLAQP 241
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
+ P E F + A C A + +RP+ ++VQ L
Sbjct: 242 IN------CPDELF----AVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 24/234 (10%)
Query: 277 LGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
LG+GGFG V V + G A K+L + G+K L+E E+L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 333 YYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHE 389
+ +S HL L L+ G L+ ++ G G L+ E + + G+ +LH
Sbjct: 61 AF---ESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHS 113
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449
+++RD K N+LL++ + +++D GLA + +G+T T+ GT GY+APE
Sbjct: 114 MD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILK 167
Query: 450 TGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVTWARPILRDKDRLE 502
D ++ G + E++ GR P D + +E L R L D+ + E
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---RRTLEDEVKFE 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF--------LVEVEMLSRL-HHRN 326
LG+G FG V+ G VAIK++ K+F L EV+ L +L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSL----ESWLHGPLGVNCHLDWETRMK-IALDAA 381
+VKL R++ + +E + G+L + P E+ ++ I
Sbjct: 60 IVKL--KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-------ESVIRSIIYQIL 109
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR-----TNYLSTRV 436
+GLA++H+ HRD K N+L+ K+ADFGLA+ E R T+Y+STR
Sbjct: 110 QGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTR- 162
Query: 437 MGTFGYVAPEYAMTGHLLVKSDVYS-------YGVVLLELLTGR 473
Y APE +L++S YS G ++ EL T R
Sbjct: 163 ----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 47/225 (20%)
Query: 270 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-------FLVEVEMLSR 321
FE + +GEG +G V++ + G VA+K++ + D E L E+ +L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREITLLLN 62
Query: 322 LHHRNLVKL----VGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWE 371
L H N+V+L VG +HL LV SL + P E
Sbjct: 63 LRHPNIVELKEVVVG--------KHLDSIFLVMEYCEQDLASLLDNMPTPFS-------E 107
Query: 372 TRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430
+++K + L RGL YLHE+ +IHRD K SN+LL + K+ADFGLA+ G
Sbjct: 108 SQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPA 162
Query: 431 YLSTRVMGTFGYVAPE--YAMTGHLLVKSDVYSYGVVLLELLTGR 473
T + T Y APE T + D+++ G +L ELL +
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTT-AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 74/269 (27%), Positives = 113/269 (42%), Gaps = 49/269 (18%)
Query: 277 LGEGGFGRV---------------FKGVLSDGTA--VAIKRLTCGGQQGDK-EFLVEVEM 318
LGEG FG V F + G VA+K L + + +FL EV++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH---------------GP 361
LSRL N+++L+G D LC E + NG L +L P
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 362 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
+ + + + +AL A G+ YL S +HRD N L+ N K+ADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481
+ G + R + ++A E + G SDV+++GV L E+L + QP
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQP 241
Query: 482 SGQ---ENLVTWARPILRDKDRLEELADP 507
G+ E ++ A RD+ R L P
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRP 270
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 277 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 329
LG+G FG V+ KGV+ D T VAIK + ++ EFL E ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGVNCHLDWETRMKIALDAARG 383
L+G S + L+ EL+ G L+S+L V + +++A + A G
Sbjct: 74 LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 441
+AYL+ + +HRD A N ++ +F K+ DFG+ + E T+Y G
Sbjct: 132 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 186
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
+++PE G SDV+S+GVVL E+ T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 81/285 (28%), Positives = 126/285 (44%), Gaps = 36/285 (12%)
Query: 277 LGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 331
LGEG FG V +G L+ AV ++ + ++FL E + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 332 GYYSSRDSSQH----LLCYELVPNGSLESWL-HGPLGVNCHLDWETRM--KIALDAARGL 384
G S+ ++ + +G L S+L + LG +C T+M K D A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGM 125
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYV 443
YL S IHRD A N +L N + VADFGL+K+ G Y R+ ++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMPVKWI 181
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 502
A E KSDV+S+GV + E+ T G+ P G EN + LR +RL+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIY--DYLRQGNRLK 234
Query: 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ D L G Y ++ ++C RP+ + L+
Sbjct: 235 QPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 48/228 (21%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---F----LVEVEMLSR 321
+E + + EG +G V++ G VA+K+L + +KE F L E+ +L +
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLK 60
Query: 322 LHHRNLVKL----VGYYSSRDSSQHLLCYELVPNG--SLESWLHGPLGVNCHLDWETRMK 375
L H N+V + VG + + + E V + SL + P + + + M
Sbjct: 61 LQHPNIVTVKEVVVG----SNLDKIYMVMEYVEHDLKSLMETMKQPFLQS---EVKCLML 113
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 435
L G+A+LH++ ++HRD K SN+LL N K+ DFGLA++ Y T+
Sbjct: 114 QLL---SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQ 165
Query: 436 VMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPV 476
++ T Y APE LL+ D++S G + ELLT +KP+
Sbjct: 166 LVVTLWYRAPE------LLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 277 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF---LVEVEMLSRLHHRNLVKLVG 332
+G G FG V F + VAIK+++ G+Q ++++ + EV L +L H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDS 391
Y ++ ++ Y L + PL E + I A +GLAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQ-------EVEIAAICHGALQGLAYLHSH- 134
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE--YAM 449
IHRD KA NILL K+ADFG A + +GT ++APE AM
Sbjct: 135 --ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAM 186
Query: 450 -TGHLLVKSDVYSYGVVLLELLTGRKP 475
G K DV+S G+ +E L RKP
Sbjct: 187 DEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 334
+G+G FG VFKG+ + VAIK + + + E + E+ +LS+ + K G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 335 SSRDSSQHLLCYELVPNGS-LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
++ + E + GS L+ GP T +K L +GL YLH + +
Sbjct: 72 LK--GTKLWIIMEYLGGGSALDLLRAGPFD---EFQIATMLKEIL---KGLDYLHSEKK- 122
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
IHRD KA+N+LL K+ADFG+A Q + T +GT ++APE
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 454 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 513
K+D++S G+ +EL G P P +R + + P L G++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHP-------------MRVLFLIPKNNPPTLTGEF 225
Query: 514 PK--EDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
K ++FI AC+ + + RPT E+++
Sbjct: 226 SKPFKEFID------ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 276 ILGEGGFGRVFKG-VLSDGTAVAIK----RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
ILG G G V+K L +A+K +T Q K+ + E+E+L + ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ---KQIMSELEILYKCDSPYIIGF 64
Query: 331 VG--YYSSRDSSQHLLCYELVPNGSLESWLHGP---LGVNCHLDWETRMKIALDAARGLA 385
G + +R S +C E + GSL+ + P LG +IA+ +GL
Sbjct: 65 YGAFFVENRIS----ICTEFMDGGSLDVYRKIPEHVLG-----------RIAVAVVKGLT 109
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
YL ++HRD K SN+L+ K+ DFG++ Q N ++ +GT Y+AP
Sbjct: 110 YLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAP 162
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
E + SDV+S G+ +EL GR P
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 51/300 (17%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLH 323
NF+ +G+G F V+K + L DG VA+K++ + ++ L E+++L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 324 HRNLVKLVGYYSSR-DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
H N++K Y +S ++++ + EL G L + + T K +
Sbjct: 61 HPNVIK---YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
L ++H ++HRD K +N+ + K+ D GL GR + S++
Sbjct: 118 ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGL------GR--FFSSKTTAAHSL 166
Query: 443 VAPEYAMTGHLL------VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496
V Y M+ + KSD++S G +L E+ + P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG------------------ 208
Query: 497 DKDRLEELADPRLGGKY---PKEDF---IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550
DK L L Y P + + +R + + C+ P+ +RP + V+Q K +
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPADHYSEELR--DLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 77/301 (25%), Positives = 115/301 (38%), Gaps = 84/301 (27%)
Query: 269 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKE----------FLV 314
++FE ++G G FG V+ L G A+K L K
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRA 50
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 373
E ++L+ +VKL YYS +D +HL L E +P G L + L + + + R
Sbjct: 51 ERDILADADSPWIVKL--YYSFQDE-EHLYLVMEYMPGGDLMNLL---IRKDVFPEETAR 104
Query: 374 -----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428
+ +ALD+ L + IHRD K NIL++ + H K+ADFGL K+ + +
Sbjct: 105 FYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
Query: 429 TNYL----------------------STRVM-----GTFGYVAPEYAMTGHLLVKSDVYS 461
RV GT Y+APE ++ D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215
Query: 462 YGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFI 519
GV+L E+L G P T+ + I+ K+ L DP E D I
Sbjct: 216 LGVILYEMLYGFPPF-----YSDTLQETYNK-IINWKESLRFPPDP----PVSPEAIDLI 265
Query: 520 R 520
Sbjct: 266 C 266
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVG 332
+G G FG V+ S VA+K+++ G+Q + ++ + EV+ L +L H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDS 391
Y ++ ++ Y L L PL E + I A +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ-------EVEIAAITHGALQGLAYLHSH- 140
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT- 450
+IHRD KA NILL K+ADFG A ++ + +GT ++APE +
Sbjct: 141 --NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAM 192
Query: 451 --GHLLVKSDVYSYGVVLLELLTGRKP 475
G K DV+S G+ +E L RKP
Sbjct: 193 DEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 277 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG+G FG+V+K + G A K + ++ ++++VE+E+L+ +H +VKL+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+ + E P G++++ + L ++ L I L YLH +
Sbjct: 80 W--DGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHSMK---I 131
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL- 454
IHRD KA N+LL + K+ADFG++ A +T +GT ++APE M +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 455 ----VKSDVYSYGVVLLEL 469
K+D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 69/232 (29%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 277 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVG 332
+G G FG V F + + VAIK+++ G+Q + ++ + EV L +L H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHE 389
Y ++ ++ Y L L PL ++IA A +GLAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPL---------QEVEIAAVTHGALQGLAYLHS 133
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAPEYA 448
+ +IHRD KA NILL K+ DFG A AP + +GT ++APE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVI 183
Query: 449 MT---GHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVTWARPILR 496
+ G K DV+S G+ +EL + P+ +M+ S ++ P L+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 40/277 (14%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
LG G FG V G VAIK + G + +F+ E +++ +L H LV+L G +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ + E + NG L ++L G L + + + D G+ YL +S I
Sbjct: 71 QKPL--YIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG------YVAPEYAMT 450
HRD A N L+ + KV+DFG+ + L + G + PE
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-------LDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509
KSDV+S+GV++ E+ T G+ P + N ++ R L P+L
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NY-----EVVEMISRGFRLYRPKL 225
Query: 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
V + +C + RPT E+++++
Sbjct: 226 ASMT-------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 277 LGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 331
LG G FG V KG+ AV I + E L E ++ +L + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 332 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
G ++ +L EL G L +L N H+ + ++ + G+ YL E +
Sbjct: 63 GIC---EAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 449
+HRD A N+LL +AK++DFGL+K A NY + G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 450 TGHLLVKSDVYSYGVVLLELLT-GRKP 475
KSDV+S+GV++ E + G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 266 EATNNFEPASILGEGGFGRV--FKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSR 321
E TN + +G G FG V + L+ G VAIK++ K E+++L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------M 374
L H N++ L + S + + EL LG + H +R
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVT-EL-------------LGTDLHRLLTSRPLEKQFIQ 111
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
RGL Y+H V+HRD K SNIL+ N K+ DFGLA+ T Y+ST
Sbjct: 112 YFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVST 168
Query: 435 RVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPV 476
R Y APE +T V+ D++S G + E+L G KP+
Sbjct: 169 RY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 51/250 (20%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEM 318
+ + +E + +G+G FG VFK VA+K++ + KE F L E+++
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKI 64
Query: 319 LSRLHHRNLVKLV------GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW-- 370
L L H N+V L+ +R L +E E L G L N ++ +
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLS-NKNVKFTL 118
Query: 371 ---ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QA 424
+ MK+ L+ GL Y+H + ++HRD KA+NIL+ + K+ADFGLA+ +
Sbjct: 119 SEIKKVMKMLLN---GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVD 477
+ N + RV+ T Y PE LL+ D++ G ++ E+ T R P+
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPE------LLLGERDYGPPIDMWGAGCIMAEMWT-RSPI- 223
Query: 478 MSQPSGQENL 487
M + Q L
Sbjct: 224 MQGNTEQHQL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRL-TCGGQQGDKEFLV-EVEMLSRL---HH 324
+E + +GEG +G V+K L+ G VA+K++ ++G + E+ +L +L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 325 RNLVKL----VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL 378
N+V+L G + R+ L+ +E V + L ++L G L ET +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLV-FEHV-DQDLATYLSKCPKPG----LPPETIKDLMR 114
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
RG+ +LH ++HRD K NIL+ ++ K+ADFGLA+ T V+
Sbjct: 115 QLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSVVV 168
Query: 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
T Y APE + D++S G + EL R+P
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 30/206 (14%)
Query: 277 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG+G FG+V+K + G A K + ++ ++++VE+++L+ H N+VKL+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 336 SRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKI----ALDAARGLAYLH 388
++ L+ E G++++ L PL E ++++ L+A L YLH
Sbjct: 73 YENNLWILI--EFCAGGAVDAVMLELERPLT-------EPQIRVVCKQTLEA---LNYLH 120
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
E+ +IHRD KA NIL + K+ADFG++ A RT +GT ++APE
Sbjct: 121 ENK---IIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 449 MTGH-----LLVKSDVYSYGVVLLEL 469
M K+DV+S G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 277 LGEGGFGRVFKGVLSDGTA--VAIKRLTC-------GGQQGDKEF---LVEVEML-SRLH 323
LG G FG V+K + +A+K + ++ DK + EV ++ +L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 324 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
H N+V+ YY + + L + +L+ L + E I +
Sbjct: 68 HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
L YLH++ + ++HRD +NI+L + + DFGLAKQ + + L T V+GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL-TSVVGTILY 179
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502
PE K+DV+++G +L ++ T + P N+++ A I +E
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKI------VE 227
Query: 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542
+ +P G Y + V + +C+ P+A RP + +V
Sbjct: 228 AVYEPLPEGMYSE----DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 28/262 (10%)
Query: 247 GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGG 305
GSL P E+ ++ F +G G FG V F + VAIK+++ G
Sbjct: 6 AGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG 62
Query: 306 QQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL 362
+Q + ++ + EV+ L R+ H N ++ G Y ++ ++ Y L L PL
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPL 122
Query: 363 GVNCHLDWETRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
E + I A +GLAYLH + +IHRD KA NILL K+ADFG A
Sbjct: 123 Q-------EVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPV-D 477
A + +GT ++APE + G K DV+S G+ +EL + P+ +
Sbjct: 173 SIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
Query: 478 MSQPSGQENLVTWARPILRDKD 499
M+ S ++ P L+ +
Sbjct: 227 MNAMSALYHIAQNESPTLQSNE 248
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 32/221 (14%)
Query: 269 NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHH-R 325
N+ E +G G G+V+K G +A+K++ G ++ +K L++++++ + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPN--GSLESWLHGP-----LGVNCHLDWETRMKIAL 378
+VK GY+ + S +C EL+ L + GP LG K+ +
Sbjct: 75 YIVKCYGYFIT--DSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----------KMTV 121
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
+ L YL E VIHRD K SNILL+ + + K+ DFG++ + + + TR G
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAG 176
Query: 439 TFGYVAPEY----AMTGHLLVKSDVYSYGVVLLELLTGRKP 475
Y+APE +++DV+S G+ L+EL TG+ P
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 23/217 (10%)
Query: 270 NFEPASILGEGGFGRVF--KGVLSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHR 325
+E +GEG FG+++ K SD IK LT + + EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAA 381
N+V + S +++ + + E G L ++ GV + L W ++I+L
Sbjct: 60 NIVTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL--- 112
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
GL ++H+ ++HRD K+ NI L +N AK+ DFG+A+Q + + L+ +GT
Sbjct: 113 -GLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTP 166
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
Y++PE K+D++S G VL EL T + P +
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 277 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 329
LG+G FG V++G D T VA+K + ++ EFL E ++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 381
L+G S + L+ EL+ +G L+S+L + P L + +++A + A
Sbjct: 74 LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIA 129
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF- 440
G+AYL+ +HRD A N ++ ++F K+ DFG+ + E T+Y G
Sbjct: 130 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 184
Query: 441 -GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
++APE G SD++S+GVVL E+ +
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 277 LGEGGFGRVFK----GVLSDGTA----VAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 326
LGEG FG+V G+ D VA+K L D LV E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-----CHLDWETR-----M 374
++ L+G ++D ++L E G+L +L P G++ C L E +
Sbjct: 80 IINLLGA-CTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
A ARG+ YL SQ C IHRD A N+L+ + K+ADFGLA+ +Y
Sbjct: 138 SCAYQVARGMEYLA--SQKC-IHRDLAARNVLVTEDNVMKIADFGLARDVHN--IDYYKK 192
Query: 435 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
G ++APE +SDV+S+GV+L E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 270 NFEPASILGEGGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRLHHR 325
+E ++G G FG V + +D V IK++ D+ E ++L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 326 NLVKLVGYYSS-RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
N++ YY + + ++ E P G+L ++ N LD +T + + L
Sbjct: 60 NII---EYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLAL 114
Query: 385 AYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
++H ++HRD K NILL+ + K+ DFG++K Y V+GT Y+
Sbjct: 115 HHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY---TVVGTPCYI 168
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
+PE KSD+++ G VL EL + ++ +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 57/274 (20%), Positives = 116/274 (42%), Gaps = 39/274 (14%)
Query: 284 RVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVKLVGYYSSRDS 339
++KG+ + V I+ +G K + E++ L R+ N++K+ G+ D
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKF-HKGHKVLIDITENEIKNLRRIDSNNILKIYGFII--DI 90
Query: 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHR 398
L L+ +L L L ++T++ +A+D +GL L++ ++P ++
Sbjct: 91 VDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 399 DFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV 455
+ + + L+ N+ K+ GL K P N++ + EY +
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY------TI 201
Query: 456 KSDVYSYGVVLLELLTGRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 514
K D+YS GVVL E+ TG+ P + ++ + ++ +L P
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII---------NKNNSL----KLPLDCP 248
Query: 515 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548
E + I AC + ++ +RP + E++ +L +
Sbjct: 249 LE----IKCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 70/245 (28%), Positives = 115/245 (46%), Gaps = 27/245 (11%)
Query: 277 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL---VG 332
LG G G VF V SD VA+K++ Q K L E++++ RL H N+VK+ +G
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 333 YYSSRDSSQHLLCYEL----VPNGSLESWL-----HGPLGVNCHLDWETRMKIALDAARG 383
S + EL + +E+ L GPL R+ RG
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEE-----HARL-FMYQLLRG 126
Query: 384 LAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAK-QAPE-GRTNYLSTRVMGTF 440
L Y+H + V+HRD K +N+ + + K+ DFGLA+ P YLS ++ +
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 441 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499
Y +P ++ + K+ D+++ G + E+LTG+ + Q L+ + P++R++D
Sbjct: 184 -YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 500 RLEEL 504
R E L
Sbjct: 243 RNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 277 LGEGGFGRVFKGVLSDG---TAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
+G G FG+V G ++ G V +K L Q +FL E + L H NL++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHG-PLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
+ + + +LL E P G L+ +L D T ++A + A GL +LH+++
Sbjct: 63 QCT--EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPEYA- 448
IH D N LL + K+ D+GL+ + + +Y T ++ ++APE
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 449 -MTGHLLV-----KSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501
+ G+LLV +S+V+S GV + EL G +P S ++ L R ++
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP--YRHLSDEQVLTYTVR------EQQ 227
Query: 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542
+L PRL K P D R + C QRP+ EV
Sbjct: 228 LKLPKPRL--KLPLSD--RWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 277 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 326
LGEG FG+V K + VA+K L + D LV E+EM+ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 374
++ L+G ++D +++ E G+L +L P G+ D ++ +
Sbjct: 83 IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
ARG+ YL SQ C IHRD A N+L+ N K+ADFGLA+ +Y
Sbjct: 141 SCTYQVARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDV--NNIDYYKK 195
Query: 435 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
G ++APE +SDV+S+GV++ E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 270 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTC--GGQQGDKE---FLVEVEMLSRLH 323
N+ +LG G FG V+ +D G +A+K++ Q+ KE E+++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAA 381
H +V+ G + + + E +P GS++ L +G L N TR +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV-----TR-RYTRQIL 116
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TRVM 437
+G++YLH + ++HRD K +NIL ++ + K+ DFG +K+ +T +S V
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVT 170
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GT +++PE K+DV+S ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 277 LGEGGFGRVFKGVL-SDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
LG+GGFG V + + G A K+L ++G + +VE +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA- 59
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
Y+ + + L ++ G L ++ N GL +LH Q
Sbjct: 60 -YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---Q 115
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 452
+I+RD K N+LL+N+ + +++D GLA + +G++ + GT G++APE
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 453 LLVKSDVYSYGVVLLELLTGRKP 475
D ++ GV L E++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 334
+G+G G V+ + ++ G VAIK++ QQ KE ++ E+ ++ H N+V + Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
D + + E + GSL + +D + + + L +LH +
Sbjct: 86 LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 135
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
VIHRD K+ NILL + K+ DFG Q PE + ++GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 192
Query: 454 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRL 501
K D++S G++ +E++ G P P L+ T P L++ ++L
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 270 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRLH 323
N+ +LG+G FGRV+ +D G +A+K++ + + V E+++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 324 HRNLVKLVGYYSSRDSSQHLLC--YELVPNGSLESWL--HGPLGVNCHLDWETRMKIALD 379
H +V+ G RD + L E +P GS++ L +G L N TR K
Sbjct: 63 HERIVQYYGCL--RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV-----TR-KYTRQ 114
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TR 435
G++YLH + ++HRD K +NIL ++ + K+ DFG +K+ +T LS
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKS 168
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
V GT +++PE K+D++S G ++E+LT + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 270 NFEPASILGEGGFGRV----FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLS 320
+E LG+G +G V S+ VAIK++T K+ L E+++L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKIT---NVFSKKILAKRALRELKLLR 56
Query: 321 RLH-HRNLVKLVGYYSSRDSS-QHLLCYELVPNGSLESWLHG--PLGVNCHLDWETRMKI 376
H+N+ L + L YE + L + PL + H +
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHFQSFIYQIL 115
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-------KQAPEGRT 429
GL Y+H + V+HRD K N+L+ + K+ DFGLA + T
Sbjct: 116 -----CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 476
Y++TR Y APE ++ K+ DV+S G +L ELL GRKPV
Sbjct: 168 EYVATR-----WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 43/218 (19%)
Query: 277 LGEGGFGRVFKGVLSD---GTAVAIKRL--TCGGQQGDKEFLVEVEMLSRL-HHRNLVKL 330
LG+G +G V+K + D VA+K++ + E+ L L H N+VKL
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+ + + L +E +E+ LH + N D R I + L Y+H
Sbjct: 73 LNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-IMYQLLKALKYIHSG 126
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--------TNYLSTRVMGTFGY 442
+ VIHRD K SNILL ++ K+ADFGLA+ E T+Y++TR Y
Sbjct: 127 N---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR-----WY 178
Query: 443 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
APE +L+ S Y+ GV +L E+L G+
Sbjct: 179 RAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 42/297 (14%)
Query: 277 LGEGGFGRV-----------------FKGVLSDGTAVAIKRLTCGGQQGDK-EFLVEVEM 318
LGEG FG V + VA+K L + + +FL E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLD----- 369
+SRL N+++L+ + D LC E + NG L +L H P D
Sbjct: 73 MSRLKDPNIIRLLAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 370 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
+ T + +A A G+ YL S +HRD N L+ N+ K+ADFG+++ G
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489
+ R + +++ E + G SDV+++GV L E+LT K SQ S E ++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-DEQVIE 244
Query: 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
RD+ R L P P + + +C A +RP+ E+ +L
Sbjct: 245 NTGEFFRDQGRQVYLPKP---ALCPDS----LYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 253 PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 309
PT R + + E ++ S +G G +G V G VA+K+L+ Q
Sbjct: 1 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60
Query: 310 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 366
K E+ +L + H N++ L+ ++ S + LV + L + + +
Sbjct: 61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 120
Query: 367 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
H+ + + RGL Y+H +IHRD K SN+ + + K+ DFGLA+ +
Sbjct: 121 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 473
T Y++TR Y APE + H D++S G ++ ELLTGR
Sbjct: 173 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 66/238 (27%), Positives = 97/238 (40%), Gaps = 65/238 (27%)
Query: 271 FEPASILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDKEFLV--------EVEML 319
+E +G G +GRV+K DG AIK+ +GDKE E+ +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALL 56
Query: 320 SRLHHRNLVKLVG-YYSSRDSSQHLLC----YEL--------------VPNGSLESWLHG 360
L H N+V LV + D S +LL ++L +P ++S L
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 361 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNFHA--KVA 416
L G+ YLH + V+HRD K +NIL+ E K+
Sbjct: 117 IL-------------------NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIG 154
Query: 417 DFGLAK--QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLT 471
D GLA+ AP + V+ T Y APE + K+ D+++ G + ELLT
Sbjct: 155 DLGLARLFNAPL-KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 36/273 (13%)
Query: 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+GEG G V G VA+K++ QQ + EV ++ HH N+V + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
D + + E + G+L + + ++ E + L R L+YLH V
Sbjct: 90 VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 139
Query: 396 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 451
IHRD K+ +ILL ++ K++DFG ++K+ P+ ++ ++GT ++APE
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS------LVGTPYWMAPEVISRL 193
Query: 452 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 511
+ D++S G++++E++ G P + P L+ R+ + PR+
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKD 240
Query: 512 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+ +R + E +QR T E++Q
Sbjct: 241 SHKVSSVLR--GFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 276 ILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEF---LVEVEMLS-RLHHRNLVKL 330
+LG+G FG+VF L AIK L D + +VE +LS H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 331 VGYYSSRDSSQHLL-CYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLH 388
Y + + ++L E + G L + +CH D A + GL +LH
Sbjct: 62 ---YCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLH 113
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMGTFGYVAPE 446
+++RD K NILL+ + H K+ADFG+ K+ + +T GT Y+APE
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAPE 166
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ D +S+GV+L E+L G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 270 NFEPASILGEGGFGRVFKGVLSDGTA------VAIKRLTCGGQQGDKEFLVEVEMLSRLH 323
+ E +G G FGRV +AI + Q+ + E +L +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE--QHVHNEKRVLKEVS 59
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAA 381
H +++L +++ D + E VP G L S+L G + L + + + AL+
Sbjct: 60 HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE-- 115
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
YLH +++RD K NILL+ H K+ DFG AK+ + RT L GT
Sbjct: 116 ----YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWTLC----GTPE 163
Query: 442 YVAPE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 483
Y+APE GH D ++ G+++ E+L G P P G
Sbjct: 164 YLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 38/224 (16%)
Query: 266 EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL 322
E + ++ S +G G +G+V + G VAIK+L+ Q K E+ +L +
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLES----WLHGPL-GVNCH-------LDW 370
H N++ L+ ++ P SLE +L L G + + L
Sbjct: 72 DHENVIGLLDVFT--------------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD 117
Query: 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430
+ + RGL Y+H +IHRD K SNI + + K+ DFGLA+ + T
Sbjct: 118 DHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG 174
Query: 431 YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGR 473
Y++TR Y APE + H D++S G ++ ELLTG+
Sbjct: 175 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
A + GL +LHE +I+RD K N+LL++ H K+ADFG+ K EG ++T
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155
Query: 437 M-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVD 477
GT Y+APE ++ + D ++ GV+L E+L G+ P +
Sbjct: 156 FCGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 77/252 (30%), Positives = 106/252 (42%), Gaps = 49/252 (19%)
Query: 293 GTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL--CYE 347
G VAIK L + + + F E + +RL+H N+V L+ S ++ LL +E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFE 59
Query: 348 LVPNGSLESWL--HGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS 403
VP +L L G L G L M LDA LA H ++HRD K
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRL-----MLQVLDA---LACAHNQG---IVHRDLKPQ 108
Query: 404 NILL---ENNFHAKVADFGLAKQAPEGR-----TNYLSTRVMGTFGYVAPEYAMTGHLLV 455
NI++ HAKV DFG+ P R T +T V+GT Y APE +
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 456 KSDVYSYGVVLLELLTGRK----------------PVDMSQPSGQEN--LVTWARPILRD 497
SD+Y++G++ LE LTG++ PVD+S P L R L
Sbjct: 169 NSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228
Query: 498 KDRLEELADPRL 509
R + P L
Sbjct: 229 DPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNL 327
NF+ LGEG + V+KG + G VA+K + ++G + E+ ++ L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
V+L + ++ +L +E + + L+ ++ GV LD T +G+A+
Sbjct: 61 VRL--HDVIHTENKLMLVFEYM-DKDLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
HE+ V+HRD K N+L+ K+ADFGLA+ A N S V+ T Y AP+
Sbjct: 117 HENR---VLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 448 AMTGHLLVKS-DVYSYGVVLLELLTGR 473
+ S D++S G ++ E++TGR
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC-GGQQGDKEFLV-EVEMLSRLH---H 324
+EP + +G G +G V+K G VA+K + + G V EV +L RL H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 325 RNLVKLVGYYSSRDSSQHL---LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALD 379
N+V+L+ ++ + + L +E V + L ++L P G L ET +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG----LPAETIKDLMRQ 116
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
RGL +LH + C++HRD K NIL+ + K+ADFGLA+ T V+ T
Sbjct: 117 FLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVT 170
Query: 440 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 476
Y APE + D++S G + E+ RKP+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 277 LGEGGFGRV----------FKGVLSDG-----TAVAIKRLTCGGQQGDK-EFLVEVEMLS 320
LGEG FG V F G + VA+K L + + +FL E++++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSL---------ESWLHGPLGVNCHLD 369
RL + N+++L+G S D LC E + NG L ES + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPS-VS 127
Query: 370 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
+ +A+ A G+ YL + +HRD N L+ N++ K+ADFG+++ G
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
+ R + ++A E + G SDV+++GV L E+ T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 37/222 (16%)
Query: 277 LGEGGFGRVFKGVLSDG-----------TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-H 323
LGEG FG+V V+++ T VA+K L + D + + E+EM+ +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-CH---------LDWE 371
H+N++ L+G ++D +++ E G+L +L P G+ C+ L ++
Sbjct: 83 HKNIINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431
+ A ARG+ YL S+ C IHRD A N+L+ + K+ADFGLA+ +Y
Sbjct: 141 DLVSCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHH--IDY 195
Query: 432 LSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
G ++APE +SDV+S+GV+L E+ T
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 45/229 (19%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-----KEFLVEVEMLSRLH 323
++P +G G +G V + G VAIK++ D K L E+++L
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI---PHAFDVPTLAKRTLRELKILRHFK 62
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSL-----------ESWLHGPLGVNCHLDWET 372
H N++ + RD L P G+ ES LH + + L E
Sbjct: 63 HDNIIAI------RDI--------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH 108
Query: 373 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRT 429
RGL Y+H VIHRD K SN+L+ + ++ DFG+A+ +P
Sbjct: 109 IRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 430 NYLSTRVMGTFGYVAPE--YAMTGHLLVKSDVYSYGVVLLELLTGRKPV 476
++ T + T Y APE ++ + D++S G + E+L GR+ +
Sbjct: 166 YFM-TEYVATRWYRAPELLLSLPEYTT-AIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 275 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKLV 331
++G+G +G V + G VAIK++ + L E+++L L H ++V++
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 332 GYY---SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
S R+ + +EL +ES LH + N L E R L Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFEL-----MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEY 447
+ V HRD K NIL + K+ DFGLA+ A + T T + T Y APE
Sbjct: 121 TAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 176
Query: 448 AMTGHLLVKS----DVYSYGVVLLELLTGR 473
+ G K D++S G + E+LTG+
Sbjct: 177 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 36/227 (15%)
Query: 266 EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL 322
E + P +G G +G V S+ VAIK++ + K L E+++L L
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL 61
Query: 323 HHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 379
H N++ + + R++ + + YEL +++ LH + + L +
Sbjct: 62 DHENVIAIKDIMPPPHREAFNDVYIVYEL-----MDTDLHQIIRSSQTLSDDHCQYFLYQ 116
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR---TNYLSTRV 436
RGL Y+H + V+HRD K SN+LL N K+ DFGLA+ E T Y+ TR
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR- 172
Query: 437 MGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV 476
Y APE LL+ DV+S G + ELL GRKP+
Sbjct: 173 ----WYRAPE------LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 35/215 (16%)
Query: 276 ILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFL---------VEVEMLSRL 322
+LG+G FG+VF K D G A+K L K L +E ++L+ +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEV 55
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAA 381
+H +VKL +Y+ + + L + + G L + L + + E +K L + A
Sbjct: 56 NHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELA 108
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
L +LH +I+RD K NILL+ H K+ DFGL+K++ + S GT
Sbjct: 109 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 163
Query: 442 YVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKP 475
Y+APE GH +D +S+GV++ E+LTG P
Sbjct: 164 YMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRLH 323
N+ +LG+G FGRV+ D G +A K++ + + V E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAA 381
H +V+ G R + E +P GS++ L +G L + TR K
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV-----TR-KYTRQIL 116
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR-VMGTF 440
G++YLH + ++HRD K +NIL ++ + K+ DFG +K+ + R V GT
Sbjct: 117 EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+++PE K+DV+S G ++E+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 277 LGEGGFGRVFKGVLSDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGY 333
LG+G +G V+K VL T V A+K + + + ++E+++L + +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
+ + +C E + GSL+ L+ + + +I +GL +L E+
Sbjct: 68 FFIEGAV--YMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTRVMGTFGYVAPEYAMTG 451
+IHRD K +N+L+ N K+ DFG++ A +TN +G Y+APE +G
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN------IGCQSYMAPERIKSG 176
Query: 452 HLL------VKSDVYSYGVVLLELLTGRKP 475
V+SDV+S G+ +LE+ GR P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 276 ILGEGGFGRVFKGVLS----DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
ILG G FG + +G L VAI R C +Q + FL E L + H N+V+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFDHSNIVR 70
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389
L G + + ++ E + NG+L+S+L G L M + A G+ YL E
Sbjct: 71 LEGVITR--GNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSE 125
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG--TFGYVAPEY 447
+H+ A +L+ ++ K++ F + E ++ + T + G + APE
Sbjct: 126 MG---YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 448 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 479
H SDV+S+G+V+ E+++ G +P DMS
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 323
+E +GEG +G VFK VA+KR+ D E L E+ +L L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKELK 57
Query: 324 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
H+N+V+L Y S + L L +E + L+ + N +D E +
Sbjct: 58 HKNIVRL---YDVLHSDKKLTLVFEYC-DQDLKKYFDS---CNGDIDPEIVKSFMFQLLK 110
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
GLA+ H + V+HRD K N+L+ N K+ADFGLA+ Y S V+ T Y
Sbjct: 111 GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWY 165
Query: 443 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 476
P+ L S D++S G + EL +P+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 20/228 (8%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNL 327
EP +G G FG V+ DG VA+K++ Q K E++ML H N+
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 328 VKLVGYYSSRDSSQ--HLLCYE--LVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAAR 382
+ + D Q H+ +E V ++S LH + L + +K+ L R
Sbjct: 62 LSAL------DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILR 114
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
GL YLH ++HRD K N+L+ +N K+ DFGLA+ + +++ V+ + Y
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 443 VAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489
APE M + H D++S G + ELL R P Q +L+T
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 271 FEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDKEF--LVEVEMLSRLH--- 323
+E + +GEG +G+VFK + + G VA+KR+ + + EV +L L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 324 HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 380
H N+V+L V S D L L +E V + L ++L + ET +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDK--VPEPGVPTETIKDMMFQL 119
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
RGL +LH V+HRD K NIL+ ++ K+ADFGLA+ T V+ T
Sbjct: 120 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 173
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 476
Y APE + D++S G + E+ RKP+
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+GEG G V V S G VA+K++ QQ + EV ++ H N+V++ Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
D + + E + G+L + + ++ E + L + L+ LH V
Sbjct: 88 VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLKALSVLHAQG---V 137
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV 455
IHRD K+ +ILL ++ K++DFG Q + S ++GT ++APE
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGP 195
Query: 456 KSDVYSYGVVLLELLTGRKP 475
+ D++S G++++E++ G P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 333
+G G +G V + G VAIK+L+ Q K E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 334 YSSRDSSQHLLCYELV-PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
++S S + LV P +++ L +G L + + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMP--YMQTDLQKIMGH--PLSEDKVQYLVYQMLCGLKYIHSAG- 137
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG- 451
+IHRD K N+ + + K+ DFGLA+ A T Y+ TR Y APE +
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWM 190
Query: 452 HLLVKSDVYSYGVVLLELLTGR 473
H D++S G ++ E+LTG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 25/285 (8%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLHHR 325
NF+ +G G F V++ L D VA+K++ + ++ + E+++L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
N++K + + + +L EL G L + + T K + +
Sbjct: 63 NVIKYLDSFIEDNELNIVL--ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
++H V+HRD K +N+ + K+ D GL + T S ++GT Y++P
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
E KSD++S G +L E+ + P + NL + + ++E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLFSLCQ-------KIEQCD 224
Query: 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550
P L ++ E + ++ C+ P+ +QRP +G V Q K +
Sbjct: 225 YPPLPTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
A + + GL +LH +I+RD K N++L++ H K+ADFG+ K E + ++TR
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160
Query: 437 M-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
GT Y+APE D ++YGV+L E+L G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 66/259 (25%), Positives = 100/259 (38%), Gaps = 73/259 (28%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVE---------- 317
++FE ++G G FG V D G A+K+L K ++E E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERD 53
Query: 318 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI- 376
+L+ + +VKL YYS +D + L E +P G + + L + + + ETR I
Sbjct: 54 ILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIA 108
Query: 377 ----ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------- 422
A+D+ L Y IHRD K N+LL+ H K++DFGL
Sbjct: 109 ETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
Query: 423 -----------QAPEGRTNYLSTR---------------VMGTFGYVAPEYAMTGHLLVK 456
S R +GT Y+APE + +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219
Query: 457 SDVYSYGVVLLELLTGRKP 475
D +S GV++ E+L G P
Sbjct: 220 CDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTA-VAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 325
N FE ++GEG +G V K + VAIK+ + ++ + L E++ML L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
N+V+L + R + L +E V LE P GV + R I + +
Sbjct: 61 NIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGV---PPEKVRSYI-YQLIKAIH 114
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR-TNYLSTRVMGTFGYVA 444
+ H++ ++HRD K N+L+ +N K+ DFG A+ EG NY T + T Y +
Sbjct: 115 WCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYVATRWYRS 169
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
PE + D++S G +L EL G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 276 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKE-FLVEVEMLSRLH-HRNLVKL 330
+LG+G FG+V L G A+K L Q D E + E +LS H L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGLAYLHE 389
Y + + E V G L + E R + A + L +LH+
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHD 114
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGYVAPEYA 448
+I+RD K N+LL++ H K+ADFG+ K EG N +T GT Y+APE
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
D ++ GV+L E+L G P +
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 41/106 (38%), Positives = 58/106 (54%), Gaps = 15/106 (14%)
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
A + A GL +LH +I+RD K N++L+ H K+ADFG+ K E +TR
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160
Query: 437 M-GTFGYVAPE---YAMTGHLLVKS-DVYSYGVVLLELLTGRKPVD 477
GT Y+APE Y G KS D +++GV+L E+L G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEML 319
E+ + + + +G G +G V + G VAIK+L Q K E+ +L
Sbjct: 12 EVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 320 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWETR 373
+ H N++ L+ ++ S + LV G L H L E R
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLS-------EDR 119
Query: 374 MK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432
++ + +GL Y+H +IHRD K N+ + + K+ DFGLA+Q T Y+
Sbjct: 120 IQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYV 176
Query: 433 STRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 473
TR Y APE + H D++S G ++ E+LTG+
Sbjct: 177 VTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 72/239 (30%), Positives = 98/239 (41%), Gaps = 43/239 (17%)
Query: 270 NFEPASILGEGGFGRVF----KGVLSDGTAVAIKRL---TCGGQQGDKEF-LVEVEMLSR 321
NFE +LG G +G+VF G G A+K L T + E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
+ + + Y D+ HL+ + V G L + L+ R
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLI-LDYVNGGELFTHLY------------QREHFTESEV 107
Query: 382 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNY 431
R L +LH Q +I+RD K NILL++ H + DFGL+K+ A E Y
Sbjct: 108 RVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164
Query: 432 LSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKP--VDMSQPSGQE 485
GT Y+APE GH D +S GV+ ELLTG P VD Q S E
Sbjct: 165 ---SFCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 277 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKL 330
+GEG FG K +L DG IK + + E EV +LS + H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 331 VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLA 385
Y S + + +L + + G L ++ GV + LDW ++ +AL
Sbjct: 64 --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------ 115
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
++H+ ++HRD K+ NI L + K+ DFG+A+ T L+ +GT Y++P
Sbjct: 116 HVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSP 170
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT 471
E KSD+++ G VL E+ T
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 47/138 (34%), Positives = 71/138 (51%), Gaps = 15/138 (10%)
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
GL +LH +I+RD K N++L+ + H K+ADFG+ K+ G ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV-----DMSQPSGQENLVTWARPILRD 497
+APE D +S+GV+L E+L G+ P D S + + + R I ++
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE 222
Query: 498 -KDRLEEL--ADP--RLG 510
KD LE+L DP RLG
Sbjct: 223 SKDILEKLFERDPTRRLG 240
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 3e-11
Identities = 58/231 (25%), Positives = 106/231 (45%), Gaps = 16/231 (6%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+G+G G VF + ++ G VAIK++ Q + + E+ ++ L + N+V + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
D + + E + GSL + +D + + + L +LH + V
Sbjct: 87 VGD--ELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHANQ---V 136
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 454
IHRD K+ N+LL + K+ DFG Q PE + ++GT ++APE
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYG 193
Query: 455 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEEL 504
K D++S G++ +E++ G P P L+ T P L++ ++L +
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 277 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+GEG G V S G VA+K++ QQ + EV ++ H N+V++ Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
D ++ E + G+L + + ++ E + L + L++LH V
Sbjct: 87 VGDELWVVM--EFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQG---V 136
Query: 396 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 451
IHRD K+ +ILL ++ K++DFG ++K+ P ++ ++GT ++APE
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS------LVGTPYWMAPEVISRL 190
Query: 452 HLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481
+ D++S G++++E++ G P P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEML 319
E+ E N P +G G +G V VA+K+L+ Q + E+ +L
Sbjct: 12 EVPERYQNLTP---VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 320 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG--VNCH-LDWETRMKI 376
+ H N++ L+ ++ S ++ LV N + L V C L E +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTN-----LMGADLNNIVKCQKLSDEHVQFL 123
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
RGL Y+H +IHRD K SN+ + + ++ DFGLA+QA + T Y++TR
Sbjct: 124 IYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR- 179
Query: 437 MGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 473
Y APE + H D++S G ++ ELL G+
Sbjct: 180 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
GL +LH+ +I+RD K N+LL+ + H K+ADFG+ K+ G ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 443 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
+APE + G +S D +S+GV+L E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 334
+G+G G V+ + ++ G VAIK++ QQ KE ++ E+ ++ + N+V + Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
D + + E + GSL + +D + + + L +LH +
Sbjct: 86 LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSNQ--- 135
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
VIHRD K+ NILL + K+ DFG Q PE + ++GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 192
Query: 454 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRL 501
K D++S G++ +E++ G P P L+ T P L++ +RL
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 60/232 (25%), Positives = 90/232 (38%), Gaps = 25/232 (10%)
Query: 270 NFEPASILGEGGFGRVFKGVLSDGTA--VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 327
+ L G GRVF G V +K GQ+G L+E +L ++H ++
Sbjct: 67 GYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSV 119
Query: 328 VKLVGYYSSRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
+++ S + C L P + L ++L L + + I GL
Sbjct: 120 IRMKDTLVSGA----ITCMVL-PHYSSDLYTYLTKRSR---PLPIDQALIIEKQILEGLR 171
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
YLH +IHRD K NI + + + D G A Q P +L + GT AP
Sbjct: 172 YLH---AQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLG--LAGTVETNAP 225
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
E K+D++S G+VL E+L + PS E V L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 277 LGEGGFGRVFK----GVLSD----GTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 326
LGEG FG+V + G+ VA+K L D L+ E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 374
++ L+G +++ +++ E G+L +L P G + D ++ +
Sbjct: 80 IINLLGV-CTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
A ARG+ YL +S+ C IHRD A N+L+ + K+ADFGLA+ + +Y
Sbjct: 138 SCAYQVARGMEYL--ESRRC-IHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKK 192
Query: 435 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
G ++APE +SDV+S+G+++ E+ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 24/163 (14%)
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
LA H S+ +IHRD K++NILL +N K+ DFG +K ++ + GT YV
Sbjct: 154 LAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503
APE K+D++S GV+L ELLT ++P D + +EE
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPF--------------------DGENMEE 252
Query: 504 LADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVV 543
+ L G+Y P + I A ++ + +RP+ +++
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 277 LGEGGFGRV---FKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLVKLV 331
+G G G V F VL G VA+K+L+ Q K E+ +L ++H+N++ L+
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 332 GYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
++ + S + L EL+ + +L +H LD E + G+ +L
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIH------MELDHERMSYLLYQMLCGIKHL 139
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
H +IHRD K SNI+++++ K+ DFGLA+ A TN++ T + T Y APE
Sbjct: 140 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEV 193
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTG 472
+ D++S G ++ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 35/193 (18%)
Query: 368 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427
LD + ++ + A+G+ +L S+ C IHRD A N+LL + AK+ DFGLA+
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL--ASKNC-IHRDVAARNVLLTDGRVAKICDFGLARDI-MN 264
Query: 428 RTNYLSTRVMGT----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPS 482
+NY+ V G ++APE V+SDV+SYG++L E+ + G+ P P
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY----PG 317
Query: 483 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMG 540
IL + + + G + + DF + +I C E +RPT
Sbjct: 318 -----------ILVNSKFYKMVKR---GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFS 363
Query: 541 EVVQSLKMVQRVI 553
++ Q ++QR +
Sbjct: 364 QISQ---LIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 55/219 (25%)
Query: 277 LGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEF--------LVEVEMLSRL-HHRN 326
+GEG F V K G AIK + K F L E++ L RL H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 327 LVKLVGY-YSSRDSSQHLLC-------YELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
+++L+ + + L+ YEL+ PL E R+K +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKG------RKRPLP-------EKRVKSYM 106
Query: 379 -DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK----QAPEGRTNYLS 433
+ L ++H + + HRD K NIL++++ K+ADFG + + P T Y+S
Sbjct: 107 YQLLKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYIS 160
Query: 434 TRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLT 471
TR Y APE +T G+ K D+++ G V E+L+
Sbjct: 161 TR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 276 ILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN---LV 328
I+G GGFG V+ +D G A+K L +QG+ L E MLS + + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 329 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARG 383
+ + + D LC+ +L+ G L L HG E M+ A + G
Sbjct: 61 CMTYAFHTPDK----LCFILDLMNGGDLHYHLSQHGVFS-------EKEMRFYATEIILG 109
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----KQAPEGRTNYLSTRVMGT 439
L ++H V++RD K +NILL+ + H +++D GLA K+ P +GT
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGT 158
Query: 440 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
GY+APE G S D +S G +L +LL G P
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 18/232 (7%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 334
+G+G G V+ + ++ G VAI+++ QQ KE ++ E+ ++ + N+V + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
D + + E + GSL + +D + + + L +LH +
Sbjct: 87 LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
VIHRD K+ NILL + K+ DFG Q PE + ++GT ++APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 193
Query: 454 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEEL 504
K D++S G++ +E++ G P P L+ T P L++ ++L +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 276 ILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN---LV 328
I+G GGFG V+ +D G A+K L +QG+ L E MLS + + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 329 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARG 383
+ + + D L + +L+ G L L HG E M+ A + G
Sbjct: 61 CMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFS-------EAEMRFYAAEIILG 109
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----KQAPEGRTNYLSTRVMGT 439
L ++H V++RD K +NILL+ + H +++D GLA K+ P +GT
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGT 158
Query: 440 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
GY+APE G S D +S G +L +LL G P
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 68/232 (29%), Positives = 96/232 (41%), Gaps = 59/232 (25%)
Query: 271 FEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKEFLV---EVEML---- 319
F ++LG G FG+V +L++ G AIK L K ++ EVE L
Sbjct: 1 FRCLAVLGRGHFGKV---LLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEK 50
Query: 320 ------SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+ H LV L + + D E G L +H H D +
Sbjct: 51 RIFETANSERHPFLVNLFACFQTEDHV--CFVMEYAAGGDL--MMH------IHTDVFSE 100
Query: 374 MKIALDAAR---GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGR 428
+ AA GL YLHE+ +++RD K N+LL+ K+ADFGL K+ R
Sbjct: 101 PRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157
Query: 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKP 475
T ST GT ++APE L S D + GV++ E+L G P
Sbjct: 158 T---ST-FCGTPEFLAPEV-----LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 40/226 (17%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTC----GGQQGDKEF----------LVEVEMLSR 321
LGEG +G+V K G VAIK++ D++ L E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
+ H N++ LV Y D ++ + S L + L I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDI-------MASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-------------KQAPEGR 428
GL LH+ +HRD +NI + + K+ADFGLA K R
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
++++V+ T Y APE M + D++S G + ELLTG+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 41/280 (14%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLHHR 325
NF +G G F V++ L DG VA+K++ + + + E+++L +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 326 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM-------KIA 377
N++K YY+S L + EL G L + H + R+ K
Sbjct: 63 NVIK---YYASFIEDNELNIVLELADAGDLSRMIK-------HFKKQKRLIPEKTVWKYF 112
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
+ L ++H V+HRD K +N+ + K+ D GL + T S ++
Sbjct: 113 VQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LV 167
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
GT Y++PE KSD++S G +L E+ + P + NL + +
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCK----- 218
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 537
++E+ P L + E+ ++ + C+ P+ +RP
Sbjct: 219 --KIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 56/291 (19%)
Query: 277 LGEGGFGRVFKGVL---SDG--------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR 325
LG+G F ++KGVL SD +V +K L + F ++S+L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIALDAARGL 384
+LVKL G RD ++++ E V G L+ +LH V+ H W ++ +A A L
Sbjct: 62 HLVKLYG-VCVRD--ENIMVEEYVKFGPLDVFLHREKNNVSLH--W--KLDVAKQLASAL 114
Query: 385 AYLHEDSQPCVIHRDFKASNILL-------ENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
YL ED + ++H + NIL+ K++D G+ R+
Sbjct: 115 HYL-EDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI- 168
Query: 438 GTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495
++APE G L + +D +S+G LLE+ + +S S E +
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICS-NGEEPLSTLSSSEKERFY----- 219
Query: 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
+D+ RL L + I C + +RP+ +++ L
Sbjct: 220 QDQHRLPMPDCAELA------NLIN------QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 326
NF+ +GEG +G V+K G VA+K RL + + E+ +L L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIAL-DAARG 383
+VKL+ + + L +E + + L+ ++ G+ L +K L +G
Sbjct: 61 IVKLLDVIHTENKL--YLVFEFL-HQDLKKFMDASPLSGIPLPL-----IKSYLFQLLQG 112
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
LA+ H V+HRD K N+L+ K+ADFGLA+ Y T + T Y
Sbjct: 113 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 167
Query: 444 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 473
APE + + D++S G + E++T R
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 46/230 (20%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLH 323
+ +++ +I+G G FG V++ + D + VAIK++ Q ++E L+ + L+
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLN 117
Query: 324 HRNLVKLVGYY---SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-- 378
H N++ L YY + + +++ N +E P V+ ++ R AL
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFL-----NVVME---FIPQTVHKYMKHYARNNHALPL 169
Query: 379 --------DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGR- 428
R LAY+H + HRD K N+L++ N H K+ DFG AK G+
Sbjct: 170 FLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226
Query: 429 -TNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTG 472
+Y+ +R Y APE + T H+ D++S G ++ E++ G
Sbjct: 227 SVSYICSRF-----YRAPELMLGATNYTTHI----DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 276 ILGEGGFGRVFKGVL-SDGTAVAIKRL---TCGGQQGDKEFLVEVE-MLSRLHHRNLVKL 330
++G+G FG+V SDG+ A+K L T ++ + E +L L H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+YS + + + + V G L L C L+ R A + A + YLH
Sbjct: 62 --HYSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARF-YAAEVASAIGYLHSL 115
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMGTFGYVAPEYA 448
+ +I+RD K NILL++ H + DFGL K+ PE T+ GT Y+APE
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC----GTPEYLAPEVL 168
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPV---DMSQ 480
D + G VL E+L G P D+SQ
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 71/224 (31%), Positives = 95/224 (42%), Gaps = 46/224 (20%)
Query: 270 NFEPASILGEGGFGRV----FKGVLSDGTAVAIKRL----TCGGQQGDKEFLVEVEMLSR 321
+FE LG G FGRV KG G AIK L +Q E +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQ-HVAQEKSILME 74
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
L H +V ++ + + LL E V G L + HL + D A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLL--EFVVGGELFT----------HL--RKAGRFPNDVA 120
Query: 382 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433
+ YLH +I+RD K N+LL+N H KV DFG AK+ P+ RT L
Sbjct: 121 KFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFTLC 176
Query: 434 TRVMGTFGYVAPEYAMT-GHLLVKS-DVYSYGVVLLELLTGRKP 475
GT Y+APE + GH K+ D ++ GV+L E + G P
Sbjct: 177 ----GTPEYLAPEVIQSKGH--GKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 30/229 (13%)
Query: 270 NFEPASILGEGGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 326
+ ++GEG FGR + V SD A+K + E E +L+++ H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 327 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAA 381
+V + S ++ HL + E G L + G + L W +M +
Sbjct: 60 IV---AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL----- 111
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGT 439
G+ ++HE V+HRD K+ NI L N K+ DFG A+ +P Y T V GT
Sbjct: 112 -GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GT 163
Query: 440 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 488
YV PE KSD++S G +L EL T + P Q + +NL+
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF---QANSWKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 34/173 (19%)
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
E+E+L ++H N+VK + Q LL E + GSLE H+ E +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLL--EFMDGGSLE---------GTHIADEQFL 170
Query: 375 KIALDAAR----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430
D AR G+AYLH ++HRD K SN+L+ + + K+ADFG+++ +
Sbjct: 171 A---DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 431 YLSTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLELLTGRKP 475
S+ +GT Y++PE T G+ D++S GV +LE GR P
Sbjct: 225 CNSS--VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 435
A + L +LH VI+RD K NILL+ H K+ADFG+ K EG N +T
Sbjct: 102 AAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GT Y+APE D ++ GV++ E++ G+ P
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 31/231 (13%)
Query: 262 EELKEATNNFEPASILGEGGFGRVFKGVLSDGT--AVAIKRL----TCGGQQGDKEFLVE 315
+ K +F LG G FGRV + VAIKR +Q D F E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SE 81
Query: 316 VEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWE 371
++L+ ++H V L G S +D S L E V G ++L P V C +
Sbjct: 82 RKILNYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF--YA 137
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431
++ + + + L +++RD K N+LL+ + K+ DFG AK + RT
Sbjct: 138 AQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTYT 187
Query: 432 LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481
L GT Y+APE + GH +D ++ G+ + E+L G P ++P
Sbjct: 188 LC----GTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
L YLHE +I+RD K N+LL++ H K+ D+G+ K+ R ++ GT Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNY 162
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 478
+APE D ++ GV++ E++ GR P D+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFGY 442
L +LHE +I+RD K N+LL+ H K+ D+G+ K EG R ++ GT Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNY 162
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM--SQPSGQEN 486
+APE D ++ GV++ E++ GR P D+ + +N
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL--V 331
+GEG +G V+KG G VA+K RL + + E+ +L L H N+V L V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 332 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
SR L +E + + L+ +L L ++D E +G+ + H
Sbjct: 68 LMQESR----LYLIFEFL-SMDLKKYLDS-LPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 451
V+HRD K N+L++N K+ADFGLA+ G + T + T Y APE +
Sbjct: 122 ---VLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 452 HLL-VKSDVYSYGVVLLELLTGRKPV 476
D++S G + E+ T +KP+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 22/231 (9%)
Query: 277 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+GEG G V G VA+K + QQ + EV ++ H+N+V++ Y S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--YKS 86
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+ + E + G+L + L+ E + + L YLH V
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---V 138
Query: 396 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 451
IHRD K+ +ILL + K++DFG ++K P+ ++ ++GT ++APE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMAPEVISRT 192
Query: 452 HLLVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTWARPILRDKDRL 501
+ D++S G++++E++ G P P + L P L++ ++
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
A + A GL +LH +I+RD K N++L++ H K+ADFG+ K E + ++T+
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160
Query: 437 M-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
GT Y+APE D +++GV+L E+L G+ P +
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGYY 334
LGEG + V+KG+ +G VA+K ++ ++G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
++++ + E + + + P G++ + RGLAY+H
Sbjct: 73 HTKETLTFVF--EYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRGLAYIHGQH--- 123
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 454
++HRD K N+L+ K+ADFGLA+ Y S V T Y P+ + G
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGATD 180
Query: 455 VKS--DVYSYGVVLLELLTGR 473
S D++ G + +E+L G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 7/93 (7%)
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGY 442
L YLH V++RD K N++L+ + H K+ DFGL K EG ++ + + GT Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+APE D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 50/241 (20%)
Query: 270 NFEPASILGEGGFGRVF---------------KGVLSDGTAVAIKRLTCGGQQGDKEFLV 314
NFE +LG G +G+VF VL T V + T +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTT-------EHTRT 53
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
E ++L + + + Y D+ HL+ + + G L + HL R
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLI-LDYINGGELFT----------HLSQRERF 102
Query: 375 K------IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428
K + + L +LH+ +I+RD K NILL++N H + DFGL+K+ E
Sbjct: 103 KEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159
Query: 429 TNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 485
+ GT Y+AP+ GH D +S GV++ ELLTG P + G++
Sbjct: 160 VER-AYSFCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTV---DGEK 214
Query: 486 N 486
N
Sbjct: 215 N 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 25/162 (15%)
Query: 330 LVGYYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAY 386
+V + S ++ +HL + E V G + L G L V+ RM A + L Y
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-----ARMYFA-ETVLALEY 116
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-------------YLS 433
LH ++HRD K N+L+ + H K+ DFGL+K T +L
Sbjct: 117 LHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+V GT Y+APE + D ++ G++L E L G P
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGYY 334
LGEG + VFKG VA+K + ++G + EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-HLDWETRMKIAL-DAARGLAYLHEDSQ 392
+ L +E + + L+ +L NC +L +KI + RGL+Y H+
Sbjct: 73 HTERCLT--LVFEYLDS-DLKQYLD-----NCGNLMSMHNVKIFMFQLLRGLSYCHKRK- 123
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TG 451
++HRD K N+L+ K+ADFGLA+ A T S V+ T Y P+ + +
Sbjct: 124 --ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 452 HLLVKSDVYSYGVVLLELLTGR 473
D++ G +L E+ TGR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
L +LHE +I+RD K N+LL+ + H K+ D+G+ K+ ++ GT Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNY 162
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 478
+APE D ++ GV++ E++ GR P D+
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 53/173 (30%), Positives = 75/173 (43%), Gaps = 24/173 (13%)
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
+ ARG+ +L S+ C IHRD A NILL N K+ DFGLA+ +
Sbjct: 180 SFQVARGMEFLA--SRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 437 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 495
++APE +SDV+S+GV+L E+ + G P P Q N R L
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQINEEFCQR--L 290
Query: 496 RDKDRLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
+D R+ E A P + I AC + +RPT +V+ L
Sbjct: 291 KDGTRMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 66/255 (25%), Positives = 103/255 (40%), Gaps = 58/255 (22%)
Query: 270 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRL---------TCGGQQGDKEFLVEVEML 319
+FE ++G G FG V D G A+K L G + +++ LVE + L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 320 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 379
+VK+ +YS +D L E +P G + + L + + + ET+ IA +
Sbjct: 62 W------VVKM--FYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIA-E 109
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNY------- 431
+ +H Q IHRD K N+LL++ H K++DFGL + RT +
Sbjct: 110 TVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 432 -------------------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVL 466
L+ +GT Y+APE M D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 467 LELLTGRKPVDMSQP 481
E+L G P P
Sbjct: 227 YEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTC-----GGQQGDKEFL---VEVEMLSRLHHRNLV 328
LG+G FG V+ ++ D AVA +RL G+ E + E ++LS+L H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 329 KLVGYYSSRDSSQHL--LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALDAARGL 384
K + RD+ + C + LE H L N +W ++ + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
Y+H+ ++HRD KA NI L+NN K+ DFG+++ G + L+T GT Y++
Sbjct: 120 HYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCD-LATTFTGTPYYMS 173
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLEL 469
PE KSD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 2/99 (2%)
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446
L E ++HRD K++NI L K+ DFG +KQ + + +++ GT Y+APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 485
K+D++S GV+L ELLT +P PS +E
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP--FKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
+ ARG+ +L S+ C IHRD A NILL N K+ DFGLA+ +
Sbjct: 179 SFQVARGMEFL--ASRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 437 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWAR 492
++APE +SDV+S+GV+L E+ + G P V + + +
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR------- 288
Query: 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
L++ R+ + P+ + +I C RPT E+V+ L
Sbjct: 289 --LKEGTRM----------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 275 SILGEGGFGRVFKGVLSDGTAV-------AIKRLTCGGQQGDKEFL-VEVEMLSRLHHRN 326
+LG+GG+G+VF+ G +K+ T Q D E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAAR--- 382
+V L+ Y+ + + L E + G L HL+ R I + D A
Sbjct: 62 IVDLI--YAFQTGGKLYLILEYLSGGELFM----------HLE---REGIFMEDTACFYL 106
Query: 383 -----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
L +LH Q +I+RD K NILL+ H K+ DFGL K++ ++
Sbjct: 107 SEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTVTHTFC 161
Query: 438 GTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKP 475
GT Y+APE M +GH K+ D +S G ++ ++LTG P
Sbjct: 162 GTIEYMAPEILMRSGH--GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRN 326
+++E LGEG + V+KG +G VA+K + ++G + E +L L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLA 385
+V L ++++ L +E V + P G+ H + +K+ L RGL+
Sbjct: 65 IVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGL--HPE---NVKLFLFQLLRGLS 117
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
Y+H Q ++HRD K N+L+ + K+ADFGLA+ Y + V T Y P
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPP 172
Query: 446 EYAM-TGHLLVKSDVYSYGVVLLELLTG 472
+ + + D++ G + +E++ G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 325
+ +E +GEG +G+V+K + G VA+K RL + L E+ +L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 326 N-LVKLVGYYSSRDSSQHLLCYELV---PNGSLESWLHGPLGVNCH-LDWETRMKIALDA 380
+V+L+ + + Y LV + L+ ++ L +T
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLY-LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGT 439
+G+A+ H+ V+HRD K N+L++ K+AD GL + +Y T + T
Sbjct: 120 LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174
Query: 440 FGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTG 472
Y APE + H D++S G + E+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 276 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSR 321
+LG+G FG+V +L + G A+K L KE ++ E +L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILK-------KEVIIAKDEVAHTLTESRVLQN 51
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKI-AL 378
H L L YS + + LC+ E G L L + E R +
Sbjct: 52 TRHPFLTAL--KYSFQ--THDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGA 102
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM- 437
+ L YLH V++RD K N++L+ + H K+ DFGL K EG ++ + +
Sbjct: 103 EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC 156
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GT Y+APE D + GVV+ E++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 277 LGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGY 333
LGEG + V+KG L+D VA+K + ++G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL-DAARGLAYLHED 390
+ S L +E + + L+ +L G +N H +K+ L RGL Y H
Sbjct: 73 IHTEKSLT--LVFEYL-DKDLKQYLDDCGNS-INMH-----NVKLFLFQLLRGLNYCHRR 123
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM- 449
V+HRD K N+L+ K+ADFGLA+ A T S V+ T Y P+ +
Sbjct: 124 K---VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 450 TGHLLVKSDVYSYGVVLLELLTGR 473
+ + D++ G + E+ TGR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 271 FEPASILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 327
+ S L G G VF V +K +T G G E+++L + HR +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR-----EIDILKTISHRAI 148
Query: 328 VKLVGYYSSRDSSQHLLCYEL-VPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGL 384
+ L+ Y + +C + L +++ GPL + + + R+ L+A L
Sbjct: 149 INLIHAYRWKS----TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL---LEA---L 198
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
AYLH +IHRD K NI L+ +A + DFG A + GT +
Sbjct: 199 AYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS 255
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
PE K+D++S G+VL E+
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 70/257 (27%), Positives = 101/257 (39%), Gaps = 80/257 (31%)
Query: 271 FEPASILGEGGFGRVFKGVLSDGTAV--AIKRLTCGGQQGDKE----------FLVEVEM 318
F+ +LG+G GRVF V GT A+K L DK+ L E E+
Sbjct: 3 FKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVL-------DKKEMIKRNKVKRVLTEQEI 54
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK-I 376
L+ L H L L Y+S + +L L + P G L L K +
Sbjct: 55 LATLDHPFLPTL---YASFQTETYLCLVMDYCPGGELFRLLQ-----------RQPGKCL 100
Query: 377 ALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEG 427
+ + AR L YLH +++RD K NILL + H ++DF L+KQ E
Sbjct: 101 SEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157
Query: 428 R--------------------------TNYLSTRVMGTFGYVAPEY-AMTGHLLVKSDV- 459
++ S +GT Y+APE + GH S V
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVD 214
Query: 460 -YSYGVVLLELLTGRKP 475
++ G++L E+L G P
Sbjct: 215 WWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 12/113 (10%)
Query: 368 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427
LD E + + A+G+++L S+ C IHRD A NILL + K+ DFGLA+
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNC-IHRDLAARNILLTHGRITKICDFGLARDI-RN 266
Query: 428 RTNYLSTRVMGT----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+NY+ V G ++APE +SDV+SYG++L E+ + G P
Sbjct: 267 DSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKL 330
++G+G FG+V ++ A+K L ++ +K + E +L + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
++S + + + + + G L L C L+ R A + A L YLH
Sbjct: 62 --HFSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARF-YAAEIASALGYLHSL 115
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 450
+ +++RD K NILL++ H + DFGL K+ E N ++ GT Y+APE
Sbjct: 116 N---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCGTPEYLAPEVLHK 170
Query: 451 GHLLVKSDVYSYGVVLLELLTGRKP 475
D + G VL E+L G P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 47/160 (29%), Positives = 65/160 (40%), Gaps = 19/160 (11%)
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV--NCHLDWETRMKIALDAARG 383
N+V L Y S DS L + G L S + L + C W M +ALDA
Sbjct: 46 NMVCLHKYIVSEDSV--FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA--- 100
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
LH + C RD +NILL++ H ++ F + + + Y
Sbjct: 101 ---LHREGIVC---RDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 483
APE D +S G +L ELLTG+ V+ PSG
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 62/218 (28%), Positives = 87/218 (39%), Gaps = 50/218 (22%)
Query: 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL---- 330
LGEG + V+KG G VA+K + ++G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 331 --------VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
V Y D Q++ + G L V L R
Sbjct: 73 HTKKTLTLVFEYLDTDLKQYM---DDCGGG-----LS-MHNVRLFL---------FQLLR 114
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL--AKQAPEGRTNYLSTRVMGTF 440
GLAY H Q V+HRD K N+L+ K+ADFGL AK P + S V+ T
Sbjct: 115 GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVV-TL 167
Query: 441 GYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGR 473
Y P+ + + L D++ G + E+ TGR
Sbjct: 168 WYRPPDVLLGSTEYSTSL----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 435
+ALDA + + IHRD K N+LL+ + H K+ADFG + T
Sbjct: 153 LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 436 VMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 475
V GT Y++PE + G+ + D +S GV L E+L G P
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 52/256 (20%)
Query: 270 NFEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKEFLV--EVE 317
+FE ++G G FG V L + V +KR + +++ LV + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 318 MLSRLHH-----RNLVKLVGYYSSRDSSQHLLCYE-LVPNGSLESWLHGPLGVNCHLDWE 371
++ LH+ NL ++ YY D L +E +P +L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL------------- 108
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431
M IA+D+ L Y +HRD K NIL++ N H ++ADFG + E T
Sbjct: 109 AEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 158
Query: 432 LSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486
S+ +GT Y++PE AM G + D +S GV + E+L G P E+
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF------YAES 212
Query: 487 LVTWARPILRDKDRLE 502
LV I+ K+R +
Sbjct: 213 LVETYGKIMNHKERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 41/218 (18%)
Query: 277 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK------ 329
+G+G FG+V++ D A+K L+ KE + + E+ + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 330 ---LVGY-YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-------IAL 378
+VG +S + S L + + G L W HL E R IA
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FW---------HLQKEGRFSEDRAKFYIA- 103
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
+ L +LH+ +++RD K NILL+ H + DFGL+K N + G
Sbjct: 104 ELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCG 158
Query: 439 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
T Y+APE + K D +S GV++ E+ G P
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 19/217 (8%)
Query: 269 NNFEPASILGEGGFGRV---FKGVLSDGTAV-AIKRLTCGGQQGDKEFLVEVEMLSRLHH 324
+F+ S++G G FG V + D A+ +K+ Q+ F E ++LS +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 325 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
+ +L Y+ +D L E P G L S L N + D A +
Sbjct: 61 PWIPQLQ--YAFQDKDNLYLVMEYQPGGDLLSLL------NRYEDQFDEDMAQFYLAELV 112
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
+H Q +HRD K N+L++ H K+ADFG A + + S +GT Y+A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIA 171
Query: 445 PEY--AMTGHLL----VKSDVYSYGVVLLELLTGRKP 475
PE M G V+ D +S GV+ E++ GR P
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 276 ILGEGGFGRV-FKGVLSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
++G+G +G V +DG IK+L ++ K E ++LS+L H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLAYLH 388
+ D +++ G L L G N ++W ++ +AL YLH
Sbjct: 67 SWEGEDGLLYIV-MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------YLH 119
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
E ++HRD K N+ L KV D G+A+ E + + ST ++GT Y++PE
Sbjct: 120 EKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMAST-LIGTPYYMSPELF 174
Query: 449 MTGHLLVKSDVYSYGVVLLELLT 471
KSDV++ G + E+ T
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 42/214 (19%)
Query: 277 LGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL--- 330
LGEG + VFKG L++ VA+K + ++G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 331 ---------VGYYSSRDSSQHLL-CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 380
V Y +D Q++ C ++ +++ +L+ L
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL------------------ 114
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
RGLAY H V+HRD K N+L+ K+ADFGLA+ A T S V+ T
Sbjct: 115 -RGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TL 168
Query: 441 GYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGR 473
Y P+ + + + D++ G + E+ +GR
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 270 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 327
N +P +G + +L VAIK+L+ Q K E+ ++ ++H+N+
Sbjct: 28 NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 328 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
+ L+ ++ + S + + EL+ + + LD E + G
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 138
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T+++ T + T Y
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
APE + D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 270 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 327
N +P +G + VL VAIK+L+ Q K E+ ++ ++H+N+
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 328 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
+ L+ ++ + S + L EL+ + + LD E + G
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 131
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T+++ T + T Y
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 185
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 477
APE + D++S G ++ E L GR +D
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFG 441
L YLH +++RD K N++L+ + H K+ DFGL K EG T+ + + GT
Sbjct: 107 ALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPE 160
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
Y+APE D + GVV+ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 42/247 (17%)
Query: 270 NFEPASILGEGGFGRVF----KGVLSDGTAVAIKRL-TCGGQQGDK---EFLVEVEMLSR 321
NFE +LG G +G+VF G A+K L Q K E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
+ + + Y ++ HL+ + V G + + L+ R + D
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLI-LDYVSGGEMFTHLY------------QRDNFSEDEV 107
Query: 382 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNY 431
R L +LH+ +++RD K NILL++ H + DFGL+K+ + E Y
Sbjct: 108 RFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
Query: 432 LSTRVMGTFGYVAPEY--AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489
GT Y+APE GH D +S G+++ ELLTG P + ++ V+
Sbjct: 165 ---SFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
Query: 490 WARPILR 496
R IL+
Sbjct: 221 --RRILK 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKE-----FLVEVEMLSRLHHRNLV 328
+GEG +G V+K G VA+K RL + + E + E+ +L L+H N+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 329 KLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM----KIALDAA-- 381
+L S L L +E + LD + M LD
Sbjct: 62 RL---LDVVHSENKLYLVFEFL-----------------DLDLKKYMDSSPLTGLDPPLI 101
Query: 382 --------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433
+G+AY H V+HRD K N+L++ K+ADFGLA+ Y
Sbjct: 102 KSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-- 156
Query: 434 TRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKP 475
T + T Y APE + D++S G + E++ R+P
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFG 441
L YLH + V++RD K N++L+ + H K+ DFGL K EG + + + GT
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPE 161
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
Y+APE D + GVV+ E++ GR P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
YYS + ++ L E + G ++S LH + + D E +K + A L YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRHG- 124
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAK 422
+IHRD K N+L+ N H K+ DFGL+K
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTFG 441
L LH+ + VI+RD K NILL+ H + DFGL K + +TN GT
Sbjct: 106 LENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC----GTPE 158
Query: 442 YVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
Y+APE + GH K+ D ++ GV+L E+LTG P
Sbjct: 159 YLAPEL-LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 66/260 (25%), Positives = 100/260 (38%), Gaps = 66/260 (25%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLS--RLHHR 325
++FE ++G G FG V D G A+K L K ++E E ++ R
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53
Query: 326 NLVKLVG------YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI--- 376
LV+ G +YS +D L E +P G + + L + + + T+ I
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAET 110
Query: 377 --ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNY-- 431
A+DA L + IHRD K N+LL+ H K++DFGL + RT +
Sbjct: 111 VLAIDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 432 ------------------------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYS 461
L+ +GT Y+APE M D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 462 YGVVLLELLTGRKPVDMSQP 481
GV++ E+L G P P
Sbjct: 222 LGVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 17/110 (15%)
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG-LAKQAPEGRTN 430
M +A+D+ L Y +HRD K N+LL+ N H ++ADFG + +G
Sbjct: 109 AEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159
Query: 431 YLSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKP 475
S +GT Y++PE AM G + D +S GV + E+L G P
Sbjct: 160 --SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 37/245 (15%)
Query: 261 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGT-------AVAIKRLTCGGQQGDKEFL 313
Y++ + N +E +G G FG VF V T A++ + L ++ + +
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLK---EREKSQLV 60
Query: 314 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+EV ++ L H+N+V+ + + ++ + + + E G L + + ++
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 374 MKIALDAARGLAYLHE----DSQPCVIHRDFKASNILLE-------------NNFH---- 412
+ I LAY H + V+HRD K NI L NN +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 413 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELL 470
AK+ DFGL+K ++ +GT Y +PE + T KSD+++ G ++ EL
Sbjct: 181 AKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 471 TGRKP 475
+G+ P
Sbjct: 238 SGKTP 242
|
Length = 1021 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---FLVEVE-MLSRLHHRNLVKL 330
++G+G FG+V +DG A+K L KE + E +L + H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKI-ALDAARGLA 385
+YS + + + + V G L L P E R + A + A L
Sbjct: 62 --HYSFQTADKLYFVLDYVNGGELFFHLQRERSFP---------EPRARFYAAEIASALG 110
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
YLH + +I+RD K NILL++ H + DFGL K+ E ++ GT Y+AP
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAP 165
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
E D + G VL E+L G P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 276 ILGEGGFGRVFKGVLS-DGTAVAIKRL---TCGGQQGDKEFLVEVE-MLSRLHHRNLVKL 330
++G+G FG+V DG A+K L ++ K + E +L + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGLAYLHE 389
+YS + + + + V G L L E R + A + A L YLH
Sbjct: 62 --HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-----EPRARFYAAEIASALGYLHS 114
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449
+ +++RD K NILL++ H + DFGL K+ +T GT Y+APE
Sbjct: 115 IN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIR 169
Query: 450 TGHLLVKSDVYSYGVVLLELLTGRKP 475
D + G VL E+L G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 54/290 (18%)
Query: 277 LGEGGFGRVFKGVLSDGTAVA---IKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
+G G FG+V + T VA +K L + EFL + + L H N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------MKIALDAARGLA 385
++ +LL +E G L+S+L W R ++A + A G+
Sbjct: 63 --QCVEAIPYLLVFEYCELGDLKSYL-------SQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYV 443
++H+ + +H D N L ++ KV D+G+ + +Y+ T ++
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS--RYKEDYIETEDDKCVPLRWL 168
Query: 444 APEY--AMTGHLLVK-----SDVYSYGVVLLELLTGRKPVDMSQP----SGQENLVTWAR 492
APE G L+ S+V++ GV L EL + +QP S +E L
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDREVL----N 219
Query: 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542
+++D+ +L P+L Y + R + C +R T EV
Sbjct: 220 HVIKDQQ--VKLFKPQLELPYSE----RWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 41/232 (17%)
Query: 263 ELKEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGG--QQGDKEFL-VEVEM 318
+L+ ++E ++G G FG V S A+K L+ ++ D F E ++
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK--- 375
++ + +V+L +Y+ +D + E +P G L VN +++ K
Sbjct: 97 MAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---------VNLMSNYDVPEKWAR 145
Query: 376 -------IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEG 427
+ALDA + + IHRD K N+LL+ + H K+ADFG K EG
Sbjct: 146 FYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196
Query: 428 RTNYLSTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 475
+GT Y++PE + G+ + D +S GV L E+L G P
Sbjct: 197 MVR--CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 53/227 (23%)
Query: 271 FEPASILGEGGFGRVFKG---VLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH 323
+E +GEG +G V+K V ++ A+ RL +Q D+ + E+ +L +
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL----EQEDEGVPSTAIREISLLKEMQ 59
Query: 324 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA- 381
H N+V+L S + L L +E + LD + M + D A
Sbjct: 60 HGNIVRL---QDVVHSEKRLYLVFEYL-----------------DLDLKKHMDSSPDFAK 99
Query: 382 -------------RGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEG 427
RG+AY H V+HRD K N+L++ +A K+ADFGLA+ G
Sbjct: 100 NPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF--G 154
Query: 428 RTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGR 473
T + T Y APE + + H D++S G + E++ +
Sbjct: 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 4/100 (4%)
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
+ A+G+ +L S+ C IHRD A NILL N K+ DFGLA+ +
Sbjct: 185 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 437 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
++APE ++SDV+S+GV+L E+ + G P
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 60/282 (21%), Positives = 117/282 (41%), Gaps = 39/282 (13%)
Query: 277 LGEGGFGRVFKGV---LSDG-----TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 328
LG+G F ++FKG+ + D T V +K L + + F M+S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
G D + ++ E V GSL+++L ++ W ++++A A L +L
Sbjct: 63 LNYGVCVCGD--ESIMVQEYVKFGSLDTYLKKN-KNLINISW--KLEVAKQLAWALHFLE 117
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT--FGYVAPE 446
+ + H + A N+LL K + K + G + + + + +V PE
Sbjct: 118 DKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 447 -YAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
+L + +D +S+G L E+ +G KP+ + + +DR +
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---------QKKLQFYEDRHQ-- 223
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
P + + + C+ E + RP+ +++ L
Sbjct: 224 --------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT---- 450
+IHRD K N+LL+ + H K+ADFG + E T V GT Y++PE +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 451 GHLLVKSDVYSYGVVLLELLTGRKP 475
G+ + D +S GV L E+L G P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG--RTNYLSTRVMGTF 440
G+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T Y+ TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
Y APE + D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 84/269 (31%)
Query: 269 NNFEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKEFLVEV----EMLSRL 322
+F ++G+G FG V + V G A+K L + K+ L V ++L+
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAES 58
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWE------TRMKI 376
+V L YYS +D+ L E +P G L + L + ++ TR +
Sbjct: 59 DSPWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFYM 107
Query: 377 A-----LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------- 421
A ++A L + IHRD K NIL++ H K++DFGL+
Sbjct: 108 AECVLAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158
Query: 422 --KQAPEGRTNYL----------------------------STRVM-----GTFGYVAPE 446
++ +G++N + R+M GT Y+APE
Sbjct: 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ + D +S G ++ E L G P
Sbjct: 219 IFLQQGYGQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
ARG+ +L S+ CV HRD A N+LL K+ DFGLA+ +NY+S TF
Sbjct: 247 ARGMEFLA--SKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKG--STF 300
Query: 441 ---GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
++APE SDV+SYG++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFG-LAKQAPEGRTNYLSTRVMGTFGYVAP 445
+H Q +HRD K N+LL+ N H ++ADFG K +G S+ +GT Y++P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTPDYISP 172
Query: 446 EY--AM---TGHLLVKSDVYSYGVVLLELLTGRKP 475
E AM G + D +S GV + E+L G P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 44/233 (18%)
Query: 276 ILGEGGFGRVFKGVLSD---GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVK 329
++G+GG G V+ D VA+K++ K FL E ++ + L H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 330 LVGYYSSRDSSQHLLCY-------ELVPN----GSLESWLHGPLGVNCHLDWETRMKIAL 378
+ S D + + Y L+ + SL L V + I
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV------GAFLSIFH 120
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPE--------GR 428
+ Y+H V+HRD K NILL + D+G A K+ E
Sbjct: 121 KICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 429 TNYLST------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
N + +++GT Y+APE + +D+Y+ GV+L ++LT P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 16/153 (10%)
Query: 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
+L G RV+ L + ++ ++ + EV +L L + L
Sbjct: 4 KLLKGGLTNRVYL--LGTKDEDYVLKIN-PSREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHG-PLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
S L L W+ G L + E IA A LA LH+
Sbjct: 61 SGESDGWSYL---------LMEWIEGETLDEVSEEEKE---DIAEQLAELLAKLHQLPLL 108
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
+ H D NIL+++ + D+ A P
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
A G+ +L S+ CV HRD A N+L+ K+ DFGLA+ +NY+S TF
Sbjct: 249 ANGMEFLA--SKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKG--STF 302
Query: 441 ---GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
++APE SDV+S+G++L E+ T
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 65/282 (23%), Positives = 101/282 (35%), Gaps = 87/282 (30%)
Query: 271 FEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKEFLVEVEMLS 320
F +G G FG V D A+ + R + +++ L E +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--- 59
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALD 379
+ +VKL YYS +D + +P G + S L R+ I D
Sbjct: 60 ---NEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRLGIFEED 101
Query: 380 AAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL----------- 420
AR + +H+ IHRD K NIL++ + H K+ DFGL
Sbjct: 102 LARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 421 ------------------------AKQAPEGRTNY------LSTRVMGTFGYVAPE-YAM 449
+ P R L+ ++GT Y+APE
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 450 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG-QENLVTW 490
TG+ + D +S GV+L E+L G+ P P+ Q ++ W
Sbjct: 219 TGYTQL-CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 62/278 (22%), Positives = 101/278 (36%), Gaps = 75/278 (26%)
Query: 271 FEPASILGEGGFGRVFKGVLSDGTAV-AIKRLTCGGQQGDKEFLV---------EVEMLS 320
F LG G FG V D A+ A+K L K+ L+ E ++L+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR------KKDVLLRNQVAHVKAERDILA 56
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL 378
+ +V+L YYS +D + +P G + S L G + + + A+
Sbjct: 57 EADNEWVVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAV 114
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----------------- 421
++ + + IHRD K NIL++ + H K+ DFGL
Sbjct: 115 ESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165
Query: 422 ----------------------------KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
++A L+ ++GT Y+APE +
Sbjct: 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225
Query: 454 LVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTW 490
D +S GV+L E+L G+ P P Q ++ W
Sbjct: 226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 50/170 (29%), Positives = 71/170 (41%), Gaps = 27/170 (15%)
Query: 311 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHL 368
E +V M + N +KL YYS H+L + + +G L L G L
Sbjct: 58 EPMVHQLMK---DNPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA--- 109
Query: 369 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEG 427
E + KI L LH+ + +IH D K N+L + D+GL K G
Sbjct: 110 --EVK-KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG 161
Query: 428 RTNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
+ GT Y +PE + GH S D ++ GV+ ELLTG+ P
Sbjct: 162 -----TPSCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 43/273 (15%)
Query: 277 LGEGGFGRVFKGVLSDGT---AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 333
+G G +G V+K DG A+K++ G E+ +L L H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE--GTGISMSACREIALLRELKHPNVIALQKV 66
Query: 334 YSSRDSSQHLLCYELVPNGSLESW----LHGPLGVN---CHLDWETRMKIALDAARGLAY 386
+ S + L ++ + + W H N L + G+ Y
Sbjct: 67 FLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 387 LHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTF 440
LH + V+HRD K +NIL+ K+AD G A+ +P L V+ TF
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 441 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK- 498
Y APE + K+ D+++ G + ELLT +P+ + QE++ T + P D+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR---QEDIKT-SNPFHHDQL 234
Query: 499 DRL---------EELADPRLGGKYP--KEDFIR 520
DR+ ++ D R +YP ++DF R
Sbjct: 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRR 267
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 59/224 (26%)
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD--WET 372
E ++L+ + +VKL YYS +D + +P G + S L L +
Sbjct: 51 ERDILAEADNEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108
Query: 373 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----------- 421
+ +A+++ + + IHRD K NIL++ + H K+ DFGL
Sbjct: 109 ELTLAIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 422 ----------------------------------KQAPEGRTNYLSTRVMGTFGYVAPEY 447
++A + L+ ++GT Y+APE
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQENLVTW 490
+ D +S GV+L E+L G+ P P+ Q ++ W
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 53/276 (19%)
Query: 230 ASPKETAKPRTADAVTLGGSLPHPTSTRFLAY----EELKEATNNFEPASILGEGGFGRV 285
+ E A P VT +LP+ + Y E++ +T F+ S+LGEG FG+V
Sbjct: 88 TTNVEVAPPPKKKKVTY--ALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKV 145
Query: 286 FKG---VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSS 336
+ + AV I R + K +E++ + ++ + L+K+ Y+
Sbjct: 146 VEAWDRKRKEYCAVKIVRNVPKYTRDAK---IEIQFMEKVRQADPADRFPLMKIQRYF-- 200
Query: 337 RDSSQHLLCYELVPNGS-LESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
++ + H +C + G L W+ HGP + HL +I L Y H ++
Sbjct: 201 QNETGH-MCIVMPKYGPCLLDWIMKHGPFS-HRHL-----AQIIFQTGVALDYFH--TEL 251
Query: 394 CVIHRDFKASNILLEN---------NFH-------AKVADFGLAKQAPEGRTNYLSTRVM 437
++H D K NIL+E N ++ D G RT +STR
Sbjct: 252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTR-- 309
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
Y +PE + + +D++S G ++ EL TG+
Sbjct: 310 ---HYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 58/228 (25%)
Query: 277 LGEGGFGRVFKGVLSDGTA---VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 333
+G G +G V+K DG A+K++ G E+ +L L H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 66
Query: 334 YSSR---------DSSQHLLCYEL--------------VPNGSLESWLHGPLGVNCHLDW 370
+ S D ++H L + + +P G ++S L+ L
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD------- 119
Query: 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK--QA 424
G+ YLH + V+HRD K +NIL+ K+AD G A+ +
Sbjct: 120 ------------GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLT 471
P L V+ TF Y APE + K+ D+++ G + ELLT
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 30/92 (32%), Positives = 40/92 (43%), Gaps = 4/92 (4%)
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
R + YLHE+ +IHRD KA NI + + + DFG A P GT
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 34/171 (19%)
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLL------CYELVPNGSLESWLHGPLGVNCHL 368
E+ L RL+H N++K+ S ++ + Y + + + + W PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-WKDRPL------ 265
Query: 369 DWETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
+TR MK L A + Y+H+ +IHRD K NI L + + DFG A
Sbjct: 266 LKQTRAIMKQLLCA---VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTA----- 314
Query: 427 GRTNYLSTRVMGTFGYV------APEYAMTGHLLVKSDVYSYGVVLLELLT 471
+ R +G+V +PE +D++S G++LL++L+
Sbjct: 315 --MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 13/112 (11%)
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD----FGLAKQAPEGRTNY 431
I A RGL YLH++ IHR+ KAS+IL+ + ++ + L + + + Y
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 432 ----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDM 478
ST V+ + G+ VKSD+YS G+ EL TGR P DM
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 35/219 (15%)
Query: 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVKL 330
+ + K T VA+K++ KE L E+ +L H N++
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILP- 63
Query: 331 VGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL---DAARGL 384
Y +S L + L+ GS E L H P G+ E IA D L
Sbjct: 64 --YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----EL--AIAFILKDVLNAL 114
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADF----GLAKQAPEGRTNYLSTR-VMGT 439
Y+H S+ IHR KAS+ILL + ++ + K R + + +
Sbjct: 115 DYIH--SKGF-IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 440 FGYVAPEY---AMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+++PE + G+ KSD+YS G+ EL G P
Sbjct: 172 LPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 46/246 (18%)
Query: 312 FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWE 371
F ++S++ H +L + G S++++ E V +G L+ L G +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKG---RVPVA 117
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA-------KVADFGLAKQA 424
++ +A A L+YL + + ++H + A NILL A K++D G++ A
Sbjct: 118 WKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174
Query: 425 --PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLEL-LTGRKPVDMSQ 480
E R + ++APE G L +D +S+G LLE+ G P+
Sbjct: 175 LSREERVERIP--------WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226
Query: 481 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540
PS +E K RL E + L T+ + C+ E QRP+
Sbjct: 227 PSEKERF-------YEKKHRLPEPSCKELA------------TLISQCLTYEPTQRPSFR 267
Query: 541 EVVQSL 546
+++ L
Sbjct: 268 TILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 615 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.98 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.83 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.68 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.54 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.48 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.13 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.02 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| PLN02236 | 344 | choline kinase | 96.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.68 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.29 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.14 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.04 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.9 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.82 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.7 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.68 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.42 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.36 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.21 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.14 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.11 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.89 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.15 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.14 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-58 Score=490.88 Aligned_cols=291 Identities=58% Similarity=0.996 Sum_probs=258.2
Q ss_pred CcccCCHHHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEe
Q 007160 255 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334 (615)
Q Consensus 255 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~ 334 (615)
..+.|++.|+..||++|...++||+|+||.||+|.+++|+.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999998865543256699999999999999999999999
Q ss_pred ecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 335 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
.+.+. +.+||||||++|+|.++|+..... .|+|.+|++||.++|+||+|||+...|+|+|||||++|||||+++++|
T Consensus 141 ~e~~~-~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGE-HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCc-eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 84332 599999999999999999975443 799999999999999999999999998999999999999999999999
Q ss_pred EEeccccccCCC-CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 415 VADFGLAKQAPE-GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 415 L~DFGla~~~~~-~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|+|||+|+..+. ... ..+...||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+....+++.|+++
T Consensus 218 lsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 999999977664 221 11111899999999999999999999999999999999999999987766677789999998
Q ss_pred hhccchhhhhhcCCccC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 494 ILRDKDRLEELADPRLG-GKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~-~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.+.+. .+.+++|+++. ..++. +++.++..++.+|++.+|.+||+|.||++.|+.+..
T Consensus 296 ~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 296 LLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88876 89999999987 66665 688899999999999999999999999999865543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=408.90 Aligned_cols=261 Identities=34% Similarity=0.527 Sum_probs=214.2
Q ss_pred ccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 272 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
...+.||+|+||+||+|.+.+...||||++....... .++|.+|+.+|.+++|||||+++|+|.... ..+++||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEEEEeC
Confidence 3345699999999999999755559999998654333 458999999999999999999999997432 2689999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEEeccccccCCCCC
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAPEGR 428 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~ 428 (615)
++|+|.++|+.. ....+++..+++++.+||+||.|||++++ |||||||++|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999864 34579999999999999999999999875 99999999999999997 99999999998765432
Q ss_pred ccccceeeccccccCCccccc--cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~--~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... . .. ...++.
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-----~~----------~~~v~~ 260 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-----QV----------ASAVVV 260 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-----HH----------HHHHHh
Confidence 2234478999999999999 66999999999999999999999999975443 1 11 111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
.......+..+...+..|+.+||+.||++||++.+++..|+.+......
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 2222334444566789999999999999999999999999998876554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=420.62 Aligned_cols=266 Identities=26% Similarity=0.435 Sum_probs=227.4
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
..+.+....+.||+|.||+||+|... +...||||.++..... ..++|.+|+++|..++|||||+|+|+|. +
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~--~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR--E 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc--c
Confidence 34566677799999999999999843 3578999999977655 6789999999999999999999999998 4
Q ss_pred CCceeEEEecCCCCChhHhhcCCCC------C----cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLG------V----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE 408 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~------~----~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 408 (615)
+..++||+|||..|||.+||..... . ..+|+..+.+.||.|||.|++||-++. +|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence 5589999999999999999953211 1 234889999999999999999999999 99999999999999
Q ss_pred CCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 007160 409 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENL 487 (615)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l 487 (615)
++..|||+||||+|.....++.....+..-.++||+||.++.++||++||||||||+|||+++ |+.||.....
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------ 711 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------ 711 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------
Confidence 999999999999999887776555556677899999999999999999999999999999998 9999974332
Q ss_pred hHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 488 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 488 ~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.+.++.+.+.++ -.+|..++.++++|+..||+.+|.+||+++||-..|+...+..
T Consensus 712 ----------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 ----------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ----------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 233444555555 4678888888999999999999999999999999998876543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=396.65 Aligned_cols=255 Identities=30% Similarity=0.456 Sum_probs=213.3
Q ss_pred cccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 271 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+...+.||+|.||.||+|.+++...||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++ .++||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEecc
Confidence 4456889999999999999988889999999865 344678999999999999999999999998433 7999999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcc
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 430 (615)
+|+|.+||+.. ....+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||||+...++. .
T Consensus 285 ~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y 358 (468)
T KOG0197|consen 285 KGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-Y 358 (468)
T ss_pred cCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc-e
Confidence 99999999862 2446888999999999999999999999 9999999999999999999999999999554433 2
Q ss_pred ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 431 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
.......-+..|.|||.+..+.++.|||||||||+||||+| |+.||...... + +...+..+.+
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------e-v~~~le~GyR--------- 422 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------E-VLELLERGYR--------- 422 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------H-HHHHHhccCc---------
Confidence 23444566889999999999999999999999999999999 88888633211 1 1112222332
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
-..|..+...+.+|+..||+.+|++|||++.+...|+.+..
T Consensus 423 -lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 423 -LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 34566677779999999999999999999998888877654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=377.13 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=208.6
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++..+.||+|..|+|||++++ +++.+|+|.+..... ...+++.+|++++++.+||+||+++|.|..... ...|+|||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEY 159 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhh
Confidence 344688999999999999975 689999999954432 335789999999999999999999999985443 69999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|++|||+++++.. +.+++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|.+||||||.++...+.
T Consensus 160 MDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999752 458999999999999999999996 66 999999999999999999999999999987654
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+. ...|+ ..+..+++.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----~~~~~-------~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----YLDIF-------ELLCAIVDE 297 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----CCCHH-------HHHHHHhcC
Confidence 346689999999999999999999999999999999999999999754211 11121 123333332
Q ss_pred ccCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 508 RLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 508 ~l~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.. ...|. ....+++.++..||+.||.+||++.|+++|=..
T Consensus 298 pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 298 PP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred CC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 11 12222 245568999999999999999999999988443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=376.73 Aligned_cols=272 Identities=28% Similarity=0.439 Sum_probs=207.6
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhh--ccCCCcceEEEEeecCC--CCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSSRD--SSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~HpnIv~l~g~~~~~~--~~~~~L 344 (615)
...+..++||+|+||.||||++. ++.||||++. .++.+.|.+|-++++. ++|+||++++++-...+ ..+++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556688999999999999996 4899999997 4557789999999874 58999999999854222 458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC------CCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS------QPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~------~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
|++|.++|+|.+||+. ..++|....+|+..+++||+|||+.- +|+|+|||||++||||.+|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999985 35999999999999999999999863 578999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCc------CCchhhHHHHHHHHHHHHhCCCCCC-CCCCCCcchhh---
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVLLELLTGRKPVD-MSQPSGQENLV--- 488 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~------~s~ksDVwS~GvvL~ElltG~~Pf~-~~~~~~~~~l~--- 488 (615)
|||..+..+.........+||.+|||||++.+.. .-.+.||||+|.|||||++...-++ ...+..+....
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999887665544555689999999999987642 2357999999999999999765443 11111111111
Q ss_pred ------HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 489 ------TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 489 ------~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
+.++..+-.+.....+.|.... -..+..+++.+..||..|++.|.|+.=|-+.+..+....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111111111111122222111 134556899999999999999999999988888776543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=383.20 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=211.8
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
..|...+.||+|||..||+++. .+|+.||+|++.+.. ....+...+||++.++|+|||||+++++|+ +..++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE--Ds~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE--DSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee--cCCceEE
Confidence 5689999999999999999996 889999999997642 233567889999999999999999999998 6669999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
|.|+|++|+|..+++. .+.+++.++..++.||+.||.|||+++ |+|||||..|+||+++.++||+|||||...
T Consensus 96 vLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 9999999999999984 457999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... .....+||+.|+|||++....++..+||||+||+||-|+.|++||+... +.+-...+...
T Consensus 169 e~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~------- 233 (592)
T KOG0575|consen 169 EYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLN------- 233 (592)
T ss_pred cCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhc-------
Confidence 75433 2356799999999999999999999999999999999999999998442 11111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+ ...|........+||.++|+.||.+|||+++|+.+-..
T Consensus 234 -~----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 234 -E----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -C----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 1 12233334457899999999999999999999987443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=362.40 Aligned_cols=257 Identities=27% Similarity=0.395 Sum_probs=209.8
Q ss_pred cCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.+|+++++||+|.||+|||++ +.+|..||.|.+..+.. ...++...|+.+|++|+|||||+++++-...+...++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468889999999999999998 67899999999985533 334678999999999999999999985444454458999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC-CCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS-QPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||..|+|...++......+.+++..+|+++.|+++||.++|+.- +..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999766666677999999999999999999999832 123999999999999999999999999999988
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... .....+|||.||+||.+....|+.|+||||+||++|||..-+.||... ++...-+.+-..
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg------- 243 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG------- 243 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC-------
Confidence 66433 456789999999999999999999999999999999999999999743 333322222111
Q ss_pred cCCccCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007160 505 ADPRLGGKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544 (615)
Q Consensus 505 ~d~~l~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 544 (615)
--+ .+| .-....+.+||..|+..||+.||+.-.+++
T Consensus 244 d~~----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 244 DYP----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred CCC----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 011 123 334556889999999999999998644443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=367.63 Aligned_cols=201 Identities=32% Similarity=0.521 Sum_probs=179.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
..+|...+.||+|.||+||+|+++ ++..||||.+.+.. ....+.+..|+.+|+.++|||||.|++++. .+..++|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~--~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE--DDDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe--cCCeEEE
Confidence 357888899999999999999964 68999999998763 334566889999999999999999999988 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC------CcEEEEec
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN------FHAKVADF 418 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~------~~vkL~DF 418 (615)
|||||.||+|.+||+.. ..+++.....++.|+|.||++||+++ ||||||||+||||+.. -.+||+||
T Consensus 87 VMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999999999863 36899999999999999999999999 9999999999999764 56899999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
|+|+...... .....+|++-|||||+++..+|+.|+|+||.|++|||+++|+.||+...
T Consensus 160 GfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 160 GFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred chhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999887543 4467899999999999999999999999999999999999999998544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=367.20 Aligned_cols=257 Identities=27% Similarity=0.387 Sum_probs=204.5
Q ss_pred HhcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCc-------hHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG-------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~-------~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++.+..... .....+|+++|++|+|||||++.+++..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 44667888999999999999998 4689999999997542211 2235799999999999999999999984
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC---CcEEE
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKV 415 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL 415 (615)
....||||||++||+|.+++-. ++.+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence 4477999999999999999965 345777788899999999999999999 9999999999999765 78999
Q ss_pred EeccccccCCCCCccccceeeccccccCCccccccCcC---CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 007160 416 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL---LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
+|||+|+...+.. .+...+||+.|.|||++.++.. ..|.|+||+||+||-+++|..||....... .+ ..
T Consensus 321 tDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl---~e 392 (475)
T KOG0615|consen 321 TDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL---KE 392 (475)
T ss_pred cccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH---HH
Confidence 9999999887443 4567899999999999987654 358899999999999999999997443221 11 11
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
++.+...... ...-.+..++..+||.++|..||++|||+.|+++|=|.
T Consensus 393 QI~~G~y~f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 393 QILKGRYAFG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred HHhcCccccc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 1222111111 11123345678899999999999999999999988554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=387.27 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=215.9
Q ss_pred cccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 271 FEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
..+.++||.|.||.||+|+++ ....||||.++..... ...+|+.|+.||.+++||||++|.|+.. ....+++|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCceeEEE
Confidence 456799999999999999975 2457999999977543 3568999999999999999999999987 55578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
.|||+||+|+.||+.+. ..+++.+...++.+||.|+.||-+.+ +|||||.++|||++.+..+|++||||+|...
T Consensus 709 TEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999998754 35999999999999999999999999 9999999999999999999999999999886
Q ss_pred CCCc-cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 426 EGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 426 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
++.. .+.+....-+.+|.|||.+...+++.++||||||+||||.++ |.+||....+++ .+..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIka 846 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIKA 846 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHHH
Confidence 6553 233333455789999999999999999999999999999887 999986433221 1111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
+ +...+-..|.++...|.+|+..||+.|-.+||.+.+|+.+|.++.+.
T Consensus 847 I-e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 847 I-EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred H-HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1 12223355677888899999999999999999999999999987654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=366.37 Aligned_cols=264 Identities=27% Similarity=0.441 Sum_probs=206.1
Q ss_pred hcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +||||++++++|.. ..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-PN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CC
Confidence 46799999999999999999974 2356899999975432 2345789999999999 89999999998864 33
Q ss_pred CceeEEEecCCCCChhHhhcCCCC--------------------------------------------------------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------- 363 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~-------------------------------------------------------- 363 (615)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 468999999999999999964221
Q ss_pred --CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccc
Q 007160 364 --VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441 (615)
Q Consensus 364 --~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 441 (615)
....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0134788899999999999999999998 99999999999999999999999999986543322222233456789
Q ss_pred cCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHH
Q 007160 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIR 520 (615)
Q Consensus 442 y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~ 520 (615)
|+|||++.+..++.++|||||||+||||++ |..||....... .+. ..+.... .. ..+......
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~------~~----~~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGT------RM----RAPENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCC------CC----CCCCCCCHH
Confidence 999999999999999999999999999997 999997533211 111 1111110 01 112223345
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 521 VCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 521 l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=399.00 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=218.2
Q ss_pred hcCcccceeeeccCceEEEEEEECC--Cc----EEEEEEeccC-CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD--GT----AVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~--g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
..+.+..+.||+|.||.||+|.+.+ |. .||||.+... +.++..+|++|..+|++++|||||+++|+|.. ..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CC
Confidence 4566778999999999999999653 33 4999999865 34556789999999999999999999999984 56
Q ss_pred ceeEEEecCCCCChhHhhcCCCC---CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEe
Q 007160 341 QHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 417 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 417 (615)
..++++|||++|+|..||+..+. ....|+....+.++.|||+|+.||++++ +|||||.++|+||+....|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 78999999999999999986421 2346899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
||+|+...+.+........+-..+|||||.+..+.++.|+|||||||+|||++| |..||....+.+.. . .+.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~---~----~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL---L----DVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH---H----HHH
Confidence 999997666554433333456789999999999999999999999999999999 89999754422111 0 111
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
++.+ -..|..+...+.+|+..||+.+|++||++..+++.+..+.+...
T Consensus 919 ~ggR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 919 EGGR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred hCCc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 1112 24566677789999999999999999999999998888766543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.16 Aligned_cols=250 Identities=21% Similarity=0.346 Sum_probs=202.6
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeec--CCCCceeEEEec
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSS--RDSSQHLLCYEL 348 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~~~LV~Ey 348 (615)
...||+|++|.||+|.+ +|+.||||++....... .+.|.+|+++|.+++||||++++|++.. .+....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 57899999998654333 3668899999999999999999999875 344578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
+++|+|.+++... ..++|...++++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 9999999999752 3589999999999999999999984 6 789999999999999999999999999865432
Q ss_pred CccccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... . .........
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~---~~~~i~~~~------- 238 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---E---IYDLIINKN------- 238 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHhcC-------
Confidence 2 23468899999999976 68899999999999999999999999743211 1 111111111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.....+......+.+++.+||+.||++|||++||++.|++++..
T Consensus 239 ---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~~ 282 (283)
T PHA02988 239 ---NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFY 282 (283)
T ss_pred ---CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHhc
Confidence 11112223344688999999999999999999999999988753
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=350.42 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=204.6
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|+++++||+|+||+||.++. ++++.+|+|.+++... .+.+...+|..+|.+++||+||++.-.|. +...+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ--t~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ--TEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc--cCCeEE
Confidence 46899999999999999999995 4689999999986532 33466889999999999999999976655 667999
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
||+||+.||.|.-+|++ .+.+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.
T Consensus 102 lVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999975 446888999999999999999999999 99999999999999999999999999996
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... .+...+||+.|||||++.+..|+..+|.||+|+++|||++|..||.... ...+...+...+
T Consensus 175 ~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k----- 241 (357)
T KOG0598|consen 175 DLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK----- 241 (357)
T ss_pred cccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc-----
Confidence 654432 2345799999999999999999999999999999999999999997443 223333333322
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP----TMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP----sm~eVl~~ 545 (615)
+ ...+.-......+++...|+.||++|- .+.+|-+|
T Consensus 242 -----~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 -----L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred -----C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1 011221234578999999999999995 45555443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.63 Aligned_cols=274 Identities=25% Similarity=0.396 Sum_probs=211.7
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhh--ccCCCcceEEEEeec
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSS 336 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~HpnIv~l~g~~~~ 336 (615)
+.+--......+..+.+.||+|.||.||+|.+. |+.||||++.. .+++.|.+|.++++. |+|+||+.+++.-..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 344444556678899999999999999999996 68899999973 446789999999985 499999999986322
Q ss_pred --CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-----CCCCcEEeccCCCCCeEEcC
Q 007160 337 --RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-----DSQPCVIHRDFKASNILLEN 409 (615)
Q Consensus 337 --~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-----~~~~~ivHrDIkp~NILl~~ 409 (615)
..-.+++||.+|.++|||.|||.. ..++.+..++++..+|.||++||. +++|.|.|||||++|||+.+
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 122468999999999999999985 458999999999999999999996 47899999999999999999
Q ss_pred CCcEEEEeccccccCCCCCc--cccceeeccccccCCccccccC----cC--CchhhHHHHHHHHHHHHhC---------
Q 007160 410 NFHAKVADFGLAKQAPEGRT--NYLSTRVMGTFGYVAPEYAMTG----HL--LVKSDVYSYGVVLLELLTG--------- 472 (615)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~----~~--s~ksDVwS~GvvL~ElltG--------- 472 (615)
++.+.|+|+|||........ .......+||.+|||||++... .+ -..+||||||+|+||+...
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999999987665422 2223456899999999998653 22 2579999999999999752
Q ss_pred -CCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 473 -RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG-----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 473 -~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
+.||....+.+- +..+ ++. -+...+++. ....+.+..+.+|++.||..+|.-|-|+=.|.+.|
T Consensus 432 y~~Pyyd~Vp~DP-s~ee-Mrk---------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 432 YQLPYYDVVPSDP-SFEE-MRK---------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred hcCCcccCCCCCC-CHHH-Hhc---------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 356654332221 1111 111 111222222 22346778899999999999999999999999999
Q ss_pred HHhHhh
Q 007160 547 KMVQRV 552 (615)
Q Consensus 547 ~~i~~~ 552 (615)
.++.+.
T Consensus 501 ~~l~~~ 506 (513)
T KOG2052|consen 501 AKLSNS 506 (513)
T ss_pred HHHhcC
Confidence 888754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=353.24 Aligned_cols=260 Identities=29% Similarity=0.416 Sum_probs=205.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++...+.||+|+||.||++... +|+..|||.+...+....+.+.+|+.+|++++|||||+++|.....+...+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999965 48999999998654333667899999999999999999999754333236889999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEeccccccCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPE 426 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~ 426 (615)
|+++|+|.+++....+ .|++..+.+++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999986432 5999999999999999999999999 999999999999999 79999999999987764
Q ss_pred CC-ccccceeeccccccCCccccccCc-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 427 GR-TNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 427 ~~-~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.. .........||+.|||||++..+. ...++|||||||++.||+||+.||... .....+...+....
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------ 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence 11 111234578999999999999643 345999999999999999999999742 11111111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.....|........+++.+|+..||++|||+.++++|....
T Consensus 240 ----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 240 ----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 11133444445678999999999999999999999986543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=355.62 Aligned_cols=264 Identities=27% Similarity=0.408 Sum_probs=218.1
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCch-HHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~-~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+....+.++||+|-||.|.++...++..||||+++....... ++|.+|+++|.+++|||||.|+|+|..++ .+++|+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHH
Confidence 445667899999999999999998889999999997765544 89999999999999999999999998544 789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|||++|+|..||..+... .+.-....+|+.|||.||+||.+.+ +|||||.++|+|+|.++++||+|||+++....
T Consensus 615 EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999764322 2455677889999999999999999 99999999999999999999999999998887
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt--G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
+.......+.+-+++|||+|.+.-++++.++|||+||++|||+++ ...||.... .+..++-...+++......
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~~~-- 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGRQV-- 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCcce--
Confidence 777666677888999999999999999999999999999999865 778886332 1223333333333322111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
....|.-+..++.+++.+||..|-++||+++++...|..
T Consensus 765 -----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 765 -----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred -----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 112344556678999999999999999999999988865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.95 Aligned_cols=269 Identities=26% Similarity=0.417 Sum_probs=210.8
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 261 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 261 ~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
.++.....+.+.+...||+|.||+||+|.+.+ .||||.+...... ..+.|.+|+.+|++-+|.||+=+.|||..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-- 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-- 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--
Confidence 34555556677788999999999999999853 4999999876543 35789999999999999999999999973
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
+ .+.+|..+|+|-+|+.+||... ..++..+.+.||.|||+|+.|||.++ |||||||..||+|.++++|||+||
T Consensus 460 p-~~AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 P-PLAIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred C-ceeeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence 2 3499999999999999999643 45889999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCcccccc---CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
||+.....-..........|...|||||+++. .+|+..+||||||+|+|||++|..||. .+..++. + |+ .
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqI-i--fm---V 605 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQI-I--FM---V 605 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhhe-E--EE---e
Confidence 99965432211111233457889999999974 468999999999999999999999998 2222111 1 10 1
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
..++...+.. .....+...+.+|+..||..++++||.+.+|+..|+.+...+
T Consensus 606 GrG~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 606 GRGYLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cccccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 1111111111 112234446889999999999999999999999888877643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.19 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=212.5
Q ss_pred hcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
...|....+||+|..|.||.+. ..+++.||||++........+-+++|+.+|+..+|+|||+++..|... .++|.||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEEE
Confidence 4567777899999999999998 557899999999988777777899999999999999999999987643 5899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|||++|+|.|.+.. ..+++.++..|+.++++||+|||.++ |+|||||.+||||+.++.+||+|||++..+..
T Consensus 350 Eym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999874 34899999999999999999999999 99999999999999999999999999988776
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... .....+||+.|||||++....|..|.||||||++++||+-|.+||-...+.....+ +..---
T Consensus 422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------------Ia~ng~ 486 (550)
T KOG0578|consen 422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------IATNGT 486 (550)
T ss_pred ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------------HhhcCC
Confidence 543 34567999999999999999999999999999999999999999975433221111 111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.+ ..+......+.+++.+||+.|+++|+++.|+++|
T Consensus 487 P~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 PKL--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCc--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 122 2233444568999999999999999999999987
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=347.53 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=201.8
Q ss_pred cCcccceeeeccCceEEEEEEECC-----------------CcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD-----------------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKL 330 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l 330 (615)
++|++.+.||+|+||.||++.+++ +..||+|.+...... ...+|.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999998532 346999998754322 24579999999999999999999
Q ss_pred EEEeecCCCCceeEEEecCCCCChhHhhcCCC---------------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcE
Q 007160 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL---------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395 (615)
Q Consensus 331 ~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~---------------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 395 (615)
++++.. ....++||||+++|+|.+++.... .....++|..+++++.|++.||.|||+.+ |
T Consensus 85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 85 LGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 999874 457899999999999999985421 11134788999999999999999999998 9
Q ss_pred EeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh--CC
Q 007160 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GR 473 (615)
Q Consensus 396 vHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt--G~ 473 (615)
+||||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999987654432222334456889999999998899999999999999999987 55
Q ss_pred CCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 474 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 474 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.||..... ..........+...... .....+......+.+++.+||+.||++|||+.+|++.|+
T Consensus 240 ~p~~~~~~---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTD---EQVIENAGEFFRDQGRQ-------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCH---HHHHHHHHHHhhhcccc-------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66653321 11222222111111000 000111223346889999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.00 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=208.5
Q ss_pred hcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.+.|+.+++||+|.||.||+|+ +.+|+.||+|++..+... ......+||.+|++|+||||++|.+.........+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4567888999999999999999 568999999999876532 3456788999999999999999999988766778999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
|+|||+. +|.-++..+ .-.++..++..++.|++.||+|||..+ |+|||||.+|||||++|.+||+|||||+.+
T Consensus 196 VFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999977 898888743 235899999999999999999999999 999999999999999999999999999977
Q ss_pred CCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh----------Hhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV----------TWARP 493 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~----------~~~~~ 493 (615)
...... ..+..+-|..|.|||.+.+. .|+.+.|+||.||||.||++|+..|......++...+ .|...
T Consensus 269 ~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 654433 24566789999999999864 7999999999999999999999999876544433221 12110
Q ss_pred hhccchhhhhhcCCccCCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 494 ILRDKDRLEELADPRLGGKYPK-------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~-------~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+.. ...+.+ ...+.. ......++|+..+|..||.+|.|+.+++++
T Consensus 348 kLP~----~~~~kp--~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPH----ATIFKP--QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCc----ccccCC--CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1100 000000 011111 111246789999999999999999999865
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.29 Aligned_cols=261 Identities=30% Similarity=0.471 Sum_probs=208.4
Q ss_pred cCcccceeeeccCceEEEEEEECC--C---cEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD--G---TAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~--g---~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
++....++||+|+||.||+|++.. + ..||||..+... ....++|++|.++|++++|||||+++|++. ...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~--~~~ 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV--LEE 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCC
Confidence 455566999999999999999642 2 238999988532 344578999999999999999999999988 445
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
.+++|||+|+||+|.+||+...+ .++..++++++.++|+||+|||+++ ++||||.++|+|+..++.+||+|||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 78999999999999999986432 5999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
++....... ......-+.+|+|||.+..+.|+.++|||||||++||+++ |..||...... +....+....
T Consensus 309 s~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~- 379 (474)
T KOG0194|consen 309 SRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNG- 379 (474)
T ss_pred ccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcC-
Confidence 886541111 1112246789999999999999999999999999999999 88898743321 1111111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
.....+......+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 380 ---------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 ---------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11223334555678899999999999999999999999998775543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=388.87 Aligned_cols=262 Identities=27% Similarity=0.496 Sum_probs=213.4
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
...|...+.||+|+||.||+|+. .++..||||++..... ....|++++++++|||||+++|+|.. ....++||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 34677889999999999999996 5789999999874332 22356889999999999999999974 45789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.++++. ++|..+.+++.|+++||+|||..+.++|+||||||+||+++.++.+++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999963 8999999999999999999997766669999999999999999888876 666543321
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
. ....+|..|||||++.+..++.|+|||||||++|||+||+.||+... .....+..|++..... .....+.|
T Consensus 835 ~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 906 (968)
T PLN00113 835 D------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSD-CHLDMWID 906 (968)
T ss_pred C------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCc-cchhheeC
Confidence 1 22368899999999999999999999999999999999999996433 2334567777655433 33556667
Q ss_pred CccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 507 PRLGG--KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 507 ~~l~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
+.+.. ..+.++..++.+++.+||+.||++||+|+||++.|+.+.+
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 76643 3345667788999999999999999999999999988754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=333.92 Aligned_cols=265 Identities=26% Similarity=0.360 Sum_probs=204.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
+.|+.+.++|+|+||.|||++.+ +|+.||||++.....+ -.+-.++||++|++++|+|+|.|+.+|. ....++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEEE
Confidence 46788899999999999999965 6999999999755432 2355789999999999999999999987 55689999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
+|||+.-=|.++-+-+ ..++...+.+++.|+++|+.|+|+++ ++||||||+|||++.++.+||||||+|+...
T Consensus 80 FE~~dhTvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred eeecchHHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 9999875454443332 23778899999999999999999999 9999999999999999999999999999887
Q ss_pred CCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh--------hhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW--------ARPILR 496 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~--------~~~~~~ 496 (615)
..... .+..+.|..|.|||.+.+ .+|....||||.||++.||++|..-|......++..++.- ...++.
T Consensus 153 ~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 153 APGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred CCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 43332 356788999999999987 6899999999999999999999998876554443322211 111222
Q ss_pred cchhhhhhcCCcc------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLEELADPRL------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......+.-|.. ...+|. ...-+++++..||+.||.+|++-+|++.|
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 2221222211111 112222 12357899999999999999999999865
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.79 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=202.8
Q ss_pred hcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++..+ +||||++++++|. +.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~--~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT--VG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec--cC
Confidence 45788999999999999999973 245689999997543 23346789999999999 8999999999987 44
Q ss_pred CceeEEEecCCCCChhHhhcCCCC--------------------------------------------------------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------- 363 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~-------------------------------------------------------- 363 (615)
...++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 578999999999999999964221
Q ss_pred ---------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 364 ---------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 364 ---------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
....++|..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 0124788999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+..+ +....
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~~~~-------- 334 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IKEGY-------- 334 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HHhCc--------
Confidence 2222223345678999999999999999999999999999998 88888643211 111111 11110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
....+......+.+|+.+||+.||++||++.||++.|++
T Consensus 335 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 --RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001111123358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=358.79 Aligned_cols=239 Identities=27% Similarity=0.425 Sum_probs=202.2
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCC
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 353 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gs 353 (615)
++-||.|+.|.||+|++. ++.||||+++. .-..+|+.|++|+|+||+.|.|+|. ....++||||||..|-
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeec--CCceeEEeeecccccc
Confidence 578999999999999996 57899999862 1235789999999999999999998 4568999999999999
Q ss_pred hhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccc
Q 007160 354 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433 (615)
Q Consensus 354 L~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 433 (615)
|.+.|+. ...++-.....+..+||.|+.|||.+. |||||||+-||||..+..+||+|||-++...+.. ..
T Consensus 199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---Tk 268 (904)
T KOG4721|consen 199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TK 268 (904)
T ss_pred HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hh
Confidence 9999986 345788889999999999999999999 9999999999999999999999999998776542 23
Q ss_pred eeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCC
Q 007160 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 513 (615)
Q Consensus 434 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~ 513 (615)
..+.||..|||||++++.+.++|.||||||||||||+||..||...+... +.| . +-...+.-..
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-----G-------VGsNsL~Lpv 332 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-----G-------VGSNSLHLPV 332 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-----e-------ccCCcccccC
Confidence 45789999999999999999999999999999999999999996433221 111 1 1112233355
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 514 PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 514 ~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
|..+...+.-|+++||+-.|.+||++++++.||+.
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 66777778889999999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.64 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=203.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|+.. ++..||||++...... ....+.+|+++++.+ +|+||++++++|. +.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT--HG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec--CC
Confidence 457889999999999999998842 3457999999754332 245688999999999 8999999999987 44
Q ss_pred CceeEEEecCCCCChhHhhcCCCC--------------------------------------------------------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------- 363 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~-------------------------------------------------------- 363 (615)
...++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 588999999999999999853210
Q ss_pred ----------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccc
Q 007160 364 ----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433 (615)
Q Consensus 364 ----------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 433 (615)
....+++.++++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1124788899999999999999999998 999999999999999999999999999866443322122
Q ss_pred eeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 434 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
....++..|||||++.+..++.++|||||||++|||++ |+.||....... .+.. .... .....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~----------~~~~~ 335 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKR----------GYQMS 335 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHc----------ccCcc
Confidence 23345678999999999999999999999999999997 999996432211 1100 1110 00111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11112345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=351.24 Aligned_cols=253 Identities=27% Similarity=0.376 Sum_probs=207.5
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCc
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 341 (615)
..++|..++.||+|+|++|++|+. .+++.||||++.+.- +...+...+|-+.|.+| .||.|++|+--|. |...
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ--D~~s 148 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ--DEES 148 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee--cccc
Confidence 346899999999999999999994 578999999987542 23345677899999999 7999999976665 6678
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
+|+|+||+++|+|.++|++ .+.+++.....++.+|+.||+|||++| ||||||||+|||||+|+++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999986 346899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-----------ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 007160 422 KQAPEGRTN-----------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 422 ~~~~~~~~~-----------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~ 490 (615)
+.+...... .....++||..|.+||++..+..+..+|+|+|||+||+|+.|.+||....+ .+ .
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yl--i 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YL--I 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HH--H
Confidence 987543211 111458999999999999999999999999999999999999999974331 11 1
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
++.++ + +.-.++......+.+|+.+.|..||.+|+|..||.+|.
T Consensus 296 FqkI~----------~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 FQKIQ----------A--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHH----------H--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11111 1 11233344445688999999999999999999998874
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=343.55 Aligned_cols=257 Identities=30% Similarity=0.479 Sum_probs=203.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCc----EEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.+|+..+.||+|+||.||+|++. ++. .||||.+..... ...++|.+|+.+++.++|+||++++|+|.. ...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence 46899999999999999999853 333 489999875432 335679999999999999999999999863 257
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++++||+++|+|.++++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 89999999999999997532 34889999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||+..... .+.. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~-- 228 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKGE-- 228 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhCCC--
Confidence 7654433222223345778999999999999999999999999999998 99998643211 1111 111110
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
....+......+.+++.+||+.+|++||++.+++..|..+.+
T Consensus 229 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred --------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 001112223457899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=337.22 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=205.0
Q ss_pred cCcccceeeeccCceEEEEEEECC------CcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
++|++.+.||+|+||.||+|...+ ...||+|.+...... ...+|.+|++++.+++|+||+++++++. +...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--KEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc--CCCc
Confidence 468889999999999999998643 257999998754322 2457899999999999999999999987 4457
Q ss_pred eeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC
Q 007160 342 HLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 409 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 409 (615)
.+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcC
Confidence 8999999999999999964321 1145888999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 007160 410 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 488 (615)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~ 488 (615)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... .+.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~ 236 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI 236 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH
Confidence 99999999999986644332222334567889999999998899999999999999999998 99998643321 111
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.. +.... ....+......+.+|+.+||+.||++||+++||+++|+.
T Consensus 237 ~~-------------i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EM-------------IRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH-------------HHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11111 111233344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.92 Aligned_cols=247 Identities=30% Similarity=0.437 Sum_probs=211.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+.... +.+.+.+|++++++++|||||.++++|+ ...++++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE--t~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE--TSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc--ccceEEEE
Confidence 57888999999999999999954 6889999999865443 3467899999999999999999999987 55689999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
.||+.| +|..+|.. ++.+.++.+..++.++..||.|||+++ |+|||+||.||||+.++++|++|||+|+...
T Consensus 80 te~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred ehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 999977 99999975 456999999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.. ....+...||+.|||||...+..|+..+|+||+||+|||+++|++||... .+...++.++.+.
T Consensus 152 ~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~------- 216 (808)
T KOG0597|consen 152 TN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP------- 216 (808)
T ss_pred cC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC-------
Confidence 53 33557789999999999999999999999999999999999999999632 3333333333321
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
- ..|......+..++...|..||.+|.+-.+++.|
T Consensus 217 --v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 --V---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --C---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1 2344555568889999999999999999999887
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.13 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=206.2
Q ss_pred hcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCc-hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.+.|++.+.||.|..++||+|+ ...++.||||++..+..+. .+++.+|+..|+.++||||++++..|. ....+|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv--v~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV--VDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE--ecceeEEe
Confidence 4679999999999999999999 5678999999998765444 478999999999999999999998887 44589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|.||.+|++.+.++... ...+++..+..|+.++++||.|||.+| .||||||+.||||+.+|.+||+|||.+....
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999997533 234889999999999999999999999 9999999999999999999999999987665
Q ss_pred CCCcc-ccc-eeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 426 EGRTN-YLS-TRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 426 ~~~~~-~~~-~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
..... ... ...+||+.|||||+++. ..|+.|+||||||++.+||.+|..||..-.+... + ...+......+
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--L---l~tLqn~pp~~ 252 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--L---LLTLQNDPPTL 252 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--H---HHHhcCCCCCc
Confidence 43322 111 45789999999999764 4689999999999999999999999974332211 1 01111111100
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. -..+..+-.......+.+++..||+.||.+|||+++++++
T Consensus 253 ~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 L---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred c---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0 0001111111122358899999999999999999999865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=349.68 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=206.9
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC----CC-CchHHHHHHHHHHhhcc-CCCcceEEEEeecCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG----GQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDS 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~-~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 339 (615)
...+|.+.+.||+|+||+|++|.. .+|+.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 456899999999999999999984 47899999977653 12 23456678999999999 999999999998544
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEEEec
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADF 418 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DF 418 (615)
..++||||+.+|+|.+++.. ..++.+..+.+++.|++.|++|||+.+ |+||||||+|||++.+ +++||+||
T Consensus 94 -~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 -KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred -eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 69999999999999999985 345888999999999999999999999 9999999999999999 99999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCc-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH-LL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s-~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|++..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .....+.+..
T Consensus 166 G~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~ 237 (370)
T KOG0583|consen 166 GLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRK 237 (370)
T ss_pred ccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhc
Confidence 99998741 112345678999999999999877 75 89999999999999999999998522 2222222222
Q ss_pred cchhhhhhcCCccCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 497 DKDRLEELADPRLGGKYPKED-FIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~-~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.... +|... ...+..|+.+||..||.+|+++.+|+.+=|.-
T Consensus 238 ~~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 238 GEFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred CCcc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 2111 22222 44578999999999999999999999665443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=338.61 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=200.9
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.|+..+.||+|+||.||++.. .+|+.||||.+.... ......+.+|++++++++|+||+++++++. +....++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~--~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE--TKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc--cCCeEEEE
Confidence 477889999999999999995 578999999986432 222346889999999999999999999887 44579999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 79 ~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 79 LTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred EEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 99999999998886422 235889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... .....||..|+|||++.+..++.++|||||||++|||++|+.||......... ..... .+.
T Consensus 154 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~----------~~~ 218 (285)
T cd05631 154 EGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDR----------RVK 218 (285)
T ss_pred CCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHH----------Hhh
Confidence 3321 23457899999999999999999999999999999999999999754322110 00000 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL 546 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~L 546 (615)
.. ...++......+.+|+.+||+.||++||+ +++++++-
T Consensus 219 ~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 219 ED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred cc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 00 01122223345789999999999999997 88888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.50 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=202.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....|.+|+.++.+++||||++++|++. .....
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cCCCc
Confidence 357889999999999999999853 357899999986532 22357899999999999999999999987 44589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999999997532 35899999999999999999999998 9999999999999999999999999876
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
....... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .+... ..+..
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~-- 225 (266)
T cd05064 156 EDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDGF-- 225 (266)
T ss_pred cccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCC--
Confidence 5432211 11122345678999999999999999999999999999775 99999643211 11111 11100
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
....+......+.+++.+||+.+|++||++.+|++.|..+
T Consensus 226 --------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 --------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111223344688999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=335.48 Aligned_cols=250 Identities=32% Similarity=0.567 Sum_probs=192.9
Q ss_pred cceeeeccCceEEEEEEEC-----CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 273 PASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..+.||.|.||.||+|.+. .+..|+||.++..... ..+.|.+|++.+++++||||++++|++. +....++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc--ccccccccc
Confidence 4688999999999999976 3578999999654332 3578999999999999999999999998 444689999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.++|+.. ....+++.+++.|+.|+++||.|||+.+ ++|+||+++|||+++++.+||+|||+++....
T Consensus 81 e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp E--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999864 1346899999999999999999999998 99999999999999999999999999987743
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
...........+...|+|||.+....++.++||||||+++|||++ |+.||..... ..+. ..+ .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~---~~~-~~~~~----- 223 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEII---EKL-KQGQR----- 223 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHH---HHH-HTTEE-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc---ccc-ccccc-----
Confidence 322222233457889999999999999999999999999999999 7788753321 1111 111 11111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
...+......+.+++.+||+.||++||++.++++.|
T Consensus 224 -----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222344588999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=349.28 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=208.5
Q ss_pred HhcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCch-HHHHHHHHHHhhcc-CCCcceEEEEeecCCCCcee
Q 007160 267 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~-~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~ 343 (615)
.-++|...++||.|.||.||+|+ ..+|..||||+++..-.... ---++|+..|++|+ |||||+|..++.+.+. .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 34678999999999999999999 55789999999986543322 23468999999999 9999999999885554 899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+|||||+ .+|.+++++. +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+||||||.
T Consensus 87 fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999995 5999999864 567999999999999999999999999 99999999999999888999999999998
Q ss_pred CCCCCccccceeeccccccCCccccc-cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-----hhhhcc
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-----RPILRD 497 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~-----~~~~~~ 497 (615)
...... .+..+.|..|.|||++. .+.|+.+.|||++|||++|+.+-+.-|......++..-+-.+ +..+.+
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 865442 35678899999999876 567899999999999999999999988755433322111000 000111
Q ss_pred chhhhhhcCCccC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDRLEELADPRLG--------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~--------~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+..+...++-++. .-.+. ...+..+++.+|+..||.+|||+.|.+++
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1122222222111 11122 44568899999999999999999999987
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.28 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=205.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|.+.+.||+|+||.||+|... +++.||||.+...... ..+.|.+|++++++++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CC
Confidence 356888899999999999999863 2478999999765444 35689999999999999999999999874 45
Q ss_pred ceeEEEecCCCCChhHhhcCCC----------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC
Q 007160 341 QHLLCYELVPNGSLESWLHGPL----------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 410 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~----------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 410 (615)
..+++|||+++|+|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCC
Confidence 8999999999999999997532 12345889999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 007160 411 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~ 489 (615)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIE 235 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH
Confidence 9999999999986543322112233456789999999999999999999999999999998 99998643221 1111
Q ss_pred hhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
... .... ...+......+.+++.+||+.||++||++.||++.|+
T Consensus 236 ~~~-------------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CIT-------------QGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHH-------------cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111 0000 0111223345889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.14 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=205.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+..|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK-PG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec-CC
Confidence 357899999999999999999732 3478999998754322 235688899999999 89999999998864 34
Q ss_pred CceeEEEecCCCCChhHhhcCCCCC-------------------------------------------------------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGV------------------------------------------------------- 364 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~------------------------------------------------------- 364 (615)
...+++|||+++|+|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5788999999999999998542110
Q ss_pred --cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeecccccc
Q 007160 365 --NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442 (615)
Q Consensus 365 --~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y 442 (615)
...++|..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 126899999999999999999999998 999999999999999999999999999876443322222334567889
Q ss_pred CCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHH
Q 007160 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRV 521 (615)
Q Consensus 443 ~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l 521 (615)
+|||++.+..++.++|||||||+||||++ |..||....... .+. ..+.... ....+......+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~----------~~~~~~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGT----------RMRAPEYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccC----------CCCCCccCCHHH
Confidence 99999999999999999999999999998 999996432211 111 0111110 011122233458
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 522 CTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 522 ~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.+++.+||+.+|++||++.||+++|+.+.+
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.20 Aligned_cols=263 Identities=26% Similarity=0.425 Sum_probs=208.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++. +...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCc
Confidence 467889999999999999999842 34679999987655555678999999999999999999999987 4458
Q ss_pred eeEEEecCCCCChhHhhcCCC---------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc
Q 007160 342 HLLCYELVPNGSLESWLHGPL---------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 412 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~---------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 412 (615)
.+++|||+++++|.+++.... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 899999999999999996422 11234899999999999999999999998 999999999999999999
Q ss_pred EEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 007160 413 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~ 491 (615)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~-- 233 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE-- 233 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence 99999999986644332222233456788999999998899999999999999999998 89998643311 1111
Q ss_pred hhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.... .. .... +......+.+++.+||+.||.+|||+.+|++.|+++.+.
T Consensus 234 -~i~~-~~------~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 -CITQ-GR------VLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHc-CC------cCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1110 00 0001 111223589999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=343.52 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=195.4
Q ss_pred eeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 275 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++. +....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ--THDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--cCCEEEEEEeCCC
Confidence 4699999999999986 468999999987532 223356788999999999999999999987 4458999999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcc
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 430 (615)
+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 150 (323)
T cd05571 79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence 9999999974 335889999999999999999999999 99999999999999999999999999975432211
Q ss_pred ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccC
Q 007160 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG 510 (615)
Q Consensus 431 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~ 510 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+... +.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~---~~~~~~--------~~--- 212 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELILME--------EI--- 212 (323)
T ss_pred -cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHH---HHHHcC--------CC---
Confidence 223457999999999999999999999999999999999999999643211 111 111110 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 511 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 511 ~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
.++......+.+++.+||+.||++|| ++.++++|
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 12223334588999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.62 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=208.6
Q ss_pred cCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++. +....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG--DGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc--cCCce
Confidence 46888899999999999999842 35679999987655555578999999999999999999999987 44578
Q ss_pred eEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC
Q 007160 343 LLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 410 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 410 (615)
++||||+++++|.+++..... ....++|..++.++.|++.||+|||+++ |+||||||+|||++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 999999999999999964321 1235899999999999999999999999 9999999999999999
Q ss_pred CcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 007160 411 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~ 489 (615)
+.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence 9999999999986654332222334557889999999999999999999999999999999 99998643221 1111
Q ss_pred hhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
. .. .... ...+......+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 237 ~----~~---------~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 C----IT---------QGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H----Hh---------CCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 01 1000 011112234588999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.72 Aligned_cols=266 Identities=25% Similarity=0.351 Sum_probs=203.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+++.. ++..||+|.+..... ...+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEE
Confidence 368999999999999999999965 688899999875432 224579999999999999999999999874 4589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 82 MEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred eecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999999752 35888999999999999999999853 19999999999999999999999999998664
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh-hhccc------
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP-ILRDK------ 498 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~-~~~~~------ 498 (615)
... .....||..|+|||++.+..++.++|||||||++|||++|+.||....... +...... .....
T Consensus 156 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred ccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccc
Confidence 322 234568999999999999999999999999999999999999996433211 1100000 00000
Q ss_pred --------------------------hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 499 --------------------------DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 499 --------------------------~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.....+................+.+|+.+||+.||++|||+.|++++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000000000000011123458899999999999999999999988654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.53 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++. +....+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEEe
Confidence 35789999999999999999998888899999986533 23578999999999999999999999876 4557899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999997532 235888999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......++..|+|||++....++.++|||||||++|||++ |+.||...... ....... .... .
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~-----~ 223 (261)
T cd05072 157 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQ----RGYR-----M 223 (261)
T ss_pred cee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCCC-----C
Confidence 221 1223346778999999998889999999999999999998 99998643211 1111111 0000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+ .... ....+.+++.+||+.+|++||+++++.+.|+.
T Consensus 224 ~-~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 P-RMEN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C-CCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 1112 22357899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=326.54 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=201.0
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||++.+.++..+|+|.+.... ...++|.+|++++++++||||+++++++. +....++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc--cCCCEEEEEEc
Confidence 4588889999999999999998888889999886433 33568999999999999999999999987 44578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.++++... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 81 MENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999999997532 25899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... +... .. .
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~---i~~~-~~---~--- 220 (256)
T cd05114 155 YT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM---ISRG-FR---L--- 220 (256)
T ss_pred ee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---HHCC-CC---C---
Confidence 11 1122345678999999998889999999999999999999 8999864321 111111 1110 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..+......+.+++.+||+.+|++||+++++++.|
T Consensus 221 ----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 ----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01112234588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=326.84 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
+++|++.+.||+|+||.||+|...+++.||+|.++... ...++|.+|++++++++|+||+++++++. .....+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT--LEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe--cCCCeeeeee
Confidence 45789999999999999999998778899999987543 34577999999999999999999999987 4457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997533 345899999999999999999999998 999999999999999999999999999876532
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... .......+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. ....
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~--------- 219 (261)
T cd05068 157 IYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----QVDQ--------- 219 (261)
T ss_pred ccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHc---------
Confidence 211 1112233468999999998899999999999999999999 99998643211 1110 0000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
......+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 220 -GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00011122334568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.46 Aligned_cols=256 Identities=32% Similarity=0.476 Sum_probs=209.8
Q ss_pred HhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
...+|++.+.||.|+||.||+|...++..+|+|.+..........+.+|++++++++|+||+++++++. +....++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS--VGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe--cCCCeEEEE
Confidence 456789999999999999999998889999999998766555678999999999999999999999987 445789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.++++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999997533 345899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ........
T Consensus 157 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~------------- 218 (261)
T cd05148 157 DVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT------------- 218 (261)
T ss_pred ccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH-------------
Confidence 321 1223456778999999988899999999999999999998 8999964321 11111110
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.......+......+.+++.+||+.||.+|||++++++.|+.
T Consensus 219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 219 -AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 001111223334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=327.50 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=204.2
Q ss_pred cCcccceeeeccCceEEEEEEECC----CcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||.||+|.+.. ...||||.+...... ...+|.+|+.++++++|+||+++++++. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT--KSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe--cCCceE
Confidence 578999999999999999999742 457999998754332 3467899999999999999999999987 445789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 82 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 82 IITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999999997533 25899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~--- 225 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGY--- 225 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCC---
Confidence 753222222223345678999999998899999999999999999998 9999853221 1111111 0000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
....+......+.+++.+||+.+|++||++.||+++|+.+
T Consensus 226 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011222334688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=330.88 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=201.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCc----EEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++|++.+.||+|+||.||+|.+. +++ .|++|.+..... ....++..|+.++++++|+||+++++++. ....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---CCcc
Confidence 46778899999999999999963 344 478888754322 22356788888999999999999999874 2357
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++++||+++|+|.++++.. ...++|..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 84 ~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 8899999999999999743 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
...............++..|+|||++.+..++.++||||||+++|||++ |+.||....... +.. .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~- 229 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LLEKGER- 229 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCc-
Confidence 7654433223344567889999999998899999999999999999998 999986433211 111 1111110
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
. ..+......+.+++.+||..||++||++.|+++.|..+.+
T Consensus 230 --~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 --L-------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --C-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 0111122357889999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.77 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=204.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhcc-CCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 339 (615)
.++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.|.+|+++|+++. ||||++++++|. +.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--KS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--cC
Confidence 568899999999999999999852 234799999975433 23457999999999996 999999999987 45
Q ss_pred CceeEEEecCCCCChhHhhcCCCC--------------------------------------------------------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------- 363 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~-------------------------------------------------------- 363 (615)
...+|||||+++|+|.++|+....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 589999999999999999864210
Q ss_pred ------------------------------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE
Q 007160 364 ------------------------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL 407 (615)
Q Consensus 364 ------------------------------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl 407 (615)
....+++..++.++.|+++||+|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 0124788899999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 007160 408 ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 486 (615)
Q Consensus 408 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~ 486 (615)
++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~ 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--T 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--H
Confidence 9999999999999986644332222233457788999999999899999999999999999997 999986432110 1
Q ss_pred hhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 487 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
+. ....... ....+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 349 ~~----~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FY----NKIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH----HHHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 10 0111110 00112223345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=330.98 Aligned_cols=270 Identities=32% Similarity=0.431 Sum_probs=207.4
Q ss_pred cccceeeeccCceEEEEEEE-----CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 271 FEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
|+..+.||+|+||+||++.. .++..||+|.+..... .....|.+|++++++++|+||+++++++...+....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988753 3578899999875432 23567899999999999999999999987655567899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+|||+++|+|.+++.. ..+++.+++.++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999964 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
....... ......++..|+|||.+....++.++||||||+++|||++|+.|+....... .....+.... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQ-MTVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccc-cchhhhhh
Confidence 5433211 1122345677999999988889999999999999999999999986433211 1111111000 00011222
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
..+.......+......+.+++.+||+.+|++||++++|++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222222223334456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.48 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=203.8
Q ss_pred CcccceeeeccCceEEEEEEEC-C-CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-D-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|++++++++||||+++++++.. ....+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEEE
Confidence 4889999999999999999853 3 67889998765554445678889999999999999999999874 458999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.++|+........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999988653333446889999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~---------- 286 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYG---------- 286 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC----------
Confidence 322233456799999999999999999999999999999999999999964321 1111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ...+......+.+++.+||+.||++||++.+++.+
T Consensus 287 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00 01112223458899999999999999999999764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.96 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=206.1
Q ss_pred cCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.+|...++||+|.||.||+|+ ..+|+.||||+++.....+ .....+||+.|+.++|+||+.|+++|. ....+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceEEE
Confidence 467778999999999999999 5689999999998764332 356789999999999999999999987 55689999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
+|||+. +|+..++.. ...++-.++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+.
T Consensus 80 fEfm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEeccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccC
Confidence 999965 999999853 446888999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh----------h
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP----------I 494 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~----------~ 494 (615)
..... .+..+-|..|.|||.+++. .|+...||||.||++.||+-|.+-|.....-+ ++...++. .
T Consensus 153 ~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 153 SPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred CCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCcc
Confidence 65543 2344789999999999875 78999999999999999998877665433222 22221111 1
Q ss_pred hcc---chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 LRD---KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 ~~~---~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.. -..+.....+.+..-++ .+.....+|+..++..||.+|.++.|++++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 01111122222222222 233456899999999999999999999976
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=332.06 Aligned_cols=274 Identities=27% Similarity=0.365 Sum_probs=206.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-----CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||.||++... ++..||+|++........+.|.+|++++++++|+||+++++++...+....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888999999999999999852 5789999999766555567899999999999999999999988655556789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999996432 35899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCcccc-ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 424 APEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 424 ~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
......... .....++..|+|||++.+..++.++|||||||++|||++|..++.................. .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ-MIVYHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccc-cchHHHH
Confidence 654332211 11123445699999999889999999999999999999988775422110000000000000 0000011
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
+..........+......+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111111222334688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=338.79 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=200.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEE
Confidence 47889999999999999999965 68999999986432 123456889999999999999999998876 4568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 79 LMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999999974 235889999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 152 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~------- 213 (291)
T cd05612 152 RDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAG------- 213 (291)
T ss_pred cCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-------
Confidence 4321 2346899999999999988999999999999999999999999643211 111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLK 547 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~L~ 547 (615)
.. .++......+.+++.+||+.||.+||+ ++++++|-+
T Consensus 214 ---~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 214 ---KL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ---Cc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 11 112222345789999999999999995 888887743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.76 Aligned_cols=267 Identities=23% Similarity=0.302 Sum_probs=200.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++. +....++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEE
Confidence 47899999999999999999975 678999999875432 23467889999999999999999999987 44589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||++++.|..+... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 79 FEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999998877655432 235889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hh-------hhcc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-RP-------ILRD 497 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~-~~-------~~~~ 497 (615)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||............... .+ .+..
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 43221 123456899999999999888999999999999999999999999753321111000000 00 0000
Q ss_pred chhhhhhcCCccCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDRLEELADPRLGG------KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~~------~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.........+.... .+.......+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 0011123358899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.30 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=202.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
.+++|++.+.||+|+||.||+|... ++..||||++..... ....+|.+|+.++++++|+||+++++++. +.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence 4678999999999999999999853 256799999864332 23457899999999999999999999986 44
Q ss_pred CceeEEEecCCCCChhHhhcCCCCC------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcE
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGV------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 413 (615)
...++||||+++|+|.++++..... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCE
Confidence 5789999999999999999642211 234688899999999999999999988 9999999999999999999
Q ss_pred EEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhh
Q 007160 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~ 492 (615)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~-- 233 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF-- 233 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH--
Confidence 9999999986644332211222346788999999998899999999999999999999 78888643211 11110
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. +... ...+......+.+++.+||+.||++||++.|+++.|+
T Consensus 234 -~~----------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 -VM----------EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -HH----------cCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 0000 0112223346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=318.94 Aligned_cols=269 Identities=25% Similarity=0.307 Sum_probs=214.5
Q ss_pred HhcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecC---CCCce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~---~~~~~ 342 (615)
..++|++.+.||+|||+.||+++ +.++..+|+|++.....++.+..++|++..++++|||++++++++... ...+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999999 678899999999988877788899999999999999999999886532 23468
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
||++.|...|+|.+.+......+..+++.+.++|+.+|++||++||+..+ +++||||||.|||+.+++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999997655555679999999999999999999999875 59999999999999999999999999987
Q ss_pred cCCCCCcc-------ccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 007160 423 QAPEGRTN-------YLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 423 ~~~~~~~~-------~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
...-.-.. ........|..|.|||.+. +...++++|||||||+||+|+.|..||+.....+.. +
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-l----- 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-L----- 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-E-----
Confidence 65421110 0112345788999999885 456789999999999999999999999754332211 0
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.-.+.+..+...-.....+.+.+++++|++.||.+||++.+++..++.+.
T Consensus 252 --------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 --------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 00111111111111123456899999999999999999999999887653
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=330.50 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=202.1
Q ss_pred cCcccceeeeccCceEEEEEEE-----CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.+|++.+.||+|+||.||+|.. .++..||+|.+..... .....|.+|++++++++|+||+++++++. .....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT--QEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cCCce
Confidence 4678889999999999999984 2467899999975432 23367899999999999999999999987 44578
Q ss_pred eEEEecCCCCChhHhhcCCCC-------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC
Q 007160 343 LLCYELVPNGSLESWLHGPLG-------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 409 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 409 (615)
+++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcC
Confidence 999999999999999853210 1234788999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 007160 410 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 488 (615)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~ 488 (615)
++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~ 236 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI 236 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH
Confidence 99999999999987644332222233456778999999988889999999999999999998 9889864321 1111
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.. ..... ....+......+.+++.+||+.||++||++.+|.++|+.
T Consensus 237 ~~----~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EM----VRKRQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----HHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 11100 001122233468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.11 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=202.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEE
Confidence 46899999999999999999975 58899999987532 223457889999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 79 AMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999999964 235889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+......+
T Consensus 152 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~~~--- 217 (333)
T cd05600 152 VT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWKETL--- 217 (333)
T ss_pred cc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHHhccccc---
Confidence 43 123457999999999999999999999999999999999999999754321110 0010000000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..+... .........+.+++.+||+.+|.+||++.+++++-
T Consensus 218 ~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 218 QRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred cCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 001100 00011234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=329.66 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=209.2
Q ss_pred HhcCcccceeeeccCceEEEEEEECC-----CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
..++|++.+.||+|+||.||+|...+ +..|++|++..... ...+.+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 35689999999999999999999765 68899999874432 2346688999999999999999999987643 45
Q ss_pred ceeEEEecCCCCChhHhhcCCCCC----cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~----~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 416 (615)
..++++||+++|+|.+++...... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999653221 146899999999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhh
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
|||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||....+ ..+..+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~--- 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK--- 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---
Confidence 9999986644332222233456778999999998889999999999999999999 9999964322 11211111
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
..... . .+......+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 234 -~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 -DGYRL------A----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -cCCCC------C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11000 0 111123458899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=359.33 Aligned_cols=261 Identities=25% Similarity=0.318 Sum_probs=207.2
Q ss_pred HHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCC--
Q 007160 265 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS-- 339 (615)
Q Consensus 265 ~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~-- 339 (615)
....++|.+.+.||+|+||+||+|+. .+|+.||||++..... .....+.+|+.++..++|+|++++...+...+.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999985 5789999999875432 234568899999999999999999877653221
Q ss_pred ----CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEE
Q 007160 340 ----SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 415 (615)
Q Consensus 340 ----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 415 (615)
..+++||||+++|+|.++++........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 1367999999999999999754444456899999999999999999999998 999999999999999999999
Q ss_pred EeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 416 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHh
Confidence 99999987654322222344679999999999999999999999999999999999999996432 111111111
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ..+ ..+......+.+++.+||+.||.+||++.+++++
T Consensus 259 ~~------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AG------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cC------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 001 1222333458899999999999999999999875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=325.24 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=203.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.+|++.+.||+|+||.||+|... +++.||+|.+... ....+++.+|++++++++|+||+++++++. .....+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc--CCCCcEEEEE
Confidence 45788899999999999999964 5889999998743 333567999999999999999999999987 4457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999996532 345899999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ........ .
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~-~--------- 220 (263)
T cd05052 158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLE-K--------- 220 (263)
T ss_pred eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH-C---------
Confidence 211 1112234678999999998999999999999999999998 8999864321 11111111 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
......+......+.+++.+||+.||++||++.++++.|+.+
T Consensus 221 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 -GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011112222334588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=325.63 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=206.4
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|++++++++||||+++++++.. ....++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 5789999999999999999995 478999999876432 2223568999999999999999999999874 457899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
++||+++|+|.+++.........+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999999988643333345788999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...... ...+.... ...
T Consensus 157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~-------~~~ 223 (267)
T cd08228 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI-------EQC 223 (267)
T ss_pred cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-------hcC
Confidence 54321 122346888999999999888999999999999999999999998643211 11111111 000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
..+. .........+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 224 ~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0111 11222335689999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.83 Aligned_cols=263 Identities=26% Similarity=0.353 Sum_probs=211.6
Q ss_pred HHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--------------CchHHHHHHHHHHhhccCCCcce
Q 007160 265 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--------------QGDKEFLVEVEMLSRLHHRNLVK 329 (615)
Q Consensus 265 ~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--------------~~~~~f~~Ei~~l~~l~HpnIv~ 329 (615)
....++|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+||.+|++++|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34568899999999999999999994 4789999999975421 11247889999999999999999
Q ss_pred EEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCccc-CChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc
Q 007160 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE 408 (615)
Q Consensus 330 l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~-l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 408 (615)
|+.+..+.....+|||+|||..|.+...=. .+. |+..++++++.++..||+|||.++ ||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 999998888889999999999988764322 233 899999999999999999999999 99999999999999
Q ss_pred CCCcEEEEeccccccCCCCCc---cccceeeccccccCCccccccCc----CCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007160 409 NNFHAKVADFGLAKQAPEGRT---NYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMSQP 481 (615)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwS~GvvL~ElltG~~Pf~~~~~ 481 (615)
++|++||+|||.+.....+.. ...-...+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~- 323 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF- 323 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-
Confidence 999999999999987643321 11223478999999999887632 3578999999999999999999996322
Q ss_pred CCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
... ....|++..+.-.-..+..+.+.+||+++|..||++|.+..+|..|.+.-..
T Consensus 324 -----~~~----------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 -----ELE----------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -----HHH----------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 111 2233444444323233456678999999999999999999999999876543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=329.94 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=203.5
Q ss_pred CcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 270 NFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
+|++.+.||+|+||.||+|+.. +...+|+|.+..... ...+.+.+|++++++++||||+++++.+. .....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS--QDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCCc
Confidence 4778899999999999999853 235789998875432 22457899999999999999999999987 44578
Q ss_pred eEEEecCCCCChhHhhcCCCC--------------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCC
Q 007160 343 LLCYELVPNGSLESWLHGPLG--------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA 402 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp 402 (615)
++++||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 999999999999999864211 1235889999999999999999999998 99999999
Q ss_pred CCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 007160 403 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 481 (615)
Q Consensus 403 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~ 481 (615)
+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....+
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999986544332222233456778999999988889999999999999999998 9999864321
Q ss_pred CCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
. .+..+. . .......+......+.+++.+||+.+|++||+++|+++.|+.+..
T Consensus 236 ~---~~~~~~----~----------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 E---RLFNLL----K----------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H---HHHHHH----h----------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 111111 1 111111122233468899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.92 Aligned_cols=246 Identities=28% Similarity=0.377 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ--DENRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--cCCEEEE
Confidence 57899999999999999999965 68899999987432 223457889999999999999999999987 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 96 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999975 235788899999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.
T Consensus 169 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~--------- 228 (329)
T PTZ00263 169 PDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKIL--------- 228 (329)
T ss_pred CCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHh---------
Confidence 4432 2357999999999999999999999999999999999999999643211 1111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL 546 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~L 546 (615)
...+ .++......+.+++.+||+.||.+||+ +++++.|-
T Consensus 229 -~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 229 -AGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred -cCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 1111 112222335789999999999999996 78888763
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=338.97 Aligned_cols=243 Identities=25% Similarity=0.324 Sum_probs=194.8
Q ss_pred eeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 275 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+.||+|+||.||+++. .+|+.||+|.+.... ......+.+|++++++++||||+++++++. .....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCEEEEEEeCCC
Confidence 4699999999999995 468999999987532 223456788999999999999999999887 4458999999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcc
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 430 (615)
+|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 79 GGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 9999998864 235889999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccC
Q 007160 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG 510 (615)
Q Consensus 431 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~ 510 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... ...
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~~~~----------~~~- 212 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L---FELILM----------EEI- 212 (323)
T ss_pred -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHhc----------CCC-
Confidence 1234569999999999999999999999999999999999999996432111 0 011111 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 511 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 511 ~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
.++......+.+++.+||+.||.+|| ++.+++++-
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 11222334578999999999999998 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.34 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=206.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecC
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 337 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 337 (615)
...++|++.+.||+|+||.||++... +...+|+|.+..... ....++.+|++++.++ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-- 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--
Confidence 34567899999999999999999863 236899999875432 2335688999999999 7999999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCC------------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
+....+++|||+++|+|.++++... .....+++..+++++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 4457899999999999999996421 22346899999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~ 484 (615)
|+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 999999999999999987654332222223345678999999998899999999999999999998 999886332111
Q ss_pred chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 485 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
+. . .... ......+......+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 243 --~~---~-~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 --LF---K-LLKE----------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HH---H-HHHc----------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 10 0 1111 1111122233456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=325.72 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=202.1
Q ss_pred cccceeeeccCceEEEEEEECC----CcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCC----C
Q 007160 271 FEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S 340 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~----~ 340 (615)
|.+.+.||+|+||.||+|.+.. +..||+|+++.... .....+.+|++.+++++|+||+++++++...+. .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 36799999875432 224578999999999999999999998764332 3
Q ss_pred ceeEEEecCCCCChhHhhcCCC--CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 341 QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
..++++||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 4789999999999999985432 12236899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
|+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .+..+. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~---~-- 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL---R-- 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---H--
Confidence 99987654432222222345678999999988899999999999999999999 88888643211 111111 0
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
+.. ....+......+.+++.+||+.||++||++.||++.|+.+
T Consensus 230 --------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 --------HGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------cCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0112223345689999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=356.39 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=212.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEECCC-cEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEE-Eeec---CC-
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLSDG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVG-YYSS---RD- 338 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g-~~~~---~~- 338 (615)
....++++.+.|.+|||+.||+|++..+ ..||+|++-..+....+...+||++|++|+ |+|||.+++ .... ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4456788999999999999999997665 999999998887777889999999999997 999999999 3221 12
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
..+++|+||||.||.|-|++..... ..|++.++++|+.++++|+++||... |+|||||||-+||||..++..|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 3578999999999999999986443 34999999999999999999999986 55999999999999999999999999
Q ss_pred cccccCCCCC-cc----ccce--eeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 007160 419 GLAKQAPEGR-TN----YLST--RVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 488 (615)
Q Consensus 419 Gla~~~~~~~-~~----~~~~--~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~ 488 (615)
|.|.-.-... .. .... ...-|+-|.|||.+. +...++|+|||+|||+||-|+....||+.....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 9986432211 00 0000 124689999999774 678899999999999999999999999854322
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.|++.+..-.........+.+||..||+.||++||++-+|+..+..++..
T Consensus 265 --------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 --------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 12222222122235566799999999999999999999999998887654
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=343.92 Aligned_cols=262 Identities=19% Similarity=0.238 Sum_probs=194.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.+|.+.+.||+|+||.||++... .++.||||... ...+.+|+++|++++|+|||++++++.. ....++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEEE
Confidence 36999999999999999999965 57889999643 2346789999999999999999999873 457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
++ .++|.+++... ...++|.+++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~-~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KY-RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99 47999988642 235899999999999999999999998 999999999999999999999999999876443
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-Cc----chhhHhhhhhhccchh--
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQ----ENLVTWARPILRDKDR-- 500 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~-~~----~~l~~~~~~~~~~~~~-- 500 (615)
..........||..|+|||++.+..++.++|||||||+||||++|..|+...... .. ..+.............
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 2222223457999999999999999999999999999999999988765322111 11 1111111100000000
Q ss_pred ------h-hhhcC---CccCCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 501 ------L-EELAD---PRLGGKYPK-------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 501 ------l-~~i~d---~~l~~~~~~-------~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+ ..... ......... .....+.+|+.+||+.||.+|||+.|++++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000 000000000 111247789999999999999999999986
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.69 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=192.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|+..+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++|+||+++++++. +....++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEEEEE
Confidence 34566789999999999999964 6899999998654322 2467899999999999999999999986 455889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.+.. .+.+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 152 e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 152 EFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred ecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999999997543 2456778899999999999999998 99999999999999999999999999987643
Q ss_pred CCccccceeeccccccCCcccccc-----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
... ......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+. ......
T Consensus 221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~---- 291 (353)
T PLN00034 221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CAICMS---- 291 (353)
T ss_pred ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHHhcc----
Confidence 321 1234579999999998743 23456899999999999999999999733221111110 000000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. ...+......+.+|+.+||+.||++||++.|++++-+
T Consensus 292 ---~~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 292 ---QP----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred ---CC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00 1112223345889999999999999999999998743
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=337.98 Aligned_cols=267 Identities=24% Similarity=0.358 Sum_probs=197.5
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCC---Ccee
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~---~~~~ 343 (615)
+|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++...+. ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999954 68999999987432 2234568899999999999999999998754322 3579
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+. ++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689998864 235899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCc-cccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH---------hh
Q 007160 424 APEGRT-NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---------WA 491 (615)
Q Consensus 424 ~~~~~~-~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~---------~~ 491 (615)
...... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||............. +.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 112234579999999999875 678999999999999999999999996443211100000 00
Q ss_pred hhhhcc--chhhhhhcCCcc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 492 RPILRD--KDRLEELADPRL---GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 492 ~~~~~~--~~~l~~i~d~~l---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...... ...+..+..... ...++ .....+.+++.+||+.||++||+++|++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 000000000000 00000 112347899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.71 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=198.6
Q ss_pred cccceeeeccCceEEEEEEECC-Cc--EEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCC----CCc
Q 007160 271 FEPASILGEGGFGRVFKGVLSD-GT--AVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQ 341 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~ 341 (615)
|.+.+.||+|+||.||+|++.+ +. .||+|.++... ....+.|.+|++++++++|+||+++++++.... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999754 32 68999887542 233467899999999999999999999875321 235
Q ss_pred eeEEEecCCCCChhHhhcCCC--CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 342 HLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999884221 12235899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcC
Confidence 9987654332111222346778999999999999999999999999999999 7888864221 11111 11111
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
... ..+......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 11122334588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=330.15 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=196.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CCcEEEEEEeccCCC--CchHHHHHHHHHHhhc---cCCCcceEEEEeec---CC
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRL---HHRNLVKLVGYYSS---RD 338 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~---~~ 338 (615)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++++++ +||||++++++|.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999862 468899999875432 2234677788887766 69999999998853 23
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||++ ++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 69999986532 235889999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhhhhcc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRD 497 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~~~~~~~~~~ 497 (615)
|+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .+...... ...
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~~ 230 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGE 230 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CCh
Confidence 9998654331 223457899999999999889999999999999999999999999754321110 00000000 000
Q ss_pred chh------hhhhcCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDR------LEELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~------l~~i~d~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... ........... .........+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 00000000000 0001122346799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.24 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=201.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
.+++|.+.+.||+|+||.||+|.+. .+..||+|.+...... ....|.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 3567999999999999999999974 3568999988644322 34579999999999999999999998874 4
Q ss_pred CceeEEEecCCCCChhHhhcCCCC---CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC---cE
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HA 413 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~v 413 (615)
...++||||+++++|.++++.... ....++|..+++++.||+.||+|||+.+ ++||||||+|||++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcce
Confidence 477999999999999999965321 1235899999999999999999999998 99999999999998654 69
Q ss_pred EEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhh
Q 007160 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~ 492 (615)
||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~--- 232 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME--- 232 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---
Confidence 9999999987643322111122334578999999999999999999999999999997 99998743321 1111
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.... ......+......+.+++.+||+.+|++||++.+|+++|+
T Consensus 233 ~~~~-----------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTG-----------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHc-----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0110 0011122233346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.53 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=205.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--------CCcEEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCC
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 338 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 338 (615)
++|.+.+.||+|+||.||++... ++..+|+|.+.... .....++.+|+++++++ +|+||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-- 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-- 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence 57899999999999999999752 23579999997542 22345788899999999 79999999999874
Q ss_pred CCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeE
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NIL 406 (615)
....++||||+++|+|.+++..... ....++|.++++++.|++.||+|||+.+ ++||||||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 4578999999999999999975321 1235899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007160 407 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE 485 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~ 485 (615)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 99999999999999986643222111222335578999999998899999999999999999998 8888853321
Q ss_pred hhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 486 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
...... .... .....+......+.+++.+||+.+|++||++.+|++.|+.+.+..
T Consensus 249 --~~~~~~-~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 --EELFKL-LKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred --HHHHHH-HHcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111111 1110 001122233446889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.04 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=200.7
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||+|...++..||+|.+.... ...++|.+|+.++++++||||+++++++.. ....+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEc
Confidence 4578889999999999999998777789999987443 335679999999999999999999999874 4468999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 81 MSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 99999999997532 25899999999999999999999998 9999999999999999999999999998664432
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++..|+|||++....++.++||||||+++|||++ |+.||...... .... ..... ..
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~~~-~~------- 219 (256)
T cd05113 155 YT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KVSQG-LR------- 219 (256)
T ss_pred ee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HHhcC-CC-------
Confidence 11 1122345678999999988889999999999999999998 99998643211 1111 11110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
...+......+.+++.+||+.+|++||++.++++.|
T Consensus 220 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 220 ---LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 011112234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=328.12 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=201.2
Q ss_pred CcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCCc-hHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 270 NFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
+|++.+.||+|+||.||+|... ++..||+|++....... ...|.+|+.++.+++|+||+++++++.. ....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CCce
Confidence 4677899999999999999853 24789999997543322 3568899999999999999999999874 4478
Q ss_pred eEEEecCCCCChhHhhcCCC------------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC
Q 007160 343 LLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 410 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 410 (615)
++++||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 99999999999999985211 11235788899999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 007160 411 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~ 489 (615)
+.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||..... . .
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~---~ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q---D 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H---H
Confidence 9999999999987654332222233456789999999988889999999999999999998 8888864321 1 1
Q ss_pred hhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+.. .+.+... ...+......+.+++.+||+.+|++||++++|++.|+.
T Consensus 235 ~~~----------~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIE----------MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH----------HHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 1111111 11223344558899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=337.00 Aligned_cols=249 Identities=28% Similarity=0.415 Sum_probs=208.6
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..|+..+.||+|.||.||||.. ..++.||+|++..... ...++...|+.+|..++++||.+++|.+. .+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl--~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL--KGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee--ecccHHHHH
Confidence 3567778999999999999995 4689999999986543 34578999999999999999999999887 556899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|||.+|++.+.|+. ...+++..+.-|+.++..||.|||.++ .+|||||+.|||+..+|.+||+|||.+.....
T Consensus 91 ey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999974 234577888889999999999999999 99999999999999999999999999987765
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ....++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..... .+.+-.-
T Consensus 164 ~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk~~P 228 (467)
T KOG0201|consen 164 TVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPKSAP 228 (467)
T ss_pred hhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccCCCC
Confidence 433 3366899999999999998899999999999999999999999997655532111 1222233
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
|.+.+.+.. .+.+++..||+.||+.||++.++++|
T Consensus 229 P~L~~~~S~----~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSP----PFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCH----HHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 444444433 38899999999999999999999876
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.19 Aligned_cols=264 Identities=27% Similarity=0.441 Sum_probs=203.8
Q ss_pred hcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|++++.++ +|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec-CC
Confidence 35789999999999999999973 3468899999975432 2345688999999999 68999999998864 33
Q ss_pred CceeEEEecCCCCChhHhhcCCCCC-------------------------------------------------------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGV------------------------------------------------------- 364 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~------------------------------------------------------- 364 (615)
...+++|||+++|+|.++++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4688999999999999998642210
Q ss_pred --------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceee
Q 007160 365 --------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436 (615)
Q Consensus 365 --------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 436 (615)
...++|..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124788899999999999999999998 999999999999999999999999999875433222122233
Q ss_pred ccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCH
Q 007160 437 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK 515 (615)
Q Consensus 437 ~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~ 515 (615)
.++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+.. .+..... . ..+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~~------~----~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCR----RLKEGTR------M----RAPD 305 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHH----HHhccCC------C----CCCC
Confidence 46778999999999999999999999999999997 99998643211 11110 1111100 0 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 516 EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 516 ~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.....+.+++.+||+.||++||++.||+++|+.+.+
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122357899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.78 Aligned_cols=266 Identities=21% Similarity=0.317 Sum_probs=198.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++. +....++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH--TERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc--CCCeEEEEE
Confidence 56899999999999999999964 688999999875432 23456889999999999999999999986 445789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 83 e~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 83 EYLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred eCCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 99974 999988642 234788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH-h-------hhhhhcc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT-W-------ARPILRD 497 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~-~-------~~~~~~~ 497 (615)
... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||............. . .++....
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 156 PTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred CCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 221 1233568999999998875 568999999999999999999999996543221111000 0 0000000
Q ss_pred chhhhhhcCCccCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDRLEELADPRLGGKY----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~----~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.........+...... .......+.+++.+||+.||.+|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011111111110000 00112347899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=324.53 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=202.7
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCc----EEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGT----AVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
.++|+..+.||+|+||+||+|++ .+|. .||+|.+...... ..+++.+|+.+++.++|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CC
Confidence 35788899999999999999985 3444 4899998754332 34678899999999999999999999863 35
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++++||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence 78999999999999999753 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||+.... ..+..+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~----~~~~ 229 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE----KGER 229 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCc
Confidence 87654332222222345678999999998899999999999999999998 8999864321 11111111 1000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
...+......+.+++.+||+.||++||++.++++.|+.+.+
T Consensus 230 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 230 ----------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01111223457899999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.28 Aligned_cols=264 Identities=24% Similarity=0.403 Sum_probs=206.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--------CCcEEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 337 (615)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 467888999999999999999741 24579999987432 23346789999999999 89999999999874
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
....+++|||+++|+|.+++..... ....++|.+++.++.|+++||.|||+.+ ++||||||+||
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 93 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 4578999999999999999975321 1235788999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~ 484 (615)
|+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 999999999999999987654332222233456778999999998889999999999999999998 788875332
Q ss_pred chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 485 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
...+...+ ..... ...+......+.+++.+||+.+|++||++.||++.|+.+....
T Consensus 245 --~~~~~~~~-~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 --VEELFKLL-KEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --HHHHHHHH-HcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111111 11110 0112233446889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.09 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=194.5
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
+.||+|+||.||+|+.. +++.||+|.+..... .....|.+|++++++++|+||+++++++.. ....++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCC
Confidence 46999999999999964 789999998764332 234579999999999999999999999874 45789999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 432 (615)
+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 79 ~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 79 DFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 999999642 235889999999999999999999998 99999999999999999999999999976543221111
Q ss_pred ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCC
Q 007160 433 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 511 (615)
Q Consensus 433 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~ 511 (615)
......+..|+|||.+.++.++.++||||||+++|||++ |..||...... .... .. ......
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~----~~----------~~~~~~ 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTRE----AI----------EQGVRL 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHH----HH----------HcCCCC
Confidence 111223567999999998899999999999999999998 88888633211 1000 00 001111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 512 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 512 ~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
..+......+.+++.+||+.+|++||++.+|.+.|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 222233446889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.70 Aligned_cols=267 Identities=26% Similarity=0.376 Sum_probs=201.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++++++|+||++++++|.. ....++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEE
Confidence 468999999999999999999965 688899998875432 224578999999999999999999999874 4589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999999974 23478899999999999999999974 5 999999999999999999999999999765
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH------hhh------
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT------WAR------ 492 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~------~~~------ 492 (615)
.... .....||..|+|||++.+..++.++|||||||++|||++|+.||............. +..
T Consensus 155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 3321 223468999999999998899999999999999999999999996433211100000 000
Q ss_pred ------------hhhccchhhhhhcCCccC---CCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 493 ------------PILRDKDRLEELADPRLG---GKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 493 ------------~~~~~~~~l~~i~d~~l~---~~~~-~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
+..+.......+.+.... ...+ ......+.+|+.+||+.||++|||+.|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000000000000000 0000 011235789999999999999999999998744
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.90 Aligned_cols=253 Identities=29% Similarity=0.467 Sum_probs=203.2
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.|.+|++++++++|+|++++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEEEEe
Confidence 46888999999999999999988888899999875433 3567999999999999999999999874 2357899999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++++|.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999997532 235899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++..|+|||++.+..++.++||||||+++|||++ |..||...... ..... +..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~---~~~----------- 218 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQ---VER----------- 218 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH---HHc-----------
Confidence 11 1122345678999999988889999999999999999999 88898643211 11111 100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
......+......+.+++.+||+.+|++|||++++.+.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00111223334568999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.17 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=199.6
Q ss_pred CcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 270 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+|++.+.||+|+||.||+|...++..+|+|.+.... .....|.+|++++++++|+||+++++++. +....++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEEEecC
Confidence 577889999999999999998777889999986433 23467899999999999999999999986 445789999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++++|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...+...
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999997532 25899999999999999999999999 99999999999999999999999999986643321
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .. .. ...
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~-~~------~~~-- 219 (256)
T cd05059 156 T-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE---SV-SA------GYR-- 219 (256)
T ss_pred c-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHH---HH-Hc------CCc--
Confidence 1 1112234568999999998999999999999999999999 89998643221 1111 00 00 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
...+......+.+++.+||+.+|++||++.|+++.|
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 --LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111222344688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.34 Aligned_cols=263 Identities=23% Similarity=0.379 Sum_probs=204.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCCc-hHHHHHHHHHHhhcc-CCCcceEEEEeecCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLH-HRNLVKLVGYYSSRD 338 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~ 338 (615)
..++|.+.+.||+|+||.||+|++. .+..||||++....... .+.+.+|+++|.++. |+||++++++|..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 3456788899999999999999863 34689999997543322 357899999999997 9999999999874
Q ss_pred CCceeEEEecCCCCChhHhhcCCCC-------------------------------------------------------
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLG------------------------------------------------------- 363 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~------------------------------------------------------- 363 (615)
....++||||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 4578999999999999999964321
Q ss_pred ---------------------------------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCC
Q 007160 364 ---------------------------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN 404 (615)
Q Consensus 364 ---------------------------------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~N 404 (615)
....++|..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 1124678889999999999999999988 9999999999
Q ss_pred eEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 007160 405 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSG 483 (615)
Q Consensus 405 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~ 483 (615)
||+++++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543221111223457889999999998889999999999999999998 888986432111
Q ss_pred cchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 484 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 484 ~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.+ ...+... .....+......+.+++.+||+.+|.+||+++||++.|+.+.
T Consensus 350 --~~----~~~~~~~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --QF----YNAIKRG----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HH----HHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00 0011110 111122223356889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=335.55 Aligned_cols=240 Identities=24% Similarity=0.326 Sum_probs=192.9
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 277 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
||+|+||.||+|+.. +++.||+|.+... .......+.+|++++.+++||||+++++++. +....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ--SPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe--cCCeEEEEEcCCCCC
Confidence 799999999999965 5789999998643 2233467889999999999999999999887 445899999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 432 (615)
+|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 149 (312)
T cd05585 79 ELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K 149 (312)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence 99999974 235889999999999999999999999 99999999999999999999999999986433221 2
Q ss_pred ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 433 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 433 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ . .
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~----------~--~ 211 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEP----------L--R 211 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCC----------C--C
Confidence 234579999999999999999999999999999999999999996432 111222222111 0 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQS 545 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPs---m~eVl~~ 545 (615)
++......+.+++.+||+.||++||+ +.|++.|
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 22223345789999999999999975 6676665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.08 Aligned_cols=243 Identities=26% Similarity=0.360 Sum_probs=194.3
Q ss_pred eeeeccCceEEEEEEE----CCCcEEEEEEeccCC----CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 275 SILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+.||+|+||.||+++. .+++.||||.+.... ......+.+|++++++++||||+++++++. +....++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ--TGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe--cCCeEEEEE
Confidence 6899999999999985 357899999987432 222356788999999999999999999987 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.+++.. ...+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 80 EYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred eCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999999964 234778889999999999999999999 99999999999999999999999999875433
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+. .
T Consensus 153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~----------~ 214 (323)
T cd05584 153 EGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL----------K 214 (323)
T ss_pred CCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH----------c
Confidence 221 223457999999999999888999999999999999999999999743211 1111111 1
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
... ..+......+.+++.+||+.||++|| ++.+++++-
T Consensus 215 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 215 GKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 111 12222334578999999999999999 899988763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=340.90 Aligned_cols=254 Identities=25% Similarity=0.324 Sum_probs=202.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++..++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEE
Confidence 47899999999999999999965 68999999997532 233467889999999999999999999887 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 99999999999999753 45889999999999999999999988 999999999999999999999999999866
Q ss_pred CCCC---------------------------ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCC
Q 007160 425 PEGR---------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477 (615)
Q Consensus 425 ~~~~---------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~ 477 (615)
.... .........||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 5432 0011234579999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 007160 478 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQSL 546 (615)
Q Consensus 478 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-m~eVl~~L 546 (615)
...... ....+...... +..+. .......+.+++.+|+. ||.+||+ +.+++++.
T Consensus 232 ~~~~~~------~~~~i~~~~~~---~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 232 SDTLQE------TYNKIINWKES---LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CCCHHH------HHHHHhccCCc---ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 543111 11111110000 00000 00123457889999998 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=318.28 Aligned_cols=260 Identities=23% Similarity=0.376 Sum_probs=208.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++.. ....++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 57999999999999999999976 78999999886422 2235678999999999999999999999874 457899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+|||+++|+|.+++.........+++.+++.++.++++||.|||+.+ ++||||+|+||+++.++.++|+|||+++..
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999998654333456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||..... ++.........
T Consensus 157 ~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-------- 222 (267)
T cd08224 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK-------- 222 (267)
T ss_pred cCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc--------
Confidence 43321 12334688999999999988899999999999999999999999864321 11111111100
Q ss_pred cCCccCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 505 ADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 505 ~d~~l~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
. .....+. .....+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 223 --~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 --C-DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --C-CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 0011111 23346889999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=337.24 Aligned_cols=243 Identities=24% Similarity=0.335 Sum_probs=195.7
Q ss_pred eeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 275 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+.||+|+||.||++.. .+|+.||||++.... ......+.+|++++++++||||+++++++. +....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence 4699999999999995 468999999997532 233457889999999999999999999887 4458999999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcc
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 430 (615)
+|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 79 GGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 9999999864 235899999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccC
Q 007160 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG 510 (615)
Q Consensus 431 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~ 510 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... +.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~--------~~--- 212 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME--------DI--- 212 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccC--------Cc---
Confidence 123457999999999999999999999999999999999999999643211 111111111 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 511 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 511 ~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
.++......+.+++.+||+.||++|| ++.|++++-
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 213 -KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred -cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 12222334578999999999999997 899998773
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=319.91 Aligned_cols=255 Identities=31% Similarity=0.462 Sum_probs=203.6
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.++||+|+||.||+|+..++..||+|++.... ...+.|.+|++++++++|+||+++++++. ....++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEEEE
Confidence 35689999999999999999998777789999997533 33567999999999999999999999864 235789999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999997532 235789999999999999999999998 999999999999999999999999999866543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......++..|+|||+..+..++.++||||||+++|||++ |..||...... ... .....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~---~~~~~---------- 218 (262)
T cd05071 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL---DQVER---------- 218 (262)
T ss_pred ccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH---HHHhc----------
Confidence 321 1123346778999999998899999999999999999999 88888643211 100 00000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
......+.+....+.+++.+|++.+|++||++.++++.|+..
T Consensus 219 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000111223345688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.48 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=203.8
Q ss_pred hcCcccceeeeccCceEEEEEEECC------CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++++++|+||+++++++. +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--TGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc--CCC
Confidence 4578899999999999999998642 46899999875432 23457899999999999999999999987 445
Q ss_pred ceeEEEecCCCCChhHhhcCCCCC------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGV------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
..++||||+++|+|.+++...... ...++|..++.++.|++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 789999999999999999643221 234789999999999999999999998 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~-- 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV-- 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH--
Confidence 999999986654332222233457889999999998889999999999999999998 8999864321 1111111
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.... ....+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 --~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 --IDGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --hcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1100 01122223456889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=321.57 Aligned_cols=268 Identities=23% Similarity=0.276 Sum_probs=208.5
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|+.++.|++|.||.||+|+. ++++.||+|+++...... .-.-++||.+|.+++|||||.+..+....+-...|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4688889999999999999995 478999999998654222 2356899999999999999999999887777789999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||||+. +|...+.... .++...++.-+..|+++||+|||.+. |+|||||++|+|+.+.|.+||+||||||.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999977 8999997532 46888999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-------hcc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI-------LRD 497 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~-------~~~ 497 (615)
.... ..+..+-|..|.|||.+.+. .|++..|+||+|||+.||+++++-|......++.+.+ ++-+ +..
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I--f~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI--FKLLGTPSEAIWPG 304 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH--HHHhCCCccccCCC
Confidence 6543 34677899999999998864 6899999999999999999999988765543332211 1100 000
Q ss_pred chhhh--------hhcCCccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 KDRLE--------ELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 ~~~l~--------~i~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
-..+. ...-..+...++.. ..+.-.+|+...|..||.+|-|+.|.+++=.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 00000 00000111112211 2244678999999999999999999998743
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=319.53 Aligned_cols=246 Identities=26% Similarity=0.419 Sum_probs=195.1
Q ss_pred eeeccCceEEEEEEE---CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 276 ILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 276 ~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
.||+|+||.||+|.+ .++..+|+|+++..... ..+++.+|+.++++++|+||+++++++. ....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence 589999999999975 35788999998754322 3467999999999999999999999874 236789999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcc
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 430 (615)
+|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 79 LGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99999999642 35889999999999999999999998 999999999999999999999999999876543321
Q ss_pred cc-ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 431 YL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 431 ~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
.. .....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+... ....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----i~~~---------- 214 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQM----IESG---------- 214 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCC----------
Confidence 11 122334678999999988889999999999999999998 99999643211 11111 1110
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.....+......+.+++.+||+.||++||++++|++.|+.
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1111222334568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=339.56 Aligned_cols=245 Identities=25% Similarity=0.343 Sum_probs=198.9
Q ss_pred cCcccceeeeccCceEEEEEEECC--CcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD--GTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++. +....+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK--DESYLY 107 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE--eCCEEE
Confidence 478999999999999999998543 3689999986432 233457889999999999999999999987 445899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999975 235889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....+..
T Consensus 181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~------- 242 (340)
T PTZ00426 181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILE------- 242 (340)
T ss_pred cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhc-------
Confidence 5432 134579999999999998889999999999999999999999997433210 0111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
... .++......+.+++.+||+.||++|+ ++++++++
T Consensus 243 ---~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 243 ---GII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 100 11222233478999999999999995 89999877
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.30 Aligned_cols=264 Identities=24% Similarity=0.397 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEECC---------------CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD---------------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVG 332 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~---------------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g 332 (615)
++|++.+.||+|+||.||+++..+ ...||+|.+..... .....|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 23589999875432 22457999999999999999999999
Q ss_pred EeecCCCCceeEEEecCCCCChhHhhcCCCC--------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCC
Q 007160 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLG--------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN 404 (615)
Q Consensus 333 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~--------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~N 404 (615)
++. .....++||||+++++|.+++..... ....++|..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 85 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 85 VCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 987 44578999999999999999964211 1124788999999999999999999998 9999999999
Q ss_pred eEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 007160 405 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQPS 482 (615)
Q Consensus 405 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt--G~~Pf~~~~~~ 482 (615)
|++++++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 9999999999999999986644332222233456789999999998899999999999999999998 5667754321
Q ss_pred CcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 483 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 483 ~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
................ ......+......+.+|+.+||+.||++||++++|++.|+
T Consensus 239 --~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 --EQVIENTGEFFRNQGR-------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHHhhhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111111000 0000111122346899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=315.79 Aligned_cols=236 Identities=29% Similarity=0.397 Sum_probs=199.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.+...- ..+...+|..+|+.+.||+++++.+-|. +...++|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~--d~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK--DNSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec--cCCeEEE
Confidence 46888999999999999999965 6889999999765322 2345778999999999999999998877 6679999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||++||.|..+|+. .++++...+.-+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+..
T Consensus 122 vmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999985 346899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
... +-..+||+.|+|||++..+.+...+|-|||||++|||+.|..||...++. .. .+.+
T Consensus 195 ~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~i----------Y~KI 253 (355)
T KOG0616|consen 195 SGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QI----------YEKI 253 (355)
T ss_pred cCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HH----------HHHH
Confidence 643 34578999999999999999999999999999999999999999865541 11 2222
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQR 536 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 536 (615)
+...+ .+|.-....+.+|+...|+.|-.+|
T Consensus 254 ~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 22222 2333333457889999999999999
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.84 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=203.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
.++|.+.+.||+|+||.||++... ++..||||.++.... ...+.+.+|+++++++ +|+||+++++++.. .
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--G 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--C
Confidence 457999999999999999999741 345799999875432 2245789999999999 79999999999874 4
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...+++|||+++|+|.++++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 57899999999999999997532 233899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... ...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~----~~~-- 258 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYK----LIK-- 258 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHH----HHH--
Confidence 9986654332212223346788999999999999999999999999999998 99998643211 11111 111
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.......+......+.+++.+||+.+|++||++.||++.|+.+
T Consensus 259 --------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 --------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0001111112234688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=321.59 Aligned_cols=261 Identities=23% Similarity=0.372 Sum_probs=207.2
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+. .+++.||||.+..... ....++.+|+++++.++|+||+++++++. +....++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI--EDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE--eCCeEEE
Confidence 4688889999999999999995 5789999998864322 22357889999999999999999999987 4458899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+|||+++++|.+++.........+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999999998643333446899999999999999999999998 999999999999999999999999998866
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... ......|+..|+|||++.+..++.++||||||+++|||++|..||...... ...+... +...
T Consensus 157 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-------~~~~ 223 (267)
T cd08229 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-------IEQC 223 (267)
T ss_pred ccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-------hhcC
Confidence 44322 123356889999999999888999999999999999999999998633211 1111111 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
..+.. .+......+.+++.+||+.||++||||.+|++.++++.
T Consensus 224 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 DYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111 11223346889999999999999999999999887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.27 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=207.3
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
-|++++.||.|+-|.|-+|+. .+|+.+|||++.+... .....+.+||-+|+-+.|||+++++++++ +..++|||
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe--~~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE--NKQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec--cCceEEEE
Confidence 477889999999999999995 5899999999976522 22356789999999999999999999987 55699999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
.||+++|.|.++|-. .+++.+.++.+++.||+.|+.|+|..+ |+|||+||+|+|||..+.+||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999975 446899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.+. .-...+|.+.|.+||++++..| ..++||||.|||||.|+||+.||+. .|+......+-+...
T Consensus 164 ~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~G~f----- 229 (786)
T KOG0588|consen 164 PGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQRGVF----- 229 (786)
T ss_pred CCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHcCcc-----
Confidence 543 3355689999999999999988 5899999999999999999999983 233332222222211
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+.|.....+..+|+.+|+..||++|.|++||++|-+.
T Consensus 230 -------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 230 -------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred -------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 1222333347789999999999999999999988643
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.29 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.+|...++||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCce
Confidence 56788899999999999999742 356899999876655556789999999999999999999999874 4578
Q ss_pred eEEEecCCCCChhHhhcCCCC-----------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 343 LLCYELVPNGSLESWLHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence 999999999999999964321 1135889999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~ 490 (615)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~- 235 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIE- 235 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHH-
Confidence 999999999976543322112223346788999999999999999999999999999998 899986432111 110
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+.... ....+......+.+++.+||+.||++||+++||++.|+
T Consensus 236 ------------~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 ------------CITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------------HHHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000000 00111122345889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=319.15 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=204.4
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.++||+|+||.||+|...+++.||+|.+.... .....|.+|++++++++|+||+++++++. ....+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEE
Confidence 46788999999999999999998889999999987544 33568999999999999999999999864 346899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999987533 345899999999999999999999998 999999999999999999999999999876532
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......++..|+|||++....++.++||||||+++|||++ |+.||...... .+... +...
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~-------- 219 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN----LERG-------- 219 (260)
T ss_pred Ccc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH----HHcC--------
Confidence 211 1123346788999999998889999999999999999999 99999643211 11111 0000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.....+......+.+++.+||+.+|++||++++++..|+.
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 --YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001112223458999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=330.89 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=204.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecCC
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 338 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 338 (615)
.+|.+.+.||+|+||.||+++.. .+..||+|.+..... ...+++.+|+++++++ +|+||++++++|. +
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--Q 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--c
Confidence 46889999999999999999742 123689998875432 2346799999999999 7999999999987 4
Q ss_pred CCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeE
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NIL 406 (615)
....+++|||+++|+|.+++..... ....++|.+++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 4578999999999999999964321 1235889999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007160 407 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE 485 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~ 485 (615)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 241 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----- 241 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 99999999999999987654322212223345678999999999999999999999999999998 888885332
Q ss_pred hhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 486 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
...+...+.. . .....+......+.+++.+||+.+|++||++.|+++.|+.+...
T Consensus 242 -~~~~~~~~~~-~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 242 -VEELFKLLKE-G----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -HHHHHHHHHc-C----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111111111 0 00111222334688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=326.75 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=197.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|+||+++++++. +....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe--cCCeEEEE
Confidence 468999999999999999999965 688999999875432 22346788999999999999999999987 44589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 82 FEYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 99995 6888888643 234888999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc------
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------ 498 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------ 498 (615)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+.... ..+...
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQLERIF-LVLGTPNEDTWP 230 (303)
T ss_pred CCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHH-HHhCCCChhhcc
Confidence 3221 1233568999999998865 45789999999999999999999999743211 01111000 000000
Q ss_pred --hhhhhhcCCccCCCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 --DRLEELADPRLGGKYPK---------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 --~~l~~i~d~~l~~~~~~---------~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...............+. .....+.+++.+||+.||++|||+.|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000000000000000 011346789999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=326.15 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=201.5
Q ss_pred cCcccceeeeccCceEEEEEEECC-C--cEEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD-G--TAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~-g--~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||.||+|...+ + ..+++|.++... ....+.|.+|++++.++ +||||+++++++. +....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE--NRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc--cCCcce
Confidence 578899999999999999998753 3 347888887432 23346789999999999 7999999999987 445789
Q ss_pred EEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 344 LCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
+++||+++|+|.++++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCC
Confidence 99999999999999964321 1235889999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~ 490 (615)
.+||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||...... . .
T Consensus 157 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~---~ 227 (297)
T cd05089 157 ASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---E---L 227 (297)
T ss_pred eEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---H---H
Confidence 99999999986432211 1111233567999999998899999999999999999997 99999643211 1 1
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
..... .......+......+.+++.+||+.+|.+||++.++++.|+.+.+..
T Consensus 228 ~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 YEKLP-----------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHh-----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 00111112223345889999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.88 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=200.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-----------------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-----------------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKL 330 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-----------------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l 330 (615)
++|++.+.||+|+||.||++... ++..||+|.+..... ...++|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999998532 244699999875432 234679999999999999999999
Q ss_pred EEEeecCCCCceeEEEecCCCCChhHhhcCCCCC-------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCC
Q 007160 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV-------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS 403 (615)
Q Consensus 331 ~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~-------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~ 403 (615)
++++.. ....+++|||+++|+|.+++...... ...+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 85 LAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred EEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 999874 45789999999999999999653211 134788899999999999999999998 999999999
Q ss_pred CeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh--CCCCCCCCCC
Q 007160 404 NILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQP 481 (615)
Q Consensus 404 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt--G~~Pf~~~~~ 481 (615)
|||+++++.+||+|||+++...............++..|++||....+.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999986644332222223345678999999888899999999999999999998 6778753321
Q ss_pred CCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. .........+..... .... ..+......+.+++.+||+.||++||++.+|++.|+
T Consensus 240 ~---~~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 E---QVIENTGEFFRDQGR--QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHHHhhccc--cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111111111110000 0000 111122346889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.60 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=197.8
Q ss_pred CcccceeeeccCceEEEEEEE----CCCcEEEEEEeccCC----CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCC
Q 007160 270 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 340 (615)
+|++.+.||+|+||.||+++. .+++.||+|.+.... ....+.+..|++++.++ +|+||+++++++. +..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence 588899999999999999885 357899999986432 22235678899999999 5999999999876 445
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence 78999999999999999964 235889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ......+..
T Consensus 152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~--- 225 (332)
T cd05614 152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK--- 225 (332)
T ss_pred CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc---
Confidence 9865433221 12345799999999998865 4788999999999999999999999643322111 111111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
.++. .+......+.+++.+||+.||++|| ++++++++-
T Consensus 226 -----~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 226 -----CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -----CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 1111 1222234578999999999999999 777888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.98 Aligned_cols=265 Identities=26% Similarity=0.415 Sum_probs=204.1
Q ss_pred hcCcccceeeeccCceEEEEEEECC-----------------CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD-----------------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVK 329 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~ 329 (615)
..+|++.+.||+|+||.||++...+ +..||+|.+..... ...++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999988542 24689999875533 23567899999999999999999
Q ss_pred EEEEeecCCCCceeEEEecCCCCChhHhhcCCCC-------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCC
Q 007160 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG-------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA 402 (615)
Q Consensus 330 l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~-------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp 402 (615)
+++++.. ....+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp 158 (296)
T cd05051 84 LLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT 158 (296)
T ss_pred EEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 9999874 3588999999999999999975331 1225899999999999999999999998 99999999
Q ss_pred CCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 007160 403 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQ 480 (615)
Q Consensus 403 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt--G~~Pf~~~~ 480 (615)
+||++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999986644332222334457789999999998889999999999999999998 667775322
Q ss_pred CCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 481 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 481 ~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. ..........+.... .......+......+.+++.+||+.||++|||+.||++.|+
T Consensus 239 ~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 D---QQVIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred h---HHHHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 111122111111110 00001111222346899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.75 Aligned_cols=249 Identities=21% Similarity=0.358 Sum_probs=195.5
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
++||+|+||.||+++.. +++.||||.++... ....+.+.+|+.++.++ +||||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCC
Confidence 46999999999999964 68899999997542 22335688899999998 7999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 79 SGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 99999998864 235899999999999999999999999 99999999999999999999999999975322211
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC--cchhhHhhhhhhccchhhhhhcCC
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG--QENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ......+...... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~ 220 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL---------EK 220 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH---------cC
Confidence 2234579999999999999999999999999999999999999997432211 1111222211111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT------MGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs------m~eVl~~ 545 (615)
.. ..+......+.+++.+||+.||.+||+ +.++++|
T Consensus 221 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 QI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11 122223345789999999999999997 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.85 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=195.6
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 277 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
||+|+||+||++... +++.||+|.+..... ...+.+..|++++++++|+||+++.+++. .....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCCC
Confidence 799999999999864 688999999875322 22356788999999999999999999876 445789999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 432 (615)
+|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~ 153 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--K 153 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--c
Confidence 999888643333456899999999999999999999998 99999999999999999999999999986654322 1
Q ss_pred ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 433 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 433 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... .+..... .
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~----------~~~~~~~--~ 219 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQ----------RILNDSV--T 219 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHH----------hhcccCC--C
Confidence 2345789999999999999999999999999999999999999964332111 000000 1111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
++......+.+++.+||+.||++|| ++++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2223334578999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=324.49 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=202.2
Q ss_pred HhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.++++++|+||+++++++. +.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--KG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence 4578999999999999999999753 245899998864432 22346889999999999999999999987 44
Q ss_pred CceeEEEecCCCCChhHhhcCCCC------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcE
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 413 (615)
...++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 578999999999999999964221 1234577888999999999999999998 9999999999999999999
Q ss_pred EEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhh
Q 007160 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~ 492 (615)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~--- 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK--- 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---
Confidence 9999999986544332222223345778999999999999999999999999999998 78888643211 1111
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.+.+... ...+......+.+++.+||+.||++||++.++++.|+..
T Consensus 233 ----------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 ----------FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ----------HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111100 011222234689999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.02 Aligned_cols=243 Identities=24% Similarity=0.325 Sum_probs=194.2
Q ss_pred eeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 275 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|++++..++|+||+++.+++. +....++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~--~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ--THDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE--cCCEEEEEEeCCC
Confidence 4699999999999985 468999999997532 223456788999999999999999999887 4458999999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
+|+|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9999999864 2358999999999999999999997 67 99999999999999999999999999875432221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ........ ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~---~~~~i~~~--------~~-- 213 (325)
T cd05594 152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---K---LFELILME--------EI-- 213 (325)
T ss_pred --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---H---HHHHHhcC--------CC--
Confidence 123456999999999999999999999999999999999999999643211 1 11111110 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
.++......+.+++.+||+.||++|+ ++.+++++-
T Consensus 214 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 214 --RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 11222234578999999999999996 899998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.57 Aligned_cols=253 Identities=29% Similarity=0.432 Sum_probs=202.1
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||+|...++..||+|.+.... ...+.|.+|++++++++|+|++++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEEc
Confidence 4688889999999999999998777789999886443 33567899999999999999999999874 2357899999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.++++... ...++|..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997532 235889999999999999999999998 9999999999999999999999999998664332
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....+. . ..
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~---~-~~--------- 219 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQV---E-RG--------- 219 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---H-cC---------
Confidence 11 1122346778999999998899999999999999999999 89998643211 111111 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.....+......+.+++.+||+.||++||++++|++.|+.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 -YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011222334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.95 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=200.7
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
+|+..++||+|+||.||++... +++.||||++..... .....+.+|++++++++|+||+++++++.. ....++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 4788899999999999999964 689999999875322 223457889999999999999999998874 4589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++...
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 79 LTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999886421 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ... ... .+.
T Consensus 154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~-~~~---------~~~ 218 (285)
T cd05605 154 EGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REE-VER---------RVK 218 (285)
T ss_pred CCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHH-HHH---------Hhh
Confidence 3321 1234689999999999988999999999999999999999999974332110 000 000 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
. ....++......+.+|+.+||+.||++|| ++++++++-
T Consensus 219 ~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 219 E--DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred h--cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 0 00112223344588999999999999999 888988763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.82 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=198.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++..++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ--DENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCeEEE
Confidence 47899999999999999999964 68999999997532 223356788999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 79 IMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999974 235899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCcc------------------------------------ccceeeccccccCCccccccCcCCchhhHHHHHHHHHH
Q 007160 425 PEGRTN------------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLE 468 (615)
Q Consensus 425 ~~~~~~------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~E 468 (615)
...... ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 321100 00112469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 007160 469 LLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQS 545 (615)
Q Consensus 469 lltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---m~eVl~~ 545 (615)
|++|+.||....... ....+......+ ..+. .......+.+++.+|+. +|.+|++ +.|++++
T Consensus 232 l~~G~~Pf~~~~~~~------~~~~i~~~~~~~---~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 232 MLVGYPPFCSDNPQE------TYRKIINWKETL---QFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hhcCCCCCCCCCHHH------HHHHHHcCCCcc---CCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999997443211 111111100000 0000 00112346789999997 8999998 9999886
Q ss_pred H
Q 007160 546 L 546 (615)
Q Consensus 546 L 546 (615)
-
T Consensus 297 ~ 297 (364)
T cd05599 297 P 297 (364)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=318.48 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=202.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CC---cEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DG---TAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+.+|++++++++|+|++++++++. +....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT--KFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc--cCCCc
Confidence 357888899999999999999964 23 379999987543 223467899999999999999999999987 44578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++++|.++++.. ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 82 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 82 MIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999999743 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccc-ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 423 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
.......... ......+..|+|||++....++.++|||||||++|||++ |+.||..... . .+...+. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~---~~~~~i~-~~-- 226 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---H---EVMKAIN-DG-- 226 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---H---HHHHHHh-cC--
Confidence 6654322111 111234567999999998889999999999999999997 9999964321 1 1111111 00
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.....+......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 --------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 --------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111122334588999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=339.79 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=196.9
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||++.. .+++.||+|... .+.+.+|++++++++||||+++++++.. ....++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEEE
Confidence 46799999999999999999996 468899999754 3457899999999999999999999874 45789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|++. ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9995 7899888642 35889999999999999999999998 99999999999999999999999999975432
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-----chhhHhhhhhh------
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPIL------ 495 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~-----~~l~~~~~~~~------ 495 (615)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.......-
T Consensus 235 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 235 INAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 2111 22345799999999999999999999999999999999999988753321110 00100000000
Q ss_pred --ccchhhhhhc----C-Ccc-CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 496 --RDKDRLEELA----D-PRL-GGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 496 --~~~~~l~~i~----d-~~l-~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.....+..+. . ... ....+ ......+.+|+.+||+.||++|||+.|++++-+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 0000000000 0 000 00000 112346889999999999999999999998643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.29 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=203.5
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
..++|+.+..||+|+||.||+++. .+|..+|+|++++... ...+..+.|-.+|....++.||+|+-.|. +..++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ--D~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ--DKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec--CCCee
Confidence 467899999999999999999995 5699999999987643 33456788999999999999999976665 77799
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
||||||++||++..+|.. ...|++..+..++.+++-|++.||..| +|||||||+|+|||..|++||+||||+.
T Consensus 217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999975 346999999999999999999999999 9999999999999999999999999984
Q ss_pred cCCC----------------------CCcc----cc-------------------ceeeccccccCCccccccCcCCchh
Q 007160 423 QAPE----------------------GRTN----YL-------------------STRVMGTFGYVAPEYAMTGHLLVKS 457 (615)
Q Consensus 423 ~~~~----------------------~~~~----~~-------------------~~~~~gt~~y~APE~~~~~~~s~ks 457 (615)
-... .... .. ....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 2210 0000 00 0125799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCc-chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 007160 458 DVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR 536 (615)
Q Consensus 458 DVwS~GvvL~ElltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 536 (615)
|.||||||+|||+.|.+||....+... .+++.|...+.. . .+ .....+..+||.+|+. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-P------~~--------~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-P------EE--------VDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-C------Cc--------CcccHHHHHHHHHHhc-CHHHh
Confidence 999999999999999999987665432 234444322111 1 00 0111457899999999 99999
Q ss_pred CC---HHHHHHH
Q 007160 537 PT---MGEVVQS 545 (615)
Q Consensus 537 Ps---m~eVl~~ 545 (615)
-- +.||-+|
T Consensus 434 LG~~G~~EIK~H 445 (550)
T KOG0605|consen 434 LGSKGAEEIKKH 445 (550)
T ss_pred cCcccHHHHhcC
Confidence 64 6666655
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=317.44 Aligned_cols=248 Identities=26% Similarity=0.445 Sum_probs=195.2
Q ss_pred eeeccCceEEEEEEEC---CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCC
Q 007160 276 ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN 351 (615)
Q Consensus 276 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~ 351 (615)
.||+|+||.||+|.+. ++..||+|.+...... ..+.|.+|++++++++|+||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCC
Confidence 3899999999999863 3567999998755332 2456899999999999999999999874 2368999999999
Q ss_pred CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccc
Q 007160 352 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431 (615)
Q Consensus 352 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 431 (615)
|+|.+++... ...+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.........
T Consensus 79 ~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 79 GPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999999642 235899999999999999999999998 9999999999999999999999999998654432211
Q ss_pred -cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 432 -LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 432 -~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......++..|+|||++.+..++.++||||||+++||+++ |..||...... .... .+... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~----------~ 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMS----FIEQG----------K 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCC----------C
Confidence 1122234678999999988889999999999999999996 99999643211 1111 11111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
....+......+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122233345688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=323.39 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=202.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||.||+|... ++..||+|.+..... ...++|.+|+.++++++|+||+++++++. +..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~--~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA--VGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc--CCC
Confidence 467999999999999999999863 467899999875432 23467999999999999999999999987 445
Q ss_pred ceeEEEecCCCCChhHhhcCCC------------------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCC
Q 007160 341 QHLLCYELVPNGSLESWLHGPL------------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA 402 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~------------------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp 402 (615)
..+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 7899999999999999996321 11234788999999999999999999998 99999999
Q ss_pred CCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 007160 403 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 481 (615)
Q Consensus 403 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~ 481 (615)
+||++++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876543322111222345678999999998899999999999999999998 8888853221
Q ss_pred CCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
..+...+ .+.... ..+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 239 ------~~~~~~~----------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 ------EEVIYYV----------RDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ------HHHHHHH----------hcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1111111 111110 112223456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.29 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=199.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++.++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~--~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ--DKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeEEE
Confidence 47899999999999999999964 68899999997542 223456889999999999999999999887 4457999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999999753 235899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccc------cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+....
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~ 225 (330)
T cd05601 153 TANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQ 225 (330)
T ss_pred CCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCC
Confidence 543321 223457999999999986 456789999999999999999999999643211 1111111110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. +...........+.+|+..||+ +|.+||++.+++++
T Consensus 226 ~~--------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 RF--------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred Cc--------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 0000001123357889999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.49 Aligned_cols=249 Identities=29% Similarity=0.494 Sum_probs=202.8
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEEe
Confidence 57888999999999999999875 78899999986543 46789999999999999999999999874 5578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999997532 235899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
. ...++..|+|||++....++.++||||||+++|||++ |+.||..... ..+... ....
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~----~~~~--------- 215 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPH----VEKG--------- 215 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HhcC---------
Confidence 1 2345678999999998899999999999999999997 9999864321 111111 1100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.....+......+.+++.+||+.+|++||++.|+++.|+.
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0011122233568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.06 Aligned_cols=245 Identities=25% Similarity=0.379 Sum_probs=193.6
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHH---hhccCCCcceEEEEeecCCCCcee
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEML---SRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l---~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
|++.+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|++++ ++++||||+++++++. +....+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEE
Confidence 677899999999999999964 68999999997432 22335567776665 5668999999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|..+++. ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 79 lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 99999999999998863 35899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 151 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~------ 216 (324)
T cd05589 151 GMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVND------ 216 (324)
T ss_pred CCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC------
Confidence 432211 223457999999999999999999999999999999999999999743211 111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
.. .++......+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ----~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ----EV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 00 12222234578999999999999999 56777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=326.63 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 337 (615)
.++|.+.+.||+|+||.||+++.. ....||+|.+..... ....++.+|+++++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 357888999999999999999742 245799999875432 2345788999999999 6999999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
+....+++|||+++|+|.+++..... ....++|.++++++.|++.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 44578999999999999999965321 1235899999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~ 484 (615)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987654322111122234568999999998899999999999999999999 88888643211
Q ss_pred chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 485 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.+.. ...... ....+......+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 244 -~~~~----~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 -ELFK----LLREGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -HHHH----HHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111 111110 00112223345789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=321.40 Aligned_cols=273 Identities=29% Similarity=0.402 Sum_probs=207.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-----CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
+.|+..+.||+|+||.||+|++. ++..||||.+...... ..+.|.+|++++++++|+||+++++++........
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999864 3678999999865443 45789999999999999999999999876556678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997532 25899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcccc-ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
.......... .....++..|++||.+.+..++.++||||||+++|||++|+.|+............. ... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~-~~~~~~~ 235 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQG-QMIVTRL 235 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccc-cccHHHH
Confidence 7763322111 112345667999999998899999999999999999999999986432211000000 000 0000001
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
............+......+.+++.+||+.+|++||++.||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111111222335688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=321.29 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=200.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCC----C
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD----S 339 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~----~ 339 (615)
.+++.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||+++++++...+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888999999999999999964 58899999987543 3456789999999998 6999999999986432 2
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 35889999999999999997532 345889999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~ 494 (615)
+++....... ......|+..|+|||++. +..++.++|||||||++|||++|+.||....... .+.. .
T Consensus 157 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~-~ 228 (272)
T cd06637 157 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL-I 228 (272)
T ss_pred Cceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH-H
Confidence 9986543221 223457899999999886 3467889999999999999999999996432111 0000 0
Q ss_pred hccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ...+.+ ........+.+++.+||+.+|.+|||+.+++++
T Consensus 229 ~~-------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 PR-------NPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred hc-------CCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 001111 111122357899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.70 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=214.8
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECC-CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
++.+-.+.+.....+||-|.||.||.|.|+. .-.||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|.. ..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~--Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CC
Confidence 3344445567778999999999999999863 567999999854 3457899999999999999999999999983 44
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
.+|||.|||.+|+|.+||+... ...++--..+.++.||+.|++||..++ +|||||.++|+|+.++..+||+||||
T Consensus 337 PFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence 7899999999999999998643 234666778899999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
++.+..+... ......-.+.|.|||.+....++.|+|||+|||+||||.| |-.||...+ + ..+..++..+.
T Consensus 412 sRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l-SqVY~LLEkgy 483 (1157)
T KOG4278|consen 412 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L-SQVYGLLEKGY 483 (1157)
T ss_pred hhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H-HHHHHHHhccc
Confidence 9988654322 2223445789999999999999999999999999999988 888886332 1 11222333333
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
+ -+-|..+..++++|++.||+.+|.+||+++|+.+.++.+.
T Consensus 484 R----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 R----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred c----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 2 2446667778999999999999999999999999998653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=324.49 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC---ceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS---QHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~---~~~L 344 (615)
-.|+..+++|.|+||.||+|.+. +++.||||+.-.+ .+.-.+|+++|+++.|||||+|+-+|...... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35677899999999999999964 5789999998643 23335699999999999999999888754444 4568
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEEEecccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQ 423 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~ 423 (615)
||||||. +|.++++.....+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ +.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 999999754333456888889999999999999999998 9999999999999976 9999999999998
Q ss_pred CCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-hhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRL 501 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l 501 (615)
...+..+ .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|+.-|...... ..++..++-+-... +.+
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 8765543 334578889999998864 7899999999999999999999999764332 23333222111100 000
Q ss_pred h-------hhcCCccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 E-------ELADPRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~-------~i~d~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. +...+.+... .......+.++++.++|..+|.+|.++.|++.+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 1111111111 222333458899999999999999999999876
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.94 Aligned_cols=268 Identities=22% Similarity=0.337 Sum_probs=196.8
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecC------CC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------DS 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~~ 339 (615)
...+|++.+.||+|+||.||+|+. .+++.||||++... .....+|+.+|++++|+||+++++++... ..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999996 46889999988632 23445799999999999999999876421 12
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEEEec
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADF 418 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DF 418 (615)
..+++||||+++ +|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 787777533233456899999999999999999999999 9999999999999865 47999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
|+++....... .....||+.|+|||++.+. .++.++|||||||+||||++|..||....... .+.......-..
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 99987654322 2235689999999988754 68999999999999999999999997543221 111111100000
Q ss_pred c-hhh-------hhhc-----CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 K-DRL-------EELA-----DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 ~-~~l-------~~i~-----d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. ..+ ..+. ...+...++......+.+|+.+||+.||.+|||+.|+++|-+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0 000 0000 000111122223346889999999999999999999998744
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.39 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=201.1
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC-----chHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ-----GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++|++.+.||+|++|.||++.. .+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 5789999999999999999985 46899999998644221 23568889999999999999999999874 4489
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 80 ~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred EEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 999999999999999874 235788999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
......... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... ... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~-~--------- 217 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAI-F--------- 217 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHH-H---------
Confidence 654322111 112345788999999999988999999999999999999999998643211 000 0
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
...........+......+.+++.+||+.+|++|||+.+++++.
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 218 -KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred -HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 00011111122333344588999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.07 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=195.0
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++++. +....++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe--cCCEEEEE
Confidence 688899999999999999985 468899999997542 223456889999999999999999999987 45589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 80 ~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 80 MDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 9999999999999752 35788899999999999999999998 9999999999999999999999999986432
Q ss_pred CCCc---------------------------------------------cccceeeccccccCCccccccCcCCchhhHH
Q 007160 426 EGRT---------------------------------------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY 460 (615)
Q Consensus 426 ~~~~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVw 460 (615)
.... ........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 1000 0011235799999999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHH--ccccCCCCCCC
Q 007160 461 SYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA--CVAPEANQRPT 538 (615)
Q Consensus 461 S~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~--Cl~~dP~~RPs 538 (615)
||||++|||++|+.||......... ..+......+ .-+. ...++ ..+.+++.+ |+..++..||+
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~---~~~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQ------LKVINWENTL---HIPP-QVKLS----PEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHH------HHHHcccccc---CCCC-CCCCC----HHHHHHHHHHccCcccccCCCC
Confidence 9999999999999999754321100 0010000000 0000 01122 346677777 55667777999
Q ss_pred HHHHHHHH
Q 007160 539 MGEVVQSL 546 (615)
Q Consensus 539 m~eVl~~L 546 (615)
+.|+++|-
T Consensus 299 ~~~~l~hp 306 (381)
T cd05626 299 ADDIKAHP 306 (381)
T ss_pred HHHHhcCc
Confidence 99999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.17 Aligned_cols=247 Identities=32% Similarity=0.474 Sum_probs=195.9
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCC
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 353 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gs 353 (615)
++||+|+||.||+|...++..||+|.+...... ....|.+|++++++++|+||+++++++.. ....++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCCc
Confidence 369999999999999888899999998754332 23468899999999999999999999874 457899999999999
Q ss_pred hhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccc
Q 007160 354 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433 (615)
Q Consensus 354 L~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 433 (615)
|.+++... ...+++..++.++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++......... ..
T Consensus 79 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~ 151 (250)
T cd05085 79 FLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SS 151 (250)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cC
Confidence 99998642 234789999999999999999999998 999999999999999999999999999754332211 11
Q ss_pred eeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 434 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
....++..|+|||++.+..++.++||||||+++||+++ |..||...... .... ..... ....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~----~~~~~----------~~~~ 214 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE----QVEKG----------YRMS 214 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHcC----------CCCC
Confidence 12234678999999998899999999999999999998 99998643211 1110 01000 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12223456899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=319.55 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=200.8
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|+||+++++++.. ....++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEE
Confidence 35789999999999999999996 5688999999976544455678899999999999999999999874 45889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.++++. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 86 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999864 235889999999999999999999998 99999999999999999999999999986643
Q ss_pred CCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.... ..+. .. .
T Consensus 159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~------~~---~ 225 (267)
T cd06646 159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMS------KS---N 225 (267)
T ss_pred ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeee------cC---C
Confidence 221 123346889999999874 345788999999999999999999998643221110 0000 00 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
...+.... .......+.+++.+||+.+|++||++++++++|
T Consensus 226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01111110 111234688999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.20 Aligned_cols=202 Identities=27% Similarity=0.387 Sum_probs=172.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||+||++... +++.||||++.... ......+.+|++++.+++|+||+++++++. +....+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~--~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ--DKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCeEEE
Confidence 47899999999999999999854 68899999997432 222356788999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 79 IMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999974 235899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcc---------------------------------ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh
Q 007160 425 PEGRTN---------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471 (615)
Q Consensus 425 ~~~~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt 471 (615)
...... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 321100 00123579999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 007160 472 GRKPVDMS 479 (615)
Q Consensus 472 G~~Pf~~~ 479 (615)
|+.||...
T Consensus 232 G~~Pf~~~ 239 (363)
T cd05628 232 GYPPFCSE 239 (363)
T ss_pred CCCCCCCC
Confidence 99999744
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.12 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||++... |..||+|.+... ...+.|.+|+.++++++|+|++++++++.. +....++++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEEEEC
Confidence 46888999999999999999875 678999998643 235679999999999999999999998653 34578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++++|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999997532 234889999999999999999999998 9999999999999999999999999988654322
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... +......+ ...
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~--------- 215 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKG--------- 215 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcC---------
Confidence 12234668999999998899999999999999999998 999986322 11111111 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.....+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00111222334588999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.10 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=205.4
Q ss_pred HhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..++|++.+.||+|+||.||+|..++++.||||.+.... ...+++.+|++++++++|+||+++++++. +....+++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee--cCCceEEEE
Confidence 346899999999999999999998888899999987543 34578999999999999999999999986 345789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.... ...+++..++.++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999997532 245899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ...
T Consensus 156 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~---~~~--------- 219 (261)
T cd05034 156 DEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQ---VER--------- 219 (261)
T ss_pred hhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHc---------
Confidence 221 11122335678999999998899999999999999999998 99998543211 11111 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
......+......+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 --GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011112223458899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.19 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEECC-C---cEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD-G---TAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.+|++.+.||+|+||.||+|.+.. + ..||||.+.... ....++|..|++++++++||||+++++++. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCceE
Confidence 357888999999999999999642 3 369999987542 223468999999999999999999999986 445789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 82 IITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999999997532 35899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCcccccee-e--ccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 424 APEGRTNYLSTR-V--MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 424 ~~~~~~~~~~~~-~--~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
............ . ..+..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~~ 228 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QDY 228 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cCC
Confidence 544322111111 1 12457999999999999999999999999999886 99998643211 1111111 000
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
....+.+....+.+++.+||+.+|++||++++|+..|+.+
T Consensus 229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122334578999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.04 Aligned_cols=251 Identities=30% Similarity=0.492 Sum_probs=202.5
Q ss_pred eeeeccCceEEEEEEECC----CcEEEEEEeccCCCCc-hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|.... +..||+|.+....... .+.+.+|++++.+++|+|++++++++.. ....+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 469999999999999653 7889999998654433 5789999999999999999999999874 56899999999
Q ss_pred CCCChhHhhcCCCCC-----cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 350 PNGSLESWLHGPLGV-----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~-----~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
++++|.+++...... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++..
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999864211 356899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.............++..|+|||.+....++.++||||||+++|||++ |..||...... .+... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~----- 223 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEY----LRKG----- 223 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcC-----
Confidence 65432222334567889999999998899999999999999999999 69999754211 11111 1100
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.....+......+.+++.+||+.+|++||++.|++++|+
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122223456889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=315.11 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=202.2
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|+||.||+|+.. +++.|++|.+.... ....+.+.+|++++++++|+|++++++++. +....++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEEEE
Confidence 4778899999999999999964 68999999986432 334567899999999999999999999987 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.++++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 79 EYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 9999999999997532 346889999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......|+..|+|||++.+..++.++|+||||+++|||++|+.||..... .... ..... ..
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~~~~------~~-- 217 (256)
T cd08529 154 NTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALI---LKIIR------GV-- 217 (256)
T ss_pred ccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHc------CC--
Confidence 322 12334688999999999999999999999999999999999999964331 1111 11110 00
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 218 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 ---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 011121233458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=330.75 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=194.8
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCC-CcceEEEEeecCCCCceeE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHR-NLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~~~L 344 (615)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..++|+ +|+++.+++. +....++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEE
Confidence 5888999999999999999965 57899999987532 23345688899999999765 5788888876 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999999964 235889999999999999999999998 999999999999999999999999998754
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+.
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i~--------- 214 (324)
T cd05587 152 IFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF---QSIM--------- 214 (324)
T ss_pred CCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHH---------
Confidence 32211 223457999999999999999999999999999999999999999743211 111 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm-----~eVl~~ 545 (615)
... ..++......+.+++.+||+.||.+|++. .++.++
T Consensus 215 -~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 215 -EHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -cCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 11222233457899999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=322.33 Aligned_cols=264 Identities=26% Similarity=0.422 Sum_probs=204.4
Q ss_pred cCcccceeeeccCceEEEEEEE-----CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
..|++.+.||+|+||.||++.+ .++..||+|.+.... ....+.+.+|++++++++|+|++++.+++...+....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999984 357889999987543 2334679999999999999999999999876545678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++++|.+++... ...++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999999642 225899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCC---------CcchhhHhhh
Q 007160 423 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS---------GQENLVTWAR 492 (615)
Q Consensus 423 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~---------~~~~l~~~~~ 492 (615)
......... ......++..|+|||++.+..++.++||||||+++|||++++.|....... .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV- 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-
Confidence 765432211 112345677899999998888999999999999999999988765321110 000000000
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
... .+. .....+......+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 237 ~~~---------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVL---------EEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHH---------HcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 000 01111222345689999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.52 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=215.6
Q ss_pred HhcCcccceeeeccCceEEEEEEECC-----CcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++.....++||+|-||.||+|.+.+ .-.||||..+.+. ....+.|+.|.-+|+.++||||++|+|+|.+ .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---Q 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---c
Confidence 34455667899999999999999632 3468999988744 3446779999999999999999999999973 3
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..|+|||.++.|.|..||+... ..|+......++.||+.+|+|||+.. +|||||..+|||+....-+||+||||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 6899999999999999998643 35888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
+|...+... +..+...-+..|||||.+.-..++.++|||-|||.+||+++ |..||..-.+.+.. ..+++++
T Consensus 538 SR~~ed~~y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGe 609 (974)
T KOG4257|consen 538 SRYLEDDAY-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGE 609 (974)
T ss_pred hhhccccch-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCC
Confidence 999877654 34456677889999999999999999999999999999987 99999754432211 0122222
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
+ ..+|..+...+..|+.+||..||.+||++.|+...|..+.+
T Consensus 610 R----------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 R----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred C----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 2 24566777789999999999999999999999999988765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=325.03 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=209.6
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCch---HHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~---~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
...+|++.+.||+|.||.|-+|.. ..|+.||||.++++...+. -.+.+||++|+.|+||||+.++.+|++ ....
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKI 128 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKI 128 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceE
Confidence 346788999999999999999984 6899999999987654444 457889999999999999999999884 4589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
.|||||..+|.|+||+.. ...|++.+..+++.||..|+.|+|.++ ++|||||.+|||||.++++||+||||+.
T Consensus 129 vivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhh
Confidence 999999999999999975 446999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
.+.+.. .-..++|++-|.+||++.+..|. +..|-|||||+||-|+.|..||+..+ ...++ +++-+..+
T Consensus 202 ly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lv---rQIs~GaY-- 270 (668)
T KOG0611|consen 202 LYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLV---RQISRGAY-- 270 (668)
T ss_pred hhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHH---HHhhcccc--
Confidence 876544 34568999999999999999884 88999999999999999999998543 22222 22221111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..| ..|. ..+-||+|||..||++|-|+.+|..|.|.
T Consensus 271 ---rEP----~~PS----dA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 271 ---REP----ETPS----DASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred ---cCC----CCCc----hHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 011 1122 35679999999999999999999998764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=331.91 Aligned_cols=249 Identities=21% Similarity=0.358 Sum_probs=194.3
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++.++ +||||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCC
Confidence 46999999999999964 67899999997542 22335678899998877 7999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 79 NGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99999998864 235889999999999999999999999 99999999999999999999999999975432211
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC--cchhhHhhhhhhccchhhhhhcCC
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG--QENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+..... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~~ 220 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LEK 220 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hcC
Confidence 1234579999999999999999999999999999999999999996422111 111111111111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT------MGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs------m~eVl~~ 545 (615)
. ...+......+.+++.+||+.||++||+ +.++++|
T Consensus 221 ~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 Q--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1 1123333445789999999999999998 5677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.28 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=195.5
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEE
Confidence 4789999999999999999985 478999999986432 223456888999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 79 IMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999964 235788999999999999999999999 999999999999999999999999999643
Q ss_pred CCCCcc---------------------------------------------ccceeeccccccCCccccccCcCCchhhH
Q 007160 425 PEGRTN---------------------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDV 459 (615)
Q Consensus 425 ~~~~~~---------------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV 459 (615)
...... .......||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 211000 00012469999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCC---
Q 007160 460 YSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR--- 536 (615)
Q Consensus 460 wS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R--- 536 (615)
|||||++|||++|+.||....... ....+......+ .-+. .......+.+++.+|+. +|.+|
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~---~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHE------TYRKIINWRETL---YFPD-----DIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHH------HHHHHHccCCcc---CCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 999999999999999996443211 011111100000 0000 00112347789999998 66665
Q ss_pred CCHHHHHHHH
Q 007160 537 PTMGEVVQSL 546 (615)
Q Consensus 537 Psm~eVl~~L 546 (615)
+++.|++++-
T Consensus 297 ~~~~~~l~hp 306 (377)
T cd05629 297 GGAHEIKSHP 306 (377)
T ss_pred CCHHHHhcCC
Confidence 6999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.94 Aligned_cols=249 Identities=32% Similarity=0.500 Sum_probs=197.4
Q ss_pred eeeeccCceEEEEEEEC-C---CcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-D---GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~---g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
++||+|+||.||+|.+. . +..||+|.+...... ..+++.+|++++++++|+||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEeC
Confidence 46999999999999853 2 268999998865442 3567999999999999999999999875 33679999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 78 PLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999999753 25899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccc-ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 430 NYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 430 ~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+..+.. ....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~------- 216 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGER------- 216 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCc-------
Confidence 211 112234568999999998899999999999999999998 9999964321 11111111 1100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
...+......+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 217 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 ---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0112223346889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.05 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=192.6
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|+.. +++.||||++... .....+.+..|++++..+ +||||+++++++. +....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999964 5889999998743 223345678899998876 6999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 79 NGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred CCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99999999864 235889999999999999999999999 99999999999999999999999999876432211
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~----------~~ 213 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILND----------EV 213 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcC----------CC
Confidence 223457999999999999999999999999999999999999999743311 111111111 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 545 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm------~eVl~~ 545 (615)
..+......+.+++.+||+.||++||++ +++++|
T Consensus 214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 --VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1122223457899999999999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=325.13 Aligned_cols=260 Identities=29% Similarity=0.440 Sum_probs=200.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCc--EEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.+.... ......+.+|++++.++ +|+||+++++++. +....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCCCc
Confidence 357888999999999999999964 443 46888776432 23346788999999999 8999999999986 44578
Q ss_pred eEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC
Q 007160 343 LLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 410 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 410 (615)
++||||+++|+|.++++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCC
Confidence 999999999999999964321 1235889999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 007160 411 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~ 489 (615)
+.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... ....
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE 234 (303)
T ss_pred CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH
Confidence 999999999986432111 1112234678999999988889999999999999999998 99998643211 1111
Q ss_pred hhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.. .. ......+......+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 235 ---~~-~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 ---KL-PQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ---HH-hc----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00 000011112234578999999999999999999999999877553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.50 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=200.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
..++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+++++.++||||+++++++. +....
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCEE
Confidence 3568999999999999999999964 6889999998642 1223455788999999999999999999887 45589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.++++. ..++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence 999999999999999964 24778888999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccC----cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+....
T Consensus 191 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~ 263 (370)
T cd05596 191 KMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHK 263 (370)
T ss_pred eccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC
Confidence 76433211 12345799999999988653 478999999999999999999999974331 11111111111
Q ss_pred hhhhhhcCCccCCCCCH--HHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 007160 499 DRLEELADPRLGGKYPK--EDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK 547 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~--~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~L~ 547 (615)
.. + .++. .....+.+++.+||+.+|.+ |+++.|+++|-+
T Consensus 264 ~~--------~--~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 264 NS--------L--TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred Cc--------C--CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 00 0 1111 12345788999999999988 999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=330.04 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=195.5
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+..|.+++..+ +|++|+++++++. +....++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEEEE
Confidence 5788999999999999999965 57899999987542 22234577788888877 5899999999887 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999999864 235889999999999999999999998 999999999999999999999999999754
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+.
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~---~~i~--------- 214 (323)
T cd05616 152 MWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---QSIM--------- 214 (323)
T ss_pred CCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHH---HHHH---------
Confidence 32221 223457999999999999999999999999999999999999999743311 111 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm-----~eVl~~ 545 (615)
... ..++......+.+++.+||+.||.+|++. .++.++
T Consensus 215 -~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 215 -EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -hCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111 11223334467899999999999999984 566544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.05 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=193.6
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
++||+|+||.||+|+.. +++.||||.+.... ....+.+..|.+++..+ +||||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCC
Confidence 46999999999999965 57899999987532 22345678899999876 7999999999987 445799999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 79 NGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99999999864 235889999999999999999999999 99999999999999999999999999976433221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... .
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~----------~ 213 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDD----------V 213 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC----------C
Confidence 223457999999999999989999999999999999999999999744311 1111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRP-------TMGEVVQSL 546 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-------sm~eVl~~L 546 (615)
..+......+.+++.+||+.||++|| ++.+++++-
T Consensus 214 --~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 214 --LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 11111223578999999999999999 888888763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.89 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=203.5
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++.. ....++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEeec
Confidence 5788899999999999999985 4688999999987666666789999999999999999999999873 458999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.++++. ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999999963 24788999999999999999999998 999999999999999999999999998765432
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||....+.. .+.. .... .
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~----~~~~---------~ 232 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL----IATN---------G 232 (296)
T ss_pred cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH----HhcC---------C
Confidence 21 1223468899999999998889999999999999999999999997543211 1111 0000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
......+......+.+++.+||..+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00001122233457899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.70 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=193.3
Q ss_pred eeeeccCceEEEEEEECC-Cc--EEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLSD-GT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|++.+ +. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++.. ....+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 468999999999999753 43 56888887432 23346788999999999 79999999999874 45789999999
Q ss_pred CCCChhHhhcCCC------------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEe
Q 007160 350 PNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 417 (615)
Q Consensus 350 ~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 417 (615)
++|+|.++++... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECC
Confidence 9999999996432 11235889999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
||+++...... .......+..|+|||++....++.++||||||+++|||++ |..||...... ... ....
T Consensus 156 fgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~---~~~~- 225 (270)
T cd05047 156 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY---EKLP- 225 (270)
T ss_pred CCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHH---HHHh-
Confidence 99986432111 1111234667999999988899999999999999999997 99998643211 111 1110
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.. .....+......+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 226 ~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 000111222345789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=321.98 Aligned_cols=267 Identities=28% Similarity=0.429 Sum_probs=206.6
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeec
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS 336 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~ 336 (615)
+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666778899999999999999999999864 57899999876432 2346788999999999 69999999998743
Q ss_pred ---CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcE
Q 007160 337 ---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413 (615)
Q Consensus 337 ---~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 413 (615)
.+....++||||+++++|.++++........+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 2345689999999999999988643333456889999999999999999999998 9999999999999999999
Q ss_pred EEEeccccccCCCCCccccceeeccccccCCcccccc-----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 007160 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 488 (615)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~ 488 (615)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF 239 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh
Confidence 9999999986643221 1233468999999998753 457889999999999999999999986432211 110
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
. ... .......+ +......+.+++.+||+.||++||++.||++++
T Consensus 240 ~----~~~--~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 K----IPR--NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred h----ccc--cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 000 00000111 111123588999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.36 Aligned_cols=249 Identities=31% Similarity=0.470 Sum_probs=198.5
Q ss_pred eeeeccCceEEEEEEECC--C--cEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLSD--G--TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.|.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 468999999999999643 3 3699999987655 456789999999999999999999999874 6789999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++..... ..++|..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999999975332 46899999999999999999999998 99999999999999999999999999987754332
Q ss_pred cc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 430 NY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 430 ~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.+ ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .. ........ .
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~---~~~~~~~~--------~ 218 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QI---LKKIDKEG--------E 218 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHHhcC--------C
Confidence 21 1123457889999999999899999999999999999998 99998633211 11 11111000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. ...+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 219 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 R--LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred c--CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 0112223346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.18 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=197.8
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|++++++++||||+++++++.. ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEE
Confidence 4678889999999999999985 578899999987542 2234678999999999999999999999874 45789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 79 EFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred ecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999999997653 2678889999999999999999998 99999999999999999999999999986543
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhhhhccchhhhhhc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~l~~i~ 505 (615)
.. .....||..|+|||++.+..++.++||||||+++|||++|+.||......... ....+.. .+.
T Consensus 148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~ 213 (279)
T cd06619 148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ----------CIV 213 (279)
T ss_pred cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH----------HHh
Confidence 22 23357899999999999989999999999999999999999999643221111 0001110 111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
++.............+.+++.+||+.+|++||+++|++++-+
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 214 DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 111000001112235789999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.71 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=191.1
Q ss_pred eeeeccCceEEEEEEECC---CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 275 SILGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+.||+|+||.||+|...+ +..+|+|.+..... .....|.+|+.++++++|+||+++++++. +....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT--EVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCCCcEEEEECCC
Confidence 368999999999998643 45799999875443 23357899999999999999999999987 4457899999999
Q ss_pred CCChhHhhcCCCC-CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 351 NGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 351 ~gsL~~~L~~~~~-~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
+|+|.++++.... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999974322 1234677888899999999999999998 99999999999999999999999999976543332
Q ss_pred cccceeeccccccCCccccccC-------cCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~-------~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
........++..|+|||++... .++.++||||||+++|||++ |+.||....... ..... .. ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~--~~~ 227 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT---VR--EQQ 227 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---hh--ccc
Confidence 2222334578899999988642 35789999999999999996 999996433211 11110 00 001
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
..+.++.+... ....+.+++..|+ .+|++|||++||++.|.
T Consensus 228 ~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11122222111 2234778999999 58999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.02 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=204.8
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|++.+.||.|+||.||++.. .+++.||+|.+..... ...+.+..|++++++++|+||+++++++...+....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 4678999999875432 2345688999999999999999999988755566789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhH-----hCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH-----EDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH-----~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
||+++++|.+++.........+++..++.++.|++.||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999754333457899999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
........ ......++..|+|||.+....++.++||||||+++|+|++|+.||..... ..+... ..
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~---~~------ 223 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASK---IK------ 223 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHH---Hh------
Confidence 87654332 12335689999999999988899999999999999999999999975431 111111 10
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. .....+......+.+++.+||+.+|++||++.+|+++
T Consensus 224 ----~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 ----EG-KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----cC-CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0112233334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=328.89 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=189.8
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|.+++..+ +||||+++++++. .....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999964 57899999987532 22344566777777754 8999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 79 NGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 99999999864 235888999999999999999999998 99999999999999999999999999986533221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~--------~~-- 213 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILND--------RP-- 213 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC--------CC--
Confidence 223457999999999999989999999999999999999999999743211 111111110 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 545 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl~~ 545 (615)
.++......+.+++.+||+.||++||++. +++++
T Consensus 214 --~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 214 --HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 12222234578999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.62 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=202.1
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 264 LKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 264 l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++. .....
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 80 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS--ENGFF 80 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec--cCCEE
Confidence 4456777877889999999999999954 67889999988666556678999999999999999999999987 44588
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccC--ChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEecc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHL--DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFG 419 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l--~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFG 419 (615)
++++||+++++|.+++.... ..+ ++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecch
Confidence 99999999999999997432 224 77888999999999999999998 999999999999976 6799999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCc--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
++........ ......|+..|+|||++.+.. ++.++||||||+++|||++|+.||....... ...+......
T Consensus 155 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~- 228 (268)
T cd06624 155 TSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK- 228 (268)
T ss_pred hheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-
Confidence 9976543221 122345889999999986643 7899999999999999999999986432111 1111110000
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.....+......+.+++.+||+.+|++|||+.|++++
T Consensus 229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111233334458899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=329.83 Aligned_cols=237 Identities=26% Similarity=0.368 Sum_probs=186.2
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHH-HHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
++||+|+||.||+|+.. +++.||+|.+.... ......+.+|.. +++.++|+||+++++++. +....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999964 68899999986432 122345566655 578899999999999887 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 79 NGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99999998864 235788889999999999999999998 99999999999999999999999999875432221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+. ...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~----------~~~~ 213 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNIL----------HKPL 213 (321)
T ss_pred --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHh----------cCCC
Confidence 22345799999999999998999999999999999999999999964321 11111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 540 (615)
..+......+.+++.+||+.||.+||+..
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12223344688999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.87 Aligned_cols=238 Identities=26% Similarity=0.356 Sum_probs=190.7
Q ss_pred eeeeccCceEEEEEEE----CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 275 SILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++. +....++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ--TEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCEEEEEEcC
Confidence 6799999999999874 3578999999975322 22345778999999999999999999987 44589999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 80 LRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999964 235899999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .
T Consensus 153 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~----------~ 214 (318)
T cd05582 153 K--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKA----------K 214 (318)
T ss_pred C--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcC----------C
Confidence 1 123457999999999999888999999999999999999999999743211 111111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 541 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~e 541 (615)
. ..+......+.+++.+||+.||++||++.+
T Consensus 215 ~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 L--GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 122222345789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.64 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||.||+|... .+..+|+|.+..... ...+.|.+|+.++++++||||+++++++. +....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccE
Confidence 57888999999999999999853 234799999875432 23467899999999999999999999987 445789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999999997532 35899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 424 APEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 424 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... ...... .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~----~~~~~- 227 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAI----EEGYR- 227 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHH----hCCCc-
Confidence 65432211 1112234568999999998899999999999999999886 99998643221 111111 11000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
. ..+......+.+++.+||+.+|.+||+|.++++.|+.+
T Consensus 228 -----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -----L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 11112234578999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.13 Aligned_cols=257 Identities=31% Similarity=0.480 Sum_probs=203.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCc----EEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.+|++.+.||+|+||.||+|... +|. .||+|.+..... ....++.+|++++++++|+||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence 46788899999999999999864 333 589998875543 234678999999999999999999999874 578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 99999999999999997532 24899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
...............++..|+|||.+....++.++|+||||+++||+++ |+.||+..... .+... +....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~-- 228 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDL----LEKGE-- 228 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HhCCC--
Confidence 7654332222222334678999999988889999999999999999998 99999643211 11111 11100
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
....+......+.+++.+||..+|++||++.++++.|+.+.+
T Consensus 229 --------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 --------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011122223457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.77 Aligned_cols=254 Identities=30% Similarity=0.466 Sum_probs=212.9
Q ss_pred ccceeeeccCceEEEEEEE-CCC----cEEEEEEeccC-CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 272 EPASILGEGGFGRVFKGVL-SDG----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~-~~g----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
...++||+|+||+||+|.+ ..| -+||+|.+... ..+..++++.|+-+|.+++|||+++|+|+|.. ..+.||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---s~~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML---STLQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc---chHHHH
Confidence 3458899999999999995 333 47899988754 34456899999999999999999999999963 348899
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
++||+.|+|.||++.++ ..+.-...+.|..|||+||.|||++. ++||||.++|||+++-..+||.|||+++...
T Consensus 776 tq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999998644 34777899999999999999999998 9999999999999999999999999999988
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.....+......-.+.|||-|.+....|+.++|||||||++||++| |..|++.....+ +..+++.+++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR---- 918 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER---- 918 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc----
Confidence 7766666666667889999999999999999999999999999999 999997543222 2223333332
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
-..|..+...+..++.+||..|+..||+++++...+..+.+
T Consensus 919 ------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 ------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 24566677789999999999999999999999988876544
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.80 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=195.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.|.+|+.++..++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEE
Confidence 47899999999999999999964 5889999998642 1223456889999999999999999999987 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 99999999999999642 235888999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCccccceeeccccccCCcccccc-----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~ 225 (331)
T cd05597 153 LADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKE 225 (331)
T ss_pred CCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCC
Confidence 44322 12233569999999999863 4578899999999999999999999964321 111111111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCC--CCCCCHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA--NQRPTMGEVVQSL 546 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP--~~RPsm~eVl~~L 546 (615)
.. .+ +.. .......+.+++.+|+..++ ..||++.+++++-
T Consensus 226 ~~-~~--~~~----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 226 HF-QF--PPD----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred cc-cC--CCc----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 00 00 000 01122346778888775543 3488999999884
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=337.44 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=198.4
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
...++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+++++.++||||+++++++. +...
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ--DDKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCE
Confidence 34578999999999999999999965 5789999998642 1223456889999999999999999999987 4558
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999964 24788899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccC----cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
+....... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||..... .....
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~----- 257 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYS----- 257 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHH-----
Confidence 87643221 112345799999999998754 378999999999999999999999974321 11111
Q ss_pred chhhhhhcCCccCCCCCH--HHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPK--EDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK 547 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~--~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~L~ 547 (615)
.+.+.......+. .....+.+++..|+..++.+ |+++.|+++|-+
T Consensus 258 -----~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 258 -----KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred -----HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 1111110011111 12345678899999865543 899999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.75 Aligned_cols=258 Identities=29% Similarity=0.496 Sum_probs=201.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCc----EEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++|+..+.||+|+||.||+|.+. +|. .||+|.+...... ...++.+|+.++++++|+||++++|+|.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence 46788899999999999999853 444 5788988754322 23478899999999999999999999863 246
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++++||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 7899999999999999753 234789999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
...............++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+..+ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~ 230 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL----LEKGERL 230 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCC
Confidence 7654332222223446778999999998999999999999999999997 8999864321 111111 1111100
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
..+......+.+++..||..+|++||+++++++.|+.+.+.
T Consensus 231 ----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11112234578999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.54 Aligned_cols=251 Identities=28% Similarity=0.479 Sum_probs=200.2
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+.... ....+|.+|++++++++|+|++++++++. +....+++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc--cCCceEEEEEc
Confidence 4678889999999999999998778899999987443 23567999999999999999999999986 44578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++++|.+++.... ..+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 81 MEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 99999999997432 34789999999999999999999998 9999999999999999999999999998654332
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++.+|+|||++.++.++.++||||||+++|||++ |+.||..... ..+. ... .... ....
T Consensus 155 ~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~---~~~-~~~~---~~~~- 222 (256)
T cd05112 155 YT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVV---ETI-NAGF---RLYK- 222 (256)
T ss_pred cc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHH---HHH-hCCC---CCCC-
Confidence 11 1122335678999999998899999999999999999998 9999864321 1111 111 0000 0011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
+......+.+|+.+||+.+|++||++.||++.|
T Consensus 223 ------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 ------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.68 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=201.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||.||++... ++..+|+|.+...... ....+.+|++++.+++||||+++++++. +....++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEEEEe
Confidence 46899999999999999999964 6788999988754222 2356889999999999999999999987 455899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||+++++|.++++.. ..+++..+..++.|+++||.|||+ .+ ++||||||+|||+++++.+||+|||++....
T Consensus 79 ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 79 EHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred eccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999999752 458899999999999999999997 46 9999999999999999999999999987654
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc---cc----
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---DK---- 498 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~---- 498 (615)
... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+...... ..
T Consensus 152 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 152 DSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred ccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcc
Confidence 322 233568899999999988889999999999999999999999986433211 1111100000 00
Q ss_pred ----------------hhhhhhcCCccCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 499 ----------------DRLEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 499 ----------------~~l~~i~d~~l~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.....+.... ....+. .....+.+++.+||+.+|++||++.+|+++.+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0000000000 000111 1223588999999999999999999999886553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.04 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=199.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCC----C
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~ 339 (615)
..++|++.+.||+|+||.||++... .++.||||++..... ...+.+.+|+.+++.++|+||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 688999999975432 23467889999999999999999999876432 2
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...++||||+++ +|.+++.. .+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 67777642 3788999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hh----------
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LV---------- 488 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~-l~---------- 488 (615)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998654322 2234578999999999999999999999999999999999999997443111100 00
Q ss_pred -----HhhhhhhccchhhhhhcCCcc--------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 489 -----TWARPILRDKDRLEELADPRL--------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 489 -----~~~~~~~~~~~~l~~i~d~~l--------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
...............+..+.. ...........+.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000000000000000000 0001111234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.20 Aligned_cols=252 Identities=28% Similarity=0.383 Sum_probs=209.4
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|-||.||+|+. +++-.||+|++.+.. .+...++.+|+++-+.|+||||+++++|+. +....|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh--d~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH--DSKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee--ccceeE
Confidence 46799999999999999999995 467899999987543 233568999999999999999999999998 556899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
|++||.++|+|...|.... ...++......+..|+|.||.|+|..+ |+||||||+|+|++.++..||+|||-+..
T Consensus 99 LilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999998533 446888999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.+.. .....+||..|++||...+..++...|+|++|++.||++.|..||+..... + . ...
T Consensus 174 ~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--e-t-------------Ykr 233 (281)
T KOG0580|consen 174 APSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--E-T-------------YKR 233 (281)
T ss_pred cCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--H-H-------------HHH
Confidence 6532 235678999999999999999999999999999999999999999744311 1 1 111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+..-+ -.+|........++|.+|+..+|.+|.+..||+.+-+.
T Consensus 234 I~k~~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 234 IRKVD--LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred HHHcc--ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 11111 12233333457899999999999999999999988654
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.90 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=195.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.+|++.+.||+|+||.||+++.. +++.||||.+.... ......+.+|++++++++|+||+++++.+. +....++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCEEEE
Confidence 36899999999999999999954 68999999986432 223456889999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 79 v~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 79 VMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999999975 235788889999999999999999999 999999999999999999999999998532
Q ss_pred CCCC-----------------------------------------ccccceeeccccccCCccccccCcCCchhhHHHHH
Q 007160 425 PEGR-----------------------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYG 463 (615)
Q Consensus 425 ~~~~-----------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~G 463 (615)
.... .........||+.|||||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 1000 00011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC---CHH
Q 007160 464 VVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP---TMG 540 (615)
Q Consensus 464 vvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP---sm~ 540 (615)
|++|||++|+.||........ ...+....... ..+. .... ...+.+++.+|+ .+|.+|+ ++.
T Consensus 232 vilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~---~~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAET------QLKVINWETTL---HIPS-QAKL----SREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred ceeeehhhCCCCCCCCCHHHH------HHHHhccCccc---cCCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 999999999999975432111 00011000000 0000 0112 234667777766 4999999 899
Q ss_pred HHHHHH
Q 007160 541 EVVQSL 546 (615)
Q Consensus 541 eVl~~L 546 (615)
|++++-
T Consensus 297 ell~h~ 302 (376)
T cd05598 297 EIKAHP 302 (376)
T ss_pred HHhCCC
Confidence 999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.42 Aligned_cols=237 Identities=26% Similarity=0.347 Sum_probs=186.8
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHH-HHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||+||+|+.. +|+.||+|++.... ....+.+..|.. +++.++||||+++++++. +....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE--eCCEEEEEEcCC
Confidence 46999999999999964 68999999987432 222345566655 457899999999999887 445889999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999999974 235888999999999999999999999 99999999999999999999999999875432221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~--------~~~ 215 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKP--------LRL 215 (323)
T ss_pred --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC--------CCC
Confidence 22345799999999999999999999999999999999999999964321 11111111110 011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 540 (615)
+......+.+++.+||+.||.+||++.
T Consensus 216 ----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 ----KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112234578999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=310.11 Aligned_cols=248 Identities=30% Similarity=0.466 Sum_probs=197.2
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCC
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 353 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gs 353 (615)
++||+|+||.||++...+++.||+|.+...... ..+.|.+|++++++++|+||+++++++. +....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV--QKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCCeEEEEEcCCCCc
Confidence 469999999999999877999999998765443 4567999999999999999999999987 4457899999999999
Q ss_pred hhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccc
Q 007160 354 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433 (615)
Q Consensus 354 L~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 433 (615)
|.+++.... ..+++..++.++.+++.||.|||+++ ++||||||+||+++.++.+||+|||+++...........
T Consensus 79 l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 79 LLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 999996432 25788999999999999999999998 999999999999999999999999999865432211111
Q ss_pred eeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 434 ~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
....++..|+|||.+.++.++.++|+||||+++|||++ |..||....... .... .. ......
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~----~~----------~~~~~~ 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER----IE----------SGYRMP 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH----Hh----------cCCCCC
Confidence 12234667999999988899999999999999999999 888886433211 1110 00 000111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+......+.+++.+||+.+|.+||++.||++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 22233446889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=327.68 Aligned_cols=242 Identities=25% Similarity=0.384 Sum_probs=193.5
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|... +++.||||.+.... ......+..|++++..+ +||||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 46999999999999965 57899999997532 23345678899999888 6999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 79 NGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99999999864 235899999999999999999999998 99999999999999999999999999875332221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... . .....+.. ...
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~---~~~~~i~~----------~~~ 213 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---D---ELFQSILE----------DEV 213 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---H---HHHHHHHc----------CCC
Confidence 12345689999999999999999999999999999999999999964321 1 11111111 110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 545 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm-----~eVl~~ 545 (615)
.++......+.+++.+||+.||++||++ .+++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1122223457899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=314.70 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=197.0
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC-----CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.+|+..+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|++++++++|+||+++++++........
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788999999999999999986 4688999998864321 123468889999999999999999998875445678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999964 234889999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCc-cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
....... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... .. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-~~~~~------ 222 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-IFKIA------ 222 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-HHHHh------
Confidence 6543211 11112345889999999999888999999999999999999999999643211 00 00000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
........+......+.+++ +||..+|++||+++||+++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 223 ----TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00001122222233456666 7888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.15 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=191.8
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 277 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
||+|+||.||+++.. +|+.||+|.+..... ...+.+..|++++++++||||+++.+++. +....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence 799999999999964 689999999864321 22345667999999999999999999887 445899999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 432 (615)
+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 150 (277)
T cd05607 79 DLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--- 150 (277)
T ss_pred CHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence 9999886422 335889999999999999999999998 99999999999999999999999999987654321
Q ss_pred ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 433 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 433 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ........... .....
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~----------~~~~~- 217 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE----------DEVKF- 217 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc----------ccccc-
Confidence 233568999999999998889999999999999999999999996432211 11111111111 01100
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
........+.+++.+||+.||++||+++|+++.+
T Consensus 218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0011223478999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.41 Aligned_cols=242 Identities=28% Similarity=0.411 Sum_probs=191.1
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|+.. +++.||||.++... ......+..|..++..+ +||||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeCC
Confidence 46999999999999965 57899999987532 22345677788888764 8999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++.++..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 79 NGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99999999964 235889999999999999999999998 99999999999999999999999999975432221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .+... +. ...+.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~---i~--------~~~~~- 214 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQS---IR--------MDNPC- 214 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHH---HH--------hCCCC-
Confidence 223457999999999999999999999999999999999999999743211 11111 00 00111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 545 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl~~ 545 (615)
++......+.+++.+||+.||++||++. ++.++
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 215 ---YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ---CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 1122233578999999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=320.82 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=164.6
Q ss_pred ceeeeccCceEEEEEEEC---CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 274 ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++........+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999987432 2456789999999999999999999987655667899999995
Q ss_pred CCChhHhhcCCC-----CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE----cCCCcEEEEecccc
Q 007160 351 NGSLESWLHGPL-----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA 421 (615)
Q Consensus 351 ~gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 421 (615)
++|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888875321 11235888999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCcc-ccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 422 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 422 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876433211 11234578999999999876 458999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.34 Aligned_cols=249 Identities=21% Similarity=0.338 Sum_probs=194.4
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCC
Confidence 47999999999999964 67899999997542 22345688899999888 6999999999887 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 79 NGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99999998864 235899999999999999999999998 99999999999999999999999999975332211
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.............+....... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~ 220 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------KPI 220 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------CCC
Confidence 123457999999999999999999999999999999999999999644322222222222111111 100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 545 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm------~eVl~~ 545 (615)
..+......+.+++.+||+.||.+|+++ .++++|
T Consensus 221 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 --RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1222223457899999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.19 Aligned_cols=251 Identities=30% Similarity=0.491 Sum_probs=195.7
Q ss_pred eeeeccCceEEEEEEECC-------CcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 275 SILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+.||+|+||.||+|+..+ +..+|+|.+.... ......|.+|++++++++|+||+++++++. +....+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL--LNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec--CCCCeEEEE
Confidence 369999999999998642 2579999886543 234567999999999999999999999987 445789999
Q ss_pred ecCCCCChhHhhcCCCC---CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-----cEEEEec
Q 007160 347 ELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-----HAKVADF 418 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-----~vkL~DF 418 (615)
||+++|+|.+++..... ....++|.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999999964321 1234789999999999999999999988 99999999999999877 8999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
|+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||..... ...... ...
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~----~~~ 228 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH----VTA 228 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH----Hhc
Confidence 99986644322212223356788999999999999999999999999999998 9999863321 111111 000
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. ....+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 229 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 00112223456889999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=311.90 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=193.0
Q ss_pred eeeeccCceEEEEEEEC----CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS----DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEecC
Confidence 46899999999999853 24579999986432 233467889999999999999999999875433 4578999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9999999997532 23678888999999999999999998 99999999999999999999999999986543221
Q ss_pred cc--cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 430 NY--LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 430 ~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
.. ......++..|+|||++.+..++.++||||||+++|||++| ..||.... ...+... .... . .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~---~~~~-~------~ 220 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVY---LLQG-R------R 220 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH---HhcC-C------C
Confidence 10 11233567789999999888999999999999999999995 45554221 1111111 1110 0 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
. ..+......+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 221 ~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 L----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 0111122358899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.22 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=190.8
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|+.. +|+.||+|.++... ....+.+..|.+++... +|+||+++++++. +....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence 46999999999999965 68899999997532 22345677788888765 8999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 79 NGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99999999864 235888999999999999999999998 99999999999999999999999999875432221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+.. ..+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~---~~~~~--------~~~-- 213 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF---ESIRV--------DTP-- 213 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHh--------CCC--
Confidence 224467999999999999999999999999999999999999999643211 111 11100 011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 545 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl~~ 545 (615)
.++......+.+++.+||+.||++||++. ++.+|
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11222234578999999999999999984 66544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.16 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
++|++.+.||+|+||.||+|+.. +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++. +...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR--EAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC--CCCc
Confidence 57889999999999999999953 3467999988754433 3467999999999999999999999986 4457
Q ss_pred eeEEEecCCCCChhHhhcCCCCCc-----ccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEE
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVN-----CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~-----~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 416 (615)
.++||||+++|+|.++++...... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 899999999999999997543211 25899999999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhh
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+...
T Consensus 160 ~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~----- 230 (275)
T cd05046 160 LLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR----- 230 (275)
T ss_pred ccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH-----
Confidence 9999875433221 12223456788999999988888999999999999999999 7888853221 111111
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.....+....+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 231 --------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 --------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00011111111223346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.60 Aligned_cols=256 Identities=26% Similarity=0.446 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEECC----CcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.|.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 468888999999999999998643 2468999887544 2334679999999999999999999998863 3578
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++... ...+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999999753 224899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
...... +..+...++..|+|||.+....++.++||||||+++||+++ |..||...... ....+. ......
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~~~- 227 (270)
T cd05056 157 LEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----ENGERL- 227 (270)
T ss_pred cccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCcC-
Confidence 654321 11223345578999999988889999999999999999986 99999644321 111111 010000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
..+......+.+++.+|+..+|++|||+.++++.|+.+..
T Consensus 228 ---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ---------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1122233468899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=311.93 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=203.4
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+.|.+|++++++++|+||+++.+++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEE
Confidence 46789999999999999999998778889999887432 235678999999999999999999998763 46899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999997532 345889999999999999999999988 999999999999999999999999999866443
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......++..|+|||++....++.++|+|||||++||+++ |+.||..... ..+..+. ....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~----~~~~------- 220 (260)
T cd05073 156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRAL----ERGY------- 220 (260)
T ss_pred Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hCCC-------
Confidence 221 1222346678999999998889999999999999999999 8999864321 1111111 0100
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
....+......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112233458899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.30 Aligned_cols=266 Identities=30% Similarity=0.434 Sum_probs=207.2
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeec
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS 336 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~ 336 (615)
+...++..++++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566777789999999999999999999996 468899999986432 2346788899999999 79999999999864
Q ss_pred CC---CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcE
Q 007160 337 RD---SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413 (615)
Q Consensus 337 ~~---~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 413 (615)
.+ ....++||||+++|+|.++++........+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 33 24689999999999999998643333456899999999999999999999998 9999999999999999999
Q ss_pred EEEeccccccCCCCCccccceeeccccccCCccccccC-----cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 007160 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 488 (615)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~ 488 (615)
||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ..+.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 9999999986543221 12234688999999987643 3689999999999999999999999643211 1111
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+. +. .. +.+ ..+......+.+++.+||+.+|++||++.|++++
T Consensus 244 ~~~----~~--~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIP----RN--PP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHh----cC--CC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 110 00 00 011 1112223458899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=337.07 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=192.2
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.|+..++||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++|+||+++++++. +....++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~--~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE--eCCEEEEE
Confidence 588999999999999999995 468899999987432 122456889999999999999999999987 44589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 80 MDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 9999999999999642 34788889999999999999999998 9999999999999999999999999975321
Q ss_pred CCC---------------------------------------------ccccceeeccccccCCccccccCcCCchhhHH
Q 007160 426 EGR---------------------------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY 460 (615)
Q Consensus 426 ~~~---------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVw 460 (615)
... .........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 100 00011234699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC--
Q 007160 461 SYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-- 538 (615)
Q Consensus 461 S~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-- 538 (615)
||||+||||++|+.||....+... ........... ..+. ....+ ..+.+++.+++ .+|.+|++
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~---~~p~-~~~~s----~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLET------QMKVINWQTSL---HIPP-QAKLS----PEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHH------HHHHHccCCCc---CCCC-cccCC----HHHHHHHHHHc-cCHhHcCCCC
Confidence 999999999999999975432110 00011000000 0000 01112 23566776665 48999987
Q ss_pred -HHHHHHH
Q 007160 539 -MGEVVQS 545 (615)
Q Consensus 539 -m~eVl~~ 545 (615)
+.|+++|
T Consensus 298 ~~~ei~~h 305 (382)
T cd05625 298 GADEIKAH 305 (382)
T ss_pred CHHHHhcC
Confidence 8888776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.88 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=199.0
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCC---CCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~---~~~~~ 343 (615)
+|++.+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ....+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999996 478999999986432 223467889999999999999999999986432 12689
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 588888754 235899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc----
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK---- 498 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---- 498 (615)
....... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||....+......+. ..+...
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~~~g~~~~~~ 228 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT---DLLGTPSLEA 228 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HHcCCCCHHH
Confidence 5433221 22334688999999998764 57899999999999999999999997544321111100 000000
Q ss_pred ------hhhhhhcCCccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 499 ------DRLEELADPRLG-------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 499 ------~~l~~i~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.....+...... ..........+.+|+.+||+.||++|||+.|++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000000000000 0011122345789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=344.80 Aligned_cols=272 Identities=19% Similarity=0.358 Sum_probs=197.6
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccC------CCcceEEEEe
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH------RNLVKLVGYY 334 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H------pnIv~l~g~~ 334 (615)
+++...+++|++.++||+|+||+||+|... +++.||||+++... ....++..|++++++++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999964 57899999986432 223456778888877755 4588898888
Q ss_pred ecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCC--
Q 007160 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNF-- 411 (615)
Q Consensus 335 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~-- 411 (615)
.. +....++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 201 ~~-~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 201 QN-ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTV 271 (467)
T ss_pred Ec-CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcc
Confidence 64 345788999988 7799998864 23589999999999999999999974 7 99999999999998765
Q ss_pred --------------cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCC
Q 007160 412 --------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477 (615)
Q Consensus 412 --------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~ 477 (615)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998864322 1234679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhH---------hhhh--------hhccchhhhhhcCCc----c-CCC-C-CHHHHHHHHHHHHHccccCC
Q 007160 478 MSQPSGQENLVT---------WARP--------ILRDKDRLEELADPR----L-GGK-Y-PKEDFIRVCTIAAACVAPEA 533 (615)
Q Consensus 478 ~~~~~~~~~l~~---------~~~~--------~~~~~~~l~~i~d~~----l-~~~-~-~~~~~~~l~~Li~~Cl~~dP 533 (615)
..........+. |... ++.....+....++. + ... . .......+++|+.+||+.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 544322111111 1000 000000000000000 0 000 0 00112357899999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 007160 534 NQRPTMGEVVQSLKM 548 (615)
Q Consensus 534 ~~RPsm~eVl~~L~~ 548 (615)
++|||++|+++|=+.
T Consensus 427 ~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 427 QKRLNARQMTTHPYV 441 (467)
T ss_pred hhCCCHHHHhcCccc
Confidence 999999999987544
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.21 Aligned_cols=192 Identities=24% Similarity=0.338 Sum_probs=163.6
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
...+|++.+.||+|+||.||+|+.. +++.||+|.... .....|+.++++++|+||+++++++.. ....++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe--CCeeEEE
Confidence 4568999999999999999999965 567899997542 234569999999999999999999874 4578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
+||+ .++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEcc-CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9999 56899988642 345899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCC
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 476 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf 476 (615)
... ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 123456999999999999999999999999999999999966655
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=317.45 Aligned_cols=269 Identities=25% Similarity=0.366 Sum_probs=208.9
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEec--cCCCCchHHHHHHHHHHhhccCCCcceEEEEeec---CCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS---RDSS 340 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~--~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~---~~~~ 340 (615)
....|...+.||+|+||.|+.+.. .+|+.||||++. .......+.-.+|+++|+.++|+||+.+++++.. .+-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 344566678999999999999995 478999999997 3445556788999999999999999999998764 3456
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
.+|+|+|+| +-+|...++. +..|+......+..|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 789999999 5699999975 334899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccc-cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
|+...........+..+-|..|.|||++. ...|+...||||.||++.||++|+.-|...+...+..++...-..- ...
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHH
Confidence 99886543333456778899999999876 4689999999999999999999999997665444433332111100 011
Q ss_pred hhhhhcC----------CccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 500 RLEELAD----------PRLG-----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 500 ~l~~i~d----------~~l~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+..+.. +... ..++ .......+|+.+||..||.+|+|++|.++|
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111110 0000 0111 112346899999999999999999999987
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.01 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=201.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCc
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 341 (615)
..++|...++||+|.||+|+++.++ +++.+|||.+++.. .++.+..+.|.+++.-.. ||.+++|+..+. ...+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ--T~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ--TKEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc--cCCe
Confidence 4578999999999999999999975 58899999999774 344567888999988775 999999998887 4559
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
+++||||+.||++..+.+ ...+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 999999999999655554 245899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
+....... .++..+||+.|||||++.+..|+...|.|||||+||||+.|..||...+.++ .+
T Consensus 516 Ke~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~F---------- 577 (694)
T KOG0694|consen 516 KEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VF---------- 577 (694)
T ss_pred cccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HH----------
Confidence 97643222 4567899999999999999999999999999999999999999997543221 11
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 539 (615)
+.|+... ..||.....+...|+.++|..+|++|.-+
T Consensus 578 dsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111111 23555556678899999999999999865
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=312.00 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=198.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-----CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++|++.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|++++++++|+||+++++++.......+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999964 589999998864321 123568889999999999999999998765445578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
+++|||+++++|.+++... ..+++...++++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998642 34788899999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
........ .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~----------- 218 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAI----------- 218 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHH-----------
Confidence 65422111 0112346889999999998888999999999999999999999999632111 000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
............+......+.+++.+|+. +|++||+++||+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00010111122344444567889999995 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=312.00 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=199.1
Q ss_pred CcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC------chHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
+|...+.||+|+||.||+|...+++.+|||.+...... ....+.+|++++++++|+||+++++++. +....+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL--DDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee--cCCeEE
Confidence 47788999999999999999888999999988743221 1245888999999999999999999987 446899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.
T Consensus 79 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 79 IFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 999999999999999642 35789999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCc----cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 424 APEGRT----NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 424 ~~~~~~----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
...... ........|+..|+|||++.+..++.++||||||+++|||++|+.||....... .... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~----~~~~~- 224 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY----IGAHR- 224 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH----hhhcc-
Confidence 532111 111223468999999999998889999999999999999999999996432111 0000 00000
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...+.+ +......+.+++.+||+.+|++||++.|++++
T Consensus 225 ----~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 225 ----GLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ----CCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 001111 22233457899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=309.96 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=202.4
Q ss_pred cCcccceeeeccCceEEEEEEECC-CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
++|+..+.||+|+||.||+|...+ ++.|++|.+..... .+++.+|++++++++|+||+++++++.. ....++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEEe
Confidence 578899999999999999999764 78999999875432 6789999999999999999999999874 468999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999999642 245899999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||....+.... .. ... ...+
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~----~~~-------~~~~ 217 (256)
T cd06612 153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FM----IPN-------KPPP 217 (256)
T ss_pred cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hh----hcc-------CCCC
Confidence 21 123345889999999999889999999999999999999999999743322110 00 000 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+ ..+......+.+++.+||+.||++||++.||+++
T Consensus 218 ~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00 1112223458899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.60 Aligned_cols=241 Identities=25% Similarity=0.373 Sum_probs=191.1
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~L 344 (615)
+|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+..|++++..+. |++|+++.+++. +....++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ--TVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe--cCCEEEE
Confidence 4778899999999999999964 68899999987532 223456788999998885 577888888876 3457999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 79 v~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 79 VMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999999999864 235899999999999999999999998 999999999999999999999999999764
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...+..
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~---~~~i~~-------- 215 (323)
T cd05615 152 MVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DEL---FQSIME-------- 215 (323)
T ss_pred CCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHH---HHHHHh--------
Confidence 33221 12335699999999999998999999999999999999999999974321 111 111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 539 (615)
... .++......+.+++.+||+.+|.+|++.
T Consensus 216 --~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 --HNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111 1222233457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=311.59 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=198.4
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc---------hHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~---------~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
+|.+.+.||+|+||.||+|.. .+++.||+|.+....... .+.+.+|++++++++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 367789999999999999986 467899999887543221 1468889999999999999999999874 4
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence 5889999999999999999642 35888999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCcc----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 420 LAKQAPEGRTN----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 420 la~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
+++........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+ .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~-------~ 222 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAI-------F 222 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHH-------H
Confidence 99876532111 1112345889999999999888999999999999999999999999743211 000 0
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......+ ..+......+.+++.+||+.||.+||++.||+++
T Consensus 223 ----~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 ----KIGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----HHhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00011111 1222334568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=319.15 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=204.1
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++. .....++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEee
Confidence 36789999999999999999995 578999999998666555677899999999999999999999987 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred cccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999863 34788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+..... . ..... .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~----~~~~~-------~ 232 (297)
T cd06656 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IATNG-------T 232 (297)
T ss_pred Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--e----eccCC-------C
Confidence 321 1233468899999999999889999999999999999999999996543221110 0 00000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+. ...+......+.+++.+||+.+|++||++.+|+++
T Consensus 233 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 PE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01122223457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=320.29 Aligned_cols=201 Identities=25% Similarity=0.354 Sum_probs=164.2
Q ss_pred ceeeeccCceEEEEEEEC---CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 274 ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++........++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999964 35789999987432 2356889999999999999999999987656668899999986
Q ss_pred CCChhHhhcCCC-----CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE----cCCCcEEEEecccc
Q 007160 351 NGSLESWLHGPL-----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA 421 (615)
Q Consensus 351 ~gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 421 (615)
++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 47888774221 11235888999999999999999999998 9999999999999 56679999999999
Q ss_pred ccCCCCCcc-ccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 422 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 422 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
+........ .......||..|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876543221 11234578999999999876 457999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=318.36 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=203.6
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|+|++++++++. +....++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe--cCceEEEEEE
Confidence 4689999999999999999985 578999999997665555678899999999999999999999987 4458999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999999863 34899999999999999999999998 999999999999999999999999998865433
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++..|+|||.+.+..++.++|||||||++|||++|+.||....+.... ....... . +
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~--~-----~ 233 (296)
T cd06655 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG--T-----P 233 (296)
T ss_pred cc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcC--C-----c
Confidence 21 123346889999999999888999999999999999999999999754321110 0000000 0 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+ ..+......+.+++.+||..||++||++.+++++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 EL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 1112223357889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.08 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=199.4
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCC----C
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~ 339 (615)
..++|++.+.||+|+||.||++.. .+|..||||++.... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999986 468999999997532 233467889999999999999999999886432 1
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...++||||+++ +|.+.++. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 357999999965 67776642 3788899999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-------- 491 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~-------- 491 (615)
+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...+... .+....
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~ 243 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQLGTPSA 243 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCcH
Confidence 997643321 2234578999999999999999999999999999999999999997543211 000000
Q ss_pred ----------hhhhccch-----hhhhhcCCccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 492 ----------RPILRDKD-----RLEELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 492 ----------~~~~~~~~-----~l~~i~d~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
........ ...+....... ..........+.+|+.+||+.||++|||+.|++++-+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 00000000 00000000000 00001112457899999999999999999999988543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=332.26 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=198.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC---CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
..+|++.+.||+|+||.||++... .+..||||.+... +.+.+|+++|++++|+||+++++++. .....++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR--WKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe--eCCEEEE
Confidence 457999999999999999999753 3578999988632 34568999999999999999999887 3457899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+||++. ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 689998843 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhhhhccc-----
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDK----- 498 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~----- 498 (615)
.............||+.|+|||++....++.++|||||||++|||++|+.||......... .+....+ .+...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccC
Confidence 5443322233467999999999999999999999999999999999999999654432211 1111100 00000
Q ss_pred ----h----hhhhhcCCccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 499 ----D----RLEELADPRLGGKYP-------KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 499 ----~----~l~~i~d~~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
. ..... .......+. ......+.+++.+||+.||++||++.|++.+-
T Consensus 315 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 315 QNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred CccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0 00000 000000000 01123477899999999999999999999873
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.02 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=187.9
Q ss_pred eeeeccCceEEEEEEECC---CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 275 SILGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+.||+|+||.||+|...+ ...+|+|.+..... .....|.+|+++++.++|+||+++++++. +....++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~--~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI--ESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCceEEEEEeCC
Confidence 358999999999997543 35788888764432 22457889999999999999999999987 4457999999999
Q ss_pred CCChhHhhcCCCCC-cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 351 NGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 351 ~gsL~~~L~~~~~~-~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
+|+|.+++...... ....++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh
Confidence 99999999754322 233567888999999999999999998 99999999999999999999999999876443322
Q ss_pred cccceeeccccccCCcccccc-------CcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 430 NYLSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
........++..|+|||++.. ..++.++|||||||++|||++ |..||...... ... ....... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~~~~~--~ 227 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVL---KQVVREQ--D 227 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HHHhhcc--C
Confidence 111223346778999998743 456889999999999999999 78888643211 110 0111110 0
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..+.++.+.. .....+.+++..|| .||++||++++|++.|
T Consensus 228 ~~~~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 228 IKLPKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1111222222 22334667888898 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.43 Aligned_cols=253 Identities=31% Similarity=0.512 Sum_probs=198.3
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchH--HHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~--~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
|++.+.||+|+||+||+++.. +++.||+|.+......... ...+|+.++++++|+||+++++++.. ....+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 677899999999999999975 4678999999866433322 34569999999999999999999874 558899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++.. ...+++..++.++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 79 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 79 YCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999972 346899999999999999999999998 999999999999999999999999999864221
Q ss_pred CccccceeeccccccCCccccc-cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
. .......++..|+|||++. +..++.++||||+|+++|+|++|..||...... +............ .. .
T Consensus 152 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~--~~---~ 221 (260)
T PF00069_consen 152 N--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKRP--LP---S 221 (260)
T ss_dssp T--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHTH--HH---H
T ss_pred c--cccccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhccccc--cc---c
Confidence 1 1234567899999999998 888999999999999999999999999744111 1111111111000 00 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. .........+.+++.+||+.||++||++.+++++
T Consensus 222 ~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 222 SS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000112568999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=318.83 Aligned_cols=268 Identities=22% Similarity=0.323 Sum_probs=198.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|.+.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.. ....++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEE
Confidence 57899999999999999999964 678899999875432 233568899999999999999999999874 45789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 84 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 84 EYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred eCCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 99975 888888642 234788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------hhhhcc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA--------RPILRD 497 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~--------~~~~~~ 497 (615)
... ......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||............... ++.+..
T Consensus 157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 221 1223467899999998865 46889999999999999999999999754332111111000 000000
Q ss_pred chhhhhhcCCccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 KDRLEELADPRLGGK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.........+..... ........+.+++.+||+.||.+|||+.|++++-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000000000000000 00112235789999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=315.82 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=197.9
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++.. ....++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEec
Confidence 577789999999999999965 577889999876554556779999999999999999999999874 45889999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++++|.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 85 AGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 999999988642 235899999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 430 NYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
......++..|+|||++. +..++.++|||||||++|||++|+.||...... ..... ....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~~~------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAKS------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHH----Hhhc-------
Confidence 123356899999999874 345788999999999999999999998643211 01111 0000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..+.+ ..+......+.+++.+||+.||.+||++.+++++-
T Consensus 224 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 224 EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00000 11112234588999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.25 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=199.5
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.|+..+.||+|+||.||++... +++.||||.+...... ....+.+|+.++++++|+|++++++.+.. ....++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 3777899999999999999964 6889999998754322 23457889999999999999999998874 4589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 79 ~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 79 LTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 99999999999986422 235889999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... .....||..|+|||++.+..++.++||||||+++|||++|+.||......... .. ...... ...
T Consensus 154 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~-~~~~~~------~~~ 221 (285)
T cd05630 154 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EE-VERLVK------EVQ 221 (285)
T ss_pred CCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HH-HHhhhh------hhh
Confidence 3321 12346899999999999999999999999999999999999999753321110 00 000000 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLK 547 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~L~ 547 (615)
. .++......+.+|+.+||+.||++||| +.|++++-+
T Consensus 222 -~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 222 -E----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred -h----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 0 111222334789999999999999999 889988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=316.60 Aligned_cols=264 Identities=25% Similarity=0.322 Sum_probs=195.1
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhc---cCCCcceEEEEeecC---CCC
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL---HHRNLVKLVGYYSSR---DSS 340 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~~---~~~ 340 (615)
+|++.+.||+|+||.||+|+.. +++.||+|.+...... ....+.+|+++++++ +|+||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999964 6889999998754322 234567788877766 699999999987632 234
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..+++|||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 48999886422 234899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc--c
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--K 498 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~ 498 (615)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... .+..... .... .
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~-~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-LIGLPPE 228 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHH-HhCCCCh
Confidence 98664322 1234568999999999998899999999999999999999999986432211 1111000 0000 0
Q ss_pred hhh-------hhhcCCccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 DRL-------EELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ~~l-------~~i~d~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... .....+... .....+....+.+++.+||+.||++|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000000 00011223457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=309.73 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=200.1
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++. +....+++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE--ADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEEe
Confidence 4788899999999999999954 68899999986432 233467889999999999999999999987 4458999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 79 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 79 YCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999999986422 235788999999999999999999998 999999999999999999999999999866443
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... .........
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~---------- 215 (255)
T cd08219 154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVCQG---------- 215 (255)
T ss_pred cc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHhcC----------
Confidence 21 223456899999999999888999999999999999999999999743211 111111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ...+......+.+++.+||+.||++||++.+++..
T Consensus 216 ~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SY-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 01122223457899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=311.68 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=199.3
Q ss_pred cccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCC----C
Q 007160 271 FEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S 340 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~----~ 340 (615)
|.+.+.||+|+||.||+|.+. +++.||||++..... ...+++.+|++++++++||||+++++++...+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 368899999875432 234578899999999999999999998764322 1
Q ss_pred ceeEEEecCCCCChhHhhcCCC--CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 341 QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
..++++||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 3478899999999998875321 11234788999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.||..... ..+..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----c
Confidence 99987654332222223346678999999998889999999999999999999 8888863321 11111111 0
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
... + ..+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~~--------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR--------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc--------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0 01122334689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.94 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=197.7
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.|+..+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|+|++++.+++. +....+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE--TKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe--cCCEEEEE
Confidence 3677899999999999999964 688999999865432 22345788999999999999999998887 34578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 79 LTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999999999886422 235899999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... .....|+..|+|||++.+..++.++|+||||+++|||++|+.||........ ...+.....
T Consensus 154 ~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~---------- 218 (285)
T cd05632 154 EGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVL---------- 218 (285)
T ss_pred CCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhh----------
Confidence 3221 1234689999999999988999999999999999999999999974322111 011111000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 545 (615)
... ..++......+.+|+..||+.||++||+ +.+++.+
T Consensus 219 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 219 ETE--EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccc--cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000 0112222335789999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=312.51 Aligned_cols=239 Identities=21% Similarity=0.372 Sum_probs=186.9
Q ss_pred eeeeccCceEEEEEEECC-------------CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 275 SILGEGGFGRVFKGVLSD-------------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~-------------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
+.||+|+||.||+|.+.+ ...||+|.+..........|.+|+.+++.++||||+++++++. +...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~--~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV--RDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCC
Confidence 468999999999998532 2358999887554445567899999999999999999999987 3457
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc-------EE
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-------AK 414 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-------vk 414 (615)
.+++|||+++|+|..+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeE
Confidence 89999999999999998642 235899999999999999999999998 999999999999987654 89
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccc-cCcCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCCcchhhHhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELL-TGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~GvvL~Ell-tG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.||.........
T Consensus 153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------- 219 (262)
T cd05077 153 LSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------- 219 (262)
T ss_pred eCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------
Confidence 9999998754322 2245788999999886 567899999999999999998 588887533211100
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.... .... ........+.+|+.+||+.||++||++.+|+++|
T Consensus 220 ~~~~----------~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFYE----------GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHh----------cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 0000 0111224578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.22 Aligned_cols=262 Identities=28% Similarity=0.355 Sum_probs=206.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++|+||++++++|...+....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 688999999875433 3356799999999999999999999998766666789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.........+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987643333445888999999999999999999998 99999999999999999999999999876543
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--CcchhhHhhhhhhccchhhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS--GQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~--~~~~l~~~~~~~~~~~~~l~~i 504 (615)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+..+.... .
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~----- 224 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----P----- 224 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----C-----
Confidence 221 2345788999999999999999999999999999999999999754321 111111211110 0
Q ss_pred cCCccCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 505 ADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 505 ~d~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+.+..... ......+.+++.+||+.+|++|||+.||+++-+
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 225 -NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred -chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 001110111 112346889999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.92 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=200.8
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|++.+.||+|++|.||++... +++.||+|++..... ...+.+.+|++++++++|+|++++++.+.. +....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence 4888999999999999999964 578899999875432 334578899999999999999999987653 334678999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.... ...+++.+++.++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred cccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999997522 335899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......+++.|+|||++.+..++.++||||||++++||++|+.||..... ..........
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~--------- 217 (257)
T cd08223 155 QCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEG--------- 217 (257)
T ss_pred cCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc---------
Confidence 221 22345688999999999999999999999999999999999999864321 1111111110
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+ ...+......+.+++.+||+.+|++||++.+++++
T Consensus 218 -~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 -KL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 11222333468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=323.84 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=196.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++..++|+||+++++++. +....++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~--~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ--DENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 47899999999999999999964 67889999986421 222345888999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999742 235888999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCcccccc-----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
...... ......||+.|+|||++.+ +.++.++|||||||+||||++|+.||..... ......+.....
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~ 225 (331)
T cd05624 153 NQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEE 225 (331)
T ss_pred cCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCC
Confidence 443221 2233579999999998875 5678999999999999999999999964321 111111111110
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSL 546 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~L 546 (615)
.. .-+. ........+.+++.+|+..++.+ |+++++++++-
T Consensus 226 ~~---~~p~----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 226 RF---QFPS----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred cc---cCCC----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 00 0000 00112345788999988865544 46899988773
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.56 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=210.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|...+++|+|+||.+++.+.+ ++..+++|++..... ...+....|+.++++++|||||.+.+.+... +...+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEEE
Confidence 57888999999999999998854 678999999976543 2334678899999999999999999998742 2338999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|+|++||+|.+.+.... ...+.++.+++++.|++.|+.|||++. |+|||||+.||+++.+..|||+|||+|+...
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999998644 345889999999999999999999888 9999999999999999999999999999887
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... .....+||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.. .++ ..+.+ ..
T Consensus 158 ~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li---~ki~~------~~- 222 (426)
T KOG0589|consen 158 PEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELI---LKINR------GL- 222 (426)
T ss_pred Cchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHH---HHHhh------cc-
Confidence 6542 346689999999999999999999999999999999999999999754321 111 11111 11
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
....+......+..++..|++.+|..||++.+++.+-
T Consensus 223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 1233445556689999999999999999999999874
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.03 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=203.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++|+||+++++++. +....+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE--eCCEEEEEE
Confidence 367899999999999999999964 57889999998765556678999999999999999999999887 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 80 EYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred eCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 999999999998753 135889999999999999999999998 99999999999999999999999999976543
Q ss_pred CCccccceeeccccccCCccccccC---cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+.. ...... . ..
T Consensus 154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~~----~-----~~ 220 (262)
T cd06613 154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLIS----K-----SN 220 (262)
T ss_pred hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH----h-----cc
Confidence 221 12335688899999998776 88999999999999999999999996433211 110000 0 00
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+..+.+ .........+.+++.+||+.+|.+||++.+|+.+
T Consensus 221 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 221 FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001111 1122234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=315.96 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=185.6
Q ss_pred eeeccCceEEEEEEECC-------------------------CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceE
Q 007160 276 ILGEGGFGRVFKGVLSD-------------------------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330 (615)
Q Consensus 276 ~LG~G~fG~Vykg~~~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l 330 (615)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13589998875444445678999999999999999999
Q ss_pred EEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC
Q 007160 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 410 (615)
Q Consensus 331 ~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 410 (615)
+++|. +....++||||+++|+|..++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++++
T Consensus 82 ~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCV--RGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEE--eCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEecc
Confidence 99987 445789999999999999998642 235889999999999999999999988 9999999999999764
Q ss_pred C-------cEEEEeccccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHH-hCCCCCCCCCC
Q 007160 411 F-------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELL-TGRKPVDMSQP 481 (615)
Q Consensus 411 ~-------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~Ell-tG~~Pf~~~~~ 481 (615)
+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3 3899999998654322 22357788999998875 56899999999999999984 69999864432
Q ss_pred CCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
... ..+ ..... . .+......+.+++.+||+.+|++||++.+|++.|
T Consensus 228 ~~~---~~~----~~~~~--------~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEK---ERF----YEKKH--------R----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH---HHH----HHhcc--------C----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 211 111 10000 0 1111123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.75 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
++|++.+.||.|+||.||+|+.. +++.||+|.+........+.+.+|++++++++|+||+++++++.. ....++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEEEe
Confidence 56889999999999999999965 588999999986655556789999999999999999999998873 458999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|..++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999887642 235899999999999999999999998 999999999999999999999999998764332
Q ss_pred CccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
.. ......++..|+|||++. ...++.++|||||||++|||++|+.||...... .........
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~----- 230 (292)
T cd06644 164 LQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS----- 230 (292)
T ss_pred cc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcC-----
Confidence 21 123456889999999885 345688999999999999999999998643211 111111100
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+.. ..+......+.+++.+||+.+|++||++.+++++
T Consensus 231 --~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 231 --EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00100 1122223457899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=311.67 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=198.5
Q ss_pred CcccceeeeccCceEEEEEEECC--CcEEEEEEeccCC----------CCchHHHHHHHHHHhh-ccCCCcceEEEEeec
Q 007160 270 NFEPASILGEGGFGRVFKGVLSD--GTAVAIKRLTCGG----------QQGDKEFLVEVEMLSR-LHHRNLVKLVGYYSS 336 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~----------~~~~~~f~~Ei~~l~~-l~HpnIv~l~g~~~~ 336 (615)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47888999999999999999754 6889999886432 1123457788888875 79999999999987
Q ss_pred CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEE
Q 007160 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKV 415 (615)
Q Consensus 337 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL 415 (615)
+....+++|||+++++|.+++.........+++..+++++.|++.||.|||+ .+ ++|+||+|+||++++++.+||
T Consensus 80 -~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 80 -ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred -cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEE
Confidence 4558999999999999999885422223458899999999999999999996 56 999999999999999999999
Q ss_pred EeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 416 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
+|||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ........
T Consensus 156 ~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~ 226 (269)
T cd08528 156 TDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIV 226 (269)
T ss_pred ecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHh
Confidence 9999998765432 22345689999999999988899999999999999999999999864321 11111111
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
+..............+.+++.+||+.||++||++.||..+++
T Consensus 227 ----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 ----------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111000001112245889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.64 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=200.9
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecC
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 337 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~ 337 (615)
.++....++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-- 113 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-- 113 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence 344555689999999999999999999965 67899999986421 223356788999999999999999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 417 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 417 (615)
+....++||||+++|+|.++++. ..++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 45589999999999999999964 24788889999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccC----cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
||+++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||..... ......
T Consensus 186 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~ 258 (371)
T cd05622 186 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSK 258 (371)
T ss_pred CCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 999987643321 122345799999999998754 378999999999999999999999974321 111111
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK 547 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~L~ 547 (615)
+......+. + .........+.+++.+|+..++.+ |+++.|++++.+
T Consensus 259 i~~~~~~~~-~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 259 IMNHKNSLT-F-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHcCCCccc-C-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 111111100 0 001122335778999999844443 789999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=311.55 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=197.4
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC---C-------chHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---Q-------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~-------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
+|...+.||+|+||.||+|.. .+|+.||+|.+..... . ..+.+.+|++++++++|+|++++++++. .
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~ 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--T 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec--c
Confidence 467789999999999999985 4688999998864211 1 1245788999999999999999999987 4
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeec
Confidence 45889999999999999999753 35889999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCc--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|+++...............|+..|+|||.+.... ++.++|+||||+++||+++|..||...... .... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~-~~~~ 226 (272)
T cd06629 153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMF-KLGN 226 (272)
T ss_pred cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHH-Hhhc
Confidence 9998654332222223456889999999987654 789999999999999999999998632211 1110 0000
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. ......... ........+.+++.+||+.+|++||++.+|+++
T Consensus 227 ~--~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 K--RSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c--ccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 000011111 111223468899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=334.84 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=209.2
Q ss_pred cccceeeeccCceEEEEEEEC--CC--cEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 271 FEPASILGEGGFGRVFKGVLS--DG--TAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~--~g--~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
....++||+|.||.|++|.|. +| ..||||.+...... ...+|++|+.+|.+|+|+|+++|+|+..+ ..+.||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV 188 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMV 188 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHH
Confidence 345688999999999999975 33 46899999876544 56899999999999999999999999863 468899
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||.++.|+|.+.|++ .....|-......++.|||.||.||..++ +|||||..+|+||-..-.+||+||||.+...
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999987 33456888899999999999999999999 9999999999999998899999999999888
Q ss_pred CCCccccce-eeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 426 EGRTNYLST-RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 426 ~~~~~~~~~-~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.....|.+. ...-.+.|+|||.+....++.++|||+|||+||||+| |..||-.... ..+-+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~ 326 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILK 326 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHH
Confidence 766655433 3456788999999999999999999999999999999 7888864321 11122
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.+|..-.-.-|+.+.+.++++++.||..+|.+|||+..|.+.+
T Consensus 327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2233333345677788899999999999999999999998554
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.55 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=204.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||+||++... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++.. ....++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEE
Confidence 56888899999999999999954 688999998875432 335679999999999999999999999874 46899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||+++++|.+++.. ...+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++....
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999864 2358999999999999999999997 46 9999999999999999999999999987543
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-----chhhHhhhhhhccchh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPILRDKDR 500 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~-----~~l~~~~~~~~~~~~~ 500 (615)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..+........
T Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (284)
T cd06620 156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-- 229 (284)
T ss_pred hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--
Confidence 221 1235689999999999888999999999999999999999999975433211 11112211111100
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.+.+. ..+....+.+++.+||+.||++||++.||+++...++
T Consensus 230 -----~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 -----PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -----CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01110 1113345889999999999999999999998865544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=311.72 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=187.5
Q ss_pred eeeccCceEEEEEEECCC---cEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCC
Q 007160 276 ILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN 351 (615)
Q Consensus 276 ~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~ 351 (615)
.||+|+||.||+|...++ ..+++|.+..... ...+.|.+|+++++.++||||++++++|. +....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV--EAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec--CCCccEEEEecCCC
Confidence 599999999999985433 3466777664432 33568999999999999999999999987 44578999999999
Q ss_pred CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccc
Q 007160 352 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431 (615)
Q Consensus 352 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 431 (615)
|+|.++++........+.+..++.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999754332334677788899999999999999998 9999999999999999999999999986432221111
Q ss_pred cceeeccccccCCcccccc-------CcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 432 LSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 432 ~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
......++..|+|||++.. ..++.++||||||+++|||++ |..||...... ......+.. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~--~~~~ 228 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD--QQVK 228 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh--cccc
Confidence 1234567889999998753 245789999999999999997 56677533211 111111111 1122
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
+.++.+...+. ..+.+++..|| .+|++||++++|++.|
T Consensus 229 ~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 23333322222 35778999999 5799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=312.66 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=201.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.. ....++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEE
Confidence 36888899999999999999965 68899999987553 3334678999999999999999999999874 45899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 79 EYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 999999999999742 6899999999999999999999998 99999999999999999999999999987754
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||....+... ..... ....
T Consensus 151 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~-------~~~~ 215 (274)
T cd06609 151 TMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLIP-------KNNP 215 (274)
T ss_pred ccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHhh-------hcCC
Confidence 321 12345688899999999988899999999999999999999999964432110 00000 0011
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.+... .....+.+++.+||..+|++||++++++++
T Consensus 216 ~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 PSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111111 022357899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=321.94 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=194.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ......|.+|+.++..++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEE
Confidence 47899999999999999999965 57889999986421 222345888999999999999999999887 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.++++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999999999742 235888999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.....
T Consensus 153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~ 225 (332)
T cd05623 153 MEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKE 225 (332)
T ss_pred ccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCc
Confidence 43322 1223357999999999986 34678999999999999999999999974321 111111111110
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQS 545 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~ 545 (615)
.. .-+. ........+.+++.+|+..++.+ |+++.|+++|
T Consensus 226 ~~---~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RF---QFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc---cCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0000 01122345778888887654444 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=312.33 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=199.6
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++|+||+++++++. +....+++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~--~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL--RRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCEEEEEE
Confidence 35788889999999999999985 468899999987655444567889999999999999999999987 445889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 86 EFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999864 235889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....+... +.. .... .
T Consensus 159 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~----~~~~-----~ 225 (267)
T cd06645 159 TIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL----MTKS-----N 225 (267)
T ss_pred ccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHh----hhcc-----C
Confidence 221 123457899999999874 45688999999999999999999999864332111 000 0000 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...+.... .......+.+++.+||+.+|++||++++|+++
T Consensus 226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 226 FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00111100 00112347899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=307.78 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=198.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-----CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
+|+..+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++. +....+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEE
Confidence 4677899999999999999976 789999999865432 23467899999999999999999999987 445889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+++||+++++|.+++... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 79 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 79 IFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 999999999999999742 35889999999999999999999998 99999999999999999999999999886
Q ss_pred CCCCCccccceeeccccccCCccccccCc-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
..... ......|+..|++||.+.... ++.++|+||||+++|||++|+.||...... ..... .... ...
T Consensus 152 ~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~~~~-~~~- 220 (258)
T cd06632 152 VVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFK----IGRS-KEL- 220 (258)
T ss_pred ccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHH----HHhc-ccC-
Confidence 54432 123456889999999988776 899999999999999999999999643311 11100 0000 000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...+......+.+++.+||+.+|++||++.+++++
T Consensus 221 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 --------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11122223457889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=308.65 Aligned_cols=237 Identities=25% Similarity=0.474 Sum_probs=188.4
Q ss_pred eeeeccCceEEEEEEECCCc-----------EEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 275 SILGEGGFGRVFKGVLSDGT-----------AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~-----------~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec---CCcE
Confidence 46999999999999975432 5788877654433 6789999999999999999999999874 4679
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-------cEEEE
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-------HAKVA 416 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-------~vkL~ 416 (615)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeC
Confidence 9999999999999997532 25889999999999999999999998 99999999999999887 79999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccC--cCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|||+++..... ....++..|+|||++... .++.++||||||+++|||++ |..||........ ..+.
T Consensus 151 Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~-- 219 (259)
T cd05037 151 DPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFY-- 219 (259)
T ss_pred CCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHH--
Confidence 99999865431 223567789999998876 78999999999999999999 5777754332111 1110
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.... ..+......+.+++.+||+.+|.+||++.+|++.|
T Consensus 220 --~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 220 --QDQH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --hcCC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 00111115688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.08 Aligned_cols=246 Identities=30% Similarity=0.505 Sum_probs=197.0
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEEC
Confidence 4588899999999999999976 57789999986432 34678999999999999999999999753 247999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 99999999997532 235789999999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||...... ..... ....
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~--------- 213 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VEKG--------- 213 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-HhCC---------
Confidence 12234568999999998899999999999999999998 99998643321 11111 1110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.....+......+.+++.+||+.+|++||+++++++.|+
T Consensus 214 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 214 -YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 001112223345789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=314.05 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=199.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++. +....++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL--KGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc--cCCceEEEEE
Confidence 4667788999999999999864 57889999887443 233457899999999999999999999987 4457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++.. ..+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 83 YLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 9999999999863 35889999999999999999999988 999999999999999999999999999766543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.|+....+... ..+ .. ....+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~------~~~~~ 219 (277)
T cd06642 155 QI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IP------KNSPP 219 (277)
T ss_pred ch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hh------cCCCC
Confidence 21 12234688899999999988999999999999999999999999864322110 000 00 00011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. ........+.+++.+||+.+|++||++.+|+++-+
T Consensus 220 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 220 T----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred C----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 1 12223345889999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.10 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=194.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|+..+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++.+++|+||+++++++. +....++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 47889999999999999999964 68999999986432 223456888999999999999999999887 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 79 IMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999999974 235889999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCcc---------------------------------ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh
Q 007160 425 PEGRTN---------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471 (615)
Q Consensus 425 ~~~~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt 471 (615)
...... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 321100 00123479999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 007160 472 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQS 545 (615)
Q Consensus 472 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs---m~eVl~~ 545 (615)
|+.||....+.. ....+...... +.-+ ... .....+.+++.+|+. ||.+|++ +.|+++|
T Consensus 232 G~~Pf~~~~~~~------~~~~i~~~~~~---~~~p---~~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 232 GYPPFCSETPQE------TYRKVMNWKET---LVFP---PEV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCCCHHH------HHHHHHcCCCc---eecC---CCC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 999997543211 11111110000 0000 000 112346778877664 9999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.89 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=202.5
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|+||.||.++. .+++.+++|++.... ....+++.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 588899999999999999884 468899999986543 3345678999999999999999999999874 45889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.+++.... ...+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 79 EYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred EecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 9999999999997532 345889999999999999999999998 99999999999999999999999999987644
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... ........
T Consensus 154 ~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~---------- 215 (256)
T cd08221 154 EYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQ---------- 215 (256)
T ss_pred ccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc----------
Confidence 332 223456899999999998888899999999999999999999999643211 11111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.... ..+......+.+++.+||+.+|.+||++.++++++
T Consensus 216 ~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 216 GNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1110 11122234588999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.41 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=196.8
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|++.+.||+|+||.||+|+.. ++..||||++..... ...+.+.+|+.++++++|+||+++++++. +....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEEEE
Confidence 5788899999999999999964 689999999875432 23467889999999999999999999987 445889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||++ ++|.+++..... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 79 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 79 EFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred ecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 9997 689998864322 346899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-------hccc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI-------LRDK 498 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~-------~~~~ 498 (615)
... ......+++.|+|||++.+. .++.++||||||+++|||++|+.||....... .+....... +...
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 154 PVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred Ccc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcc
Confidence 221 12334678899999988654 57899999999999999999999997432211 000000000 0000
Q ss_pred hhh---hhhcCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 DRL---EELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ~~l---~~i~d~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+ .......... ........++.+++.+||+.||++|||+.+|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 0000000000 0001122357899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.46 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=186.9
Q ss_pred eeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHH-HHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|+. .+|+.||+|++.... ......+..|.. +++.++||||+++++++. +....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEcCC
Confidence 4699999999999995 468999999986431 223345666665 467789999999999887 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99999998864 335889999999999999999999999 99999999999999999999999999875432211
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~----------~~ 213 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHK----------PL 213 (325)
T ss_pred --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcC----------Cc
Confidence 223457999999999999999999999999999999999999999643211 111111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 541 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~e 541 (615)
..+......+.+++.+|++.+|.+||++.+
T Consensus 214 --~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 --VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred --cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 011122345778999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.51 Aligned_cols=266 Identities=25% Similarity=0.328 Sum_probs=199.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++|+|++++++++. +....++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR--RKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe--eCCEEEEE
Confidence 46888999999999999999975 589999999865432 23456889999999999999999999987 44588999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++++|..++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 79 FEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecC
Confidence 999999988887754 234899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhhhhc-------
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVTWARPILR------- 496 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~-l~~~~~~~~~------- 496 (615)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... +.........
T Consensus 152 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 152 GPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred CCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 43321 123457889999999876 567899999999999999999999997443221110 0000000000
Q ss_pred cchhhhhhcCCccCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..........+......+. .....+.+++.+||+.+|++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000011111100010 112457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.72 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=198.9
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCC----C
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~ 339 (615)
..++|++.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++|+||+++++++...+ .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999954 58899999997542 233467889999999999999999999875322 2
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 78777742 3788999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-------
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR------- 492 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~------- 492 (615)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ +.....
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 246 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCP 246 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence 998654322 22345789999999999999999999999999999999999999975432111 000000
Q ss_pred -----------hhhccch-----hhhhhcCCcc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 493 -----------PILRDKD-----RLEELADPRL---GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 493 -----------~~~~~~~-----~l~~i~d~~l---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
....... ....+..... ...........+.+++.+||+.||.+|||+.|+++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0000000 0000000000 0000111223578999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=348.51 Aligned_cols=263 Identities=22% Similarity=0.295 Sum_probs=202.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.++||+|+||.||+|+.. +|+.||||++...... ..+.|.+|++++++++||||+++++++. +....++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~--d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS--DGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe--eCCEEEE
Confidence 57899999999999999999964 5899999999754222 2457999999999999999999999987 4458899
Q ss_pred EEecCCCCChhHhhcCCC-------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEe
Q 007160 345 CYELVPNGSLESWLHGPL-------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 417 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~-------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 417 (615)
+|||+++|+|.+++.... .....+++..+++++.|+++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEe
Confidence 999999999999986321 11234677888999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCc----------------cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007160 418 FGLAKQAPEGRT----------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481 (615)
Q Consensus 418 FGla~~~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~ 481 (615)
||+++....... ........||+.|||||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999986621110 0011235699999999999999999999999999999999999999964321
Q ss_pred CCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHh
Q 007160 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR 551 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-sm~eVl~~L~~i~~ 551 (615)
.. .. + .. .+.++.... ...+....+.+++.+|++.||++|| +++++++.|+...+
T Consensus 237 ~k---i~-~-~~---------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 237 RK---IS-Y-RD---------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh---hh-h-hh---------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 00 0 00 000110000 0011223478899999999999995 67777777777654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=314.95 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=199.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|+..+.||+|+||.||+|... +++.||+|++...... ..+.+.+|++++++++|+||+++++++. +....++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence 47889999999999999999975 5899999988654322 3467889999999999999999999986 45689999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++++|.++... ...++|.+++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 79 FEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 999999999887754 224899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhhhhcc------
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRD------ 497 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~~~~~~~~~~------ 497 (615)
.... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... .+..+.......
T Consensus 152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 152 APGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred CCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 4332 1233568899999998875 45788999999999999999999998643321100 011110000000
Q ss_pred -chhhhhhcCCccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 -KDRLEELADPRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 -~~~l~~i~d~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.........+..... ........+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000000 011223458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=313.91 Aligned_cols=263 Identities=26% Similarity=0.433 Sum_probs=203.8
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeec
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS 336 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~ 336 (615)
.++.++....+.|++.+.||.|+||.||+|.. .+++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34556666778999999999999999999996 468899999886543 2345788899999998 69999999998753
Q ss_pred C----CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc
Q 007160 337 R----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 412 (615)
Q Consensus 337 ~----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 412 (615)
. .....+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 2 2457899999999999999997533 234788889999999999999999998 999999999999999999
Q ss_pred EEEEeccccccCCCCCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 007160 413 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 487 (615)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l 487 (615)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.....
T Consensus 160 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~- 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF- 236 (282)
T ss_pred EEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-
Confidence 99999999876543211 123356899999999875 3467889999999999999999999996432211000
Q ss_pred hHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 488 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 488 ~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. ......+... .......+.+++.+||+.||.+||++.|++++
T Consensus 237 -~-----------~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 -L-----------IPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -h-----------HhhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 0000011111 11123458899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=310.89 Aligned_cols=258 Identities=32% Similarity=0.481 Sum_probs=202.5
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCC----CC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD----SS 340 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~----~~ 340 (615)
.+++|++.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+++++++ +|+||+++++++.... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999974 578999999875433 346799999999999 6999999999986432 34
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+++++|.+++.........+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 589999999999999998753323456899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCcccccc-----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
+........ ......|+..|+|||++.. ..++.++||||||+++|||++|+.||...... ..+.. ..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~ 231 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP 231 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh
Confidence 876543221 1233568999999998753 35678999999999999999999999633211 11110 00
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ..+.+ ..+......+.+++.+||..||++|||+.+++++
T Consensus 232 ~~-------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RN-------PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cc-------CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 00111 1122233468899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=324.25 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=197.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCC----
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---- 338 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~---- 338 (615)
...++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999985 4688999999875322 23456788999999999999999998875321
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....+++++++ +++|.++++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 24578999988 7899988863 34899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
|+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+....-..
T Consensus 163 g~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 235 (343)
T cd07878 163 GLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTP 235 (343)
T ss_pred ccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence 9998654322 33468999999999876 578999999999999999999999996432111 111100000000
Q ss_pred -chhh--------hhhcCCccCCCCCH--------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 -KDRL--------EELADPRLGGKYPK--------EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 -~~~l--------~~i~d~~l~~~~~~--------~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.... ..... .+. ..+. .....+.+++.+||+.||++|||+.|+++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 236 SPEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred CHHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0000 00000 000 0010 11124679999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=313.42 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=202.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||.|+||.||+|... ++..||+|.+........+.|.+|++++++++|+||+++++++. +....++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF--YENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe--cCCeEEEEe
Confidence 357889999999999999999964 68899999997655555678999999999999999999999987 445889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 82 EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 999999999998642 235899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
... ......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ..+.. ....
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~---- 223 (280)
T cd06611 156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLK----ILKS---- 223 (280)
T ss_pred ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHH----HhcC----
Confidence 221 223456899999999875 345678999999999999999999999643211 11111 1000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
..+.+ ..+......+.+++.+||+.+|.+||++.+|+++-+
T Consensus 224 ---~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 224 ---EPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred ---CCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 00111 111122335789999999999999999999998733
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.07 Aligned_cols=251 Identities=30% Similarity=0.497 Sum_probs=198.9
Q ss_pred cccceeeeccCceEEEEEEECC-----CcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 271 FEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
|++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|++++.+++|+||+++++++.. ....++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEE
Confidence 4567899999999999999753 388999999765443 46789999999999999999999999874 458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+|||+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++..
T Consensus 79 i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceec
Confidence 9999999999999975221 12899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......++..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+... ... ..
T Consensus 154 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~---~~~-~~---- 221 (258)
T smart00219 154 YDDDYY-KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEY---LKK-GY---- 221 (258)
T ss_pred cccccc-ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---Hhc-CC----
Confidence 654221 1112347889999999988889999999999999999998 7888864221 111111 110 00
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
....+......+.+++.+||..||++|||+.|+++.|
T Consensus 222 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011112334588999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=353.09 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=201.8
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
...++|++.+.||+|+||+||++... ++..||+|.+..... .....|..|+.++++++|||||++++++.......+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999964 577899998875432 234678999999999999999999998876566678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCC----CcEEeccCCCCCeEEcC---------
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ----PCVIHRDFKASNILLEN--------- 409 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~----~~ivHrDIkp~NILl~~--------- 409 (615)
+|||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+. ..|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997533333468999999999999999999998542 23999999999999964
Q ss_pred --------CCcEEEEeccccccCCCCCccccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007160 410 --------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMS 479 (615)
Q Consensus 410 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~ 479 (615)
...+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998664332 1234579999999999864 45889999999999999999999999643
Q ss_pred CCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 480 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 480 ~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ....... +... +.+. .......+.+|+..||+.+|.+||++.|++.+
T Consensus 247 ~~-----~~qli~~-lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NN-----FSQLISE-LKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred Cc-----HHHHHHH-HhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 21 1111111 1110 1110 01112458899999999999999999999865
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.75 Aligned_cols=239 Identities=23% Similarity=0.313 Sum_probs=185.8
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHH-HHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|.. +++.++|+||+++++++. +....++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE--cCCeEEEEEeCC
Confidence 46999999999999965 57889999987432 122334555554 567889999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+.+..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 79 NGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999999974 234778888899999999999999999 99999999999999999999999999975432221
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~----------~~ 213 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNK----------PL 213 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhC----------Cc
Confidence 223457999999999999999999999999999999999999999643211 111111111 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eV 542 (615)
..+......+.+++.+||+.||.+||++.+.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 1111223357899999999999999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.92 Aligned_cols=255 Identities=28% Similarity=0.410 Sum_probs=195.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHH-HhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+..|+.. ++.++|+||+++++++. +....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEEE
Confidence 47889999999999999999965 689999999875432 234556667775 55668999999999987 44579999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
|||++ |+|.+++.........+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++..
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99996 689888865333345689999999999999999999987 6 999999999999999999999999999865
Q ss_pred CCCCccccceeeccccccCCcccccc----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
.... ..+...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ...+.. ...
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~---- 222 (283)
T cd06617 155 VDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----VVE---- 222 (283)
T ss_pred cccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----HHh----
Confidence 4322 1233468899999998864 45688999999999999999999999632211 011100 000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
-..+.+. .......+.+++.+||+.+|.+||++.+++++-+
T Consensus 223 ---~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 223 ---EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred ---cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 0011110 0112245889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.49 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=198.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++. +....++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeEEEEE
Confidence 57899999999999999999864 678999999875432 23456788999999999999999999987 445799999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||++ ++|.+++... ...+++..++.++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 84 EYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred eccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 9997 5999988643 234788999999999999999999998 99999999999999999999999999976543
Q ss_pred CCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc--------
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-------- 497 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~-------- 497 (615)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .......+..
T Consensus 157 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 157 PTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchh
Confidence 221 1223457889999998865 4578999999999999999999999975432111 1111000000
Q ss_pred ---chhhhhhcCCccCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 498 ---KDRLEELADPRLGGKY----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 498 ---~~~l~~i~d~~l~~~~----~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.........+.....+ .......+.+|+.+||+.||.+|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000000001000000 011223578999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.51 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=203.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..|+..+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++. +....++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEEEE
Confidence 35777889999999999999964 58899999987543 233567899999999999999999999987 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 82 EYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999999863 24788999999999999999999998 99999999999999999999999999977644
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......++..|+|||++.+..++.++|+|||||++|||++|..||....+.... . ...
T Consensus 154 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~-----------~~~ 214 (277)
T cd06640 154 TQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F-----------LIP 214 (277)
T ss_pred Ccc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h-----------hhh
Confidence 321 123346888999999999888999999999999999999999998643221100 0 000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.......+......+.+++.+||+.+|++||++.+++++-..
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 001112233445568899999999999999999999988543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.65 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=201.0
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|+||.||+++. .+|+.||+|++.... ....+++.+|++++++++|+||+++++++. +....++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEE
Confidence 478899999999999999985 468899999987532 233467899999999999999999999986 455899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 79 DYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred ecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999999997422 234788999999999999999999998 99999999999999999999999999986644
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......|+..|+|||++.+..++.++|+|||||+++||++|+.||..... ..........
T Consensus 154 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~--------- 216 (256)
T cd08218 154 TVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRG--------- 216 (256)
T ss_pred chh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcC---------
Confidence 321 12234588899999999988899999999999999999999999864321 1111111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ...+......+.+++.+||+.+|++||++.+|+++
T Consensus 217 -~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 -SY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 01122334458899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.23 Aligned_cols=267 Identities=27% Similarity=0.390 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.. ....+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36889999999999999999965 57899999887532 2234678999999999999999999999874 4579999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||++++.|..++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 79 FEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 999998777766643 234889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhh-------hhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARP-------ILR 496 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~-~~~~~-------~~~ 496 (615)
..... ......++..|+|||++.+. .++.++||||||+++|||++|+.||............ ..... .+.
T Consensus 152 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 152 ARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 54321 22345688999999999888 8899999999999999999999998643221110000 00000 000
Q ss_pred cchhhh-----hhcCCc-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLE-----ELADPR-LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~-----~i~d~~-l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...... ...++. ....++......+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 000000 0001122224568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=312.07 Aligned_cols=239 Identities=24% Similarity=0.444 Sum_probs=187.9
Q ss_pred eeeeccCceEEEEEEECC--------CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 275 SILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+.||+|+||.||+|.... ...||+|.+........+.|.+|+.+++.++|+||+++++++.. ....++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEEE
Confidence 469999999999998532 23488888865554455788999999999999999999999874 34789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc--------EEEEec
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--------AKVADF 418 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------vkL~DF 418 (615)
||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. ++++||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999997532 25889999999999999999999998 999999999999987765 699999
Q ss_pred cccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcchhhHhhhhhhc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~-~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|++...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+........ .. ...
T Consensus 153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~----~~~ 219 (258)
T cd05078 153 GISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQ----FYE 219 (258)
T ss_pred ccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HH----HHH
Confidence 998755322 23467889999999886 45799999999999999999985 55543221110 00 000
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
. . ...+......+.+++.+||+.||++|||++++++.|
T Consensus 220 ~----------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 220 D----------R--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred c----------c--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0 112222334688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.51 Aligned_cols=249 Identities=22% Similarity=0.378 Sum_probs=199.2
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|+||.||++.. .+++.+|||.+.... ....+.+.+|++++++++|+|++++++.+. +....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEE
Confidence 588899999999999999985 468899999987543 223567899999999999999999999876 445889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~ 425 (615)
||+++++|.+++.... ...+++..++.++.++++||+|||+.+ ++|+||||+||+++++ +.+||+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 79 EYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred ecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 9999999999997532 235889999999999999999999998 9999999999999854 568999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~-------- 216 (256)
T cd08220 154 SKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSG-------- 216 (256)
T ss_pred CCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhc--------
Confidence 4322 22356889999999999888899999999999999999999998643321 111111110
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. ....+......+.+++.+||+.+|++|||+.|++++
T Consensus 217 --~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 --T-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --C-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 001122233458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.86 Aligned_cols=269 Identities=23% Similarity=0.315 Sum_probs=201.8
Q ss_pred hcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCC-cceEEEEeecCC----C
Q 007160 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRN-LVKLVGYYSSRD----S 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~----~ 339 (615)
...|+..++||+|+||+||+|+ ..+|+.||+|++.....+ -...-.+|+.+|++++|+| ||.|.+++...+ .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3457777889999999999999 457899999999866442 2345789999999999999 999999987533 2
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
..++|||||++. +|.+++.........++...+..++.|+++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 378899999954 999999764432234666889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
+|+...-.... .+..++|..|.|||++.+. .|+...||||+||+++||++++.-|...... ..+...++ .+...
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~-~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFR-LLGTP 240 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHH-HcCCC
Confidence 99976543322 3556889999999999987 7899999999999999999999888654321 11111111 00000
Q ss_pred -----hhhhhhcCCcc-----C--CCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 -----DRLEELADPRL-----G--GKYPK---EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 -----~~l~~i~d~~l-----~--~~~~~---~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.....+.+-+. . ..... .......+++.+||+.+|.+|.|++.++.|
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00001111110 0 00000 001257889999999999999999999886
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=312.73 Aligned_cols=272 Identities=22% Similarity=0.286 Sum_probs=200.1
Q ss_pred CcccceeeeccCceEEEEEEEC---CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999998633 33346788999999999999999999999866557899
Q ss_pred EEEecCCCCChhHhhcCCCCC-cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC----CCcEEEEec
Q 007160 344 LCYELVPNGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADF 418 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkL~DF 418 (615)
+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777777533222 236888999999999999999999998 999999999999999 999999999
Q ss_pred cccccCCCCCc-cccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-------hhhH
Q 007160 419 GLAKQAPEGRT-NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-------NLVT 489 (615)
Q Consensus 419 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-------~l~~ 489 (615)
|+++....... ........++..|+|||++.+. .++.++||||||+++|||++|+.||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987654322 1122345688999999988764 5789999999999999999999999754433210 0100
Q ss_pred hhhhhh----------ccchhhhhhcCCccCCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 490 WARPIL----------RDKDRLEELADPRLGGKYP---------K--EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 490 ~~~~~~----------~~~~~l~~i~d~~l~~~~~---------~--~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....+- ..........+......++ . .....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 0000000000000001111 0 223458899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.83 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|++++++++|+||+++++++. .....++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF--IEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee--cCCeEEEEE
Confidence 36888999999999999999975 68999999887542 222467899999999999999999999887 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||+++++|..+++... ....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred eecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999999987532 123689999999999999999999974 6 9999999999999999999999999997654
Q ss_pred CCCccccceeeccccccCCccccccC------cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
... .....++..|+|||.+.+. .++.++|+|||||++|||++|+.||...... .....
T Consensus 155 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~--------- 218 (286)
T cd06622 155 ASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQ--------- 218 (286)
T ss_pred CCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHH---------
Confidence 322 2234588899999988544 3588999999999999999999999643211 11110
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
+..+.+.. ....+......+.+++.+||+.+|++||++.+++.+-+
T Consensus 219 -~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 219 -LSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred -HHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 11111111 01123334456889999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.73 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=200.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|+..+.||+|+||.||++... +++.||+|.+...... ..+.+.+|++++++++|+||+++++++. +....++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEE
Confidence 46889999999999999999965 4899999999765332 3456889999999999999999999986 4458899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+|||+.+++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 79 VMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999999997432 346899999999999999999999998 999999999999999999999999998755
Q ss_pred CCCCcc---------------------------ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCC
Q 007160 425 PEGRTN---------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477 (615)
Q Consensus 425 ~~~~~~---------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~ 477 (615)
...... .......||..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 322110 01123468899999999998889999999999999999999999996
Q ss_pred CCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 007160 478 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT----MGEVVQS 545 (615)
Q Consensus 478 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs----m~eVl~~ 545 (615)
..... .. +..+.+..............+.+++.+||+.||++||+ +.|++++
T Consensus 234 ~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 234 GSNRD--ET--------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCchH--HH--------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 43321 11 11111111111111113456899999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=322.34 Aligned_cols=241 Identities=22% Similarity=0.262 Sum_probs=185.4
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhc---cCCCcceEEEEeecCCCCceeEEEecC
Q 007160 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRL---HHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 277 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
||+|+||+||+|+.. +++.||||++..... .....+..|..++.+. +||||+++++++. +....++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence 799999999999964 689999999864321 1223456677777665 6999999999887 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 79 SGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred CCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99999999864 335889999999999999999999999 99999999999999999999999999975433221
Q ss_pred cccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
......||..|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~--------~~ 215 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGK--------VR 215 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCC--------CC
Confidence 12345799999999998754 4789999999999999999999999643211 1111111100 01
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRP----TMGEVVQS 545 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP----sm~eVl~~ 545 (615)
+.. ......+.+++.+||+.||.+|| ++.+++++
T Consensus 216 ~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 FPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 100 01123477899999999999998 57777665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.26 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=198.4
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
.|.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+. .....++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee--cCCeEEEEEeC
Confidence 3444577999999999999864 68899999987655555667899999999999999999999887 44588999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++++|.+++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 101 ~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 101 LEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999999999853 24889999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||....... .... +.....+.
T Consensus 173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~----------~~~~~~~~ 237 (292)
T cd06658 173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRR----------IRDNLPPR 237 (292)
T ss_pred c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----------HHhcCCCc
Confidence 1 1233568999999999988889999999999999999999999996432211 0000 01111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... ......+.+++.+||..||++|||++|++++
T Consensus 238 ~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 VKDS--HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccc--cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1110 1122347789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.01 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=200.2
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC------CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
+|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++. +....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeE
Confidence 478889999999999999985 5789999999874321 12357899999999999999999999987 45588
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEEecccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLA 421 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla 421 (615)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++
T Consensus 79 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred EEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 999999999999999964 235889999999999999999999998 99999999999998765 6999999999
Q ss_pred ccCCCCCc--cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 422 KQAPEGRT--NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 422 ~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
........ ........++..|+|||.+.+..++.++||||+|+++|||++|+.||.......... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~------- 221 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIF------- 221 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHH-------
Confidence 76654311 111223468899999999988889999999999999999999999996433221111 100
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...........+......+.+++.+||+.+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 ---KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0000011112333344568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.20 Aligned_cols=266 Identities=17% Similarity=0.215 Sum_probs=192.9
Q ss_pred cceeeecc--CceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 273 PASILGEG--GFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 273 ~~~~LG~G--~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
+.++||+| +||+||+++. .+|+.||+|++...... ..+.+.+|+++++.++||||+++++++.. ....++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 45789999 7899999985 47899999999754322 23467789999999999999999999874 457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+......
T Consensus 80 ~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 80 FMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred ccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 999999999996432 234889999999999999999999998 999999999999999999999999876443221
Q ss_pred Ccc-----ccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc---c
Q 007160 428 RTN-----YLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---D 497 (615)
Q Consensus 428 ~~~-----~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~---~ 497 (615)
... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........... +
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 232 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccc
Confidence 110 01122356788999999876 468999999999999999999999996432110 00000000000 0
Q ss_pred ch--hhhh--------hcCCcc-----------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 KD--RLEE--------LADPRL-----------------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 ~~--~l~~--------i~d~~l-----------------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. ..++ ..+... ...........+.+++.+||+.||++|||++|++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 00 0000 000000 00011122346889999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=303.27 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=199.7
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++|+||+++++++. +....++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence 4788899999999999999964 6889999998765443 4578999999999999999999999876 455899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++... ..+++..++.++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 79 EYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred ecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999999999752 34788999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcccc--ceeeccccccCCccccccCc---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 427 GRTNYL--STRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 427 ~~~~~~--~~~~~gt~~y~APE~~~~~~---~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
...... .....++..|+|||++.... .+.++||||||+++||+++|+.||...... .. ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~---~~~~~~------ 220 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQ---IMFHVG------ 220 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HH---HHHHHh------
Confidence 332111 11346788999999998766 889999999999999999999999643211 00 000000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....+.+.. .......+.+++.+||+.+|.+||++.+++.+
T Consensus 221 -~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 221 -AGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -cCCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000111100 01113457899999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=302.51 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=205.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|++|.||+|+.. +++.|+||++..... ...+.+.+|++++.+++|+|++++++++. .....+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY--KEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--cCCeEEEEE
Confidence 46888999999999999999976 589999999876544 34578999999999999999999999987 446899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 79 EYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999752 458999999999999999999999 88 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
..... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..........+..+..
T Consensus 152 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 216 (264)
T cd06623 152 NTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------- 216 (264)
T ss_pred cCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------
Confidence 43321 134568899999999999999999999999999999999999997554311111111111
Q ss_pred CCccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... ...+.. ....+.+++.+||+.+|++||++.|++++
T Consensus 217 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 DGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1100 011111 33468899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.03 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=203.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||.|+||+||+|... ++..+|+|++..... ...+.+.+|+++++.++|+|++++++.+. +....++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe--eCCEEEEEE
Confidence 47899999999999999999954 678999999875432 24578999999999999999999999886 455889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 79 PYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred eccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999999975321 235889999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccc--cceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 427 GRTNY--LSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 427 ~~~~~--~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..... ......|+..|+|||++... .++.++|+|||||++|||++|+.||...... ..+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~----~~------ 222 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTL----QN------ 222 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHh----cC------
Confidence 33221 22334689999999998877 7899999999999999999999999644321 1111111 10
Q ss_pred hcCCccCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKY-PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+.+.... .......+.+++.+||+.||++||++.+++++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011111110 01223457899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=306.79 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=199.8
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++|+||+++++++. +....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP--HGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeeEEEe
Confidence 4788899999999999999964 689999999976542 23467999999999999999999999987 455889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+ +++|.+++.... ..+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 79 e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 79 EYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred ccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 999 999999986432 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-------
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------- 498 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------- 498 (615)
... .......|+..|+|||.+.+. .++.++||||+|+++|||++|+.+|...... ....+....+...
T Consensus 152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 152 EEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhh
Confidence 321 112345689999999988654 4689999999999999999998777543221 1111111100000
Q ss_pred ----hhhhhhcCCccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 ----DRLEELADPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ----~~l~~i~d~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.....+..+.... ....+....+.+++.+||+.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 0001223568999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.45 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=202.9
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
++|++.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++|||++++++++.. ....++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEEEEe
Confidence 5788999999999999999985 4678999999876555556788999999999999999999999873 457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999999964 24788999999999999999999998 999999999999999999999999998765433
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......+++.|+|||.+....++.++||||||+++||+++|+.||.......... . ... .+
T Consensus 169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~----~~~---------~~ 231 (293)
T cd06647 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IAT---------NG 231 (293)
T ss_pred cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--e----hhc---------CC
Confidence 22 1233468899999999988889999999999999999999999997543221110 0 000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
......+......+.+++.+||+.+|++||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000011122234578999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.56 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=195.3
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++|+||+++++++. +....++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH--SDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc--cCCceEEEE
Confidence 4788899999999999999964 688999999875432 22356788999999999999999999986 455899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||++ ++|.+++... ...+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 79 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 79 EYCD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 9996 5888887642 235899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc--h---h
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--D---R 500 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--~---~ 500 (615)
.... .....++..|+|||++.+. .++.++|||||||++|||++|+.|+...... ...+.. ....+... . .
T Consensus 152 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~ 227 (284)
T cd07839 152 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKR-IFRLLGTPTEESWPG 227 (284)
T ss_pred CCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHH-HHHHhCCCChHHhHH
Confidence 3221 1234678899999988765 4689999999999999999999987432211 111100 00000000 0 0
Q ss_pred hhhhcCCccCCC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 501 LEELADPRLGGK---------YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 501 l~~i~d~~l~~~---------~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+..+.+...... ........+.+++.+||+.||.+|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 001111000000 011123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=321.85 Aligned_cols=245 Identities=30% Similarity=0.415 Sum_probs=199.0
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCch---HHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~---~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.|..++.||.|+||.||.++. .+.+.||||++...+.+.. ++++.|+..|.+++|||++.+.|+|. .....|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL--re~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL--REHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee--ccchHHHH
Confidence 366778899999999999995 5678999999987766553 57889999999999999999999987 44578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||| -|+-.|+|.-. .+++-+-.+..|+.+.+.||+|||+++ .||||||+.||||.+.|.|||+|||.|....
T Consensus 105 MEYC-lGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHH-hccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 9999 55777777532 346888899999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
.. ..++||+.|||||++. .++|+-|+||||||++..||.-.++|+..-.. ..-... +.
T Consensus 178 PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYH-------IA 238 (948)
T KOG0577|consen 178 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-------IA 238 (948)
T ss_pred ch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHH-------HH
Confidence 43 3578999999999875 68999999999999999999999999753221 111111 11
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.--.|.+. ..+-...++.++..||+.-|.+|||..++++|
T Consensus 239 QNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 239 QNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred hcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11122222 23344568899999999999999999988765
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=311.37 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=196.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+. +....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE--TKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe--cCCEEEE
Confidence 47889999999999999999964 578999999875432 23457889999999999999999999887 4458899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 79 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 79 VMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999964 235889999999999999999999998 999999999999999999999999998742
Q ss_pred CCCC-------------ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 425 PEGR-------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 425 ~~~~-------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
.... .........++..|+|||++.+..++.++|+||||+++|||++|+.||...... .+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~ 225 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELF 225 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 1110 001112345788999999998888999999999999999999999999643211 111
Q ss_pred hhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..... .....+.....+ ...+.+++.+||+.||++||++.++.+.|
T Consensus 226 ~~~~~-----~~~~~~~~~~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 226 GQVIS-----DDIEWPEGDEAL----PADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred HHHHh-----cccCCCCccccC----CHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 11110 011111111112 23478999999999999999965444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.17 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=205.6
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++........++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 689999999875543 3457899999999999999999999998754336889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999752 26899999999999999999999988 99999999999999999999999999987765
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
...........++..|+|||.+.+...+.++||||||+++++|++|+.||..... ...... .+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~----------~~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALY----------KIGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHH----------hccc
Confidence 4321112345688999999999888899999999999999999999999975431 111111 1111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......+......+.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111112233334568999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.05 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=201.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++|+||+++++++.. ....++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEE
Confidence 36788899999999999999975 688999999876533 334678999999999999999999999874 46899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 79 EYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999999997532 458889999999999999999999 77 9999999999999999999999999987654
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ............
T Consensus 153 ~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~--------- 218 (265)
T cd06605 153 NSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVN--------- 218 (265)
T ss_pred HHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhc---------
Confidence 3221 12568889999999999899999999999999999999999996442211 111121111111
Q ss_pred CCccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... ...+.. ....+.+++.+||..||++|||+.+++.+
T Consensus 219 -~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 -EPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 100 011111 33458899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=307.28 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=195.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++. +....++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH--TKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe--cCCeEEEEE
Confidence 67899999999999999999965 6899999998754322 2346788999999999999999999987 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++ +|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 83 EYLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred ecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 99975 9999886432 25889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc--chhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--KDRLEE 503 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~~~l~~ 503 (615)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ..+ ......+.. ......
T Consensus 156 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 156 PSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQL-HKIFRVLGTPTEETWPG 231 (291)
T ss_pred CCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHH-HHHHHhcCCCChhhhhh
Confidence 2111 122356889999998875 457899999999999999999999996433110 000 000000000 000000
Q ss_pred h------c--------CCccCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 L------A--------DPRLGGKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i------~--------d~~l~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. . ...+....+ ......+.+++.+||+.+|++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0 000000000 0111457789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=312.40 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=199.6
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
|+....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++. .....++++||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee--eCCeEEEEEecC
Confidence 334467999999999999864 68999999997655555677899999999999999999999887 445889999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 101 QGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999998853 34889999999999999999999998 99999999999999999999999999976543321
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... +... ..+..
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~----~~~~------~~~~~ 237 (297)
T cd06659 173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKR----LRDS------PPPKL 237 (297)
T ss_pred --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----Hhcc------CCCCc
Confidence 1233568999999999998889999999999999999999999996433211 1100 0000 00000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
. ........+.+++.+||+.+|++||++.+++++-..
T Consensus 238 ~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 238 K--NAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred c--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence 0 011122347889999999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.49 Aligned_cols=254 Identities=27% Similarity=0.300 Sum_probs=208.9
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCc
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 341 (615)
....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ......+|+.+|+++. |||||.+.+.++. ...
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence 3467888899999999999999965 4999999999865443 3358999999999998 9999999999984 458
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC----CCcEEEEe
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVAD 417 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkL~D 417 (615)
+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+.. ++.+|++|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 99999999999999999753 2899999999999999999999999 999999999999953 35799999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
||++.....+ ......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+...
T Consensus 183 FGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~ 253 (382)
T KOG0032|consen 183 FGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG 253 (382)
T ss_pred CCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC
Confidence 9999987762 24567899999999999999999999999999999999999999997554322111 11111
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. ......-......+.+++..|+..||.+|+|+.++++|-|
T Consensus 254 ~~--------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 DF--------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CC--------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 11 1111112223445789999999999999999999999744
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.46 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=209.6
Q ss_pred HHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccC--CCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCc
Q 007160 265 KEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 265 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 341 (615)
......|+++++||+||.+.||++...+.+.+|+|++... +.+....|.+|+..|.+|+ |.+||+|++|-. ..+.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv--~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV--TDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec--cCce
Confidence 3445678999999999999999999888889999988643 3444578999999999995 999999999966 3568
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
+||||||- .-+|..+|++... ....| .++.+..|++.++.+.|.++ |||.||||.|+|+-+ |.+||+|||+|
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA 506 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIA 506 (677)
T ss_pred EEEEeecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechh
Confidence 99999997 5599999986432 23445 77889999999999999999 999999999999985 58999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccC-----------cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~ 490 (615)
..+..+.+.......+||+.||+||.+... ..++++||||+||+||+|+.|+.||.... ..|
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~ 579 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQI 579 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHH
Confidence 999988888888889999999999988532 25689999999999999999999996211 111
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHH-HHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFI-RVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~-~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+..+.||.-.-+++.-... .+.++++.||+.||++||++.|++++
T Consensus 580 --------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 --------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 235566777554444432221 28899999999999999999999976
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.63 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=199.1
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
-|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++. +....++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCeEEEEEE
Confidence 467789999999999999986 4688999998864432 23467889999999999999999999987 4457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 83 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 9999999999863 34889999999999999999999998 999999999999999999999999998766443
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......++..|+|||++.+..++.++|+|||||++|||++|..||...... .+...... . ..+
T Consensus 155 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~------~~~ 219 (277)
T cd06641 155 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPK-N------NPP 219 (277)
T ss_pred hh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhc-C------CCC
Confidence 21 123346888999999999888999999999999999999999998643211 01110000 0 011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.+ +......+.+++.+||+.+|.+||++.+++++-
T Consensus 220 ~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 220 TL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred CC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 11 222234578999999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=296.60 Aligned_cols=262 Identities=26% Similarity=0.404 Sum_probs=207.7
Q ss_pred HHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc--------hHHHHHHHHHHhhc-cCCCcceEEEEe
Q 007160 265 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRL-HHRNLVKLVGYY 334 (615)
Q Consensus 265 ~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~~l~~l-~HpnIv~l~g~~ 334 (615)
+..-++|...+.||+|..+.|-+... .+|..+|+|++....... .++-..|+.+|+++ .||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 44456788899999999999998875 468899999987543211 13456799999998 599999999998
Q ss_pred ecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 335 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
+ .+..+++|+|.|+.|.|.|+|.. ...++++...+|+.|+.+|++|||..+ ||||||||+|||+|++.++|
T Consensus 93 e--s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 93 E--SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred c--CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 7 45588999999999999999975 456899999999999999999999999 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccc------cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 488 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~ 488 (615)
|+|||++.....+.. -...+||++|+|||.+. ...|+...|+|++||++|-|+.|..||..... .
T Consensus 164 isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------m 234 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------M 234 (411)
T ss_pred EeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------H
Confidence 999999998877653 24678999999999875 24688899999999999999999999964321 1
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
-..+.++..+.. +-.|. -.+....+.+||.+||+.||.+|.|++|+++|-..++-.
T Consensus 235 lMLR~ImeGkyq---F~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 235 LMLRMIMEGKYQ---FRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred HHHHHHHhcccc---cCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 111212221111 11111 112234578999999999999999999999997665433
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.02 Aligned_cols=263 Identities=25% Similarity=0.323 Sum_probs=197.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-----chHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-----GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
+|+..+.||+|+||.||+|... +|+.||||++...... ....+..|++++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 4778899999999999999964 6899999999765432 23567789999999999999999999874 45889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+ +|+|.+++.... ..+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 79 lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 999999 999999997532 35899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc------
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR------ 496 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~------ 496 (615)
....... .....++..|+|||.+.+ ..++.++|||||||++|||++|..+|....... .+.........
T Consensus 152 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 152 FGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENW 227 (298)
T ss_pred ccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhh
Confidence 6543221 123456888999998865 467899999999999999999977776433211 11110000000
Q ss_pred -cchhhhhhcCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 -DKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 -~~~~l~~i~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....+............+ ......+.+++.+||+.||++|||+.||+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000111 1223568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=295.77 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=202.7
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
+|+..+.||+|++|.||++... ++..+++|++........+.+.+|++++++++|+|++++++++.. ....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEec
Confidence 4778899999999999999975 688999999986655456789999999999999999999999874 4578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 79 CSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 99999999997532 45899999999999999999999988 9999999999999999999999999998765543
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. .....++..|++||++....++.++||||||+++++|++|+.||....... .+.. ... ... +.
T Consensus 153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~--~~~-----~~ 216 (253)
T cd05122 153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALFK----IAT--NGP-----PG 216 (253)
T ss_pred c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHHH----HHh--cCC-----CC
Confidence 2 234568899999999988889999999999999999999999986432111 0000 000 000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+. .+......+.+++.+||+.||++|||+.|++++
T Consensus 217 ~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 011113458899999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.15 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=199.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ--DDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCeEEE
Confidence 47889999999999999999964 68999999986432 223466889999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 79 VMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 99999999999999752 45889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
... .....+++.|+|||.+.+...+.++||||||+++|||++|+.||...... .. .. .+
T Consensus 152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~----------~~ 210 (290)
T cd05580 152 KGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QI---YE----------KI 210 (290)
T ss_pred CCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH---HH----------HH
Confidence 543 22346889999999998888899999999999999999999999643310 00 00 11
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
..... ..+......+.+++.+||+.||.+|+ +++|++++
T Consensus 211 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 211 LEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred hcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11110 12222234688999999999999999 77887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.48 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC-----CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.+|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++|+||+++++++...+....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999995 468999999875321 1223578899999999999999999999876555678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999864 234788999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCc-cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
....... ........++..|+|||++.+..++.++|+|||||++|||++|+.||...... .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~--------------~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AA--------------I 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HH--------------H
Confidence 6532111 11112356899999999999888999999999999999999999999633211 00 0
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
............+......+.+++.+||+ ++..||+..+++.|
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11111111122333444568899999999 47999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.91 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=195.7
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++++|.+.+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+|++++++++|+||+++.+++. +....++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe--cCCeEEE
Confidence 457899999999999999999985 46889999998754332 2346789999999999999999999987 4457899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+. ++|.+++... ...+.+..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 81 v~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEeccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 999995 6887777532 234778889999999999999999998 999999999999999999999999999765
Q ss_pred CCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-----
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK----- 498 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~----- 498 (615)
...... .....++..|+|||++.+. .++.++|||||||++|||++|+.||+...... +.+... +..+...
T Consensus 154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~ 229 (291)
T cd07870 154 SIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKI-WTVLGVPTEDTW 229 (291)
T ss_pred CCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHH-HHHcCCCChhhh
Confidence 432211 1234578999999998754 57889999999999999999999997443211 111000 0000000
Q ss_pred ---hhhhhhcCCccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 ---DRLEELADPRLGGKYP---------KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ---~~l~~i~d~~l~~~~~---------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+............+ ......+.+++.+|++.||++|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000 0112357789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.02 Aligned_cols=249 Identities=26% Similarity=0.416 Sum_probs=198.5
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhcc---CCCcceEEEEeecCCCCceeE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~~~L 344 (615)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|++++++++ |+|++++++++. +....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEEE
Confidence 477889999999999999996 578999999987543 233467889999999997 999999999987 4457899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 9999999999999864 25899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..... ......|+..|+|||++.++ .++.++|||||||++|||++|+.||........ ... . ..
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~----~------~~ 216 (277)
T cd06917 152 NQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MML----I------PK 216 (277)
T ss_pred CCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhc----c------cc
Confidence 54332 12334689999999988754 568999999999999999999999964332110 000 0 00
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
...+.+... .....+.+++.+||+.||++||++.+++++-
T Consensus 217 ~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 217 SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 011111111 1234588999999999999999999998763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.45 Aligned_cols=245 Identities=28% Similarity=0.450 Sum_probs=202.9
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 353 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gs 353 (615)
-+||+|.||+||-|+.. +...+|||.+...+....+-+..||.+-++|+|.|||+++|.|. +++..-+.||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCCCCc
Confidence 36999999999999954 56789999998777777778999999999999999999999976 5557889999999999
Q ss_pred hhHhhcCCCCCcccC--ChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc-CCCcEEEEeccccccCCCCCcc
Q 007160 354 LESWLHGPLGVNCHL--DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTN 430 (615)
Q Consensus 354 L~~~L~~~~~~~~~l--~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~ 430 (615)
|.++|+..-+ ++ .+.++--+..||++||.|||++. |||||||-+|||++ -.|.+||+|||-++....- +
T Consensus 659 LSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--n 730 (1226)
T KOG4279|consen 659 LSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--N 730 (1226)
T ss_pred HHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--C
Confidence 9999975332 34 56778889999999999999999 99999999999995 5899999999999876432 3
Q ss_pred ccceeeccccccCCccccccC--cCCchhhHHHHHHHHHHHHhCCCCCCCCC-CCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 431 YLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQ-PSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 431 ~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~GvvL~ElltG~~Pf~~~~-~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
..+..+.||..|||||++..+ .|..++|||||||++.||.||++||..-. +.. .+.++---
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----------------AMFkVGmy 794 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----------------AMFKVGMY 794 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----------------hhhhhcce
Confidence 345678899999999999866 58899999999999999999999995322 111 01111112
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.....|.+...+...+|.+|+.+||.+||++.++++.
T Consensus 795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 23345677888889999999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=303.85 Aligned_cols=272 Identities=26% Similarity=0.370 Sum_probs=225.9
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEE
Q 007160 261 YEELKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGY 333 (615)
Q Consensus 261 ~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~ 333 (615)
..++....++++...++-+|.||.||+|.+. +.+.|-||.++....+ ....++.|.-++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3456666788999999999999999999653 3466788888755433 24568889999999999999999999
Q ss_pred eecCCCCceeEEEecCCCCChhHhhcCCC----CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC
Q 007160 334 YSSRDSSQHLLCYELVPNGSLESWLHGPL----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 409 (615)
Q Consensus 334 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~----~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 409 (615)
+.+ +....+.+|.++.-|+|..||...+ ...+.++..+...++.|++.|++|||+++ |||.||.++|+++|+
T Consensus 356 ~ie-~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 356 SIE-DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred Eee-ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 875 5567888999999999999997322 22345788889999999999999999999 999999999999999
Q ss_pred CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 007160 410 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 488 (615)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~ 488 (615)
...+||+|-.++|..-..+.++.......+..||+||.+.+..|+.++|||||||+||||+| |+.||...++.+...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-- 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-- 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence 99999999999998888888877777788999999999999999999999999999999998 999997665544322
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
++.++.++. .|..+..++..++.-||..+|++||+++|++.-|.++...+
T Consensus 510 -----ylkdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 510 -----YLKDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -----HHhccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 334444442 34455566899999999999999999999999998875543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.60 Aligned_cols=268 Identities=23% Similarity=0.305 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++.+++||||+++++++...+....++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999975 5889999999754322 23457889999999999999999999876555789999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 59999886432 25899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhh-------hhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWA-------RPILR 496 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~~~~-------~~~~~ 496 (615)
..... .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||......... .+.... +..+.
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 43221 1334578899999988754 4689999999999999999999999744321100 000000 00000
Q ss_pred c----c-hhhhhhcCCccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 D----K-DRLEELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~----~-~~l~~i~d~~l~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. . ..........+...++.. ....+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0 000000011111112221 23457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=305.99 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=195.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|+||+++++++. +....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEe
Confidence 5888999999999999999964 688999999875432 22357889999999999999999999986 455889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+. ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 79 e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 79 EFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred eccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9995 68999986532 345899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCccccceeeccccccCCccccccCc-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch------
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD------ 499 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~------ 499 (615)
.... .....++..|+|||++.+.. ++.++||||||+++|||+||+.||...... ..+.......-....
T Consensus 153 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 153 PVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred Cccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhh
Confidence 3211 12345788999999887644 588999999999999999999999643211 111111100000000
Q ss_pred -hh-------hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 500 -RL-------EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 500 -~l-------~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+ .......+. .........+.+++.+||+.||.+||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 000000000 0000112346789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.57 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=194.6
Q ss_pred cccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEEe
Q 007160 271 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
|++.+.||+|+||.||+|.. .+++.||+|+++.... .......+|+.++.++. |+|++++++++...+....++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999995 4688999999875422 22344567999999985 999999999988654468999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|++ |+|.+++... ...++|.+++.++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 5888888642 235899999999999999999999998 999999999999999 99999999999876433
Q ss_pred CccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-hhhh---
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRLE--- 502 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l~--- 502 (615)
.. .....++..|+|||++.. +.++.++|||||||++|||++|..||......+ .+.+........ ....
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence 22 123457889999997654 567899999999999999999999996543211 111111111000 0000
Q ss_pred ------hhcCCccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ------ELADPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ------~i~d~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....+.... .........+.+++.+||+.+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0011224568999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.85 Aligned_cols=249 Identities=29% Similarity=0.385 Sum_probs=195.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+.|+..+.||+|+||.||+|... +++.||+|.+...... ..+++.+|++++++++||||++++++|.. ....++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 45888899999999999999964 6899999998654332 23568899999999999999999999874 457899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++...
T Consensus 93 v~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999996 5787777532 235899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
... ....++..|+|||++. ...++.++||||||+++|||++|+.||....... ........
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~~---- 229 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN---- 229 (307)
T ss_pred CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhcC----
Confidence 432 2346788999999874 4568899999999999999999999986432111 00000000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..+.+ ........+.+++.+||+.+|++||++.+|+.+.+.
T Consensus 230 ---~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 230 ---DSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred ---CCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 00111 112233468899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=304.81 Aligned_cols=254 Identities=24% Similarity=0.283 Sum_probs=203.8
Q ss_pred cCcccceeeeccCceEEEEEEECC-CcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+.|+.++.||+|.-|+||++.+.+ +..+|+|++.+.... .......|-+||+.++||.+..|++.++ .....+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe--t~~~~cl 154 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE--TDKYSCL 154 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee--ccceeEE
Confidence 356778999999999999999764 589999999865432 3345677999999999999999999987 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+||||+||+|..+++... .+.+++..+.-++..|+-||+|||-.| ||.|||||+||||.++|++.|+||.|+...
T Consensus 155 ~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999998643 456999999999999999999999999 999999999999999999999999997533
Q ss_pred CC---------------------------------CCc---------------------cccceeeccccccCCcccccc
Q 007160 425 PE---------------------------------GRT---------------------NYLSTRVMGTFGYVAPEYAMT 450 (615)
Q Consensus 425 ~~---------------------------------~~~---------------------~~~~~~~~gt~~y~APE~~~~ 450 (615)
.. ... ...+...+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 11 000 011223689999999999999
Q ss_pred CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccc
Q 007160 451 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVA 530 (615)
Q Consensus 451 ~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~ 530 (615)
...+.+.|.|+|||+||||+.|+.||....... .+..++-..+.-.-..+....+.+||++.|.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999999997554321 1222222222111111344568899999999
Q ss_pred cCCCCCCC----HHHHHHH
Q 007160 531 PEANQRPT----MGEVVQS 545 (615)
Q Consensus 531 ~dP~~RPs----m~eVl~~ 545 (615)
.||++|.- +.||-+|
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999998 8888776
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=296.33 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=204.4
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|++.+.||+|+||.||++... ++..||+|++..... ...+.+.+|++++++++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 5788899999999999999965 688999999976543 345678999999999999999999998874 46889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 999999999999764322356899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
.. .......|++.|+|||.+....++.++||||||+++|+|++|+.||...... ........
T Consensus 156 ~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---------- 217 (258)
T cd08215 156 TV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILK---------- 217 (258)
T ss_pred Cc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhc----------
Confidence 32 1223356889999999999888999999999999999999999998643311 11111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ....+......+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 218 GQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 111222233458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.52 Aligned_cols=273 Identities=25% Similarity=0.308 Sum_probs=200.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+|++++++++|+||+++++++...+....++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999964 6899999998754322 2345678999999999999999999987655567899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+. ++|.+++... ...+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 4898888642 245899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hhHhh-------hhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVTWA-------RPIL 495 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~-l~~~~-------~~~~ 495 (615)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... +..+. ++.+
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 543221 123346788999998865 567899999999999999999999997543221110 00000 0000
Q ss_pred ccchhhhhhcCCccC-CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 496 RDKDRLEELADPRLG-GKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~-~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
...........+.-. ... .......+.+++.+||+.||++|||+.|++++-+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 000000000000000 000 001134567899999999999999999999875543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.54 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=202.2
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|++.+.||+|+||.||++... +++.+|+|.+..... .....+.+|++++++++|+||+++++++. +....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL--DGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc--cCCEEEEEe
Confidence 5788999999999999999854 678999999875432 23457889999999999999999999877 346899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999999999998653333356899999999999999999999999 99999999999999999999999999987655
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
.. .....++..|++||.+.+..++.++|+||||+++|||++|+.||...... .+.. ...
T Consensus 156 ~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~----------- 214 (256)
T cd08530 156 NM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY---KVQ----------- 214 (256)
T ss_pred CC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHh-----------
Confidence 41 12345888999999999988999999999999999999999999643311 1110 000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......+......+.+++.+||+.+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011111222334568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.20 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=199.4
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
.|...+.||+|++|.||++.. .+++.|++|++........+.+.+|+.++++++|+||+++++++. .....++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~--~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE--cCCeEEEEEec
Confidence 344558999999999999985 468899999987655555667899999999999999999999887 44588999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 98 LEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999999874 24889999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....+. ......... ..+.
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-------~~~~ 234 (285)
T cd06648 170 P--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-------LPPK 234 (285)
T ss_pred c--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-------CCCC
Confidence 1 122346899999999998888999999999999999999999998643321 111111100 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. .+......+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 235 LK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred Cc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11 111123458899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.76 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=198.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++. +....++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEE
Confidence 5788899999999999999965 57899999986542 233457889999999999999999999886 455889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 425 (615)
||+++++|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 79 EYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred ecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 9999999999997532 235799999999999999999999998 99999999999998875 57999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ...+......
T Consensus 154 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~--------- 216 (257)
T cd08225 154 DSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ--------- 216 (257)
T ss_pred CCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc---------
Confidence 4321 1123468899999999988889999999999999999999999986432 1111111111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... .........+.+++.+||+.+|++|||+.+++++
T Consensus 217 -~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 -GYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -ccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1110 1111223458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.25 Aligned_cols=269 Identities=20% Similarity=0.268 Sum_probs=195.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhcc-CCCcceEEEEeecCCC---Cc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDS---SQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~---~~ 341 (615)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++ |+||+++++++...+. ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47889999999999999999964 689999998865432 23467889999999995 6999999998764332 23
Q ss_pred eeEEEecCCCCChhHhhcCCCCC-cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEecc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFG 419 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFG 419 (615)
.+++|||+++ +|.+++...... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 899888643322 346899999999999999999999998 999999999999998 8999999999
Q ss_pred ccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||....... .+.......-...
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 99865432211 122356889999998865 457899999999999999999999996432111 1111000000000
Q ss_pred h-h---hhhhcC----CccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 D-R---LEELAD----PRLG----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ~-~---l~~i~d----~~l~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. . .....+ +... ..........+.+++.+||+.||.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0 000000 0000 00001123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.20 Aligned_cols=264 Identities=25% Similarity=0.310 Sum_probs=200.7
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-C-----CCcceEEEEeecCCCCce
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-H-----RNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-----pnIv~l~g~~~~~~~~~~ 342 (615)
+|++.+.||+|.||.|.++.. .+++.||||+++... .-..+-..|+.+|..|+ | -|+|++++|+.. .++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccce
Confidence 789999999999999999994 579999999998432 12345567999999997 4 489999999884 4589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC--CCcEEEEeccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGL 420 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkL~DFGl 420 (615)
|||+|.+ .-+|.++|+.+. ...++...+..++.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.
T Consensus 264 ciVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999 559999998744 345899999999999999999999999 999999999999965 34799999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh---------
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA--------- 491 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~--------- 491 (615)
|......-. ....+..|.|||++.+.+|+.+.||||||||++||++|.+-|......++...+..+
T Consensus 338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987655433 345677899999999999999999999999999999998877654433332211100
Q ss_pred ------hhhhcc----------ch------------hhhhhcCCc--------cCCCCCHHHHHHHHHHHHHccccCCCC
Q 007160 492 ------RPILRD----------KD------------RLEELADPR--------LGGKYPKEDFIRVCTIAAACVAPEANQ 535 (615)
Q Consensus 492 ------~~~~~~----------~~------------~l~~i~d~~--------l~~~~~~~~~~~l~~Li~~Cl~~dP~~ 535 (615)
...+.. .. ......+.. +.......+-..+.+++++||..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 000000 00 000000110 001112234456899999999999999
Q ss_pred CCCHHHHHHHHH
Q 007160 536 RPTMGEVVQSLK 547 (615)
Q Consensus 536 RPsm~eVl~~L~ 547 (615)
|+|..|.++|-+
T Consensus 493 R~tp~qal~Hpf 504 (586)
T KOG0667|consen 493 RITPAQALNHPF 504 (586)
T ss_pred cCCHHHHhcCcc
Confidence 999999998844
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.43 Aligned_cols=269 Identities=25% Similarity=0.339 Sum_probs=200.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC--CCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 342 (615)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +|+||+++++++...+....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4568899999999999999999965 6889999988643 223345678899999999 99999999999876556678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||++ ++|.+++... .++|..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5999998642 5789999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc---ccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhhh----
Q 007160 423 QAPEGRTN---YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL-VTWARP---- 493 (615)
Q Consensus 423 ~~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l-~~~~~~---- 493 (615)
........ .......||..|+|||++.+ ..++.++||||||+++|||++|+.||........... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 66543221 12234568999999998765 5678999999999999999999999964332111000 000000
Q ss_pred ---hhccchhhhhhcC----CccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 494 ---ILRDKDRLEELAD----PRLG--GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 494 ---~~~~~~~l~~i~d----~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+.. .....+.+ .... ..........+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKS-PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHh-hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 00000110 0000 00001123458899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.05 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=204.3
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
..+++|+..+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++++++|+|++++++++.. ....++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEE
Confidence 35667888899999999999999976 688999999976544 46778999999999999999999999874 358999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
++||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999999999997532 36899999999999999999999988 999999999999999999999999998755
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... ......++..|++||++.+..++.++||||||+++|||++|+.||....+.. . ....... ..
T Consensus 167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~----~~~~~~~--~~--- 233 (286)
T cd06614 167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--A----LFLITTK--GI--- 233 (286)
T ss_pred ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--H----HHHHHhc--CC---
Confidence 43221 1223457889999999988889999999999999999999999986432211 0 0000000 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
+.. ..+......+.+++.+||+.+|.+||++.+|+++..
T Consensus 234 --~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 234 --PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred --CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 000 001112345889999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=307.60 Aligned_cols=250 Identities=29% Similarity=0.397 Sum_probs=196.2
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.|+..+.||+|+||.||+|+. .++..||+|++...... ..+.+.+|++++++++|+|++++++++.. ....++|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEE
Confidence 477789999999999999995 46889999998754322 23568899999999999999999999874 4578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||++ |+|.+++... ...++|.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++....
T Consensus 104 ~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 104 MEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred EeCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 99996 5888877532 235899999999999999999999998 9999999999999999999999999987544
Q ss_pred CCCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
.. ....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ..+.. ...
T Consensus 177 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~~------ 238 (317)
T cd06635 177 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH----IAQ------ 238 (317)
T ss_pred Cc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHH----HHh------
Confidence 32 2346888999999874 457889999999999999999999998643211 00100 000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
..............+.+++.+||+.+|.+||++.+|++++..+.
T Consensus 239 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 239 ----NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ----ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00000111122345889999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=300.24 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=197.8
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
+|+..+.||+|++|.||+|+.. +|+.||||.+...... ..+.+.+|++++++++|+||+++++++.. ....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEe
Confidence 5888999999999999999975 6889999999765433 34567889999999999999999999874 457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++ +|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 79 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred cCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9985 89998864322 345899999999999999999999998 999999999999999999999999999765432
Q ss_pred CccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc--chhhhhh
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--KDRLEEL 504 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~~~l~~i 504 (615)
.. ......++..|++||++.+. .++.++||||||+++|||++|+.||........ ...... .... ......+
T Consensus 154 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~ 228 (284)
T cd07836 154 VN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFR-IMGTPTESTWPGI 228 (284)
T ss_pred cc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHH-HhCCCChhhHHHH
Confidence 21 11234578899999988654 568999999999999999999999975432211 110000 0000 0000000
Q ss_pred cC-CccCCCC-----------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 AD-PRLGGKY-----------PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 ~d-~~l~~~~-----------~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+ +...... .......+.+++.+|++.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000000 01123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.64 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=201.0
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
+|++.+.||.|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++. +....++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence 5888999999999999999975 589999999975432 33568999999999999999999999876 45589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 79 VDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred EeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 9999999999999752 35889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......... +.......
T Consensus 152 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~-------- 216 (258)
T cd05578 152 PDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET-------- 216 (258)
T ss_pred CCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhcc--------
Confidence 432 123356888999999999888999999999999999999999999754432111 11111110
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM--GEVVQ 544 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm--~eVl~ 544 (615)
.....+......+.+++.+||+.||.+||++ +|+++
T Consensus 217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0112222333568899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.62 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=198.1
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++...+....++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999965 58899999998653 233467889999999999999999999987543368999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8999886432 35899999999999999999999998 999999999999999999999999999876544
Q ss_pred CccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc--hhhhhh
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DRLEEL 504 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--~~l~~i 504 (615)
... ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ........... .....+
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGV 229 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccc
Confidence 321 1233457889999998765 4678999999999999999999999975432111 00000000000 000000
Q ss_pred --------c------CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 --------A------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 --------~------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. ...+...+.......+.+++.+||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 0000000001113468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=297.63 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=195.1
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 277 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
||.|+||.||+++.. +++.||+|.+..... ...+.+.+|++++++++|+||+++++++. +....++++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE--cCCccEEEEecCCCC
Confidence 699999999999975 488999999875432 23467999999999999999999999887 455889999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 432 (615)
+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++...... .
T Consensus 79 ~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~ 148 (262)
T cd05572 79 ELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---K 148 (262)
T ss_pred cHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---c
Confidence 999999752 34889999999999999999999988 9999999999999999999999999998775432 1
Q ss_pred ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 433 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 433 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
.....++..|++||.+....++.++|+||||+++|||++|..||...... ...... .+.+......
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----------~~~~~~~~~~ 214 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYN----------DILKGNGKLE 214 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHH----------HHhccCCCCC
Confidence 22346888999999998888999999999999999999999999754321 111111 1111111122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 545 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 545 (615)
++......+.+++.+||+.+|++||+ ++|++++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 23333456899999999999999999 6777664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.31 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=193.4
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. |+||+++++++. +....+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEEEEE
Confidence 5566788999999999999964 689999999875433 23457899999999996 999999999886 345788999
Q ss_pred ecCCCCChhHhhcCC-CCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 347 ELVPNGSLESWLHGP-LGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~-~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||+.. +|.++.... ......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99864 655543210 01124589999999999999999999975 6 999999999999999999999999999765
Q ss_pred CCCCccccceeeccccccCCccccccC---cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
..... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ............
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~---- 226 (288)
T cd06616 159 VDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG---- 226 (288)
T ss_pred ccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC----
Confidence 43321 1334688999999998766 68999999999999999999999996432 111111111100
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..+.+...........+.+++.+||+.+|++|||+.+|+++-
T Consensus 227 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 227 ---DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred ---CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 011121111122344688999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.11 Aligned_cols=271 Identities=23% Similarity=0.321 Sum_probs=196.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCC------
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------ 338 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 338 (615)
-++|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999964 689999999865432 22345678999999999999999999886432
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||+. ++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 235699999996 5888888642 235899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCcc--ccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-
Q 007160 419 GLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI- 494 (615)
Q Consensus 419 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~- 494 (615)
|++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..................
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866432211 112334678899999988664 4788999999999999999999999754432111111110000
Q ss_pred ----hccchhhh---hhcCCcc-----CCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 ----LRDKDRLE---ELADPRL-----GGK-YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 ----~~~~~~l~---~i~d~~l-----~~~-~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+....... .+..+.- ... .+......+.+++.+||+.||.+|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000 0000000 000 000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.93 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=200.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC--CCCchHHHHHHHHHHhhccCCCcceEEEEeecCC----C
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~ 339 (615)
..++|+..+.||+|+||.||+|+.. +|+.||+|.+... .....+.+.+|++++++++|+||+++++++.... .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999954 7899999998643 2233456888999999999999999999876332 2
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588888853 2788899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhh--------Hh
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLV--------TW 490 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~--------~~ 490 (615)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .+. .+
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998764322 123346889999999999999999999999999999999999999644321100 000 00
Q ss_pred hh-------hhhccc-----hhhhhhcCCcc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 491 AR-------PILRDK-----DRLEELADPRL----GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 491 ~~-------~~~~~~-----~~l~~i~d~~l----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. ...... ....++..... ....+......+.+++.+||+.||++|||+.|++++=+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 00 000000 00001110000 00111123446789999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.86 Aligned_cols=266 Identities=25% Similarity=0.345 Sum_probs=198.0
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCC---CCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~---~~~~ 342 (615)
+++|++.+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++...+ ....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 468999999986432 223456889999999999999999999875332 2357
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++++||++ ++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 488888763 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc--
Q 007160 423 QAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-- 498 (615)
Q Consensus 423 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-- 498 (615)
........ .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 65432211 11233568999999998754 568999999999999999999999996432111 111111111100
Q ss_pred hhhhhhcCCcc---------CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 DRLEELADPRL---------GGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ~~l~~i~d~~l---------~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+....+.+... ....+ ......+.+++.+||+.+|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111110000 00000 1113457899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.68 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=195.8
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
|++.+.||.|++|.||+|... +|..||+|++..... .....+.+|++++++++|+|++++++++. +....+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEEe
Confidence 567899999999999999964 789999999875432 22357889999999999999999999987 4468999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|++ ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.....
T Consensus 79 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 79 FLD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred ccC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 995 69999987532 135899999999999999999999988 999999999999999999999999999765432
Q ss_pred CccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch-------
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD------- 499 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~------- 499 (615)
... .....++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..+....+.......
T Consensus 153 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 153 VRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred ccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhh
Confidence 211 1223568899999987654 5789999999999999999999999644321 111111110000000
Q ss_pred hhhhhc-------CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 500 RLEELA-------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 500 ~l~~i~-------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+.+.. ..... .........+.+++.+||+.||.+||+++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00000 0011122457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=294.08 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=201.9
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC--CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+++|++.+.||+|.|+.||+... .+|+.+|+|++... ...+.+++.+|+++-+.|+|||||+|...+. +....||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeEE
Confidence 46788889999999999999874 57899999887643 2335678999999999999999999999876 4568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc---CCCcEEEEecccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLA 421 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkL~DFGla 421 (615)
|+|+|.|++|..-+-. ....++..+-..+.||+++|.|+|.++ |||||+||.|+||. ..--+||+|||+|
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999766543 234677888899999999999999999 99999999999994 3456999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
.....+. .....+||++|||||++...+|+..+|||+.||+||-|+.|+.||...+. ..+. .++......
T Consensus 161 i~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rly---e~I~~g~yd- 230 (355)
T KOG0033|consen 161 IEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY---EQIKAGAYD- 230 (355)
T ss_pred EEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHH---HHHhccccC-
Confidence 9887433 34567899999999999999999999999999999999999999975321 1111 112111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+++.-.. ...+...+|+.+||..||.+|.|+.|.++|-|.
T Consensus 231 ---~~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 231 ---YPSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred ---CCCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 1111111 222346789999999999999999999877553
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=300.07 Aligned_cols=243 Identities=25% Similarity=0.345 Sum_probs=186.7
Q ss_pred eeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhh---ccCCCcceEEEEeecCCCCceeEEEec
Q 007160 276 ILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSR---LHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 276 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~---l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
.||+|+||.||++... +++.||+|.+..... .....+.+|..++.. .+|+||+.+++++.. ....++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999964 688999998865422 122344555544443 479999999998874 4478999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 79 ~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 79 MNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999999864 235899999999999999999999999 9999999999999999999999999987554322
Q ss_pred ccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.....||..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+... .. ...
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~--------~~~- 215 (279)
T cd05633 152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL--------TVN- 215 (279)
T ss_pred ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh--------cCC-
Confidence 123468999999998864 5678999999999999999999999964432211111000 00 011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
...+......+.+++.+||+.||.+|| +++|+++|.
T Consensus 216 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 216 ---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred ---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 112223344688999999999999999 699998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.26 Aligned_cols=244 Identities=24% Similarity=0.413 Sum_probs=196.4
Q ss_pred ceeeeccCceEEEEEEEC-CCcEEEEEEeccC----CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 274 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
..+||+|.|-+||||.+. +|.+||--.++.. +....+.|..|+++|+.|+|+||++++.++.+.+.....+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 367999999999999964 5888885443321 22334789999999999999999999999987777778999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEeccccccCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~ 427 (615)
+..|+|..|+++. +.++.+.+..|+.||++||.|||++.+ +|+|||||.+||+|+. .|.|||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999864 357888999999999999999999864 5999999999999964 689999999999987654
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc--chhhhhhc
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--KDRLEELA 505 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~~~l~~i~ 505 (615)
. ...+.|||.|||||... ..|++..||||||+.++||+|+..||..-.... ...+.+... ...+..+-
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-----QIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-----QIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-----HHHHHHHcCCCHHHhhccC
Confidence 3 23478999999999776 899999999999999999999999997543221 111112111 11222222
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
| .++.++|.+|+.. .++|||+.|++++
T Consensus 270 d------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 D------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred C------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2 2478999999999 9999999999875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.02 Aligned_cols=267 Identities=19% Similarity=0.287 Sum_probs=194.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|+||+++++++. +....++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeEEEE
Confidence 57899999999999999999965 688999999865432 22457889999999999999999999987 44589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~ 424 (615)
|||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||+|+||++++ ++.+||+|||+++..
T Consensus 80 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred Eeccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99995 58888875422 223578888899999999999999998 999999999999985 567999999999765
Q ss_pred CCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhh----hhhccc
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWAR----PILRDK 498 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~~~~~----~~~~~~ 498 (615)
..... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ....+.. ..+...
T Consensus 154 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 154 GIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred CCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 43221 1123467889999998866 45789999999999999999999999754321110 0000000 000000
Q ss_pred hhhhhhcC--CccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 DRLEELAD--PRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ~~l~~i~d--~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+..... +.... .........+.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00000 0011123457899999999999999999999975
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.30 Aligned_cols=270 Identities=23% Similarity=0.362 Sum_probs=201.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecC--CCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~~ 342 (615)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++... +....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999954 68999999987542 23346788899999999999999999887532 33468
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+. |+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 699999864 234899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCc--cccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc--
Q 007160 423 QAPEGRT--NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-- 497 (615)
Q Consensus 423 ~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~-- 497 (615)
....... ........|+..|+|||.+.. ..++.++|||||||++|||++|+.||.......... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~---~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK---LILSVLGSPS 232 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH---HHHHHhCCCh
Confidence 6543221 112234578999999998865 468899999999999999999999996543211100 00000000
Q ss_pred --------chhhhhhcCC-ccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 498 --------KDRLEELADP-RLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 498 --------~~~l~~i~d~-~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
...+....+. ......+ ......+.+++.+||+.+|++||++.+++.+-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0001000000 0000111 1224568999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.52 Aligned_cols=248 Identities=31% Similarity=0.475 Sum_probs=201.2
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|++.+.||+|++|.||+++.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++. +....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE--TSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEEEEEE
Confidence 4788899999999999999865 678999999986644 34567999999999999999999999987 346889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 79 EYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred ecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 999999999999752 45899999999999999999999998 99999999999999999999999999987755
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
.... .....++..|+|||...+...+.++||||||+++|+|++|+.||...... ..... ... ...
T Consensus 152 ~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~-------~~~ 216 (254)
T cd06627 152 VSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFR-IVQ-------DDH 216 (254)
T ss_pred Cccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHH-Hhc-------cCC
Confidence 4321 23356889999999998888899999999999999999999998643211 10000 000 000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+ ..+......+.+++.+||+.+|++||++.+++.+
T Consensus 217 ~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 217 P----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred C----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1 1122223457899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.47 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=209.6
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.-|.+.+.||+|.|..|-+|+. -+|..||||++.+..... ...++.|++.|+-++|||||+|+.+.. ....+|||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD--TQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID--TQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc--ccceEEEE
Confidence 3477778999999999999983 479999999998664333 357889999999999999999999976 44589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE-cCCCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl-~~~~~vkL~DFGla~~~ 424 (615)
+|.-++|+|+||+-++. ..+.+....+++.||..|+.|+|... +|||||||+||.+ .+-|-+||.|||++..+
T Consensus 96 LELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 99999999999996533 34889999999999999999999999 9999999999875 67789999999999888
Q ss_pred CCCCccccceeeccccccCCccccccCcCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..+.. -+..+|...|-|||++.+..|+ ++.||||||||||-|++|+.||+... +.+.+..
T Consensus 170 ~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTm 230 (864)
T KOG4717|consen 170 QPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTM 230 (864)
T ss_pred CCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhh
Confidence 77653 3567899999999999999886 78999999999999999999997433 2234555
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
++|-+. ..|.....++.+||..||..||.+|.+.+||+.+
T Consensus 231 ImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 231 IMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 555433 4566667789999999999999999999999754
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=295.79 Aligned_cols=243 Identities=28% Similarity=0.428 Sum_probs=192.2
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 277 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|++++++++|+||+++++.+. +....+++|||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence 689999999999976 489999999875433 33467889999999999999999998876 455889999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc---
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT--- 429 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~--- 429 (615)
+|.++++.. ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 79 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 79 DLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 999999752 25899999999999999999999998 99999999999999999999999999876543321
Q ss_pred ---cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 430 ---NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 430 ---~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
........++..|++||.......+.++||||||+++|||++|+.||...... ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---------- 215 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN---------- 215 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc----------
Confidence 11223356888999999998888999999999999999999999999744321 11111111
Q ss_pred CccCCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 507 PRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 507 ~~l~~~~~~~--~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
... ..+.. ....+.+++.+||+.+|.+|||+.++.+.|
T Consensus 216 ~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 216 GKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 000 01111 134578999999999999999995554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.02 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=193.6
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCC----CC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~ 340 (615)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++|+||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999995 468999999987532 222356889999999999999999999876432 23
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++|+||+.. +|.+++. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 56899999964 7877653 24788999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-------- 491 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~-------- 491 (615)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 98653321 23467889999999876 46889999999999999999999999753321110000000
Q ss_pred hhhhccchhhhhhcC--Ccc-CCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 492 RPILRDKDRLEELAD--PRL-GGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d--~~l-~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
........ ...... +.. .... .......+.+++.+||+.||++||++++++.+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKA-AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccc-hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000000 000 0000 00122357899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=330.13 Aligned_cols=265 Identities=27% Similarity=0.443 Sum_probs=210.5
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC----C----CcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEE
Q 007160 264 LKEATNNFEPASILGEGGFGRVFKGVLS----D----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGY 333 (615)
Q Consensus 264 l~~~~~~f~~~~~LG~G~fG~Vykg~~~----~----g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~ 333 (615)
.+...++..+.+.||+|.||.|++|... . ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3344455566679999999999999843 1 45799999986543 3457899999999999 59999999999
Q ss_pred eecCCCCceeEEEecCCCCChhHhhcCCC---CCc---------ccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCC
Q 007160 334 YSSRDSSQHLLCYELVPNGSLESWLHGPL---GVN---------CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 401 (615)
Q Consensus 334 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~---~~~---------~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 401 (615)
|.. ....++|+||+..|+|.++|+..+ ... ..|+....+.++.|||.|++||++.. ++||||.
T Consensus 371 ~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 371 CTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred ecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 984 568999999999999999998655 111 13888999999999999999999998 9999999
Q ss_pred CCCeEEcCCCcEEEEeccccccCCCCCccccceeec--cccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 007160 402 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM--GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDM 478 (615)
Q Consensus 402 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~ 478 (615)
++|||++++..+||+|||+|+......... ..... -...|||||.+....|+.|+|||||||+||||+| |..||..
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999766544322 12122 4567999999999999999999999999999999 8889864
Q ss_pred CCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 479 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 479 ~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.. ....+.. .++++.++ ..|..+..++.++++.||+.+|++||++.++++.+....
T Consensus 525 ~~--~~~~l~~----~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 525 IP--PTEELLE----FLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CC--cHHHHHH----HHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11 0112221 23333322 334455567889999999999999999999999998853
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.05 Aligned_cols=267 Identities=24% Similarity=0.358 Sum_probs=198.5
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC--CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCC---Cc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~---~~ 341 (615)
.++|.+.+.||+|+||.||+|+. .+++.||||.+... .......+.+|+.++++++|+||+++++++..... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999995 46899999998753 22334567889999999999999999998764321 35
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 689998864 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhh-------
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL-VTWAR------- 492 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l-~~~~~------- 492 (615)
+....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||........... .....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 87644321 1233467889999998865 4688999999999999999999999964321110000 00000
Q ss_pred hhhccch---hhhhh---cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 493 PILRDKD---RLEEL---ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 493 ~~~~~~~---~l~~i---~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....... .+..+ .++... .........+.+++.+||+.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 00000 000000 0011223457899999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.22 Aligned_cols=273 Identities=20% Similarity=0.237 Sum_probs=188.2
Q ss_pred HhcCcccceeeeccCceEEEEEEECC--CcEEEEE------------------EeccCCCCchHHHHHHHHHHhhccCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSD--GTAVAIK------------------RLTCGGQQGDKEFLVEVEMLSRLHHRN 326 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK------------------~l~~~~~~~~~~f~~Ei~~l~~l~Hpn 326 (615)
..++|++.+.||+|+||+||++.++. +..+++| ++. ........+.+|+++|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 2222222 111 11122356889999999999999
Q ss_pred cceEEEEeecCCCCceeEEEecCCCCChhHhhcCCC-CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 327 Iv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~-~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
|+++++++.. ....++++|++ +++|.+++.... ..........+..++.|++.||.|||+.+ |+||||||+||
T Consensus 225 Iv~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 225 ILKIEEILRS--EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred cCcEeEEEEE--CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9999999874 44789999998 457888775321 11122345667889999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~P-f~~~~~~~~ 484 (615)
|++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..+ +........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 9999999999999999876543321 22345799999999999999999999999999999999998754 432221111
Q ss_pred chhhHhhhhhhcc-------chhhhhhcCCc-cC---CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 485 ENLVTWARPILRD-------KDRLEELADPR-LG---GKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 485 ~~l~~~~~~~~~~-------~~~l~~i~d~~-l~---~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
..+......+... ...+...++.. .. ...+. .....+.+++.+||+.||++|||+.|++++-+
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 2221111100000 00000000000 00 00000 01123667899999999999999999998643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.80 Aligned_cols=260 Identities=17% Similarity=0.210 Sum_probs=183.5
Q ss_pred cCcccceeeeccCceEEEEEEECC----CcEEEEEEeccCCCCch-----------HHHHHHHHHHhhccCCCcceEEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGD-----------KEFLVEVEMLSRLHHRNLVKLVGY 333 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~-----------~~f~~Ei~~l~~l~HpnIv~l~g~ 333 (615)
++|++.++||+|+||.||+|...+ +..+|+|.......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999999654 34566665433222111 112233344566789999999987
Q ss_pred eecCCC--CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 334 YSSRDS--SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 334 ~~~~~~--~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
+..... ...++++|++. .++.+.+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 653332 13467777764 3666666531 22567888999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 007160 412 HAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~ 486 (615)
.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 9999999999876432211 11123469999999999999999999999999999999999999997542211 1
Q ss_pred hhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 487 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
+...... +.+..+...... .......+.+++..|++.+|++||+++++++.|
T Consensus 242 ~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKC-----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHH-----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111000 011111111111 111234588999999999999999999998865
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.92 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=191.2
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 277 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
||+|+||+||++... +|+.||+|.+.... ......+.+|++++++++||||+++++++. .....++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE--TKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe--cCCeEEEEEecCCCC
Confidence 689999999999854 68899999986432 223456788999999999999999999887 345789999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 432 (615)
+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....... .
T Consensus 79 ~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 150 (277)
T cd05577 79 DLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---K 150 (277)
T ss_pred cHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---c
Confidence 9999997532 235889999999999999999999998 9999999999999999999999999997654321 1
Q ss_pred ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 433 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 433 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ...... .. ....
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~----------~~--~~~~ 216 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRRT----------LE--MAVE 216 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhcc----------cc--cccc
Confidence 223467889999999988889999999999999999999999996543211100 000000 00 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
.+......+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 2222234578999999999999999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.08 Aligned_cols=268 Identities=25% Similarity=0.351 Sum_probs=198.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCC----
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---- 338 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~---- 338 (615)
...++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 588999999975432 23356788999999999999999999886433
Q ss_pred ----CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 339 ----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 339 ----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
....++++||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 2378999999976 777777642 235899999999999999999999998 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+.....
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~~~- 232 (302)
T cd07864 157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELISR- 232 (302)
T ss_pred eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHH-
Confidence 9999999876543321 1123356788999998764 45789999999999999999999999743321 11111100
Q ss_pred hhccc--hhhhhh--------cC------CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 494 ILRDK--DRLEEL--------AD------PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 494 ~~~~~--~~l~~i--------~d------~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... .....+ .+ ....... ......+.+++.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 000000 00 0000000 0113458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=293.62 Aligned_cols=263 Identities=24% Similarity=0.300 Sum_probs=194.8
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhc---cCCCcceEEEEeecCCC---Cc
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL---HHRNLVKLVGYYSSRDS---SQ 341 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~~~~---~~ 341 (615)
|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+++++++ +|+|++++++++...+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999976 4899999999754322 234577788887766 59999999999875432 23
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 58999886532 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
........ .....++..|+|||++.+..++.++|+||||+++|||++|+.||...... +.+..+...... ....
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~ 228 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGL-PSEE 228 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCC-CChH
Confidence 87644321 12345788999999999989999999999999999999999998743321 111111110000 0000
Q ss_pred ---------hhhcCCccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 ---------EELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ---------~~i~d~~l~---~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
......... .....+....+.+++.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 00111223567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.74 Aligned_cols=274 Identities=22% Similarity=0.305 Sum_probs=203.2
Q ss_pred cCCHHHHHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEe
Q 007160 258 FLAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334 (615)
Q Consensus 258 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~ 334 (615)
.....++...+++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 344567778899999999999999999999985 578999999997532 22245688899999999999999999987
Q ss_pred ecCC----CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC
Q 007160 335 SSRD----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 410 (615)
Q Consensus 335 ~~~~----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 410 (615)
.... ....+++++++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 5322 23467888876 8899988863 24899999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 007160 411 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~ 489 (615)
+.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+..
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~ 229 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKL 229 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 99999999999865332 123467889999998866 567899999999999999999999996433211 1110
Q ss_pred hhhhhhccc-hhhhhh-----------cCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 490 WARPILRDK-DRLEEL-----------ADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 490 ~~~~~~~~~-~~l~~i-----------~d~~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
......... .....+ ........+ .......+.+++.+|++.||.+||++.+++.+-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000000000 000000 000000000 0011235789999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.91 Aligned_cols=255 Identities=28% Similarity=0.488 Sum_probs=194.7
Q ss_pred hcCcccceeeeccCceEEEEEEECC-CcEEEEEEeccCCC-CchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+|...+ ++.||||.+..... ....++..|+.++.+.. |+||+++++++. +....++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCeEEE
Confidence 3578889999999999999999764 89999999975432 23456777888777775 999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+|||+. ++|.+++... ...+++..+..++.|+++||+|||+ .+ |+||||+|+||++++++.+||+|||++..
T Consensus 92 v~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 92 CMELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EeeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 999985 5777776532 2368999999999999999999997 46 99999999999999999999999999976
Q ss_pred CCCCCccccceeeccccccCCccccccCc----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
....... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .......+...
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~- 235 (296)
T cd06618 165 LVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE- 235 (296)
T ss_pred ccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-
Confidence 6443221 2335788999999987553 789999999999999999999999642211 01111111110
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.+... ........+.+++.+||+.||++||++.+++++.+.
T Consensus 236 ------~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 236 ------PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred ------CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 00000 011123458899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.60 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=195.6
Q ss_pred ceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 274 ASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
..+||+|+||.||++.. .+++.||||++..........+.+|+.++++++|+|++++++++.. ....+++|||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCC
Confidence 36799999999999986 4689999999876555556679999999999999999999999874 45899999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 432 (615)
+|.+++.. ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 103 ~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~ 172 (292)
T cd06657 103 ALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 172 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence 99998853 24789999999999999999999998 99999999999999999999999999876543221 1
Q ss_pred ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 433 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 433 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
.....|+..|+|||++.+..++.++|+||||+++|||++|..||...... ....... ....+.+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~----------~~~~~~~~~- 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR----------DNLPPKLKN- 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----------hhCCcccCC-
Confidence 23356889999999998888899999999999999999999998643211 1111000 001111100
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 239 -~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 01122347889999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.09 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=206.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
-|.++++||+|+||.||++..+ .|..||+|++... .+.+++..|+.+|++.+.+++|+++|.|. ....+++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF--K~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF--KHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc--cCCceEeehhh
Confidence 4778899999999999999964 6999999998754 34789999999999999999999999876 45689999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
|--|++.|.++.. +++|++.++..++...++||+|||... -+|||||+.||||+.+|.+||+|||.|....+..
T Consensus 110 CGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 110 CGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred cCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 9999999999743 457999999999999999999999988 7999999999999999999999999998765432
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. ....+.||+.|||||++..-.|..++||||||++..||..|++||....+.... +. +..-.-|.
T Consensus 184 A--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------FM----IPT~PPPT 248 (502)
T KOG0574|consen 184 A--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------FM----IPTKPPPT 248 (502)
T ss_pred H--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------Ee----ccCCCCCC
Confidence 2 235678999999999999999999999999999999999999999754433211 00 00000111
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. .-|.+-...+-+++++||-..|++|-|+.++++|
T Consensus 249 F--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 F--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred C--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 1234445568899999999999999999999876
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.34 Aligned_cols=273 Identities=25% Similarity=0.366 Sum_probs=206.3
Q ss_pred cccceeeeccCceEEEEEE-ECCCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCC----CCceeE
Q 007160 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQHLL 344 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~~~L 344 (615)
+...+.||+|+||.||+|+ ..+|+.||||.+.... ....+.+.+|+++|++++|+|||+++++-.... .....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556889999999999999 5679999999998644 334577999999999999999999999855444 456789
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc--CCC--cEEEEeccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE--NNF--HAKVADFGL 420 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~--~vkL~DFGl 420 (615)
+||||.+|||...|..+.+ ...|++.+.+.++.+++.||.|||+++ |+||||||.||++- ++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999998765 356999999999999999999999999 99999999999983 333 479999999
Q ss_pred cccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
|+...++. .....+||..|++||.+.. +.|+..+|.|||||++||++||..||..........-+.|.. ..+...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-ITKKPS 246 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-hccCCC
Confidence 99987765 4567899999999999984 889999999999999999999999996544322111111211 111111
Q ss_pred hhhhhcCCccC------------CCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhHh
Q 007160 500 RLEELADPRLG------------GKYPKEDFIRVCTIAAACVAPEANQRP--TMGEVVQSLKMVQR 551 (615)
Q Consensus 500 ~l~~i~d~~l~------------~~~~~~~~~~l~~Li~~Cl~~dP~~RP--sm~eVl~~L~~i~~ 551 (615)
......++... .........++-..+..+|..+|++|- ...+....+..|.+
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11111111111 112233345566677777888888887 66666666655544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.43 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=201.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++ |+||+++++++. +....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence 47889999999999999999965 68999999987532 223467889999999998 999999999876 455889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 79 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 999999999999999752 35999999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCcc------------------ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007160 424 APEGRTN------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 485 (615)
Q Consensus 424 ~~~~~~~------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~ 485 (615)
....... .......++..|+|||......++.++||||||++++|+++|+.||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 228 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--- 228 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---
Confidence 6433210 1122346789999999998888999999999999999999999999744310
Q ss_pred hhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 007160 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM----GEVVQS 545 (615)
Q Consensus 486 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm----~eVl~~ 545 (615)
.. .. .+.+ .....+......+.+++.+||+.+|.+||++ ++++++
T Consensus 229 ~~---~~----------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 229 LT---FQ----------KILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH---HH----------HHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00 00 0110 1112222334468899999999999999999 777754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.45 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=197.8
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
|+..+.||+|++|.||+|... +++.+++|++...... ....+.+|++++++++|+||+++++++. +....++++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEe
Confidence 566789999999999999964 6889999998754332 3467889999999999999999999987 4468999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++ +|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+......
T Consensus 79 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 79 FMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred ccCC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 9975 888888642 246899999999999999999999998 999999999999999999999999999876554
Q ss_pred CccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh-H-------hhhhhhcc-
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-T-------WARPILRD- 497 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~-~-------~~~~~~~~- 497 (615)
.. ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............ . ..+..+..
T Consensus 152 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 152 VR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred cc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 31 12234678899999998876 7899999999999999999999999654321110000 0 00000000
Q ss_pred -chhhhhhcCCccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 -KDRLEELADPRLG--GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 -~~~l~~i~d~~l~--~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
........+.... ..........+.+++.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000000 00111234568999999999999999999999865
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.71 Aligned_cols=271 Identities=25% Similarity=0.335 Sum_probs=196.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCC------
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------ 338 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 338 (615)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999964 6889999998654322 2346789999999999999999998875322
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
...+++|+||+.+ +|.+.+... ...+++.++..++.|+++||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 2357999999965 787777642 235899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccc---------cceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 007160 419 GLAKQAPEGRTNY---------LSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 488 (615)
Q Consensus 419 Gla~~~~~~~~~~---------~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~ 488 (615)
|+++......... ..+...++..|+|||.+.+. .++.++||||||+++|||++|+.||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9998654322111 11234678899999987654 5789999999999999999999999643321111100
Q ss_pred -Hhhhh----hhccchhhhhhcCCccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 489 -TWARP----ILRDKDRLEELADPRLGGKYP-------KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 489 -~~~~~----~~~~~~~l~~i~d~~l~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... .+.....+....+.......+ ......+.+++.+||+.||.+|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000 000000000000000000000 0111457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=291.45 Aligned_cols=250 Identities=23% Similarity=0.282 Sum_probs=191.5
Q ss_pred HHHHHHhcCcccceee--eccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecC
Q 007160 262 EELKEATNNFEPASIL--GEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 337 (615)
Q Consensus 262 ~el~~~~~~f~~~~~L--G~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 337 (615)
.+.....++|++.+.+ |+|+||.||+++. .++..+|+|.+....... .|+.....+ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 3445556777777776 9999999999995 467889999986432211 122222222 69999999999874
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEE
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVA 416 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~ 416 (615)
....++||||+++|+|.+++... ..++|..++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+
T Consensus 81 -~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 -LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred -CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence 44899999999999999999752 26899999999999999999999998 99999999999999988 99999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|||+++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+....
T Consensus 153 dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-- 223 (267)
T PHA03390 153 DYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-- 223 (267)
T ss_pred cCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--
Confidence 999987654321 2358899999999999899999999999999999999999997433211 1112221111
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-m~eVl~~ 545 (615)
.... .........+.+++.+||+.+|.+||+ ++|++++
T Consensus 224 ---------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 ---------QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0000 111123345889999999999999995 6998865
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=294.76 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=195.2
Q ss_pred CcccceeeeccCceEEEEEEE----CCCcEEEEEEeccCCC----CchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCC
Q 007160 270 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQ----QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~~----~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 340 (615)
+|++.+.||+|+||.||++.. .+|+.||+|++..... ...+.+.+|++++.++ +|+||+++++++. ...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCC
Confidence 478889999999999999985 3688999999875321 2246688899999999 5999999998876 345
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred eEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence 78999999999999999974 235788999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccC--cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
++........ ......|+..|+|||.+... .++.++||||||+++|||++|+.||...... .....+.......
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~- 227 (290)
T cd05613 152 SKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS- 227 (290)
T ss_pred ceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc-
Confidence 9876443211 12235689999999998753 4678999999999999999999999643221 1111111111110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
. ..++......+.+++.+||+.||++|| ++.+++.+
T Consensus 228 -------~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -------E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 112222334578999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.39 Aligned_cols=250 Identities=27% Similarity=0.384 Sum_probs=194.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+.|+..+.||+|+||.||+|+.. ++..||+|.+..... ...+++.+|++++++++|+|++++++++.. ....++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEE
Confidence 34777789999999999999964 678899999864322 223568899999999999999999999874 457899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 93 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999996 6888877532 234889999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
... ....++..|+|||++. ...++.++|||||||++|||++|+.||....... ....+ ...
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~----~~~---- 229 (308)
T cd06634 166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI----AQN---- 229 (308)
T ss_pred cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHH----hhc----
Confidence 432 2346788999999874 3567889999999999999999999985322110 00000 000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
..+.. ........+.+++.+||+.+|++||++.+|+++.+..
T Consensus 230 ---~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 230 ---ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ---CCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 00111 1112234578999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=299.87 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=192.9
Q ss_pred eeeecc--CceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEG--GFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G--~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
..||+| +||+||++.. .+|+.||+|.+...... ..+.+.+|+.+++.++|+||+++++++.. ....++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 456666 9999999996 47899999998754322 23678899999999999999999999874 45789999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
.+|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+........
T Consensus 82 ~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 82 AYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 9999999997532 234888999999999999999999998 99999999999999999999999986543322111
Q ss_pred c----c-cceeeccccccCCccccccC--cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh---------
Q 007160 430 N----Y-LSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP--------- 493 (615)
Q Consensus 430 ~----~-~~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~--------- 493 (615)
. . ......++..|+|||++.+. .++.++|||||||++|||++|+.||....... .+......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccc
Confidence 0 0 01112356679999998763 57899999999999999999999996432111 00000000
Q ss_pred hhccc----------------------hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 494 ILRDK----------------------DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 494 ~~~~~----------------------~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..... .....+.+..+...........+.+|+.+||+.||++|||+.|++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 00000 00000111111122223345678999999999999999999999988553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=292.07 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=193.5
Q ss_pred CcccceeeeccCceEEEEEEECC-CcEEEEEEeccC-----CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
+|.+.+.||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++++. +....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCceE
Confidence 47888999999999999998643 444555555431 1223346778999999999999999999886 445789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++++|.+++.........+++..++.++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||+++.
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceee
Confidence 999999999999998643333456899999999999999999999998 999999999999986 4699999999977
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... ...........
T Consensus 155 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~------ 220 (260)
T cd08222 155 LMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG------ 220 (260)
T ss_pred cCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC------
Confidence 644322 1233468889999999988888999999999999999999999986322 11111111100
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+ ..+......+.+++.+||+.+|++||++.|++++
T Consensus 221 -~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 -PTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 011 1223334468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=315.57 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=200.6
Q ss_pred CcccceeeeccCceEEEEEEECC-CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 270 NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
-|++...||.|+||.||+|+.++ +...|.|.+...+....++|+-||+||+...||+||+|++.|... +.++++.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEEee
Confidence 46677889999999999999654 455677888776667778999999999999999999999976643 478999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
|.||-.+..+-. ....|+..++.-++.|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+.......
T Consensus 111 C~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred cCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 999999988753 2456999999999999999999999999 9999999999999999999999999986543321
Q ss_pred ccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 429 TNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.....+.||++|||||+.+ ..+|+.++||||||++|.||..+.+|-.... .......+..
T Consensus 185 --qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKiaK------- 249 (1187)
T KOG0579|consen 185 --QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAK------- 249 (1187)
T ss_pred --hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHhh-------
Confidence 2335678999999999875 4578999999999999999999999865322 1211111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
--.|.+ ..|..-...+.+++.+||..||..||+++++++|-
T Consensus 250 SePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 250 SEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred cCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 111111 12333345688999999999999999999998763
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.96 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=192.1
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEEeccC--CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++. +....+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccC
Confidence 344555666666666655 6899999999754 2334467999999999999999999999887 4457899999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc-
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT- 429 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~- 429 (615)
+|+|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 83 YGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999997532 234788999999999999999999998 99999999999999999999999999875532211
Q ss_pred ----cccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh----hhccc-
Q 007160 430 ----NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP----ILRDK- 498 (615)
Q Consensus 430 ----~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~----~~~~~- 498 (615)
........++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+...... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCc
Confidence 111233457889999999876 357899999999999999999999997533211 11110000 00000
Q ss_pred -----hhhhh----hcCCcc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 499 -----DRLEE----LADPRL----GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 499 -----~~l~~----i~d~~l----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
..... ..++.. ...........+.+++.+||+.||++|||+++++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00000 000000 01112222346889999999999999999999998744
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=294.33 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=195.3
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEEe
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
|++.+.||+|+||.||+|+.. +++.||||++...... ......+|+..+++++ |+|++++++++.. ....++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 567899999999999999975 5788999998754322 2334567999999999 9999999999874 568999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+ +|+|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 79 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 79 YM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred cC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 99 889999987532 235899999999999999999999998 999999999999999999999999999866443
Q ss_pred CccccceeeccccccCCccccc-cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhh----hhccchhh
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LVTWARP----ILRDKDRL 501 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~-l~~~~~~----~~~~~~~l 501 (615)
.. .....++..|+|||++. ...++.++|+||||+++|||++|+.||.......... ...+... .+.+...+
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 153 PP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred CC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 21 12346788999999875 4557899999999999999999999986443211100 0000000 00000000
Q ss_pred hhhcCCccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGG-------KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~-------~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....+..... .........+.+++.+||+.+|++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 0001113468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=300.33 Aligned_cols=268 Identities=23% Similarity=0.275 Sum_probs=193.9
Q ss_pred CcccceeeeccCceEEEEEEEC-C--CcEEEEEEeccCC--CCchHHHHHHHHHHhhc-cCCCcceEEEEeecC--CCCc
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-D--GTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR--DSSQ 341 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~--g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~--~~~~ 341 (615)
+|++.+.||+|+||.||+++.. + +..||+|++.... ....+.+.+|+++++++ +|+||+++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999964 3 7789999987432 22246788999999999 599999999875422 2345
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++++||+. ++|.+++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788888885 689999864 335899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCcc--ccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-hh--------H
Q 007160 422 KQAPEGRTN--YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-LV--------T 489 (615)
Q Consensus 422 ~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~-l~--------~ 489 (615)
+........ .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 11234578999999998765 468999999999999999999999997543211000 00 0
Q ss_pred hhhhhhccch-hh-hh---hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 490 WARPILRDKD-RL-EE---LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 490 ~~~~~~~~~~-~l-~~---i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
+......... .. .. .....+.. ........+.+++.+||+.||++|||+.+++++=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000 00 00 00000000 0011124588999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=292.50 Aligned_cols=242 Identities=25% Similarity=0.343 Sum_probs=186.0
Q ss_pred eeeccCceEEEEEEE-CCCcEEEEEEeccCCCC---chHHHHHHHHH---HhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 276 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEM---LSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 276 ~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~~---l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
.||+|+||.||++.. .+++.||+|.+...... ....+..|..+ ++...|+||+++++++. +....++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee--cCCEEEEEEec
Confidence 489999999999985 46889999998754322 12234455444 34457999999999887 44588999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 79 ~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 79 MNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999999999864 235899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.....|+..|+|||.+.++ .++.++||||||+++|||++|+.||............ ... .....
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~--------~~~~~ 216 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT--------LTMAV 216 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHh--------hccCC
Confidence 1234689999999998754 6899999999999999999999999754322111100 000 00111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
. .+......+.+++.+|+..+|.+|| ++.+++++
T Consensus 217 ~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 E----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred C----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1 1222234688999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.44 Aligned_cols=244 Identities=30% Similarity=0.422 Sum_probs=191.0
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
|...+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|++++++++|+|++++++++.. ....++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEE
Confidence 566688999999999999964 6889999998754332 23568899999999999999999999874 45789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+. |+|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 101 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 9995 5888877532 235899999999999999999999998 99999999999999999999999999865332
Q ss_pred CCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
. ....|+..|+|||++. ...++.++|||||||++|||++|..||....... ........
T Consensus 174 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~------ 235 (313)
T cd06633 174 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN------ 235 (313)
T ss_pred C------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhc------
Confidence 1 2346889999999874 4568899999999999999999999986432211 01101000
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+... .......+.+++.+||+.+|.+||++.+++++
T Consensus 236 -~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 -DSPTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001110 11112347889999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=293.84 Aligned_cols=255 Identities=25% Similarity=0.328 Sum_probs=196.7
Q ss_pred CcccceeeeccCceEEEEEEE----CCCcEEEEEEeccCC----CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCC
Q 007160 270 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 340 (615)
+|++.+.||+|+||.||+++. .+++.||||.+.... ....+.+.+|++++.++ +|+||+++++.+. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence 477889999999999999984 357889999987432 22345688999999999 5999999998876 445
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred EEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcc
Confidence 78999999999999999864 235888999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCc--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
++........ ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ............
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~- 227 (288)
T cd05583 152 SKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS- 227 (288)
T ss_pred cccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-
Confidence 8875443221 122346889999999987654 7889999999999999999999996332111 111111111110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.+ ..+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 228 -------~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -------KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01 1122223457899999999999999998888765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=299.31 Aligned_cols=266 Identities=25% Similarity=0.316 Sum_probs=199.5
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 264 LKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 264 l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
+...+++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLE 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-CCC
Confidence 3456789999999999999999999854 78999999886432 2234678899999999999999999998863 234
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++++||+ +++|.++++. ..+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 788999998 5699988863 24778888999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhh--------Hh
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLV--------TW 490 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~--------~~ 490 (615)
++...... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||......... .+. ++
T Consensus 155 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 155 ARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred ccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 97543221 23457889999998766 56899999999999999999999999644321100 000 01
Q ss_pred hhhhhccchhhhhhcCCccCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...... ......+..-......+. .....+.+++.+||+.+|++||++.+++.+
T Consensus 230 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 110000 011111111111111111 123468899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=300.63 Aligned_cols=265 Identities=22% Similarity=0.348 Sum_probs=196.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCC---
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--- 339 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~--- 339 (615)
...++|++.+.||+|+||.||+|.. .++..||||++..... ...+.+.+|++++++++|+||+++++++.....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999985 4789999999864322 223568899999999999999999998864321
Q ss_pred -CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 340 -SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 340 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
...++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 2468999999 7799988863 35889999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhh--------
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLV-------- 488 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~-------- 488 (615)
|+++...... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... .+.
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9998654321 23467889999998876 46889999999999999999999999743321100 000
Q ss_pred Hhhhhhhccc--hhhhhhcC---CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 489 TWARPILRDK--DRLEELAD---PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 489 ~~~~~~~~~~--~~l~~i~d---~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+...+.... .....+.. ..+ ..........+.+++.+|++.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00000000 000 00001122347899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=288.57 Aligned_cols=241 Identities=22% Similarity=0.280 Sum_probs=183.9
Q ss_pred eeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHH-hhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEML-SRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l-~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|... +++.||||.+...... ....+..|..++ ...+|+|++++++++. +....++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence 56999999999999864 6889999998754321 123345555554 4558999999999987 445899999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 80 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 80 NGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 999999999642 35888999999999999999999998 99999999999999999999999999876433
Q ss_pred cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc
Q 007160 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l 509 (615)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...... .......... ...
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--------~~~ 212 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRR--------INW 212 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcc--------cCC
Confidence 12346888999999998888899999999999999999999999643221 1111110000 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007160 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544 (615)
Q Consensus 510 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 544 (615)
...........+.+++.+||+.+|++||++.++.+
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 00111122345889999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.04 Aligned_cols=269 Identities=26% Similarity=0.323 Sum_probs=200.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCC---CCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~---~~~~~ 343 (615)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ....+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999965 58999999987543 334567999999999999999999999876432 23689
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++|||++ ++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 5899988742 26899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcc-ccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhhh----hh-
Q 007160 424 APEGRTN-YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL-VTWARP----IL- 495 (615)
Q Consensus 424 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l-~~~~~~----~~- 495 (615)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........... ...... .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 6544210 112345688899999999887 889999999999999999999999965432111000 000000 00
Q ss_pred -ccchhhhhhcCC-ccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 496 -RDKDRLEELADP-RLGG-----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 496 -~~~~~l~~i~d~-~l~~-----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
............ .... .........+.+++.+||+.+|++||++.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 000000000000 0000 00111234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.48 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=195.5
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCC--------
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS-------- 339 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~-------- 339 (615)
.+|++.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++|+||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6799999999999999999996 4688999999977666666789999999999999999999987653321
Q ss_pred ----CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc-CCCcEE
Q 007160 340 ----SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAK 414 (615)
Q Consensus 340 ----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vk 414 (615)
...++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 24689999997 599988863 24889999999999999999999998 99999999999997 456799
Q ss_pred EEeccccccCCCCCcc-ccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 007160 415 VADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 415 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
|+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999765332111 11123457889999998754 567899999999999999999999996443211110000000
Q ss_pred hhhcc--chh----hhh-hcCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 493 PILRD--KDR----LEE-LADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 493 ~~~~~--~~~----l~~-i~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.... ... ... ..........+ ......+.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 000 000 00000000000 1122457899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=290.79 Aligned_cols=260 Identities=26% Similarity=0.346 Sum_probs=196.7
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+|++++++++. +....++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH--TERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh--cCCceEEEec
Confidence 566788999999999999965 58999999998653 233467889999999999999999999987 4468999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|++ ++|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||+++.....
T Consensus 79 ~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 79 YCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred CcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 997 59999997532 35899999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc--------
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-------- 498 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-------- 498 (615)
... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ + ......+...
T Consensus 152 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 152 LRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ--L-FKIFQILGTPTEESWPGV 226 (282)
T ss_pred ccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H-HHHHHHhCCCcHHHHHhh
Confidence 221 1234567889999998776 789999999999999999999999965332111 0 0000000000
Q ss_pred -------hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 -------DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 -------~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...............+ .....+.+++.+||+.||++||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000000001 113468999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.45 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=194.2
Q ss_pred cCcc-cceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc--------------hHHHHHHHHHHhhccCCCcceEEE
Q 007160 269 NNFE-PASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--------------DKEFLVEVEMLSRLHHRNLVKLVG 332 (615)
Q Consensus 269 ~~f~-~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--------------~~~f~~Ei~~l~~l~HpnIv~l~g 332 (615)
++|. +.+.||+|+||.||+|... +++.||||.+....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3577999999999999964 68999999986543221 125788999999999999999999
Q ss_pred EeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc
Q 007160 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 412 (615)
Q Consensus 333 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 412 (615)
++. .....+++|||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.
T Consensus 88 ~~~--~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 88 VYV--EGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEe--cCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 987 4458899999996 699999864 235889999999999999999999998 999999999999999999
Q ss_pred EEEEeccccccCCCCCc------------cccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007160 413 AKVADFGLAKQAPEGRT------------NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMS 479 (615)
Q Consensus 413 vkL~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~ 479 (615)
+||+|||+++....... ........++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999976541110 0111223568899999998764 4689999999999999999999999754
Q ss_pred CCCCcchhhHhhhhhhccch--------hhh------hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 480 QPSGQENLVTWARPILRDKD--------RLE------ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 480 ~~~~~~~l~~~~~~~~~~~~--------~l~------~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... .......+.... .+. ....+... .........+.+++.+||+.+|++||+++|++.+
T Consensus 238 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 238 NEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 32211 111100000000 000 00000000 0001123457899999999999999999999976
Q ss_pred HH
Q 007160 546 LK 547 (615)
Q Consensus 546 L~ 547 (615)
-+
T Consensus 314 ~~ 315 (335)
T PTZ00024 314 EY 315 (335)
T ss_pred cc
Confidence 44
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=334.59 Aligned_cols=254 Identities=28% Similarity=0.373 Sum_probs=199.5
Q ss_pred HhcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 267 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.+-++.....||.|.||.||-|. .++|+..|||.+.... ....+.+.+|..+|..++|||+|+++|+-. +...++
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv--HRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV--HREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee--cHHHHH
Confidence 45567778899999999999998 6679999999887443 233467889999999999999999999866 455889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
|.||||++|+|.+.+... ...++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..
T Consensus 1311 IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999742 23556666778899999999999999 99999999999999999999999999988
Q ss_pred CCCCCcc--ccceeeccccccCCccccccC---cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 424 APEGRTN--YLSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 424 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
....... ..-...+||+.|||||++.+. ....+.||||+|||++||+||++||..-+. .|+..+--..
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAA 1456 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhc
Confidence 7654211 112346899999999999753 456789999999999999999999964332 1221111110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+ -. ...|......-.+++.+||..||++|-++.|++++
T Consensus 1457 g-----h~----Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 G-----HK----PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred c-----CC----CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 11 12333344456789999999999999888888765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.83 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=196.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCC----
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---- 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~---- 339 (615)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999975 57899999986432 2234567889999999999999999987653221
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...++|+||+ +++|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 3489999998 6799999864 35899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc-
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD- 497 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~- 497 (615)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +. ........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~-~i~~~~~~~ 235 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LK-RIMNLVGTP 235 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HH-HHHHhcCCC
Confidence 99866432 123467889999998865 4678999999999999999999999964432110 00 00000000
Q ss_pred ---------chhhhhhcCC---ccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 ---------KDRLEELADP---RLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ---------~~~l~~i~d~---~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......... .....+ .......+.+++.+||+.+|++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000 000000 00113468899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=304.31 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
...|.+...||+|.|+.|.+|+. .++..||+|.+.+..... .+.+.+|+++|+.++|||||+++.+... ...+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEE
Confidence 46788999999999999999995 468999999998654322 3458899999999999999999999874 458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+.+|.+++||..+ ..+.......++.|+.++++|||+++ |+|||||++||||+.+..+||+|||++..+
T Consensus 133 V~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999753 34566888899999999999999999 999999999999999999999999999887
Q ss_pred CCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..+. .....+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+...- ...-.+.++.+.++
T Consensus 206 ~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------k~Lr~rvl~gk~rI-- 274 (596)
T KOG0586|consen 206 DYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------KELRPRVLRGKYRI-- 274 (596)
T ss_pred cccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------ccccchheeeeecc--
Confidence 6433 3356789999999999998877 5899999999999999999999984331 11111122222211
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+.-....+.++++++|-.+|.+|++++++.++-|.
T Consensus 275 ----------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 275 ----------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred ----------cceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 11112346789999999999999999999887654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=281.02 Aligned_cols=239 Identities=29% Similarity=0.379 Sum_probs=192.0
Q ss_pred eeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCC
Q 007160 277 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 277 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
||+|+||.||++... +++.+|+|.+...... ....+..|++++++++|+||+++++.+. +....+++|||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCCC
Confidence 699999999999965 5889999998754332 3457899999999999999999999876 455899999999999
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 432 (615)
+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 79 ~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~ 149 (250)
T cd05123 79 ELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R 149 (250)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence 999999752 25899999999999999999999988 99999999999999999999999999987654321 2
Q ss_pred ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 433 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 433 ~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
.....++..|++||...+...+.++|+||||+++|||++|+.||..... ... ...... .. ..
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~---~~~~~~----------~~--~~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI---YEKILK----------DP--LR 211 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHhc----------CC--CC
Confidence 2345688899999999888889999999999999999999999964432 111 111111 01 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH---HHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPTM---GEVVQ 544 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPsm---~eVl~ 544 (615)
.+......+.+++.+||..||++||++ .++.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 222223457899999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=322.16 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=190.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecC------
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------ 337 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------ 337 (615)
.-..+|+.+++||+||||.|||++.+ ||+.||||++.... ........+|+..|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45678999999999999999999954 89999999998654 22235688899999999999999987322100
Q ss_pred ----------------------------------------------------------------------C---------
Q 007160 338 ----------------------------------------------------------------------D--------- 338 (615)
Q Consensus 338 ----------------------------------------------------------------------~--------- 338 (615)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHH
Q 007160 339 --------------------------------SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386 (615)
Q Consensus 339 --------------------------------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~y 386 (615)
...+||=||||+..+|.++++.+.-.. .-...|+++.+|+.||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 023678899999988888887532110 357789999999999999
Q ss_pred hHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC----------------CCCccccceeeccccccCCcccccc
Q 007160 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP----------------EGRTNYLSTRVMGTFGYVAPEYAMT 450 (615)
Q Consensus 387 LH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~APE~~~~ 450 (615)
+|+.+ ||||||||.||+|+++..|||+|||+|.... .+......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998721 0111123456789999999999875
Q ss_pred C---cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC--CCHHHHHHHHHHH
Q 007160 451 G---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK--YPKEDFIRVCTIA 525 (615)
Q Consensus 451 ~---~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~--~~~~~~~~l~~Li 525 (615)
. .|+.|+|+||+||||+||+. ||.... +.. ..+..+.+..+... +.......=..+|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa-------------~iL~~LR~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERA-------------SILTNLRKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchH--HHH-------------HHHHhcccCCCCCCcccccccchHHHHHH
Confidence 4 59999999999999999985 454221 111 11222222222211 2222333346899
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 007160 526 AACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 526 ~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.++++.||++|||+.|+++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHhcCCCccCCCHHHHhhc
Confidence 99999999999999999853
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=277.59 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=192.8
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEEe
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.+.+..||.|..|.||+.+.. +|..+|||.+...+. .+.+.++..++++.+-+ .|.||+.+|||.. ...++++||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHHHHHH
Confidence 344577999999999999964 689999999986543 34567888888877765 8999999999984 347889999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
.| ...++.+|+.. ..++.+..+-++...+.+||.||.+++. |+|||+||+|||+|+.|.+||||||++-..-+.
T Consensus 172 lM-s~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LM-STCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HH-HHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecc
Confidence 99 44566666532 3457778888999999999999987653 999999999999999999999999999877654
Q ss_pred CccccceeeccccccCCcccccc---CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.. .++..|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.....+- + ....++.+.
T Consensus 246 kA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e----~ltkvln~e------ 311 (391)
T KOG0983|consen 246 KA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-E----VLTKVLNEE------ 311 (391)
T ss_pred cc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-H----HHHHHHhcC------
Confidence 43 356689999999998863 478899999999999999999999997543221 1 111111110
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
-|.+.+. ......+++++..||+.|+.+||.+.++++|
T Consensus 312 -PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 -PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1222211 1123358899999999999999999999876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=315.51 Aligned_cols=145 Identities=28% Similarity=0.392 Sum_probs=128.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|++++..++|+||+++++++. .....+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ--SANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE--ECCEEEE
Confidence 67999999999999999999975 6899999999754322 2357889999999999999999998876 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
||||+++++|.++++.. ..+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999642 34788999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=292.39 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=201.9
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.+.|+.-++||+||||.||-.+. .+|+.+|.|++.+.. .++..--++|-.||.+++.+.||.+--.|. ....++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe--Tkd~LC 261 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE--TKDALC 261 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec--CCCceE
Confidence 46788889999999999999985 469999999886432 333455788999999999999999865555 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
||+..|.||+|.-+|.... +..+++..++-++.+|+-||++||+.. ||.||+||+|||||+.|+++|+|+|||..
T Consensus 262 lVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999999997643 246899999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
+.++... ...+||.+|||||++.++.|+...|.||+||+||||+.|+.||......... .+.-+..+.+
T Consensus 337 i~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eEvdrr~~~~------ 405 (591)
T KOG0986|consen 337 IPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EEVDRRTLED------ 405 (591)
T ss_pred cCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HHHHHHHhcc------
Confidence 8876532 3448999999999999999999999999999999999999999643211100 0000111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 545 (615)
...++....+...+|....|+.||++|.- +++|.+|
T Consensus 406 ------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 406 ------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 12344444556778888999999999964 4566554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.69 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=199.2
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.-++|+.+++||+|.||+|-+++- .+++.+|+|++++.-.-. ...-+.|-++|+..+||.+..|.-.+. ....+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ--t~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ--TQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc--cCceE
Confidence 347899999999999999999984 478999999998654322 234567999999999999988865554 45589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||..||.|.-+|.. ...+++....-+...|..||.|||+.+ ||.||||.+|.|||+||++||+||||++
T Consensus 244 CFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence 999999999999999875 345788888889999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
.--... ..+...+||+.|+|||++....|....|.|.+||++|||++|+.||...+.. .+... ++ ++
T Consensus 317 E~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeL---Il-----~e 383 (516)
T KOG0690|consen 317 EEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFEL---IL-----ME 383 (516)
T ss_pred hccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHH---HH-----hh
Confidence 643322 2345689999999999999999999999999999999999999999754422 11111 11 11
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
++ .+|.....+...|+...|..||.+|. .+.||.++
T Consensus 384 d~-------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 DL-------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hc-------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 22 22333333467788899999999994 46666654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.11 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=215.6
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeec-
Q 007160 260 AYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS- 336 (615)
Q Consensus 260 ~~~el~~~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~- 336 (615)
.++.+...++.|++.+.||.|.+|.||+++ .++++.+|||++.... ...++...|.++|+.+ +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344455567789999999999999999999 5678999999887543 4467788999999987 69999999999864
Q ss_pred --CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 337 --RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 337 --~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
..++++|||||||.+||..|+++... ...+.|..+..|+..+++||.+||.+. ++|||||-.||||+.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 23568999999999999999998765 567999999999999999999999998 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCcccccc-----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~ 489 (615)
|.|||++........ ......||+.|||||++.. ..|+.++|+||||++..||.-|.+|+....+..
T Consensus 164 LvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------ 235 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------ 235 (953)
T ss_pred Eeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------
Confidence 999999987655432 3455789999999999863 357789999999999999999999986433221
Q ss_pred hhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+ .....+|.....-+..-.+++.++|..||..|.++||++.++++|
T Consensus 236 ---aL------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ---AL------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---hh------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11 111223333334466667789999999999999999999999865
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=276.03 Aligned_cols=207 Identities=27% Similarity=0.349 Sum_probs=171.5
Q ss_pred HhcCcccceeeeccCceEEEEEEEC---C--CcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS---D--GTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~---~--g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
....|+....||+|.||.||+|.-. + ...+|+|+++.... .-.....+|+.+++.++|+|++.|..++... .
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-D 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-C
Confidence 3456889999999999999999632 2 33799999985532 2245678999999999999999999998754 5
Q ss_pred CceeEEEecCCCCChhHhhcCCCC-CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC----CcEE
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN----FHAK 414 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~-~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vk 414 (615)
..++|++||.+. +|...++-++. ....+....+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 689999999977 88888864332 2346788889999999999999999998 9999999999999877 8999
Q ss_pred EEeccccccCCCCCcc-ccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007160 415 VADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDM 478 (615)
Q Consensus 415 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~ 478 (615)
|+|||+++.+.+.-.. +....++-|+.|.|||.+.+. +||.+.|||+.||++.||+|-.+-|..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999988654332 233457889999999998864 789999999999999999998877753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=274.41 Aligned_cols=221 Identities=20% Similarity=0.204 Sum_probs=175.0
Q ss_pred cCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCChhHhh
Q 007160 280 GGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL 358 (615)
Q Consensus 280 G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L 358 (615)
|.||.||+++. .+++.||+|++.... .+.+|...+....||||+++++++. +....+++|||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV--SEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee--cCCeEEEEEecCCCCCHHHHH
Confidence 89999999996 468999999997532 3445556666667999999999887 445899999999999999998
Q ss_pred cCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeecc
Q 007160 359 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438 (615)
Q Consensus 359 ~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 438 (615)
... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||++....... ....+
T Consensus 77 ~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~ 144 (237)
T cd05576 77 SKF----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAV 144 (237)
T ss_pred HHh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCc
Confidence 642 34899999999999999999999998 9999999999999999999999999887654321 22345
Q ss_pred ccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHH
Q 007160 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF 518 (615)
Q Consensus 439 t~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~ 518 (615)
+..|+|||.+.+..++.++||||+|+++|||++|+.|+....... .... . ...+....
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~---~-------~~~~~~~~ 202 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT---T-------LNIPEWVS 202 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc---c-------cCCcccCC
Confidence 778999999988889999999999999999999998875321100 0000 0 01122223
Q ss_pred HHHHHHHHHccccCCCCCCCHHH
Q 007160 519 IRVCTIAAACVAPEANQRPTMGE 541 (615)
Q Consensus 519 ~~l~~Li~~Cl~~dP~~RPsm~e 541 (615)
..+.+++.+|++.||++||++.+
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCCc
Confidence 45789999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=311.61 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=208.0
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeec
Q 007160 261 YEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336 (615)
Q Consensus 261 ~~el~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~ 336 (615)
..+++...++|+++++||+|+||.|..++. .+++.||+|++.+. ...+..-|..|-++|..-+.+=|+.+.-.|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-- 144 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-- 144 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--
Confidence 356666788999999999999999999996 46889999999763 233456788899999888888888886444
Q ss_pred CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEE
Q 007160 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416 (615)
Q Consensus 337 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 416 (615)
+|..++|||||||+||+|..+|... ..+++..+.-++..|.-||.-||+.| +|||||||+|||||..|++||+
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence 4777999999999999999999752 25888999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccc----c-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM----T-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
|||.+-.+..+. .......+|||.|++||++. + +.|...+|.||+||++|||+.|..||.. ++++.-.
T Consensus 218 DFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY 290 (1317)
T KOG0612|consen 218 DFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETY 290 (1317)
T ss_pred cchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHH
Confidence 999998776543 23455678999999999985 2 5789999999999999999999999973 3444443
Q ss_pred hhhhccchhhhhhcCCccCCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 007160 492 RPILRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPT---MGEVVQSL 546 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~RPs---m~eVl~~L 546 (615)
..++.-++.+ .+| .+..+...+||.+.+. +|+.|.. +.++-.|-
T Consensus 291 ~KIm~hk~~l----------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 291 GKIMNHKESL----------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred HHHhchhhhc----------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 3343332221 223 2234457788888777 5888988 88888774
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=297.04 Aligned_cols=265 Identities=22% Similarity=0.339 Sum_probs=184.9
Q ss_pred HhcCcccceeeeccCceEEEEEEE-----------------CCCcEEEEEEeccCCCCchHH--------------HHHH
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-----------------SDGTAVAIKRLTCGGQQGDKE--------------FLVE 315 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-----------------~~g~~VAVK~l~~~~~~~~~~--------------f~~E 315 (615)
..++|++.++||+|+||.||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999964 235689999987543332233 3447
Q ss_pred HHHHhhccCCCc-----ceEEEEeecC------CCCceeEEEecCCCCChhHhhcCCCCC--------------------
Q 007160 316 VEMLSRLHHRNL-----VKLVGYYSSR------DSSQHLLCYELVPNGSLESWLHGPLGV-------------------- 364 (615)
Q Consensus 316 i~~l~~l~HpnI-----v~l~g~~~~~------~~~~~~LV~Ey~~~gsL~~~L~~~~~~-------------------- 364 (615)
+.++.+++|.++ +++++||... +....+|||||+++|+|.++|+...+.
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 6788887532 234689999999999999999753210
Q ss_pred cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCC
Q 007160 365 NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444 (615)
Q Consensus 365 ~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~A 444 (615)
...++|..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567889999999999999999998 99999999999999999999999999976543221 11122345889999
Q ss_pred ccccccCc----------------------CCchhhHHHHHHHHHHHHhCCC-CCCCCCCCC------cchhhHhhhhhh
Q 007160 445 PEYAMTGH----------------------LLVKSDVYSYGVVLLELLTGRK-PVDMSQPSG------QENLVTWARPIL 495 (615)
Q Consensus 445 PE~~~~~~----------------------~s~ksDVwS~GvvL~ElltG~~-Pf~~~~~~~------~~~l~~~~~~~~ 495 (615)
||.+.... ...+.||||+||+++||++|.. |+....... ...+..|.. .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence 99875432 1235799999999999999875 664221100 011111110 0
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHH
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA---NQRPTMGEVVQSL 546 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP---~~RPsm~eVl~~L 546 (615)
.. ....-...........+|+.++|..+| .+|+|++|+++|-
T Consensus 457 ~~---------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 457 KG---------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred cc---------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 00 000000111123457789999999766 6899999999873
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=273.17 Aligned_cols=268 Identities=23% Similarity=0.404 Sum_probs=204.6
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecC
Q 007160 260 AYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSR 337 (615)
Q Consensus 260 ~~~el~~~~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~ 337 (615)
.++++...|. +.||+|+|+.|--++ +.+|.++|||++.+..........+|++++.+.+ |+||+.|+.+|+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE-- 146 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE-- 146 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--
Confidence 3566666654 789999999999887 7789999999998776666788999999999985 999999999998
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC---cEE
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAK 414 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vk 414 (615)
+....|||||-|.||+|..++++ ...+++.++.++..+|+.||.|||.++ |.|||+||+|||..+-. -+|
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred ccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCcee
Confidence 55689999999999999999986 456899999999999999999999999 99999999999996543 489
Q ss_pred EEeccccccCCCCCcc-----ccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007160 415 VADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ 484 (615)
Q Consensus 415 L~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~ 484 (615)
|+||.|..-......- ..-...+|+..|||||+.. ...|+.++|.||||||||-|++|..||...-..+
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d- 298 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD- 298 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc-
Confidence 9999987544322110 0112457899999999763 2357899999999999999999999996433211
Q ss_pred chhhHhhhhhh---ccchhhhhhcCCccCCCCCHHHH----HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 485 ENLVTWARPIL---RDKDRLEELADPRLGGKYPKEDF----IRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 485 ~~l~~~~~~~~---~~~~~l~~i~d~~l~~~~~~~~~----~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
..|-+... -+....+.|.+.. .++|.++. ....+++...+..|+.+|-++.+++++-+
T Consensus 299 ---CGWdrGe~Cr~CQ~~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 299 ---CGWDRGEVCRVCQNKLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred ---CCccCCCccHHHHHHHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 11111000 0011222232322 24555544 34567888899999999999999998644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=266.46 Aligned_cols=238 Identities=31% Similarity=0.411 Sum_probs=191.4
Q ss_pred CceEEEEEEEC-CCcEEEEEEeccCCCCc-hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCChhHhh
Q 007160 281 GFGRVFKGVLS-DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL 358 (615)
Q Consensus 281 ~fG~Vykg~~~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L 358 (615)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++.. ....++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHH
Confidence 58999999976 48999999998665544 6789999999999999999999999873 45889999999999999999
Q ss_pred cCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeecc
Q 007160 359 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438 (615)
Q Consensus 359 ~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 438 (615)
.... .+++..++.++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......+
T Consensus 79 ~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~ 148 (244)
T smart00220 79 KKRG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG 148 (244)
T ss_pred Hhcc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence 7522 2889999999999999999999998 9999999999999999999999999998765532 2234568
Q ss_pred ccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHH-H
Q 007160 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE-D 517 (615)
Q Consensus 439 t~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~-~ 517 (615)
+..|++||.+....++.++||||||+++|+|++|..||..... ...+..+.. ........... .
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~-------------~~~~~~~~~~~~~ 213 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG-------------KPKPPFPPPEWKI 213 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh-------------ccCCCCccccccC
Confidence 8899999999988899999999999999999999999864211 111111111 00000000000 2
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 518 FIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 518 ~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...+.+++.+|+..+|++||++.+++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 3458899999999999999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=303.12 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=171.6
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-C----CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEe----ecC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-D----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY----SSR 337 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~----~~~ 337 (615)
..++|++.+.||+|+||.||+|++. + +..||||++..... .+.+..| .+.+..+.++..++..+ ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999975 4 68999999864321 1222221 12222223333222211 113
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCC----------------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCC
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGV----------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 401 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~----------------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 401 (615)
+....+|||||+++++|.++++..... ........+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456789999999999999998642100 001123345679999999999999998 9999999
Q ss_pred CCCeEEcC-CCcEEEEeccccccCCCCCccccceeeccccccCCccccccC----------------------cCCchhh
Q 007160 402 ASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG----------------------HLLVKSD 458 (615)
Q Consensus 402 p~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~ksD 458 (615)
|+|||+++ ++.+||+|||+++...... .+......+|+.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 6799999999998664432 2234456789999999965322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh---hhhcCCccCCC----C--CHHHHHHHHHHHHHcc
Q 007160 459 VYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL---EELADPRLGGK----Y--PKEDFIRVCTIAAACV 529 (615)
Q Consensus 459 VwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l---~~i~d~~l~~~----~--~~~~~~~l~~Li~~Cl 529 (615)
||||||+||||+++..+++.. +..+...+....... .....+..... + .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999987665421 111111110000000 01111110000 0 0001123458999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 007160 530 APEANQRPTMGEVVQS 545 (615)
Q Consensus 530 ~~dP~~RPsm~eVl~~ 545 (615)
+.||++|||+.|+++|
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=280.61 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=198.1
Q ss_pred hcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCC-c------hHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ-G------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~-~------~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
.++|-.+.+||+|||+.||++. +...+.||||+-...... + .+...+|.++-+.|.||.||++++|+.- +.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-Dt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-DT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-cc
Confidence 4567788999999999999998 567899999986543211 1 2346789999999999999999999864 55
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEE
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVA 416 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~ 416 (615)
..++-|+|||+|.+|+-||+. .+.++++++..|+.||+.||.||.+.. |+|||-||||.||||.+ -|.+||.
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 678999999999999999986 345899999999999999999999886 45999999999999954 4789999
Q ss_pred eccccccCCCCCcc-----ccceeeccccccCCccccccC----cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 007160 417 DFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 487 (615)
Q Consensus 417 DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~----~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l 487 (615)
||||++.+.++..+ ..++...||..|++||.+.-+ ..+.|.||||.||++|.++.|+.||...... ..+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHH
Confidence 99999998766543 234557899999999988643 5689999999999999999999999754321 121
Q ss_pred hHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007160 488 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544 (615)
Q Consensus 488 ~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 544 (615)
.... .++... ++--| ...........+|++||+.--++|....++..
T Consensus 694 LqeN-TIlkAt----EVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQEN-TILKAT----EVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhhh-chhcce----eccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1110 011110 00000 00111224678999999999999987776654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=291.00 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=195.3
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++.|.....+|.|+|+.|-++.. .+++..+||++.... .+-.+|+.++.+. +|+||+++.+.+. +..+.++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceec--CCceeee
Confidence 367788888899999999999884 468899999997552 2345677776666 6999999999987 5668999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE-cCCCcEEEEecccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQ 423 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl-~~~~~vkL~DFGla~~ 423 (615)
|||++.++-|.+.+... .... ..+..|+.+|+.++.|||+++ |+||||||+|||+ ++.++++|+|||.++.
T Consensus 394 v~e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eehhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999988887642 1223 677789999999999999999 9999999999999 6899999999999988
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.... ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+ +..
T Consensus 466 ~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei-------------~~~ 525 (612)
T KOG0603|consen 466 LERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI-------------HTR 525 (612)
T ss_pred Cchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH-------------HHh
Confidence 7654 12335688999999999999999999999999999999999999754322 111 111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+..+. +.........+|+.+||+.||.+||+|.++..+-+.
T Consensus 526 i~~~~----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 526 IQMPK----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hcCCc----cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11111 112333457899999999999999999999987555
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=247.30 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=196.7
Q ss_pred CcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+|...++||+|.||+||+|+ .++++.||+|++..++.. .....++||-+|+.++|.|||+++++.. ....+-||+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh--sdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc--cCceeEEeH
Confidence 45667899999999999999 456899999999865433 2357899999999999999999999876 344788999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|||.. +|.+|.... +..++.+....++.|+++||.|+|+++ +.|||+||.|.|++.+|+.|++|||+++.+.-
T Consensus 81 e~cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred HHhhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99954 898888643 345888999999999999999999999 99999999999999999999999999998765
Q ss_pred CCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhh--ccc--hh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL--RDK--DR 500 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~--~~~--~~ 500 (615)
.-.. .+..+-|..|.+|.++.+. -|++..|+||-||++.|+.. |++-|...+..+ .+...++.+- .+. ..
T Consensus 154 pvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 154 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred ceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHhCCCccccCCc
Confidence 4322 2345679999999999876 47899999999999999987 555555433322 2222222111 100 12
Q ss_pred hhhhcCCccCCCCCHHH-----H----HHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 501 LEELADPRLGGKYPKED-----F----IRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~-----~----~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+..+.|......++... + ..=.+++...+.-+|.+|.++++.+++
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 33344443333333211 1 123567777777799999999988765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=273.48 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=188.7
Q ss_pred ceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 274 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+..||.|.||+|+|-..+ .|+.+|||+++.... .+.++++.|.+...+- +.||||+++|.+. ..+..|++||.|+
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F--~EGdcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF--SEGDCWICMELMD 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh--cCCceeeeHHHHh
Confidence 467999999999998854 699999999987654 4457788999876554 6899999999876 3457899999994
Q ss_pred CCChhHhhcCC-CCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 351 NGSLESWLHGP-LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 351 ~gsL~~~L~~~-~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
-||+.+.+.- .-.+..+.+...-+|+....+||.||.+.-. |||||+||+||||+..|.+||||||++-...+.
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 4776654310 0113357778888888889999999987643 999999999999999999999999999765432
Q ss_pred cccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 430 NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 430 ~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
...+...|-..|||||.+.. ..|+.++||||||++|+|+.||+.||.... +..+....+.... -|
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gd-------pp 288 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGD-------PP 288 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCC-------CC
Confidence 23455678889999998863 458999999999999999999999996432 1222222111110 01
Q ss_pred ccCCCCCHH---HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKE---DFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~---~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+. .+.+ ....++.++..|+..|-++||.+.++.++
T Consensus 289 ~l~--~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILL--FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eec--CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 1112 23468899999999999999999998764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=265.56 Aligned_cols=256 Identities=23% Similarity=0.272 Sum_probs=198.4
Q ss_pred HhcCcccc-eeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeec--CCCCc
Q 007160 267 ATNNFEPA-SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS--RDSSQ 341 (615)
Q Consensus 267 ~~~~f~~~-~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~--~~~~~ 341 (615)
.+++|.+. ++||-|-.|.|-.+.. .+++.+|+|++.. .....+|+++--.. .|+|||.++++|.+ .....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667654 6799999999999885 4789999999863 33456788764444 69999999999864 23456
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEEec
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADF 418 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DF 418 (615)
+++|||.|+||.|...+.... ...+++.++-.|..||+.|+.|||+.+ |.||||||+|+|... |-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 789999999999999998633 456999999999999999999999999 999999999999964 557999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
|+|+...... .....+-|+.|.|||++....|+..+|+||+||++|-|++|.+||........ .--.+
T Consensus 209 GFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk------ 276 (400)
T KOG0604|consen 209 GFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMK------ 276 (400)
T ss_pred ccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHH------
Confidence 9999765422 23456789999999999999999999999999999999999999974332111 00001
Q ss_pred hhhhhhcCCccCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 499 DRLEELADPRLGGKYPKE----DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~----~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
..+.... ..+|.+ ..+...++|+.+|..+|.+|.|+.+++.+-+.-
T Consensus 277 ---~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 277 ---RRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred ---hHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 0111111 123332 234567899999999999999999999876543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=265.76 Aligned_cols=272 Identities=22% Similarity=0.339 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecC------CC
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------DS 339 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~------~~ 339 (615)
..|+...+||+|.||.||+|+. ++|+.||+|++-..++. -...-++|+++|..++|+|++.++..|... +.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466678899999999999995 46788999877543322 235678999999999999999999988532 33
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...+|||++|+. +|.-+|... ...++..++.++..++..||.|+|... |+|||+|+.|+|++.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 458999999976 888888642 345888999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCc--cccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh------
Q 007160 420 LAKQAPEGRT--NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW------ 490 (615)
Q Consensus 420 la~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~------ 490 (615)
+++.+..... ....+..+-|..|.+||.+.+ ..|+.+.|||.-||++.||+||.+-+.......+..++..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9986653321 112345667999999998876 5789999999999999999999988875544333322221
Q ss_pred --hhhhhccchhhhhhcCCcc-CCCCC--HHH------HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 491 --ARPILRDKDRLEELADPRL-GGKYP--KED------FIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 491 --~~~~~~~~~~l~~i~d~~l-~~~~~--~~~------~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
+|+....-.....+..+.+ .+.+. .+. ....++|+..++..||.+|+++++++.|-.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 1111111111111111101 01100 000 114678999999999999999999987743
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=273.96 Aligned_cols=263 Identities=22% Similarity=0.325 Sum_probs=198.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccC--C----CcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--R----NLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--p----nIv~l~g~~~~~~~~ 340 (615)
+++|.+...+|+|.||.|-..... .+..||||+++.-. .-.+.-+-|+++|.++.+ | -+|.+.+|+. -.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd--yrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD--YRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh--ccC
Confidence 678999999999999999998854 47899999987432 223456779999999942 2 2677777776 345
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-----------
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----------- 409 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~----------- 409 (615)
+.++|+|.+ |-|+.++|..+ ...++....+..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence 889999999 67999999863 3456888999999999999999999999 999999999999942
Q ss_pred ---------CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 410 ---------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 410 ---------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
+..+||+|||.|....+.. +..+.|..|.|||++.+-.++.++||||+||||.|+.+|..-|...+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3458999999998755433 45788999999999999999999999999999999999999997665
Q ss_pred CCCcchhhHh--------------hhhhhccchhhh-----------hhcCC-c---cCCCCCHHHHHHHHHHHHHcccc
Q 007160 481 PSGQENLVTW--------------ARPILRDKDRLE-----------ELADP-R---LGGKYPKEDFIRVCTIAAACVAP 531 (615)
Q Consensus 481 ~~~~~~l~~~--------------~~~~~~~~~~l~-----------~i~d~-~---l~~~~~~~~~~~l~~Li~~Cl~~ 531 (615)
..++..+.+. ...++..+ .+. .+.++ + ..-.....+...|.+|+..+|..
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 3332111110 00000000 000 00000 0 00112345566799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 007160 532 EANQRPTMGEVVQS 545 (615)
Q Consensus 532 dP~~RPsm~eVl~~ 545 (615)
||.+|+|++|+++|
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=280.37 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=194.3
Q ss_pred ceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 274 ASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
.++||+|.||+||-|.. ++|+.||||.+.+.. ......+.+|+.+|++++||.||.|...|+ .....+.|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E--T~ervFVVMEKl- 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE--TPERVFVVMEKL- 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec--CCceEEEEehhh-
Confidence 47899999999999995 579999999997653 334567899999999999999999998887 445899999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC---CcEEEEeccccccCCCC
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFGLAKQAPEG 427 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~~~~~ 427 (615)
+|++.+.+-. ....+|++....-++.||+.||.|||.++ |+|+||||+||||... -.+||||||+|+.+++.
T Consensus 646 ~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 646 HGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred cchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 4565555532 22346888888889999999999999999 9999999999999643 46999999999998875
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
. ....++||+.|+|||+++++.|...-|+||.||++|--++|..||..... +.+.. . ...-+.-+
T Consensus 721 s---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQI----Q---NAaFMyPp 785 (888)
T KOG4236|consen 721 S---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQI----Q---NAAFMYPP 785 (888)
T ss_pred h---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHh----h---ccccccCC
Confidence 4 33567899999999999999999999999999999999999999963321 11100 0 00111112
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
..+. +.....++||...|+..-.+|-+...-+.+-|
T Consensus 786 ~PW~----eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 786 NPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred Cchh----hcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 2222 22334678999999999999999988876654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=269.59 Aligned_cols=240 Identities=25% Similarity=0.355 Sum_probs=192.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.+|..+.+||+|+||.|.+|..+ +.+.+|||+++++-. .+.+--+.|-++|+-. +-|.++++..++. ....+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ--TmDRLy 426 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ--TMDRLY 426 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh--hhhhee
Confidence 47888999999999999999854 467899999986532 1223345677777766 4678888887776 445899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+.||+|--++++- ..+.+..+.-+|..||-||-+||+++ |+.||||.+||+||.+|++||+|||+++.
T Consensus 427 FVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999888752 34777889999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.--+.. .+...+||+.|+|||++...+|....|.|||||+||||+.|+.||+..+..+ ....
T Consensus 500 ni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~a 561 (683)
T KOG0696|consen 500 NIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQA 561 (683)
T ss_pred cccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHH
Confidence 543322 3456899999999999999999999999999999999999999998654221 1112
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 537 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 537 (615)
+.+.. -.+|.....+...+....|...|.+|.
T Consensus 562 I~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 562 IMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 22222 245666666778889999999999994
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=290.67 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=188.1
Q ss_pred CcccceeeeccCceE-EEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEe
Q 007160 270 NFEPASILGEGGFGR-VFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
-|...+++|.|+.|+ ||+|.+ +|+.||||++-.+ ......+||..|+.- +|||||++++. +.+....|++.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~--E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS--EQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee--ccCCceEEEEeh
Confidence 345557799998876 899999 4789999999632 234557899999887 59999999665 557778999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-----CCcEEEEeccccc
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAK 422 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkL~DFGla~ 422 (615)
.| ..+|.|++...........-...+.+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 55999999864111111111456788999999999999999 999999999999965 3579999999999
Q ss_pred cCCCCCcccc-ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 423 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
....+..... .....||-+|+|||.+....-+.++||||+|||+|..++| .+||...-.. +.| ++.....
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N-------Il~~~~~ 731 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN-------ILTGNYT 731 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------hhcCccc
Confidence 8876654322 3456799999999999988888899999999999999995 8999643211 111 2222222
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+..+.. ..++ ...+||.+|++++|..||++.+|+.|
T Consensus 732 L~~L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVHLEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 211110 1111 56789999999999999999999865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=276.84 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=205.3
Q ss_pred cCcccceeeeccCceEEEEEEECCCc-EEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGT-AVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~-~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.+++....||-||||.|=++..+... .+|+|.+++.. ....+....|-++|...+.+.||+++.-|. +..++|+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyvYm 497 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYVYM 497 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhhhh
Confidence 45566778999999999999876433 38888887543 333456788999999999999999988776 6668999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+||-|-||.|...|++ ...++..+..-++..+.+|++|||+++ ||.|||||+|.+|+.+|-+||.|||+|+..
T Consensus 498 LmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999976 345888889999999999999999999 999999999999999999999999999998
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..+.. +-.++||+.|.|||++.++..+...|.||||+++|||++|++||...++....+++ +.. ++.+
T Consensus 571 ~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkG---id~i 638 (732)
T KOG0614|consen 571 GSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKG---IDKI 638 (732)
T ss_pred ccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhh---hhhh
Confidence 77653 34579999999999999999999999999999999999999999876655433322 221 2222
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLKM 548 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~L~~ 548 (615)
.+|........+|+++....+|.+|.- +.+|.+|-|.
T Consensus 639 -------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 639 -------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred -------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 223333345678898988999999975 7788777553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=243.17 Aligned_cols=206 Identities=29% Similarity=0.405 Sum_probs=168.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCce
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 342 (615)
...++......||+|++|.|-+-++ .+|+..|||++...- .+..+..++|+++..+. ..|.+|.++|.+. +....
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccE
Confidence 3444555668899999999988884 579999999997543 34456788899987665 6899999999765 45589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++.||.|+ -||+.+-++-......+.+..+-+|+..+.+||.|||++-+ ++|||+||+|||++.+|++|+||||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 58888776544445678889999999999999999998753 9999999999999999999999999997
Q ss_pred cCCCCCccccceeeccccccCCcccccc----CcCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKPVDMS 479 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~ 479 (615)
...+.- ..+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.||+..
T Consensus 198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 765432 2233467788999998753 47899999999999999999999999743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=236.50 Aligned_cols=210 Identities=36% Similarity=0.572 Sum_probs=181.3
Q ss_pred eeccCceEEEEEEECC-CcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCCh
Q 007160 277 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL 354 (615)
Q Consensus 277 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL 354 (615)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.+++++|++++++++++.. ....++++||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCcH
Confidence 6899999999999754 899999999855432 34679999999999999999999999874 3588999999999999
Q ss_pred hHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEeccccccCCCCCccccc
Q 007160 355 ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLS 433 (615)
Q Consensus 355 ~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~ 433 (615)
.+++.... ..+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (215)
T cd00180 79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL 150 (215)
T ss_pred HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence 99997531 35889999999999999999999998 999999999999999 89999999999987654321 12
Q ss_pred eeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCC
Q 007160 434 TRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512 (615)
Q Consensus 434 ~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~ 512 (615)
....+...|++||..... ..+.+.|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 334578899999998877 888999999999999999
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 513 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 513 ~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+.+++..|++.+|++||++.+++++
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246789999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=251.62 Aligned_cols=248 Identities=21% Similarity=0.339 Sum_probs=196.8
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC---chHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|.++++||+|+|.+|.++++ ++.+.+|+|++++.-.. +.+-.+.|-.+..+. +||.+|.|..++. ....+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--tesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--ccceE
Confidence 46899999999999999999995 46789999999865322 223356677777766 6999999998876 44589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++|.||++||+|--++++ +..|.++.+.-+...|.-||.|||+.+ |+.||||.+|||||..|++||.|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 999999999999877765 446899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCC-CCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~-~~~~~l~~~~~~~~~~~~~l 501 (615)
..-.... .++..+||+.|+|||++++..|....|.|++||+++||+.|+.||+.... ....+..++.-+++-
T Consensus 400 e~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil----- 472 (593)
T KOG0695|consen 400 EGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL----- 472 (593)
T ss_pred cCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-----
Confidence 6543322 35678999999999999999999999999999999999999999985332 122333333322221
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 537 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 537 (615)
...+ ..|.....+...+++.-|+.||.+|.
T Consensus 473 ----ekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 ----EKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----hhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 1111 22333344566788899999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=267.26 Aligned_cols=208 Identities=25% Similarity=0.375 Sum_probs=171.9
Q ss_pred cCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.-|..++.||-|+||+|.+++ .++...+|+|.+.+.+- +......+|-+||.....+=||+|+-.|. +...+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ--DkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec--cCCceEE
Confidence 346677889999999999998 45577899999986542 22345778999999999999999975554 6779999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||+|++||++-.+|-+ ...+.+..+.-++..+..|+++.|..| +|||||||+|||||.+|++||.||||+.-+
T Consensus 707 VMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999998864 234677778888899999999999999 999999999999999999999999998533
Q ss_pred C---------CCC-------------------------------ccccceeeccccccCCccccccCcCCchhhHHHHHH
Q 007160 425 P---------EGR-------------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV 464 (615)
Q Consensus 425 ~---------~~~-------------------------------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~Gv 464 (615)
. +++ ..+.....+||+.|+|||++....++.-+|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 1 100 001123468999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcc
Q 007160 465 VLLELLTGRKPVDMSQPSGQE 485 (615)
Q Consensus 465 vL~ElltG~~Pf~~~~~~~~~ 485 (615)
|||||+.|+.||-...+.+..
T Consensus 860 il~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcce
Confidence 999999999999877776544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=254.14 Aligned_cols=269 Identities=23% Similarity=0.328 Sum_probs=196.7
Q ss_pred cccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCC---CceeE
Q 007160 271 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQHLL 344 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~---~~~~L 344 (615)
.+..+-||.|+||.||..+. ++|+.||.|++..-- ....+.+.+|+++|..++|.|++..+++..-... .+.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999885 479999999986421 2234788999999999999999999887542221 25678
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+.|.|.. +|.+.+-.+ ..|+-..+.-+..||++||+|||+.+ |.||||||.|.|++.+...||+|||+++..
T Consensus 135 ~TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 8898854 888887643 45888889999999999999999999 999999999999999999999999999977
Q ss_pred CCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------hhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR--------PIL 495 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~--------~~~ 495 (615)
..+... .++..+-|..|.|||++++. +|+.+.||||.||++.||+..+.-|....+..+..++.-.. +..
T Consensus 207 e~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 654433 34556789999999999975 78999999999999999998888887655544433332110 000
Q ss_pred ccchhhhhhc----CCccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 496 RDKDRLEELA----DPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 496 ~~~~~l~~i~----d~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
-++-.-..+. .|.+.. ..+...-.+...+...++..||++|.+..+.+.++..
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 0000000010 011100 0111122234567788899999999999998877543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=233.56 Aligned_cols=261 Identities=19% Similarity=0.314 Sum_probs=200.4
Q ss_pred hcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+++|+|.++.||.|. ..+++.++||.++ .-..+.+.+|+.+|..|. ||||++|+++..+.......||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4689999999999999999998 5678899999997 344678999999999997 9999999999988888889999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~ 424 (615)
+||+.+.+...+.. .|+.-.+..++.++++||.|+|+.| |.|||+||.|+++|.. -.++|+|+|||...
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999988776543 4777889999999999999999999 9999999999999864 56999999999877
Q ss_pred CCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc------
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD------ 497 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~------ 497 (615)
..+... ...+.+..|--||.+.. ..|+..-|+|||||+|.+|+..+.||..... ...+++..++-+-.+
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHH
Confidence 655432 23456677889998865 4578889999999999999999999965432 223444433321110
Q ss_pred -------chhhhhhcCCccCCC---C-C----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 -------KDRLEELADPRLGGK---Y-P----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 -------~~~l~~i~d~~l~~~---~-~----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
......++....+.. + + .-...+..+++...|..|-.+|+|++|...|
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 011111111111000 0 0 0011357889999999999999999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=232.80 Aligned_cols=199 Identities=35% Similarity=0.481 Sum_probs=171.1
Q ss_pred cccceeeeccCceEEEEEEECC-CcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 271 FEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++.. ....++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEec
Confidence 5667899999999999999764 889999999866544 56789999999999999999999999873 4578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++++|.+++..... .+++..+..++.+++++|.+||+.+ ++|+||+++||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred cCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 999999999975321 1789999999999999999999998 9999999999999999999999999998775542
Q ss_pred ccccceeeccccccCCcccc-ccCcCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKPVDM 478 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~-~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~ 478 (615)
.. ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11 12335678899999998 666778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=243.70 Aligned_cols=135 Identities=22% Similarity=0.347 Sum_probs=112.4
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-----C---CCcceEEEEeec--
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----H---RNLVKLVGYYSS-- 336 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H---pnIv~l~g~~~~-- 336 (615)
..+|.+.++||-|.|++||++.. .+.+.||+|+.+.. ..-.+.-+.||++|++++ | ..||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36789999999999999999984 56789999998743 233456788999999884 2 369999998863
Q ss_pred CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc
Q 007160 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE 408 (615)
Q Consensus 337 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 408 (615)
.++.+++||+|++ |-+|..+|.... .+.+....+.+|+.||+.||.|||.++ +|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4566899999999 779999997532 345888999999999999999999987 499999999999993
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=263.56 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=201.0
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|+....+|.|.||.|||++. ..++..|||.++.....+..-...|+-+++..+|+|||.++|.|... ...+++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh--cCcEEEE
Confidence 46889999999999999999995 56899999999987777777788999999999999999999988743 4789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|||.+|+|.+.-+. ..+|++.++..+++...+||+|||+.+ =+|||||-.|||+++.+.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence 99999999998875 457999999999999999999999999 78999999999999999999999999876543
Q ss_pred CCccccceeeccccccCCcccc---ccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~---~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.- .....+.||+.|||||+. +.+.|..++|||+.|+...|+---+.|.....+. ..+. +..+. .
T Consensus 165 ti--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~------LmTkS---~ 231 (829)
T KOG0576|consen 165 TI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALF------LMTKS---G 231 (829)
T ss_pred hh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHH------Hhhcc---C
Confidence 22 123457899999999976 4678999999999999999998777775432221 1111 00000 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.--+.+... ..-...+-++++.|+..+|++||+++.+++|
T Consensus 232 ~qpp~lkDk--~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 232 FQPPTLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCCCcccCC--ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 011112111 1122347789999999999999999887653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=251.48 Aligned_cols=197 Identities=24% Similarity=0.376 Sum_probs=167.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--------chHHHHHHHHHHhhcc---CCCcceEEEEee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--------GDKEFLVEVEMLSRLH---HRNLVKLVGYYS 335 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~ 335 (615)
..+|...+.+|+|+||.|+++.++ +...|+||.+.+...- ..-..-.||.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999975 4678899988754211 0112345999999997 999999999998
Q ss_pred cCCCCceeEEEecC-CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 336 SRDSSQHLLCYELV-PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 336 ~~~~~~~~LV~Ey~-~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
+...+||+||-. ++-+|.+++.. ...+++.+...|+.||+.|+++||+.+ |||||||-+||.++.+|-+|
T Consensus 640 --ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 640 --DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred --cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence 555899999854 46789999964 446899999999999999999999999 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCC
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVD 477 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~ 477 (615)
|+|||.|.....+. ...++||.+|.|||++.+..| ...-|||++|++||-++....||.
T Consensus 711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999998776553 245789999999999999887 466899999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=248.69 Aligned_cols=274 Identities=23% Similarity=0.258 Sum_probs=203.3
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhcc------CCCcceEEE
Q 007160 260 AYEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH------HRNLVKLVG 332 (615)
Q Consensus 260 ~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~------HpnIv~l~g 332 (615)
.+.--+....+|.+....|+|-|++|.+|... -|..||||++..... ..+.=++|+++|++|+ .-|+++|+-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 33334445678999999999999999999954 477999999985432 2456678999999995 347888887
Q ss_pred EeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-C
Q 007160 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-F 411 (615)
Q Consensus 333 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~ 411 (615)
.|. ...++|||||-+ ..+|.+.|+.. +.+..|....+..++.|+.-||..|...+ |+|.||||+|||+++. .
T Consensus 502 ~F~--hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 502 HFK--HKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKN 574 (752)
T ss_pred Hhh--hcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcc
Confidence 776 556899999988 56999999853 44556888999999999999999999999 9999999999999864 5
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
.+||||||.|....+... +-..-+..|.|||++.+..|+...|+||.||.||||.||+..|.......+..+..-+
T Consensus 575 iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 789999999987765432 1123345699999999999999999999999999999999998765543332221111
Q ss_pred h-----hhhccchhhhh--------------------------hcCC------ccC--CCCCHHH---HHHHHHHHHHcc
Q 007160 492 R-----PILRDKDRLEE--------------------------LADP------RLG--GKYPKED---FIRVCTIAAACV 529 (615)
Q Consensus 492 ~-----~~~~~~~~l~~--------------------------i~d~------~l~--~~~~~~~---~~~l~~Li~~Cl 529 (615)
. .+++...-..+ .+.| .+. ..++.++ ...+.+|+..|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 0 00111000000 0011 010 1133333 456889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 007160 530 APEANQRPTMGEVVQS 545 (615)
Q Consensus 530 ~~dP~~RPsm~eVl~~ 545 (615)
..||++|.|..+.++|
T Consensus 731 ~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 731 ILDPEKRITVNQALKH 746 (752)
T ss_pred ccChhhcCCHHHHhcC
Confidence 9999999999999876
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=233.82 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=193.9
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC--CCCchHHHHHHHHHHhhccCCCcceEEEEeecCC----CCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~ 341 (615)
.+|.-+..+|.|.- .|..+.. -.++.||+|++... .....+...+|..++..++|+||++++.++.-.. -.+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666677888887 5555543 25789999988653 3445577889999999999999999999886432 246
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.|+||||| .++|...++- .++-..+..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 78999999 5699988862 3666888999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh---------
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR--------- 492 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~--------- 492 (615)
+..... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|...+ .+..|.+
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCC
Confidence 875443 34566788999999999998889999999999999999999998886332 2222211
Q ss_pred ------------hhhccchh------hhhhcCCccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 493 ------------PILRDKDR------LEELADPRLGG--KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 493 ------------~~~~~~~~------l~~i~d~~l~~--~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+.+.... -+.+.|..... +.+........+++.+||-.||++|-+++++++|
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111100 00111111110 1111223346789999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=226.40 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=188.5
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~L 344 (615)
..+.|.+.+.||+|.||.+-++.++ .++.+++|-+.... ...++|.+|...--.| .|.||+.-+++... ..+.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~d~YvF 99 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TSDAYVF 99 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh-cCceEEE
Confidence 3467889999999999999999965 57889999887432 3467899999876666 48999988876432 3447889
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE-c-CCCcEEEEeccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-E-NNFHAKVADFGLAK 422 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl-~-~~~~vkL~DFGla~ 422 (615)
++||++.|+|.+-+.. ..+.+....+++.|++.||.|+|+++ +||||||.+|||+ + +..++||||||+.+
T Consensus 100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999988753 23677888999999999999999999 9999999999998 3 34589999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccC-----cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
..+..- ....-+..|.+||..... ...+.+|+|.||++++.++||+.||... ......+..|..-.-+.
T Consensus 172 k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 172 KVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhccc
Confidence 764321 223445679999976532 3467799999999999999999999732 23334444443322111
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.- .-|+.-..+. .++.++-++-+.+++++|--..++.+...
T Consensus 246 ~~-----~~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 246 NP-----ALPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred Cc-----cCchhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11 1122212222 24667888899999999976666655543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=270.35 Aligned_cols=200 Identities=19% Similarity=0.269 Sum_probs=140.7
Q ss_pred hccC-CCcceEEEEeecC-----CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCc
Q 007160 321 RLHH-RNLVKLVGYYSSR-----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394 (615)
Q Consensus 321 ~l~H-pnIv~l~g~~~~~-----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ 394 (615)
.++| .||++++++|... +...+++++||+ +++|.++|... ...+++.+++.++.||++||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4556 6888888876221 223567788987 66999999743 245899999999999999999999999
Q ss_pred EEeccCCCCCeEEcCC-------------------CcEEEEeccccccCCCCCc--------------cccceeeccccc
Q 007160 395 VIHRDFKASNILLENN-------------------FHAKVADFGLAKQAPEGRT--------------NYLSTRVMGTFG 441 (615)
Q Consensus 395 ivHrDIkp~NILl~~~-------------------~~vkL~DFGla~~~~~~~~--------------~~~~~~~~gt~~ 441 (615)
|+||||||+||||+.. +.+|++|||+++....... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999653 4556666666653211000 000112458899
Q ss_pred cCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHH
Q 007160 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRV 521 (615)
Q Consensus 442 y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l 521 (615)
|||||++.+..++.++|||||||+||||++|..|+.... ....... .....+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~----------~~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLR----------HRVLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHH----------HhhcChhh-----hhcCHHH
Confidence 999999999999999999999999999999988764211 0000000 00111111 1112235
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHH
Q 007160 522 CTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 522 ~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..++.+||+.+|.+||+|.||+++-
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhch
Confidence 6788999999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=211.75 Aligned_cols=169 Identities=21% Similarity=0.189 Sum_probs=127.3
Q ss_pred CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccc
Q 007160 352 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431 (615)
Q Consensus 352 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 431 (615)
|+|.++++.. ...++|.+++.++.|+++||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 7899999742 235999999999999999999999876 999999999999999 99998754322
Q ss_pred cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCC
Q 007160 432 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 511 (615)
Q Consensus 432 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~ 511 (615)
..||+.|||||++.+..++.++|||||||++|||++|+.||....... ..+..+...... . ++. ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~-------~-~~~-~~ 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA-------D-DPR-DR 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc-------C-Ccc-cc
Confidence 258999999999999999999999999999999999999996432211 111111110000 0 000 00
Q ss_pred CCCHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 512 KYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 512 ~~~~~~~~--~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
..+..... .+.+++.+||+.+|++||++.|+++++..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11111122 58999999999999999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=233.12 Aligned_cols=202 Identities=28% Similarity=0.421 Sum_probs=166.1
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCC
Q 007160 264 LKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRD 338 (615)
Q Consensus 264 l~~~~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~ 338 (615)
+....+.|...++||+|.|++||++.+. .++.||+|.+...+. .....+|+++|..+. +.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rn-- 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRN-- 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhcc--
Confidence 3345678899999999999999999853 467899999975443 456899999999995 9999999998874
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEe
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVAD 417 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~D 417 (615)
.+...+|+||++...-.+++.. ++...+..++..+.+||+++|.+| ||||||||+|+|.+. .+.-.|.|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence 4489999999999999998864 778999999999999999999999 999999999999974 56789999
Q ss_pred ccccccCCC-------------------C--------------Cccc---------cceeeccccccCCcccccc-CcCC
Q 007160 418 FGLAKQAPE-------------------G--------------RTNY---------LSTRVMGTFGYVAPEYAMT-GHLL 454 (615)
Q Consensus 418 FGla~~~~~-------------------~--------------~~~~---------~~~~~~gt~~y~APE~~~~-~~~s 454 (615)
||||..... + .... ......||+||.|||++.. ...+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 999972100 0 0000 0112469999999999875 4568
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCC
Q 007160 455 VKSDVYSYGVVLLELLTGRKPVDMS 479 (615)
Q Consensus 455 ~ksDVwS~GvvL~ElltG~~Pf~~~ 479 (615)
+++||||.|||++-+++++.||...
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred CccceeeccceeehhhccccccccC
Confidence 9999999999999999999999643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-25 Score=213.08 Aligned_cols=247 Identities=19% Similarity=0.301 Sum_probs=192.8
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
...+|.+...|..|+|+++.+ .+++|++.... ....++|..|.-.|+-+.||||+.++|.|. .+..+.++..||+
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn--sppnlv~isq~mp 270 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN--SPPNLVIISQYMP 270 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc--CCCCceEeeeecc
Confidence 346788999999999999754 46667775432 233468999999999999999999999997 4568899999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEE--eccccccCCCCC
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA--DFGLAKQAPEGR 428 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~--DFGla~~~~~~~ 428 (615)
.|+|+..|++.. ...++-.++.++++++|+|++|||+..+ -|.---|.+..+++|++.+++|+ |--++.
T Consensus 271 ~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf------ 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF------ 341 (448)
T ss_pred chHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee------
Confidence 999999999743 3457788999999999999999999863 24455789999999999998875 211111
Q ss_pred ccccceeeccccccCCccccccCcCC---chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s---~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
......-.+.||+||.+..++-+ +.+|+|||.++||||.|...||....+.+-. -++.
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mkia 402 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MKIA 402 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hhhh
Confidence 11123456789999999876543 6799999999999999999999755543211 1223
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
-+.++...|......+++|+.-|++.||.+||.+..|+-.|++++
T Consensus 403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 344455667777778999999999999999999999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-23 Score=215.10 Aligned_cols=263 Identities=21% Similarity=0.244 Sum_probs=193.9
Q ss_pred CcccceeeeccCceEEEEEEECC--CcEEEEEEeccCCCCchHHHHHHHHHHhhccC----CCcceEEEEeecCCCCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH----RNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H----pnIv~l~g~~~~~~~~~~~ 343 (615)
+|.+.+.||+|+||.||++.... ...+|+|............+..|+.++..+.+ .++..+++... ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 79999999999999999999654 35788888775533333378889999998873 57888887763 2445789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-----CcEEEEec
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-----FHAKVADF 418 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~vkL~DF 418 (615)
+||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999988 889999885433 456999999999999999999999999 9999999999999754 46999999
Q ss_pred cccc--cCCCCCcc----cc--ceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 007160 419 GLAK--QAPEGRTN----YL--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 419 Gla~--~~~~~~~~----~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~ 490 (615)
|+++ ........ .. .....||..|.++..+.+...+.+.|+||++.++.|++.|..||.............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~- 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE- 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH-
Confidence 9999 33222111 11 123569999999999999999999999999999999999999996443221111000
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.. ........ ....... .+.++...+-..+...+|....+...|+.....
T Consensus 251 --~~-----~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 251 --KD-----PRKLLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred --HH-----hhhhcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00 00001110 1122223 344555555558999999999999988776554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=222.06 Aligned_cols=167 Identities=20% Similarity=0.168 Sum_probs=130.8
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CCcEEEEEEeccCC-----CCchHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
...++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|++++|+|+++.+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 44578999999999999999999864 57788999875331 11245689999999999999999643221
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccC-CCCCeEEcCCCcEEEEe
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF-KASNILLENNFHAKVAD 417 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkL~D 417 (615)
...+|||||+++++|... .. . ....++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~-~---------~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP-H---------GDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc-c---------chHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 257999999999999732 11 0 11467889999999999998 999999 99999999999999999
Q ss_pred ccccccCCCCCcccc------ceeeccccccCCccccccC
Q 007160 418 FGLAKQAPEGRTNYL------STRVMGTFGYVAPEYAMTG 451 (615)
Q Consensus 418 FGla~~~~~~~~~~~------~~~~~gt~~y~APE~~~~~ 451 (615)
||+|+.......... -+...+++.|+|||++...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999997765432211 1356789999999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=200.33 Aligned_cols=261 Identities=30% Similarity=0.405 Sum_probs=196.4
Q ss_pred cccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC---chHHHHHHHHHHhhccCC-CcceEEEEeecCCCCceeEEE
Q 007160 271 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHR-NLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~~~LV~ 346 (615)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++. .....++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEEE
Confidence 667889999999999999986 78999999765443 367899999999999988 7999999985 333479999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 425 (615)
+|+.+++|.+++...... ..+.......+..|++.++.|+|+.+ ++|||+||+||+++... .++++|||+++...
T Consensus 78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999777643211 25788899999999999999999999 99999999999999988 79999999998655
Q ss_pred CCCccc----cceeeccccccCCcccccc---CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-CcchhhHhhhhhhcc
Q 007160 426 EGRTNY----LSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQENLVTWARPILRD 497 (615)
Q Consensus 426 ~~~~~~----~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~-~~~~l~~~~~~~~~~ 497 (615)
...... ......||..|++||.+.. .......|+||+|++++++++|..||...... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-- 231 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP-- 231 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC--
Confidence 433221 2356789999999999987 57889999999999999999999997544321 0011111111000
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. .................+.+++..|+..+|..|.++.+....
T Consensus 232 -~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 -TP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -Cc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000000000001122457789999999999999999987765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=190.22 Aligned_cols=260 Identities=21% Similarity=0.335 Sum_probs=199.1
Q ss_pred hcCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccC-CCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~~~LV 345 (615)
..+|.+.++||.|+||.+|.|. ..+|..||||.-+.... ..++.-|.+++..|+| ..|..+..|.. +...-.||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGT--EKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcc--ccccceee
Confidence 4679999999999999999999 67899999998764332 3467789999999976 45555555544 45577899
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEEeccccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAK 422 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~ 422 (615)
|+.+ |-+|++++.-. ...++..+++-++.|++.-++|+|.++ ++||||||+|+|..- -..+.++|||||+
T Consensus 90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 9999 88999988632 345889999999999999999999999 999999999999864 3468999999999
Q ss_pred cCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 423 QAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 423 ~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
...+..+. .......||.+|.+=..+.+...+.+.|+-|+|.+|..+.-|..||..-.+.....
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q----------- 231 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ----------- 231 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-----------
Confidence 87654332 11234679999999888888888999999999999999999999997554332211
Q ss_pred chhhhhhcCCcc-------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 498 KDRLEELADPRL-------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 498 ~~~l~~i~d~~l-------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
..+.+...++ ...+|. ++.-.+.-|-..-=++-|...-+.+.+..+.+.+..
T Consensus 232 --KyEkI~EkK~s~~ie~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 232 --KYEKISEKKMSTPIEVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred --HHHHHHHhhcCCCHHHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 1122222221 223333 466677888888888899999888888777666543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=191.44 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=192.8
Q ss_pred cCcccceeeeccCceEEEEEE-ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
-+|++.++||+|.||..+.|+ +-+++.||||.-...+ ...++..|.+.++.|. .++|-..+ |...++.+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vY--YFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVY--YFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCcee--eeccccchhhhhh
Confidence 468999999999999999999 5679999999765332 3457788999998885 57777664 3345677788999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-----CCcEEEEecccc
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLA 421 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkL~DFGla 421 (615)
|.+ |-||+|+..-. ...++.+++..+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|
T Consensus 104 dLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999 88999988632 346899999999999999999999999 999999999999963 346899999999
Q ss_pred ccCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 422 KQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 422 ~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
+...+..+. .......||.+||+=....+...+.+.|+-|+|-+++.++-|..||........
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn------------ 244 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN------------ 244 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch------------
Confidence 988665432 112346799999999999999999999999999999999999999975433221
Q ss_pred cchhhhhhcCCcc-------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 497 DKDRLEELADPRL-------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 497 ~~~~l~~i~d~~l-------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
+...+.|-+.+- ...+|. + +..-+.-.-..+=.+-|..+-+...+..+...+
T Consensus 245 -K~kYeKIGe~Kr~T~i~~Lc~g~P~-e---fa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 245 -KEKYEKIGETKRSTPIEVLCEGFPE-E---FATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -HHHHHHhccccccCCHHHHHhcCHH-H---HHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 112222222211 112232 2 333333333456678899988887777665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-22 Score=224.24 Aligned_cols=251 Identities=23% Similarity=0.267 Sum_probs=183.7
Q ss_pred ccceeeeccCceEEEEEEE-CCCcEEEEEEecc---CCCCch---HHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 272 EPASILGEGGFGRVFKGVL-SDGTAVAIKRLTC---GGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~---~~~~~~---~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
...+++|.|.+|.|+.... ......+.|.... ...... ..+..|+-+-..++|+|++..+..+.... ...-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchh
Confidence 3568899999997777663 3344444443321 111111 12555777778889999988877665333 3344
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
.|||+++ +|..++... ..++...+..++.|+.+|+.|||+.+ |.|||+|++|++++.++.+||+|||.+...
T Consensus 399 ~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceee
Confidence 4999999 999999752 35788899999999999999999999 999999999999999999999999999877
Q ss_pred CCCCcc--ccceeeccccccCCccccccCcCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcch----hhHhhhhhhcc
Q 007160 425 PEGRTN--YLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN----LVTWARPILRD 497 (615)
Q Consensus 425 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~----l~~~~~~~~~~ 497 (615)
...... ......+|+-.|+|||.+.+..|. ...||||.|+++..|++|+.||.......... ...|.. ....
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~-~~~~ 549 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN-IFEG 549 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc-cccC
Confidence 655443 556678899999999999999986 56899999999999999999997554433221 001100 0000
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... .-.....+...++.++|+.||.+|-|+++|++.
T Consensus 550 ~~~------------~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 550 PNR------------LLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hHH------------HHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000 111223346789999999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-21 Score=189.44 Aligned_cols=173 Identities=12% Similarity=0.159 Sum_probs=135.9
Q ss_pred HhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHH---------HHHHHHHHhhccCCCcceEEEEeecC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---------FLVEVEMLSRLHHRNLVKLVGYYSSR 337 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~~l~~l~HpnIv~l~g~~~~~ 337 (615)
..++|+..++||.|+||.||+... ++..+|||.+.......... |.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999766 56789999997543333222 68899999999999999999886533
Q ss_pred C------CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 338 D------SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 338 ~------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
+ ....+|+|||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||++|+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 2 235789999999999988742 221 34568999999999999 99999999999999988
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHH
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 470 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ell 470 (615)
++|+|||........... ..+.....+..++|+|+||+.+.-+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999998765332211 01444556678999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=218.47 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=181.7
Q ss_pred CcccceeeeccCceEEEEEEECCCcEEEEEEeccCC-CCchHHHHHHHHH--HhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 270 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG-QQGDKEFLVEVEM--LSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~--l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++...+.||++.|=+|.+|+.++|. |+||++-+.. .-..+.|.++++- ...++|||++++..+.. .....|||=
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~--t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV--TDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH--hhHHHHHHH
Confidence 5777899999999999999998887 9999987654 2334455544443 44568999999887644 334567888
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC--
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-- 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~-- 424 (615)
+|..+ +|+|.|.. +..|...+...|+.|++.||..+|+.+ |+|||||.+|||++.-.-+.|+||-.-+-.
T Consensus 101 qyvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 88854 99998864 445788889999999999999999999 999999999999999999999999776533
Q ss_pred CCCC---ccccceeeccccccCCccccccC-----------cCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 007160 425 PEGR---TNYLSTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 425 ~~~~---~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~ 489 (615)
++++ ..+.......-..|+|||.+... .++++.||||+||+++||++ |+++|+.. ++..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh
Confidence 2221 11222222334479999976431 26789999999999999988 78888632 2222
Q ss_pred hhhhh-hccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 490 WARPI-LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 490 ~~~~~-~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
+...- ......++++.|. .+..++..|++.||++|-++++.++.-
T Consensus 247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 22210 1111234444443 367899999999999999999999873
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=182.04 Aligned_cols=140 Identities=16% Similarity=0.176 Sum_probs=109.0
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCC--c-------hHHH-----------------HHHHHHHhhccCCCc
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--G-------DKEF-----------------LVEVEMLSRLHHRNL 327 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~-------~~~f-----------------~~Ei~~l~~l~HpnI 327 (615)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 1 1122 349999999988876
Q ss_pred ceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHh-HhCCCCcEEeccCCCCCeE
Q 007160 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL-HEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 328 v~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yL-H~~~~~~ivHrDIkp~NIL 406 (615)
.....+.. . ..+|||||+++++|...+.. ...+++.....++.|++.+|.|| |+.+ |+||||||+|||
T Consensus 82 ~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILL--K--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEe--c--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 44333321 1 34899999998877654322 23588899999999999999999 6888 999999999999
Q ss_pred EcCCCcEEEEeccccccCC
Q 007160 407 LENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~ 425 (615)
++ ++.++|+|||+|....
T Consensus 151 i~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EE-CCcEEEEEccccccCC
Confidence 98 4789999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=175.29 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=111.5
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc--------------------------hHHHHHHHHHHhhccCCCc
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------------------------DKEFLVEVEMLSRLHHRNL 327 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--------------------------~~~f~~Ei~~l~~l~HpnI 327 (615)
...||+|+||.||+|...+|+.||||++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 47899999999999998789999999987642110 1123578999999999987
Q ss_pred ceEEEEeecCCCCceeEEEecCCCCChhHh-hcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCe
Q 007160 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESW-LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNI 405 (615)
Q Consensus 328 v~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~-L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NI 405 (615)
.....+.. . ..+|||||++++++... +.. ..++......++.|++.+|.+||+ .+ |+||||||+||
T Consensus 82 ~~p~~~~~--~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NI 149 (190)
T cd05145 82 PVPEPILL--K--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNI 149 (190)
T ss_pred CCceEEEe--c--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhE
Confidence 55444432 1 24899999998865443 332 246778899999999999999999 88 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCC
Q 007160 406 LLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~ 426 (615)
|++ ++.++|+|||++.....
T Consensus 150 ll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE-CCCEEEEEcccceecCC
Confidence 999 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.2e-19 Score=171.48 Aligned_cols=186 Identities=18% Similarity=0.098 Sum_probs=140.7
Q ss_pred ccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCch----HHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEE
Q 007160 272 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD----KEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~----~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.+...|++|+||+||.+.. ++..++.+.+.....-.. .-|.+|+++|++++ |+++.+++++ + ..+++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~--~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D--GRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c--CEEEEE
Confidence 4568899999999997766 677888887765443211 24788999999995 5889999886 2 468999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccC-CCCCeEEcCCCcEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF-KASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||++|.+|.+.+.. ....++.|++++|.++|+.+ |+|||| ||+|||++.++.++|+|||++....
T Consensus 78 eyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 78 SYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99999998764421 11357789999999999999 999999 7999999999999999999998655
Q ss_pred CCCcc-----------ccceeeccccccCCccccccC-cCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 007160 426 EGRTN-----------YLSTRVMGTFGYVAPEYAMTG-HLL-VKSDVYSYGVVLLELLTGRKPVDM 478 (615)
Q Consensus 426 ~~~~~-----------~~~~~~~gt~~y~APE~~~~~-~~s-~ksDVwS~GvvL~ElltG~~Pf~~ 478 (615)
..... ........++.|++|+...-. ..+ .+.+.++-|.-+|.++|++.+...
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 43210 001123467888888754322 223 567889999999999999988643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=194.18 Aligned_cols=218 Identities=24% Similarity=0.387 Sum_probs=160.7
Q ss_pred HhhccCCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEec
Q 007160 319 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHR 398 (615)
Q Consensus 319 l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 398 (615)
|+.+.|.|+.+++|.+.. +...+.|.+||..|+|.|.+.. ....++|.-...+..++++||+|||+-. -..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeee
Confidence 457899999999999984 4789999999999999999975 2446899999999999999999999754 23999
Q ss_pred cCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccC-------cCCchhhHHHHHHHHHHHHh
Q 007160 399 DFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVLLELLT 471 (615)
Q Consensus 399 DIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-------~~s~ksDVwS~GvvL~Ellt 471 (615)
.++++|+++|..+.+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999998776431111111223345679999988763 24678999999999999999
Q ss_pred CCCCCCCCCCCCc-chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 472 GRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 472 G~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.+.||+....... ..++.+++. ......-|.+... .+....+..++..||..+|++||++++|-..++.+.
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccCccccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9999986443322 122222111 0011111111100 022235889999999999999999999987776654
Q ss_pred h
Q 007160 551 R 551 (615)
Q Consensus 551 ~ 551 (615)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 3
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.5e-19 Score=178.80 Aligned_cols=236 Identities=18% Similarity=0.268 Sum_probs=151.8
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccC----------CCcceEEEEee
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHH----------RNLVKLVGYYS 335 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H----------pnIv~l~g~~~ 335 (615)
.+...+.||.|+|+.||.++.. +|+.+|||.+..... ...+++.+|.-....+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556789999999999999975 589999998865442 233566666654444322 11221111111
Q ss_pred ---------c-CCCC-----ceeEEEecCCCCChhHhhc---CCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEe
Q 007160 336 ---------S-RDSS-----QHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 397 (615)
Q Consensus 336 ---------~-~~~~-----~~~LV~Ey~~~gsL~~~L~---~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 397 (615)
. .+.. ..+++|+-+ -++|.+++. ........+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 0 0111 346778877 568888763 11122334566778888899999999999999 999
Q ss_pred ccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCcccccc--------CcCCchhhHHHHHHHHHHH
Q 007160 398 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLEL 469 (615)
Q Consensus 398 rDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwS~GvvL~El 469 (615)
+||+++|++++.+|.++|+||+......... .....+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887654321 11345678999997643 2578999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 007160 470 LTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR 536 (615)
Q Consensus 470 ltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R 536 (615)
.+|+.||+.......... . -..|. +..+.+.+||..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986543221110 0 11233 455668899999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=199.72 Aligned_cols=201 Identities=21% Similarity=0.242 Sum_probs=159.3
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc---CCCcceEEEEeecCC
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRD 338 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~ 338 (615)
.+++...+.|.+.+.||+|+||+||+|...+|+.||+|.-+... ..+|.--.+++.||+ -+-|..+...+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 34555677899999999999999999998889999999876433 334555556666666 122333333333233
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-------CC
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-------NF 411 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------~~ 411 (615)
.-+||+||.+.|+|.+++.. .+.++|...+.++.|+++-++.||..+ |||+||||+|+||.. ..
T Consensus 768 --~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 768 --ASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred --cceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence 56899999999999999983 456899999999999999999999999 999999999999942 34
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCC
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK 474 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~ 474 (615)
.++|+|||.+-.+.--..........+|-.+-.+|...+..++..+|.|.+..+++-|+.|+.
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 699999999865432222223455678899999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=168.79 Aligned_cols=138 Identities=19% Similarity=0.240 Sum_probs=106.7
Q ss_pred ccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-----cCCCcceEEEEeecCCC-Cc-eeE
Q 007160 272 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-----HHRNLVKLVGYYSSRDS-SQ-HLL 344 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-----~HpnIv~l~g~~~~~~~-~~-~~L 344 (615)
...+.||+|+||.||. .-.++. .+||++........+.+.+|+++++++ .||||++++|++....+ +. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 223344 479988765555567899999999999 57999999999876432 23 337
Q ss_pred EEec--CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHH-HHhHhCCCCcEEeccCCCCCeEEcC----CCcEEEEe
Q 007160 345 CYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL-AYLHEDSQPCVIHRDFKASNILLEN----NFHAKVAD 417 (615)
Q Consensus 345 V~Ey--~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL-~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkL~D 417 (615)
|+|| +++|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 6679999999642 24444 35677888777 8999999 999999999999974 34799999
Q ss_pred cccc
Q 007160 418 FGLA 421 (615)
Q Consensus 418 FGla 421 (615)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-19 Score=193.18 Aligned_cols=225 Identities=28% Similarity=0.342 Sum_probs=174.8
Q ss_pred eeeccCceEEEEEE----ECCCcEEEEEEeccCCCCc--hHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEEec
Q 007160 276 ILGEGGFGRVFKGV----LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 276 ~LG~G~fG~Vykg~----~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
.+|+|.||.|++++ .+.|..+|+|.+++..... ......|..++...+ |+.+|++.-.+. .....+++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq--t~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ--TDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec--cccchhHhhhh
Confidence 37999999999866 2357789999887543211 124556888888887 999999976655 45578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
..+|.|...+... ..++......+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-+..
T Consensus 79 ~rgg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 79 LRGGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cccchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 9999999988752 34666777778888999999999999 9999999999999999999999999998765543
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. .+||..|||||++. ......|-||||++++||+||..||.. +..+.++..
T Consensus 152 ~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~----------- 202 (612)
T KOG0603|consen 152 I------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA----------- 202 (612)
T ss_pred h------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------
Confidence 2 17999999999988 556789999999999999999999963 111112211
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm 539 (615)
.-..|.+......+++..++..+|.+|--.
T Consensus 203 -~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 -ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 113455555567778888888899998654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-17 Score=161.04 Aligned_cols=134 Identities=19% Similarity=0.316 Sum_probs=111.5
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCCc--------hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
+.||+|++|.||+|.. +|..|+||+........ ...+.+|++++..++|+++.....++.. ....+++|
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEE
Confidence 5799999999999988 56789999866432211 1357889999999999998877766653 34678999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
||++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++.
T Consensus 79 e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998631 22 78899999999999999999 99999999999999 78999999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=160.16 Aligned_cols=146 Identities=17% Similarity=0.176 Sum_probs=114.9
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC----------------------chHHHHHHHHHH
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ----------------------GDKEFLVEVEML 319 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ei~~l 319 (615)
.++......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 4455555568888999999999999999888999999987643210 012366789999
Q ss_pred hhccCCC--cceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEe
Q 007160 320 SRLHHRN--LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 397 (615)
Q Consensus 320 ~~l~Hpn--Iv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 397 (615)
.++.|.+ +...++. ...+++|||+++++|.+.... .....++.+++.++.++|+.+ |+|
T Consensus 88 ~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H 148 (198)
T cd05144 88 KALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIH 148 (198)
T ss_pred HHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCc
Confidence 9998874 4444432 245899999999999765431 345678899999999999988 999
Q ss_pred ccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 398 RDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 398 rDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|||||+||++++++.++|+|||++.....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-18 Score=183.93 Aligned_cols=171 Identities=27% Similarity=0.448 Sum_probs=132.2
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
++++.|++|...+|.+||.+... ....+|...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999975433 3457889999999999999999 66 89999999999999999999999999
Q ss_pred cccCCCCC----ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhh
Q 007160 421 AKQAPEGR----TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 421 a~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
........ .....+...||..||+||.+.+.+|+.|+||||||++|+|++. -...++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------------- 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------------- 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------
Confidence 98766544 1223466789999999999999999999999999999999997 2322221
Q ss_pred ccchhhhhhcC----CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 007160 496 RDKDRLEELAD----PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542 (615)
Q Consensus 496 ~~~~~l~~i~d----~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eV 542 (615)
...+.++.| +....++|.+ ..++.+++.+.|.+||++.++
T Consensus 466 --~~t~~d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 --IATLTDIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --HHhhhhhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence 111222222 2222233433 578999999999999954443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=163.57 Aligned_cols=144 Identities=16% Similarity=0.177 Sum_probs=111.7
Q ss_pred cCcccceeeeccCceEEEEEE--ECCCcEEEEEEeccCCCC------------------------chHHHHHHHHHHhhc
Q 007160 269 NNFEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQ------------------------GDKEFLVEVEMLSRL 322 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~--~~~g~~VAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l 322 (615)
..|++.+.||+|+||.||+|. ..+|+.||||++...... ....+..|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358888999999999999998 568999999998754211 012356899999999
Q ss_pred cCCC--cceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccC
Q 007160 323 HHRN--LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF 400 (615)
Q Consensus 323 ~Hpn--Iv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 400 (615)
.+.+ +.+++++ . ..+|||||+++++|..++.. ...+...+...++.|++.+|.+||+.+. |+||||
T Consensus 108 ~~~~i~~p~~~~~----~--~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Di 175 (237)
T smart00090 108 YEAGVPVPKPIAW----R--RNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDL 175 (237)
T ss_pred HhcCCCCCeeeEe----c--CceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCC
Confidence 7633 3344432 1 34899999999888776532 1234556678999999999999998863 999999
Q ss_pred CCCCeEEcCCCcEEEEeccccccCC
Q 007160 401 KASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 401 kp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||+||+++ ++.++|+|||++....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.6e-17 Score=165.21 Aligned_cols=199 Identities=23% Similarity=0.295 Sum_probs=139.2
Q ss_pred cCCCcceEEEEeec-------------------------CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHH
Q 007160 323 HHRNLVKLVGYYSS-------------------------RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 377 (615)
Q Consensus 323 ~HpnIv~l~g~~~~-------------------------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia 377 (615)
+|||||++.++|.+ .++..+|+||.-++. +|.+++.. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 59999999987643 124568899988854 99999964 235667778899
Q ss_pred HHHHHHHHHhHhCCCCcEEeccCCCCCeEE--cCCC--cEEEEeccccccCCCCC--ccccc--eeeccccccCCccccc
Q 007160 378 LDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNF--HAKVADFGLAKQAPEGR--TNYLS--TRVMGTFGYVAPEYAM 449 (615)
Q Consensus 378 ~qia~gL~yLH~~~~~~ivHrDIkp~NILl--~~~~--~vkL~DFGla~~~~~~~--~~~~~--~~~~gt~~y~APE~~~ 449 (615)
.|+++|+.|||.++ |.|||+|++|||+ |+|. ...|+|||++-...... -.+.+ -..-|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999998 4443 47899999985433211 11111 1234777899999876
Q ss_pred cCc------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHH
Q 007160 450 TGH------LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCT 523 (615)
Q Consensus 450 ~~~------~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~ 523 (615)
..+ --.|+|.|+.|.+.||+++...||...... .+.. ....+-.-|.+...+|. .+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~---------r~Yqe~qLPalp~~vpp----~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDT---------RTYQESQLPALPSRVPP----VARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eech---------hhhhhhhCCCCcccCCh----HHHH
Confidence 432 236999999999999999999999753211 1100 01111122333333343 4788
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 007160 524 IAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 524 Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
++...|+.||++|++..-....|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999866554444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.4e-17 Score=181.36 Aligned_cols=139 Identities=20% Similarity=0.283 Sum_probs=110.8
Q ss_pred HhcCcccceeeeccCceEEEEEEECCCcEEEEEEe-ccCCC-------CchHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRL-TCGGQ-------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l-~~~~~-------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
....|...+.||+|+||.||+|.+.+.. +++|+. ..... ...+.+.+|++++.+++|++++....++..
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-- 407 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-- 407 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence 3445567899999999999999976544 444432 21111 112468899999999999999887777653
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 346789999999999999874 35678999999999999999 9999999999999 5779999999
Q ss_pred cccccC
Q 007160 419 GLAKQA 424 (615)
Q Consensus 419 Gla~~~ 424 (615)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=155.99 Aligned_cols=130 Identities=21% Similarity=0.299 Sum_probs=104.1
Q ss_pred eeeccCceEEEEEEECCCcEEEEEEeccCCCCc--------hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 276 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.||+|+||.||+|.+ +|..|++|......... ...+.+|++++..++|+++.....++. +....+++||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV--DPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE--ECCCCEEEEE
Confidence 489999999999996 56789999865432111 245778999999999887654444443 2335689999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
|++|++|.+++.... ..++.+++++|.+||+.+ ++|+|++|+||+++ ++.+++.|||+++.
T Consensus 78 ~~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999875311 078999999999999999 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.8e-15 Score=136.71 Aligned_cols=135 Identities=22% Similarity=0.194 Sum_probs=113.2
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccC--CCcceEEEEeecCCCCceeEEEecCC
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++... ....+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecC
Confidence 45789999999999999855 7899999865433 5679999999999986 588899887653 357899999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++.+..+ ++.....++.+++++|++||.....+++|+|++++||++++++.+++.|||.++.
T Consensus 77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8877653 4466778899999999999987555699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.6e-16 Score=176.83 Aligned_cols=209 Identities=23% Similarity=0.349 Sum_probs=141.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..+|+.+++|..|+||.||+.+++ ..+.+|+|+-+ .. -..+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence 357888999999999999999865 45778884322 11 11110 12222222222
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|+-...++.. +++.. +++.+++|||+.+ |+|||+||+|.+++.-|++|+.|||+++....
T Consensus 136 -----gDc~tllk~~----g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKNI----GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhcccC----CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 4444444421 11211 1277899999999 99999999999999999999999999875532
Q ss_pred CCc-------------cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 427 GRT-------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 427 ~~~-------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
... ......++||+.|.|||++....|....|.|++|+++||.+-|+.||....+++- +..
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~ 269 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQ 269 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhh
Confidence 111 1122356899999999999999999999999999999999999999986654321 111
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 537 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 537 (615)
++.+.... +.-...++. +..+++.+.|+.+|..|-
T Consensus 270 visd~i~w-----pE~dea~p~----Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 270 VISDDIEW-----PEEDEALPP----EAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhccc-----cccCcCCCH----HHHHHHHHHHHhChHhhc
Confidence 12111100 111122333 367899999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.6e-15 Score=144.02 Aligned_cols=137 Identities=21% Similarity=0.264 Sum_probs=99.5
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc--hHHH----------------------HHHHHHHhhccCCC--c
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKEF----------------------LVEVEMLSRLHHRN--L 327 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--~~~f----------------------~~Ei~~l~~l~Hpn--I 327 (615)
.+.||+|+||.||+|...+|+.||||++....... ...+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999887532211 1111 34666666665433 4
Q ss_pred ceEEEEeecCCCCceeEEEecCCCCChhHh-hcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCe
Q 007160 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESW-LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNI 405 (615)
Q Consensus 328 v~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~-L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NI 405 (615)
.+.+++ ...+++|||++++.+... +... ... .....++.+++.++.++|. .+ |+|+||||+||
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 444433 145899999999654321 1110 011 6678899999999999999 77 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCC
Q 007160 406 LLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~ 426 (615)
+++ ++.++|+|||.+.....
T Consensus 147 li~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE-CCcEEEEECcccccccC
Confidence 999 88999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=145.98 Aligned_cols=138 Identities=20% Similarity=0.249 Sum_probs=106.1
Q ss_pred ceeee-ccCceEEEEEEECCCcEEEEEEeccCCC-------------CchHHHHHHHHHHhhccCCCc--ceEEEEeecC
Q 007160 274 ASILG-EGGFGRVFKGVLSDGTAVAIKRLTCGGQ-------------QGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSR 337 (615)
Q Consensus 274 ~~~LG-~G~fG~Vykg~~~~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~~l~~l~HpnI--v~l~g~~~~~ 337 (615)
...|| .||.|+||++... +..++||++..... .....+.+|++++.+++|+++ ...+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999998885 67799998853210 122457889999999998875 6777765432
Q ss_pred CCC--ceeEEEecCCC-CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 338 DSS--QHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 338 ~~~--~~~LV~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
... ..++||||+++ .+|.+++... .++. ..+.+++.+|.+||+.+ |+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 221 23599999997 6999988641 2333 23678999999999999 99999999999999988999
Q ss_pred EEeccccccC
Q 007160 415 VADFGLAKQA 424 (615)
Q Consensus 415 L~DFGla~~~ 424 (615)
|+|||.++..
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-15 Score=171.96 Aligned_cols=256 Identities=24% Similarity=0.293 Sum_probs=187.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CCcEEEEEEeccCC--CCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~ 343 (615)
..|.+.+.||+|.|+.|-+.... ....+|+|.+.... .........|..+-..+. |.|++.+++... +....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~--~~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS--SPRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC--CCcccc
Confidence 35666778999999999887753 34567777766443 111233344777767776 999999999866 556889
Q ss_pred EEEecCCCCChhHhh-cCCCCCcccCChhhHHHHHHHHHHHHHHhH-hCCCCcEEeccCCCCCeEEcCCC-cEEEEeccc
Q 007160 344 LCYELVPNGSLESWL-HGPLGVNCHLDWETRMKIALDAARGLAYLH-EDSQPCVIHRDFKASNILLENNF-HAKVADFGL 420 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L-~~~~~~~~~l~~~~~~~ia~qia~gL~yLH-~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGl 420 (615)
+..+|..+|++.+.+ +... ...+....-.++.|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred cccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchh
Confidence 999999999999988 4321 13556677789999999999999 888 99999999999999999 999999999
Q ss_pred cccCCC-CCccccceeecc-ccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 421 AKQAPE-GRTNYLSTRVMG-TFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 421 a~~~~~-~~~~~~~~~~~g-t~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
|..... ...........| ++.|+|||...+. ......|+||.|+++.-+++|..|++....... ....|....
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~--- 247 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK--- 247 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---
Confidence 988776 444444455678 9999999998874 456789999999999999999999975543321 112221110
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... .... .........++...++..+|..|.+.+++...
T Consensus 248 -~~~----~~~~----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 -GRF----TQLP----WNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -ccc----ccCc----cccCChhhhhcccccccCCchhcccccccccc
Confidence 000 0011 11112235678888999999999999988653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.6e-13 Score=145.82 Aligned_cols=143 Identities=24% Similarity=0.264 Sum_probs=103.1
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc----------------------------------------hHHHH
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----------------------------------------DKEFL 313 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~----------------------------------------~~~f~ 313 (615)
.+.||.|++|.||+|++.+|+.||||+.+.+.... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986431100 01255
Q ss_pred HHHHHHhhcc----CCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHH-HHHHhH
Q 007160 314 VEVEMLSRLH----HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR-GLAYLH 388 (615)
Q Consensus 314 ~Ei~~l~~l~----HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~-gL~yLH 388 (615)
+|.+.+.++. |.+-+.+-.++.. .....+|||||++|++|.++...... .. .+.+++..+++ .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~-~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD-RTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh-hcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHH
Confidence 5666666552 3334444444432 22357999999999999987642111 11 34567777766 478899
Q ss_pred hCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 389 ~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
..+ ++|+|++|.||++++++.++++|||++.....
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 888 99999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.5e-14 Score=139.84 Aligned_cols=209 Identities=22% Similarity=0.286 Sum_probs=144.6
Q ss_pred HHHhhccCCCcceEEEEeecC---CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCC
Q 007160 317 EMLSRLHHRNLVKLVGYYSSR---DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393 (615)
Q Consensus 317 ~~l~~l~HpnIv~l~g~~~~~---~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~ 393 (615)
.-|-++-|-|||++..|+.+. +.....++.|||..|+|..+|++.......+......+++.||..||.|||+.. |
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566799999999987642 345678999999999999999876655666777888899999999999999986 5
Q ss_pred cEEeccCCCCCeEEcCCCcEEEEeccccccCCC--CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh
Q 007160 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471 (615)
Q Consensus 394 ~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt 471 (615)
+|+|+++..+.|++..++-+|+.----...... ...........+-++|.+||+-.....+..+|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 599999999999999999888842111100000 000011223456789999998888888899999999999999988
Q ss_pred CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 472 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 472 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
|..--.... .....-+.... .+..+-++. =+.++..|++.+|+.||+|++++.|.
T Consensus 278 lEiq~tnse-S~~~~ee~ia~-------~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSE-SKVEVEENIAN-------VIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCc-ceeehhhhhhh-------heeeccCcc------------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 764211110 00000000000 000111111 13578899999999999999987664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=6e-12 Score=119.18 Aligned_cols=131 Identities=16% Similarity=0.070 Sum_probs=98.5
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcce-EEEEeecCCCCceeEEEecCCCC
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK-LVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~-l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
.+.|+.|.++.||+++.. +..|++|....... ....+.+|+++++.+.+.++++ ++.+.. ...++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCC
Confidence 367899999999999875 67899998764322 2345788999999987666554 444321 2357999999998
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC--CCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--QPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++.+.. .....++.+++++|+.||..+ ...++|+|+++.||+++ ++.++++|||.+..
T Consensus 77 ~l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 876430 112345778999999999887 34469999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-12 Score=139.81 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=176.2
Q ss_pred cCcccceeeec--cCceEEEEEEE---CCCcEEEEEEeccC--CCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCC
Q 007160 269 NNFEPASILGE--GGFGRVFKGVL---SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 269 ~~f~~~~~LG~--G~fG~Vykg~~---~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~ 340 (615)
..|.....+|. |.+|.||.+.. .++..+|+|+-+.. .......=.+|+....+++ |+|.++....+. +.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--GSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc--cCC
Confidence 34566788999 99999999986 35788999984432 2233344456777777774 999999666655 555
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHH----HHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR----GLAYLHEDSQPCVIHRDFKASNILLENN-FHAKV 415 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~----gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL 415 (615)
..++-.|++ +.+|.++.+... ..+.....+.+..+..+ ||.++|... ++|-|+||.||++..+ ...++
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 778888888 578988887532 23566777778888878 999999998 9999999999999998 88999
Q ss_pred EeccccccCCCCCccc---cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 007160 416 ADFGLAKQAPEGRTNY---LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
+|||+...+.+..... ...+..|...|++||.. .+-++...|+|++|.+.+|..+|.......-. ..|.
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~- 336 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS- 336 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc-
Confidence 9999999887654211 11233678899999965 45678899999999999999998765532211 1111
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 544 (615)
.++....-.++.+ .-...+...+.++++.++..|++.+.+..
T Consensus 337 -~~r~~~ip~e~~~---------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -QLRQGYIPLEFCE---------GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccccCchhhhc---------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111110111111 11123445888999999999998887754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-11 Score=134.90 Aligned_cols=149 Identities=17% Similarity=0.196 Sum_probs=97.2
Q ss_pred hcCcccceeeeccCceEEEEEEECC-CcEEEEEEeccCCCC--------------------------c--------h---
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ--------------------------G--------D--- 309 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~--------------------------~--------~--- 309 (615)
-..|+. +.||+|++|.||+|++.+ |+.||||++..+-.. . .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 789999999999999987 999999998743100 0 0
Q ss_pred ---HHHHHHHHHHhhcc----CCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHH
Q 007160 310 ---KEFLVEVEMLSRLH----HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382 (615)
Q Consensus 310 ---~~f~~Ei~~l~~l~----HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~ 382 (615)
-+|.+|+..+.+++ +.+.+.+-.++.+- ....+|||||++|+.|.++-.-... ..+ +..++...++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~---g~d---~~~la~~~v~ 270 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAA---GTD---MKLLAERGVE 270 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhc---CCC---HHHHHHHHHH
Confidence 12445555555553 44445444444321 3467899999999999875321000 111 1122222221
Q ss_pred -HHHHhHhCCCCcEEeccCCCCCeEEcCCC----cEEEEeccccccCCCC
Q 007160 383 -GLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVADFGLAKQAPEG 427 (615)
Q Consensus 383 -gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~DFGla~~~~~~ 427 (615)
-+..++..+ ++|+|+||.||+++.++ .+++.|||++......
T Consensus 271 ~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 271 VFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 233345577 99999999999999888 9999999999877543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.9e-10 Score=112.15 Aligned_cols=144 Identities=22% Similarity=0.245 Sum_probs=110.7
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCC-CchHHHHHHHHHHhhccC--CCcceEEEEeecCC-CCceeEEEecCC
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRD-SSQHLLCYELVP 350 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H--pnIv~l~g~~~~~~-~~~~~LV~Ey~~ 350 (615)
+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++ .++.+++.+..... .+..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778899998764332 134578999999999976 34567777754321 125689999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC---------------------------------------
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--------------------------------------- 391 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--------------------------------------- 391 (615)
|.+|.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876531 23667778888888888888888531
Q ss_pred --------------CCcEEeccCCCCCeEEcC--CCcEEEEecccccc
Q 007160 392 --------------QPCVIHRDFKASNILLEN--NFHAKVADFGLAKQ 423 (615)
Q Consensus 392 --------------~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~ 423 (615)
..+++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 356899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-09 Score=106.39 Aligned_cols=137 Identities=17% Similarity=0.167 Sum_probs=98.5
Q ss_pred ceeeeccCceEEEEEEECC-------CcEEEEEEeccCCC----------------------CchHHHH----HHHHHHh
Q 007160 274 ASILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGGQ----------------------QGDKEFL----VEVEMLS 320 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~~----------------------~~~~~f~----~Ei~~l~ 320 (615)
...||.|--+.||.|...+ +..+|||..+.... ...+.+. +|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 47899997753210 0012233 7999999
Q ss_pred hccC--CCcceEEEEeecCCCCceeEEEecCCCCChhH-hhcCCCCCcccCChhhHHHHHHHHHHHHHHh-HhCCCCcEE
Q 007160 321 RLHH--RNLVKLVGYYSSRDSSQHLLCYELVPNGSLES-WLHGPLGVNCHLDWETRMKIALDAARGLAYL-HEDSQPCVI 396 (615)
Q Consensus 321 ~l~H--pnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~-~L~~~~~~~~~l~~~~~~~ia~qia~gL~yL-H~~~~~~iv 396 (615)
++.. -++-+.+++ ...+|||||+.+..+.. .|+. ..++..+...+..+++.+|..| |..+ |+
T Consensus 82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lV 147 (197)
T cd05146 82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LV 147 (197)
T ss_pred HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9863 456666654 24689999997654422 2221 1244456677889999999998 8888 99
Q ss_pred eccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 397 HRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 397 HrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|+||++.|||+++ +.+.|+|||.+....
T Consensus 148 HGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999999974 679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.7e-10 Score=122.68 Aligned_cols=166 Identities=18% Similarity=0.221 Sum_probs=124.6
Q ss_pred ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCC
Q 007160 290 LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 369 (615)
Q Consensus 290 ~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~ 369 (615)
..++.+|.|...+...........+-++.|+.++||||++++..+. .....|||+|-+. .|..+++. ++
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e--~~~~~ylvTErV~--Pl~~~lk~-------l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE--EEGTLYLVTERVR--PLETVLKE-------LG 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc--ccCceEEEeeccc--cHHHHHHH-------hH
Confidence 4467888888887655433345677888999999999999999876 4458999999874 57777764 34
Q ss_pred hhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccc
Q 007160 370 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449 (615)
Q Consensus 370 ~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~ 449 (615)
.......+.||+.||.|||+.+. ++|++|.-+.|+++..|..||++|.++........ ......--..|..|+.+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence 56677788999999999997664 99999999999999999999999998865543221 011111222466666544
Q ss_pred cCcCCchhhHHHHHHHHHHHHhC
Q 007160 450 TGHLLVKSDVYSYGVVLLELLTG 472 (615)
Q Consensus 450 ~~~~s~ksDVwS~GvvL~ElltG 472 (615)
... -..|.|-||++++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 332 346999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-10 Score=126.05 Aligned_cols=248 Identities=23% Similarity=0.260 Sum_probs=170.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEE--CCCcEEEEEEeccCCCCchHH--HHHHHHHHhhc-cCCCcceEEEEeecCCCC
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVL--SDGTAVAIKRLTCGGQQGDKE--FLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~~~~~~~--f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 340 (615)
..+.+|..+..||.|.|+.|++... .++..+++|.+.........+ -+.|+-+...+ .|.+++.....+...+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-- 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-- 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--
Confidence 3456788999999999999999774 367889999887654333222 24466666665 4777777665444323
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEEEecc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFG 419 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFG 419 (615)
..++=-||++++++...+.. ...++...++++..|++.++.++|+.. ++|+|+||+||++.++ +..+++|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccc
Confidence 55688899999998877632 234777889999999999999999888 9999999999999886 889999999
Q ss_pred ccccCCCCCccccceeeccccccC--CccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYV--APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
++....... ......-+++ +++......+..+.|+||||.-+.|.++|..--. +.+.|.. ++
T Consensus 413 ~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~--i~- 476 (524)
T KOG0601|consen 413 CWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLT--IR- 476 (524)
T ss_pred cccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCc--------cccccee--ee-
Confidence 986532211 1112222344 5555566778899999999999999998875321 1111211 00
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.+.. +++ +. ....+..+...+..+++..||.+.++..+...
T Consensus 477 ~~~~-----p~~----~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 477 SGDT-----PNL----PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cccc-----cCC----Cc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0000 111 11 11345567788899999999999888766443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.5e-08 Score=108.36 Aligned_cols=172 Identities=20% Similarity=0.243 Sum_probs=130.2
Q ss_pred CceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeec--CCCCceeEEEecCCC-CChhH
Q 007160 281 GFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS--RDSSQHLLCYELVPN-GSLES 356 (615)
Q Consensus 281 ~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~~~LV~Ey~~~-gsL~~ 356 (615)
.-.+.||+.. .||..|+.|+++....+.......-+++++++.|.|+|++..++.. .+...++|||+|+|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3467899884 4799999999954333333334456889999999999999987652 234578999999997 67777
Q ss_pred hhcCCCC-----------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 357 WLHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 357 ~L~~~~~-----------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
+-..... .+....+..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+.+|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 6543221 1234677899999999999999999999 8889999999999999999999999877665
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCC
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK 474 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~ 474 (615)
.+... -+.. -.+-|.=.||.+++.|.||..
T Consensus 445 ~d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPTE----------------PLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCCc----------------chhH---HhhhhHHHHHHHHHHHhhccc
Confidence 44311 1111 125699999999999999964
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-08 Score=95.42 Aligned_cols=132 Identities=18% Similarity=0.271 Sum_probs=95.3
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEe-ccCCCCc-------hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRL-TCGGQQG-------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l-~~~~~~~-------~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..+++|+-+.+|.+.+.+ ..+++|.= .+.-... ...-.+|.+++.+++--.|..-.=|.. +.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCCEEEE
Confidence 357899999999997643 44566633 2221111 134567999999886444332222222 555778999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||++|-.|.+.+... ...++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+...
T Consensus 79 e~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999999888642 3566777777888999999 99999999999998765 999999999743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3e-08 Score=93.61 Aligned_cols=144 Identities=21% Similarity=0.307 Sum_probs=100.7
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEE-eccCCCC-------chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKR-LTCGGQQ-------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~-l~~~~~~-------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
....|-+|+-+.|+++.+. |+...||. +.+.-.. ..+...+|++.|.++.--.|.--.-++. +...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~--D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI--DTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE--ecCCCeE
Confidence 5688999999999999985 56666663 3322111 1346778999999886444433333333 3335578
Q ss_pred EEecCCC-CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC---cEEEEeccc
Q 007160 345 CYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGL 420 (615)
Q Consensus 345 V~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGl 420 (615)
+|||+++ .++.+++..... ..........++..|-+.+.-||.++ |+|+||..+||+|..++ .+.++|||+
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecc
Confidence 8999977 478888864221 11222333678888999999999999 99999999999996543 468999999
Q ss_pred cccC
Q 007160 421 AKQA 424 (615)
Q Consensus 421 a~~~ 424 (615)
+...
T Consensus 163 s~~s 166 (229)
T KOG3087|consen 163 SSVS 166 (229)
T ss_pred hhcc
Confidence 8643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.4e-09 Score=124.26 Aligned_cols=249 Identities=22% Similarity=0.236 Sum_probs=163.9
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
..+.|.+.+-+-+|.++.++.+.-. .|...+.|...... .+..+....+-.++-..+||-++...--+ ......
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCc
Confidence 4567777788889999999987632 23333444332211 11112222222233223445555443221 234467
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
+|+++|+.+++|...|+... ..+.+........+...++|||... +.|+|++|.|+|...++..+++|||...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 89999999999999998532 3455555666777888999999887 8999999999999999999999998443
Q ss_pred cCCCC----------------------C-------ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCC
Q 007160 423 QAPEG----------------------R-------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473 (615)
Q Consensus 423 ~~~~~----------------------~-------~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~ 473 (615)
....- . .........||+.|.+||...+......+|.|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 22100 0 001123467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCcc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007160 474 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL-GGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540 (615)
Q Consensus 474 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 540 (615)
.||....+.... . .+....+ ....+.+......+++...+..++.+|-.|.
T Consensus 1033 pp~na~tpq~~f------~----------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIF------E----------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhhh------h----------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999765543211 1 1111111 1112223334466788888899999997666
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.1e-08 Score=99.22 Aligned_cols=143 Identities=18% Similarity=0.122 Sum_probs=102.2
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCC-----------chHHHHHHHHHHhhccCC--CcceEEEEeecCC---
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-----------GDKEFLVEVEMLSRLHHR--NLVKLVGYYSSRD--- 338 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~Hp--nIv~l~g~~~~~~--- 338 (615)
+.+-+.....|++..+ +|+.|.||+....... ....+.+|.+.+.++..- .....+++.....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455555556778777 5678999977533311 011478999999888533 3345555653221
Q ss_pred CCceeEEEecCCCC-ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-------C
Q 007160 339 SSQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-------N 410 (615)
Q Consensus 339 ~~~~~LV~Ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------~ 410 (615)
....+||+|++++- +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 8999885321 123445677789999999999999999 999999999999975 5
Q ss_pred CcEEEEecccccc
Q 007160 411 FHAKVADFGLAKQ 423 (615)
Q Consensus 411 ~~vkL~DFGla~~ 423 (615)
..+.|+||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 7899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.2e-08 Score=93.38 Aligned_cols=126 Identities=22% Similarity=0.320 Sum_probs=84.6
Q ss_pred EEEEEEECCCcEEEEEEeccCCC-------------C--------c-----hHHHHHHHHHHhhccCC--CcceEEEEee
Q 007160 284 RVFKGVLSDGTAVAIKRLTCGGQ-------------Q--------G-----DKEFLVEVEMLSRLHHR--NLVKLVGYYS 335 (615)
Q Consensus 284 ~Vykg~~~~g~~VAVK~l~~~~~-------------~--------~-----~~~f~~Ei~~l~~l~Hp--nIv~l~g~~~ 335 (615)
.||.|...+|..+|||..+.... . . .....+|.+.|.++..- ++-+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999998754210 0 0 12356799999999765 455666542
Q ss_pred cCCCCceeEEEecCC--CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHH-hHhCCCCcEEeccCCCCCeEEcCCCc
Q 007160 336 SRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY-LHEDSQPCVIHRDFKASNILLENNFH 412 (615)
Q Consensus 336 ~~~~~~~~LV~Ey~~--~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~y-LH~~~~~~ivHrDIkp~NILl~~~~~ 412 (615)
..+|||||++ |..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-C
T ss_pred -----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-e
Confidence 3489999998 5555443331 12245667788888886665 57888 9999999999999988 9
Q ss_pred EEEEeccccccCC
Q 007160 413 AKVADFGLAKQAP 425 (615)
Q Consensus 413 vkL~DFGla~~~~ 425 (615)
+.|+|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7e-07 Score=93.71 Aligned_cols=268 Identities=18% Similarity=0.194 Sum_probs=157.6
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEE----eec-CCCCceeEEE
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY----YSS-RDSSQHLLCY 346 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~----~~~-~~~~~~~LV~ 346 (615)
..+-||+|+-+.+|-.- .-..-+.|+..........+ .+.+|... .||-+-.=+.| ... +.+...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45779999999999532 11122446665433222222 23334333 45543321111 011 1222255667
Q ss_pred ecCCCC-ChhHhhcC--CCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 347 ELVPNG-SLESWLHG--PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 347 Ey~~~g-sL~~~L~~--~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
..+.+. .+.+++.- .+......+|...++++..+|.+.+-||+.| .+-+|++++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 776653 23333321 1223446899999999999999999999999 88899999999999999999998654443
Q ss_pred CCCCCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcc--hhh-Hhhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQE--NLV-TWARPI 494 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG-~~Pf~~~~~~~~~--~l~-~~~~~~ 494 (615)
..++. .....+|...|.+||.-. +-.-+...|-|.+||++++++.| ++||......... .+. +.+...
T Consensus 167 ~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32221 223457899999999654 33456789999999999999886 9999643221111 000 001000
Q ss_pred hccch--hhhhhcCCccCCCCCHHH-HHHHHHHHHHccccC--CCCCCCHHHHHHHHHHhHhhhh
Q 007160 495 LRDKD--RLEELADPRLGGKYPKED-FIRVCTIAAACVAPE--ANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 495 ~~~~~--~l~~i~d~~l~~~~~~~~-~~~l~~Li~~Cl~~d--P~~RPsm~eVl~~L~~i~~~~~ 554 (615)
+.... ......-| ...|-+. ...+-.+..+|+... +.-|||++..+..|..+.+.+.
T Consensus 244 f~ya~~~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 244 FAYASDQRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeechhccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 10000 00000000 1111111 123455667777653 5689999999999988877653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.6e-07 Score=89.31 Aligned_cols=137 Identities=21% Similarity=0.217 Sum_probs=100.5
Q ss_pred cccceeeeccCceEEEEEEECCCcEEEEEEeccCCC----------------C------chHHHHHHHHHHhhccCC--C
Q 007160 271 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ----------------Q------GDKEFLVEVEMLSRLHHR--N 326 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~----------------~------~~~~f~~Ei~~l~~l~Hp--n 326 (615)
..+.+.||.|--+.||.|....|.++|||.-+.+.. . ......+|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999995432210 0 012456799999998754 6
Q ss_pred cceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeE
Q 007160 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 327 Iv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NIL 406 (615)
+-+-+++ +...+||||++|-.|...- ++.+..-.++..|++-+.-+-..| +||+|+..-||+
T Consensus 173 VP~P~~~------nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIl 234 (304)
T COG0478 173 VPKPIAW------NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNIL 234 (304)
T ss_pred CCCcccc------ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEE
Confidence 6666654 3568999999986665422 233444555666666666555677 999999999999
Q ss_pred EcCCCcEEEEeccccccCC
Q 007160 407 LENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~ 425 (615)
+++||.+.++||-.+....
T Consensus 235 V~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred EecCCCEEEEeCcccccCC
Confidence 9999999999998775543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.8e-07 Score=87.71 Aligned_cols=110 Identities=25% Similarity=0.273 Sum_probs=84.8
Q ss_pred hHHHHHHHHHHhhcc--CCCcceEEEEeecCCC--CceeEEEecCCCC-ChhHhhcCCCCCcccCChhhHHHHHHHHHHH
Q 007160 309 DKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS--SQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARG 383 (615)
Q Consensus 309 ~~~f~~Ei~~l~~l~--HpnIv~l~g~~~~~~~--~~~~LV~Ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~g 383 (615)
.....+|.+.+.++. .-...+.+++...... ...+||+|++++. +|.+++.... .++......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 346788888888875 3345566666553222 2458999999984 7999987421 14556778999999999
Q ss_pred HHHhHhCCCCcEEeccCCCCCeEEcCCC---cEEEEeccccccCC
Q 007160 384 LAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGLAKQAP 425 (615)
Q Consensus 384 L~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~~~ 425 (615)
++-||..+ |+|+|+++.|||++.+. .+.++||+.++...
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999 99999999999998877 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.7e-06 Score=84.70 Aligned_cols=140 Identities=17% Similarity=0.165 Sum_probs=103.0
Q ss_pred eeccCceEEEEEEECCCcEEEEEEeccC---C---CCchHHHHHHHHHHhhccC--CCcceEEEEee---cCCCCceeEE
Q 007160 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCG---G---QQGDKEFLVEVEMLSRLHH--RNLVKLVGYYS---SRDSSQHLLC 345 (615)
Q Consensus 277 LG~G~fG~Vykg~~~~g~~VAVK~l~~~---~---~~~~~~f~~Ei~~l~~l~H--pnIv~l~g~~~---~~~~~~~~LV 345 (615)
-|+||.+-|++-.+.+ ..+-+|+-... + ......|.+|+..|.++.. -.+.+.+ ++. ......-+||
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4578999999987754 47889987522 1 2356789999999999863 2344444 332 1122346799
Q ss_pred EecCCC-CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc--EEEEeccccc
Q 007160 346 YELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADFGLAK 422 (615)
Q Consensus 346 ~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~ 422 (615)
+|-+++ -+|.+++.... -.+.+...+..+..++++.+.-||+.+ +.|+|+.+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997754 68998885421 123566777899999999999999999 999999999999986666 9999998776
Q ss_pred c
Q 007160 423 Q 423 (615)
Q Consensus 423 ~ 423 (615)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.8e-08 Score=108.93 Aligned_cols=151 Identities=21% Similarity=0.258 Sum_probs=101.7
Q ss_pred HHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcc-------ccceeeccccccCCcccccc
Q 007160 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-------YLSTRVMGTFGYVAPEYAMT 450 (615)
Q Consensus 378 ~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-------~~~~~~~gt~~y~APE~~~~ 450 (615)
.+++.||.|+|..- .+||++|.|++|.++.++..||+.|+.+......... ....-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999754 4999999999999999999999999998765442111 01111234568999999999
Q ss_pred CcCCchhhHHHHHHHHHHHHhCCCCC-CCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHcc
Q 007160 451 GHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACV 529 (615)
Q Consensus 451 ~~~s~ksDVwS~GvvL~ElltG~~Pf-~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl 529 (615)
...+.++|+||+||++|-+..|..+. ........... ....+..-...++.+...++.+=+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccccccccccccCcHHHHHHHHHHh
Confidence 88999999999999999999555443 32211110000 0000110011122333345777788889
Q ss_pred ccCCCCCCCHHHHHH
Q 007160 530 APEANQRPTMGEVVQ 544 (615)
Q Consensus 530 ~~dP~~RPsm~eVl~ 544 (615)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998887753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.9e-06 Score=82.67 Aligned_cols=139 Identities=17% Similarity=0.228 Sum_probs=83.0
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc--ceEEEEeecCCCCceeEEEecCCCC
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI--v~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.+++.. +.....+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~--~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE--DGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe--cCCeeeeeeeecCCc
Confidence 67899999999983 24457788876422 34567889999999864444 55666654 334567899999886
Q ss_pred C-hhHhh---------------------cCCCCCcccCChhhHHH-HHH----------HHHH-HHHHhHh-CCCCcEEe
Q 007160 353 S-LESWL---------------------HGPLGVNCHLDWETRMK-IAL----------DAAR-GLAYLHE-DSQPCVIH 397 (615)
Q Consensus 353 s-L~~~L---------------------~~~~~~~~~l~~~~~~~-ia~----------qia~-gL~yLH~-~~~~~ivH 397 (615)
+ +.+.+ |...... ........ +.. .+.+ ...+|.. ...+.++|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 3 22111 1110000 01010000 000 0001 1122221 12345899
Q ss_pred ccCCCCCeEEcCCCcEEEEecccccc
Q 007160 398 RDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 398 rDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=5e-06 Score=82.20 Aligned_cols=146 Identities=19% Similarity=0.205 Sum_probs=85.6
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCC--cceEEEEeecCC-CCceeEEEecCC
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLVGYYSSRD-SSQHLLCYELVP 350 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~-~~~~~LV~Ey~~ 350 (615)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.++.... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999877 68999987533 33567888999998886433 456666443222 234689999999
Q ss_pred CCChhH----------------hh---cCCCCCcccCChhh---------HHHH------------HHHHHH-HHHHhHh
Q 007160 351 NGSLES----------------WL---HGPLGVNCHLDWET---------RMKI------------ALDAAR-GLAYLHE 389 (615)
Q Consensus 351 ~gsL~~----------------~L---~~~~~~~~~l~~~~---------~~~i------------a~qia~-gL~yLH~ 389 (615)
+..+.. .+ +..........+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 11100000111100 0000 111222 2333332
Q ss_pred ----CCCCcEEeccCCCCCeEEc-CCCcEEEEeccccc
Q 007160 390 ----DSQPCVIHRDFKASNILLE-NNFHAKVADFGLAK 422 (615)
Q Consensus 390 ----~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~ 422 (615)
.....++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2456699999999999999 66667899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.4e-06 Score=92.72 Aligned_cols=142 Identities=21% Similarity=0.266 Sum_probs=94.9
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCC---------------------c-----h----H----------HHHH
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ---------------------G-----D----K----------EFLV 314 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---------------------~-----~----~----------~f~~ 314 (615)
+-|+.++-|.||+|++.+|+.||||+.+.+-.. . . + +|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 678999999999999999999999987543100 0 0 1 2444
Q ss_pred HHHHHhhcc----CCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHH-HHHhHh
Q 007160 315 EVEMLSRLH----HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG-LAYLHE 389 (615)
Q Consensus 315 Ei~~l~~l~----HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~g-L~yLH~ 389 (615)
|..-+.+++ +..-+++=.+|.+ -.+...|+|||++|-.+.+...-.. ..++ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehh-ccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 555555552 2223333344432 2346789999999999988852211 1133 33444444443 334444
Q ss_pred CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 390 ~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
.+ +.|.|..|.||+++.++++.+.|||+.....+
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 67 99999999999999999999999999877654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.7e-05 Score=78.49 Aligned_cols=141 Identities=21% Similarity=0.226 Sum_probs=84.5
Q ss_pred eeeccCc-eEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEEecCCCCC
Q 007160 276 ILGEGGF-GRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGS 353 (615)
Q Consensus 276 ~LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gs 353 (615)
.|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++... ....++|||+++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCCcc
Confidence 3455555 789998764 4678888876432 345778999998884 4345567766542 245789999999988
Q ss_pred hhHhh-------------------cCCCCCcccCC--hhhHHHHHH--------------------HHHHHHHHhH----
Q 007160 354 LESWL-------------------HGPLGVNCHLD--WETRMKIAL--------------------DAARGLAYLH---- 388 (615)
Q Consensus 354 L~~~L-------------------~~~~~~~~~l~--~~~~~~ia~--------------------qia~gL~yLH---- 388 (615)
|.... |........+. +........ .+...+..|-
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 76432 11100000110 000000000 0111112221
Q ss_pred hCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 389 ~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
....+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1134679999999999999998788999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=78.47 Aligned_cols=140 Identities=16% Similarity=0.164 Sum_probs=93.8
Q ss_pred HhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHH---------HHHHHHHHhhccCC---CcceEEEEe
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---------FLVEVEMLSRLHHR---NLVKLVGYY 334 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~~l~~l~Hp---nIv~l~g~~ 334 (615)
...+|...+++-......|.+-.. +|..+.+|..........+. ..+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 457788888888888888888777 46789999887544322222 23344444444322 222222221
Q ss_pred ec---CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 335 SS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 335 ~~---~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
.- .-....+|+|||++|..|.++.. ++. .++..+.+++.-||..| +.|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 11 11235578999999988877643 221 35566778899999999 99999999999999654
Q ss_pred cEEEEecccccc
Q 007160 412 HAKVADFGLAKQ 423 (615)
Q Consensus 412 ~vkL~DFGla~~ 423 (615)
+++.||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.5e-05 Score=74.88 Aligned_cols=153 Identities=18% Similarity=0.222 Sum_probs=103.3
Q ss_pred CCHHHHHHHhcCcccceeee---ccCceEEEEEEECCCcEEEEEEeccCCCC-------------------chH----H-
Q 007160 259 LAYEELKEATNNFEPASILG---EGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-------------------GDK----E- 311 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG---~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-------------------~~~----~- 311 (615)
.+++.+....++..+....| .|--..||+|...++..||||++...... ..+ .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45566666666666666555 56667899999888999999998643211 001 1
Q ss_pred HHHHHHHHhhcc--CCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh
Q 007160 312 FLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389 (615)
Q Consensus 312 f~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 389 (615)
-.+|..-|.++. +-.+-+-+++. .-.|||||+.... ...+.-....+.......+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~------~nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR------NNVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec------CCeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 234777777774 44555555553 3479999996541 11111112233334567778888888888776
Q ss_pred -CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 390 -DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 390 -~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
.+ +||+||..-|||+. ++.+.|+|||.|....
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 56 99999999999999 7899999999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.3e-05 Score=77.84 Aligned_cols=105 Identities=25% Similarity=0.230 Sum_probs=81.7
Q ss_pred HHHHHHHhhccC-CCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC
Q 007160 313 LVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391 (615)
Q Consensus 313 ~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~ 391 (615)
..|.-+|+.+++ +++.+++|+|- .+++.||...+++...- .....-..-+|..|.+||.++++.+.+|++..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 347888888876 69999999983 36789999877664220 00000113689999999999999999999865
Q ss_pred CCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 392 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
...+...|++++|+-+++++++|+.|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 445888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.4e-05 Score=89.18 Aligned_cols=81 Identities=16% Similarity=0.213 Sum_probs=58.1
Q ss_pred ceeeeccCceEEEEEEECCC---cEEEEEEeccCCC-CchHHHHHHHHHHhhcc-CCCc--ceEEEEeecCC-CCceeEE
Q 007160 274 ASILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNL--VKLVGYYSSRD-SSQHLLC 345 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-HpnI--v~l~g~~~~~~-~~~~~LV 345 (615)
.+.|+.|.++.+|+....++ ..+++|+...... .....+.+|+++|+.+. |.++ .+++++|.+.+ .+..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47789999999999887654 3677787654322 23457889999999995 6664 77788775321 1357899
Q ss_pred EecCCCCCh
Q 007160 346 YELVPNGSL 354 (615)
Q Consensus 346 ~Ey~~~gsL 354 (615)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.2e-07 Score=97.51 Aligned_cols=188 Identities=20% Similarity=0.162 Sum_probs=131.3
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCC-cceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN-LVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~~~LV~ 346 (615)
+.-+....-+++|+++++||.+-.-.+...++.+... ....-++++|.+++||| .+..++-+. .....++.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i~~ 313 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWIPM 313 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCC--cccccchhh
Confidence 3444445668899999999987432333446665422 45566899999999999 555555443 334678899
Q ss_pred ecCCCC-ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 347 ELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
+++..| +-..-.. .....+..-+...+...-+++|+|||+.. =+|+| ||+..+ ...|..||+......
T Consensus 314 ~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 314 RICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 999877 2221111 01112333344556667788999999875 57998 787776 578999999987665
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCC
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 476 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf 476 (615)
... ......+|+.|+|||+.....+..+-|+|+.|+--.++--|-.|-
T Consensus 383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 443 234467999999999999999999999999998777777776664
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.7e-05 Score=74.92 Aligned_cols=143 Identities=18% Similarity=0.202 Sum_probs=78.2
Q ss_pred eeeeccCce-EEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCC---CcceEEEEeecCCC-CceeEEEecC
Q 007160 275 SILGEGGFG-RVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR---NLVKLVGYYSSRDS-SQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG-~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp---nIv~l~g~~~~~~~-~~~~LV~Ey~ 349 (615)
+.|+.||.. .||+. +..+++|.... ......+.+|.+++..+... .+-+.++.....+. ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777776 59975 23567776543 22345788999999888532 23344443322111 2347899999
Q ss_pred CCCChhHh------------------hcCCCCCcccC-------------ChhhHH--HHH-------HHHHHH-HH-Hh
Q 007160 350 PNGSLESW------------------LHGPLGVNCHL-------------DWETRM--KIA-------LDAARG-LA-YL 387 (615)
Q Consensus 350 ~~gsL~~~------------------L~~~~~~~~~l-------------~~~~~~--~ia-------~qia~g-L~-yL 387 (615)
+|.++.+. ||......... .|.... .+. .+.+.. ++ ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 99777432 12111000000 111110 000 011111 11 11
Q ss_pred Hh--CCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 388 HE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 388 H~--~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+. ...+.++|+|+.+.||+++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1345699999999999999776677999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00029 Score=73.48 Aligned_cols=81 Identities=14% Similarity=0.065 Sum_probs=58.5
Q ss_pred cccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccC---CCcceEEEEeecC-CCCceeEEE
Q 007160 271 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH---RNLVKLVGYYSSR-DSSQHLLCY 346 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---pnIv~l~g~~~~~-~~~~~~LV~ 346 (615)
....+.||.|..+.||+....+++ +.+|..+. ......|.+|.+.|+.+.. -.+.+++++|... ..+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 334577999999999998766664 66676432 1124588999999998853 3677888877532 234579999
Q ss_pred ecCCCCCh
Q 007160 347 ELVPNGSL 354 (615)
Q Consensus 347 Ey~~~gsL 354 (615)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00013 Score=69.14 Aligned_cols=130 Identities=19% Similarity=0.185 Sum_probs=88.8
Q ss_pred ccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcce-EEEEeecCCCCceeEEEecCC
Q 007160 272 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK-LVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~-l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
...+.|++|++|.||+|.+. |..+|+|.-..++ ....+..|+++|..++-.++-+ ++.|- .-++.|||+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG------EDFIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec------hhhhhhhhhc
Confidence 34578999999999999986 4579999876443 3568899999999998766654 43331 2345699999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCC-CCCeEEcCCCcEEEEeccccccC
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK-ASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk-p~NILl~~~~~vkL~DFGla~~~ 424 (615)
|-.|.++-... + .+-...+++.---|...+ |-|+.|. |..++|.++..+.|+||.-|+..
T Consensus 96 G~~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 96 GRPLGKLEIGG-------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred Ccchhhhhhcc-------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 98888765421 1 122333444433455556 8888887 44444444559999999988743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00011 Score=74.67 Aligned_cols=139 Identities=18% Similarity=0.130 Sum_probs=80.3
Q ss_pred eeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcc-eEEEEeecCCCCceeEEEecCCCCChh
Q 007160 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELVPNGSLE 355 (615)
Q Consensus 277 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~LV~Ey~~~gsL~ 355 (615)
+..|-.+.+|+... ++..+++|........-.-+..+|.++++.+....++ ++++.. + -++||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~---~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---E---HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---C---CEEEEEeccCcccc
Confidence 45677889998874 4667888876543222112467899999988654443 344332 1 26899999987664
Q ss_pred Hh-----------------hcCCCCCcccCChhhH-HHHHHH---------HHHHHHHhHhC-----CCCcEEeccCCCC
Q 007160 356 SW-----------------LHGPLGVNCHLDWETR-MKIALD---------AARGLAYLHED-----SQPCVIHRDFKAS 403 (615)
Q Consensus 356 ~~-----------------L~~~~~~~~~l~~~~~-~~ia~q---------ia~gL~yLH~~-----~~~~ivHrDIkp~ 403 (615)
.. ||........++.... ..+..+ +.+.+..+-.. .++.++|+|+.+.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1221111112222111 111111 11112222111 1346999999999
Q ss_pred CeEEcCCCcEEEEecccccc
Q 007160 404 NILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 404 NILl~~~~~vkL~DFGla~~ 423 (615)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=9.1e-05 Score=82.19 Aligned_cols=142 Identities=18% Similarity=0.200 Sum_probs=90.8
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCCc-------------------------------------hHHHHHHHH
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-------------------------------------DKEFLVEVE 317 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-------------------------------------~~~f~~Ei~ 317 (615)
+-||.-+.|.||+|++++|+.||||+-+.+-... +-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999765331110 013555655
Q ss_pred HHhhc----cCCCc---ceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHH-HHhHh
Q 007160 318 MLSRL----HHRNL---VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL-AYLHE 389 (615)
Q Consensus 318 ~l~~l----~HpnI---v~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL-~yLH~ 389 (615)
-..++ .|-+. |.+=.++.+ -.....|+||||+|..+.|.-.-. ...++-. .++..+.++. +-+-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~-~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~---~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD-LSTKRVLTMEYVDGIKINDLDAID---KRGISPH---DILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh-cCcceEEEEEecCCccCCCHHHHH---HcCCCHH---HHHHHHHHHHHHHHHh
Confidence 44443 45551 222233332 234689999999998877654211 1123333 3333333332 22233
Q ss_pred CCCCcEEeccCCCCCeEEc----CCCcEEEEeccccccCCC
Q 007160 390 DSQPCVIHRDFKASNILLE----NNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 390 ~~~~~ivHrDIkp~NILl~----~~~~vkL~DFGla~~~~~ 426 (615)
.| ++|+|=.|.||++. .++.+.+-|||+......
T Consensus 320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 45 99999999999998 367899999999876654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00049 Score=68.80 Aligned_cols=143 Identities=21% Similarity=0.175 Sum_probs=82.4
Q ss_pred ceeeeccCceEEEEEEECC--CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcc-eEEEEeecCCCCceeEEEecCC
Q 007160 274 ASILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
.+.|..|-...+|+....+ +..|++|....... ...+..+|+.+++.+...+++ ++++.+ +. .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~---~~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF---QN---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe---CC---cEEEEeeC
Confidence 3567788889999988764 57888997653321 122345788899888644444 444332 21 37999999
Q ss_pred CCChhHh-----------------hcCCCCCc-------ccC-ChhhHHHHHH----------------------HHH--
Q 007160 351 NGSLESW-----------------LHGPLGVN-------CHL-DWETRMKIAL----------------------DAA-- 381 (615)
Q Consensus 351 ~gsL~~~-----------------L~~~~~~~-------~~l-~~~~~~~ia~----------------------qia-- 381 (615)
|.++... +|...... ... -|..+..+.. .+.
T Consensus 76 G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 155 (235)
T cd05157 76 GRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDE 155 (235)
T ss_pred CCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHH
Confidence 9776321 11111000 011 1222111111 111
Q ss_pred -HHHH-HhHhC-CCCcEEeccCCCCCeEEcC-CCcEEEEecccccc
Q 007160 382 -RGLA-YLHED-SQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQ 423 (615)
Q Consensus 382 -~gL~-yLH~~-~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~ 423 (615)
..|. .+... ....++|+|+.+.|||+++ +..+.|+||..|..
T Consensus 156 ~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 156 ISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 11111 2346999999999999997 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00087 Score=65.58 Aligned_cols=133 Identities=17% Similarity=0.272 Sum_probs=91.3
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEEeccCC----------------CCchHHHHHHHHHHhhcc------CCCcceE
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG----------------QQGDKEFLVEVEMLSRLH------HRNLVKL 330 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------------~~~~~~f~~Ei~~l~~l~------HpnIv~l 330 (615)
....||+|+.-.||. ++++....||++.... ....+++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999995 5556667888887554 223467888888877776 7889999
Q ss_pred EEEeecCCCCceeEEEecCCC------CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCC
Q 007160 331 VGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN 404 (615)
Q Consensus 331 ~g~~~~~~~~~~~LV~Ey~~~------gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~N 404 (615)
+|+..... ..-+|+|.+.+ -+|.+++.. ..++. ...+ .+-+-..||-+++ |+.+|++|.|
T Consensus 83 ~G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~N 148 (199)
T PF10707_consen 83 YGFVETNL--GLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHN 148 (199)
T ss_pred eEEEecCC--ceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHH---HHHHHHHHHHHcC---CeecCCCccc
Confidence 99987433 56788877654 357788753 22443 3333 3334456777777 9999999999
Q ss_pred eEEcCC---C-cEEEEe-cccc
Q 007160 405 ILLENN---F-HAKVAD-FGLA 421 (615)
Q Consensus 405 ILl~~~---~-~vkL~D-FGla 421 (615)
|++... . .+.|+| ||-.
T Consensus 149 Iv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEEEecCCCceEEEEEeCCCCc
Confidence 999532 2 567776 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.001 Score=72.00 Aligned_cols=75 Identities=19% Similarity=0.200 Sum_probs=53.8
Q ss_pred eeeeccCceEEEEEEECCC-cEEEEEEeccC------C-CCchHHHHHHHHHHhhcc---CCCcceEEEEeecCCCCcee
Q 007160 275 SILGEGGFGRVFKGVLSDG-TAVAIKRLTCG------G-QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~------~-~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~~~ 343 (615)
+.||.|.+..||++...+| +.|+||.-... . ....+.+..|.+.|..+. -.++.+++.+ +....+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~----D~~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY----DEELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE----CCCCCE
Confidence 5799999999999998777 48999974311 1 123456778888888763 2456677766 334578
Q ss_pred EEEecCCCCC
Q 007160 344 LCYELVPNGS 353 (615)
Q Consensus 344 LV~Ey~~~gs 353 (615)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998744
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0007 Score=66.04 Aligned_cols=127 Identities=26% Similarity=0.372 Sum_probs=90.8
Q ss_pred cCcccceeeeccCc-eEEEEEEECCCcEEEEEEeccC---CC------------------CchHHHHHHHHHHhhcc---
Q 007160 269 NNFEPASILGEGGF-GRVFKGVLSDGTAVAIKRLTCG---GQ------------------QGDKEFLVEVEMLSRLH--- 323 (615)
Q Consensus 269 ~~f~~~~~LG~G~f-G~Vykg~~~~g~~VAVK~l~~~---~~------------------~~~~~f~~Ei~~l~~l~--- 323 (615)
.+++.++.||.|.- |.||++.+. |+.+|+|.+..- .. .....|..|-+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 999999994 679999994321 00 01135888999988885
Q ss_pred CCCc--ceEEEEeecC----------------CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHH
Q 007160 324 HRNL--VKLVGYYSSR----------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385 (615)
Q Consensus 324 HpnI--v~l~g~~~~~----------------~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~ 385 (615)
+.++ |+.+||..-. ......||.||++... ....+-+.++.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchhHHHHHHHHHH
Confidence 4566 8999986322 1122356777775532 112334566777788
Q ss_pred HhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 386 yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 999999 999999999986 3489999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0004 Score=72.08 Aligned_cols=146 Identities=18% Similarity=0.151 Sum_probs=86.6
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCC--cceEEEEee----cCCCCceeEEEe
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLVGYYS----SRDSSQHLLCYE 347 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~g~~~----~~~~~~~~LV~E 347 (615)
.+.|..|....+|+....++ .+++|+... ........|++++..+.+.+ +.+++.... ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677788889999876554 688888763 23456777888888885433 444443211 011235688999
Q ss_pred cCCCCChhH----hh----------cCCC-CC------cccCChhhHH----------HHHHHHHHHHHHhHh----CCC
Q 007160 348 LVPNGSLES----WL----------HGPL-GV------NCHLDWETRM----------KIALDAARGLAYLHE----DSQ 392 (615)
Q Consensus 348 y~~~gsL~~----~L----------~~~~-~~------~~~l~~~~~~----------~ia~qia~gL~yLH~----~~~ 392 (615)
|++|..+.. .+ |... +. .....|.... .....+...+.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 00 1100 00 0112222211 011123334455443 123
Q ss_pred CcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 393 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
..++|+|+.+.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00085 Score=70.49 Aligned_cols=161 Identities=16% Similarity=0.136 Sum_probs=86.6
Q ss_pred CCHHHHHHHhcCccc-----ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCC--cceEE
Q 007160 259 LAYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLV 331 (615)
Q Consensus 259 ~~~~el~~~~~~f~~-----~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~ 331 (615)
++.+++......|.+ .+.|+.|....+|+....+| .+++|++. . ...+....|++++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 445566555555644 34566777789999887665 58889875 1 22344445666666664222 23333
Q ss_pred EEe----ecCCCCceeEEEecCCCCChhH-----------h---hcCCC-CC------cccCCh-hhHHHH---------
Q 007160 332 GYY----SSRDSSQHLLCYELVPNGSLES-----------W---LHGPL-GV------NCHLDW-ETRMKI--------- 376 (615)
Q Consensus 332 g~~----~~~~~~~~~LV~Ey~~~gsL~~-----------~---L~~~~-~~------~~~l~~-~~~~~i--------- 376 (615)
... .....+..+++++|++|..+.. . +|... +. ...+.| .....-
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 210 0011335689999999875421 1 11110 00 011112 211111
Q ss_pred ---HHH-HHHHHHHhHhC----CCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 377 ---ALD-AARGLAYLHED----SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 377 ---a~q-ia~gL~yLH~~----~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
..+ +...++.+... -+.+++|+|+.+.||+++++...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 111 11122333211 234699999999999999776668999998753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0006 Score=80.26 Aligned_cols=198 Identities=22% Similarity=0.201 Sum_probs=135.9
Q ss_pred HHHHHHHHhhccCCCcceEEEEeecCCCC--ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh
Q 007160 312 FLVEVEMLSRLHHRNLVKLVGYYSSRDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389 (615)
Q Consensus 312 f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~--~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 389 (615)
...|++.+.++.|+|++.+++|-...... ...+..+++..-++...+.. -..+.....+.+..++..||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 44577788899999999999885532221 23345578888888877764 2346778888999999999999999
Q ss_pred CCCCcEEeccCCCC---CeEEcCCCcEEEE--eccccccCCCCCccccceeeccccccCCccccccCcCC--chhhHHHH
Q 007160 390 DSQPCVIHRDFKAS---NILLENNFHAKVA--DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL--VKSDVYSY 462 (615)
Q Consensus 390 ~~~~~ivHrDIkp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s--~ksDVwS~ 462 (615)
.. ..|.-+..+ +.-.+.++.+.++ ||+.++...+.... ....-+..|.++|......+. ...|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence 86 666666555 5555667777777 99988876654321 222345567888877665554 45899999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 007160 463 GVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542 (615)
Q Consensus 463 GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eV 542 (615)
|.++..+..|..+-.... ....+.+. .... .+.+....|+..+.++|+...++
T Consensus 379 gll~~~~~~~~~i~~~~~-------------------~~~~~l~~----~~~~----~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-------------------VPVSLLDV----LSTS----ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCccccccc-------------------chhhhhcc----ccch----hhhhhhhhhcchhhhhccchhhh
Confidence 999999998876432110 00111110 1111 35677889999999999999999
Q ss_pred HHHH
Q 007160 543 VQSL 546 (615)
Q Consensus 543 l~~L 546 (615)
+.+.
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 8763
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0015 Score=68.40 Aligned_cols=160 Identities=19% Similarity=0.203 Sum_probs=90.7
Q ss_pred CHHHHHHHhcCccc-----ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCC--cceEEE
Q 007160 260 AYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLVG 332 (615)
Q Consensus 260 ~~~el~~~~~~f~~-----~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~g 332 (615)
+.++|....+.|.+ .+.++.|....+|+....+| .+++|+..... ...+...|++++..|.... +.+.+.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 44556555555544 34567777789999876555 47788765321 2345567778887774322 344443
Q ss_pred Eee----cCCCCceeEEEecCCCCChhH--------------hhcCCC-CCc-------ccCChhhHH------------
Q 007160 333 YYS----SRDSSQHLLCYELVPNGSLES--------------WLHGPL-GVN-------CHLDWETRM------------ 374 (615)
Q Consensus 333 ~~~----~~~~~~~~LV~Ey~~~gsL~~--------------~L~~~~-~~~-------~~l~~~~~~------------ 374 (615)
... ....+..+++++|++|..+.. .+|... +.. ..-.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 211 112345689999999865421 112100 000 001121111
Q ss_pred HHHHHHHHHHHHhHh----CCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 375 KIALDAARGLAYLHE----DSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 375 ~ia~qia~gL~yLH~----~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
.....+.+.++++.. ..+..++|+|+.+.||++++++...|.||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011123334555542 224569999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0016 Score=67.92 Aligned_cols=142 Identities=27% Similarity=0.277 Sum_probs=84.8
Q ss_pred eeeeccCceEEEEEEECC-------CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcc-eEEEEeecCCCCceeEEE
Q 007160 275 SILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~LV~ 346 (615)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+...++. ++++++. + .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C----Cchh
Confidence 456677778999988655 4788999875432 2234567888888888644444 4555432 2 3589
Q ss_pred ecCCCCChhHh-----------------hcCCCCCc-------ccCChhhHHH--------------------------H
Q 007160 347 ELVPNGSLESW-----------------LHGPLGVN-------CHLDWETRMK--------------------------I 376 (615)
Q Consensus 347 Ey~~~gsL~~~-----------------L~~~~~~~-------~~l~~~~~~~--------------------------i 376 (615)
||++|..+... ||...... ...-|..... +
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99998776431 11111000 0001111111 1
Q ss_pred HHHHHHHHHHhHh------CCCCcEEeccCCCCCeEEcCC----CcEEEEecccccc
Q 007160 377 ALDAARGLAYLHE------DSQPCVIHRDFKASNILLENN----FHAKVADFGLAKQ 423 (615)
Q Consensus 377 a~qia~gL~yLH~------~~~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~~ 423 (615)
...+.+-+.+|-. ..+..++|+|+.+.|||++++ +.++++||..|..
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 1122223334432 245579999999999999875 7899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0036 Score=64.88 Aligned_cols=141 Identities=22% Similarity=0.323 Sum_probs=72.1
Q ss_pred ccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc---CCCcceEEEEeecCCCCceeEEEec
Q 007160 272 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
+..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+ ..+|++||
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CCEEEEE-
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--CceEEEEe
Confidence 445778999999999977 567889999876 233457889999998883 344667887765433 45999999
Q ss_pred CCCCCh--------h---HhhcC-CC-CC----------------cccCChhh-----HHHHHHHHH-------------
Q 007160 349 VPNGSL--------E---SWLHG-PL-GV----------------NCHLDWET-----RMKIALDAA------------- 381 (615)
Q Consensus 349 ~~~gsL--------~---~~L~~-~~-~~----------------~~~l~~~~-----~~~ia~qia------------- 381 (615)
++.+.. - ..||. .. +. ...-+|.. |+....+.+
T Consensus 94 l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l 173 (288)
T PF03881_consen 94 LEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERL 173 (288)
T ss_dssp -------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHH
T ss_pred ecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHH
Confidence 988711 0 11222 11 00 00113321 222222111
Q ss_pred -HHH-HHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 382 -RGL-AYLHE-DSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 382 -~gL-~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
+.+ ..|+. .-+|+++|+||.+.|++.+.++.+.|.|=
T Consensus 174 ~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DP 213 (288)
T PF03881_consen 174 VERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDP 213 (288)
T ss_dssp HHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S-
T ss_pred HHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeecc
Confidence 111 12232 22688999999999999999998998874
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.00077 Score=69.59 Aligned_cols=138 Identities=20% Similarity=0.192 Sum_probs=95.5
Q ss_pred CcccceeeeccCceEEEEEEECCCcEEEEEEeccCC-----------------CC-----chHHHHHHHHHHhhcc-CCC
Q 007160 270 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG-----------------QQ-----GDKEFLVEVEMLSRLH-HRN 326 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-----------------~~-----~~~~f~~Ei~~l~~l~-Hpn 326 (615)
-+.+.+.||-|--+.||.+...+|+..++|.-..+. .. ..-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 457789999999999999999999999988432210 00 0113456888888885 332
Q ss_pred -cceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 327 -LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 327 -Iv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
+.+.++ ....++|||++.+-.|...-+- .+..+ +...+..-+.-|..+| +||+|+.-=||
T Consensus 173 pVPkpiD------~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPID------HNRHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNI 233 (465)
T ss_pred CCCCccc------ccceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHHHHHcC---ceecccchhee
Confidence 333433 3467899999998887754321 12233 3334444456677788 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCC
Q 007160 406 LLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~ 426 (615)
+++++..++++||-.......
T Consensus 234 mv~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred EEecCCCEEEeechHhhccCC
Confidence 999999999999977655443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.012 Score=61.65 Aligned_cols=136 Identities=18% Similarity=0.194 Sum_probs=78.9
Q ss_pred ccCceEEEEEEECCCcEEEEEEecc--CCCCchHHHHHHHHHHhhccC--CCcceEEEEeecCCCCceeEEEecCCCCCh
Q 007160 279 EGGFGRVFKGVLSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHLLCYELVPNGSL 354 (615)
Q Consensus 279 ~G~fG~Vykg~~~~g~~VAVK~l~~--~~~~~~~~f~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL 354 (615)
.|-.-.+|+.... ++.+++. ... ..........+|.++|+.+.- --+-..+++|....-...+.||+|++|..+
T Consensus 35 ~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 35 GGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred CCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 3333344444333 6777777 321 122233456678888887643 233455666654332467899999998544
Q ss_pred hHhhcCCCCCcccCChhhHHHHH-HHHHHHHH------------------------------------------------
Q 007160 355 ESWLHGPLGVNCHLDWETRMKIA-LDAARGLA------------------------------------------------ 385 (615)
Q Consensus 355 ~~~L~~~~~~~~~l~~~~~~~ia-~qia~gL~------------------------------------------------ 385 (615)
.+.+.... . . .+++ ..+++.|+
T Consensus 113 ~~~~~~~~-----~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 113 WSALPPES-----L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred cCcCCccc-----c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 33332100 0 0 0111 13333333
Q ss_pred --HhHhC-----CCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 386 --YLHED-----SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 386 --yLH~~-----~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
+|+.+ ++++++|+|+.+.|++++.+..+-|.||+++....
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 33332 24679999999999999998889999999997654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.011 Score=61.14 Aligned_cols=32 Identities=22% Similarity=0.462 Sum_probs=26.7
Q ss_pred CCcEEeccCCCCCeEEcCCCc-EEEEecccccc
Q 007160 392 QPCVIHRDFKASNILLENNFH-AKVADFGLAKQ 423 (615)
Q Consensus 392 ~~~ivHrDIkp~NILl~~~~~-vkL~DFGla~~ 423 (615)
.+.++|+|+.+.|||+++++. .-|.||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 456999999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.013 Score=62.59 Aligned_cols=142 Identities=17% Similarity=0.188 Sum_probs=81.8
Q ss_pred eeeeccCceEEEEEEECC-----CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcc-eEEEEeecCCCCceeEEEec
Q 007160 275 SILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~LV~Ey 348 (615)
+.|-.|-...+|+....+ ++.|++|....... ..-+..+|..+++.+..-++. ++++.+. + ..|++|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~--~----g~v~ef 114 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFP--N----GRVEEF 114 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEEC--C----ceEEEe
Confidence 345557778899887532 36788887765432 222346799999888655554 4555542 2 157999
Q ss_pred CCCCChhHh-----------------hcCCC--CCcccCChhhHHHHHHHH-----------------HHHHHHh----H
Q 007160 349 VPNGSLESW-----------------LHGPL--GVNCHLDWETRMKIALDA-----------------ARGLAYL----H 388 (615)
Q Consensus 349 ~~~gsL~~~-----------------L~~~~--~~~~~l~~~~~~~ia~qi-----------------a~gL~yL----H 388 (615)
+++.+|... +|... +.....-|..+.++..++ ...+..| .
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 988776421 12211 001011233332332111 1112222 2
Q ss_pred h-CCCCcEEeccCCCCCeEEcC-CCcEEEEecccccc
Q 007160 389 E-DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQ 423 (615)
Q Consensus 389 ~-~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~ 423 (615)
. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2 22346999999999999976 46899999988753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.00037 Score=83.54 Aligned_cols=162 Identities=15% Similarity=0.009 Sum_probs=114.8
Q ss_pred HHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC--
Q 007160 313 LVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-- 390 (615)
Q Consensus 313 ~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-- 390 (615)
..|.+.++...|+++.....=....+..+.+..++|+.+|.+.+.|-+.......++..-+...-.+......-.|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 335555566789888776654444556678899999999999999865444444444433333333324444444432
Q ss_pred CCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHH
Q 007160 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 470 (615)
Q Consensus 391 ~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ell 470 (615)
.....+|+++|+-|.+|..+..+|++++|+.+...... .......+++.|+.++....-.++.++|+|..|+.+|+..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 23347899999999999999999999999999332211 1223456788999999988888999999999999999998
Q ss_pred hCCCCC
Q 007160 471 TGRKPV 476 (615)
Q Consensus 471 tG~~Pf 476 (615)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 877665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.05 Score=56.66 Aligned_cols=30 Identities=30% Similarity=0.426 Sum_probs=25.7
Q ss_pred CCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 392 QPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 392 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
...++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 345999999999999987 578899998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.023 Score=55.94 Aligned_cols=30 Identities=30% Similarity=0.468 Sum_probs=21.3
Q ss_pred cEEeccCCCCCeEE-cCCCcEEEEecccccc
Q 007160 394 CVIHRDFKASNILL-ENNFHAKVADFGLAKQ 423 (615)
Q Consensus 394 ~ivHrDIkp~NILl-~~~~~vkL~DFGla~~ 423 (615)
.++|+|+.+.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.071 Score=56.80 Aligned_cols=79 Identities=18% Similarity=0.210 Sum_probs=50.5
Q ss_pred eeeccCceEEEEEEECCC-cEEEEEEec----c-C-C-CCchHHHHHHHHHHhhcc--CC-CcceEEEEeecCCCCceeE
Q 007160 276 ILGEGGFGRVFKGVLSDG-TAVAIKRLT----C-G-G-QQGDKEFLVEVEMLSRLH--HR-NLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 276 ~LG~G~fG~Vykg~~~~g-~~VAVK~l~----~-~-~-~~~~~~f~~Ei~~l~~l~--Hp-nIv~l~g~~~~~~~~~~~L 344 (615)
.||.|....||++...+| +.|+||.-. . . + .-.......|.+.|.... -| .+.+++.| +.....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~----D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF----DTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE----cccccee
Confidence 479999999999998654 579999643 1 1 1 222344556778887653 34 34456554 4456789
Q ss_pred EEecCCCCC-hhHhh
Q 007160 345 CYELVPNGS-LESWL 358 (615)
Q Consensus 345 V~Ey~~~gs-L~~~L 358 (615)
|||+++... |.+.|
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 999996533 43444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.077 Score=56.09 Aligned_cols=142 Identities=23% Similarity=0.291 Sum_probs=83.4
Q ss_pred eeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc------ceEEEEeecCCC--CceeEEEec
Q 007160 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL------VKLVGYYSSRDS--SQHLLCYEL 348 (615)
Q Consensus 277 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI------v~l~g~~~~~~~--~~~~LV~Ey 348 (615)
|.+ .-..+|+....+|+. ++|..... ....+...|+..|..|.-.+| ..+=|-....-. ...+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 556799988877776 88877654 345667778888887742222 111121111112 367788999
Q ss_pred CCCCChhH-hh--------------c----C----CCCCcccCChhh-------------HHHHHHHHHHHHHHhHhC--
Q 007160 349 VPNGSLES-WL--------------H----G----PLGVNCHLDWET-------------RMKIALDAARGLAYLHED-- 390 (615)
Q Consensus 349 ~~~gsL~~-~L--------------~----~----~~~~~~~l~~~~-------------~~~ia~qia~gL~yLH~~-- 390 (615)
++|..+.. .. | + +........|.. ......++...+..+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988873 11 1 0 111111234431 112233344444444432
Q ss_pred --CCCc---EEeccCCCCCeEEcCCCc-EEEEeccccc
Q 007160 391 --SQPC---VIHRDFKASNILLENNFH-AKVADFGLAK 422 (615)
Q Consensus 391 --~~~~---ivHrDIkp~NILl~~~~~-vkL~DFGla~ 422 (615)
-+.. +||+|+.+.||+++.+.. +.+.|||-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1222 899999999999998874 8999999875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.11 Score=56.37 Aligned_cols=80 Identities=15% Similarity=0.105 Sum_probs=52.3
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCC----C---CchHHHHHHHHHHhhcc---CCCcceEEEEeecCCCCcee
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG----Q---QGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----~---~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~~~ 343 (615)
.+.||.|....||+.... +..|+||+-.... . .....-..|.+.|+.+. ..++.+++.++. ...+
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de----d~~v 111 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR----TMAL 111 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC----CCCE
Confidence 467899999999998764 4568999765211 1 12233344577776553 247778888865 2468
Q ss_pred EEEecCCC--CChhHhh
Q 007160 344 LCYELVPN--GSLESWL 358 (615)
Q Consensus 344 LV~Ey~~~--gsL~~~L 358 (615)
++|||+++ ..+.+.+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 89999977 3454444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.076 Score=56.26 Aligned_cols=142 Identities=15% Similarity=0.190 Sum_probs=80.9
Q ss_pred eeeeccCceEEEEEEECC----CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcc-eEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.|..|-...+|+....+ +..|++|....... ..-+..+|..+++.+..-++- ++++++. . + +|.+|+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~-G---~i~~fi 92 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--N-G---MIQSFI 92 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--C-c---Eeehhh
Confidence 445557778899887543 23788887764332 223446789999988765554 4555542 2 1 589999
Q ss_pred CCCChhH-----------------hhcCCC--CCcccCChhhHHHHHHHH----------------------HHHHHH--
Q 007160 350 PNGSLES-----------------WLHGPL--GVNCHLDWETRMKIALDA----------------------ARGLAY-- 386 (615)
Q Consensus 350 ~~gsL~~-----------------~L~~~~--~~~~~l~~~~~~~ia~qi----------------------a~gL~y-- 386 (615)
++..|.. .+|... .....--|..+.++..++ .+-+..
T Consensus 93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 172 (330)
T PLN02421 93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK 172 (330)
T ss_pred cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence 8766531 112211 001011233322222221 111111
Q ss_pred --hHh-CCCCcEEeccCCCCCeEEcC-CCcEEEEecccccc
Q 007160 387 --LHE-DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQ 423 (615)
Q Consensus 387 --LH~-~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~ 423 (615)
+.. ..+..++|+|+.+.|||+++ ++.++++||..|..
T Consensus 173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 211 12345899999999999974 57899999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.071 Score=55.83 Aligned_cols=32 Identities=16% Similarity=0.259 Sum_probs=28.3
Q ss_pred CCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 392 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+.+++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.13 Score=62.64 Aligned_cols=145 Identities=21% Similarity=0.231 Sum_probs=80.0
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc--CCC--cceEEE--------EeecCCC-Cc
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH--HRN--LVKLVG--------YYSSRDS-SQ 341 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--Hpn--Iv~l~g--------~~~~~~~-~~ 341 (615)
+.|+ |..-.+|+....+|..+++|+..... .......|.+.|..|. ++. +.+.+- .....++ ..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4453 45678899888888889999987542 2334445556666552 122 222221 1111111 14
Q ss_pred eeEEEecCCCCChhHhh-----------------c------CCCCCcccCChhhH-----------------HHHHHHHH
Q 007160 342 HLLCYELVPNGSLESWL-----------------H------GPLGVNCHLDWETR-----------------MKIALDAA 381 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L-----------------~------~~~~~~~~l~~~~~-----------------~~ia~qia 381 (615)
.+-+++|++|..|.+.. + ........+.|... ..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999998776511 0 01111123444321 12222222
Q ss_pred HHHH-----HhHhCCCCcEEeccCCCCCeEEcCCC--cEE-EEecccccc
Q 007160 382 RGLA-----YLHEDSQPCVIHRDFKASNILLENNF--HAK-VADFGLAKQ 423 (615)
Q Consensus 382 ~gL~-----yLH~~~~~~ivHrDIkp~NILl~~~~--~vk-L~DFGla~~ 423 (615)
+... .|.+ -+..+||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 1211 234499999999999999875 454 999998764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.015 Score=63.50 Aligned_cols=50 Identities=22% Similarity=0.316 Sum_probs=40.1
Q ss_pred hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcC
Q 007160 309 DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 360 (615)
Q Consensus 309 ~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~ 360 (615)
..+.+....+++.+.|+|+...+.+... ......+|+|++ +.||++.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~-~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRG-KHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecC-ccceEEEEehhh-ccchHHHHHh
Confidence 4567778889999999999999988653 334578899998 6799998864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.085 Score=55.80 Aligned_cols=141 Identities=17% Similarity=0.200 Sum_probs=93.9
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEEeccCC-----C----C------------c-h---HH-HHHHHHHHhhccCCC
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG-----Q----Q------------G-D---KE-FLVEVEMLSRLHHRN 326 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-----~----~------------~-~---~~-f~~Ei~~l~~l~Hpn 326 (615)
+...|..|--.-||.+.-.+|..+|||+++..- . . . . +- ...|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345678888999999998899999999875320 0 0 0 0 11 234777788887655
Q ss_pred cceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeE
Q 007160 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 327 Iv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NIL 406 (615)
|-.---+.. ....|||+|+-+.... .+.-.+..++...+..+-.++++-+.-|-..+. +||.||.--|+|
T Consensus 228 IP~PePIlL----k~hVLVM~FlGrdgw~----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~L 297 (520)
T KOG2270|consen 228 IPCPEPILL----KNHVLVMEFLGRDGWA----APKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLL 297 (520)
T ss_pred CCCCCceee----ecceEeeeeccCCCCc----CcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhhe
Confidence 332111111 1357999999532111 111123456767788888888888888877664 999999999999
Q ss_pred EcCCCcEEEEeccccccC
Q 007160 407 LENNFHAKVADFGLAKQA 424 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~ 424 (615)
+-+ |.+.|+|-+.+...
T Consensus 298 yhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 298 YHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred EEC-CEEEEEEccccccC
Confidence 874 58999998877644
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.42 Score=50.50 Aligned_cols=93 Identities=15% Similarity=0.085 Sum_probs=54.9
Q ss_pred CCHHHHHHHhcCcccc---e-eeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCC--CcceEE-
Q 007160 259 LAYEELKEATNNFEPA---S-ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLV- 331 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~---~-~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--nIv~l~- 331 (615)
++.+.+..+...+-+. + ..-.+.-..||+....+|..+++|..... .....+...|++.+..|... .++..+
T Consensus 11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~ 89 (325)
T PRK11768 11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLA 89 (325)
T ss_pred CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCcc
Confidence 5556666555544321 1 22234567899998878888999987532 23456777888888777421 222222
Q ss_pred --E--EeecCCCCceeEEEecCCCCCh
Q 007160 332 --G--YYSSRDSSQHLLCYELVPNGSL 354 (615)
Q Consensus 332 --g--~~~~~~~~~~~LV~Ey~~~gsL 354 (615)
| +.. -++..+.++++++|...
T Consensus 90 ~~G~~~~~--~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 90 FNGQTLHE--HQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCCCEEEE--ECCEEEEEEeeeCCCCC
Confidence 1 111 12356789999987653
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.11 Score=55.94 Aligned_cols=81 Identities=17% Similarity=0.223 Sum_probs=52.7
Q ss_pred ceeeeccCceEEEEEEECC-CcEEEEEEecc----C-C-CCchHHHHHHHHHHhhcc--CCC-cceEEEEeecCCCCcee
Q 007160 274 ASILGEGGFGRVFKGVLSD-GTAVAIKRLTC----G-G-QQGDKEFLVEVEMLSRLH--HRN-LVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~----~-~-~~~~~~f~~Ei~~l~~l~--Hpn-Iv~l~g~~~~~~~~~~~ 343 (615)
.+.||.|.-..||++...+ ++.|+||.-.. . + .-..+...-|.+.|+... -|. +.+++.| +.....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~----D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF----DSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE----CcHHhh
Confidence 4678999999999999743 56799996431 1 1 122355666888888763 343 4456554 445678
Q ss_pred EEEecCCCCC-hhHhh
Q 007160 344 LCYELVPNGS-LESWL 358 (615)
Q Consensus 344 LV~Ey~~~gs-L~~~L 358 (615)
+|||+++... |.+.|
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 9999996533 44443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.2 Score=54.22 Aligned_cols=74 Identities=18% Similarity=0.252 Sum_probs=45.7
Q ss_pred eeeeccCceEEEEEEECCC--cE-----EEEEEeccCCCCchHHHHHHHHHHhhccCCCcce-EEEEeecCCCCceeEEE
Q 007160 275 SILGEGGFGRVFKGVLSDG--TA-----VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK-LVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g--~~-----VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~-l~g~~~~~~~~~~~LV~ 346 (615)
+.|..|-...+|++...++ .. |.++... ......-+-.+|+++++.+...++-+ +++.+. -.+++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~g~l~ 128 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------DFTIQ 128 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC------CEEEE
Confidence 4565688889999876433 12 4444322 12222234467899999997666655 444432 26899
Q ss_pred ecCCCCChh
Q 007160 347 ELVPNGSLE 355 (615)
Q Consensus 347 Ey~~~gsL~ 355 (615)
||++|.+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999998764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.12 Score=51.03 Aligned_cols=153 Identities=16% Similarity=0.185 Sum_probs=93.3
Q ss_pred cCceEEEEEEECCCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCCCCChhHhh
Q 007160 280 GGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL 358 (615)
Q Consensus 280 G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L 358 (615)
|+..+.-.+..+-| ...+|++..-... ...-|..+.+++++++ .|++|.. .+...+-++.|+|-.-.
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~----- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIK----- 140 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcc-----
Confidence 34444444443323 3456666644444 4567888999999886 4677762 24445668888884311
Q ss_pred cCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeecc
Q 007160 359 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438 (615)
Q Consensus 359 ~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 438 (615)
... ..++.-=++.|.-.|+..+ ..+|+|-.|+||+-|..|.+||.|=+..-.-
T Consensus 141 -----------i~~-~N~i~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-------------- 193 (308)
T PF07387_consen 141 -----------INF-SNFITAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-------------- 193 (308)
T ss_pred -----------cch-hHHHHHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhhhhh--------------
Confidence 011 1122222466778886643 3999999999999999999999997654211
Q ss_pred ccccCCccccccCcCCchhhHHHHHHHHHHHHhCCC
Q 007160 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK 474 (615)
Q Consensus 439 t~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~ 474 (615)
+..|.--| ....+.++.+-+|=.-++++....+
T Consensus 194 ~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 194 QVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eeeEEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 11122211 1335677888888777888876443
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.2 Score=49.83 Aligned_cols=75 Identities=16% Similarity=0.208 Sum_probs=49.1
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccC---CCcceEEEEeecCCCCceeEEEecCCC
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH---RNLVKLVGYYSSRDSSQHLLCYELVPN 351 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---pnIv~l~g~~~~~~~~~~~LV~Ey~~~ 351 (615)
+.+.-|.--..|...+ +...+.||.-. ......|.+|+.-|..|.- -++-+.+.+- .+..+.+||+||++-
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sylVle~L~~ 95 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYLVLEYLPT 95 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEEEEeeccC
Confidence 4455555555665444 35678888643 2234678889888777743 4455665553 356688999999998
Q ss_pred CChh
Q 007160 352 GSLE 355 (615)
Q Consensus 352 gsL~ 355 (615)
|.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 7775
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.26 Score=50.13 Aligned_cols=76 Identities=24% Similarity=0.192 Sum_probs=54.3
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHH---HHHhhccCCCcceEEEEeecCCCCceeEEEecC-
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEV---EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV- 349 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei---~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~- 349 (615)
...+..|..+.|+.++..+|+.+++|....... +..|. ..|+..+-...|++++. +...-.|++|.+
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~----d~~~~AlLLErl~ 77 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAA----DPERGALLLERLD 77 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeecc----ccccchhhhhhcc
Confidence 345668999999999999999999998763321 22233 55777777888999986 333557788998
Q ss_pred CCCChhHhh
Q 007160 350 PNGSLESWL 358 (615)
Q Consensus 350 ~~gsL~~~L 358 (615)
++.+|.+..
T Consensus 78 ~g~~L~~~~ 86 (253)
T PF04655_consen 78 PGRSLASLP 86 (253)
T ss_pred CCCchhhcc
Confidence 555776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.48 Score=48.97 Aligned_cols=31 Identities=32% Similarity=0.463 Sum_probs=25.5
Q ss_pred CcEEeccCCCCCeEEcCC--C---cEEEEecccccc
Q 007160 393 PCVIHRDFKASNILLENN--F---HAKVADFGLAKQ 423 (615)
Q Consensus 393 ~~ivHrDIkp~NILl~~~--~---~vkL~DFGla~~ 423 (615)
..++|||++..|||+..+ + .+++.||-+++.
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 459999999999999654 3 689999988764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 615 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-54 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-38 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 615 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 0.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-178 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-173 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-101 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-70 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-67 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-67 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-66 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-62 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 4e-62 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 8e-62 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-60 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-60 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-60 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-59 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-59 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-58 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 7e-56 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-44 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-43 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-43 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-43 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-42 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-42 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-41 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-40 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-39 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-39 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-39 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-39 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 7e-39 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-39 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-37 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-37 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-37 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-37 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-37 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-37 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-37 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-37 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-37 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-37 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 7e-37 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 7e-37 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 9e-37 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 9e-37 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-36 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-36 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-36 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-36 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-36 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-36 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-36 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-36 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 6e-36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-36 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-36 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-36 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-35 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-35 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-35 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-35 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-35 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-35 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-35 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-35 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-34 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-34 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-34 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-34 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 6e-34 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-34 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-34 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 7e-34 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-33 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-33 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-33 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-33 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-33 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-33 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-33 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-32 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-32 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-32 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-32 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-32 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-32 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-31 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-31 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-31 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-31 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-31 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-31 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 9e-31 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-30 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-30 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-30 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-30 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-30 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-30 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-30 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-30 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-29 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-29 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-28 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-28 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-28 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-27 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-27 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-27 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-27 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-27 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-27 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-26 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-26 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-26 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-26 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-26 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 9e-26 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-25 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-25 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-24 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-24 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-24 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-24 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-24 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 9e-24 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-24 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-23 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-23 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-23 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-23 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-23 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-23 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 6e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-23 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-22 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-22 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-22 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 9e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-21 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-21 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-21 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-21 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-21 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 9e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-20 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-20 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-20 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-20 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-20 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 6e-20 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-20 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 7e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 8e-20 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-19 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-19 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-19 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-19 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 8e-19 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-18 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-18 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-18 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-18 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-18 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 8e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 9e-18 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-09 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-17 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-16 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-16 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-16 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-16 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-16 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-15 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-15 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-14 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-14 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-14 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-14 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-13 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-13 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-13 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-13 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-12 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-11 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 4e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-07 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-08 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-08 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-07 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-06 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 517 bits (1335), Expect = 0.0
Identities = 126/316 (39%), Positives = 178/316 (56%), Gaps = 6/316 (1%)
Query: 237 KPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAV 296
K + L S P + + +L+EATNNF+ ++G G FG+V+KGVL DG V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 297 AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLES 356
A+KR T QG +EF E+E LS H +LV L+G+ R+ + +L Y+ + NG+L+
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKR 124
Query: 357 WLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416
L+G + WE R++I + AARGL YLH +IHRD K+ NILL+ NF K+
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT 181
Query: 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 476
DFG++K+ E +LST V GT GY+ PEY + G L KSDVYS+GVVL E+L R +
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 477 DMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR 536
S P NL WA +LE++ DP L K E + A C+A + R
Sbjct: 242 VQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300
Query: 537 PTMGEVVQSLKMVQRV 552
P+MG+V+ L+ R+
Sbjct: 301 PSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 507 bits (1308), Expect = e-178
Identities = 128/299 (42%), Positives = 183/299 (61%), Gaps = 7/299 (2%)
Query: 252 HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-DK 310
H + + EL+ A++NF +ILG GGFG+V+KG L+DGT VA+KRL QG +
Sbjct: 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 311 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 370
+F EVEM+S HRNL++L G+ ++ LL Y + NGS+ S L LDW
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 430
R +IAL +ARGLAYLH+ P +IHRD KA+NILL+ F A V DFGLAK T
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT- 189
Query: 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE--NLV 488
+++T V GT G++APEY TG K+DV+ YGV+LLEL+TG++ D+++ + + L+
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
W + +L++K +LE L D L G Y E+ ++ +A C +RP M EVV+ L+
Sbjct: 250 DWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 492 bits (1270), Expect = e-173
Identities = 105/309 (33%), Positives = 172/309 (55%), Gaps = 21/309 (6%)
Query: 252 HPTSTRFLAYEELKEATNNFEP------ASILGEGGFGRVFKGVLSDGTAVAIKRLTCG- 304
T ++ ELK TNNF+ + +GEGGFG V+KG + + T VA+K+L
Sbjct: 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66
Query: 305 ---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 361
++ ++F E++++++ H NLV+L+G+ S D L Y +PNGSL L
Sbjct: 67 DITTEELKQQFDQEIKVMAKCQHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 362 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
G L W R KIA AA G+ +LHE+ IHRD K++NILL+ F AK++DFGLA
Sbjct: 125 DG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481
+ + + +++R++GT Y+APE + G + KSD+YS+GVVLLE++TG VD +
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 541
+ L+ I ++ +E+ D ++ + ++A+ C+ + N+RP + +
Sbjct: 240 --PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 542 VVQSLKMVQ 550
V Q L+ +
Sbjct: 297 VQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-101
Identities = 86/325 (26%), Positives = 132/325 (40%), Gaps = 26/325 (8%)
Query: 246 LGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG 305
+G H +S L E L + + + G FG V+K L VA+K
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD 59
Query: 306 QQGDKEFLVEVEMLSRLHHRNLVKLVGY--YSSRDSSQHLLCYELVPNGSLESWLHGPLG 363
+Q + EV L + H N+++ +G + L GSL +L +
Sbjct: 60 KQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV- 117
Query: 364 VNCHLDWETRMKIALDAARGLAYLHED-------SQPCVIHRDFKASNILLENNFHAKVA 416
+ W IA ARGLAYLHED +P + HRD K+ N+LL+NN A +A
Sbjct: 118 ----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLT 471
DFGLA + G++ + +GT Y+APE ++ D+Y+ G+VL EL +
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 472 GRKPVDMSQPSGQENL--VTWARPILRDKDRL--EELADPRLGGKYPKEDFIR-VCTIAA 526
D P L D + + P L + K + +C
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 527 ACVAPEANQRPTMGEVVQSLKMVQR 551
C +A R + G V + + +QR
Sbjct: 294 ECWDHDAEARLSAGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 5e-70
Identities = 70/338 (20%), Positives = 131/338 (38%), Gaps = 41/338 (12%)
Query: 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 318
A E +N + ++G G +G V+KG L D VA+K + + F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 319 --LSRLHHRNLVKLVGY---YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+ + H N+ + + ++ ++LL E PNGSL +L DW +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113
Query: 374 MKIALDAARGLAYLHED------SQPCVIHRDFKASNILLENNFHAKVADFGLAK----- 422
++A RGLAYLH + +P + HRD + N+L++N+ ++DFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 423 -QAPEGRTNYLSTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVLLELLTGRK 474
G + + +GT Y+APE L + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 475 PVDMSQPSGQENL----VTWARPILRDKDRL--EELADPRLGGKYPKEDFI--RVCTIAA 526
+ + + + P D L E P+ + + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 527 ACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSN 564
C +A R T + + + + E +++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 6e-67
Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 38/298 (12%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGYY 334
+G G FG V + G+ VA+K L + EFL EV ++ RL H N+V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA- 102
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
+ E + GSL LH G LD R+ +A D A+G+ YLH P
Sbjct: 103 -VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 454
++HR+ K+ N+L++ + KV DFGL++ + T S GT ++APE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 455 VKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE--ELADPRLGG 511
KSDVYS+GV+L EL T ++P +++ V A + RLE +P++
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAA--VGFKCKRLEIPRNLNPQVA- 269
Query: 512 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANL 569
I C E +RP+ ++ L+ + + + NR++L
Sbjct: 270 -----------AIIEGCWTNEPWKRPSFATIMDLLRPLIK-------SAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 8e-67
Identities = 89/317 (28%), Positives = 136/317 (42%), Gaps = 51/317 (16%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
++G G FG V K VAIK++ + K F+VE+ LSR++H N+VKL G
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA-- 69
Query: 336 SRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
+ +C E GSL + LHG + M L ++G+AYLH
Sbjct: 70 ----CLNPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 394 CVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 452
+IHRD K N+LL K+ DFG A T G+ ++APE +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFEGSN 179
Query: 453 LLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWA-----RPILRDKDRLEELAD 506
K DV+S+G++L E++T RKP ++ P+ + + WA RP L
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHNGTRPPL----------- 225
Query: 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNR 566
+ PK + ++ C + + +QRP+M E+V+ + + R D L
Sbjct: 226 IK---NLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC-- 276
Query: 567 ANLRQSSTTFDSDGTSS 583
Q S DG
Sbjct: 277 ----QHSLPPGEDGRVE 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-66
Identities = 82/290 (28%), Positives = 133/290 (45%), Gaps = 48/290 (16%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-------KEFLVEVEMLSRLHHRNL 327
+G+GGFG V KG + D + VAIK L G +G+ +EF EV ++S L+H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
VKL G + + E VP G L L + W ++++ LD A G+ Y+
Sbjct: 86 VKLYGLMHN----PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138
Query: 388 HEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
+ P ++HRD ++ NI L++ AKVADFGL++Q + + + ++G F +
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192
Query: 443 VAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKD 499
+APE K+D YS+ ++L +LTG P + S + + I +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247
Query: 500 RLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
R E PRL + C + + +RP +V+ L
Sbjct: 248 RPTIPEDCPPRLR------------NVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-62
Identities = 59/287 (20%), Positives = 110/287 (38%), Gaps = 44/287 (15%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGY 333
L E G ++KG G + +K L ++F E L H N++ ++G
Sbjct: 17 KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
S + L +P GSL + LH +D +K ALD ARG+A+LH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------Y 447
+ + +++++ + A+++ + ++ S M +VAPE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPE 185
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE--EL 504
+D++S+ V+L EL+T P D+S + + + R
Sbjct: 186 DTNRR---SADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLRPTIPPG 235
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
P + + C+ + +RP +V L+ +Q
Sbjct: 236 ISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 4e-62
Identities = 72/287 (25%), Positives = 115/287 (40%), Gaps = 46/287 (16%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD----KEFLVEVEMLSRLHHRNLVKLV 331
I+G GGFG+V++ G VA+K + + E ++ + L H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 332 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
G L E G L L G + + + A+ ARG+ YLH+++
Sbjct: 73 G--VCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 392 QPCVIHRDFKASNILL--------ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
+IHRD K+SNIL+ +N K+ DFGLA++ G + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWM 181
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE 502
APE SDV+SYGV+L ELLTG P + + V + + +K L
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYG--VAMNKLALP 234
Query: 503 --ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ C P+ + RP+ ++ L
Sbjct: 235 IPSTCPEPFA------------KLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 8e-62
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 32/282 (11%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGYY 334
+G G FG V+KG G VA+K L + F EV +L + H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 335 SSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
S+ L + SL LH + + + IA ARG+ YLH
Sbjct: 89 ----STAPQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---YAM 449
+IHRD K++NI L + K+ DFGLA + ++ ++ G+ ++APE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 450 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509
+ +SDVY++G+VL EL+TG+ P Q + + R +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM--VGRGSLSPDLSKVRS- 252
Query: 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
PK + + A C+ + ++RP+ ++ ++ + R
Sbjct: 253 --NCPKR----MKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-60
Identities = 68/357 (19%), Positives = 134/357 (37%), Gaps = 51/357 (14%)
Query: 228 SKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFK 287
+ P E+ + + + G P + ++++ +G+G +G V+
Sbjct: 3 TYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMV-------KQIGKGRYGEVWM 55
Query: 288 GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY--YSSRDSSQHL 343
G G VA+K + + E E+ + H N++ + + +Q
Sbjct: 56 GKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111
Query: 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-----SQPCVIHR 398
L + NGSL +L LD ++ +K+A + GL +LH + +P + HR
Sbjct: 112 LITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 399 DFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV- 455
D K+ NIL++ N +AD GLA + + +GT Y+ PE + L
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRN 225
Query: 456 ------KSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLVTWARPILRDKDR 500
+D+YS+G++L E+ + + + + K R
Sbjct: 226 HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285
Query: 501 LEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 556
P ++ ++ +R + + C A R T V ++L + + +
Sbjct: 286 ------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-60
Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 42/298 (14%)
Query: 277 LGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG+G FG+ K G + +K L ++ + FL EV+++ L H N++K +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG--V 75
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+ E + G+L + + W R+ A D A G+AYLH + +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---I 129
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY------------LSTRVMGTFGYV 443
IHRD + N L+ N + VADFGLA+ + +T V+G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP---VDMSQPSGQENLVTWARPILRDKDR 500
APE K DV+S+G+VL E++ N+ + +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-YCPPNC 248
Query: 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP 558
I C + +RP+ ++ L+ ++ + P
Sbjct: 249 PPSFFP-----------------ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-59
Identities = 65/299 (21%), Positives = 121/299 (40%), Gaps = 42/299 (14%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY 333
+G+G +G V++G G VA+K + + +K + E E+ L H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 334 --YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 390
S S+Q L GSL +L LD + ++I L A GLA+LH +
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 391 ----SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT--NYLSTRVMGTFGYVA 444
+P + HRD K+ NIL++ N +AD GLA + + + +GT Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 445 PE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLVT 489
PE + D++++G+VL E+ + + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 490 WARPILRDKDRLEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLK 547
+ + D+ R P + ++ + + + + C + R T + ++L
Sbjct: 246 MRKVVCVDQQR------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-59
Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 51/295 (17%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGY 333
++G+G FG+V+ G G VAI+ + D K F EV + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
+ L +L S + LD +IA + +G+ YLH ++
Sbjct: 98 --CMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLH--AKG 150
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEYAMT 450
++H+D K+ N+ +N + DFGL GR G ++APE
Sbjct: 151 -ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 451 GHLLV---------KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-----RPILR 496
SDV++ G + EL P +QP+ + W +P L
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEA---IIWQMGTGMKPNLS 264
Query: 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
+E++D I C A E +RPT +++ L+ + +
Sbjct: 265 QIGMGKEISD-----------------ILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 7e-56
Identities = 63/303 (20%), Positives = 123/303 (40%), Gaps = 42/303 (13%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY 333
+G+G FG V++G G VA+K + + ++ + E E+ L H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 334 YSSRDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
+ + + Q L + +GSL +L+ + E +K+AL A GLA+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEI 159
Query: 392 Q-----PCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 444
P + HRD K+ NIL++ N +AD GLA + + +GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 445 PEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLV 488
PE + + + ++D+Y+ G+V E+ + + ++
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548
+ + K R + + + + + I C R T + ++L
Sbjct: 279 EMRKVVCEQKLRP-NIPNRWQSCEALRV----MAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 549 VQR 551
+ +
Sbjct: 334 LSQ 336
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-44
Identities = 91/299 (30%), Positives = 127/299 (42%), Gaps = 31/299 (10%)
Query: 275 SILGEGGFGRVFKGVL-----SDGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLV 328
LGEG FG+V G VA+K L G Q + E+++L L+H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
K G ++ L E VP GSL +L + + A G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH 151
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV----- 443
+Q IHRD A N+LL+N+ K+ DFGLAK PEG Y + G
Sbjct: 152 --AQHY-IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 502
APE SDV+S+GV L ELLT S P+ L+ A+ + E
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 503 ELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPT 559
L G + P+ D V + C EA+ RPT ++ LK V + Q P+
Sbjct: 263 LLER---GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 85/302 (28%), Positives = 124/302 (41%), Gaps = 28/302 (9%)
Query: 275 SILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
S LG+G FG V + G VA+K+L G ++F E+++L LH +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389
G L E +P+G L +L LD + + +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG- 144
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEY 447
S+ C +HRD A NIL+E+ H K+ADFGLAK P +Y R G + APE
Sbjct: 145 -SRRC-VHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWYAPES 201
Query: 448 AMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506
+SDV+S+GVVL EL T K S + ++ R + LE L +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 507 PRLGGKYPKEDFIRVCTIA-----AACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLT 561
G + P C C AP RP+ + L M+ +
Sbjct: 260 ---GQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313
Query: 562 SS 563
++
Sbjct: 314 TA 315
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 79/283 (27%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 277 LGEGGFGRVFKGVL-SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
+G G FG VF G L +D T VA+K +FL E +L + H N+V+L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 335 SSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
+ + + ELV G ++L G L +T +++ DAA G+ YL S+
Sbjct: 182 TQKQP--IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLE--SK 232
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMT 450
C IHRD A N L+ K++DFG++++ +G Y ++ + APE
Sbjct: 233 CC-IHRDLAARNCLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWTAPEALNY 289
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPR 508
G +SDV+S+G++L E + G P ++ S Q+ R + RL
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNL---SNQQ-----TREFVEKGGRLPC----- 336
Query: 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
P+ V + C A E QRP+ + Q L+ +++
Sbjct: 337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-43
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 35/271 (12%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVG 332
+G G F V+KG+ VA L + F E EML L H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 333 YYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+ S + + EL+ +G+L+++L + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 391 SQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449
+ P +IHRD K NI + K+ D GLA + + V+GT ++APE
Sbjct: 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYE 203
Query: 450 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DRLEELADP 507
+ DVY++G+ +LE+ T P S +N R + +++A P
Sbjct: 204 EKYDE-SVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT 538
+ ++ I C+ ++R +
Sbjct: 258 EV------KEIIE------GCIRQNKDERYS 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 19/286 (6%)
Query: 275 SILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
LG+G FG V + G VA+K+L ++ ++F E+E+L L H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389
G S L E +P GSL +L +D ++ +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG- 131
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEY 447
++ IHRD NIL+EN K+ DFGL K P+ + + + G + APE
Sbjct: 132 -TKRY-IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYAPES 188
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507
V SDV+S+GVVL EL T + + + + +E L +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN- 247
Query: 508 RLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
G+ P+ D + I C NQRP+ ++ + ++
Sbjct: 248 --NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 81/330 (24%), Positives = 128/330 (38%), Gaps = 28/330 (8%)
Query: 239 RTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVL--- 290
D T + + FE + LG+G FG V
Sbjct: 10 HDYDIPTTENLYFQGAMGSAFEDRDPTQ----FEERHLKFLQQLGKGNFGSVEMCRYDPL 65
Query: 291 --SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348
+ G VA+K+L ++ ++F E+E+L L H N+VK G S L E
Sbjct: 66 QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125
Query: 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE 408
+P GSL +L +D ++ +G+ YL ++ IHRD NIL+E
Sbjct: 126 LPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG--TKRY-IHRDLATRNILVE 179
Query: 409 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVL 466
N K+ DFGL K P+ + Y + G + APE V SDV+S+GVVL
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
Query: 467 LELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTI 524
EL T + + + + +E L + G+ P+ D + I
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMI 295
Query: 525 AAACVAPEANQRPTMGEVVQSLKMVQRVIE 554
C NQRP+ ++ + ++ +
Sbjct: 296 MTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 24/288 (8%)
Query: 275 SILGEGGFGRVFKGVL-----SDGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLV 328
LGEG FG+V + G VA+K L G + E+E+L L+H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
K G + + L E +P+GSL+ +L ++ + ++K A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLG 143
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPE 446
S+ +HRD A N+L+E+ K+ DFGL K + Y + + + APE
Sbjct: 144 --SRQY-VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-TVKDDRDSPVFWYAPE 199
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
M + SDV+S+GV L ELLT S + ++ + + L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 506 DPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ 550
+ G + P V + C + + R + +++ +++
Sbjct: 258 E---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 41/308 (13%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 328
++ LGEGGF V L DG A+KR+ C QQ +E E +M +H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 329 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+LV Y ++H G+L + + L + + + L RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-------GT 439
+H HRD K +NILL + + D G QA + T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 440 FGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493
Y APE + + ++DV+S G VL ++ G P DM G +
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258
Query: 494 ILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
++++ ++ + + + + +QRP + ++ L+ +Q
Sbjct: 259 AVQNQLS------IPQSPRHSSALWQLLN------SMMTVDPHQRPHIPLLLSQLEALQP 306
Query: 552 VIECQDPT 559
Q T
Sbjct: 307 PAPGQHTT 314
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 42/307 (13%)
Query: 248 GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG-----TAVAIKRLT 302
G P+ R L E K+ +LG G FG V+KG+ VAIK L
Sbjct: 1 GEAPNQALLRILKETEFKKIK-------VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 53
Query: 303 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 361
+ +KE L E +++ + + ++ +L+G + S L +L+P G L ++
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREH 110
Query: 362 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
++ + + + A+G+ YL ++HRD A N+L++ H K+ DFGLA
Sbjct: 111 KD---NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMS 479
K Y + ++A E + +SDV+SYGV + EL+T G KP +
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI- 223
Query: 480 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539
E IL +RL + P I V I C +A+ RP
Sbjct: 224 --PASE-----ISSILEKGERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKF 266
Query: 540 GEVVQSL 546
E++
Sbjct: 267 RELIIEF 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 277 LGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVG 332
LG G FG V +GV VAIK L G ++ D E + E +++ +L + +V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 392
+ +L E+ G L +L G + ++ + G+ YL +
Sbjct: 78 VCQA---EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYL---EE 128
Query: 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 450
+HRD A N+LL N +AK++DFGL+K + Y + R G + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINF 187
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKP 475
+SDV+SYGV + E L+ G+KP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 25/231 (10%)
Query: 259 LAYEELKEATNNFEPASI------LGEGGFGRVFKGVL---SDGTAVAIKRLTCG--GQQ 307
+A EE++ + + LG G FG V KG VA+K L
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 308 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH 367
E L E ++ +L + +V+++G + +L E+ G L +L N H
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQ----NRH 113
Query: 368 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427
+ + +++ + G+ YL + +HRD A N+LL +AK++DFGL+K
Sbjct: 114 VKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170
Query: 428 RTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
Y + G + + APE KSDV+S+GV++ E + G+KP
Sbjct: 171 ENYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 73/326 (22%), Positives = 124/326 (38%), Gaps = 74/326 (22%)
Query: 252 HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK 310
H RF +F+ ++G GGFG+VFK DG IKR+ + ++
Sbjct: 3 HTVDKRFG---------MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNE 49
Query: 311 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY--------------ELVPNGSLES 356
+ EV+ L++L H N+V G + D E G+LE
Sbjct: 50 KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109
Query: 357 WLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416
W+ G LD +++ +G+ Y+H +I+RD K SNI L + K+
Sbjct: 110 WIEKRRGE--KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIG 164
Query: 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELL 470
DFGL + GT Y++PE Y G + D+Y+ G++L ELL
Sbjct: 165 DFGLVTSL--KNDGKRTRSK-GTLRYMSPEQISSQDY---GK---EVDLYALGLILAELL 215
Query: 471 TGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAAC 528
T +L D + + K+ ++
Sbjct: 216 HVCDT-----AFETSKFFT-------------DLRDGIISDIFDKKEKTLLQ------KL 251
Query: 529 VAPEANQRPTMGEVVQSLKMVQRVIE 554
++ + RP E++++L + ++ E
Sbjct: 252 LSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 54/306 (17%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 326
++FE ++LG+G FG+V K D AIK++ ++ L EV +L+ L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 327 LVKLVGYYSSRDSSQHLLCY-----------ELVPNGSLESWLHGPLGVNCHLDWETRMK 375
+V+ + R + + E NG+L +H N + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ------------ 423
+ L+Y+H +IHRD K NI ++ + + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 424 -APEGRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481
G ++ L++ + GT YVA E TGH K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------F 228
Query: 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTM 539
S V + + P K IR + + N+RP
Sbjct: 229 STGMERVNILKKLRSVSIEF----PPDFDDNKMKVEKKIIR------LLIDHDPNKRPGA 278
Query: 540 GEVVQS 545
++ S
Sbjct: 279 RTLLNS 284
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 276 ILGEGGFGRVFKGVL----SDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLV 328
LG+G FG V +G +VA+K L + +F+ EV + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
+L G + + EL P GSL L G H T + A+ A G+ YL
Sbjct: 85 RLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYL- 137
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAP 445
IHRD A N+LL K+ DFGL + P+ +Y+ F + AP
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEE 503
E T SD + +GV L E+ T G++P + + +G + L I ++ +RL
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQIL----HKIDKEGERLPR 246
Query: 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
P++ + + C A + RPT + L
Sbjct: 247 ----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+G G FG V G + VAIK + G + +F+ E E++ +L H LV+L G
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+ + L E + +G L +L G ET + + LD G+AYL E++ V
Sbjct: 74 --EQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYL-EEAC--V 125
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 453
IHRD A N L+ N KV+DFG+ + + + ++ F +PE
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 454 LVKSDVYSYGVVLLELLT-GRKP 475
KSDV+S+GV++ E+ + G+ P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 74/327 (22%), Positives = 126/327 (38%), Gaps = 46/327 (14%)
Query: 247 GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG 305
G +P + L + NF +G G F V++ L DG VA+K++
Sbjct: 10 GPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69
Query: 306 QQGDKE---FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGP 361
K + E+++L +L+H N++K YY+S L EL G L +
Sbjct: 70 LMDAKARADCIKEIDLLKQLNHPNVIK---YYASFIEDNELNIVLELADAGDLSRMIKHF 126
Query: 362 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
+ T K + L ++H V+HRD K +N+ + K+ D GL
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ +T + V GT Y++PE Y KSD++S G +L E+ + P
Sbjct: 184 RFF-SSKTTAAHSLV-GTPYYMSPERIHENGYNF------KSDIWSLGCLLYEMAALQSP 235
Query: 476 VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEA 533
+ NL + + I + P Y +E + C+ P+
Sbjct: 236 FYGD----KMNLYSLCKKIEQCD------YPPLPSDHYSEELRQLVN------MCINPDP 279
Query: 534 NQRPTMGEVVQSLKMVQRVIECQDPTL 560
+RP + V + +R+ C +L
Sbjct: 280 EKRPDVTYV---YDVAKRMHACTASSL 303
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+G+G FG V G G VA+K + + FL E ++++L H NLV+L+G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+++ E + GSL +L L + +K +LD + YL
Sbjct: 85 EEKGGLYIVT-EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 453
+HRD A N+L+ + AKV+DFGL + ST+ G APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLT------KEAS-STQDTGKLPVKWTAPEALREKKF 191
Query: 454 LVKSDVYSYGVVLLELLT-GRKP 475
KSDV+S+G++L E+ + GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 86/315 (27%), Positives = 133/315 (42%), Gaps = 37/315 (11%)
Query: 240 TADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVLSDGT 294
+ A L L T + L + S+ LG+G FG V+ G + T
Sbjct: 150 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT 209
Query: 295 AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL 354
VAIK L G + FL E +++ +L H LV+L S + E + GSL
Sbjct: 210 RVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSL 265
Query: 355 ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414
+L G G +L + +A A G+AY+ + +HRD +A+NIL+ N K
Sbjct: 266 LDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCK 320
Query: 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GR 473
VADFGLA+ + + APE A+ G +KSDV+S+G++L EL T GR
Sbjct: 321 VADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 474 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTIAAACVAP 531
P P + +++ L+++ G + P + + C
Sbjct: 380 VPY----------------PGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWRK 420
Query: 532 EANQRPTMGEVVQSL 546
E +RPT + L
Sbjct: 421 EPEERPTFEYLQAFL 435
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 276 ILGEGGFGRVFKGVLSDG-----TAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
+LG G FG V KGV V IK + G+Q + + + L H ++V+
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389
L+G S L + +P GSL + G L + + + A+G+ YL
Sbjct: 80 LLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYL-- 131
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449
+ ++HR+ A N+LL++ +VADFG+A P L + ++A E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 450 TGHLLVKSDVYSYGVVLLELLT-GRKP 475
G +SDV+SYGV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 69/304 (22%), Positives = 118/304 (38%), Gaps = 55/304 (18%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 326
+FEP LG GGFG VF+ D AIKR+ ++ +E + EV+ L++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 327 LVKLVGYYSS-----------RDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETR 373
+V+ Y+++ S + L +L +L+ W++G + +
Sbjct: 65 IVR---YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVC 120
Query: 374 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---------- 423
+ I L A + +LH ++HRD K SNI + KV DFGL
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 483
T +GT Y++PE K D++S G++L ELL P
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFS 228
Query: 484 QENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 541
+ +R+ P L + ++ ++P +RP
Sbjct: 229 TQMERVRTLTDVRNLKF------PPLFTQKYPCEYVMVQ------DMLSPSPMERPEAIN 276
Query: 542 VVQS 545
++++
Sbjct: 277 IIEN 280
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 276 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVK 329
ILGEG FG V +G L VA+K + Q+ +EFL E + H N+++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 330 LVGYYSSRDSSQHLLCY---ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGL 384
L+G S + G L ++L H+ +T +K +D A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLSTR 435
YL S +HRD A N +L ++ VADFGL+ +Q + + +
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK---MPVK 214
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ A E KSDV+++GV + E+ T G P
Sbjct: 215 WI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 46/297 (15%)
Query: 276 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 330
++G G FG V+ G L D A+K L G+ +FL E ++ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLH 388
+G R L+ + +G L +++ + + + L A+G+ YL
Sbjct: 92 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLA 145
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG------Y 442
S+ V HRD A N +L+ F KVADFGLA+ + Y V G +
Sbjct: 146 --SKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYD--KEY--YSVHNKTGAKLPVKW 198
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDR 500
+A E T KSDV+S+GV+L EL+T G P D+ + + L R
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFD-----ITVYLLQGRR 250
Query: 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 557
L + P+ + + C P+A RP+ E+V + + +
Sbjct: 251 LLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG G FG V G VA+K + G D EF E + + +L H LVK G S
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 336 SRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
+ E + NG L ++L HG L+ +++ D G+A+L
Sbjct: 74 --KEYPIYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFL---ESH 123
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMT 450
IHRD A N L++ + KV+DFG+ + + Y +GT + APE
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQY--VSSVGTKFPVKWSAPEVFHY 179
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKP 475
KSDV+++G+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG G FG V+ G + T VA+K L G D FL E ++ +L H+ LV+L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+ E + NGSL +L P G+ L + +A A G+A++ +
Sbjct: 79 QE---PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFI---EERNY 130
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGH 452
IHRD +A+NIL+ + K+ADFGLA+ + Y T G + APE G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIED--NEY--TAREGAKFPIKWTAPEAINYGT 186
Query: 453 LLVKSDVYSYGVVLLELLT-GRKP 475
+KSDV+S+G++L E++T GR P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-37
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
+G+G FG V G G VA+K + + FL E ++++L H NLV+L+G
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV-I 255
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+ + E + GSL +L L + +K +LD + YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLL 454
+HRD A N+L+ + AKV+DFGL K+A + L + APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------APEALREKKFS 364
Query: 455 VKSDVYSYGVVLLELLT-GRKP 475
KSDV+S+G++L E+ + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 85/355 (23%), Positives = 141/355 (39%), Gaps = 46/355 (12%)
Query: 248 GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG-----TAVAIKRLT 302
G P+ R L E K+ +LG G FG V+KG+ VAIK L
Sbjct: 1 GEAPNQALLRILKETEFKKIK-------VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 53
Query: 303 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 361
+ +KE L E +++ + + ++ +L+G + S L +L+P G L ++
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREH 110
Query: 362 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
++ + + + A+G+ YL ++HRD A N+L++ H K+ DFGLA
Sbjct: 111 KD---NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMS 479
K Y + ++A E + +SDV+SYGV + EL+T G KP +
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI- 223
Query: 480 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539
E IL +RL + P I V I C +A+ RP
Sbjct: 224 --PASE-----ISSILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKF 266
Query: 540 GEVVQSL-KMVQ---RVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPY 590
E++ KM + R + Q + + D + + + Y
Sbjct: 267 RELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY 321
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 276 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 330
++G+G FG V+ G D AIK L+ + FL E ++ L+H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+G + + +G L ++ P + + + L ARG+ YL
Sbjct: 88 IGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL--A 141
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV-----AP 445
Q +HRD A N +L+ +F KVADFGLA+ + Y S + + A
Sbjct: 142 EQKF-VHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQ-QHRHARLPVKWTAL 197
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
E T KSDV+S+GV+L ELLT G P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-37
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG G FG V G VAIK + G D EF+ E +++ L H LV+L G +
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+ E + NG L ++L + +++ D + YL
Sbjct: 90 --KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYL---ESKQF 141
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 453
+HRD A N L+ + KV+DFGL++ + + ++ V F PE M
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 454 LVKSDVYSYGVVLLELLT-GRKP 475
KSD++++GV++ E+ + G+ P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 19/265 (7%)
Query: 218 ICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASIL 277
+ S + ++ + + +P D P + ++ + L
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD--IEL 344
Query: 278 GEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGY 333
G G FG V +GV VAIK L G ++ D E + E +++ +L + +V+L+G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
+ +L E+ G L +L G + ++ + G+ YL +
Sbjct: 405 CQA---EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTG 451
+HR+ A N+LL N +AK++DFGL+K + Y + R G + APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR 514
Query: 452 HLLVKSDVYSYGVVLLELLT-GRKP 475
+SDV+SYGV + E L+ G+KP
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
+LG+G +G V+ G LS+ +AIK + + + E+ + L H+N+V+ Y
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---YL 85
Query: 335 SSRDSSQHLLCY-ELVPNGSLESWL---HGPLGVNCHLDWETRMK-IALDAARGLAYLHE 389
S + + + E VP GSL + L GPL N E + GL YLH+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIGFYTKQILEGLKYLHD 140
Query: 390 DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-- 446
+ ++HRD K N+L+ + K++DFG +K+ + GT Y+APE
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195
Query: 447 -YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQP 481
G+ +D++S G ++E+ TG+ P ++ +P
Sbjct: 196 DKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHR 325
++E +G G +GR K SDG + K L G + +K+ LV EV +L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
N+V+ R ++ + E G L S + +LD E +++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 386 YLHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
H D V+HRD K +N+ L+ + K+ DFGLA+ T++ T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYM 183
Query: 444 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
+PE Y KSD++S G +L EL P + A I
Sbjct: 184 SPEQMNRMSYNE------KSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREG 231
Query: 498 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
K R+ +Y E + I + + RP++ E+++
Sbjct: 232 K-------FRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILE 267
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 276 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 330
++G G FG V+ G L D A+K L G+ +FL E ++ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+G R L+ + +G L +++ + + + L A+G+ +L
Sbjct: 156 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFL--A 209
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV-----AP 445
S+ V HRD A N +L+ F KVADFGLA+ + + S T + A
Sbjct: 210 SKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVH-NKTGAKLPVKWMAL 265
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
E T KSDV+S+GV+L EL+T G P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 276 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVK 329
+LG+G FG V + L VA+K L +EFL E + H ++ K
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 330 LVGYYSSRDSSQHLLCY----ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 383
LVG + L + +G L ++L +L +T ++ +D A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--G 441
+ YL S+ IHRD A N +L + VADFGL+++ +Y
Sbjct: 150 MEYL--SSRNF-IHRDLAARNCMLAEDMTVCVADFGLSRKIYS--GDYYRQGCASKLPVK 204
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
++A E V SDV+++GV + E++T G+ P
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 71/326 (21%), Positives = 110/326 (33%), Gaps = 50/326 (15%)
Query: 226 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 285
+K +AK + T T E +E + +G G FG V
Sbjct: 15 SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEV 74
Query: 286 FKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342
+ G A+K RL + E+ + L +V Y +
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVP---LYGAVREGPW 124
Query: 343 LLCY-ELVPNGSLESWL--HGPLGVNCHLDWETR-MKIALDAARGLAYLHEDSQPCVIHR 398
+ + EL+ GSL + G L E R + A GL YLH ++H
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLP-------EDRALYYLGQALEGLEYLHTR---RILHG 174
Query: 399 DFKASNILLENN-FHAKVADFGLAKQ-APEGRTNYLSTR--VMGTFGYVAPEYAM-TGHL 453
D KA N+LL ++ A + DFG A P+G L T + GT ++APE M
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 454 LVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 512
K D++S ++L +L G P + + + PI L
Sbjct: 235 A-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT------- 286
Query: 513 YPKEDFIRVCTIAAACVAPEANQRPT 538
I+ + E R +
Sbjct: 287 ---AQAIQ------EGLRKEPVHRAS 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 64/350 (18%), Positives = 123/350 (35%), Gaps = 55/350 (15%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHR 325
+ +GEG FG+ DG IK + ++E EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 326 NLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
N+V+ + S L + G L ++ GV + + +
Sbjct: 84 NIVQYRESFEENGS----LYIVMDYCEGGDLFKRINAQKGV--LFQEDQILDWFVQICLA 137
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
L ++H+ ++HRD K+ NI L + ++ DFG+A+ + GT Y+
Sbjct: 138 LKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYL 192
Query: 444 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
+PE Y KSD+++ G VL EL T + + ++ I+
Sbjct: 193 SPEICENKPYNN------KSDIWALGCVLYELCTLKHAFE------AGSMKNLVLKIISG 240
Query: 498 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555
P + Y + + RP++ +++ + +R+ +
Sbjct: 241 S-------FPPVSLHYSYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKF 287
Query: 556 QDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTA 605
P L + TF G+ + + P SG ++ +
Sbjct: 288 LSPQLIAEE------FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKIT 331
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 6e-36
Identities = 75/236 (31%), Positives = 109/236 (46%), Gaps = 16/236 (6%)
Query: 246 LGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVLSDGTAVAIKR 300
L L T + L + S+ LG+G FG V+ G + T VAIK
Sbjct: 239 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT 298
Query: 301 LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 360
L G + FL E +++ +L H LV+L S + E + GSL +L G
Sbjct: 299 LKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKG 354
Query: 361 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420
G +L + +A A G+AY+ + +HRD +A+NIL+ N KVADFGL
Sbjct: 355 ETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 409
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
A+ + + APE A+ G +KSDV+S+G++L EL T GR P
Sbjct: 410 ARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-36
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 276 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
LG G +G V++GV VA+K L + + EFL E ++ + H NLV+L+G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
+ + E + G+L +L + + +A + + YL + +
Sbjct: 286 T--REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--- 338
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGH 452
IHR+ A N L+ N KVADFGL++ + + F APE
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 453 LLVKSDVYSYGVVLLELLT-GRKP 475
+KSDV+++GV+L E+ T G P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-36
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 276 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG G FG V+ + T VA+K + G + FL E ++ L H LVKL +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395
+ E + GSL +L G + + A G+A++ Q
Sbjct: 254 K---EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFI---EQRNY 305
Query: 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 453
IHRD +A+NIL+ + K+ADFGLA+ + N + R F APE G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 454 LVKSDVYSYGVVLLELLT-GRKP 475
+KSDV+S+G++L+E++T GR P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-36
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 276 ILGEGGFGRVFKGVLSDG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
LG G +G V++GV VA+K L + + EFL E ++ + H NLV+L+G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394
+ + E + G+L +L + + +A + + YL +
Sbjct: 79 TREPPF--YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYL---EKKN 131
Query: 395 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGH 452
IHRD A N L+ N KVADFGL++ + + F APE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 453 LLVKSDVYSYGVVLLELLT-GRKP 475
+KSDV+++GV+L E+ T G P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-36
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 276 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 330
+GEG FG V +G+ AVAIK + +FL E + + H ++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+G + + + EL G L S+L LD + + A + LAYL
Sbjct: 82 IGVITE---NPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYL--- 132
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 450
+HRD A N+L+ +N K+ DFGL++ E T Y +++ ++APE
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 191
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKP 475
SDV+ +GV + E+L G KP
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 64/305 (20%), Positives = 107/305 (35%), Gaps = 63/305 (20%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRL-H 323
T F +G G FG VFK V DG AIKR G ++ L EV + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 324 HRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
H ++V+ Y+S+ H+L E GSL + + + + L R
Sbjct: 70 HSHVVR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENN-------------------FHAKVADFGLAKQ 423
GL Y+H S ++H D K SNI + K+ D G +
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 424 APEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481
+ G ++A E HL K+D+++ + ++ P
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL-----P 231
Query: 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTM 539
+ W +R PR+ +E + ++ + P+ +RP+
Sbjct: 232 RNGD---QWHE--IRQGRL------PRIPQVLSQEFTELLK------VMIHPDPERRPSA 274
Query: 540 GEVVQ 544
+V+
Sbjct: 275 MALVK 279
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 276 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 330
I+G G G V G L VAIK L G + + +FL E ++ + H N+++L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
G + ++ E + NGSL+++L G + + G+ YL
Sbjct: 116 EGVVT--RGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYL--- 167
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYA 448
S +HRD A N+L+++N KV+DFGL++ E + T G APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 449 MTGHLLVKSDVYSYGVVLLELLT-GRKP 475
SDV+S+GVV+ E+L G +P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 276 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 330
ILGEG FG V++GV + VA+K +K +F+ E ++ L H ++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+G + EL P G L +L L T + +L + +AYL
Sbjct: 79 IGIIEE---EPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYL--- 129
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEY 447
+HRD NIL+ + K+ DFGL++ + +Y + T +++PE
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDY--YKASVTRLPIKWMSPES 185
Query: 448 AMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
SDV+ + V + E+L+ G++P
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 65/356 (18%), Positives = 125/356 (35%), Gaps = 57/356 (16%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL--HHRNLVKLVG 332
+G GG +VF+ + AIK + + E+ L++L H +++L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
Y + E N L SWL + D R + + +H+
Sbjct: 77 YE--ITDQYIYMVMECG-NIDLNSWLKKKKSI------DPWERKSYWKNMLEAVHTIHQH 127
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---- 446
++H D K +N L+ + K+ DFG+A Q T+ + +GT Y+ PE
Sbjct: 128 G---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 447 --YAMTGHLLV-----KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499
+ KSDV+S G +L + G+ P N +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI----------S 228
Query: 500 RLEELADPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553
+L + DP ++P +D ++ C+ + QR ++ E++ + +
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 554 ECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSE 609
++ + +S + + Y S ++ N S + F +
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEK 338
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 65/282 (23%), Positives = 96/282 (34%), Gaps = 42/282 (14%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL-HHR 325
+F+ S LG G +G VFK DG A+KR G + L EV ++ H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 326 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
V+ + + L L EL SL+ L D L
Sbjct: 118 CCVR---LEQAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLAL 170
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
A+LH ++H D K +NI L K+ DFGL + G + G Y+A
Sbjct: 171 AHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQE-GDPRYMA 224
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
PE + +DV+S G+ +LE+ + P G E LR
Sbjct: 225 PELLQGSYGT-AADVFSLGLTILEVACNMEL-----PHGGEGW-----QQLRQGY----- 268
Query: 505 ADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
P E + + P+ R T ++
Sbjct: 269 LPPEFTAGLSSELRSVLV------MMLEPDPKLRATAEALLA 304
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 276 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 330
++G G FG V G L +VAIK L G + + +FL E ++ + H N+++L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
G + S ++ E + NGSL+S+L + + A G+ YL
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYL--- 163
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYA 448
S +HRD A NIL+ +N KV+DFGL + + +TR G +PE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-GGKIPIRWTSPEAI 222
Query: 449 MTGHLLVKSDVYSYGVVLLELLT-GRKP 475
SDV+SYG+VL E+++ G +P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-35
Identities = 95/450 (21%), Positives = 156/450 (34%), Gaps = 62/450 (13%)
Query: 114 ITPHTGISFSASDASAINFSLTTHKVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPM 173
I P GIS+ + ++V + K + Q +A +P
Sbjct: 244 IGPEEGISYLTDKGANPTHLADFNQVQTIQYSNSEDK-------DRKGMLQLKIAGAP-- 294
Query: 174 KAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIIC----SCAFRGRKSK 229
P + ++ S + LI G L+ II K
Sbjct: 295 -------EPLTVTAPSLTIAENMADLIDGYC--RLVNGATQSFIIRPQKEGERALPSIPK 345
Query: 230 ASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGR 284
+ E R+ Y + I +GEG FG
Sbjct: 346 LANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGD 405
Query: 285 VFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339
V +G+ AVAIK + +FL E + + H ++VKL+G +
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462
Query: 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRD 399
+ + EL G L S+L LD + + A + LAYL S+ V HRD
Sbjct: 463 NPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLE--SKRFV-HRD 516
Query: 400 FKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDV 459
A N+L+ +N K+ DFGL++ E T Y +++ ++APE SDV
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 460 YSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKED 517
+ +GV + E+L G KP + + + + +RL P
Sbjct: 576 WMFGVCMWEILMHGVKPFQGV---KNND-----VIGRIENGERLPM----------PPNC 617
Query: 518 FIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ ++ C A + ++RP E+ L
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 276 ILGEGGFGRVFKGVLSDGTA-----VAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 329
++G G FG V+KG+L + VAIK L G + + +FL E ++ + H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389
L G S ++ E + NG+L+ +L G + + A G+ YL
Sbjct: 111 LEGVIS--KYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYL-- 163
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV-------MGTFGY 442
+ +HRD A NIL+ +N KV+DFGL++ + +T
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----- 217
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
APE SDV+S+G+V+ E++T G +P
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 44/289 (15%)
Query: 270 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL-HH 324
+F P +LG G G + + D VA+KR+ E EV++L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREVQLLRESDEH 77
Query: 325 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
N+++ D + EL +L+ ++ + L+ + + GL
Sbjct: 78 PNVIRYFCTEK--DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGL 131
Query: 385 AYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLSTR-VMG 438
A+LH + ++HRD K NIL+ A ++DFGL K+ GR ++ V G
Sbjct: 132 AHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 439 TFGYVAPEY---AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495
T G++APE + D++S G V +++ P G+ IL
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQAN--IL 241
Query: 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
L+ L + + + I +A + +RP+ V++
Sbjct: 242 LGACSLDCLHPEKHEDVIAR-ELIE------KMIAMDPQKRPSAKHVLK 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 22/227 (9%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGY 333
ILG+G VF+G G AIK + + E E+L +L+H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 393
+ +L E P GSL + L P L + + D G+ +L E+
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 394 CVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449
++HR+ K NI+ + K+ DFG A++ + + GT Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLY-GTEEYLHPDMYE 188
Query: 450 TGHLLV--------KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENL 487
L D++S GV TG P P + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 276 ILGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 327
LG+G F ++FKGV T V +K L + + F M+S+L H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
V G +++L E V GSL+++L ++ ++++A A + +L
Sbjct: 75 VLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFL 129
Query: 388 HEDSQPCVIHRDFKASNILLE--------NNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
+ +IH + A NILL N K++D G++ + L R+
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--KDILQERIPWV 184
Query: 440 FGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLT-GRKP 475
PE L + +D +S+G L E+ + G KP
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 37/223 (16%)
Query: 276 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 328
LG+G FG V++GV T VAIK + ++ EFL E ++ + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK----IALDAAR 382
+L+G S L+ EL+ G L+S+L P N + + +A + A
Sbjct: 92 RLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLS 433
G+AYL+ + V HRD A N ++ +F K+ DFG+ ++ +G L
Sbjct: 150 GMAYLN--ANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL---LP 203
Query: 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
R M +PE G SDV+S+GVVL E+ T +P
Sbjct: 204 VRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 50/240 (20%), Positives = 88/240 (36%), Gaps = 30/240 (12%)
Query: 253 PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--K 310
T L ++ + + +G GG +VF+ + AIK +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71
Query: 311 EFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNC 366
+ E+ L++L + ++L Y + E N L SWL +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYE--ITDQYIYMVMECG-NIDLNSWLKKKKSI---- 124
Query: 367 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
D R + + +H+ ++H D K +N L+ + K+ DFG+A Q
Sbjct: 125 --DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178
Query: 427 GRTNYLSTRVMGTFGYVAPE------YAMTGHLLV-----KSDVYSYGVVLLELLTGRKP 475
T+ + +GT Y+ PE + KSDV+S G +L + G+ P
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-34
Identities = 66/316 (20%), Positives = 109/316 (34%), Gaps = 48/316 (15%)
Query: 271 FEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNL 327
+E + GG G ++ + +G V +K L G + + E + L+ + H ++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 328 VKLVGYYSSRDSSQHLLCY---ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
V++ + D + Y E V SL+ L + L+ L
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL------PVAEAIAYLLEILPAL 195
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
+YLH +++ D K NI+L K+ D G + Y + GT G+ A
Sbjct: 196 SYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGY----LYGTPGFQA 245
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
PE V +D+Y+ G L L + G + P+L+ D L
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LPEDDPVLKTYDSYGRL 300
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQRVIECQDPTLTSS 563
+ A P+ QR T E+ L V R + QD +
Sbjct: 301 -------------------LRRAI-DPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRP 340
Query: 564 NNRANLRQSSTTFDSD 579
S +TF D
Sbjct: 341 GLSTIFSPSRSTFGVD 356
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 277 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGEG FG+VF + VA+K L + ++F E E+L+ L H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR---------MKIALD 379
G + L+ +E + +G L +L HGP + + +A
Sbjct: 109 FG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
A G+ YL + +HRD N L+ K+ DFG+++ T+Y R +G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--TDY--YR-VGG 218
Query: 440 FGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ PE + +SDV+S+GVVL E+ T G++P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 73/405 (18%), Positives = 141/405 (34%), Gaps = 51/405 (12%)
Query: 224 RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 283
RG K + + + D+ LG S+ A E + + +G GG
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS--ANECISVKGRIYSILKQIGSGGSS 70
Query: 284 RVFKGVLSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDS 339
+VF+ + AIK L Q + E+ L++L + ++L Y
Sbjct: 71 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--ITD 128
Query: 340 SQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 397
+ E N L SWL + D R + + +H+ ++H
Sbjct: 129 QYIYMVMECG-NIDLNSWLKKKKSI------DPWERKSYWKNMLEAVHTIHQHG---IVH 178
Query: 398 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTG 451
D K +N L+ + K+ DFG+A Q T+ + +G Y+ PE +
Sbjct: 179 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 452 HLLV-----KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE--EL 504
KSDV+S G +L + G+ P N ++ I+ +E ++
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDI 292
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSN 564
+ L +D ++ C+ + QR ++ E++ + + ++
Sbjct: 293 PEKDL------QDVLK------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340
Query: 565 NRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSE 609
+ +S + + Y S ++ N S + F +
Sbjct: 341 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEK 385
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 38/225 (16%)
Query: 277 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 330
LGEG FG+VF D VA+K L K+F E E+L+ L H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIAL 378
G D ++ +E + +G L +L P L + IA
Sbjct: 83 YG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS--TRV 436
A G+ YL + +HRD N L+ N K+ DFG++ R Y + RV
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDYYRV 191
Query: 437 MGTFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
G + PE M +SDV+S+GV+L E+ T G++P
Sbjct: 192 GGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 90/326 (27%), Positives = 135/326 (41%), Gaps = 60/326 (18%)
Query: 276 ILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNLVKL 330
++GEG FG+V K + AIKR+ + D +F E+E+L +L HH N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIAL 378
+G R L E P+G+L +L L + + A
Sbjct: 92 LGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST---- 434
D ARG+ YL SQ IHRD A NIL+ N+ AK+ADFGL++ Y+
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGR 202
Query: 435 ---RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVT 489
R M A E SDV+SYGV+L E+++ G P M + E
Sbjct: 203 LPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAE---- 249
Query: 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KM 548
L RLE+ P E V + C + +RP+ +++ SL +M
Sbjct: 250 -LYEKLPQGYRLEK---PL---NCDDE----VYDLMRQCWREKPYERPSFAQILVSLNRM 298
Query: 549 VQRVIECQDPTLTSSNNRANLRQSST 574
++ + TL A + S+
Sbjct: 299 LEERKTYVNTTLYEKFTYAGIDCSAE 324
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 276 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 328
LG G FG V++G +S VA+K L + D+ +FL+E ++S+ +H+N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-LGVNCHLDWETRMKIALDAARGLA 385
+ +G S S + EL+ G L+S+L P L + +A D A G
Sbjct: 97 RCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 386 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
YL + IHRD A N LL AK+ DFG+A+ S G
Sbjct: 155 YL--EENHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGCAM 206
Query: 443 V-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ PE M G K+D +S+GV+L E+ + G P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 22/234 (9%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 326
+ + + ILG+G VF+G G AIK + + E E+L +L+H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+VKL + +L E P GSL + L P L + + D G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127
Query: 387 LHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
L E+ ++HR+ K NI+ + K+ DFG A++ + + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLY-GTEEY 181
Query: 443 VAPEYAMTGHLLV--------KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENL 487
+ P+ L D++S GV TG P P + +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 275 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 329
LG GG V+ VAIK + + +E L EV S+L H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 387
+ + + L E + +L ++ HGPL +T + G+ +
Sbjct: 76 M--IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL------SVDTAINFTNQILDGIKHA 127
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
H+ ++HRD K NIL+++N K+ DFG+AK A + + V+GT Y +PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKP 475
A +D+YS G+VL E+L G P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 276 ILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 327
LG G FG+V + + VA+K L G + + E+++L + HH N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMK 375
V L+G ++ ++ E G+L ++L L E +
Sbjct: 94 VNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST- 434
+ A+G+ +L + IHRD A NILL K+ DFGLA+ + +Y+
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKG 208
Query: 435 ------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ M APE ++SDV+S+GV+L E+ + G P
Sbjct: 209 DARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-33
Identities = 68/258 (26%), Positives = 103/258 (39%), Gaps = 22/258 (8%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL 322
+ +E LG GGFG V + + G VAIK+ ++E E++++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 323 HHRNLVKLVGYYSSR----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
+H N+V + LL E G L +L+ C L +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLS 128
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTR 435
D + L YLHE+ +IHRD K NI+L K+ D G AK+ +G +
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEF 183
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495
V GT Y+APE V D +S+G + E +TG +P V W +
Sbjct: 184 V-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-----PNWQPVQWHG-KV 236
Query: 496 RDKDRLEELADPRLGGKY 513
R+K + L G
Sbjct: 237 REKSNEHIVVYDDLTGAV 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 276 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 328
LG G FG V++G +S VA+K L + D+ +FL+E ++S+ +H+N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-LGVNCHLDWETRMKIALDAARGLA 385
+ +G S S + EL+ G L+S+L P L + +A D A G
Sbjct: 138 RCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 386 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
YL + IHRD A N LL AK+ DFG+A+ G
Sbjct: 196 YL--EENHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGCAM 247
Query: 443 V-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ PE M G K+D +S+GV+L E+ + G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 277 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 329
LGE FG+V+KG L AVAIK L + + EF E + +RL H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIA 377
L+G + + + +G L +L V L+ + +
Sbjct: 77 LLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
A G+ YL S V H+D N+L+ + + K++D GL ++ +Y
Sbjct: 135 AQIAAGMEYL--SSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREVYA--ADYYKLLGN 189
Query: 438 GTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
++APE M G + SD++SYGVVL E+ + G +P
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 275 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 329
ILG GG V L D VA+K L D F + E + + L+H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 330 L--VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLA 385
+ G + + E V +L + GP+ + +++ DA + L
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------TPKRAIEVIADACQALN 130
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST-RVMGTFGYVA 444
+ H++ +IHRD K +NI++ KV DFG+A+ + + T V+GT Y++
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
PE A + +SDVYS G VL E+LTG P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 4e-32
Identities = 41/348 (11%), Positives = 77/348 (22%), Gaps = 51/348 (14%)
Query: 229 KASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKG 288
+ +P P T + L + + L G VF
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLV 81
Query: 289 V-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHHRN------------------ 326
+ A+K T G + E +RL +
Sbjct: 82 RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141
Query: 327 ------LVKLVGYYSSRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHLDWETRMKIAL 378
+L + +LL L S L +
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
R A L ++H F N+ + + + D +
Sbjct: 202 QLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSV 253
Query: 439 TFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496
Y E+ + + G+ + + P + P + +W RP LR
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG---SWKRPSLR 310
Query: 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+ I + + +R E ++
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPLEAME 352
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 67/221 (30%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVE 317
+FE LG+G FG V+ +A+K L K L EVE
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-------FKAQLEKAGVEHQLRREVE 61
Query: 318 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK 375
+ S L H N+++L GY+ D+++ L E P G++ L + T
Sbjct: 62 IQSHLRHPNILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTA-T 113
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 435
+ A L+Y H VIHRD K N+LL + K+ADFG + AP R L
Sbjct: 114 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 168
Query: 436 VMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKP 475
GT Y+ PE H K D++S GV+ E L G+ P
Sbjct: 169 --GTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPP 206
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 53/208 (25%), Positives = 80/208 (38%), Gaps = 20/208 (9%)
Query: 275 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 329
++G GG G V++ VA+K ++ D F E RL ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 387
+ + Q + L+ L + L GPL + I L
Sbjct: 99 I--HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP------PRAVAIVRQIGSALDAA 150
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
H HRD K NIL+ + A + DFG+A + + L +GT Y+APE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPER 206
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKP 475
H ++D+Y+ VL E LTG P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 42/229 (18%)
Query: 277 LGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRN 326
LGEG FG+V VA+K L + D + + E+EM+ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------M 374
++ L+G + + E G+L +L P G+ D +
Sbjct: 103 IINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
ARG+ YL + IHRD A N+L+ N K+ADFGLA+ Y T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKKT 216
Query: 435 RV-------MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
M APE +SDV+S+GV++ E+ T G P
Sbjct: 217 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 43/238 (18%), Positives = 90/238 (37%), Gaps = 48/238 (20%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV-------------- 314
N++ L +G F ++ D A+K+ +K L
Sbjct: 31 NDYRIIRTLNQGKFNKI-ILCEKDNKFYALKKY-------EKSLLEKKRDFTKSNNDKIS 82
Query: 315 ----------EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPL 362
E+++++ + + + G + + + + YE + N S+ + L
Sbjct: 83 IKSKYDDFKNELQIITDIKNEYCLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 363 --GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420
C + + I +Y+H ++ + HRD K SNIL++ N K++DFG
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKP 475
++ + + + GT+ ++ PE + K D++S G+ L + P
Sbjct: 199 SEYMVDKK---IKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 47/235 (20%)
Query: 276 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 328
LGEG FG+V K T VA+K L + + L E +L +++H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNC------------------HL 368
KL G S+D L+ E GSL +L +G L
Sbjct: 90 KLYGA-CSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 369 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428
+ A ++G+ YL ++ ++HRD A NIL+ K++DFGL++ E
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE- 203
Query: 429 TNYLST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+Y+ + M A E +SDV+S+GV+L E++T G P
Sbjct: 204 DSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 38/226 (16%)
Query: 276 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 327
LG G FG+V + VA+K L +K + E++++S L H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL----------HGPLGVNCHLDWETRMKIA 377
V L+G + L+ E G L ++L N + +
Sbjct: 113 VNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--- 434
A+G+A+L + IHRD A N+LL N AK+ DFGLA+ +NY+
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNA 226
Query: 435 ----RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ M APE V+SDV+SYG++L E+ + G P
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 42/230 (18%)
Query: 276 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 327
LG G FG+V + VA+K L ++ + E+++LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR------------ 373
V L+G + L+ E G L ++L +
Sbjct: 90 VNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 374 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433
+ + A+G+A+L + IHRD A NILL + K+ DFGLA+ +NY+
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND-SNYVV 203
Query: 434 T-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+ M APE +SDV+SYG+ L EL + G P
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 38/362 (10%), Positives = 97/362 (26%), Gaps = 73/362 (20%)
Query: 226 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 285
R +A+ + T++ + A +L + T F EL E ++LG+
Sbjct: 30 RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 89
Query: 286 FKGV-LSDGTAVAIKRLTCGGQQGDKE----------------------------FLVEV 316
+ G + + + F+
Sbjct: 90 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149
Query: 317 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV--PNGSLESWLHGPLGVNCHLDWETRM 374
+++ + ++++ Y + + L + L R+
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
++ L R LA LH ++H + +I+L+ + F +
Sbjct: 210 QLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV----- 261
Query: 435 RVMGTFGYVAPEYAMTGHLLV-----------KSDVYSYGVVLLELLTGRKPVDMSQPSG 483
+ G+ PE + D ++ G+V+ + P+
Sbjct: 262 -SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT------ 314
Query: 484 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 543
++ + + I R + + + + R + +
Sbjct: 315 KDAALGGSEWIFRSCKNIPQPV----------RALLE------GFLRYPKEDRLLPLQAM 358
Query: 544 QS 545
++
Sbjct: 359 ET 360
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 71/308 (23%), Positives = 117/308 (37%), Gaps = 59/308 (19%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL----VEVEMLSRL-H 323
N ILG G G V G VA+KR+ +F +E+++L+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDD 67
Query: 324 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL-D 379
H N+++ ++ L + EL N +L+ + N L E L
Sbjct: 68 HPNVIRYYCSETTDR---FLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILL-------------ENNFHAKVADFGLAKQAPE 426
A G+A+LH +IHRD K NIL+ N ++DFGL K+
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 427 GRTNYLSTR--VMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVD 477
G++++ + GT G+ APE + L D++S G V +L+ K
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-- 238
Query: 478 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQR 536
P G + I+R L+E+ + D I + + +R
Sbjct: 239 ---PFGDKYSRESN--IIRGIFSLDEMKCLHDRSLIAEATDLIS------QMIDHDPLKR 287
Query: 537 PTMGEVVQ 544
PT +V++
Sbjct: 288 PTAMKVLR 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 42/230 (18%)
Query: 276 ILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHR 325
LGEG FG+V VA+K L + D + + E+EM+ + H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETR 373
N++ L+G + + E G+L +L + ++
Sbjct: 148 NIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 374 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433
+ ARG+ YL + IHRD A N+L+ N K+ADFGLA+ Y
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKK 261
Query: 434 TRV-------MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
T M APE +SDV+S+GV++ E+ T G P
Sbjct: 262 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 77/341 (22%), Positives = 129/341 (37%), Gaps = 72/341 (21%)
Query: 277 LGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRN 326
LGEG FG+V + T VA+K L + D + + E+EM+ + H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------M 374
++ L+G + + E G+L +L P G+ + +
Sbjct: 137 IINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
A ARG+ YL + IHRD A N+L+ + K+ADFGLA+ Y T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-DYYKKT 250
Query: 435 -------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP----S 482
+ M APE +SDV+S+GV+L E+ T G P
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGVP 298
Query: 483 GQENLVTWARPILRDKDRLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540
+E +L++ R++ L Y + C +QRPT
Sbjct: 299 VEELF-----KLLKEGHRMDKPSNCTNEL---Y---------MMMRDCWHAVPSQRPTFK 341
Query: 541 EVVQSL-KMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDG 580
++V+ L ++V + ++ ++ +G
Sbjct: 342 QLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFNG 382
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVE 317
++F+ LG+G FG V+ + +A+K L K L E+E
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVL-------FKSQLEKEGVEHQLRREIE 66
Query: 318 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK 375
+ S L H N++++ Y+ D + L E P G L L HG + +
Sbjct: 67 IQSHLRHPNILRMYNYFH--DRKRIYLMLEFAPRGELYKELQKHGRFD-----EQRSATF 119
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 435
+ + A L Y HE VIHRD K N+L+ K+ADFG + AP R +
Sbjct: 120 ME-ELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-- 173
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GT Y+ PE K D++ GV+ E L G P
Sbjct: 174 --GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 61/232 (26%), Positives = 90/232 (38%), Gaps = 43/232 (18%)
Query: 277 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 329
+GEG FGRVF+ T VA+K L + +F E +++ + N+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR-------------- 373
L+G L +E + G L +L P V +
Sbjct: 115 LLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 374 ----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
+ IA A G+AYL + V HRD N L+ N K+ADFGL++
Sbjct: 173 CAEQLCIARQVAAGMAYLS--ERKFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 430 NYLSTRVMGTFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
Y + PE +SDV++YGVVL E+ + G +P
Sbjct: 230 -Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 62/260 (23%), Positives = 94/260 (36%), Gaps = 35/260 (13%)
Query: 230 ASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV 289
+P + K G P + + + LG+GGF + F+
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 290 -LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHRNLVKLVGYYSSRD 338
A K + K L+ E+ + L H+++V G++ D
Sbjct: 62 DADTKEVFAGKIV-------PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--D 112
Query: 339 SSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 396
+ + EL SL L + E R G YLH + VI
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALT-----EPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 397 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLV 455
HRD K N+ L + K+ DFGLA + E + GT Y+APE GH
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-LCGTPNYIAPEVLSKKGHSF- 220
Query: 456 KSDVYSYGVVLLELLTGRKP 475
+ DV+S G ++ LL G+ P
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 42/416 (10%), Positives = 99/416 (23%), Gaps = 78/416 (18%)
Query: 226 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 285
++ AD++ R + EL E ++LG+
Sbjct: 37 PQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAY 94
Query: 286 FKGV-LSDGTAVAIKRLTCGGQQGDKE----------------------------FLVEV 316
+ G + + + F+
Sbjct: 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 317 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV--PNGSLESWLHGPLGVNCHLDWETRM 374
+++ + ++++ Y + + L + L R+
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
++ L R LA LH ++H + +I+L+ + F + +
Sbjct: 215 QLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS-PIG 270
Query: 435 RVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489
R A + D ++ G+ + + P + +
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD------DAALG 324
Query: 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
+ I R + + + + R + +
Sbjct: 325 GSEWIFRSCKNIPQPV----------RALLE------GFLRYPKEDRLLPLQAM------ 362
Query: 550 QRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTA 605
+ P R L + + +DG + P SG S D +
Sbjct: 363 ------ETPEYE--QLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAV 410
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 47/235 (20%)
Query: 276 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 327
+LG G FG+V VA+K L ++ + E++M+++L H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR------------ 373
V L+G + L +E G L ++L +++E +
Sbjct: 112 VNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 374 -----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428
+ A A+G+ +L +HRD A N+L+ + K+ DFGLA+
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225
Query: 429 TNYLST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 475
+NY+ + M APE G +KSDV+SYG++L E+ + G P
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 69/326 (21%), Positives = 116/326 (35%), Gaps = 56/326 (17%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYY 334
L EGGF V++ + G A+KRL ++ ++ + EV + +L H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 335 SSRDSSQHLLCYELV-----PNGSL-----ESWLHGPLGVNCHLDWETR-MKIALDAARG 383
S E + G L + GPL +KI R
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL-------SCDTVLKIFYQTCRA 148
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA---PEGRTNYLSTRVM--- 437
+ ++H +P +IHRD K N+LL N K+ DFG A P+ + ++
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 438 ----GTFGYVAPE-YAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490
T Y PE + + + K D+++ G +L L + P +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--------- 258
Query: 491 ARPILRDKDRLEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
I+ K + P +Y IR A + +R ++ EVV L+ +
Sbjct: 259 -LRIVNGKYSI-----PPHDTQYTVFHSLIR------AMLQVNPEERLSIAEVVHQLQEI 306
Query: 550 QRVIECQDPTLTSSNNRANLRQSSTT 575
+ + N S T
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSAT 332
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 40/230 (17%)
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV------- 314
+ E +F+ ++LG+G F V++ + G VAIK + DK+ +
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-------DKKAMYKAGMVQR 57
Query: 315 ---EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHL 368
EV++ +L H ++++L Y+ DS+ L E+ NG + +L P
Sbjct: 58 VQNEVKIHCQLKHPSILELYNYFE--DSNYVYLVLEMCHNGEMNRYLKNRVKPFS----- 110
Query: 369 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPE 426
+ E R + G+ YLH ++HRD SN+LL N + K+ADFGLA + P
Sbjct: 111 ENEARHFMH-QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
Query: 427 GRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKP 475
+ T + GT Y++PE A + H L +SDV+S G + LL GR P
Sbjct: 167 EK---HYT-LCGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPP 211
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 70/310 (22%), Positives = 122/310 (39%), Gaps = 58/310 (18%)
Query: 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRN 326
++FE S LG G G VFK G +A K + + + + E+++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 327 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 383
+V +Y + S + +C E + GSL+ L G + K+++ +G
Sbjct: 93 IVG---FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKG 143
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
L YL E + ++HRD K SNIL+ + K+ DFG++ Q + ++ +GT Y+
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYM 197
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP------------VDMSQPSGQENLVTWA 491
+PE H V+SD++S G+ L+E+ GR P
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 492 RPILRDKDRLEELADPRLG------------------GKYPKE--DFIRVCTIAAACVAP 531
R R ++ + P + G + E DF+ C I
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK------ 311
Query: 532 EANQRPTMGE 541
+R + +
Sbjct: 312 NPAERADLKQ 321
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 37/235 (15%), Positives = 75/235 (31%), Gaps = 29/235 (12%)
Query: 262 EELKEATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDKEFLVE 315
E + + +LGEG F +V++ D +K EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYIG 114
Query: 316 VEMLSRL---HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWE 371
+++ RL +K + ++ S +L EL G+L + ++ +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-----------ENNFHAKVADFGL 420
+ A+ + +H+ +IH D K N +L + + + D G
Sbjct: 173 LVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ + T T G+ E + D + + +L G
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 59/222 (26%), Positives = 87/222 (39%), Gaps = 35/222 (15%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEM 318
+ LG+GGF + F+ A K + K L+ E+ +
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV-------PKSLLLKPHQREKMSMEISI 68
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKI 376
L H+++V G++ D +L EL SL L + E R
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVL--ELCRRRSLLELHKRRKALT-----EPEAR-YY 120
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
G YLH + VIHRD K N+ L + K+ DFGLA + E +
Sbjct: 121 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-L 175
Query: 437 MGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVD 477
GT Y+APE GH + DV+S G ++ LL G+ P +
Sbjct: 176 CGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFE 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 38/281 (13%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEM-LSRLHHR 325
++ EP LG G +G V K + G +A+KR+ + K L+++++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
V G +C EL+ + SL+ + + + + KIA+ + L
Sbjct: 67 FTVTFYGALF--REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS-TRVMGTFGYVA 444
+LH VIHRD K SN+L+ K+ DFG++ + ++ G Y+A
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMA 177
Query: 445 PE----YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500
PE VKSD++S G+ ++EL R P +W P + +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP-----------YDSWGTPF-QQLKQ 225
Query: 501 LEELADPRL-GGKYPKE--DFIRVCTIAAACVAPEANQRPT 538
+ E P+L K+ E DF C + +RPT
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTSQCLKK------NSKERPT 260
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 82/279 (29%), Positives = 118/279 (42%), Gaps = 49/279 (17%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLV 328
F +G+G FG VFKG+ VAIK + + + E + E+ +LS+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 329 KLVGYYSSRDSSQHL-LCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL---DAARG 383
K YY S L + E + GS L GPL +IA + +G
Sbjct: 84 K---YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL---------DETQIATILREILKG 131
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFG 441
L YLH + IHRD KA+N+LL + K+ADFG+A Q T+ R +GT
Sbjct: 132 LDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL----TDTQIKRNTFVGTPF 184
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501
++APE K+D++S G+ +EL G P P L+ P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------- 236
Query: 502 EELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPT 538
P L G Y K +F+ AC+ E + RPT
Sbjct: 237 -----PTLEGNYSKPLKEFV------EACLNKEPSFRPT 264
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 67/296 (22%), Positives = 124/296 (41%), Gaps = 44/296 (14%)
Query: 261 YEELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFL 313
E+L+ + +P +G+G G V+ + ++ G VAI+++ Q + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 314 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 372
E+ ++ + N+V Y S L + E + GSL + +D
Sbjct: 66 NEILVMRENKNPNIVN---YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQ 117
Query: 373 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432
+ + + L +LH + VIHRD K+ NILL + K+ DFG Q T
Sbjct: 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQ 170
Query: 433 STR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVT 489
S R ++GT ++APE K D++S G++ +E++ G P ++ + + T
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
Query: 490 WARPILRDKDRL-EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
P L++ ++L DF+ C + E +R + E++Q
Sbjct: 231 NGTPELQNPEKLSAIF-----------RDFLNRCL----EMDVE--KRGSAKELLQ 269
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 40/250 (16%)
Query: 249 SLPHPTSTRFLAYEEL---KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG 304
S+ + R L +L ++ FE ++G G +G+V+KG + G AIK +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 305 GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGS----LE 355
G + ++E E+ ML + HHRN+ G + ++ L E GS ++
Sbjct: 61 GDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 356 SWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 412
+ L IA + RGL++LH+ VIHRD K N+LL N
Sbjct: 120 NTKGNTL---------KEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167
Query: 413 AKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVV 465
K+ DFG++ Q + R +GT ++APE KSD++S G+
Sbjct: 168 VKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223
Query: 466 LLELLTGRKP 475
+E+ G P
Sbjct: 224 AIEMAEGAPP 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 261 YEELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFL 313
L+ + +P + +GEG G V G VA+K + QQ +
Sbjct: 31 KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90
Query: 314 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 372
EV ++ H N+V+ Y S + L + E + G+L + L+ E
Sbjct: 91 NEVVIMRDYQHFNVVE---MYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQ 142
Query: 373 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432
+ + LAYLH VIHRD K+ +ILL + K++DFG Q + +
Sbjct: 143 IATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI----SKDV 195
Query: 433 STR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
R ++GT ++APE + D++S G++++E++ G P
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 61/253 (24%), Positives = 102/253 (40%), Gaps = 42/253 (16%)
Query: 249 SLPHPTSTRFLAYEELKEATNNFEPASI---------LGEGGFGRVFKGV-LSDGTAVAI 298
+L + F+ + +L + P ++ LG G G V VAI
Sbjct: 107 ALSLSRNKVFV-FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165
Query: 299 KRL------TCGGQQGDKEFLV--EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350
+ + ++ D V E+E+L +L+H ++K+ ++ D+ + + EL+
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---DAEDYYIVLELME 222
Query: 351 NGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL- 407
G L + + L + + YLHE+ +IHRD K N+LL
Sbjct: 223 GGELFDKVVGNKRLKEA-----TCK-LYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 273
Query: 408 --ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---YAMTGHLLVKSDVYSY 462
E + K+ DFG +K E + + T GT Y+APE T D +S
Sbjct: 274 SQEEDCLIKITDFGHSKILGET--SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 463 GVVLLELLTGRKP 475
GV+L L+G P
Sbjct: 331 GVILFICLSGYPP 343
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 70/304 (23%), Positives = 129/304 (42%), Gaps = 40/304 (13%)
Query: 249 SLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ 307
S+ + + + + +G G +G V K V G +A+KR+ +
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 308 GD-KEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV 364
+ K+ L++++++ R +V+ +Y + +C EL+ + S + + V
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQ---FYGALFREGDCWICMELM-STSFDKFYKYVYSV 117
Query: 365 NCHLDWETRM-KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423
+ E + KI L + L +L E+ + +IHRD K SNILL+ + + K+ DFG++ Q
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 424 APEGRTNYLS-TRVMGTFGYVAPEYAMTGHLL----VKSDVYSYGVVLLELLTGRKPVDM 478
+ ++ TR G Y+APE V+SDV+S G+ L EL TGR P
Sbjct: 176 L----VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 479 SQPSGQ--ENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEAN 534
+V P L + + ++ +F+ +C + +
Sbjct: 232 WNSVFDQLTQVVKGDPPQLSNSE----------EREFSPSFINFVNLCLTK------DES 275
Query: 535 QRPT 538
+RP
Sbjct: 276 KRPK 279
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 331
+LG+G FG V G A+K + + + L EV++L +L H N++KL
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 332 GYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----MKIALDAARGLA 385
++ D L E+ G L + E ++ L +
Sbjct: 93 EFFE--DKGYFYLVGEVYTGGELFDEIISRKRFS-------EVDAARIIRQVLSG---IT 140
Query: 386 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
Y+H++ ++HRD K N+LLE+ + + ++ DFGL+ + + ++ GT Y
Sbjct: 141 YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKI-GTAYY 194
Query: 443 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+APE + G K DV+S GV+L LL+G P
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 68/268 (25%), Positives = 106/268 (39%), Gaps = 42/268 (15%)
Query: 229 KASPKETAKPRTADAVTLGGSLPHPTSTRF--LAYEELKEATNNFEPASI------LGEG 280
+ P T + G P P R L ++ E +P + +G G
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHG 65
Query: 281 GFGRVFKGV-LSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSS 336
FG V+ + + VAIK+++ G+Q + ++ + EV L +L H N ++ Y
Sbjct: 66 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---YRGC 122
Query: 337 RDSSQHL-LCYELVPNGSLE--SWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHED 390
L E + + PL ++IA A +GLAYLH
Sbjct: 123 YLREHTAWLVMEYCLGSASDLLEVHKKPL---------QEVEIAAVTHGALQGLAYLHSH 173
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 450
+ +IHRD KA NILL K+ DFG A + +GT ++APE +
Sbjct: 174 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILA 224
Query: 451 GHLL---VKSDVYSYGVVLLELLTGRKP 475
K DV+S G+ +EL + P
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 59/208 (28%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 332
LG G +G V AIK + T + + L EV +L L H N++KL
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
++ D + L E G L + + I G+ YLH+
Sbjct: 104 FFE--DKRNYYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 391 SQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
+ ++HRD K N+LLE+ + K+ DFGL+ + R+ GT Y+APE
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERL-GTAYYIAPE- 208
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ K DV+S GV+L LL G P
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 62/231 (26%), Positives = 90/231 (38%), Gaps = 58/231 (25%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRL------------TCGGQQGDKEFLV-EVEMLSR 321
LG G +G V + + AIK + + E + E+ +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---- 377
L H N++KL + D L E G L + +I
Sbjct: 103 LDHPNIIKLFDVFE--DKKYFYLVTEFYEGGEL-------------FE-----QIINRHK 142
Query: 378 ---LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQA 424
DAA G+ YLH+ + ++HRD K NILLEN + K+ DFGL+
Sbjct: 143 FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ L R+ GT Y+APE + K DV+S GV++ LL G P
Sbjct: 200 SKDYK--LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 66/345 (19%), Positives = 112/345 (32%), Gaps = 92/345 (26%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEML------- 319
+FEP +G GGFG VF+ D AIKR+ ++ +E + EV+ L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 320 ----------------------------------------------SRLHHRNLVKLVGY 333
R K
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 334 YSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
S + L +L +L+ W++ + + + I + A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE-DREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQ----------APEGRTNYLSTRVMGTFG 441
++HRD K SNI + KV DFGL T +GT
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501
Y++PE + K D++S G++L ELL E + +R+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-------QMERVRIITD--VRNLKF- 291
Query: 502 EELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 545
KYP+E ++ ++P +RP +++++
Sbjct: 292 ----PLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDIIEN 326
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
+E LG+G FG+V+K G A K + ++ ++++VE+E+L+ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 330 LVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
L+G Y L + E P G++++ + L + L +LH
Sbjct: 81 LLGAYYHDG---KLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH 134
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPE 446
+IHRD KA N+L+ ++ADFG++ + L R +GT ++APE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN----LKTLQKRDSFIGTPYWMAPE 187
Query: 447 YAMTGHLL-----VKSDVYSYGVVLLELLTGRKP 475
M + K+D++S G+ L+E+ P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 55/278 (19%)
Query: 226 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 285
++A A+P+ + + P + A +E + ++P ++G G V
Sbjct: 54 LLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ---KYDPKDVIGRGVSSVV 110
Query: 286 FKGV-LSDGTAVAIK-------RLTCGGQQGDKEFLV-EVEMLSRLH-HRNLVKLVGYYS 335
+ V + G A+K RL+ + +E E +L ++ H +++ L+ Y
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170
Query: 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----------ETR--MKIALDAARG 383
SS L ++L+ G L D+ ETR M+ L+A
Sbjct: 171 --SSSFMFLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEA--- 212
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
+++LH ++ ++HRD K NILL++N +++DFG + G L GT GY+
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELC-GTPGYL 266
Query: 444 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
APE + D+++ GV+L LL G P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 73/244 (29%), Positives = 105/244 (43%), Gaps = 48/244 (19%)
Query: 252 HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL-TCGGQQGD 309
H +S R Y + + +LG+G FG V K A+K + + D
Sbjct: 6 HHSSGRENLYFQ-GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 310 KE-FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL 368
L EVE+L +L H N++KL DSS + EL G L
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILE--DSSSFYIVGELYTGGEL-------------F 109
Query: 369 DWETRMKIA-------LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NF 411
D +I DAAR G+ Y+H+ + ++HRD K NILLE+ +
Sbjct: 110 D-----EIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161
Query: 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 471
K+ DFGL+ + + R+ GT Y+APE + G K DV+S GV+L LL+
Sbjct: 162 DIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217
Query: 472 GRKP 475
G P
Sbjct: 218 GTPP 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 42/238 (17%), Positives = 81/238 (34%), Gaps = 23/238 (9%)
Query: 252 HPTSTRFLAYEELKEATNNFEPASILGEG--GFGRVFKGV-LSDGTAVAIKR--LTCGGQ 306
H + F +E +++G+G V G V ++R L
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 307 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVN 365
+ E+ + +H N+V Y ++ + L + + GS + +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVP---YRATFIADNELWVVTSFMAYGSAKDLIC--THFM 122
Query: 366 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425
++ I + L Y+H +HR KAS+IL+ + ++
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 426 EGRT-----NYLSTRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVLLELLTGRKP 475
+ + +++PE + +L KSD+YS G+ EL G P
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 66/233 (28%), Positives = 94/233 (40%), Gaps = 21/233 (9%)
Query: 251 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD 309
H +S R Y + + F LG G FG V S G IK + Q
Sbjct: 5 HHHSSGRENLYFQ-GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63
Query: 310 KE-FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL 368
E E+E+L L H N++K+ + D + E G L + L
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFE--DYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 369 ---DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAK 422
MK ++A LAY H V+H+D K NIL ++ + K+ DFGLA+
Sbjct: 122 SEGYVAELMKQMMNA---LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ + GT Y+APE + K D++S GVV+ LLTG P
Sbjct: 176 LFKSD--EHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 68/230 (29%), Positives = 108/230 (46%), Gaps = 37/230 (16%)
Query: 262 EELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV 314
++L E + +P + LGEG +G V+K + G VAIK++ + +E +
Sbjct: 16 KKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIK 73
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLE---SWLHGPLGVNCHLDW 370
E+ ++ + ++VK YY S + L + E GS+ + L
Sbjct: 74 EISIMQQCDSPHVVK---YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL-------- 122
Query: 371 ETRMKIAL---DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427
T +IA +GL YLH IHRD KA NILL HAK+ADFG+A Q
Sbjct: 123 -TEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQL--- 175
Query: 428 RTNYLSTR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
T+ ++ R V+GT ++APE +D++S G+ +E+ G+ P
Sbjct: 176 -TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 61/216 (28%), Positives = 84/216 (38%), Gaps = 41/216 (18%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
+LG G F VF G A+K + D E+ +L ++ H N+V L Y
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----------ETR--MKIALDAAR 382
S + L +LV G L D + ++ L A
Sbjct: 76 ESTTH--YYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSA-- 118
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
+ YLHE+ ++HRD K N+L N + DFGL+K G +ST GT
Sbjct: 119 -VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTAC-GT 170
Query: 440 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GYVAPE D +S GV+ LL G P
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 61/260 (23%)
Query: 245 TLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK---- 299
T +LP ST N+EP ILG G V + + A+K
Sbjct: 1 TRDAALPGSHST--------HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDV 52
Query: 300 ----RLTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 353
+ Q +E + EV++L ++ H N+++L Y ++ L ++L+ G
Sbjct: 53 TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--TNTFFFLVFDLMKKGE 110
Query: 354 LESWLHGPLGVNCHLDW----------ETR--MKIALDAARGLAYLHEDSQPCVIHRDFK 401
L D+ ETR M+ L+ + LH+ + ++HRD K
Sbjct: 111 L-------------FDYLTEKVTLSEKETRKIMRALLEV---ICALHKLN---IVHRDLK 151
Query: 402 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLV 455
NILL+++ + K+ DFG + Q G L GT Y+APE
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPG--EKLREVC-GTPSYLAPEIIECSMNDNHPGYGK 208
Query: 456 KSDVYSYGVVLLELLTGRKP 475
+ D++S GV++ LL G P
Sbjct: 209 EVDMWSTGVIMYTLLAGSPP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 54/239 (22%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL------TCGGQQGDKEFLV--E 315
K + + + LG G G V VAIK + ++ D V E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 316 VEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----- 370
+E+L +L+H ++K+ ++ D+ + + EL+ G L D
Sbjct: 66 IEILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGEL-------------FDKVVGNK 109
Query: 371 -----ETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGL 420
+ L A + YLHE+ +IHRD K N+LL + + K+ DFG
Sbjct: 110 RLKEATCKLYFYQMLLA---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163
Query: 421 AKQAPEGRTNYLSTRVMGTFGYVAPE----YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+K E + + T GT Y+APE G+ D +S GV+L L+G P
Sbjct: 164 SKILGET--SLMRTLC-GTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPP 218
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 60/290 (20%), Positives = 120/290 (41%), Gaps = 51/290 (17%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH-HR 325
N+ E +G G G+V+K G +A+K++ G + + K L++++++ + H
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 326 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLE--SWLHGPLGVNCHLDWETRMKIALDAAR 382
+V+ + + ++ + + EL+ + + + GP+ K+ + +
Sbjct: 85 YIVQ---CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL------GKMTVAIVK 135
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTRVMGTF 440
L YL E VIHRD K SNILL+ K+ DFG++ + + + G
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-----AGCA 188
Query: 441 GYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQPSGQ--ENLVTWARP 493
Y+APE +++DV+S G+ L+EL TG+ P + + ++ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248
Query: 494 ILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 541
+L + + F++ C + +RP +
Sbjct: 249 LLPGHM------------GFSGDFQSFVKDCLTK------DHRKRPKYNK 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 17/218 (7%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 326
+++E ++G G V VAIKR+ Q + L+ E++ +S+ HH N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 327 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWE-TRMKIAL---DAA 381
+V YY+S L L +L+ GS+ + + H IA +
Sbjct: 75 IVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTR--VMG 438
GL YLH++ Q IHRD KA NILL + ++ADFG++ A G R +G
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 439 TFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKP 475
T ++APE K+D++S+G+ +EL TG P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 58/257 (22%)
Query: 247 GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGG 305
G + A E ++ + F+ + G+G FG V G G +VAIK++
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--- 57
Query: 306 QQGDKEF----LVEVEMLSRLHHRNLVKLVGYYSSRDSSQH-----LLCYELVPNGSLES 356
D F L ++ L+ LHH N+V+L Y+ + + E VP
Sbjct: 58 --QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----D 110
Query: 357 WLHGPLGVNCHLDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNIL 406
LH R ++A R + LH S V HRD K N+L
Sbjct: 111 TLHR------CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVL 163
Query: 407 L-ENNFHAKVADFGLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKS------ 457
+ E + K+ DFG AK+ N Y+ +R Y APE L+ +
Sbjct: 164 VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPE------LIFGNQHYTTA 212
Query: 458 -DVYSYGVVLLELLTGR 473
D++S G + E++ G
Sbjct: 213 VDIWSVGCIFAEMMLGE 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 45/224 (20%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-----------EVEMLSRLHH 324
LGEG +G+V + + A+K L K+ L E+++L RL H
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKIL-------KKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 325 RNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 382
+N+++LV + + Q + + E G E + LD + + A
Sbjct: 66 KNVIQLVDVLYN-EEKQKMYMVMEYCVCGMQE------M-----LDSVPEKRFPVCQAHG 113
Query: 383 -------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 435
GL YLH ++H+D K N+LL K++ G+A+ +
Sbjct: 114 YFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 436 VMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 477
G+ + PE A K D++S GV L + TG P +
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 59/277 (21%), Positives = 89/277 (32%), Gaps = 67/277 (24%)
Query: 254 TSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQ 307
+ L E + +G+G +G V + AIK ++ +
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70
Query: 308 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL------------- 354
+ EV ++ +LHH N+ +L Y D L EL G L
Sbjct: 71 DVERIKTEVRLMKKLHHPNIARLYEVYE--DEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 355 -------------ESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHEDS 391
+ + + + L YLH
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 392 QPCVIHRDFKASNILLEN--NFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPE 446
+ HRD K N L +F K+ DFGL+K + G ++T+ GT +VAPE
Sbjct: 189 ---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE 244
Query: 447 --------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
Y K D +S GV+L LL G P
Sbjct: 245 VLNTTNESYGP------KCDAWSAGVLLHLLLMGAVP 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 55/234 (23%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLH 323
++ + ++G G FG VF+ L + VAIK++ DK F E++++ +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVK 90
Query: 324 HRNLVKLVGYYSSRDSSQHLLC----YELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 379
H N+V L ++ S + + E VP ++ ++K +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR------ASRHYAKLKQTMP 139
Query: 380 AA----------RGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR 428
R LAY+H + HRD K N+LL + K+ DFG AK G
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 429 TN--YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 473
N Y+ +R Y APE L+ + D++S G V+ EL+ G+
Sbjct: 197 PNVSYICSRY-----YRAPE------LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 72/282 (25%), Positives = 111/282 (39%), Gaps = 63/282 (22%)
Query: 225 GRKSKASPKETAKPRTADAVTLGGSLPHP-------TSTRFLAYEELKEATNNFEPASIL 277
GR S E+ KP + + T + ++ ++
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 278 GEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLHHRNLVKLVGYYS 335
G G FG V++ L D G VAIK++ DK F E++++ +L H N+V+L ++
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 336 SRDSSQHLLC----YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA---------- 381
S + + + VP ++ +R K L
Sbjct: 118 SSGEKKDEVYLNLVLDYVP-----ETVYR------VARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMG 438
R LAY+H + HRD K N+LL+ + K+ DFG AKQ G N Y+ +R
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 439 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 473
Y APE L+ + DV+S G VL ELL G+
Sbjct: 222 ---YRAPE------LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 67/249 (26%), Positives = 99/249 (39%), Gaps = 56/249 (22%)
Query: 251 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQ 306
H +S R Y + + +LG+G FG V K A+K + +
Sbjct: 5 HHHSSGRENLYFQ-GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 307 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 366
L EVE+L +L H N++KL DSS + EL G L
Sbjct: 64 DTST-ILREVELLKKLDHPNIMKLFEILE--DSSSFYIVGELYTGGEL------------ 108
Query: 367 HLDWETR------------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NF 411
D + +K + Y+H+ + ++HRD K NILLE+ +
Sbjct: 109 -FDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDC 161
Query: 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVL 466
K+ DFGL+ + + R+ GT Y+APE Y K DV+S GV+L
Sbjct: 162 DIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIAPEVLRGTYDE------KCDVWSAGVIL 212
Query: 467 LELLTGRKP 475
LL+G P
Sbjct: 213 YILLSGTPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 42/268 (15%)
Query: 227 KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFE------PASILGEG 280
S A E ++ L +P P + + + ILG G
Sbjct: 43 WSNADLTERMPVKSKRTSALAVDIPAPPAPF--DHRIVTAKQGAVNSFYTVSKTEILGGG 100
Query: 281 GFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339
FG+V K + G +A K + G + +E E+ ++++L H NL++L +
Sbjct: 101 RFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE--SK 158
Query: 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHE 389
+ +L E V G L D L D G+ ++H+
Sbjct: 159 NDIVLVMEYVDGGEL-------------FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 390 DSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 447
++H D K NIL N K+ DFGLA++ L GT ++APE
Sbjct: 206 MY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNF-GTPEFLAPEV 259
Query: 448 AMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ +D++S GV+ LL+G P
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 53/231 (22%)
Query: 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLV----------EVE 317
+F+ ILGEG F V + AIK L +K ++ E +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERD 82
Query: 318 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 377
++SRL H VKL Y++ +D + NG L ++
Sbjct: 83 VMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLK----------YIRKIGS--FD 128
Query: 378 LDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
R L YLH +IHRD K NILL + H ++ DFG AK
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 185
Query: 430 NYLSTRVMGTFGYVAPEYAMTGHLLVK-----SDVYSYGVVLLELLTGRKP 475
+ +GT YV+PE L K SD+++ G ++ +L+ G P
Sbjct: 186 QARANSFVGTAQYVSPEL-----LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 51/262 (19%), Positives = 93/262 (35%), Gaps = 35/262 (13%)
Query: 227 KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 286
+ P+ D + + + ++ + ++ LG G FG V
Sbjct: 10 HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVH 68
Query: 287 KGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345
+ V + G K + E+ ++++LHH L+ L + D + +L
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLI 126
Query: 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHEDSQPCV 395
E + G L D + + GL ++HE S +
Sbjct: 127 LEFLSGGEL-------------FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 396 IHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 453
+H D K NI+ E + K+ DFGLA + + T + APE +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTT-ATAEFAAPEIVDREPV 227
Query: 454 LVKSDVYSYGVVLLELLTGRKP 475
+D+++ GV+ LL+G P
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP 249
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 45/218 (20%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 334
+G G +G V V A K++ + F E+E++ L H N+++L +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 335 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR----- 382
D++ L EL G L + ++ DAAR
Sbjct: 76 E--DNTDIYLVMELCTGGEL-------------FE-----RVVHKRVFRESDAARIMKDV 115
Query: 383 --GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVM 437
+AY H+ + V HRD K N L + K+ DFGLA + G + T+V
Sbjct: 116 LSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKV- 169
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GT YV+P+ + G + D +S GV++ LL G P
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 269 NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLV---EVEM------ 318
N+F I+G GGFG V+ G A+K L DK+ + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-------DKKRIKMKQGETLALNERI 241
Query: 319 ----LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
+S +V + Y+ + +L+ G L L + E M
Sbjct: 242 MLSLVSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADM 294
Query: 375 KI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433
+ A + GL ++H V++RD K +NILL+ + H +++D GLA + + +
Sbjct: 295 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--- 348
Query: 434 TRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
V GT GY+APE G S D +S G +L +LL G P
Sbjct: 349 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 70/269 (26%), Positives = 101/269 (37%), Gaps = 60/269 (22%)
Query: 227 KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 286
+S +S +A P TA V +E E LG G V+
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE----------LGRGATSIVY 70
Query: 287 KGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344
+ A+K L + DK+ + E+ +L RL H N++KL + + L
Sbjct: 71 RCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISL 125
Query: 345 CYELVPNGSLESWLHGPLGVNCHLDW--------ETRMKIALDAAR-------GLAYLHE 389
ELV G L D E DAA +AYLHE
Sbjct: 126 VLELVTGGEL-------------FDRIVEKGYYSER------DAADAVKQILEAVAYLHE 166
Query: 390 DSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446
+ ++HRD K N+L + K+ADFGL+K + T GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC-GTPGYCAPE 220
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ D++S G++ LL G +P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 56/239 (23%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIK----------------------RLTCGGQQGDKEFL 313
+G+G +G V +D T A+K R GG + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 314 V----EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 369
E+ +L +L H N+VKLV + + +ELV G + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127
Query: 370 WETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
T ++ D AR G+ YLH +IHRD K SN+L+ + H K+ADFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKPVD 477
+ +G LS V GT ++APE + DV++ GV L + G+ P
Sbjct: 185 NE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 60/235 (25%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLH 323
++N++ LG+G F V + V + G A K + + K E + +L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA------ 377
H N+V+L + S H L ++LV G L + I
Sbjct: 64 HPNIVRLHDSIQ--EESFHYLVFDLVTGGEL-------------FE-----DIVAREFYS 103
Query: 378 -LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPE 426
DA+ +AY H + ++HR+ K N+LL K+ADFGLA + +
Sbjct: 104 EADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 427 GRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GT GY++PE Y+ D+++ GV+L LL G P
Sbjct: 161 SEA--WHGFA-GTPGYLSPEVLKKDPYSK------PVDIWACGVILYILLVGYPP 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 60/233 (25%), Positives = 91/233 (39%), Gaps = 51/233 (21%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 320
+ ++ LG G F V K S G A K + + +E + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 377
++ H N++ L Y + + +L ELV G L D +A
Sbjct: 71 QVLHHNVITLHDVYE--NRTDVVLILELVSGGEL-------------FD-----FLAQKE 110
Query: 378 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK 422
+A G+ YLH + H D K NI+L H K+ DFGLA
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ +G GT +VAPE L +++D++S GV+ LL+G P
Sbjct: 168 EIEDGVE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 62/228 (27%), Positives = 84/228 (36%), Gaps = 60/228 (26%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--------EVEMLSRLHHRNL 327
LGEG +G V V AVA+K + D + V E+ + L+H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENV 67
Query: 328 VKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR-- 382
VK Y R L E G L + M A+
Sbjct: 68 VKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPE--PDAQRF 110
Query: 383 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 435
G+ YLH + HRD K N+LL+ + K++DFGLA L+
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 436 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
GT YVAPE + DV+S G+VL +L G P D
Sbjct: 168 C-GTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 46/220 (20%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV---------EVEMLSRLHHRN 326
+G+G F +V + G VAIK + DK L EV ++ L+H N
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKII-------DKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 327 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 383
+VKL + ++ + L L E G + +L HG + E R
Sbjct: 76 IVKL---FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EAR-SKFRQIVSA 126
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
+ Y H Q ++HRD KA N+LL+ + + K+ADFG + + G L G Y
Sbjct: 127 VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFC-GAPPYA 180
Query: 444 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
APE Y G + DV+S GV+L L++G P D
Sbjct: 181 APELFQGKKYD--GP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 60/233 (25%), Positives = 93/233 (39%), Gaps = 51/233 (21%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 320
+++E LG G F V K G A K RL+ + +E + EV +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 377
+ H N++ L + + + +L ELV G L D +A
Sbjct: 64 EIRHPNIITLHDIFE--NKTDVVLILELVSGGEL-------------FD-----FLAEKE 103
Query: 378 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAK 422
+A + G+ YLH + H D K NI+L + N K+ DFG+A
Sbjct: 104 SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
Query: 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ G GT +VAPE L +++D++S GV+ LL+G P
Sbjct: 161 KIEAGNE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 80/404 (19%), Positives = 129/404 (31%), Gaps = 110/404 (27%)
Query: 236 AKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGT 294
P + GG L + +E ++G+G F V + + G
Sbjct: 1 GSPGISGGG--GGILDMADDDVLF--------EDVYELCEVIGKGPFSVVRRCINRETGQ 50
Query: 295 AVAIK-----RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349
A+K + T ++ E + L H ++V+L+ YS + +E +
Sbjct: 51 QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS--SDGMLYMVFEFM 108
Query: 350 PNGSL--ESWLHGPLGVN------CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 401
L E G H M+ L+A L Y H+++ +IHRD K
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHY-----MRQILEA---LRYCHDNN---IIHRDVK 157
Query: 402 ASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---YAMTGHLLV 455
+LL EN+ K+ FG+A Q E RV GT ++APE G
Sbjct: 158 PHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRV-GTPHFMAPEVVKREPYGK--- 212
Query: 456 KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY-- 513
DV+ GV+L LL+G P + E L + + GKY
Sbjct: 213 PVDVWGCGVILFILLSGCLP-------------FYGTK--------ERLFEGIIKGKYKM 251
Query: 514 PKE----------DFIRVC---------TIAAA------CVAPEANQRPTMGEVVQSLK- 547
D +R T+ A + + E V+ L+
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311
Query: 548 ---------MVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTS 582
V + ++ + + F D TS
Sbjct: 312 FNARRKLKGAVLAAVSSH----KFNSFYGDPPEELPDFSEDPTS 351
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 60/233 (25%), Positives = 91/233 (39%), Gaps = 51/233 (21%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 320
+ ++ LG G F V K S G A K + + +E + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 377
++ H N++ L Y + + +L ELV G L D +A
Sbjct: 71 QVLHPNIITLHDVYE--NRTDVVLILELVSGGEL-------------FD-----FLAQKE 110
Query: 378 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK 422
+A G+ YLH + H D K NI+L H K+ DFGLA
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ +G GT +VAPE L +++D++S GV+ LL+G P
Sbjct: 168 EIEDGVE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 63/246 (25%), Positives = 107/246 (43%), Gaps = 46/246 (18%)
Query: 253 PTSTRFLAYEELKEAT---NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQG 308
RFL ++ L+ + F +LG GGFG VF + G A K+L
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL------- 218
Query: 309 DKEFLV---EVEM-------LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESW 357
+K+ L + L+++H R +V L + ++ L L ++ G +
Sbjct: 219 NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL---AYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 358 LHGPLGVNCHLDWETRMK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 412
++ N E R I GL +LH+ + +I+RD K N+LL+++ +
Sbjct: 276 IYNVDEDNPGFQ-EPRAIFYTAQIVS----GLEHLHQRN---IIYRDLKPENVLLDDDGN 327
Query: 413 AKVADFGLAKQAPEG--RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLEL 469
+++D GLA + G +T GT G++APE + G S D ++ GV L E+
Sbjct: 328 VRISDLGLAVELKAGQTKTK---GYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEM 382
Query: 470 LTGRKP 475
+ R P
Sbjct: 383 IAARGP 388
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 61/253 (24%), Positives = 93/253 (36%), Gaps = 68/253 (26%)
Query: 250 LPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTC 303
+ T TRF +L E LG+G F V + V + G A +L+
Sbjct: 1 MATITCTRFTEEYQLFE---------ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA 51
Query: 304 GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG 363
Q + E + L H N+V+L S H L ++LV G L
Sbjct: 52 RDHQKLER---EARICRLLKHPNIVRLHDSISEEGH--HYLIFDLVTGGEL--------- 97
Query: 364 VNCHLDW----------ETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---E 408
+ + ++ L+A + + H+ V+HR+ K N+LL
Sbjct: 98 ----FEDIVAREYYSEADASHCIQQILEA---VLHCHQMG---VVHRNLKPENLLLASKL 147
Query: 409 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSY 462
K+ADFGLA + GT GY++PE Y D+++
Sbjct: 148 KGAAVKLADFGLAIEVEGE-QQAWFGFA-GTPGYLSPEVLRKDPYGK------PVDLWAC 199
Query: 463 GVVLLELLTGRKP 475
GV+L LL G P
Sbjct: 200 GVILYILLVGYPP 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 63/265 (23%), Positives = 101/265 (38%), Gaps = 65/265 (24%)
Query: 236 AKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGT 294
A + G ST+F ++KE LG+G F V + V + G
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKE---------ELGKGAFSVVRRCVHKTTGL 55
Query: 295 AVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN 351
A K + + K E + +L H N+V+L + S H L ++LV
Sbjct: 56 EFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ--EESFHYLVFDLVTG 112
Query: 352 GSLESWLHGPLGVNCHLDW----------ETR--MKIALDAARGLAYLHEDSQPCVIHRD 399
G L + + ++ L++ +AY H + ++HR+
Sbjct: 113 GEL-------------FEDIVAREFYSEADASHCIQQILES---IAYCHSNG---IVHRN 153
Query: 400 FKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 456
K N+LL K+ADFGLA + + GT GY++PE +L K
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA-GTPGYLSPE------VLKK 204
Query: 457 S------DVYSYGVVLLELLTGRKP 475
D+++ GV+L LL G P
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPP 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 60/224 (26%), Positives = 86/224 (38%), Gaps = 51/224 (22%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLSRLHHRNLVK 329
LG G F V K S G A K R + +E + EV +L + H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR 382
L Y + + +L ELV G L D +A +A
Sbjct: 79 LHEVYE--NKTDVILILELVAGGEL-------------FD-----FLAEKESLTEEEATE 118
Query: 383 -------GLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAKQAPEGRTNY 431
G+ YLH + H D K NI+L + K+ DFGLA + G
Sbjct: 119 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 432 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
GT +VAPE L +++D++S GV+ LL+G P
Sbjct: 174 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 62/228 (27%), Positives = 84/228 (36%), Gaps = 60/228 (26%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--------EVEMLSRLHHRNL 327
LGEG +G V V AVA+K + D + V E+ + L+H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENV 67
Query: 328 VKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR-- 382
VK Y R L E G L + M A+
Sbjct: 68 VKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPE--PDAQRF 110
Query: 383 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 435
G+ YLH + HRD K N+LL+ + K++DFGLA L+
Sbjct: 111 FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 436 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
GT YVAPE + DV+S G+VL +L G P D
Sbjct: 168 C-GTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 71/311 (22%), Positives = 107/311 (34%), Gaps = 77/311 (24%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY 333
+LGEG RV + L A+K + EVEML + HRN+++L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR---- 382
+ + + L +E + GS+ L I L+A+
Sbjct: 80 FE--EEDRFYLVFEKMRGGSI-------------LS-----HIHKRRHFNELEASVVVQD 119
Query: 383 ---GLAYLHEDSQPCVIHRDFKASNILLENNFHA---KVADFGLAKQAPEGR------TN 430
L +LH + HRD K NIL E+ K+ DF L T
Sbjct: 120 VASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 431 YLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKPVDMSQPSGQE 485
L T G+ Y+APE D++S GV+L LL+G P G+
Sbjct: 177 ELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-----GRC 230
Query: 486 NLVTWARPILRDKDRLEELADPRLGGKY--PKE----------DFIRVCTIAAACVAPEA 533
L + GKY P + D I + +A
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS------KLLVRDA 284
Query: 534 NQRPTMGEVVQ 544
QR + +V+Q
Sbjct: 285 KQRLSAAQVLQ 295
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 55/246 (22%)
Query: 256 TRFLAYEELKEAT---NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE 311
RFL ++ L+ N F +LG+GGFG V + G A K+L +K+
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL-------EKK 220
Query: 312 FLV---EVEM-------LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH 359
+ M L +++ R +V L Y ++D+ LC L+ G L+
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA----LCLVLTLMNGGDLKF--- 273
Query: 360 GPLGVNCHLDWETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNF 411
H+ + A GL LH + +++RD K NILL+++
Sbjct: 274 -------HIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHG 323
Query: 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLEL 469
H +++D GLA PEG+T RV GT GY+APE + S D ++ G +L E+
Sbjct: 324 HIRISDLGLAVHVPEGQTI--KGRV-GTVGYMAPEVVKNERY--TFSPDWWALGCLLYEM 378
Query: 470 LTGRKP 475
+ G+ P
Sbjct: 379 IAGQSP 384
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 47/225 (20%), Positives = 83/225 (36%), Gaps = 37/225 (16%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL 322
KE + A LG G FG V + V S K + G D+ + E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIA 58
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---D 379
HRN++ L + S + ++ +E + + + L +
Sbjct: 59 RHRNILHLHESFESMEE--LVMIFEFISGLDI-------------FERINTSAFELNERE 103
Query: 380 AAR-------GLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTN 430
L +LH + + H D + NI+ + + K+ +FG A+Q G
Sbjct: 104 IVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159
Query: 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
Y APE + +D++S G ++ LL+G P
Sbjct: 160 -FRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 4e-22
Identities = 52/267 (19%), Positives = 95/267 (35%), Gaps = 38/267 (14%)
Query: 226 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEP----ASILGEGG 281
R+ ++ R V+ + + ++ ++ LG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 282 FGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340
FG V + + G A K + + + E++ +S L H LV L + +
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE- 228
Query: 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHED 390
++ YE + G L + + +A GL ++HE+
Sbjct: 229 -MVMIYEFMSGGEL-------------FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 391 SQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
+ +H D K NI+ K+ DFGL ++ + GT + APE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTT-GTAEFAAPEVA 328
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ +D++S GV+ LL+G P
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 55/264 (20%), Positives = 88/264 (33%), Gaps = 79/264 (29%)
Query: 244 VTLGGSLPHPTSTRFLA-YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL 301
+ + P P Y+ K+ +LG G G+V + G A+K L
Sbjct: 12 LEVLFQGPEPKKYAVTDDYQLSKQ---------VLGLGVNGKVLECFHRRTGQKCALKLL 62
Query: 302 TCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVGYY--SSRDSSQHLLCYELVPNGSLES 356
EV+ + ++V ++ Y L+ E + G L
Sbjct: 63 -------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL-- 113
Query: 357 WLHGPLGVNCHLDWETRMKIA---------LDAAR-------GLAYLHEDSQPCVIHRDF 400
+I +AA + +LH + + HRD
Sbjct: 114 -----------FS-----RIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDV 154
Query: 401 KASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS 457
K N+L + + K+ DFG AK+ + L T T YVAPE +L
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAPE------VLGPE 204
Query: 458 ------DVYSYGVVLLELLTGRKP 475
D++S GV++ LL G P
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 66/310 (21%), Positives = 102/310 (32%), Gaps = 98/310 (31%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL-HHRNLVK 329
LGEG F K V A A+K + K E+ L H N+VK
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII-------SKRMEANTQKEITALKLCEGHPNIVK 70
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR 382
L + D L EL+ G L + +I +A+
Sbjct: 71 LHEVFH--DQLHTFLVMELLNGGEL-------------FE-----RIKKKKHFSETEASY 110
Query: 383 -------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYL 432
++++H+ V+HRD K N+L + N K+ DFG A+ P L
Sbjct: 111 IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPL 166
Query: 433 STRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGRKPVDMSQPSGQEN 486
T T Y APE LL ++ D++S GV+L +L+G+ P
Sbjct: 167 KTPC-FTLHYAAPE------LLNQNGYDESCDLWSLGVILYTMLSGQVPF---------- 209
Query: 487 LVTWARPILRDKDRLEELADPRLGGKY--PKE----------DFIRVCTIAAACVAPEAN 534
+ E+ G + E D I+ + + N
Sbjct: 210 ---QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQ------GLLTVDPN 260
Query: 535 QRPTMGEVVQ 544
+R M +
Sbjct: 261 KRLKMSGLRY 270
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 63/229 (27%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHR 325
LG G FG+V G G VA+K L +++ + E++ L H
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 326 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR 382
+++KL Y + + E V G L ++ HG R++ AR
Sbjct: 72 HIIKL---YQVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEE--MEAR 114
Query: 383 --------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
+ Y H + V+HRD K N+LL+ + +AK+ADFGL+ +G +L T
Sbjct: 115 RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 169
Query: 435 RVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
G+ Y APE YA G + D++S GV+L LL G P D
Sbjct: 170 SC-GSPNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGTLPFD 212
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 62/231 (26%), Positives = 94/231 (40%), Gaps = 53/231 (22%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV----------EVE 317
++FE +G+G FG+V +D A+K + +K+ V E++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQ 67
Query: 318 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 377
++ L H LV L +YS +D + +L+ G L HL K
Sbjct: 68 IMQGLEHPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRY----------HLQQNVHFKE- 114
Query: 378 LDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
+ + L YL +IHRD K NILL+ + H + DF +A P
Sbjct: 115 -ETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 430 NYLSTRVMGTFGYVAPE----YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
T + GT Y+APE G+ + D +S GV ELL GR+P
Sbjct: 171 ---ITTMAGTKPYMAPEMFSSRKGAGYS--FAVDWWSLGVTAYELLRGRRP 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 59/271 (21%), Positives = 104/271 (38%), Gaps = 42/271 (15%)
Query: 224 RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 283
+S A L + P + + + ++ +LG GGFG
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEK-------EPLESQYQVGPLLGSGGFG 57
Query: 284 RVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFL-VEVEMLSRLHHR--NLVKLVGYY 334
V+ G+ +SD VAIK R++ G+ + + +EV +L ++ +++L+ ++
Sbjct: 58 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117
Query: 335 SSRDSSQHLLCYELV-PNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
DS +L E P L ++ G L R + + H
Sbjct: 118 ERPDS--FVLILERPEPVQDLFDFITERGALQEE-----LAR-SFFWQVLEAVRHCH--- 166
Query: 392 QPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM- 449
V+HRD K NIL+ N K+ DFG + + GT Y PE+
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFD-GTRVYSPPEWIRY 222
Query: 450 ---TGHLLVKSDVYSYGVVLLELLTGRKPVD 477
G + V+S G++L +++ G P +
Sbjct: 223 HRYHGR---SAAVWSLGILLYDMVCGDIPFE 250
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 60/242 (24%), Positives = 90/242 (37%), Gaps = 61/242 (25%)
Query: 262 EELKEATNNF----EPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQQGDKEFL 313
++L + F E +G G + + + + A+K + +
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------ 64
Query: 314 VEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWET 372
E+E+L R H N++ L Y D + EL+ G L LD
Sbjct: 65 -EIEILLRYGQHPNIITLKDVYD--DGKYVYVVTELMKGGEL-------------LDKIL 108
Query: 373 RMK---------IALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFG 419
R K + + + YLH V+HRD K SNIL N ++ DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 473
AKQ L T T +VAPE +L + D++S GV+L +LTG
Sbjct: 166 FAKQLRAE-NGLLMTPC-YTANFVAPE------VLERQGYDAACDIWSLGVLLYTMLTGY 217
Query: 474 KP 475
P
Sbjct: 218 TP 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 50/253 (19%), Positives = 92/253 (36%), Gaps = 66/253 (26%)
Query: 268 TNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLHHR 325
+ + LG G FG V + + G A+K++ D + E++++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKVLDHV 60
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH------------------ 367
N++KLV Y+ + + + L +G +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 368 -------LDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENN 410
L R ++ R + ++H + HRD K N+L+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177
Query: 411 FHA-KVADFGLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVY 460
+ K+ DFG AK+ + Y+ +R Y APE L++ + D++
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE------LMLGATEYTPSIDLW 226
Query: 461 SYGVVLLELLTGR 473
S G V EL+ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 61/245 (24%), Positives = 93/245 (37%), Gaps = 49/245 (20%)
Query: 256 TRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD------ 309
EL + + + G +G V GV S+G VAIKR+ G
Sbjct: 9 AMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILS 68
Query: 310 -----KEFLVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGP 361
K L E+ +L+ HH N++ L + + + L L EL + + L
Sbjct: 69 DSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQV 123
Query: 362 LGVNCHLDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENNF 411
+ +I + GL LHE V+HRD NILL +N
Sbjct: 124 IHDQ---------RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNN 171
Query: 412 HAKVADFGLAKQAPEGR--TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLE 468
+ DF LA++ T+Y++ R Y APE M K D++S G V+ E
Sbjct: 172 DITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 469 LLTGR 473
+ +
Sbjct: 227 MFNRK 231
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 62/251 (24%), Positives = 97/251 (38%), Gaps = 50/251 (19%)
Query: 251 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCG 304
P LA E E + + S LG G FG V+ V V +K ++
Sbjct: 7 PKAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED 65
Query: 305 GQQGDKEFL---VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 361
D + +E+ +LSR+ H N++K++ + ++ ++LV +E HG
Sbjct: 66 CWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF------FQLV----ME--KHGS 113
Query: 362 LG-VNCHLDWETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFH 412
+ +D R+ A + YL +IHRD K NI++ +F
Sbjct: 114 GLDLFAFIDRHPRLDE--PLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFT 168
Query: 413 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVL 466
K+ DFG A G T GT Y APE Y G + +++S GV L
Sbjct: 169 IKLIDFGSAAYLERG--KLFYTFC-GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTL 220
Query: 467 LELLTGRKPVD 477
L+ P
Sbjct: 221 YTLVFEENPFC 231
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 55/227 (24%), Positives = 82/227 (36%), Gaps = 61/227 (26%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV------EVEMLSRLHHRNLVK 329
+G G FG VA+K + ++ + E+ L H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-------ERGAAIDENVQREIINHRSLRHPNIVR 80
Query: 330 LVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR---- 382
+ HL + E G L + G R D AR
Sbjct: 81 F---KEVILTPTHLAIIMEYASGGELYERICNAG------------RFSE--DEARFFFQ 123
Query: 383 ----GLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRV 436
G++Y H + HRD K N LL+ + K+ DFG +K + + + V
Sbjct: 124 QLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTV 178
Query: 437 MGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
GT Y+APE Y G +DV+S GV L +L G P +
Sbjct: 179 -GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 63/229 (27%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR----------LHHR 325
LG G FG+V G G VA+K L +++ + ++++ + H
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKIL-------NRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 326 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR 382
+++KL Y + + + E V G L ++ +G R+ +R
Sbjct: 77 HIIKL---YQVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDE--KESR 119
Query: 383 --------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
G+ Y H + V+HRD K N+LL+ + +AK+ADFGL+ +G +L T
Sbjct: 120 RLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 174
Query: 435 RVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
G+ Y APE YA G + D++S GV+L LL G P D
Sbjct: 175 SC-GSPNYAAPEVISGRLYA--G---PEVDIWSSGVILYALLCGTLPFD 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 49/222 (22%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVG 332
LG G F V + + S G A K L + D + E+ +L ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDAAR- 382
Y ++S+ +L E G + D R
Sbjct: 97 VYE--NTSEIILILEYAAGGEI-------------FS-----LCLPELAEMVSENDVIRL 136
Query: 383 ------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLS 433
G+ YLH+++ ++H D K NILL + K+ DFG++++ L
Sbjct: 137 IKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LR 191
Query: 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
+ GT Y+APE + +D+++ G++ LLT P
Sbjct: 192 EIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 57/283 (20%), Positives = 90/283 (31%), Gaps = 77/283 (27%)
Query: 224 RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 283
+ P+ + L + Y+ + +LG G G
Sbjct: 26 PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGING 76
Query: 284 RVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVGYY--SSR 337
+V + A+K L EVE+ R ++V++V Y
Sbjct: 77 KVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDAAR------ 382
L+ E + G L +I +A+
Sbjct: 130 GRKCLLIVMECLDGGEL-------------FS-----RIQDRGDQAFTEREASEIMKSIG 171
Query: 383 -GLAYLHEDSQPCVIHRDFKASNILLENNFHA---KVADFGLAKQAPEGRTNYLSTRVMG 438
+ YLH + + HRD K N+L + K+ DFG AK+ N L+T
Sbjct: 172 EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPC-Y 225
Query: 439 TFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGRKP 475
T YVAPE +L D++S GV++ LL G P
Sbjct: 226 TPYYVAPE------VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 25/236 (10%)
Query: 249 SLPHPTSTRFLAYEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG 304
S P P + F E K E + +G G +G V V G VAIK+L
Sbjct: 2 SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP 61
Query: 305 GQQGD--KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWL 358
Q K E+ +L + H N++ L+ ++ ++ L + + L
Sbjct: 62 FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDL 116
Query: 359 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418
+ L + + +GL Y+H +IHRD K N+ + + K+ DF
Sbjct: 117 GKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 172
Query: 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
GLA+QA T Y+ TR Y APE + ++ D++S G ++ E++TG+
Sbjct: 173 GLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 58/231 (25%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---------- 314
+ F+ LG G FGRV K G A+K L DK+ +V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKIL-------DKQKVVKLKQIEHTLN 90
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
E +L ++ LVKL +S +D+S + E V G + S HL R
Sbjct: 91 EKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFS----------HLRRIGR- 137
Query: 375 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
+ AR YLH +I+RD K N+L++ + +V DFG AK+ +
Sbjct: 138 -FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-K 192
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKS-DVYSYGVVLLELLTGRKP 475
GRT L GT +APE ++ G+ K+ D ++ GV++ E+ G P
Sbjct: 193 GRTWTLC----GTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPP 237
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 56/225 (24%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHR 325
LGEG FG+V VA+K + ++ L E+ L L H
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFI-------SRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 326 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMK----IAL 378
+++KL Y + + + E G L ++ + + E R I
Sbjct: 70 HIIKL---YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQIIC- 119
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
+ Y H + ++HRD K N+LL++N + K+ADFGL+ +G N+L T G
Sbjct: 120 ----AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSC-G 169
Query: 439 TFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 477
+ Y APE YA G + DV+S G+VL +L GR P D
Sbjct: 170 SPNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGRLPFD 209
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 266 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL 322
E + + +G G +G V + G VAIK+L+ Q K E+ +L +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 323 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
H N++ L+ ++ S ++ L +++ L +G+ E +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLK--FSEEKIQYLVY 133
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
+GL Y+H V+HRD K N+ + + K+ DFGLA+ A T Y+ TR
Sbjct: 134 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188
Query: 439 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
Y APE ++ ++ D++S G ++ E+LTG+
Sbjct: 189 ---YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEV 316
++K +E LGEG F V+K + VAIK++ G + K+ L E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 317 EMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK 375
++L L H N++ L+ + + + + L ++ + LE + + L
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSN---ISLVFDFMET-DLEVIIKDN---SLVLTPSHIKA 116
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLST 434
L +GL YLH+ ++HRD K +N+LL+ N K+ADFGLAK R +
Sbjct: 117 YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTH 171
Query: 435 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
+V+ T Y APE LL + +Y GV +L ELL
Sbjct: 172 QVV-TRWYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFL-VEVEMLSRLH----HR 325
LG+GGFG VF G L+D VAIK R+ D +EV +L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 383
+++L+ ++ +++ +L +P L ++ GPLG +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERP-LPAQDLFDYITEKGPLGEG-----PSR-CFFGQVVAA 151
Query: 384 LAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 442
+ + H V+HRD K NIL+ AK+ DFG + + GT Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFD-GTRVY 204
Query: 443 VAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 477
PE+ ++ H + V+S G++L +++ G P +
Sbjct: 205 SPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 266 EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTC--GGQQGDKEFLVEVEMLSRL 322
++ +G G G V + VAIK+L+ Q K E+ ++ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 323 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
+H+N++ L+ ++ + S + + EL+ +L + L RM L
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMEL-------DHERMSYLL 133
Query: 379 -DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--TNYLSTR 435
G+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T Y+ TR
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
Y APE + D++S G ++ E++ G
Sbjct: 191 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 59/224 (26%), Positives = 87/224 (38%), Gaps = 45/224 (20%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF-----LVEVEMLSRL 322
+E +GEG +G VFK G VAIK+ + D L E+ ML +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQL 59
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNCHLDWETRMKIALD 379
H NLV L+ + R HL+ +E + L+ + I
Sbjct: 60 KHPNLVNLLEVFR-RKRRLHLV-FEYCDHTVLHELDR-------YQRGVPEHLVKSITWQ 110
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGR--TNYLSTRV 436
+ + + H+ + IHRD K NIL+ + K+ DFG A+ + ++TR
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR- 166
Query: 437 MGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
Y +PE LLV Y V V ELL+G
Sbjct: 167 ----WYRSPE------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 38/268 (14%), Positives = 74/268 (27%), Gaps = 61/268 (22%)
Query: 277 LGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKL 330
G + ++ + D VA+ + G D +E L LSR+ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+ L+ E + GSL+ ++ A H
Sbjct: 97 --LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP------VGAIRAMQSLAAAADAAHRA 148
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 450
V S + + + +G V+ +
Sbjct: 149 G---VALSIDHPSRVRV----------------SIDGDV------VLAYPATMPDANP-- 181
Query: 451 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR-L 509
+ D+ G L LL R P+ + + + P RD + +P +
Sbjct: 182 -----QDDIRGIGASLYALLVNRWPLP------EAGVRSGLAPAERDTA--GQPIEPADI 228
Query: 510 GGKYPKEDFIRVCTIAAACVAPEANQRP 537
P + + +AA V + R
Sbjct: 229 DRDIPFQ----ISAVAARSVQGDGGIRS 252
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 26/235 (11%)
Query: 251 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD 309
+ + ++ + + S +GEG +G V + VAIK+++ Q
Sbjct: 9 AAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY 68
Query: 310 -KEFLVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVN 365
+ L E+++L R H N++ + + + + + + + +L +E+ L+ L
Sbjct: 69 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQ 123
Query: 366 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425
HL + RGL Y+H + V+HRD K SN+LL K+ DFGLA+ A
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 426 EGR------TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
T Y++TR Y APE + KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 55/233 (23%), Positives = 91/233 (39%), Gaps = 41/233 (17%)
Query: 262 EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 314
+L+ ++E ++G G FG V K A+K L+ + F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
E ++++ + +V+L +Y+ +D + E +P G L + +
Sbjct: 119 ERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMS-------------NY 163
Query: 375 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
+ AR L +H IHRD K N+LL+ + H K+ADFG + +
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVK----SDVYSYGVVLLELLTGRKP 475
T V GT Y++PE + D +S GV L E+L G P
Sbjct: 221 EGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 58/231 (25%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
+F+ LG G FGRV + +G A+K L KE +V +VE
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVL-------KKEIVVRLKQVEHTND 55
Query: 318 ---MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
MLS + H ++++ + + +D+ Q + + + G L S L R
Sbjct: 56 ERLMLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFS----------LLRKSQRF 103
Query: 375 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
A+ L YLH +I+RD K NILL+ N H K+ DFG AK P+
Sbjct: 104 PN--PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 427 GRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
T L GT Y+APE + + KS D +S+G+++ E+L G P
Sbjct: 159 -VTYTLC----GTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 46/248 (18%)
Query: 246 LGGSLPHPTSTRFLAYEEL-KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC 303
+G H +S L E L ++ +E ++GEG +G V K G VAIK+
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL- 59
Query: 304 GGQQGDKEF-----LVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLE 355
+ D + + E+++L +L H NLV L+ + +L+ +E V + LE
Sbjct: 60 --ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-KKKRWYLV-FEFVDHTILDDLE 115
Query: 356 SWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 415
LD++ K G+ + H + +IHRD K NIL+ + K+
Sbjct: 116 L-------FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKL 165
Query: 416 ADFGLAKQ-APEGR--TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------V 465
DFG A+ A G + ++TR Y APE LLV Y V +
Sbjct: 166 CDFGFARTLAAPGEVYDDEVATR-----WYRAPE------LLVGDVKYGKAVDVWAIGCL 214
Query: 466 LLELLTGR 473
+ E+ G
Sbjct: 215 VTEMFMGE 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 8e-19
Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 40/234 (17%)
Query: 262 EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 314
++++ +FE ++G G FG V K A+K L E F
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
E ++L + + L +Y+ +D + L + G L + L +
Sbjct: 124 ERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLS-----------KFED 170
Query: 375 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
++ + AR + +H+ +HRD K NIL++ N H ++ADFG + E
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKP 475
T S V GT Y++PE D +S GV + E+L G P
Sbjct: 228 DGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 35/221 (15%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRL 322
+E +GEG +G VFK VA+KR+ D E L E+ +L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKEL 58
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
H+N+V+L S L +E L+ + N LD E +
Sbjct: 59 KHKNIVRLHDVLHSDKKL--TLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLK 112
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFG 441
GL + H V+HRD K N+L+ N K+A+FGLA+ R S V+ T
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVV-TLW 166
Query: 442 YVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGRKP 475
Y P+ +L + +YS + + EL +P
Sbjct: 167 YRPPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/232 (21%), Positives = 94/232 (40%), Gaps = 43/232 (18%)
Query: 261 YEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEV 316
YE ++++ LG G + VF+ + +++ V +K L K+ E+
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREI 81
Query: 317 EMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-- 373
++L L N++ L S L +E V N + L D++ R
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-TLT-----DYDIRFY 135
Query: 374 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR--TN 430
M L + L Y H ++HRD K N+++ + ++ D+GLA+ G+
Sbjct: 136 MYEIL---KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 431 YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKP 475
+++R + PE LLV D++S G +L ++ ++P
Sbjct: 190 RVASRY-----FKGPE------LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 266 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRL 322
++ +G G G V VAIK+L+ Q K E+ ++ +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 323 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
+H+N++ L+ ++ + + + L EL +++ L + + LD E +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQME--LDHERMSYLLY 171
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--TNYLSTRV 436
G+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T Y+ TR
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 437 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
Y APE + D++S G ++ E++ +
Sbjct: 229 -----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 39/227 (17%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEMLSRL 322
+ +E + +G+G FG VFK G VA+K++ + +KE F L E+++L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLL 73
Query: 323 HHRNLVKLVGYYSSRDSSQHL------LCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 376
H N+V L+ ++ S + L ++ + L L ++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRV 129
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---APEGRTNYLS 433
GL Y+H + ++HRD KA+N+L+ + K+ADFGLA+ A + N +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
RV+ T Y PE LL+ Y + ++ E+ T
Sbjct: 187 NRVV-TLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 249 SLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ 307
S PT R + + E ++ S +G G +G V + G VA+K+L+ Q
Sbjct: 9 SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 308 GD--KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGP 361
K E+ +L + H N++ L+ ++ S + L L + + L+
Sbjct: 69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNI 123
Query: 362 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
+ L + + RGL Y+H +IHRD K SN+ + + K+ DFGLA
Sbjct: 124 VKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
+ + T Y++TR Y APE + ++ D++S G ++ ELLTGR
Sbjct: 180 RHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 51/307 (16%), Positives = 98/307 (31%), Gaps = 62/307 (20%)
Query: 225 GRKSKASPKETAKPRTADAVTLGGSLPHPTST--------RFLAYEELKEATNNFEPASI 276
G +A+ + T V+ + + +E +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVEVEMLSRLHHRN 326
+G G +G V + + VAIK++ + F L E+ +L+RL+H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDH 113
Query: 327 LVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
+VK+ + + L + E+ +S +L + + G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLST 434
+ Y+H ++HRD K +N L+ + KV DFGLA
Sbjct: 169 VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 435 RVMGTFGYVAPEYAMTGH----------LLVKSDVYSYGV-------VLLELLTGRKPVD 477
++ + +TGH L++ + Y+ + + ELL K
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 478 MSQPSGQ 484
Sbjct: 286 AYHADRG 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 267 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSR 321
+++ F+ LG G + V+KG+ + G VA+K + ++G + E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKE 59
Query: 322 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL 378
L H N+V+L + + L L +E + N L+ ++ L+
Sbjct: 60 LKHENIVRLYDVIHTENK---LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVM 437
+GLA+ HE+ ++HRD K N+L+ K+ DFGLA+ T S+ V+
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVV 170
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
T Y AP+ +L+ S YS + +L E++TG+
Sbjct: 171 -TLWYRAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 56/269 (20%), Positives = 95/269 (35%), Gaps = 48/269 (17%)
Query: 262 EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 314
+E++ ++FE ++G G F V K G A+K + E F
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
E ++L R + +L +++ +D + L E G L + L +
Sbjct: 111 ERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLS-----------KFGE 157
Query: 375 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
+I + AR + +H +HRD K NILL+ H ++ADFG +
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY-------SYGVVLLELLTGRKPVDMS 479
T V GT Y++PE + Y + GV E+ G+ P
Sbjct: 215 DGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-- 271
Query: 480 QPSGQENLVTWARPILRDKDRLEELADPR 508
++ I+ K+ L
Sbjct: 272 ----ADSTAETYGKIVHYKEHLSLPLVDE 296
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 323
++ +GEG +G V+K S G VA+KR+ + E + E+ +L LH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH 77
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
H N+V L+ S L +E + L+ L L RG
Sbjct: 78 HPNIVSLIDVIHSERCL--TLVFEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRG 131
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGY 442
+A+ H+ ++HRD K N+L+ ++ K+ADFGLA+ R+ + V+ T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVV-TLWY 185
Query: 443 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
AP+ +L+ S YS V + E++TG+
Sbjct: 186 RAPD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 35/229 (15%)
Query: 266 EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH 324
+ + + LG GG G VF V +D VAIK++ Q K L E++++ RL H
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67
Query: 325 RNLVKLV-----------GYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 372
N+VK+ S + + E +E+ L L L E
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQG-PLLEEH 121
Query: 373 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR--- 428
RGL Y+H + V+HRD K +N+ + + K+ DFGLA+
Sbjct: 122 ARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 429 ---TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
+ L T+ Y +P ++ + K+ D+++ G + E+LTG+
Sbjct: 179 GHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 9e-18
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 34/218 (15%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 323
+ +GEG +G V+K + G A+K++ + + E + E+ +L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
H N+VKL ++ +L +E + L+ L L+ T L G
Sbjct: 59 HSNIVKLYDVIHTKKRL--VLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNG 112
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGY 442
+AY H+ V+HRD K N+L+ K+ADFGLA+ R + ++ T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIV-TLWY 166
Query: 443 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
AP+ +L+ S YS + + E++ G
Sbjct: 167 RAPD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 266 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH 323
+++F+ S+LGEG +G V G VAIK++ + L E+++L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 324 HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLH-----GPLGVNCHLDWETRMK 375
H N++ + + S ++ + + EL +++ LH L + H+ +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLS-DDHIQY----- 116
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 435
R + LH + VIHRD K SN+L+ +N KV DFGLA+ E +
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 436 VMGTF--GYV------APEYAMTGHLLVKS-DVYSYGVVLLELLTGR 473
+ +V APE +T ++ DV+S G +L EL R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 59/238 (24%)
Query: 267 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ-GDKEF----LVEVEMLS 320
AT+ +EP + +G G +G V+K G VA+K + G + EV +L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 321 RLH---HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW------E 371
RL H N+V+L+ ++ + + + LV E H+D +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVT-LV----FE-----------HVDQDLRTYLD 110
Query: 372 TRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
L A RGL +LH + C++HRD K NIL+ + K+ADFGLA
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 473
+ L+ V+ T Y APE +L++S D++S G + E+ +
Sbjct: 168 RIY--SYQMALTPVVV-TLWYRAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 42/225 (18%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
N FE +LG+G FG+V K G A+K L KE +V EV
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKIL-------KKEVIVAKDEVAHTLT 197
Query: 318 ---MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+L H L L S + L E G L L + E R
Sbjct: 198 ENRVLQNSRHPFLTAL---KYSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDR 249
Query: 374 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432
+ + L YLH S+ V++RD K N++L+ + H K+ DFGL K EG +
Sbjct: 250 ARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGA 304
Query: 433 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
+ + GT Y+APE + + ++ D + GVV+ E++ GR P
Sbjct: 305 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 27/226 (11%)
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR---MKIALDAARGL 384
V L S SSQ V SL + + D+ T + + A+G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
+L S+ C IHRD A NILL K+ DFGLA+ + ++A
Sbjct: 207 EFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE- 502
PE ++SDV+S+GV+L E+ + G P P + + R L++ R+
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRR--LKEGTRMRA 317
Query: 503 -ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ P + Y C E +QRPT E+V+ L
Sbjct: 318 PDYTTPEM---Y---------QTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 30/155 (19%), Positives = 58/155 (37%), Gaps = 20/155 (12%)
Query: 276 ILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNL 327
LG G FG+V + + VA+K L G + + + E+++L + HH N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
V L+G ++ ++ E G+L ++L R + +G +
Sbjct: 89 VNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLR-----------SKRNEFVPYKTKGARFR 136
Query: 388 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422
I D K + ++ + + F K
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 269 NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRN 326
+ LGEG + V+KG VA+K + ++G + EV +L L H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+V L + S L +E + L+ +L ++ RGLAY
Sbjct: 62 IVTLHDIIHTEKSL--TLVFEYLDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAY 115
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAP 445
H + V+HRD K N+L+ K+ADFGLA+ + +T V+ T Y P
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVV-TLWYRPP 169
Query: 446 EYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
+ +L+ S YS + + E+ TGR
Sbjct: 170 D------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 51/222 (22%), Positives = 84/222 (37%), Gaps = 42/222 (18%)
Query: 277 LGEGGFGRVFKGV---LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 333
+G G +G V+K D A+K++ G E+ +L L H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA----------RG 383
+ S + L ++ + L + + + L G
Sbjct: 87 FLSHADRKVWLLFDYAEH-DLWHIIK-----FHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 384 LAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQ-APEGRTNYLSTRVMG 438
+ YLH + V+HRD K +NIL+ K+AD G A+ + V+
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 439 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 473
TF Y APE LL+ + D+++ G + ELLT
Sbjct: 198 TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 70/280 (25%), Positives = 105/280 (37%), Gaps = 55/280 (19%)
Query: 224 RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 283
+ D ++ H T L K NFE +LG G +G
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYG 68
Query: 284 RVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLVE----VE--------MLSRLHHRNL 327
+VF K D G A+K L K +V+ E + L
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVL-------KKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR----- 382
V L +Y+ + ++ L + + G L + HL R +
Sbjct: 122 VTL--HYAFQTETKLHLILDYINGGELFT----------HLSQRERFT--EHEVQIYVGE 167
Query: 383 ---GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
L +LH+ +I+RD K NILL++N H + DFGL+K+ T GT
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GT 223
Query: 440 FGYVAPE---YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
Y+AP+ +GH K+ D +S GV++ ELLTG P
Sbjct: 224 IEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 69/229 (30%), Positives = 100/229 (43%), Gaps = 49/229 (21%)
Query: 269 NNFEPASILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLV---EVEM--- 318
+ FE +LG+G FG+VF K SD A+K L K L V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKME 76
Query: 319 ---LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
L ++H +VKL + + + L L + + G L + L + E +
Sbjct: 77 RDILVEVNHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLS-----KEVMFTEEDV 128
Query: 375 K-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
K +AL L +LH +I+RD K NILL+ H K+ DFGL+K E
Sbjct: 129 KFYLAELAL----ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESID 178
Query: 430 NYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
+ GT Y+APE GH +S D +S+GV++ E+LTG P
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTLP 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 57/262 (21%), Positives = 95/262 (36%), Gaps = 54/262 (20%)
Query: 252 HPTSTRFLAYEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ 307
H +S R Y + +N+ ++G G +G V+ + VAIK++
Sbjct: 6 HHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN----- 60
Query: 308 GDKEF---------LVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLE 355
+ F L E+ +L+RL +++L + L + E+ +
Sbjct: 61 --RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----AD 113
Query: 356 SWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414
S L L E +K I + G ++HE +IHRD K +N LL + K
Sbjct: 114 SDLKKLFKTPIFLT-EEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVK 169
Query: 415 VADFGLA----KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----------LLVKS--- 457
V DFGLA + N L + +T H L++
Sbjct: 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229
Query: 458 ----DVYSYGVVLLELLTGRKP 475
D++S G + ELL +
Sbjct: 230 TKSIDIWSTGCIFAELLNMLQS 251
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 63/233 (27%), Positives = 94/233 (40%), Gaps = 59/233 (25%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
N+F+ +LG+G FG+V K G A+K L KE ++ EV
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKIL-------RKEVIIAKDEVAHTVT 54
Query: 318 ---MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+L H L L + + L E G L HL E
Sbjct: 55 ESRVLQNTRHPFLTAL---KYAFQTHDRLCFVMEYANGGELFF----------HLSRERV 101
Query: 374 MKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425
+ AR L YLH V++RD K N++L+ + H K+ DFGL K
Sbjct: 102 FT--EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--- 153
Query: 426 EGRTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
EG ++ + + GT Y+APE + ++ D + GVV+ E++ GR P
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLP 204
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 269 NNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSR 321
+E + +GEG +G+VFK + + G VA+KR+ Q +E + EV +L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRH 67
Query: 322 LH---HRNLVKL----VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
L H N+V+L + R++ L+ +E V L ++L + ET
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLV-FEHVDQ-DLTTYLDKVPEP--GVPTETIK 123
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
+ RGL +LH V+HRD K NIL+ ++ K+ADFGLA+ L++
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTS 178
Query: 435 RVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 473
V+ T Y APE +L++S D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 41/224 (18%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRL 322
+ + + LGEG +G V+K + VAIKR+ + ++E + EV +L L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
HRN+++L L +E E+ L + N +
Sbjct: 91 QHRNIIELKSVIHHNHRL--HLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHA-----KVADFGLAKQ-APEGRTNYLSTRV 436
G+ + H +HRD K N+LL + + K+ DFGLA+ R + +
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198
Query: 437 MGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 473
+ T Y PE +L+ S YS V + E+L
Sbjct: 199 I-TLWYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 59/235 (25%)
Query: 269 NNFEPASILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLV----EVE--- 317
FE +LG+GG+G+VF K ++ G A+K L K +V +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-------KKAMIVRNAKDTAHTK 69
Query: 318 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 372
+L + H +V L + + L L E + G L L+ E
Sbjct: 70 AERNILEEVKHPFIVDL---IYAFQTGGKLYLILEYLSGGELFM----------QLEREG 116
Query: 373 RMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424
D A L +LH+ +I+RD K NI+L + H K+ DFGL K++
Sbjct: 117 IFM--EDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171
Query: 425 --PEGRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
T+ GT Y+APE +GH ++ D +S G ++ ++LTG P
Sbjct: 172 IHDGTVTHTFC----GTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPP 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 49/228 (21%)
Query: 275 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---------- 323
LG G F V+ + + T VA+K + + + E+++L R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 324 -HRNLVKLVGYYSSR-DSSQHL-LCYELV-PN--GSLESWLHGPLGVNCHLDWETRMKIA 377
+++KL+ +++ + + H+ + +E++ N ++ + H + + + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY-----VK-QIS 137
Query: 378 LDAARGLAYLHEDSQPCVIHRDFKASNILL------ENNFHAKVADFGLAKQAPEGRTNY 431
GL Y+H +IH D K N+L+ EN K+AD G A E TN
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 432 LSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 473
+ TR Y +PE + +D++S ++ EL+TG
Sbjct: 196 IQTRE-----YRSPEVLLGAPWGC------GADIWSTACLIFELITGD 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 5e-15
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 42/225 (18%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
+F +LG+G FG+V KG A+K L K+ ++ +VE
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMV 390
Query: 318 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+ L +L + + + E V G L + E
Sbjct: 391 EKRVLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEPH 443
Query: 374 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432
A + A GL +L +I+RD K N++L++ H K+ADFG+ K E + +
Sbjct: 444 AVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGV 497
Query: 433 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
+T+ GT Y+APE + KS D +++GV+L E+L G+ P
Sbjct: 498 TTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK------RLTCGGQQGDKEFLVEVEMLS 320
+ +E S++G+G FG+V K + VAIK Q +EV +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---NQA----QIEVRLLE 105
Query: 321 RLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWE 371
++ +V L ++ R HL L +E++ + +L L GV+ +L
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFR---NHLCLVFEML-SYNLYDLLRNTNFRGVSLNL--- 158
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRT 429
TR K A L +L + +IH D K NILL N + K+ DFG + Q +
Sbjct: 159 TR-KFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 430 NYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 473
Y+ +R F Y +PE Y + D++S G +L+E+ TG
Sbjct: 217 QYIQSR----F-YRSPEVLLGMPYDL------AIDMWSLGCILVEMHTGE 255
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 50/229 (21%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
+F +LG+G FG+VF K AIK L K+ ++ +VE
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKAL-------KKDVVLMDDDVECTMV 66
Query: 318 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+ H L + + + + E + G L + +CH +R
Sbjct: 67 EKRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSR 119
Query: 374 MK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428
I L GL +LH +++RD K NILL+ + H K+ADFG+ K E
Sbjct: 120 ATFYAAEIIL----GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENM 169
Query: 429 TNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
T GT Y+APE + G S D +S+GV+L E+L G+ P
Sbjct: 170 LGDAKTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 46/227 (20%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
+F +LG+G FG+V KG A+K L K+ ++ +VE
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMV 69
Query: 318 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 372
+ L +L +S + L E V G L + E
Sbjct: 70 EKRVLALPGKPPFLTQL---HSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEP 121
Query: 373 RMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431
A + A GL +L +I+RD K N++L++ H K+ADFG+ K E +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG 175
Query: 432 LSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
++T+ GT Y+APE A + KS D +++GV+L E+L G+ P
Sbjct: 176 VTTKTFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 54/231 (23%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
++F ++G+G FG+V K + A+K L K+ ++ E +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVL-------QKKAILKKKEEKHIMS 87
Query: 318 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 372
+L + H LV L + S ++ L + + G L L E
Sbjct: 88 ERNVLLKNVKHPFLVGL---HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEP 139
Query: 373 RMK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427
R + IA L YLH + +++RD K NILL++ H + DFGL K E
Sbjct: 140 RARFYAAEIAS----ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK---EN 189
Query: 428 RTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
+ +T GT Y+APE + ++ D + G VL E+L G P
Sbjct: 190 IEHNSTTSTFCGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPP 238
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 63/228 (27%)
Query: 275 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLHHR---- 325
++G+G FG+V K VA+K + + +K F E+ +L L +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 326 --NLVKLVGYYSSRDSSQHLLC----------YELVPNGSLESWLHGPLGVNCHLDWETR 373
N++ ++ ++ R H+ C YEL+ + G + L R
Sbjct: 158 TMNVIHMLENFTFR---NHI-CMTFELLSMNLYELIKKNKFQ-------GFSLPL---VR 203
Query: 374 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNY 431
K A + L LH++ +IH D K NILL+ + KV DFG + + Y
Sbjct: 204 -KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259
Query: 432 LSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 473
+ +R F Y APE Y M D++S G +L ELLTG
Sbjct: 260 IQSR----F-YRAPEVILGARYGM------PIDMWSLGCILAELLTGY 296
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 64/234 (27%), Positives = 97/234 (41%), Gaps = 60/234 (25%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
+NFE +LG+G FG+V K G A+K L K+ ++ +VE
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVL-------KKDVILQDDDVECTMT 72
Query: 318 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 372
+ +H L +L + + L E V G L H+
Sbjct: 73 EKRILSLARNHPFLTQL---FCCFQTPDRLFFVMEFVNGGDLMF----------HIQKSR 119
Query: 373 RMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424
R AR L +LH+ +I+RD K N+LL++ H K+ADFG+ K
Sbjct: 120 RFD--EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-- 172
Query: 425 PEGRTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
EG N ++T GT Y+APE + + D ++ GV+L E+L G P
Sbjct: 173 -EGICNGVTTATFCGTPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHAP 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 47/225 (20%), Positives = 72/225 (32%), Gaps = 77/225 (34%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLV 331
+LG G G+V + A+K L EVE+ R ++V++V
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 332 GYY--SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDA 380
Y L+ E + G L +I +A
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGEL-------------FS-----RIQDRGDQAFTEREA 119
Query: 381 AR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTN 430
+ + YLH + + HRD K N+L + N K+ DFG AK+
Sbjct: 120 SEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------- 169
Query: 431 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475
G Y D++S GV++ LL G P
Sbjct: 170 -----TTGE-KYDK-----------SCDMWSLGVIMYILLCGYPP 197
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 3e-13
Identities = 43/254 (16%), Positives = 69/254 (27%), Gaps = 66/254 (25%)
Query: 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--------QQGDKEFLVEVEM 318
T + +GEG FG VF+ + D T VAIK + G Q+ +E L E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 319 LSRLH---------HRNLVKLVGYY----------------------------SSRDSSQ 341
L + L + Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 401
+ E G + L T I LA + HRD
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL-----SSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 402 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP--EYAMTGHLLVKSDV 459
N+LL+ K+ K + + + G +Y ++ V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 460 YSYGVVLLELLTGR 473
+ + +L TG
Sbjct: 239 FCDVSMDEDLFTGD 252
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 56/232 (24%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
+F+ ++G G + +V K A+K + KE + +++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVV-------KKELVNDDEDIDWVQT 58
Query: 318 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+H LV L + + S+ E V G L + H+ + +
Sbjct: 59 EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDL---MF-------HMQRQRK 106
Query: 374 MKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425
+ + AR L YLHE +I+RD K N+LL++ H K+ D+G+ K
Sbjct: 107 LP--EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--- 158
Query: 426 EGRTNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
EG +T GT Y+APE + G S D ++ GV++ E++ GR P
Sbjct: 159 EGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 65/248 (26%)
Query: 266 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVE 315
+E LG+G +G V+K + G VA+K++ F E
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFRE 58
Query: 316 VEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
+ +L+ L H N+V L+ + + L ++ +E+ LH + R
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVI----------RA 103
Query: 375 KIALDA---------ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---K 422
I + + YLH ++HRD K SNILL H KVADFGL+
Sbjct: 104 NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----------LLVKS-------DVYSYGVV 465
N + T + + +T + +L+ S D++S G +
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220
Query: 466 LLELLTGR 473
L E+L G+
Sbjct: 221 LGEILCGK 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 269 NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 317
+F+ ++G G + +V K A++ + KE + +++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVV-------KKELVNDDEDIDWVQT 101
Query: 318 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 373
+H LV L + + S+ E V G L + E
Sbjct: 102 EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEH 154
Query: 374 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 432
+ + + + L YLHE +I+RD K N+LL++ H K+ D+G+ K EG
Sbjct: 155 ARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD 208
Query: 433 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 475
+T GT Y+APE + G S D ++ GV++ E++ GR P
Sbjct: 209 TTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 75/251 (29%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK------RLTCGGQQGDKEFLVEVEMLS 320
N F +G+G FGRV + + A+K + T + +E ++L
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---RSA----KIEADILK 86
Query: 321 RL-----HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWET 372
++ ++ N+VK G + D H+ L +E + SL + + G +
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYD---HMCLIFEPL-GPSLYEIITRNNYNGFHIED---I 139
Query: 373 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA------------------- 413
+ ++ + L YL + S + H D K NILL++ +
Sbjct: 140 K-LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 414 ------KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYS 461
K+ DFG A + + ++TR Y APE + + SD++S
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMWS 244
Query: 462 YGVVLLELLTG 472
+G VL EL TG
Sbjct: 245 FGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 52/247 (21%), Positives = 88/247 (35%), Gaps = 71/247 (28%)
Query: 268 TNNFEPASILGEGGFGRVFKGV--LSDGTAVAIK------RLTCGGQQGDKEFLVEVEML 319
+E LGEG FG+V + + + VA+K + + +E+ +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR---EAA----RLEINVL 70
Query: 320 SRLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDW 370
++ + V + +++ H+ + +EL+ + +L +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFH---GHMCIAFELL-GKNTFEFLKENNFQPYPLPH-- 124
Query: 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA----------------- 413
R +A L +LHE+ + H D K NIL N+
Sbjct: 125 -VR-HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 414 --KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVV 465
+VADFG A E T ++TR Y PE +A DV+S G +
Sbjct: 180 SIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGCI 228
Query: 466 LLELLTG 472
L E G
Sbjct: 229 LFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 71/247 (28%)
Query: 268 TNNFEPASILGEGGFGRVFKGV--LSDGTAVAIK--RLTCGGQQGDKEF----LVEVEML 319
+ +E LGEG FG+V + + + G VA+K + + E+++L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVL 65
Query: 320 SRLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDW 370
L+ V+++ ++ H+ + +EL+ S ++ +G L
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHH---GHICIVFELL-GLSTYDFIKENGFLPFRLDH-- 119
Query: 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA----------------- 413
R K+A + + +LH + + H D K NIL + +
Sbjct: 120 -IR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 414 --KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVV 465
KV DFG A E + +STR Y APE ++ DV+S G +
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCI 223
Query: 466 LLELLTG 472
L+E G
Sbjct: 224 LIEYYLG 230
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 42/235 (17%), Positives = 80/235 (34%), Gaps = 53/235 (22%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLV------ 328
+G+GGFG ++ ++ +V + E++ R +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 329 ---KLVG----YYSSRDSSQHLLCYELV-----PNGSLESWLHGPLGVNC--HLDWETRM 374
K +G + S ++ L+ + +T +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQK-----IYEANAKRFSRKTVL 155
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTN 430
+++L L Y+HE +H D KASN+LL + + + D+GLA + +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY--LVDYGLAYRYCPEGVH 210
Query: 431 ----YLSTRVM-GTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 475
R GT E+ + H V + D+ G +++ LTG P
Sbjct: 211 KAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 54/232 (23%), Positives = 86/232 (37%), Gaps = 49/232 (21%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 325
+++ +GEG FG +F+G L + VAIK Q E+ ++
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---------YK 60
Query: 326 NLVKLVG----YYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIAL 378
L G YY ++ ++L +L+ G SLE L C +T A
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLED-----LLDLCGRKFSVKTVAMAAK 113
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK-----VADFGLAKQAPEGRTN--- 430
+ +HE S +++RD K N L+ V DFG+ K + T
Sbjct: 114 QMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170
Query: 431 -YLSTR-VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 475
Y + + GT Y + HL + D+ + G V + L G P
Sbjct: 171 PYREKKNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 66/416 (15%), Positives = 128/416 (30%), Gaps = 95/416 (22%)
Query: 92 VSQIELINFYVLSLSQLNISMDITPH----TGISFSASDA-------SAINFS---LTTH 137
VS+++ +L +L + ++ +G ++ A D ++F L
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLK 190
Query: 138 KVHFDSTLVGDYKLLNFTWFEPPAPSQAPLASSPPMKAPTHRASPSSSSSTSNKG-KHSN 196
+ T++ + L + +P S++ +S+ + H +K ++
Sbjct: 191 NCNSPETVLEMLQKLLYQ-IDPNWTSRSDHSSNIKL--RIHSIQAELRRLLKSKPYENCL 247
Query: 197 LIL----------IFGIG-TGLLITAIISVLIICSCAFRGRKSKA------SPKET---- 235
L+L F + LL T V S A S +P E
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 236 AK---------PRTADAV------TLGGSLPHPTST----RFLAYEELKEAT----NNFE 272
K PR + S+ +T + + ++L N E
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 273 PASILGEGGFGRVFK--GVLSDGTAVAIKRLTCGGQQGDKEFLVEVE-MLSRLHHRNLVK 329
PA + ++F V + L+ K +V ++++LH +LV+
Sbjct: 368 PAE------YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS---DVMVVVNKLHKYSLVE 418
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-----HLDWETRMKIALDAARG- 383
S + EL E LH + V+ D + + LD
Sbjct: 419 --KQPKESTISIPSIYLELKVKLENEYALHRSI-VDHYNIPKTFDSDDLIPPYLD---QY 472
Query: 384 ----LAYLH-EDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAPEGRTNYLS 433
+ + H ++ + R + L+ F K+ A A N L
Sbjct: 473 FYSHIGH-HLKNIEH--PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 7e-07
Identities = 65/402 (16%), Positives = 115/402 (28%), Gaps = 106/402 (26%)
Query: 262 EELKEATNNFEPASILGEG----GFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVE-- 315
+ K + E I+ G R+F +LS + +++ + + +FL+
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEM-VQKFVEEVLRINYKFLMSPI 98
Query: 316 --------------VEMLSRLHHRNLVKLVGYYSSRDSS-----QHLLCYELVPNGSLES 356
+E RL++ N Y SR Q L EL P ++
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDN-QVFAKYNVSRLQPYLKLRQAL--LELRPAKNVL- 154
Query: 357 WLHGPLGVNCHLDWETRMK--IALDAARGLAYLHEDSQPCVIH-----RDFKASNIL--L 407
+ G LG K +ALD +Y + I +L L
Sbjct: 155 -IDGVLGSG---------KTWVALDVCL--SYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 408 ENNFHAKVADF---GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV 464
+ + ++ + R + + + + Y LLV +V +
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL--KSKPYENC--LLVLLNVQNAKA 258
Query: 465 VLLELLTGRKPVDMSQPSGQENLVTWARPILRDK---DRL------EELADPRLGGKYPK 515
++ + L+T R K D L D P
Sbjct: 259 W--------NAFNL----SCKILLT-----TRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 516 ED---FIRVCTIAAACVAPEANQR-PTMGEVVQSLKMVQRVIECQDPTLTSSN-NRANLR 570
E ++ + E P + L ++ I +D T N N
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNP------RRLSIIAESI--RDGLATWDNWKHVNCD 353
Query: 571 QSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSEDLH 612
+ +T + SS+ P FD +VF H
Sbjct: 354 KLTTIIE----SSLNVLEPAEYRKMFDR-----LSVFPPSAH 386
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 39/226 (17%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 325
N + +G G FG ++ G ++ G VAIK + Q +E ++ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 64
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIALDAAR 382
+ + + + +++ EL+ G SLE L C +T + +A
Sbjct: 65 VGIPTI-RWCGAEGDYNVMVMELL--GPSLED-----LFNFCSRKFSLKTVLLLADQMIS 116
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAK---VADFGLAKQAPEGRTN----YLSTR 435
+ Y+H + IHRD K N L+ + DFGLAK+ + RT+ Y +
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 436 -VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 475
+ GT YA + HL + + D+ S G VL+ G P
Sbjct: 174 NLTGT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 55/232 (23%), Positives = 84/232 (36%), Gaps = 49/232 (21%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 325
NF +G G FG + G L VAIK + Q E+ ++
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---------YK 59
Query: 326 NLVKLVG----YYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNCH--LDWETRMKIAL 378
L G YY + + EL+ G SLE L C +T + IA+
Sbjct: 60 QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLED-----LFDLCDRTFSLKTVLMIAI 112
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKV--ADFGLAKQAPEGRTN--- 430
+ Y+H + +I+RD K N L+ N + DF LAK+ + T
Sbjct: 113 QLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169
Query: 431 -YLSTR-VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 475
Y + + GT Y + HL + D+ + G + + L G P
Sbjct: 170 PYREHKSLTGT-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 44/232 (18%), Positives = 81/232 (34%), Gaps = 50/232 (21%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV------- 328
+G GGFG ++ + A + Q + E++ R+ ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 329 --KLVG----YYSSRDSSQHLLCYELV-----PNGSLESWLHGPLGVNCH--LDWETRMK 375
+G Y S + +V L+ + T ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQKIS------GQNGTFKKSTVLQ 155
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV--ADFGLAKQAPEGRTN--- 430
+ + L Y+HE+ +H D KA+N+LL +V AD+GL+ + +
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 431 -YLSTRVM-GTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 475
+ GT E+ + H V +SDV G +L L G+ P
Sbjct: 213 QENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 50/277 (18%), Positives = 85/277 (30%), Gaps = 67/277 (24%)
Query: 247 GGSLPHPTSTRFLAY---EELKEAT-------NNFEPASILGEGGFGRVFKGV------- 289
G L E L T ++ S G +++
Sbjct: 10 GVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTC 69
Query: 290 --LSDGTAVAIK------RLTCGG---QQGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSR 337
++K RL Q+ K V L + +G+ +
Sbjct: 70 DSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ 129
Query: 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQPC 394
D + L+ L SL+S L L + +++A L +LHE+
Sbjct: 130 DKYRFLVLPSLGR--SLQSALD-----VSPKHVLSERSVLQVACRLLDALEFLHENE--- 179
Query: 395 VIHRDFKASNILLENNFHAKV--ADFGLAKQ---------APEGRTNYLSTRVMGTFGYV 443
+H + A NI ++ ++V A +G A + EG + G
Sbjct: 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE----GD---- 231
Query: 444 APEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 475
E+ M H +SD+ S G +L+ L G P
Sbjct: 232 -LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 39/226 (17%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 325
N F +G G FG ++ G + VAIK + Q L E ++ L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGG 62
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIALDAAR 382
+ V + + ++L +L+ G SLE L C L +T + +A
Sbjct: 63 TGIPNV-RWFGVEGDYNVLVMDLL--GPSLED-----LFNFCSRKLSLKTVLMLADQMIN 114
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAK---VADFGLAKQAPEGRTN----YLSTR 435
+ ++H S +HRD K N L+ A + DFGLAK+ + T+ Y +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 436 -VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 475
+ GT YA + HL + + D+ S G VL+ L G P
Sbjct: 172 NLTGT-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 56/302 (18%), Positives = 91/302 (30%), Gaps = 87/302 (28%)
Query: 277 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335
LG G F V+ + VA+K + + L E+ +L + + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD-PNDPNREM 102
Query: 336 SRDSSQHLL-CYELV-PNGSLESWLHGPLGVN----------CHLDWETRMKIALDAARG 383
LL +++ NG+ + LG + L KI +G
Sbjct: 103 VV----QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 384 LAYLHEDSQPCVIHRDFKASNILLE----------------------------------- 408
L YLH + +IH D K NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 409 --------------NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 454
K+AD G A + T + TR Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 455 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 514
+D++S + EL TG + RD+D + + + L GK P
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEY----------TRDEDHIALIIE--LLGKVP 319
Query: 515 KE 516
++
Sbjct: 320 RK 321
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 615 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.64 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.15 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.99 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.55 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.99 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.39 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.89 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=462.24 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=207.4
Q ss_pred cCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|. +....
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT--EGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEE
Confidence 56788899999999999999864 47899999998766566678999999999999999999999997 45589
Q ss_pred eEEEecCCCCChhHhhcCCCC-----------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 343 LLCYELVPNGSLESWLHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
+||||||++|+|.++|+.... ....++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 999999999999999975321 1246999999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~ 490 (615)
.+||+|||+|+...........+...||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~- 271 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAID- 271 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHH-
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence 999999999997765544434456789999999999999999999999999999999999 8999974321 11111
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.+. ... ....|......+.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 272 --~i~-~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 --CIT-QGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --HHH-HTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHH-cCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111 111 1122333445688999999999999999999999999988653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-56 Score=460.07 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=214.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
.++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|. +...
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe--eCCE
Confidence 357889999999999999999863 47889999998766566678999999999999999999999997 4558
Q ss_pred eeEEEecCCCCChhHhhcCCC---------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc
Q 007160 342 HLLCYELVPNGSLESWLHGPL---------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 412 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~---------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 412 (615)
.+||||||++|+|.++|+... .....++|.++++|+.|||+||+|||+++ |+||||||+||||++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence 999999999999999997431 12346999999999999999999999998 999999999999999999
Q ss_pred EEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 007160 413 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~ 491 (615)
+||+|||+|+...............||++|||||++.+..++.++|||||||+||||+| |+.||..... ..+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~-- 241 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE-- 241 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH--
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH--
Confidence 99999999987655433333344679999999999999999999999999999999999 8999974321 11111
Q ss_pred hhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.+.. .. ....|......+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 242 -~i~~-~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 -CITQ-GR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -HHHH-TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHc-CC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 10 0122333445688999999999999999999999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=455.74 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=210.7
Q ss_pred cCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
.++++.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|. +...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~--~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT--KDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE--ECCE
Confidence 35667899999999999999963 468899999975433 34578999999999999999999999997 4457
Q ss_pred eeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC
Q 007160 342 HLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 409 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 409 (615)
.+||||||++|+|.++|+.... ....++|..+++|+.|||+||+|||+.+ |+||||||+||||++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECC
Confidence 8999999999999999964321 1246899999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 007160 410 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV 488 (615)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~ 488 (615)
++.+||+|||+|+...........+...||++|||||++.++.++.++|||||||+||||+| |+.||..... ..+.
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~ 257 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV 257 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 99999999999987654433334455689999999999999999999999999999999998 8999974331 1111
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.. +..+. ....|..+...+.+|+.+||+.||++||||+||+++|+.+
T Consensus 258 ~~----i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EM----IRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH----HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH----HHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 11111 1123444555689999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=447.22 Aligned_cols=263 Identities=28% Similarity=0.469 Sum_probs=205.2
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.++||+|+||+||+|++++ .||||+++.... ...+.|.+|+++|++++|||||+++|+|.. ..++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEE
Confidence 3577889999999999999999753 599999875432 234679999999999999999999999852 368999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||||++|+|.++|+.. ...++|.+++.|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 110 mEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999999999753 235999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCcccccc---CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
............||+.|||||++.+ +.|+.++|||||||+||||+||+.||...... ..+.. .+..
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~----~~~~----- 252 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIF----MVGR----- 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHH----HHHT-----
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHH----HHhc-----
Confidence 4433333456789999999999864 46899999999999999999999999743321 11111 1111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
....+.+. ..+......+.+|+.+||+.||++||||.||+++|+.++..+
T Consensus 253 ~~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 253 GYASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TCCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 11112111 122334456889999999999999999999999999887643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=449.49 Aligned_cols=271 Identities=25% Similarity=0.395 Sum_probs=218.2
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECC------CcEEEEEEeccCCCC-chHHHHHHHHHHhhccC-CCcceEEEE
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHH-RNLVKLVGY 333 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H-pnIv~l~g~ 333 (615)
.+.+...++|++.+.||+|+||+||+|++.+ ++.||||++...... ..++|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444556889999999999999999998642 368999999765433 34679999999999965 899999999
Q ss_pred eecCCCCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCC
Q 007160 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 401 (615)
Q Consensus 334 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 401 (615)
|.. +...++||||||++|+|.++|+.... ....++|..++.++.|||+||+|||+++ |||||||
T Consensus 137 ~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 137 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp ECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 863 33468999999999999999974321 1245899999999999999999999999 9999999
Q ss_pred CCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 007160 402 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQ 480 (615)
Q Consensus 402 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~ 480 (615)
|+||||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999997765544434456789999999999999999999999999999999998 999997433
Q ss_pred CCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 481 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 481 ~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.. ..+ ...+.+.. ....|......+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 293 ~~--~~~----~~~i~~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 293 ID--EEF----CRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CS--HHH----HHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH--HHH----HHHHHcCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 21 111 11111111 1122333345688999999999999999999999999988664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=435.33 Aligned_cols=273 Identities=23% Similarity=0.364 Sum_probs=203.1
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHH--HHHHHHhhccCCCcceEEEEeecCCC--CceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL--VEVEMLSRLHHRNLVKLVGYYSSRDS--SQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~--~Ei~~l~~l~HpnIv~l~g~~~~~~~--~~~~L 344 (615)
++|.+.+.||+|+||+||+|++ +|+.||||++... ..+++. +|+..+.+++|||||+++|+|...+. ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4578889999999999999998 5799999999643 234444 45556678999999999999975432 35799
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-----CCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-----SQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-----~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
|||||++|+|.++|+. ..++|..+++++.|+++||+|||++ ..++|+||||||+||||++++++||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999974 3589999999999999999999987 23449999999999999999999999999
Q ss_pred ccccCCCCCcc--ccceeeccccccCCccccccC------cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 420 LAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 420 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
+|+........ ......+||+.|||||++.+. .++.++|||||||+||||+||+.||........ ....+.
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-p~~~~~ 232 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLV 232 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTS
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-cchhcc
Confidence 99876544322 122346799999999998754 478899999999999999999888753322111 000000
Q ss_pred hhhhccchhhhhhcCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 492 RPILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
............+.+..+....+ .+....+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 00000000111122222222222 2455678999999999999999999999999998865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=437.59 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=208.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.. ...+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEe
Confidence 56999999999999999999964 699999999987666666789999999999999999999999984 458999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
||++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 152 y~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 152 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999999973 35899999999999999999999999 999999999999999999999999999977544
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .....+.. -..+
T Consensus 224 ~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~-------~~~~ 288 (346)
T 4fih_A 224 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRD-------NLPP 288 (346)
T ss_dssp SC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-------SSCC
T ss_pred CC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHc-------CCCC
Confidence 32 234578999999999999999999999999999999999999999743211 11111111 0111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+ .........+.+|+.+||+.||++|||+.|+++|
T Consensus 289 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 1112233458899999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=430.09 Aligned_cols=258 Identities=21% Similarity=0.234 Sum_probs=207.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.+.|+..++||+|+||+||+|+.. +|+.||||+++.... +.+|+++|++++|||||++++++. +...+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~--~~~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR--EGPWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE--ETTEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEEE
Confidence 356888999999999999999964 689999999975432 247999999999999999999987 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 425 (615)
|||+||+|.++|+. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+...
T Consensus 130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999974 346999999999999999999999999 99999999999999987 69999999999775
Q ss_pred CCCcc---ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 426 EGRTN---YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 426 ~~~~~---~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
..... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||......... ..+........
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~~~~ 276 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPPPIR 276 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCCGGG
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCCCch
Confidence 43221 1123457999999999999999999999999999999999999999754432211 11111111111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
..+......+.+++.+||+.||++|||+.|++++|....+...
T Consensus 277 ---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 277 ---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 1122233458899999999999999999999999988766544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=436.45 Aligned_cols=253 Identities=20% Similarity=0.338 Sum_probs=201.8
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.|.+|+++|++++|||||++++++. +...+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~--~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE--ENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE--ECCEEEEE
Confidence 6899999999999999999996 46899999999765332 3467999999999999999999999987 44589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
||||+||+|.++|.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 102 mEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999996422 235788999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
... ...+..+||+.|||||++.+..|+.++|||||||+||||++|+.||.... .......+....
T Consensus 177 ~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~------- 241 (350)
T 4b9d_A 177 STV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGS------- 241 (350)
T ss_dssp HHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTC-------
T ss_pred CCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC-------
Confidence 321 12345679999999999999999999999999999999999999997432 112222222111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
-+.+...+ ...+.+|+.+||+.||++|||++|+++|-+
T Consensus 242 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 242 FPPVSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CCCCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 01111223 345889999999999999999999998743
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=423.56 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=197.8
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecC--CCCceeEE
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHLLC 345 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~~~LV 345 (615)
|+..+.||+|+||+||+|+.. +++.||||++..... ...+.|.+|+++|++++|||||++++++... ....++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356678999999999999964 688999999975432 2346799999999999999999999998642 23468999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~ 424 (615)
||||++|+|.++|+. ...+++..+..++.||+.||+|||+++. +|+||||||+||||+. ++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999974 3468999999999999999999999864 4999999999999974 799999999999865
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ......+... .
T Consensus 183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i~~~-~----- 246 (290)
T 3fpq_A 183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSG-V----- 246 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTT-C-----
T ss_pred CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHHHcC-C-----
Confidence 432 2345689999999998864 6999999999999999999999999643211 1111111110 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+...... ...+.+|+.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 247 KPASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCGGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111112 2347899999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=429.47 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=208.8
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++. +...+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence 5799999999999999999996 47899999999743 2334577999999999999999999999987 4568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||++||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+..
T Consensus 110 vmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999999974 346999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
............+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ......+....
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~------ 250 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLE------ 250 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC------
T ss_pred CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC------
Confidence 654433344567899999999999999999999999999999999999999974321 11111122111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. .++......+.+|+.+||+.||++|||++|++.+
T Consensus 251 --~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 251 --Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --C----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --C----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 1 1222233457899999999999999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=439.75 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=209.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.+.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.. ...+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEEE
Confidence 357999999999999999999964 689999999987766667789999999999999999999999984 45899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
|||++|+|.++++. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 228 Ey~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 228 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp ECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999999999963 35899999999999999999999999 99999999999999999999999999997754
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .....+. ....
T Consensus 300 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~-------~~~~ 364 (423)
T 4fie_A 300 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIR-------DNLP 364 (423)
T ss_dssp SCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-------HSCC
T ss_pred CCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH-------cCCC
Confidence 432 234578999999999999999999999999999999999999999643211 1111111 1111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.+. ........+.+|+.+||+.||++|||+.|+++|
T Consensus 365 ~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 PRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 111223457899999999999999999999886
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=410.61 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=191.2
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++. +....++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK--SKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEEEE
Confidence 5899999999999999999995 478999999997543 233467999999999999999999999987 4568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 91 vmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 99999 6899999964 345999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.... .....+||+.|||||++.+..+ +.++||||+||+||||++|+.||.... .......+....
T Consensus 163 ~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~----- 228 (275)
T 3hyh_A 163 TDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGV----- 228 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-----
T ss_pred CCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCC-----
Confidence 5432 2345689999999999998876 589999999999999999999997432 111111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. .++......+.+|+.+||+.||++|||++|+++|=+
T Consensus 229 ---~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 229 ---Y----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp ---C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred ---C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 1 112222345789999999999999999999998743
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=420.18 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=195.8
Q ss_pred cCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++|++++|||||++++++.. ...+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 47999999999999999999852 47899999997542 1223468899999999999999999999884 4589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
||||||++||+|.++|.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 102 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 999999999999999974 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
....... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ......+...
T Consensus 175 ~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~----- 241 (304)
T 3ubd_A 175 ESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKA----- 241 (304)
T ss_dssp C-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-----
T ss_pred eccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcC-----
Confidence 7544322 23456899999999999999999999999999999999999999974321 1111112211
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 545 (615)
.. .+|......+.+|+.+||+.||++||| ++|+++|
T Consensus 242 -----~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 242 -----KL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -----CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -----CC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11 122233345889999999999999998 4677765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=408.81 Aligned_cols=251 Identities=26% Similarity=0.467 Sum_probs=189.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCC-------
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS------- 339 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~------- 339 (615)
++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999964 6899999999765433 24678999999999999999999999864332
Q ss_pred ---CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEE
Q 007160 340 ---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416 (615)
Q Consensus 340 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 416 (615)
..+|+||||+++|+|.++++.... ....++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 247899999999999999975332 234566778999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCcc----------ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 007160 417 DFGLAKQAPEGRTN----------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486 (615)
Q Consensus 417 DFGla~~~~~~~~~----------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~ 486 (615)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----ME 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cH
Confidence 99999876543221 11234579999999999999999999999999999999996 77421 01
Q ss_pred hhHhhhhhhccchhhhhhcCCccCCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 487 LVTWARPILRDKDRLEELADPRLGGKYPK---EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 487 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~---~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... +..+.+ ..++. .....+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~----------~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 RVRT----------LTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH----------HHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH----------HHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0100 111111 11121 222346789999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=401.79 Aligned_cols=288 Identities=42% Similarity=0.705 Sum_probs=246.3
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
+.+.++...+++|++.+.||+|+||.||+|++.+|+.||||++........+.+.+|++++++++||||+++++++. +
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~ 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD--E 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC--C
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--C
Confidence 44555666789999999999999999999998889999999998776666788999999999999999999999987 4
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||+++|+|.+++.........++|..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 55889999999999999999765444456999999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
|+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|...... .
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-N 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-T
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-c
Confidence 999876543333333455799999999999999999999999999999999999999987666665666666544332 2
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
..+..+.++.+....+.+....+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 345566677777777888889999999999999999999999999999988764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=391.92 Aligned_cols=290 Identities=43% Similarity=0.730 Sum_probs=243.8
Q ss_pred CcccCCHHHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEE
Q 007160 255 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGY 333 (615)
Q Consensus 255 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~ 333 (615)
..+.+++.++....++|++.+.||+|+||.||+|+..+|+.||||++...... ....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34668999999999999999999999999999999888999999999765322 23479999999999999999999999
Q ss_pred eecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcE
Q 007160 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413 (615)
Q Consensus 334 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 413 (615)
+. +....++||||+++|+|.++++........++|..++.++.|++.||+|||+...++|+||||||+|||+++++.+
T Consensus 96 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 96 CM--TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EC--CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred Ee--cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 87 4457899999999999999998765555679999999999999999999999932339999999999999999999
Q ss_pred EEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCCcchhhHhh
Q 007160 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ--PSGQENLVTWA 491 (615)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~--~~~~~~l~~~~ 491 (615)
||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||+... ......+..|.
T Consensus 174 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99999999876543322 2344569999999999999999999999999999999999999996321 12233455565
Q ss_pred hhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
...... ..+..+.+..+...++.+....+.+++.+||+.||.+|||+.||+++|+.
T Consensus 253 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 554443 44566777777778888889999999999999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=403.63 Aligned_cols=267 Identities=22% Similarity=0.329 Sum_probs=201.7
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecC----CCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~----~~~~ 341 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++++|||||++++++... +...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999996 47999999999754332 235788999999999999999999987532 3457
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
+|||||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 789999975 346999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC--ccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 422 KQAPEGR--TNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 422 ~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
+...... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...........+ ........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I--~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI--MMVLGTPS 283 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH--HHHHCCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH--HHhcCCCC
Confidence 8764332 12233457899999999998875 5699999999999999999999999754322111110 00000000
Q ss_pred ---------hhhhhhcCCc-cCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 ---------DRLEELADPR-LGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ---------~~l~~i~d~~-l~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......... .....+. .....+.+|+.+||+.||++|||+.|+++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 0000110 112357899999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=396.50 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=170.5
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCC
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 340 (615)
...+.|++.+.||+|+||+||+|+.+ +++.||||++... .....+.+|+++|+++ +|||||++++++.. ..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--ND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CC
Confidence 35678999999999999999999853 4688999998653 3356788999999998 69999999999874 45
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEEEecc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFG 419 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFG 419 (615)
..+|||||+++|+|.++++ .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 8999999999999999995 2889999999999999999999999 9999999999999876 799999999
Q ss_pred ccccCCCCCcc--------------------------ccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhC
Q 007160 420 LAKQAPEGRTN--------------------------YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTG 472 (615)
Q Consensus 420 la~~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG 472 (615)
+|+........ ...+..+||+.|||||++.+. .++.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865433211 012335799999999999875 589999999999999999999
Q ss_pred CCCCCCC
Q 007160 473 RKPVDMS 479 (615)
Q Consensus 473 ~~Pf~~~ 479 (615)
+.||...
T Consensus 244 ~~Pf~~~ 250 (361)
T 4f9c_A 244 RYPFYKA 250 (361)
T ss_dssp CSSSSCC
T ss_pred CCCCCCC
Confidence 9999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=411.03 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=207.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. +...++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEEE
Confidence 368999999999999999999964 68999999998765555677999999999999999999999987 556899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC--CcEEEEeccccccC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN--FHAKVADFGLAKQA 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~vkL~DFGla~~~ 424 (615)
|||++|+|.++|... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+..
T Consensus 234 E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 234 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp ECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred eecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999999643 235899999999999999999999999 9999999999999854 89999999999987
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .....+.......
T Consensus 308 ~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~~--- 375 (573)
T 3uto_A 308 DPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWNM--- 375 (573)
T ss_dssp CTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCCC---
T ss_pred cCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCCC---
Confidence 6543 234568999999999999999999999999999999999999999743311 1111111111000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......+ ...+.+|+.+||+.||++|||+.|+++|
T Consensus 376 -~~~~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 -DDSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -CSGGGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CcccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111112 2357899999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=382.14 Aligned_cols=275 Identities=27% Similarity=0.370 Sum_probs=212.4
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCC--CCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD--SSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~~~LV 345 (615)
.++|++.+.||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.... ....++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999985 7899999996432 22345667899999999999999999987543 2347999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC----------CCCcEEeccCCCCCeEEcCCCcEEE
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED----------SQPCVIHRDFKASNILLENNFHAKV 415 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~----------~~~~ivHrDIkp~NILl~~~~~vkL 415 (615)
|||+++|+|.++++. ..++|..++.++.|+++||+|||+. + |+||||||+|||++.++.+||
T Consensus 101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 999999999999974 3489999999999999999999998 6 999999999999999999999
Q ss_pred EeccccccCCCCCccccceeeccccccCCcccccc-----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 007160 416 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~ 490 (615)
+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987655443323344679999999999886 3567899999999999999999999975543322222111
Q ss_pred hhhhhccchhhhhhcCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 491 ARPILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.............+.........+ ......+.+|+.+||+.||++|||+.||++.|+.+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 110000001111111111111111 23455689999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=368.30 Aligned_cols=283 Identities=36% Similarity=0.607 Sum_probs=231.7
Q ss_pred ccCCHHHHHHHhcCcccc------eeeeccCceEEEEEEECCCcEEEEEEeccCC----CCchHHHHHHHHHHhhccCCC
Q 007160 257 RFLAYEELKEATNNFEPA------SILGEGGFGRVFKGVLSDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRN 326 (615)
Q Consensus 257 ~~~~~~el~~~~~~f~~~------~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~Hpn 326 (615)
..|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999887 8999999999999987 57899999987532 233567999999999999999
Q ss_pred cceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeE
Q 007160 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 327 Iv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NIL 406 (615)
|+++++++. +....++||||+++|+|.+++.... ....++|..++.++.|+++||.|||+.+ |+||||||+|||
T Consensus 92 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 92 LVELLGFSS--DGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp BCCEEEEEC--SSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred eEEEEEEEe--cCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999999987 4457899999999999999997432 2345899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 007160 407 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~ 486 (615)
+++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... .
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~ 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--L 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--B
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--H
Confidence 99999999999999987655433333345679999999998764 58899999999999999999999997544322 2
Q ss_pred hhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 487 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
+..+..........+....++.+. ..+......+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222222222333345555555543 456677788999999999999999999999999998874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=382.81 Aligned_cols=265 Identities=25% Similarity=0.399 Sum_probs=213.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC--------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhc-cCCCcceEEEEeecC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 337 (615)
.++|++.+.||+|+||.||+|+.. ++..||||++...... ..+.+.+|+++++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 468999999999999999999852 3567999999755322 246799999999999 8999999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
+....++||||+++|+|.+++..... ....+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence 44579999999999999999975321 1235899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~ 484 (615)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-- 312 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 312 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 999999999999999987655433223344567899999999999999999999999999999999 99999743311
Q ss_pred chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 485 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
.+... +... .....+......+.+++.+||+.||++||++.|++++|+.+.+...
T Consensus 313 -~~~~~----~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 -ELFKL----LKEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp -GHHHH----HHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -HHHHH----HhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11111 1110 1112233334468899999999999999999999999999877543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=369.97 Aligned_cols=268 Identities=25% Similarity=0.417 Sum_probs=215.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|.+.+.||+|+||+||+|... +++.||+|++........+.|.+|++++++++||||+++++++.. ....++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEEEE
Confidence 357899999999999999999974 689999999876555566789999999999999999999999874 45899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.++++.. ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 87 EYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp ECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999999752 235899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccc------------cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 007160 427 GRTNY------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494 (615)
Q Consensus 427 ~~~~~------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~ 494 (615)
..... ......||+.|+|||++.+..++.++||||||+++|||++|..|+............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------ 234 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------ 234 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------
Confidence 32211 011457999999999999999999999999999999999999998654332211100
Q ss_pred hccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcCCC
Q 007160 495 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP 558 (615)
Q Consensus 495 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~~~~ 558 (615)
......+......++. .+.+++.+||+.||++|||+.++++.|+.+...+....+
T Consensus 235 -----~~~~~~~~~~~~~~~~----~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~ 289 (310)
T 3s95_A 235 -----NVRGFLDRYCPPNCPP----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289 (310)
T ss_dssp -----CHHHHHHHTCCTTCCT----THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCC
T ss_pred -----hhhccccccCCCCCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCccc
Confidence 0011111111122232 478999999999999999999999999999887665433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=408.24 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=199.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHH---HHHHhhccCCCcceEEEEeecCCCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVE---VEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
++|++.++||+|+||+||+|+.. +|+.||||++.+.. ........+| +.+++.++|||||++++++. +...
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~--~~~~ 266 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDK 266 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSSE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE--ECCE
Confidence 67999999999999999999964 68999999996431 2223334444 56667789999999999987 4568
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
+||||||++||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|
T Consensus 267 lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999974 346899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
+...... ....+||+.|||||++.. ..|+.++|+|||||+||||++|+.||..........+ .......
T Consensus 340 ~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~~--- 409 (689)
T 3v5w_A 340 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTM--- 409 (689)
T ss_dssp EECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHHC---
T ss_pred eecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcCC---
Confidence 8775443 234689999999999975 5799999999999999999999999974332221111 1111111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL 546 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~L 546 (615)
.. .++......+.+|+.+||+.||++|++ ++||++|-
T Consensus 410 -----~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 410 -----AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp -----CC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred -----CC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 11 122233345789999999999999998 78888763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.52 Aligned_cols=264 Identities=30% Similarity=0.459 Sum_probs=203.3
Q ss_pred HHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
...++|++.+.||+|+||.||+|+. +|+.||||++....... .+.|.+|++++++++||||+++++++. +....+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT--QPPNLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--STTCCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCceE
Confidence 3457899999999999999999987 57889999997654332 357899999999999999999999987 445789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.... ....+++..++.++.|+++||+|||+.+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~-ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSSC-CCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-EECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999997532 123489999999999999999999998643 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... .
T Consensus 189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~---~--------- 251 (309)
T 3p86_A 189 KASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAA---V--------- 251 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHH---H---------
T ss_pred cccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---H---------
Confidence 543321 223467999999999999999999999999999999999999999743211 11110 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.........+......+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 252 -~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 252 -GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000011122333334588999999999999999999999999887654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=372.11 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=208.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|.+. .+..||||++..... ...+.|.+|++++++++||||+++++++. +....
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT--RGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--GGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCcc
Confidence 457889999999999999999974 345699999975432 23467999999999999999999999987 44578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 9999999999999999753 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCc-cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 423 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
....... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+... .
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~---~------ 267 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISS---V------ 267 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHH---H------
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH---H------
Confidence 7754332 122233457889999999999999999999999999999999 99999643211 11110 0
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.. ......+......+.+|+.+||+.||++|||+.||++.|+.+.+..
T Consensus 268 ----~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 268 ----EE-GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ----HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ----Hc-CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 00 0111122333446889999999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=367.73 Aligned_cols=276 Identities=27% Similarity=0.378 Sum_probs=210.6
Q ss_pred hcCcccceeeeccCceEEEEEEE-----CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.|.+|++++++++||||+++++++...+....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999985 3688999999986655556789999999999999999999999865555578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999743 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc---c
Q 007160 423 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD---K 498 (615)
Q Consensus 423 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~ 498 (615)
........ .......+|..|+|||.+.+..++.++||||||+++|||++|..|+..... ............ .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIV 238 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH----HHHHHHCTTCCTHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH----HHHhhhcCccccchhH
Confidence 76543321 122334578889999999999999999999999999999999999863210 000000000000 0
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
..+............+......+.+++.+||+.||++|||+.|+++.|+.+.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0011111111112223344456899999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=366.47 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=208.1
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEEEE
Confidence 46899999999999999999995 5789999999986666667789999999999999999999999874 45789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999999974 24889999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ ..
T Consensus 169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~-------~~ 233 (297)
T 3fxz_A 169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATN-------GT 233 (297)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHH-------CS
T ss_pred ccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-------CC
Confidence 432 2344679999999999999999999999999999999999999996432111 00001000 00
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+ ....+......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 234 P--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp C--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 111223334458899999999999999999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=378.51 Aligned_cols=274 Identities=24% Similarity=0.401 Sum_probs=217.5
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCCCC-chHHHHHHHHHHhhc-cCCCcceE
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKL 330 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l-~HpnIv~l 330 (615)
+...+.....++|++.+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34555666778999999999999999999984 24579999999764332 235799999999999 79999999
Q ss_pred EEEeecCCCCceeEEEecCCCCChhHhhcCCCCC----------------------------------------------
Q 007160 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV---------------------------------------------- 364 (615)
Q Consensus 331 ~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~---------------------------------------------- 364 (615)
++++... ....++||||+++|+|.++++.....
T Consensus 92 ~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 92 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9998743 34589999999999999999764321
Q ss_pred ----------------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 365 ----------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 365 ----------------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 112889999999999999999999999 9999999999999999999999999998765544
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.........||+.|+|||++.+..++.++||||||+++|||++ |+.||....... .+.. .+... ...
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~------~~~ 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEG------TRM 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHT------CCC
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcC------CCC
Confidence 3333455678999999999999999999999999999999998 999996543221 1111 11110 011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
..+......+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 11222334588999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=381.98 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=209.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|.+.+.||+|+||.||+|++. +++.||||.+...... ..+.|.+|+++|++++||||+++++++. +....++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--cCCCcEEE
Confidence 467899999999999999999986 7899999998754322 2356889999999999999999999987 44578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999742 235899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
............++..|+|||.+....++.++|||||||++|||++ |+.||...... .... .....
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~------ 331 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTRE----FVEKG------ 331 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHH----HHHTT------
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcC------
Confidence 4322111122346788999999999999999999999999999998 99999643211 1111 11111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.....+......+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 332 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 ----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11122333344688999999999999999999999999988653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=365.87 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=216.3
Q ss_pred cCCHHHHHHHhcC----------cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCC
Q 007160 258 FLAYEELKEATNN----------FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 326 (615)
Q Consensus 258 ~~~~~el~~~~~~----------f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn 326 (615)
.+++++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4788898888865 777889999999999999976 79999999998776666788999999999999999
Q ss_pred cceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeE
Q 007160 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 327 Iv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NIL 406 (615)
|+++++++.. ....++||||+++|+|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||||+|||
T Consensus 104 iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 104 VVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp BCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred cceEEEEEEE--CCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 9999999874 4589999999999999999874 35899999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 007160 407 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~ 486 (615)
++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~ 248 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---Q 248 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---H
T ss_pred ECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence 99999999999999987654322 123467999999999999999999999999999999999999999643211 1
Q ss_pred hhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 487 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. .. +.....+.+. ........+.+++.+||+.||++|||+.|++++-+
T Consensus 249 ~~---~~-------~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 249 AM---KR-------LRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HH---HH-------HHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HH---HH-------HhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 11 11 1111111111 11122345889999999999999999999998744
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=357.40 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=210.6
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.+.||+|+||.||+|+..+++.||||++.... ...+++.+|++++++++||||+++++++. +....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCceEEEEE
Confidence 35789999999999999999999888999999998543 34578999999999999999999999987 4457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999753 235899999999999999999999999 999999999999999999999999999876543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .... .
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~---~~~~----------~ 222 (269)
T 4hcu_A 160 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVV---EDIS----------T 222 (269)
T ss_dssp HH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHH----------T
T ss_pred cc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHH---HHHh----------c
Confidence 21 12233457888999999999999999999999999999999 99999743211 111 1010 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
. .....+......+.+++.+||+.||++||++.|++++|+.+.+
T Consensus 223 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 223 G-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp T-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 0 0111122223458899999999999999999999999998865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=363.13 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=211.7
Q ss_pred hcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--QDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe--cCC
Confidence 56899999999999999999985 2458899999975432 23467899999999999999999999987 445
Q ss_pred ceeEEEecCCCCChhHhhcCCCC--------------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccC
Q 007160 341 QHLLCYELVPNGSLESWLHGPLG--------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF 400 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 400 (615)
..++||||+++|+|.+++..... ....+++..++.++.|+++||.|||+.+ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 78999999999999999975322 1234899999999999999999999999 999999
Q ss_pred CCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 007160 401 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMS 479 (615)
Q Consensus 401 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~ 479 (615)
||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987755443333344567899999999999999999999999999999999 99999754
Q ss_pred CCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 480 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 480 ~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.... +... +... .....+......+.+++.+||+.||++||++.|++++|+.+..
T Consensus 257 ~~~~---~~~~----~~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 257 PPER---LFNL----LKTG----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CGGG---HHHH----HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHH---HHHH----hhcC----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3211 1111 1100 0111222333458899999999999999999999999998765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=375.16 Aligned_cols=267 Identities=27% Similarity=0.396 Sum_probs=214.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC--------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhc-cCCCcceEEEEeecC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 337 (615)
.++|.+.+.||+|+||.||+|+.. .+..||||++...... ..+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence 468999999999999999999852 2357999999765332 236789999999999 8999999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
+....++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 44578999999999999999975321 1235899999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~ 484 (615)
|+++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999987755433233344568899999999999999999999999999999999 9999964321
Q ss_pred chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcC
Q 007160 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 556 (615)
Q Consensus 485 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~~ 556 (615)
..+... +... .....+......+.+++.+||+.||++|||+.||+++|+.+.......
T Consensus 300 ~~~~~~----~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 300 EELFKL----LKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHH----HHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHH----HHcC----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 111111 1110 011122233345889999999999999999999999999988765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=369.54 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=204.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCc----EEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
.++|++.+.||+|+||.||+|++. +++ .||+|.+.... ....+.|.+|++++++++||||++++++|.. ..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---ST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---SS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---CC
Confidence 357999999999999999999954 344 46888886433 3445789999999999999999999999974 24
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++|+||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcce
Confidence 78999999999999999753 235899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
+...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~---------- 231 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI---------- 231 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----------
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH----------
Confidence 87765444333445567899999999999999999999999999999999 999997543211 1111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.........+......+.+++.+||+.||++||++.||+++|+.+.+..
T Consensus 232 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 232 ----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ----HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ----HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111111223334456889999999999999999999999999886643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=354.66 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=210.3
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.+.||+|+||.||+|...++..||||++..... ..+++.+|++++.+++||||+++++++. +....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCceEEEEE
Confidence 468999999999999999999998888999999975543 3577999999999999999999999986 4557899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999642 235899999999999999999999999 999999999999999999999999999876554
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ....... ..
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~---~~~~~~~-------~~ 223 (268)
T 3sxs_A 158 QYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EV---VLKVSQG-------HR 223 (268)
T ss_dssp CEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HH---HHHHHTT-------CC
T ss_pred hhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HH---HHHHHcC-------CC
Confidence 321 2233457788999999999999999999999999999999 99999643311 11 0000000 00
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
...+......+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 224 ----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 01112223358899999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=377.26 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=198.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|++. ++..||||+++.... ...+.|.+|++++++++||||+++++++. +....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT--KSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCce
Confidence 357999999999999999999864 577899999976432 23467999999999999999999999987 44578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.++++.. ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999999753 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 423 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+... +.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~----i~---- 264 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKA----VD---- 264 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHH----HH----
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HH----
Confidence 76543221 11223346789999999999999999999999999999998 9999964321 111111 00
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.......+......+.+++.+||+.||++||++.+|++.|+.+.+..
T Consensus 265 ------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 265 ------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ------TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ------cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 11111122233456889999999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=378.07 Aligned_cols=266 Identities=27% Similarity=0.413 Sum_probs=210.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++. +..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL--QSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCC
Confidence 467999999999999999999953 46789999997542 233457899999999999999999999987 445
Q ss_pred ceeEEEecCCCCChhHhhcCCC---CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC---cEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPL---GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAK 414 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~---~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vk 414 (615)
..++||||+++|+|.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 7899999999999999996422 12245899999999999999999999999 99999999999998554 599
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~--- 298 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF--- 298 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH---
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---
Confidence 999999985533222222334568999999999999999999999999999999998 99999743311 11111
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
+.. . .....+......+.+|+.+||+.||++||++.+|+++|+.+.+..+.
T Consensus 299 i~~-~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 299 VTS-G----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp HHT-T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred HHc-C----------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 100 0 01112223334588999999999999999999999999998776544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=367.52 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=209.7
Q ss_pred HhcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 338 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 338 (615)
..++|++.+.||+|+||.||+|+. .++..||||++.... ....+.+.+|+++++++ +||||+++++++. +
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--L 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--e
Confidence 457899999999999999999996 245689999997543 23456899999999999 8999999999987 4
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCC-------------------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEecc
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGV-------------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRD 399 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 399 (615)
....++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 45789999999999999999754321 134899999999999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 007160 400 FKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDM 478 (615)
Q Consensus 400 Ikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~ 478 (615)
|||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987654433323344568899999999999999999999999999999998 9999975
Q ss_pred CCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 479 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 479 ~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
..... .+... +.. ......+......+.+|+.+||+.||.+|||+.||+++|+.+...
T Consensus 278 ~~~~~--~~~~~----~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 278 IPVDA--NFYKL----IQN----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCCSH--HHHHH----HHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcHH--HHHHH----Hhc----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 43221 11111 111 111112223344688999999999999999999999999887553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=364.32 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=203.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++. +....++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCCeEEEE
Confidence 368999999999999999999965 789999999875432 22466899999999999999999999987 45588999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999999975 335899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
............||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|...
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~----------- 224 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK----------- 224 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTT-----------
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcc-----------
Confidence 4333333345679999999999987775 7899999999999999999999975433211 11111110
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.............+.+|+.+||+.||++|||+.|++++-
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 225 ---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 000001112234578999999999999999999998763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=369.12 Aligned_cols=265 Identities=26% Similarity=0.389 Sum_probs=210.5
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
...++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.|.+|++++++++||||+++++++. +
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA--V 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--S
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--c
Confidence 34678999999999999999999974 3488999999754332 2467999999999999999999999987 4
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCC--------------------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGV--------------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHR 398 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 398 (615)
....++||||+++|+|.+++...... ...+++.+++.++.|+++||.|||+.+ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 55889999999999999999753211 146899999999999999999999999 9999
Q ss_pred cCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCC
Q 007160 399 DFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVD 477 (615)
Q Consensus 399 DIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~ 477 (615)
||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986643322222334568999999999999999999999999999999999 999996
Q ss_pred CCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 478 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 478 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.... ..+. .. +.+... ...+......+.+++.+||+.||++||++.+|+++|+.+.+.
T Consensus 279 ~~~~---~~~~---~~----------~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAH---EEVI---YY----------VRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCH---HHHH---HH----------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCh---HHHH---HH----------HhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 4321 1111 11 111110 112223334688999999999999999999999999887553
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=356.49 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=207.8
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.+.||+|+||.||+|...++..||||++.... ...+++.+|++++.+++|+||+++++++. +....++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEe--cCCCeEEEEe
Confidence 46899999999999999999999888899999998543 33578999999999999999999999987 4557899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999752 245899999999999999999999999 999999999999999999999999999876543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+. ..
T Consensus 174 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~---~~~~-------~~-- 237 (283)
T 3gen_A 174 EY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA---EHIA-------QG-- 237 (283)
T ss_dssp HH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH---HHHH-------TT--
T ss_pred cc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHH---HHHh-------cc--
Confidence 21 11223457888999999999999999999999999999998 99999743311 111 1000 00
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.....+......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 238 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 --LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1111122223458899999999999999999999999998765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.01 Aligned_cols=263 Identities=24% Similarity=0.405 Sum_probs=203.7
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhh--ccCCCcceEEEEeecC--CCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSSR--DSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~HpnIv~l~g~~~~~--~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+. +|+.||||++.. .....+..|.+++.. ++||||+++++++... .....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 688999999863 345667778888776 7999999999986532 234689
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhH--------hCCCCcEEeccCCCCCeEEcCCCcEEE
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--------EDSQPCVIHRDFKASNILLENNFHAKV 415 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH--------~~~~~~ivHrDIkp~NILl~~~~~vkL 415 (615)
+||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 99999999999999963 35899999999999999999999 666 999999999999999999999
Q ss_pred EeccccccCCCCCccc--cceeeccccccCCccccccC------cCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 007160 416 ADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTG----------RKPVD 477 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~GvvL~ElltG----------~~Pf~ 477 (615)
+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998654433211 12234799999999999876 566899999999999999999 77775
Q ss_pred CCCCCCcchhhHhhhhhhccchhhhhhcCCccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 478 MSQPSGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 478 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
........ .... ....... ...+.+. ...+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 235 ~~~~~~~~-~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS-FEDM-RKVVCVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC-HHHH-HHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc-hhhh-hHHHhcc-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43322211 1111 0000000 0011110 011234566799999999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=365.20 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=205.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcE----EEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTA----VAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~----VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++|++.+.||+|+||.||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ....
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcc
Confidence 57999999999999999999964 4443 8888876443 333467889999999999999999999985 3468
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 9999999999999999753 346899999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
...............||..|+|||++.+..++.++||||||+++|||++ |+.||....... +.... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~-- 234 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLL----EKGE-- 234 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHH----HTTC--
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHH----HcCC--
Confidence 8765544444455678899999999999999999999999999999999 999997543221 11111 1000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
. ...+......+.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 235 ----~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 235 ----R----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ----B----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ----C----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 011111222467899999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=358.22 Aligned_cols=272 Identities=21% Similarity=0.298 Sum_probs=213.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357999999999999999999975 58999999997543 2335778899999999999999999999886666688999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE----cCCCcEEEEecccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA 421 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 421 (615)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999975322 223899999999999999999999999 9999999999999 78888999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccc--------cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAM--------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ .......
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~ 238 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYK 238 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHH
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHH
Confidence 87755432 23457999999999886 57889999999999999999999999964332211 1111111
Q ss_pred hhccch--hhh---hhc--------CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 494 ILRDKD--RLE---ELA--------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 494 ~~~~~~--~l~---~i~--------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
++.... ... ... +-......+......+.+++.+||+.||++|||++|++++...
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 111100 000 000 0011123456667788999999999999999999999999765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=360.98 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=212.8
Q ss_pred HhcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 338 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 338 (615)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++. +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--I 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe--c
Confidence 346899999999999999999985 3468999999975543 2346799999999999 9999999999987 4
Q ss_pred CCceeEEEecCCCCChhHhhcCCCC--------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCC
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLG--------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN 404 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~N 404 (615)
....++||||+++|+|.+++..... ....+++..++.++.|+++||.|||+.+ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 4578999999999999999975321 1224899999999999999999999999 9999999999
Q ss_pred eEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 007160 405 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSG 483 (615)
Q Consensus 405 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~ 483 (615)
||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999987765543333344568889999999999999999999999999999999 999996543211
Q ss_pred cchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 484 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 484 ~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.... ... ..... ..+......+.+++.+||+.||.+|||+.|++++|+.+...
T Consensus 256 --~~~~----~~~------~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 256 --KFYK----MIK------EGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp --HHHH----HHH------HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHH----Hhc------cCCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111 111 11111 11222334588999999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.33 Aligned_cols=254 Identities=29% Similarity=0.463 Sum_probs=196.4
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCC----CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~----~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|... ++.||||++..... ...+.+.+|++++++++||||+++++++. +....+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL--KEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--CC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCceE
Confidence 367999999999999999999985 78999999875432 22467899999999999999999999987 445789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC--------CCcEEE
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--------NFHAKV 415 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--------~~~vkL 415 (615)
+||||+++++|.+++.. ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++. ++.+||
T Consensus 83 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999999963 35899999999999999999999998666899999999999986 678999
Q ss_pred EeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 416 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
+|||+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..
T Consensus 158 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~-------- 222 (271)
T 3dtc_A 158 TDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AV-------- 222 (271)
T ss_dssp CCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HH--------
T ss_pred ccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH--------
Confidence 99999986644321 2457999999999999999999999999999999999999999643211 00
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.............+......+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 -----AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011111111222333345688999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=366.77 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=205.0
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++. +....++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE--TEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEE
Confidence 46899999999999999999996 5789999999975432 23457889999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999964 235899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||.... .......+....
T Consensus 165 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~----- 230 (328)
T 3fe3_A 165 TVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGK----- 230 (328)
T ss_dssp SSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-----
T ss_pred CCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-----
Confidence 54332 2445799999999999988775 89999999999999999999997432 111111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
. ..+......+.+++.+||+.||.+|||+.|++++-
T Consensus 231 -----~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 231 -----Y--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp -----C--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred -----C--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 1 11222334578999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.93 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=199.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--------------------------chHHHHHHHHHHh
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--------------------------GDKEFLVEVEMLS 320 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--------------------------~~~~f~~Ei~~l~ 320 (615)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999964 6899999998754311 1356899999999
Q ss_pred hccCCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccC
Q 007160 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF 400 (615)
Q Consensus 321 ~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 400 (615)
+++||||+++++++........++||||+++|+|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986556689999999999999987642 35899999999999999999999999 999999
Q ss_pred CCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCc---CCchhhHHHHHHHHHHHHhCCCCCC
Q 007160 401 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVD 477 (615)
Q Consensus 401 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwS~GvvL~ElltG~~Pf~ 477 (615)
||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654322 223457999999999987655 4789999999999999999999996
Q ss_pred CCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 478 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 478 ~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
... ...+....... .............+.+++.+||+.||++|||+.|+++|-
T Consensus 242 ~~~------~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 242 DER------IMCLHSKIKSQ----------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp CSS------HHHHHHHHHHC----------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred Ccc------HHHHHHHHhcc----------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 432 11111111110 000000111223588999999999999999999998763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.72 Aligned_cols=279 Identities=30% Similarity=0.417 Sum_probs=215.8
Q ss_pred CcccceeeeccCceEEEEEEEC-----CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.|++.+.||+|+||.||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++...+....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3489999999999999998753 688999999986532 2346799999999999999999999999876567889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999974 24899999999999999999999999 99999999999999999999999999988
Q ss_pred CCCCCcc-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 424 APEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 424 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+..... ....+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHHHH
Confidence 7654322 12334568889999999999999999999999999999999999986321100 00000000000 001112
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcCCC
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP 558 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~~~~ 558 (615)
...........+......+.+|+.+||+.||++|||+.|+++.|+.+.+....+.|
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 22222222233344445689999999999999999999999999999887765443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=383.70 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=211.7
Q ss_pred HHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 265 KEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 265 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++. ....++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~l 259 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYI 259 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEE
Confidence 33467899999999999999999999888999999998643 44688999999999999999999999985 346899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.++++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 260 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999997421 235888999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..... .......+|..|+|||++....++.++|||||||+||||++ |+.||...... .+... +...
T Consensus 335 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----i~~~----- 401 (454)
T 1qcf_A 335 EDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERG----- 401 (454)
T ss_dssp CCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----HHHT-----
T ss_pred CCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcC-----
Confidence 54221 11233457889999999999999999999999999999999 99999643211 11111 1110
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.....+......+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 402 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 -----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0111223334568899999999999999999999999987644
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=350.29 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=206.1
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||.||+|+.. ++.||||++..... ...+.|.+|++++++++||||+++++++...+....++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57899999999999999999985 78899999986542 2345799999999999999999999999866557889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.++++... ...+++..++.++.|+++||+|||+.+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~~-i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSSSC-CTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCCCc-eecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999998532 23589999999999999999999987643 99999999999999999999999998765322
Q ss_pred CCccccceeeccccccCCccccccCcCCc---hhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~---ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||...... .......
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~-------- 224 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVA-------- 224 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHH--------
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHH--------
Confidence 2346899999999998765544 899999999999999999999643211 1111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
........+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 225 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 225 --LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111222333445889999999999999999999999998874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=366.28 Aligned_cols=277 Identities=28% Similarity=0.377 Sum_probs=215.8
Q ss_pred hcCcccceeeeccCceEEEEEEE-----CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++|+||+++++++...+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999984 3688999999987655556779999999999999999999999876666778
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999742 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-hhhccchh
Q 007160 423 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR-PILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~-~~~~~~~~ 500 (615)
........ .......||..|+|||++.+..++.++||||||+++|||++|+.||....... ...+.. ........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALSR 252 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC----CCHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhcccccccccHHH
Confidence 77544322 12234568889999999999999999999999999999999999985321100 000000 00000011
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
+............+......+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11122222222334444556899999999999999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=361.23 Aligned_cols=266 Identities=25% Similarity=0.406 Sum_probs=212.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC--------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 337 (615)
.++|++.+.||+|+||.||+|+.. ++..||||++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence 468999999999999999999863 467899999975432 2346789999999999 8999999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCC------------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGV------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
+....++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 445789999999999999999754321 234899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~ 484 (615)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 999999999999999987765433223344567889999999999999999999999999999999 9999964321
Q ss_pred chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 485 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
..+... +... ... ..+......+.+++.+||+.||.+||++.|++++|+.+.+....
T Consensus 266 ~~~~~~----~~~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 EELFKL----LKEG------HRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHH----HHHT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHH----HhcC------CCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 111111 1000 011 11222334588999999999999999999999999998876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.64 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=195.9
Q ss_pred HhcCcccceeeeccCceEEEEEEECC-C---cEEEEEEeccC--CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSD-G---TAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
..++|++.+.||+|+||.||+|+... + ..||||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999999643 3 27999999754 233457899999999999999999999998743321
Q ss_pred ----ceeEEEecCCCCChhHhhcCCC--CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 341 ----QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 341 ----~~~LV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
..++||||+++|+|.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 2389999999999999995321 11225899999999999999999999999 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~--- 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNY--- 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHH---
Confidence 999999987655433323344567889999999999999999999999999999999 999997543211 1110
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
... .. ....+......+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 252 ~~~----------~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 LIG----------GN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHT----------TC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred Hhc----------CC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 110 00 01122233346889999999999999999999999999887643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=376.11 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=207.0
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+++|++++||||+++++++... ....++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEEEE
Confidence 467899999999999999999985 6899999998543 457899999999999999999999998643 346899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.++++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999997422 234789999999999999999999999 999999999999999999999999999865332
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
. ....+|..|+|||.+.+..++.++|||||||+||||++ |+.||....... ... .+...
T Consensus 343 ~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~-------- 402 (450)
T 1k9a_A 343 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKG-------- 402 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTT--------
T ss_pred c-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcC--------
Confidence 1 22367889999999999999999999999999999998 999997543221 111 11111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.....+......+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1112233334568899999999999999999999999998865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=359.29 Aligned_cols=274 Identities=24% Similarity=0.398 Sum_probs=216.9
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCCCC-chHHHHHHHHHHhhc-cCCCcceEE
Q 007160 260 AYEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLV 331 (615)
Q Consensus 260 ~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l-~HpnIv~l~ 331 (615)
...+.....++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444555678999999999999999999984 34689999999765332 345789999999999 799999999
Q ss_pred EEeecCCCCceeEEEecCCCCChhHhhcCCCCC------------cccCChhhHHHHHHHHHHHHHHhHhCCCCcEEecc
Q 007160 332 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRD 399 (615)
Q Consensus 332 g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 399 (615)
+++.. +....++||||+++|+|.+++...... ...+++..++.++.|+++||.|||+.+ |+|||
T Consensus 98 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 98 GACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEECC-TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEec-CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99864 334689999999999999999764321 123889999999999999999999999 99999
Q ss_pred CCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 007160 400 FKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDM 478 (615)
Q Consensus 400 Ikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~ 478 (615)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987655443333345678999999999999999999999999999999998 9999964
Q ss_pred CCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 479 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 479 ~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
..... .+.. .+... ... ..+......+.+++.+||+.||.+|||+.||+++|+.+.+..
T Consensus 254 ~~~~~--~~~~----~~~~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDE--EFCR----RLKEG------TRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSH--HHHH----HHHHT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhH--HHHH----HhccC------ccC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 43211 1111 11100 011 112222345889999999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=383.70 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=211.0
Q ss_pred HhcCcccceeeeccCceEEEEEEECC-CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
..++|++.+.||+|+||.||+|++.. +..||||++.... ...++|.+|+++|++++||||++++++|. +....+||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCcEEEE
Confidence 35678999999999999999999764 8899999997543 34678999999999999999999999987 44578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.++++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 295 ~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999997422 245899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... .......+|..|+|||++....++.++|||||||+||||++ |+.||...... .+... +.
T Consensus 370 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~-------- 433 (495)
T 1opk_A 370 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LE-------- 433 (495)
T ss_dssp TCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HH--------
T ss_pred CCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH--------
Confidence 4322 12233456789999999999999999999999999999999 99999744321 11111 11
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.......+......+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 434 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 434 --KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11111223334456889999999999999999999999988753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.69 Aligned_cols=272 Identities=24% Similarity=0.370 Sum_probs=205.9
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhc--cCCCcceEEEEeecCCC
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL--HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l--~HpnIv~l~g~~~~~~~ 339 (615)
..-....++|++.+.||+|+||.||+|+.. ++.||||++.. .....+.+|.+++..+ +|+||+++++++.....
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec---cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334445678999999999999999999985 89999999863 2345566677776655 89999999999875432
Q ss_pred --CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC-----CCcEEeccCCCCCeEEcCCCc
Q 007160 340 --SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS-----QPCVIHRDFKASNILLENNFH 412 (615)
Q Consensus 340 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~ 412 (615)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 578999999999999999964 35899999999999999999999881 112999999999999999999
Q ss_pred EEEEeccccccCCCCCcc--ccceeeccccccCCccccccCcCCc------hhhHHHHHHHHHHHHhC----------CC
Q 007160 413 AKVADFGLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLV------KSDVYSYGVVLLELLTG----------RK 474 (615)
Q Consensus 413 vkL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~------ksDVwS~GvvL~ElltG----------~~ 474 (615)
+||+|||+++........ .......||+.|+|||++.+..... ++|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999876543321 1122457999999999998776655 49999999999999999 55
Q ss_pred CCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 475 PVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 475 Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
||......... .... ...+....+....+ .+....+.+++.+||+.||++|||+.||+++|+.+
T Consensus 261 p~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 261 PYHDLVPSDPS-YEDM----------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTTSCSSCC-HHHH----------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cHhhhcCCCCc-hhhh----------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 55433222111 0000 00111111222222 25667799999999999999999999999999998
Q ss_pred Hhhh
Q 007160 550 QRVI 553 (615)
Q Consensus 550 ~~~~ 553 (615)
.+..
T Consensus 330 ~~~~ 333 (337)
T 3mdy_A 330 SESQ 333 (337)
T ss_dssp HHTT
T ss_pred Hhhc
Confidence 7653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.69 Aligned_cols=255 Identities=22% Similarity=0.363 Sum_probs=200.8
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccC--CCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||++...+++.||||++...... ..+.+.+|+++|.+++| +||+++++++. +....+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe--eCCEEE
Confidence 4679999999999999999999888999999999754332 23678999999999976 99999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||| +.+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 86 lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9999 568899999975 235899999999999999999999999 99999999999997 57899999999987
Q ss_pred CCCCCccccceeeccccccCCcccccc-----------CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~----- 227 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QI----- 227 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HH-----
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----HH-----
Confidence 765443333445679999999999865 6789999999999999999999999963221 00
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..+..+.++.....++......+.+|+.+||+.||.+|||+.|++++.+.
T Consensus 228 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 228 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp ------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 11222333333333343334568899999999999999999999998664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=351.31 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=211.4
Q ss_pred HhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..++|++.+.||+|+||.||+|...++..||||.+.... ...+.+.+|++++++++||||+++++++. ....++||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~ 86 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYIIT 86 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc---CCCcEEEE
Confidence 346899999999999999999999888899999997543 34678999999999999999999999975 23589999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp ECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999997421 235899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .+. .. .
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---~~~-~~------~ 227 (279)
T 1qpc_A 162 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ---NLE-RG------Y 227 (279)
T ss_dssp SCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH---HHH-TT------C
T ss_pred cccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHH---HHh-cc------c
Confidence 3321 1233457889999999999999999999999999999999 99999643211 1111 110 00 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
.. ..+......+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 228 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 228 RM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 11 11222334588999999999999999999999999998765443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.54 Aligned_cols=272 Identities=25% Similarity=0.375 Sum_probs=208.6
Q ss_pred cCcccceeeeccCceEEEEEEE-----CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
+.|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++|+||+++++++...+....
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4689999999999999999984 368899999997543 3345789999999999999999999999986655678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999532 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc--cch
Q 007160 423 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR--DKD 499 (615)
Q Consensus 423 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~--~~~ 499 (615)
........ .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.... ............ ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----ALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hHHhhccCCcccccCHH
Confidence 77654322 22334568889999999999999999999999999999999999864211 000000000000 000
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.+............+......+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111111112233334456889999999999999999999999998875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.05 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=205.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++. +....+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE--eCCEEE
Confidence 367999999999999999999965 6899999999753 2334567899999999999999999999987 445899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 99999999999999964 235899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 155 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~------ 220 (337)
T 1o6l_A 155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILME------ 220 (337)
T ss_dssp SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC------
T ss_pred cccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcC------
Confidence 433221 23456799999999999999999999999999999999999999964321 1111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
.. .++......+.+++.+||+.||++|| ++.||++|-
T Consensus 221 ----~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 221 ----EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ----CC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----CC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 11 12222334588999999999999999 899998874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.85 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=202.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+.. +++.||+|++....... .+.|.+|++++++++||||+++++++. +....+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--EDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eCCeEE
Confidence 467999999999999999999964 68999999986543322 357899999999999999999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999999964 235899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-hhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRLE 502 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l~ 502 (615)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ....
T Consensus 161 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 233 (294)
T 4eqm_A 161 LSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVPNVT 233 (294)
T ss_dssp C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCCCHH
T ss_pred ccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCCCcc
Confidence 6543221 223457999999999999999999999999999999999999999743211 1111111110 0000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQ 550 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-sm~eVl~~L~~i~ 550 (615)
......+ ...+.+++.+||+.||++|| +++++.+.|+.+.
T Consensus 234 ----~~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 ----TDVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ----HHSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ----hhcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0111122 34588999999999999998 8999988877653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=347.24 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=209.7
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++. +....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCeEEEEe
Confidence 357899999999999999999998889999999986543 3578999999999999999999999987 4457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++++|.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999743 235889999999999999999999999 999999999999999999999999999876432
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
.. .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ...+...
T Consensus 158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~---~~~i~~~--------- 221 (267)
T 3t9t_A 158 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EV---VEDISTG--------- 221 (267)
T ss_dssp HH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHHHTT---------
T ss_pred cc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HH---HHHHhcC---------
Confidence 11 11223457889999999999999999999999999999999 89999743211 11 1111100
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.....+......+.+++.+||+.||++||++.+++++|+.+.+
T Consensus 222 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 222 --FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011122223458899999999999999999999999998865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=350.14 Aligned_cols=255 Identities=32% Similarity=0.574 Sum_probs=203.5
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCch-------HHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD-------KEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~-------~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|+. .+++.||||++........ +.+.+|++++++++||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 36899999999999999999997 4789999999975443221 678999999999999999999999853
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc-----EE
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AK 414 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vk 414 (615)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+.+ |+||||||+|||++.++. +|
T Consensus 95 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~-ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 95 -PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -TTEEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSSSC-CBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -CCeEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCCCC-eecCCCCcceEEEeccCCCCceeEE
Confidence 237999999999999998653 23589999999999999999999998643 999999999999988776 99
Q ss_pred EEeccccccCCCCCccccceeeccccccCCcccc--ccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA--MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
|+|||+++..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||......... +..
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~ 240 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FIN 240 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHH
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHH
Confidence 9999999854332 2346799999999998 4556789999999999999999999999754322111 000
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.+.........+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 241 ----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 ----------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 01111111222333345688999999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=358.07 Aligned_cols=255 Identities=23% Similarity=0.404 Sum_probs=199.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCC------
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS------ 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~------ 339 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999976 789999999975443 345789999999999999999999998864322
Q ss_pred -------------------------------------------------CceeEEEecCCCCChhHhhcCCCCCcccCCh
Q 007160 340 -------------------------------------------------SQHLLCYELVPNGSLESWLHGPLGVNCHLDW 370 (615)
Q Consensus 340 -------------------------------------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~ 370 (615)
...++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 137999999999999999986432 344677
Q ss_pred hhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCcc----------ccceeecccc
Q 007160 371 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN----------YLSTRVMGTF 440 (615)
Q Consensus 371 ~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~gt~ 440 (615)
..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 789999999999999999999 999999999999999999999999999877654211 1223457999
Q ss_pred ccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHH
Q 007160 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIR 520 (615)
Q Consensus 441 ~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~ 520 (615)
.|+|||++.+..++.++|||||||++|||++|..|+.. ..... ........ ..........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~----------~~~~~~~~-~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRII----------TDVRNLKF-PLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHH----------HHHHTTCC-CHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHH----------HHhhccCC-CcccccCChh
Confidence 99999999999999999999999999999998766420 00000 00101000 0001122345
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 007160 521 VCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 521 l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.+++.+||+.||++|||+.|++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7889999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=350.74 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=197.0
Q ss_pred hcCcccceeeeccCceEEEEEEECC----CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|.... +..||+|++..... ...+.+.+|+.++++++||||+++++++. ....
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc---cCcc
Confidence 4689999999999999999999642 45799999875432 23467899999999999999999999974 3468
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 9999999999999999742 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
....... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||...... ..... +.
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~---i~------ 231 (281)
T 1mp8_A 165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---IE------ 231 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---HH------
T ss_pred ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH---HH------
Confidence 7654322 12234467889999999999999999999999999999997 99999754321 11111 00
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
... ....+......+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 232 ----~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 232 ----NGE-RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ----TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000 0112223334588999999999999999999999999988654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=377.78 Aligned_cols=258 Identities=30% Similarity=0.444 Sum_probs=205.1
Q ss_pred HhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.. ...++||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEe
Confidence 456789999999999999999999888889999998544 346789999999999999999999999863 4689999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.++++... ...+++..++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 258 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999996421 235899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... ......+|..|+|||.+....++.++||||||++||||++ |+.||...... .... . +...
T Consensus 333 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~---~-i~~~------- 397 (452)
T 1fmk_A 333 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---Q-VERG------- 397 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH---H-HHTT-------
T ss_pred Ccee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HHcC-------
Confidence 3211 2233457889999999999999999999999999999999 99999643211 1111 0 1110
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.....+......+.+|+.+||+.||++|||+++|++.|+.+..
T Consensus 398 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 398 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1112233344568899999999999999999999999887654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=357.04 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=201.1
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||+||+|+..+|+.||||++...... ..+.+.+|++++++++||||+++++++. +....++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH--SERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC--CSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc--cCCEEEEE
Confidence 4789999999999999999999988999999999754322 2467899999999999999999999987 45589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||++ |+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99997 4888888653 235899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc------
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------ 498 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------ 498 (615)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..... .+...
T Consensus 171 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~-~~~~~~~~~~~ 245 (311)
T 3niz_A 171 IPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFS-ILGTPNPREWP 245 (311)
T ss_dssp SCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHH-HHCCCCTTTSG
T ss_pred CCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHH-HHCCCChHHhh
Confidence 3322 2234578999999999876 56899999999999999999999999754433221 11110 00000
Q ss_pred --hhhhhhcCCccC--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 --DRLEELADPRLG--GKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 --~~l~~i~d~~l~--~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+....+.... ...+ ......+.+|+.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000000 0000 1112357899999999999999999999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.49 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC------chHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||.||+++.. +|+.||||.+...... ..+.+.+|+++|++++||||+++++++. +..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE--NRT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE--eCC
Confidence 467999999999999999999975 6899999999765322 2467999999999999999999999987 456
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC----cEEEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA 416 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~ 416 (615)
..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence 89999999999999999965 345899999999999999999999999 99999999999998776 79999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..
T Consensus 162 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~ 232 (361)
T 2yab_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITA 232 (361)
T ss_dssp CCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHT
T ss_pred ecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh
Confidence 9999987755322 23457999999999999999999999999999999999999999643211 11111111
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..... ++..... ....+.+++.+||+.||++|||+.|+++|-
T Consensus 233 ~~~~~----~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 233 VSYDF----DEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp TCCCC----CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred cCCCC----CchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 10000 0000011 123578999999999999999999999763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.45 Aligned_cols=265 Identities=18% Similarity=0.217 Sum_probs=210.6
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||.+..... .+.+.+|+++++++ +|+||+++++++.. ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEE
Confidence 46899999999999999999995 5789999999875432 34688999999999 99999999999874 4578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc-----EEEEeccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AKVADFGL 420 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vkL~DFGl 420 (615)
|||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9999 99999999743 246999999999999999999999999 999999999999998887 99999999
Q ss_pred cccCCCCCccc-----cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 421 AKQAPEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 421 a~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. +.
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~ 233 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK---IG 233 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH---HH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH---HH
Confidence 98764432211 12356799999999999999999999999999999999999999976543322111111 11
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
.... ......+...++ .+.+++.+||+.||.+||++.+|++.|+.+.+...
T Consensus 234 ~~~~---~~~~~~~~~~~p-----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 234 DTKR---ATPIEVLCENFP-----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHH---HSCHHHHTTTCH-----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hhhc---cCCHHHHhccCh-----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1000 000000111112 58899999999999999999999999998876654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.13 Aligned_cols=259 Identities=31% Similarity=0.462 Sum_probs=200.3
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++||||+++++++. + ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C--CcEEEEEc
Confidence 57889999999999999999985 688999998643 34578999999999999999999999875 2 47999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc-EEEEeccccccCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-AKVADFGLAKQAPEG 427 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-vkL~DFGla~~~~~~ 427 (615)
+++|+|.++++... ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999997532 1234788999999999999999999932223999999999999988876 799999999765432
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....|. ... ...+
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~--~~~-------~~~~ 223 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWA--VHN-------GTRP 223 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHH--HHT-------TCCC
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHH--Hhc-------CCCC
Confidence 123469999999999999999999999999999999999999997433211 111111 000 0011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
.....+ ...+.+++.+||+.||++|||+.|++++|+.+.+....
T Consensus 224 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PLIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CCBTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred Cccccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 111222 33588999999999999999999999999998776543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=357.53 Aligned_cols=276 Identities=27% Similarity=0.392 Sum_probs=213.3
Q ss_pred hcCcccceeeeccCceEEEEEEE-----CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++|+||+++++++...+....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45789999999999999999984 3688999999987665556789999999999999999999999876555678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999753 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc---c
Q 007160 423 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD---K 498 (615)
Q Consensus 423 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~ 498 (615)
......... ......+|..|+|||.+.+..++.++||||||+++|||++|..|+.... ............. .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~----~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP----AEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH----HHHHHHHCTTCCTHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH----HHHHHhhccccchhhhH
Confidence 776543221 1233457888999999999999999999999999999999999875221 0000000000000 0
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
..+............+......+.+++.+||+.||++|||+.||++.|+.+.+.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0011111111111223334456899999999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=347.78 Aligned_cols=267 Identities=18% Similarity=0.210 Sum_probs=211.8
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+++++++ +|+|++++++++. +....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCceeEEE
Confidence 46799999999999999999995 578999999987443 335688999999999 7999999999987 44588999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc-----EEEEeccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AKVADFGL 420 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vkL~DFGl 420 (615)
|||+ +++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 99999999743 235899999999999999999999998 999999999999987766 99999999
Q ss_pred cccCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 421 AKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 421 a~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--- 234 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG--- 234 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH---
Confidence 9876543221 12245679999999999999999999999999999999999999997654332222111111
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
.... ....+.+...++ ..+.+++.+||+.||++||++++|++.|+.+.+....
T Consensus 235 ~~~~---~~~~~~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 235 EKKQ---STPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHH---HSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhcc---CccHHHHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 0000 000011111233 3588999999999999999999999999998776543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.71 Aligned_cols=275 Identities=24% Similarity=0.405 Sum_probs=202.1
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHH--hhccCCCcceEEEEee---cCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEML--SRLHHRNLVKLVGYYS---SRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l--~~l~HpnIv~l~g~~~---~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++ ..++|+||+++++++. ..+....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 5799999999732 345556665554 4589999999998653 2233467
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC---------CCCcEEeccCCCCCeEEcCCCcE
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---------SQPCVIHRDFKASNILLENNFHA 413 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~---------~~~~ivHrDIkp~NILl~~~~~v 413 (615)
++||||+++|+|.+++.. ...++..++.++.|+++||+|||+. + |+||||||+|||++.++.+
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 899999999999999964 2358899999999999999999998 6 9999999999999999999
Q ss_pred EEEeccccccCCCCCc------cccceeeccccccCCcccccc-------CcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 414 KVADFGLAKQAPEGRT------NYLSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 414 kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987653221 111234569999999999886 466789999999999999999988774332
Q ss_pred CCCcc--hhhHhhhhhhccchhhh-hhcCCccCCCCC------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 481 PSGQE--NLVTWARPILRDKDRLE-ELADPRLGGKYP------KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 481 ~~~~~--~l~~~~~~~~~~~~~l~-~i~d~~l~~~~~------~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
..... .+....... .....+. .+........++ ......+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNH-PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCCTTHHHHCSS-CCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCC-chHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 21111 000000000 0000000 011111111111 2345579999999999999999999999999999887
Q ss_pred hhhc
Q 007160 552 VIEC 555 (615)
Q Consensus 552 ~~~~ 555 (615)
..+.
T Consensus 319 ~~~~ 322 (336)
T 3g2f_A 319 IWER 322 (336)
T ss_dssp CCCC
T ss_pred HHHh
Confidence 5544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=352.78 Aligned_cols=271 Identities=25% Similarity=0.402 Sum_probs=212.7
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhh--ccCCCcceEEEEeec
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSS 336 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~HpnIv~l~g~~~~ 336 (615)
..........++|++.+.||+|+||.||+|+. +|+.||||++.. ...+.+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34444455677899999999999999999998 489999999963 345678899999987 789999999999875
Q ss_pred CCC--CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhH--------hCCCCcEEeccCCCCCeE
Q 007160 337 RDS--SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--------EDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 337 ~~~--~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH--------~~~~~~ivHrDIkp~NIL 406 (615)
.+. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+|||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence 432 278999999999999999974 35899999999999999999999 667 999999999999
Q ss_pred EcCCCcEEEEeccccccCCCCCccc--cceeeccccccCCccccccC------cCCchhhHHHHHHHHHHHHhC------
Q 007160 407 LENNFHAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTG------ 472 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~GvvL~ElltG------ 472 (615)
++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 9999999999999998765433211 22345799999999998765 345799999999999999999
Q ss_pred ----CCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 007160 473 ----RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVV 543 (615)
Q Consensus 473 ----~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl 543 (615)
+.||........ ....+.. .+....+....+ .+....+.+|+.+||+.||++|||+.||+
T Consensus 260 ~~~~~~p~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDP-SVEEMRK----------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp CCCCCCTTTTTSCSSC-CHHHHHH----------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ccccccCccccCcCcc-cHHHHHH----------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 677754332211 1111111 111111222222 35566799999999999999999999999
Q ss_pred HHHHHhHhh
Q 007160 544 QSLKMVQRV 552 (615)
Q Consensus 544 ~~L~~i~~~ 552 (615)
++|+.+.+.
T Consensus 329 ~~L~~i~~~ 337 (342)
T 1b6c_B 329 KTLSQLSQQ 337 (342)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHH
Confidence 999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=359.14 Aligned_cols=259 Identities=28% Similarity=0.456 Sum_probs=201.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCc----EEEEEEeccC-CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
.++|++.+.||+|+||.||+|+.. +++ .||+|.+... .....+.+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---C
Confidence 367999999999999999999964 444 3578877643 334567899999999999999999999998742 4
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++++||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 78999999999999999743 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
+...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +... +
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~----- 232 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----L----- 232 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----H-----
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----H-----
Confidence 87755443333344567889999999999999999999999999999999 999997543221 1111 1
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
........+......+.+++.+||+.||.+||++.|+++.|+.+.+.
T Consensus 233 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 233 -----EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11111112233344588999999999999999999999999988754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.81 Aligned_cols=269 Identities=26% Similarity=0.392 Sum_probs=200.8
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
...++|.+.+.||+|+||.||+|... ++..||||++...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34678999999999999999999854 3458999999755332 23678999999999999999999999875433
Q ss_pred C---ceeEEEecCCCCChhHhhcCCC--CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 340 S---QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 340 ~---~~~LV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
. ..++||||+++|+|.+++.... .....+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 2 4599999999999999984321 22346899999999999999999999998 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~--- 261 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY--- 261 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH---
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH---
Confidence 999999987654432222334567889999999999999999999999999999999 888986443211 1111
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
.... . ....+......+.+++.+||+.||++|||+.+++++|+.+.+.++
T Consensus 262 ~~~~-------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 262 LLHG-------H----RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHTT-------C----CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHcC-------C----CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1100 0 011122233458899999999999999999999999999877543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=357.60 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=203.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC------chHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|++++++++||||+++++++. +..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCC
Confidence 356999999999999999999975 6899999999754322 3567999999999999999999999987 455
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC----cEEEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA 416 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~ 416 (615)
..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 89999999999999999974 345899999999999999999999999 99999999999998887 89999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+..
T Consensus 161 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~~~~ 231 (326)
T 2y0a_A 161 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANVSA 231 (326)
T ss_dssp CCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHH
T ss_pred ECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HH---HHHHHh
Confidence 9999987754322 23457999999999999999999999999999999999999999643211 11 110100
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
... .............+.+++.+||+.||++|||+.|++++-
T Consensus 232 ~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 232 VNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp TCC--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred cCC--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 000 000000011123578999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=351.66 Aligned_cols=260 Identities=27% Similarity=0.477 Sum_probs=194.8
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|+..+ .||||++...... ..+.|.+|++++++++|+||+++++++. ....++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEEE
Confidence 4679999999999999999998643 5999999755432 3467999999999999999999999764 3468999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999643 345899999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
............||+.|+|||.+. ...++.++||||||+++|||++|+.||...... ..+.... ...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~~---- 241 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMV----GRG---- 241 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHH----HHT----
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHh----ccc----
Confidence 433222334567999999999986 667889999999999999999999999643321 1111111 100
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
...+.+ ..........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 242 -~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 242 -SLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -SCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -ccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 001111 1112223346889999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=347.31 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=211.4
Q ss_pred hcCcccce-eeeccCceEEEEEEEC---CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPAS-ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|.+.+ .||+|+||.||+|.+. ++..||||++..... ...+.+.+|++++++++||||+++++++. ....
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCCc
Confidence 35666766 9999999999999853 578899999986532 23567999999999999999999999984 2368
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp EEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccccee
Confidence 9999999999999999642 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 423 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i----~~~-- 229 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----EQG-- 229 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH----HTT--
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----hcC--
Confidence 775433221 1223457899999999998999999999999999999998 99999643321 111111 000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcC
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 556 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~~ 556 (615)
.....+......+.+++.+||+.||++||++.+++++|+.+.......
T Consensus 230 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 230 --------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred --------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 011222333446889999999999999999999999999998766543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=360.31 Aligned_cols=246 Identities=24% Similarity=0.286 Sum_probs=192.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.++||+|+||+||+|+.. +|+.||||++...... ....+..|+..+.++ +|+||++++++|. +....+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~--~~~~~~ 133 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE--EGGILY 133 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE--eCCEEE
Confidence 367999999999999999999976 7899999998754332 234566677666666 8999999999997 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+ +++|.+++... ...++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 134 lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999 77999988642 235999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ..... +..
T Consensus 207 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~-----~~~------ 266 (311)
T 3p1a_A 207 LGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQ-----LRQ------ 266 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHH-----HTT------
T ss_pred cccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHH-----Hhc------
Confidence 65432 2234569999999998875 7899999999999999999997766421 11110 000
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......+......+.+++.+||+.||++|||+.|++++
T Consensus 267 ---~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 267 ---GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 000000011122458899999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.61 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=206.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|++++++++||||+++++++.. ....++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEEEE
Confidence 468999999999999999999965 68899999987442 335678899999999999999999999874 45899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC--CCcEEEEeccccccC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~ 424 (615)
||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999999999999742 235899999999999999999999999 999999999999987 789999999999887
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~--- 222 (321)
T 1tki_A 155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTF--- 222 (321)
T ss_dssp CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC---
T ss_pred CCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCCC---
Confidence 55432 34567999999999999988999999999999999999999999743211 1111111110000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
+......+ ...+.+++.+||+.||.+|||+.|++++-+.
T Consensus 223 -~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 223 -DEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp -CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -ChhhhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 00000111 2357899999999999999999999998654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=360.65 Aligned_cols=268 Identities=26% Similarity=0.405 Sum_probs=211.4
Q ss_pred HHHhcCcccceeeeccCceEEEEEEECC------CcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeec
Q 007160 265 KEATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS 336 (615)
Q Consensus 265 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~ 336 (615)
....++|++.+.||+|+||.||+|.... ...||+|.+..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT- 120 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-
Confidence 3346789999999999999999999642 24799999975533 2346789999999999 8999999999987
Q ss_pred CCCCceeEEEecCCCCChhHhhcCCCC----------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeE
Q 007160 337 RDSSQHLLCYELVPNGSLESWLHGPLG----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 337 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~----------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NIL 406 (615)
+....++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 121 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 121 -HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred -cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 44578999999999999999963210 1235789999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007160 407 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE 485 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~ 485 (615)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 99999999999999986654433223344567889999999999999999999999999999999 999997443211
Q ss_pred hhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 486 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.+.. ..... .....+......+.+++.+||+.||.+|||+.||+++|+.+.+..
T Consensus 275 ~~~~----~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 275 KFYK----LVKDG----------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHH----HHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHH----HHhcC----------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 11110 011112222345889999999999999999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=350.37 Aligned_cols=263 Identities=25% Similarity=0.353 Sum_probs=198.8
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++. +....++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc--cCCeEEEEE
Confidence 57999999999999999999998899999999975432 22467899999999999999999999987 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp ECCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 99975 999998753 235889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch-----h
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-----R 500 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~-----~ 500 (615)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..... ...... .
T Consensus 153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~~~~~~~~~~~ 227 (288)
T 1ob3_A 153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFR-ILGTPNSKNWPN 227 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH-HHCCCCTTTSTT
T ss_pred ccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH-HHCCCChhhchh
Confidence 221 1234578999999999876 45899999999999999999999999743311 11111110 000000 0
Q ss_pred hhh--hcCCccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 501 LEE--LADPRLG-------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 501 l~~--i~d~~l~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... ..++... ..........+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0011100 00111223457899999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=348.88 Aligned_cols=261 Identities=26% Similarity=0.379 Sum_probs=213.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
..++|++.+.||+|+||.||+|... ++..||||.+... ....+.+.+|++++++++||||+++++++. +....++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCEEEE
Confidence 4578999999999999999999976 4889999999753 334578999999999999999999999987 45578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999997532 345899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... ..... .
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~----------~-- 226 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----------E-- 226 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----------H--
T ss_pred CCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----------h--
Confidence 4332 12234567889999999999999999999999999999999 999997543211 11111 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.......+......+.+++.+||+.||.+|||+.|+++.|+.+.+..
T Consensus 227 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 227 --KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111222233346889999999999999999999999999876643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=363.06 Aligned_cols=275 Identities=17% Similarity=0.216 Sum_probs=208.8
Q ss_pred HhcCcccceeeeccCceEEEEEEECC------CcEEEEEEeccCCCCc-----------hHHHHHHHHHHhhccCCCcce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQG-----------DKEFLVEVEMLSRLHHRNLVK 329 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~~-----------~~~f~~Ei~~l~~l~HpnIv~ 329 (615)
..++|++.+.||+|+||.||+|.+.+ ++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999754 4789999987543211 112344555667778999999
Q ss_pred EEEEeecCC--CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE
Q 007160 330 LVGYYSSRD--SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL 407 (615)
Q Consensus 330 l~g~~~~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl 407 (615)
+++++.... ....+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 999987532 24589999999 99999999752 245999999999999999999999998 9999999999999
Q ss_pred c--CCCcEEEEeccccccCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 408 E--NNFHAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 408 ~--~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
+ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999876432211 11133459999999999999999999999999999999999999997432
Q ss_pred CCCcchhhHhhhhhhccchhhhhhcCCccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhcC
Q 007160 481 PSGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 556 (615)
Q Consensus 481 ~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~~ 556 (615)
.. .....+..... ...+..+.++.+. ..++ ..+.+++.+||+.||++||++.+|++.|+.+.+.....
T Consensus 266 ~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 266 KD--PKYVRDSKIRY--RENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp TC--HHHHHHHHHHH--HHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cC--HHHHHHHHHHh--hhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 21 12222221111 1223333333322 2233 35889999999999999999999999999987765443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=362.75 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=204.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC-----CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
.+.|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 457999999999999999999964 6899999998532 12245789999999999999999999999874 458
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc---EEEEec
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADF 418 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~DF 418 (615)
.++||||+++|+|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999888643222335899999999999999999999999 999999999999976554 999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+ ...+....
T Consensus 178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~---~~~i~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL---FEGIIKGK 248 (351)
T ss_dssp TTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH---HHHHHHTC
T ss_pred cceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH---HHHHHcCC
Confidence 99987755322 2344679999999999999999999999999999999999999997421 111 11111110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
... .+.....+ ...+.+|+.+||+.||++|||+.|++++-+
T Consensus 249 ~~~----~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 249 YKM----NPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp CCC----CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCC----CccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 000 00000112 235789999999999999999999998744
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.59 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEECC----CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|++.+ +..||||.+..... ...+.|.+|++++++++||||+++++++.. ...
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCC
Confidence 4689999999999999999998643 34699999976532 335679999999999999999999999752 356
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 8999999999999999642 234899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..... ...
T Consensus 162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~--- 230 (281)
T 3cc6_A 162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKG--- 230 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHT---
T ss_pred ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcC---
Confidence 7654322 12234567889999999999999999999999999999998 999996433211 11110 000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
... ..+......+.+++.+||+.||++||++.|++++|+.+.+..
T Consensus 231 ---~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 231 ---DRL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 001 112222345889999999999999999999999999887653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.71 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=199.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 57999999999999999999975 6899999999755432 24678999999999999999999999874 4589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EECCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 999975 666655432 245899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCc-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-----h
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-----D 499 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-----~ 499 (615)
.... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||...... ...+..... ..... .
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~-~~~~~~~~~~~ 228 (292)
T 3o0g_A 153 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFR-LLGTPTEEQWP 228 (292)
T ss_dssp SCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHH-HHCCCCTTTCT
T ss_pred Cccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHH-HhCCCChhhhh
Confidence 4322 224457899999999998765 799999999999999999999886432211 111111111 00000 0
Q ss_pred hhhhhcCCc---------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 500 RLEELADPR---------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 500 ~l~~i~d~~---------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
......+.. ............+.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000 0001112233457899999999999999999999876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=365.84 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=200.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCc
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 341 (615)
..++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|.+++..+ +||||+++++++. +...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ--TPDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE--eCCE
Confidence 3478999999999999999999965 6899999999743 123346688999999988 7999999999987 4558
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999999974 245899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 172 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~----- 238 (353)
T 3txo_A 172 KEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILN----- 238 (353)
T ss_dssp BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-----
T ss_pred eecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHc-----
Confidence 86433221 23456799999999999999999999999999999999999999974321 111111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQSL 546 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm------~eVl~~L 546 (615)
... .++......+.+++.+||+.||++||++ .|+++|-
T Consensus 239 -----~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 239 -----DEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp -----CCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred -----CCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 111 1222233458899999999999999998 7787763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.16 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=199.7
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCC--CchHHHHHHHHHHhhcc--CCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||++...+++.||||++..... ...+.+.+|+++|++++ |+||+++++++.. ....++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEE
Confidence 46999999999999999999988899999999975433 23467999999999996 5999999999874 457999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 134 v~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 5688999999752 35888999999999999999999998 99999999999996 579999999999877
Q ss_pred CCCCccccceeeccccccCCcccccc-----------CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
.............||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... .
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~----- 274 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I----- 274 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H-----
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H-----
Confidence 55433333345679999999999865 46899999999999999999999999643210 0
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..+..+.++.....++......+.+|+.+||+.||++|||+.|++++-+.
T Consensus 275 -----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 275 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp -----HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -----HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 11222233322222333333468899999999999999999999988654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=357.13 Aligned_cols=268 Identities=26% Similarity=0.423 Sum_probs=211.3
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEe
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYY 334 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~ 334 (615)
++.....++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556788999999999999999999854 367899999975432 2345689999999999999999999998
Q ss_pred ecCCCCceeEEEecCCCCChhHhhcCCC------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc
Q 007160 335 SSRDSSQHLLCYELVPNGSLESWLHGPL------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE 408 (615)
Q Consensus 335 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 408 (615)
. +....++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 98 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 98 S--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp C--SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred c--cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 7 4457899999999999999996421 01134789999999999999999999999 99999999999999
Q ss_pred CCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 007160 409 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENL 487 (615)
Q Consensus 409 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l 487 (615)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~ 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQV 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHH
Confidence 999999999999986644332222334467899999999999999999999999999999999 8899864321 111
Q ss_pred hHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 488 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 488 ~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.. ... .... ...+......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 250 ~~---~~~----------~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LR---FVM----------EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH---HHH----------TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH---HHH----------cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 111 1100 01122233458899999999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.56 Aligned_cols=256 Identities=21% Similarity=0.361 Sum_probs=202.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|..++.++ +||||+++++++. +....
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--ECCEE
Confidence 467999999999999999999975 57899999997542 22335688999999887 8999999999987 45589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
+|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 129 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999999974 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc--chhhHhhhhhhccchh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ--ENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~--~~l~~~~~~~~~~~~~ 500 (615)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+..
T Consensus 202 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~-------- 271 (396)
T 4dc2_A 202 EGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-------- 271 (396)
T ss_dssp CCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--------
T ss_pred ecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--------
Confidence 6433221 23456899999999999999999999999999999999999999964322111 11111111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 545 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm------~eVl~~ 545 (615)
..+....+ .++......+.+|+.+||+.||++||++ .||++|
T Consensus 272 -~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 272 -QVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -HHHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11111111 2233334458899999999999999985 677765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=361.49 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=205.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+..........+.+|+++|++++||||+++++++. +....++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE--eCCEEEEEE
Confidence 468999999999999999999975 68899999997655445567999999999999999999999987 456899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC--CCcEEEEeccccccC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~ 424 (615)
||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 128 E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 128 EFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp ECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceec
Confidence 999999999999742 235899999999999999999999999 999999999999974 578999999999877
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~----~ 268 (387)
T 1kob_A 202 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDW----E 268 (387)
T ss_dssp CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCC----C
T ss_pred CCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC----C
Confidence 5432 22345799999999999999999999999999999999999999974321 111111111000 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.++.. .......+.+++.+||+.||++|||+.|++++-
T Consensus 269 ~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 269 FDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp CCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 01111 112234588999999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=372.23 Aligned_cols=264 Identities=21% Similarity=0.269 Sum_probs=209.1
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeec
Q 007160 261 YEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336 (615)
Q Consensus 261 ~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~ 336 (615)
+.++...+++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|++++..++||||++++++|.
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~- 144 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ- 144 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence 4455566789999999999999999999976 47899999986421 122345889999999999999999999987
Q ss_pred CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEE
Q 007160 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416 (615)
Q Consensus 337 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 416 (615)
+....+|||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 145 -~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 -DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp -CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred -eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 456899999999999999999752 235899999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...
T Consensus 218 DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~ 290 (437)
T 4aw2_A 218 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETY 290 (437)
T ss_dssp CCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH
T ss_pred chhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHH
Confidence 9999987654432 2233468999999999987 567899999999999999999999999743311 111
Q ss_pred hhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 007160 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSL 546 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~L 546 (615)
..++.... .+.-+.....++ ..+.+|+.+||..+|++ ||+++|+++|-
T Consensus 291 ~~i~~~~~---~~~~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 291 GKIMNHKE---RFQFPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHHHTHHH---HCCCCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred Hhhhhccc---cccCCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 11111111 111111111222 34789999999988888 99999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=354.57 Aligned_cols=262 Identities=26% Similarity=0.453 Sum_probs=202.1
Q ss_pred cCcccceeeeccCceEEEEEEECC-----CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
++|++.+.||+|+||.||+|.... +..||||++..... .....+.+|++++++++||||+++++++. +....
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe--cCCCc
Confidence 567888999999999999998642 24699999975432 23457899999999999999999999987 45589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999742 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCc-cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 423 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~----------- 261 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMK----------- 261 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH-----------
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHH-----------
Confidence 7654322 112233456889999999999999999999999999999999 9999964321 11111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
.+.+. .....+......+.+++.+||+.||++||++.+|+++|+.+.+..+.
T Consensus 262 --~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 262 --AINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp --HHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred --HHHCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 01010 01111223344688999999999999999999999999988765443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=362.98 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=203.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++|++++|||||++++++. +....++
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~l 92 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ--DEEDMFM 92 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCEEEE
Confidence 57999999999999999999965 5889999998643 2334567899999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999975 335899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCcccccc---CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.... ..
T Consensus 166 ~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~----- 234 (384)
T 4fr4_A 166 PRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---ET----- 234 (384)
T ss_dssp CTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---HH-----
T ss_pred cCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hh-----
Confidence 5432 2345679999999999874 45899999999999999999999999754433222211111 00
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-m~eVl~~ 545 (615)
. ...++......+.+|+.+||+.||.+||+ +++|.++
T Consensus 235 -----~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 235 -----T--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -----C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -----c--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 0 01122333346889999999999999998 7777654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=362.56 Aligned_cols=276 Identities=21% Similarity=0.300 Sum_probs=215.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+....++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999975 58999999997543 2335678899999999999999999999886666678999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE----cCCCcEEEEecccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA 421 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 421 (615)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999975322 223899999999999999999999999 9999999999999 77888999999999
Q ss_pred ccCCCCCccccceeeccccccCCcccccc--------CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ......
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~ 238 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence 87654322 234579999999998865 56788999999999999999999999643322111 111111
Q ss_pred hhccch--hh---hhhc--------CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 494 ILRDKD--RL---EELA--------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 494 ~~~~~~--~l---~~i~--------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
...... .. .... +.......+......+.+++.+||+.||++||++.|+++.++.+...
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111100 00 0000 00111234466677889999999999999999999999999887653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.72 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=195.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++. +....++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe--eCCEEEEEE
Confidence 468999999999999999999975 789999999975433 3467899999999999999999999987 455899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc--EEEEeccccccC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADFGLAKQA 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~~~ 424 (615)
||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999964 235899999999999999999999999 999999999999987765 999999999754
Q ss_pred CCCCccccceeeccccccCCccccccCcCCch-hhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK-SDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~k-sDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ .........
T Consensus 169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~-------- 235 (361)
T 3uc3_A 169 VLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRIL-------- 235 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHH--------
T ss_pred cccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHh--------
Confidence 3222 2234579999999999988887655 9999999999999999999975432211 111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
...............+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 236 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 236 --SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp --TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred --cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 1111101111122457899999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.50 Aligned_cols=254 Identities=26% Similarity=0.471 Sum_probs=206.6
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeec---------
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS--------- 336 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--------- 336 (615)
...+|++.+.||+|+||.||+|+.. +|+.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999975 78999999997432 467889999999999999999998753
Q ss_pred -----CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 337 -----RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 337 -----~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
......++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 12345799999999999999996422 245899999999999999999999999 99999999999999999
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+... ..+
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~- 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKF- 227 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHH-
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHH-
Confidence 999999999987755332 23456999999999999999999999999999999999999886310 011
Q ss_pred hhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
...+.+..+...++ ..+.+++.+||+.||.+|||+.|++++|+.+.+..+
T Consensus 228 ---------~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 228 ---------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ---------HHHHHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ---------HHHhhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11111222222233 347899999999999999999999999998865443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=383.61 Aligned_cols=258 Identities=30% Similarity=0.439 Sum_probs=209.8
Q ss_pred HhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|+||+++++++.. ...+|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEee
Confidence 456789999999999999999999888889999998654 346789999999999999999999999863 4689999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.++|+... ...+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 341 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999996421 234899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
... .......+|..|+|||++....++.++|||||||+||||++ |+.||...... .+.. .+...
T Consensus 416 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~----~i~~~------- 480 (535)
T 2h8h_A 416 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERG------- 480 (535)
T ss_dssp HHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHH----HHHTT-------
T ss_pred Cce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcC-------
Confidence 211 11223457889999999999999999999999999999999 99999643211 1111 11111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.....+......+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 481 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 481 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1112233334568899999999999999999999999887643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=347.93 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=206.6
Q ss_pred HhcCcccce-eeeccCceEEEEEEE---CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 267 ATNNFEPAS-ILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 267 ~~~~f~~~~-~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
..++|.+.+ .||+|+||.||+|.+ .+++.||||++...... ..+.+.+|++++++++||||+++++++. ..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CC
Confidence 346788888 999999999999964 24688999999755322 2467999999999999999999999984 34
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence 68999999999999999975 235899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 421 AKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 421 a~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+... +...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~ 236 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----LEKG 236 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTT
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcC
Confidence 98775543221 1223456789999999999999999999999999999999 99999743311 11111 1100
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
.....+......+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus 237 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 237 ----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0111223334468899999999999999999999999999876654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=359.13 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=204.5
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
..++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++. +....+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEE
Confidence 4568999999999999999999965 6899999999755332 3357889999999999999999999987 455889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC---CcEEEEeccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFGL 420 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGl 420 (615)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 105 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999999975 235899999999999999999999999 9999999999999765 4599999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ..+......
T Consensus 178 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~---~~i~~~~~~ 248 (362)
T 2bdw_A 178 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY---AQIKAGAYD 248 (362)
T ss_dssp CBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTCCC
T ss_pred ceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhCCCC
Confidence 987654332 2346799999999999999999999999999999999999999964321 1111 111110000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
............+.+|+.+||+.||++||++.|++++-+
T Consensus 249 --------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 249 --------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp --------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred --------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000000122345789999999999999999999998744
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=346.15 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=204.4
Q ss_pred hcCcccceeeeccCceEEEEEEECC----CcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
..+|++.+.||+|+||.||+|+..+ ...||||.+..... ...+.+.+|++++++++||||+++++++.. +....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-CCCce
Confidence 3468889999999999999999642 23689999875433 234678999999999999999999998754 34578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 103 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence 9999999999999999752 245889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc--ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 423 QAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 423 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
........ .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||....... .... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~~-- 248 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQG-- 248 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHTT--
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---HhcC--
Confidence 76543211 122345678899999999999999999999999999999994 55554332211 1110 0100
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
... ..+......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 249 -----~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 249 -----RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -----CCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000 1112223458899999999999999999999999999877543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.73 Aligned_cols=247 Identities=28% Similarity=0.374 Sum_probs=204.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. +....+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE--eCCEEE
Confidence 357999999999999999999975 68999999997431 234567889999999999999999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp EEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCccee
Confidence 99999999999999974 235889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~------- 217 (318)
T 1fot_A 156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN------- 217 (318)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-------
T ss_pred cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-------
Confidence 6432 2345799999999999999999999999999999999999999964321 111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
..+ .++......+.+++.+||+.||++|| +++|+++|-
T Consensus 218 ---~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 218 ---AEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp ---CCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred ---CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 111 12222334588999999999999999 899998763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=342.03 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=204.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++. +....++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE--cCCEEEEE
Confidence 467999999999999999999975 68999999987443 234577999999999999999999999987 44578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999999974 235899999999999999999999999 9999999999999999999999999998664
Q ss_pred CCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
............||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..+..|.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~~~----- 226 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE----KKT----- 226 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHT----TCT-----
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhh----ccc-----
Confidence 3332222345679999999999987765 789999999999999999999997543221 11111111 000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...........+.+++.+||+.||++|||+.|++++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 -----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000011223357899999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=381.18 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=205.9
Q ss_pred cCcccce-eeeccCceEEEEEEEC---CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPAS-ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|++++|||||+++++|.. ...+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeE
Confidence 4455555 7999999999999864 467899999986533 346789999999999999999999999863 3689
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 412 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 999999999999999753 345899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 424 APEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 424 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
........ ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+... +...
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i~~~--- 555 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQG--- 555 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHH----HHTT---
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcC---
Confidence 65433211 1223346789999999999999999999999999999998 99999754321 11111 1111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
.....+......+.+|+.+||+.||++||++.+|++.|+.+......
T Consensus 556 -------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 556 -------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred -------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 11122333445689999999999999999999999999998766543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.87 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=194.5
Q ss_pred hcCcccceeeeccCceEEEEEEE----CCCcEEEEEEeccCC----CCchHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++. +.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ--TG 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--CS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--cC
Confidence 46799999999999999999997 478999999997542 223456889999999999999999999987 45
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred CEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence 589999999999999999964 235889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 167 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~-- 236 (327)
T 3a62_A 167 LCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKC-- 236 (327)
T ss_dssp CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT--
T ss_pred cccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhC--
Confidence 9986433221 22345799999999999999999999999999999999999999974321 1111111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
.. ..+......+.+++.+||+.||++|| ++.|+++|-
T Consensus 237 --------~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 237 --------KL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp --------CC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred --------CC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 11 12222334588999999999999999 788888763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=358.22 Aligned_cols=252 Identities=26% Similarity=0.327 Sum_probs=188.2
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++. +....++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE--TPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe--cCCeEEEE
Confidence 3568999999999999999999975 57899999997543 3467889999999999999999999987 45589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEEeccccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAK 422 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~ 422 (615)
|||+++|+|.+++.. ...+++..++.++.|+++||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999975 235899999999999999999999999 999999999999975 8899999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+ ...+.....
T Consensus 200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~---~~~i~~~~~--- 268 (349)
T 2w4o_A 200 IVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFM---FRRILNCEY--- 268 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHH---HHHHHTTCC---
T ss_pred ccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHH---HHHHHhCCC---
Confidence 764332 223467999999999999999999999999999999999999999643211 101 111111100
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.............+.+|+.+||+.||++|||+.|++++
T Consensus 269 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 -----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001112223458899999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.36 Aligned_cols=266 Identities=27% Similarity=0.421 Sum_probs=205.7
Q ss_pred hcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.++++++||||+++++++. +..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL--QSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc--CCC
Confidence 46899999999999999999984 247789999997443 233467899999999999999999999987 445
Q ss_pred ceeEEEecCCCCChhHhhcCCCC---CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAK 414 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vk 414 (615)
..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 78999999999999999975321 1235899999999999999999999999 999999999999984 45699
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~-- 258 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV-- 258 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH--
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHH--
Confidence 999999986543332222334568999999999999999999999999999999998 9999864321 1111111
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
. .. ... ..+......+.+++.+||+.||.+||++.+|+++|+.+.+..+.
T Consensus 259 -~-~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 259 -T-SG------GRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp -H-TT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred -h-cC------CCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 0 00 001 11222334588999999999999999999999999998775543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=350.82 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=201.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CC-------cEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DG-------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g-------~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|++++++++||||+++++++. +.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV--CG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC--CT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--eC
Confidence 367999999999999999999854 23 479999997666566788999999999999999999999987 44
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc-------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH------- 412 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~------- 412 (615)
...++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccc
Confidence 5789999999999999999742 234899999999999999999999999 999999999999988877
Q ss_pred -EEEEeccccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 007160 413 -AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 413 -vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~ 490 (615)
+||+|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+...... .....
T Consensus 159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~- 229 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQ- 229 (289)
T ss_dssp EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH-
T ss_pred eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHH-
Confidence 999999998755321 23468999999999987 77899999999999999999965554322111 11000
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.... ...+.... ...+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 230 ---~~~~--------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 ---FYED--------RHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ---HHHT--------TCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ---Hhhc--------cCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0000 01111111 2247889999999999999999999999987754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.56 Aligned_cols=265 Identities=25% Similarity=0.273 Sum_probs=201.2
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC-----CCCchHHHHHHHHHHhhccCCCcceEEEEeecC
Q 007160 264 LKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 337 (615)
Q Consensus 264 l~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~ 337 (615)
+....++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-- 98 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-- 98 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc--
Confidence 456678899999999999999999996 46889999998643 2344578999999999999999999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCC------------------------------------CcccCChhhHHHHHHHHH
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLG------------------------------------VNCHLDWETRMKIALDAA 381 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~------------------------------------~~~~l~~~~~~~ia~qia 381 (615)
+....++||||+++|+|.+++..... ....+++..++.++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 45589999999999999999952100 012346777889999999
Q ss_pred HHHHHhHhCCCCcEEeccCCCCCeEEcCCC--cEEEEeccccccCCCCC--ccccceeeccccccCCcccccc--CcCCc
Q 007160 382 RGLAYLHEDSQPCVIHRDFKASNILLENNF--HAKVADFGLAKQAPEGR--TNYLSTRVMGTFGYVAPEYAMT--GHLLV 455 (615)
Q Consensus 382 ~gL~yLH~~~~~~ivHrDIkp~NILl~~~~--~vkL~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~~~~--~~~s~ 455 (615)
+||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... .........||+.|+|||.+.+ ..++.
T Consensus 179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999999 99999999999998766 89999999998653321 1112345679999999999875 67899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCC
Q 007160 456 KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ 535 (615)
Q Consensus 456 ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~ 535 (615)
++||||||+++|||++|+.||...... ............. ...........+.+++.+||+.||.+
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF--------ENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT--------TSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc--------CCcccccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999999643311 1111111111000 00000112345889999999999999
Q ss_pred CCCHHHHHHHHH
Q 007160 536 RPTMGEVVQSLK 547 (615)
Q Consensus 536 RPsm~eVl~~L~ 547 (615)
||++.|++++-+
T Consensus 322 Rps~~~~l~hp~ 333 (345)
T 3hko_A 322 RFDAMRALQHPW 333 (345)
T ss_dssp SCCHHHHHHSHH
T ss_pred CCCHHHHhcChh
Confidence 999999998743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=343.89 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=205.4
Q ss_pred CcccceeeeccCceEEEEEEEC-CC---cEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.|...++||+|+||.||+|.+. ++ ..||+|.+..... ...+.|.+|++++++++||||+++++++...+ ...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcEE
Confidence 4666799999999999999853 22 3799999975433 23467899999999999999999999986433 34589
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 101 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999999999999753 345899999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCc--cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 425 PEGRT--NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 425 ~~~~~--~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
..... ........+|..|+|||.+.+..++.++||||||+++|||++|..|+...... ..+..... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~----~----- 243 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLA----Q----- 243 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHH----T-----
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhh----c-----
Confidence 44321 11223456889999999999999999999999999999999966665322211 11111110 0
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
.. ....+......+.+++.+||+.||.+|||+.++++.|+.+.+.+..
T Consensus 244 -~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 244 -GR----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -TC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -CC----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 00 0111222234588999999999999999999999999998876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.97 Aligned_cols=265 Identities=25% Similarity=0.326 Sum_probs=205.6
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecC--CCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~~~L 344 (615)
.++|++.+.||+|+||.||+++. .+|+.||||++........+.+.+|++++++++||||+++++++... .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999996 57899999999765555567899999999999999999999998632 3347899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999753223456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCcc-------ccceeeccccccCCccccccCc---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 007160 425 PEGRTN-------YLSTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494 (615)
Q Consensus 425 ~~~~~~-------~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~ 494 (615)
...... .......||+.|+|||.+.... ++.++||||||+++|||++|+.||........ .+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----
Confidence 421110 0012345799999999987553 68999999999999999999999952111100 00000
Q ss_pred hccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 495 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 495 ~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
... ......+......+.+++.+||+.||.+||++.+++++|+.+.
T Consensus 260 ~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000 0001111222345889999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.06 Aligned_cols=266 Identities=22% Similarity=0.350 Sum_probs=199.2
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++|+||+++++++.. ....+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEE
Confidence 35799999999999999999996 4789999999975432 234578999999999999999999999874 45889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.........+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 999999999999999642222345899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... .
T Consensus 186 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-------~ 252 (310)
T 2wqm_A 186 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-------Q 252 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHH-------T
T ss_pred ecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhh-------c
Confidence 644321 223457899999999999999999999999999999999999999643211 111111111 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
...+.. ........+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 253 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 253 CDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TCSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 001111 111223358899999999999999999999999999876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=351.87 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=204.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcE--EEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTA--VAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~--VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||.||+|+.. ++.. ||||.+.... ....+.+.+|+++++++ +||||+++++++.. ....+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCceE
Confidence 57999999999999999999964 5654 4999987532 33456799999999999 89999999999874 45899
Q ss_pred EEEecCCCCChhHhhcCCC------------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 344 LCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
+||||+++|+|.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence 9999999999999997643 22346899999999999999999999999 99999999999999999
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~ 490 (615)
.+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~-- 251 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY-- 251 (327)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH--
T ss_pred eEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHH--
Confidence 99999999997543211 1233467889999999999999999999999999999998 99999643211 111
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
..+ .. ......+......+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 252 -~~~-~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 -EKL-PQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -HHG-GG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HHh-hc----------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 00 001112223334688999999999999999999999999987664
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=349.64 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=205.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 689999999975532 23467899999999999999999999886555668999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC--CCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--QPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
||||+++|+|.+++.........+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999743222345899999999999999999999976 2349999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+.. .+..
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~i~~------ 230 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG---KIRE------ 230 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHH------
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHH---HHhh------
Confidence 7654321 12345789999999999999999999999999999999999999974321 11111 1100
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
...+ ..+......+.+++.+||+.||++||++.||+++++
T Consensus 231 -~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 231 -GKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -cccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0001 112223345889999999999999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.63 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=197.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CC--cEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS--DG--TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~--~g--~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.|++.+.||+|+||.||+|++. ++ ..||||.+..... ...+.|.+|+.++++++||||++++++|.. .....++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC-CSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCCCeEE
Confidence 4677899999999999999863 22 4689999875432 335689999999999999999999998753 3347889
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999999753 235889999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCcc--ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 425 PEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 425 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||....... ..... .. ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~~-~~-- 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQ-GR-- 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---HT-TC--
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---Hc-CC--
Confidence 443211 12234567889999999999999999999999999999999 677776443221 11111 00 00
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
. ...+......+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus 314 ----~----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ----R----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----C----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 01122233458899999999999999999999999999877554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=352.57 Aligned_cols=263 Identities=21% Similarity=0.351 Sum_probs=189.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++. +....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH--TENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC--CTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE--ECCeEEEE
Confidence 457999999999999999999964 689999999975533 33467899999999999999999999987 44589999
Q ss_pred EecCCCCChhHhhcCCC--CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 346 YELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
|||++ |+|.+++.... .....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 69999985321 11235889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc----
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK---- 498 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---- 498 (615)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 158 FGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESL 232 (317)
T ss_dssp TTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTT
T ss_pred cCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhH
Confidence 653322 1234578999999999876 4689999999999999999999999975432111 11110000000
Q ss_pred -------------------hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 -------------------DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 -------------------~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+.....+.....+ ...+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000011111111122 2358899999999999999999999876
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.89 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=194.6
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeecCCCC--c
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS--Q 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~--~ 341 (615)
.++|++.+.||+|+||.||+|+. .+++.||||++....... ...+.+|++++++++||||+++++++...+.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 578999999997654332 34688999999999999999999998643322 3
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||+++|+|.++++. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4899999999999999974 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 422 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 422 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence 876543221 1223457999999999999999999999999999999999999999643211 111111111100
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... ....+ ...+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~----~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 238 PPSA----RHEGL----SADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CHHH----HSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred Cccc----ccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 0000 01112 2357899999999999999987776654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=361.55 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=203.9
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 265 KEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 265 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
....++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++.++ +||||+++++++. +.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~--~~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TK 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE--eC
Confidence 345678999999999999999999975 68999999997532 23456788899999987 8999999999987 45
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence 589999999999999999974 235899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .....+...
T Consensus 164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~~~~~i~~~-- 233 (345)
T 1xjd_A 164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---E---ELFHSIRMD-- 233 (345)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHC--
T ss_pred hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---H---HHHHHHHhC--
Confidence 9986543221 23456899999999999999999999999999999999999999974321 1 111111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 545 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl~~ 545 (615)
.+ .++......+.+++.+||+.||++||++. +|++|
T Consensus 234 ------~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 234 ------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ------CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11 12222334588999999999999999998 77765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=370.47 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=207.5
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecC
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 337 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~ 337 (615)
.++....++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-- 139 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-- 139 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence 344456789999999999999999999975 5889999998642 1223356889999999999999999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 417 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 417 (615)
+....+|||||+++|+|.++++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence 45689999999999999999974 24889999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccCc----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
||+++....... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||..... ......
T Consensus 212 FG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~ 284 (410)
T 3v8s_A 212 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSK 284 (410)
T ss_dssp CTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH
T ss_pred cceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHH
Confidence 999987654432 1233568999999999998655 88999999999999999999999974321 111111
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHH
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK 547 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPsm~eVl~~L~ 547 (615)
++..... +.-+. ...+ ...+.+|+.+||+.+|.+ ||+++||++|-+
T Consensus 285 i~~~~~~---~~~p~-~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 285 IMNHKNS---LTFPD-DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHTHHHH---CCCCT-TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred HHhcccc---ccCCC-cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 2111110 10110 0122 235789999999999988 999999998843
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=344.42 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=199.4
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.+.||+|+||.||+|... |+.||||.+.... ..+.+.+|++++++++||||+++++++.. +....++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCCceEEEEe
Confidence 467999999999999999999885 7899999997533 45789999999999999999999998753 3347899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999642 1223889999999999999999999999 999999999999999999999999999865432
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. . ...
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~---~-~~~--------- 229 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---R-VEK--------- 229 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH---H-HTT---------
T ss_pred c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-Hhc---------
Confidence 2 23367889999999999999999999999999999998 99999643211 1111 0 000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
......+......+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 230 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 230 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 001112223334588999999999999999999999999988653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.98 Aligned_cols=267 Identities=20% Similarity=0.297 Sum_probs=211.3
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|++++++++|++++..++++.. +....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC-CCCceEEEE
Confidence 57899999999999999999996 5789999999875432 3578999999999999998888777654 445789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE---cCCCcEEEEecccccc
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ 423 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~ 423 (615)
||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 99999999732 235899999999999999999999999 9999999999999 4888999999999987
Q ss_pred CCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhhhhcc
Q 007160 424 APEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRD 497 (615)
Q Consensus 424 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~-~~~~~~~~~ 497 (615)
....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6544321 1124467999999999999999999999999999999999999999764433222211 111111100
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
. . +.+...++ ..+.+++.+||+.||++|||+.+|++.|+.+......
T Consensus 238 ~--~-----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 238 P--I-----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp C--H-----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred c--h-----HHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 0 01112233 3488999999999999999999999999998775543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.67 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=203.7
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++++.++||||+++++++. +....+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT--TPTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEE
Confidence 35899999999999999999996 57899999998642 1223457899999999999999999999987 445899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+ +|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 86 lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp EEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecccee
Confidence 999999 7899999864 235899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... .
T Consensus 158 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------~------ 218 (336)
T 3h4j_B 158 MTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------K------ 218 (336)
T ss_dssp TTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------C------
T ss_pred ccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------H------
Confidence 65432 2234579999999999988776 68999999999999999999999743321110 0
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.+... ....+......+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 219 ~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 219 KVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 00000 011222233457899999999999999999999988654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.38 Aligned_cols=267 Identities=20% Similarity=0.298 Sum_probs=207.7
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|++++++++|++++..++++.. +....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEEE
Confidence 457899999999999999999996 5789999998764432 3468899999999999998888877653 44578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE---cCCCcEEEEeccccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK 422 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~ 422 (615)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 99999999732 235899999999999999999999999 9999999999999 788999999999998
Q ss_pred cCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhhhhhc
Q 007160 423 QAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT-WARPILR 496 (615)
Q Consensus 423 ~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~-~~~~~~~ 496 (615)
........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 76543321 12234679999999999999999999999999999999999999997644332222111 1111110
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhh
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 554 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~ 554 (615)
.. . +.+...++ ..+.+++.+||+.||++|||+.+|++.|+.+.+...
T Consensus 237 ~~--~-----~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 237 TP--I-----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp SC--H-----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ch--h-----hhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00 0 00111223 358899999999999999999999999999877654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.90 Aligned_cols=255 Identities=21% Similarity=0.357 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++.++ +||||+++++++. +....+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~~~ 86 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLF 86 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE--eCCEEE
Confidence 57999999999999999999975 6899999999754322 235688899999988 8999999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999999964 235899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc--hhhHhhhhhhccchhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE--NLVTWARPILRDKDRL 501 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~l 501 (615)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......
T Consensus 160 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------- 228 (345)
T 3a8x_A 160 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------- 228 (345)
T ss_dssp SCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH---------
T ss_pred ccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH---------
Confidence 433221 234568999999999999999999999999999999999999999643221110 0011111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm------~eVl~~ 545 (615)
..+..... .++......+.+++.+||+.||++||++ .|+++|
T Consensus 229 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 229 QVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11111111 1233334458899999999999999995 677765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=361.13 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=197.2
Q ss_pred ccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecCC
Q 007160 272 EPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
...+.||+|+||.||+|+. .+|+.||+|++........+.+.+|++++++++||||+++++++. +....+|||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE--SKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEEEeCCC
Confidence 3357899999999999996 468999999998765555678999999999999999999999987 4458999999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE--cCCCcEEEEeccccccCCCCC
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl--~~~~~vkL~DFGla~~~~~~~ 428 (615)
+|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 170 ~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 170 GGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp TCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999998642 345899999999999999999999999 9999999999999 667899999999998775433
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... ...
T Consensus 244 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~~----~~~ 310 (373)
T 2x4f_A 244 K---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWDL----EDE 310 (373)
T ss_dssp B---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCS----CSG
T ss_pred c---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCC----Chh
Confidence 2 23346999999999999999999999999999999999999999743211 1111111110000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
....+ ...+.+|+.+||+.||.+|||+.|++++-+
T Consensus 311 ~~~~~----~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 311 EFQDI----SEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp GGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred hhccC----CHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 00112 235889999999999999999999998744
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=367.88 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=203.3
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
..++|++.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|++++++++||||+++++++. +....+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS--EEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE--CSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE--ECCEEE
Confidence 457899999999999999999986 47899999999754422 2456899999999999999999999987 556899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc---CCCcEEEEeccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGL 420 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkL~DFGl 420 (615)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 87 lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999974 235899999999999999999999999 99999999999998 567899999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...+.....
T Consensus 160 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~---~~~i~~~~~- 230 (444)
T 3soa_A 160 AIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRL---YQQIKAGAY- 230 (444)
T ss_dssp CBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHTCC-
T ss_pred eEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHH---HHHHHhCCC-
Confidence 987654332 22346799999999999999999999999999999999999999964321 111 111111100
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
....+ ....+ ...+.+|+.+||+.||++|||+.|++++-
T Consensus 231 --~~~~~-~~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 231 --DFPSP-EWDTV----TPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp --CCCTT-TTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred --CCCcc-ccccC----CHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 00000 01112 34578999999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=346.79 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=197.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++.. ....++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEE
Confidence 67999999999999999999975 58999999987554322 3568899999999999999999999874 4588999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 81 FEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999998864 235899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-h-------hhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-R-------PILR 496 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~-~-------~~~~ 496 (615)
.... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||............... . ..+.
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 154 GPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred Cccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 4322 2234578999999999876 67899999999999999999999999754322111111000 0 0000
Q ss_pred cchhhhhhcCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..........+......+ ......+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000000 1122347899999999999999999999976
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=357.54 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=204.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 118 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--cCCEEEE
Confidence 57999999999999999999975 68999999986432 234567899999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 119 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999974 235899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 192 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~-------- 252 (350)
T 1rdq_E 192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVS-------- 252 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH--------
T ss_pred cCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHc--------
Confidence 432 2345799999999999999999999999999999999999999974321 111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL 546 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~L 546 (615)
..+ .++......+.+++.+||+.||++||+ ++||++|-
T Consensus 253 --~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 253 --GKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp --CCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --CCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 111 122223345889999999999999998 88988764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=355.40 Aligned_cols=257 Identities=16% Similarity=0.159 Sum_probs=204.8
Q ss_pred HHhcCcccceeeeccCceEEEEEE------ECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc---CCCcceEEEEeec
Q 007160 266 EATNNFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSS 336 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~------~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~ 336 (615)
...++|.+.+.||+|+||.||+|. ..+++.||||++... ...++..|++++++++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~- 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL- 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee-
Confidence 345789999999999999999994 456889999999743 4567888999888886 999999999987
Q ss_pred CCCCceeEEEecCCCCChhHhhcCCCC-CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC------
Q 007160 337 RDSSQHLLCYELVPNGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN------ 409 (615)
Q Consensus 337 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~-~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~------ 409 (615)
.....+|||||+++|+|.++++.... ....++|..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 138 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 138 -FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp -CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred -cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 44578999999999999999963211 1346999999999999999999999998 999999999999998
Q ss_pred -----CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007160 410 -----NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ 484 (615)
Q Consensus 410 -----~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~ 484 (615)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 89999999999976543222223455679999999999999999999999999999999999999985322110
Q ss_pred chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhHhh
Q 007160 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR-PTMGEVVQSLKMVQRV 552 (615)
Q Consensus 485 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R-Psm~eVl~~L~~i~~~ 552 (615)
..+ ...+. .++ ....+.+++..|++.+|.+| |+++++.+.|+.+...
T Consensus 293 --------------~~~----~~~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 --------------CKP----EGLFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------EEE----CSCCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------eee----chhcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 000 01111 111 12346789999999999999 6888888888876553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=341.84 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=204.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++. +....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE--DNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCeEEEEE
Confidence 467999999999999999999975 57799999998765666788999999999999999999999987 456899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE---cCCCcEEEEecccccc
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ 423 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~ 423 (615)
||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999999864 335899999999999999999999999 9999999999999 7889999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||...... . .........
T Consensus 159 ~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~~~~----- 223 (277)
T 3f3z_A 159 FKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---E---VMLKIREGT----- 223 (277)
T ss_dssp CCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHCC-----
T ss_pred ccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHhCC-----
Confidence 654332 2345799999999988654 899999999999999999999999743211 1 111111100
Q ss_pred hcCCccCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 504 LADPRLGGKYPK----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 504 i~d~~l~~~~~~----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. ..+. .....+.+++.+||+.||++|||+.|++++-+
T Consensus 224 -----~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 224 -----F--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp -----C--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred -----C--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 0 1111 11245889999999999999999999998744
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=358.49 Aligned_cols=269 Identities=16% Similarity=0.231 Sum_probs=202.3
Q ss_pred hcCcccceeeecc--CceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEG--GFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+| +||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++.. ....
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEE
Confidence 4579999999999 99999999975 6899999999754322 23568889999999999999999999884 4589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999997532 235899999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCc-----cccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 423 QAPEGRT-----NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 423 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 254 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 254 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-----
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCC
Confidence 5432211 111223478999999999987 6789999999999999999999999975432221 111000000
Q ss_pred cc----c----hh-------------hhhhc---CCc------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 496 RD----K----DR-------------LEELA---DPR------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 496 ~~----~----~~-------------l~~i~---d~~------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. . .. +.... .+. .....+......+.+|+.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0 00 00000 000 0001122223458899999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.83 Aligned_cols=252 Identities=26% Similarity=0.338 Sum_probs=203.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC------chHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|++++++++||||+++++++. +..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE--NRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCC
Confidence 457999999999999999999975 6899999999764322 3567999999999999999999999987 455
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC----cEEEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA 416 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~ 416 (615)
..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEc
Confidence 89999999999999999975 235899999999999999999999999 99999999999999887 79999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..
T Consensus 162 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~ 232 (321)
T 2a2a_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITS 232 (321)
T ss_dssp CCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHT
T ss_pred cCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh
Confidence 9999987655322 23457999999999999999999999999999999999999999643211 11111111
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... ++.....+ ...+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~----~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 VSYDF----DEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCCCC----CHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccccc----Chhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000112 2357899999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=356.62 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=203.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCc
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 341 (615)
..++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|.+++..+ +||||+++++++. +...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--CSSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--cCCE
Confidence 3578999999999999999999975 4789999999753 223456788999999988 7999999999987 4558
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999974 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~----- 235 (353)
T 2i0e_A 169 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME----- 235 (353)
T ss_dssp BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-----
T ss_pred cccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-----
Confidence 86433221 23456799999999999999999999999999999999999999974321 111111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 545 (615)
... .++......+.+|+.+||+.||.+||+ +.+|++|
T Consensus 236 -----~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 236 -----HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 122233345889999999999999995 5788766
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.20 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=191.9
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeec------CC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSS------RD 338 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~------~~ 338 (615)
...+|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++.. .+
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457999999999999999999964 68999999997665555678999999999996 9999999999842 23
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....+++|||+. |+|.+++.... ....+++..++.++.|++.||.|||+.+. +|+||||||+|||++.++.+||+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEecC
Confidence 445899999995 79999886321 12358999999999999999999998763 3999999999999999999999999
Q ss_pred cccccCCCCCccc----------cceeeccccccCCcccc---ccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007160 419 GLAKQAPEGRTNY----------LSTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 485 (615)
Q Consensus 419 Gla~~~~~~~~~~----------~~~~~~gt~~y~APE~~---~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~ 485 (615)
|+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998765432211 11134689999999998 56678999999999999999999999996432110
Q ss_pred hhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 486 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.... ..........+ ..+.+|+.+||+.||++|||+.|++++|+.+....
T Consensus 261 --------~~~~------~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 --------IVNG------KYSIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -------------------CCCCTTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --------hhcC------cccCCcccccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0000 00000111112 23678999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=347.26 Aligned_cols=267 Identities=25% Similarity=0.324 Sum_probs=200.2
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC-----CCchHHHHHHHHHHhhcc---CCCcceEEEEeecC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSR 337 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~ 337 (615)
..++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 578999999987432 122357788888888775 99999999998754
Q ss_pred CCC---ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 338 DSS---QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 338 ~~~---~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
... ..++||||+. |+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 322 4789999996 69999997633 234899999999999999999999999 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~ 494 (615)
|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+..... .
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~-~ 234 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-L 234 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHH-H
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-H
Confidence 999999987654322 244679999999999999999999999999999999999999997543211 1111100 0
Q ss_pred hccc--h------hhh-hhcCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 LRDK--D------RLE-ELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 ~~~~--~------~l~-~i~d~~l~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... . .+. ....+.... ....+....+.+|+.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000 0 000 000000000 0001123457899999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.87 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=178.8
Q ss_pred ceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEEecCCC
Q 007160 274 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPN 351 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~Ey~~~ 351 (615)
.+.||+|+||.||+|+.. +|+.||||++.. .....+.+|+++++++. ||||+++++++. +....++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~--~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFH--DQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE--cCCEEEEEEEccCC
Confidence 378999999999999975 689999999963 34567889999999997 999999999987 45688999999999
Q ss_pred CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC---cEEEEeccccccCCCCC
Q 007160 352 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGLAKQAPEGR 428 (615)
Q Consensus 352 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~~~~~~ 428 (615)
|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 91 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 91 GELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999975 245899999999999999999999999 99999999999997665 89999999998765433
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-chhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....... ..+...
T Consensus 164 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------~~i~~~ 231 (325)
T 3kn6_A 164 Q--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM----------KKIKKG 231 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH----------HHHTTT
T ss_pred C--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH----------HHHHcC
Confidence 2 22345789999999999999999999999999999999999999975432211 1111111 111111
Q ss_pred ccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGK--YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~--~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... ........+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11000 001123458899999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.52 Aligned_cols=257 Identities=24% Similarity=0.264 Sum_probs=195.1
Q ss_pred cCcccc-eeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhh-ccCCCcceEEEEeec--CCCCcee
Q 007160 269 NNFEPA-SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRNLVKLVGYYSS--RDSSQHL 343 (615)
Q Consensus 269 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~-l~HpnIv~l~g~~~~--~~~~~~~ 343 (615)
++|.+. +.||+|+||+||+++.. +|+.||||++.. ...+.+|++++.+ .+||||+++++++.. .+....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 467766 78999999999999965 689999999862 3567889998755 489999999998763 2345789
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEEeccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGL 420 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGl 420 (615)
|||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999997532 245899999999999999999999999 999999999999987 78999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhhhhccch
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKD 499 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~ 499 (615)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... +....
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~~~- 283 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRMGQ- 283 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHHTC-
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHcCc-
Confidence 98765332 224567899999999999999999999999999999999999999754332211 01110 00000
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
...+. .........+.+|+.+||+.||++|||+.|+++|-+..
T Consensus 284 ----~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 284 ----YEFPN---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp ----CCCCT---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ----ccCCC---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 00000 00012234588999999999999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.79 Aligned_cols=268 Identities=23% Similarity=0.348 Sum_probs=194.2
Q ss_pred HHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCc
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 341 (615)
...++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.++. |+||+++++++...+...
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999996 468999999986442 223456889999999997 999999999997666667
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 999999997 699999974 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC-------------------ccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007160 422 KQAPEGR-------------------TNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481 (615)
Q Consensus 422 ~~~~~~~-------------------~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~ 481 (615)
+...... .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8654311 0112234679999999999886 6789999999999999999999999975432
Q ss_pred CCcchhhHhhhhhhccc--hhhhhhc------------------CCccCCCC------------CHHHHHHHHHHHHHcc
Q 007160 482 SGQENLVTWARPILRDK--DRLEELA------------------DPRLGGKY------------PKEDFIRVCTIAAACV 529 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~--~~l~~i~------------------d~~l~~~~------------~~~~~~~l~~Li~~Cl 529 (615)
... +.... ..+... ..+..+. .......+ .......+.+|+.+||
T Consensus 237 ~~~--~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 MNQ--LERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHH--HHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HHH--HHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 111 11100 000000 0000000 00000000 0012235789999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 007160 530 APEANQRPTMGEVVQS 545 (615)
Q Consensus 530 ~~dP~~RPsm~eVl~~ 545 (615)
+.||++|||+.|+++|
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=342.29 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=198.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCce
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~ 342 (615)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+..+.++ +||||+++++++.. ....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeE
Confidence 3567999999999999999999975 78999999997643 23356789999999999 99999999999874 4589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-------------
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN------------- 409 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~------------- 409 (615)
++||||+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999743222245899999999999999999999999 999999999999984
Q ss_pred ------CCcEEEEeccccccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 007160 410 ------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 482 (615)
Q Consensus 410 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~ 482 (615)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..++...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--- 234 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--- 234 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---
Confidence 4479999999998765432 23589999999999866 6678999999999999999998876421
Q ss_pred CcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 483 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 483 ~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... .. .-..+.+ +......+.+++.+||+.||++|||+.|++++
T Consensus 235 --~~~~~----~~-------~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 --DQWHE----IR-------QGRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --HHHHH----HH-------TTCCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --hHHHH----HH-------cCCCCCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11100 00 0001111 22223458899999999999999999999876
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.33 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=194.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++.. ....+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence 467999999999999999999964 6899999999743 23334678899999999999999999999874 45799
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++
T Consensus 225 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 99999999999999964 3458999999999999999999998 88 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......+....
T Consensus 298 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~---- 365 (446)
T 4ejn_A 298 EGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE---- 365 (446)
T ss_dssp TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC----
T ss_pred eccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCC----
Confidence 6443322 23456799999999999999999999999999999999999999964321 11111111110
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
. .++......+.+|+.+||+.||.+|| ++.|+++|-
T Consensus 366 ----~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 366 ----I----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ----C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----C----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 1 12222334588999999999999999 999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=355.06 Aligned_cols=249 Identities=28% Similarity=0.388 Sum_probs=200.2
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+.|+..+.||+|+||.||+|+. .+|+.||||++....... .+.+.+|++++++++||||+++++++.. ....++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEEE
Confidence 4589999999999999999996 578999999997654332 3568899999999999999999999874 458899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||++ |+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 132 v~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 999997 6888888532 235899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
... ....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..........
T Consensus 205 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~---- 268 (348)
T 1u5q_A 205 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN---- 268 (348)
T ss_dssp SSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS----
T ss_pred CCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc----
Confidence 432 2357999999999885 56789999999999999999999999964321 1111111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..+... +......+.+++.+||+.||++|||+.+++++.+.
T Consensus 269 ---~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 269 ---ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp ---CCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ---CCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 011111 11122357899999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=343.30 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=196.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|.+.+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++. +....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE--DYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee--cCCeEEEE
Confidence 357999999999999999999964 68899999987543 334578999999999999999999999987 45589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE---cCCCcEEEEeccccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK 422 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~ 422 (615)
|||+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999998542222346899999999999999999999999 9999999999999 456789999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
...... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||...... .... ...
T Consensus 176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~---~~~------- 238 (285)
T 3is5_A 176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQ---KAT------- 238 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-------
T ss_pred ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHh---hhc-------
Confidence 765432 224457999999999875 56899999999999999999999999743211 1110 000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
...+..... .......+.+++.+||+.||++|||+.||+++
T Consensus 239 -~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 239 -YKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -HCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -cCCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111000 00112357899999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=381.84 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=199.5
Q ss_pred eeeeccCceEEEEEEEC---CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
+.||+|+||.||+|.+. +++.||||+++.... ...++|.+|+++|++++|||||++++++.. ...++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 47999999999999753 467899999975432 235789999999999999999999999862 3588999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.++++. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 452 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 452 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999974 345899999999999999999999999 99999999999999999999999999987754432
Q ss_pred c-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 430 N-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 430 ~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
. .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+.. .+..
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~---------- 587 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEK---------- 587 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHT----------
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHc----------
Confidence 2 12234467889999999999999999999999999999998 99999643311 1111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
......+......+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111122333445689999999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=352.99 Aligned_cols=266 Identities=18% Similarity=0.225 Sum_probs=197.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCCC-----------chHHHHHHHHHHhhccCCCcceEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ-----------GDKEFLVEVEMLSRLHHRNLVKLVG 332 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~HpnIv~l~g 332 (615)
.++|++.+.||+|+||.||+|+.. ++..||||++...... ....+.+|+..++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 5788999998755322 1234677888999999999999999
Q ss_pred Eeec--CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC
Q 007160 333 YYSS--RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN 410 (615)
Q Consensus 333 ~~~~--~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 410 (615)
++.. .+....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9875 2256789999999 9999999974 236999999999999999999999998 9999999999999887
Q ss_pred C--cEEEEeccccccCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 007160 411 F--HAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 483 (615)
Q Consensus 411 ~--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~ 483 (615)
+ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432111 11234579999999999999999999999999999999999999996322111
Q ss_pred cchhhHhhhhhhcc-chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 484 QENLVTWARPILRD-KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 484 ~~~l~~~~~~~~~~-~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
............. ...+..... ...++ ..+.+++.+||+.||++||++.+|++.|+.+
T Consensus 268 -~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 -VAVQTAKTNLLDELPQSVLKWAP---SGSSC----CEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -HHHHHHHHHHHHTTTHHHHHHSC---TTSCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -HHHHHHHHhhcccccHHHHhhcc---ccccH----HHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111111110000 000100000 01222 3588999999999999999999999988764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.35 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=203.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++. +....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE--cCCEEEE
Confidence 478999999999999999999965 589999999875432 23467889999999999999999999987 4557899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc---EEEEecccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLA 421 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~DFGla 421 (615)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++
T Consensus 83 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999998864 245899999999999999999999999 999999999999976655 999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ........
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~---~~~~~~~~-- 224 (284)
T 3kk8_A 156 IEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY---AQIKAGAY-- 224 (284)
T ss_dssp EECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTCC--
T ss_pred EEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHH---HHHHhccc--
Confidence 87654332 23457999999999999999999999999999999999999999643211 111 11110000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. + ..........+.+++.+||+.||++|||+.|++++-+
T Consensus 225 -~~--~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 225 -DY--P---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp -CC--C---TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred -cC--C---chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 00 0 0001122235789999999999999999999998744
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=347.73 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=197.7
Q ss_pred cCcccc-eeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPA-SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~-~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
+.|++. +.||+|+||.||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++.. ....++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEE
Confidence 567774 7899999999999995 47899999999876666678899999999985 79999999999874 4589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc---EEEEeccccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAK 422 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~DFGla~ 422 (615)
|||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999974 235899999999999999999999998 999999999999988766 9999999998
Q ss_pred cCCCCCc-----cccceeeccccccCCcccccc-----CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 007160 423 QAPEGRT-----NYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 423 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
....... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6543211 011123469999999999875 568899999999999999999999997554322110000000
Q ss_pred hhhccchhhhhhcCCccCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 493 PILRDKDRLEELADPRLGGKYPK----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... .......+..... ..+. .....+.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PAC-QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHH-HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhH-HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000 0000111111111 1111 122458899999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=340.13 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=183.1
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE--DSNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE--CSSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc--cCCeEE
Confidence 46799999999999999999996 578999999986432 223467899999999999999999999987 455889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 999999999999999753 245899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..
T Consensus 162 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~ 223 (278)
T 3cok_A 162 LKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------------NK 223 (278)
T ss_dssp CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred ccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------HH
Confidence 6533221 22357899999999999989999999999999999999999999754322110 00
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+..... ..+......+.+++.+||+.||++||++.+++++
T Consensus 224 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 224 VVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Hhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000000 1122223457899999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=343.44 Aligned_cols=259 Identities=29% Similarity=0.425 Sum_probs=197.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CCc--EEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS--DGT--AVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~--~g~--~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||.||+|++. +++ .||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 467999999999999999999853 233 68999987542 23356799999999999999999999998632
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccc
Confidence 488999999999999999742 245899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 421 AKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 421 a~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
++......... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~- 240 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKE- 240 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTS-
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHcc-
Confidence 98775543221 2234567889999999999999999999999999999999 99999643211 111111111
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
......+......+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 241 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 ---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 11111122333458899999999999999999999999987643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.77 Aligned_cols=207 Identities=26% Similarity=0.348 Sum_probs=177.6
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-----CCCcceEEE
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----HRNLVKLVG 332 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----HpnIv~l~g 332 (615)
+++.+.....++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+..|++++++++ |+||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 44444455678999999999999999999997 46899999999732 233456788999999986 999999999
Q ss_pred EeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---
Q 007160 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--- 409 (615)
Q Consensus 333 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--- 409 (615)
++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~--~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 104 KFMY--YDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEE--TTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred eeeE--CCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9874 45899999999 999999997532 235899999999999999999999999 999999999999975
Q ss_pred ----------------------CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHH
Q 007160 410 ----------------------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLL 467 (615)
Q Consensus 410 ----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ 467 (615)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7899999999998754322 3457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 007160 468 ELLTGRKPVDMS 479 (615)
Q Consensus 468 ElltG~~Pf~~~ 479 (615)
||++|+.||...
T Consensus 251 ell~g~~pf~~~ 262 (360)
T 3llt_A 251 ELYTGSLLFRTH 262 (360)
T ss_dssp HHHHSSCSCCCS
T ss_pred HHHHCCCCCCCC
Confidence 999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.31 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=207.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.+.|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++++++|+||+++++++.. ....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEE
Confidence 457999999999999999999864 68999999997554 3345789999999999999999999999874 4578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecC
Confidence 999999999999964 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... +....
T Consensus 171 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----------~~~~~ 235 (303)
T 3a7i_A 171 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----------IPKNN 235 (303)
T ss_dssp TTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----------HHHSC
T ss_pred cccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----------hhcCC
Confidence 4321 223457999999999999999999999999999999999999999643211 11100 00111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.+.+...++ ..+.+++.+||+.||++|||+.|++++.+..
T Consensus 236 ~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 236 PPTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp CCCCCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred CCCCccccC----HHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 122222333 3488999999999999999999999986654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=343.77 Aligned_cols=259 Identities=19% Similarity=0.306 Sum_probs=202.5
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||.||+|+. .+++.||||++.. ...+.+.+|++++++++ |+||+++++++........++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999985 5789999999973 34678999999999997 99999999999865567889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 425 (615)
||+++++|.+++. .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999985 3888999999999999999999999 99999999999999766 89999999998765
Q ss_pred CCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch-----
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD----- 499 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~----- 499 (615)
.... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+..... .+....
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~-~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAK-VLGTEDLYDYI 257 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHH-HHCHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHH-hcCCchhhhHH
Confidence 4332 234578999999999887 67899999999999999999999999543321 111111110 000000
Q ss_pred ---------hhhhhcCCc--------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 500 ---------RLEELADPR--------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 500 ---------~l~~i~d~~--------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....+.... ............+.+|+.+||+.||++|||++|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 0011111123468899999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=341.76 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=201.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++. +....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 85 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVY 85 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe--cCCEEE
Confidence 468999999999999999999965 57799999986432 223467899999999999999999999987 445899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999999999964 235899999999999999999999998 99999999999999999999999999865
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+. .
T Consensus 159 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-------~ 221 (279)
T 3fdn_A 159 APSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRIS-------R 221 (279)
T ss_dssp C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-------H
T ss_pred CCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHH-------h
Confidence 54332 23457899999999999999999999999999999999999999743211 1111010 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.. ...+......+.+++.+||+.||++|||+.|++++-+.
T Consensus 222 -~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 222 -VE----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp -TC----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred -CC----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence 01 11222233457899999999999999999999998554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=362.32 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=206.6
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEee
Q 007160 260 AYEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335 (615)
Q Consensus 260 ~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~ 335 (615)
.++++....++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++.+++|+||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556789999999999999999999975 68999999996421 122345889999999999999999999987
Q ss_pred cCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEE
Q 007160 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 415 (615)
Q Consensus 336 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 415 (615)
+....+|||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 132 --~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 132 --DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp --CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred --eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEE
Confidence 455899999999999999999742 135899999999999999999999999 999999999999999999999
Q ss_pred EeccccccCCCCCccccceeeccccccCCccccc-------cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 007160 416 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 488 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~ 488 (615)
+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 204 ~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------ 276 (412)
T 2vd5_A 204 ADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ 276 (412)
T ss_dssp CCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------
T ss_pred eechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------
Confidence 99999987654332 1223457999999999987 457899999999999999999999999743311
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHH
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR---PTMGEVVQSL 546 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~R---Psm~eVl~~L 546 (615)
.....+..... .+..+.....++ ..+.+|+.+||+ +|.+| |+++||++|-
T Consensus 277 ~~~~~i~~~~~---~~~~p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 277 ETYGKIVHYKE---HLSLPLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHHHHHHTHHH---HCCCC----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred HHHHHHHhccc---CcCCCccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 11111111110 111111112233 357899999999 99998 6999998773
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=365.50 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=204.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++. +....++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~l 93 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS--TPSDIFM 93 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEE
Confidence 57999999999999999999975 78999999996432 223467899999999999999999999987 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 94 VMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999974 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
..... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||+.... ......+.
T Consensus 167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~-------- 229 (476)
T 2y94_A 167 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKIC-------- 229 (476)
T ss_dssp CTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHH--------
T ss_pred ccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHh--------
Confidence 54332 234579999999999988765 7899999999999999999999974321 11111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
+... ..+......+.+|+.+||+.||++|||+.|+++|-+
T Consensus 230 --~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 230 --DGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp --TTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred --cCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 1111 112222345789999999999999999999998744
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=338.83 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC------chHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
++|++.+.||+|+||.||+|+.. +|+.||||.+...... ..+.+.+|++++++++||||+++++++. +...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE--NKTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec--CCCe
Confidence 56999999999999999999976 6899999998754321 3578999999999999999999999987 4558
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC----cEEEEe
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVAD 417 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~D 417 (615)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999964 335899999999999999999999999 99999999999998877 899999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. .......
T Consensus 156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~~~ 226 (283)
T 3bhy_A 156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ET---LTNISAV 226 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHTT
T ss_pred cccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HH---HHHhHhc
Confidence 999987654322 23456999999999999999999999999999999999999999643211 11 0100000
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.... ....... ....+.+++.+||+.||++||++.|++++-
T Consensus 227 ~~~~----~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 227 NYDF----DEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CCCC----CHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred ccCC----cchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 0000 0000011 123578999999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.83 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=202.0
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--------chHHHHHHHHHHhhccCCCcceEEEEeecC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 337 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~ 337 (615)
..++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 457899999999999999999995 46899999999765321 2346788999999999999999999987
Q ss_pred CCCceeEEEecCCCC-ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEE
Q 007160 338 DSSQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 416 (615)
+....++||||+.+| +|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEe
Confidence 455889999999877 99999975 235899999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 173 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~- 236 (335)
T 3dls_A 173 DFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------T- 236 (335)
T ss_dssp CCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------G-
T ss_pred ecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------H-
Confidence 9999987755432 234679999999999988876 8899999999999999999999963110 0
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..... ..+......+.+|+.+||+.||++|||+.|++++-
T Consensus 237 -----~~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 -----VEAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -----TTTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -----Hhhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00000 01111223588999999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=339.15 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=204.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 91 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH--DRKRIYL 91 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE--cCCEEEE
Confidence 57999999999999999999975 57899999986431 233467899999999999999999999987 4558899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 92 MLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999974 235899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+
T Consensus 165 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~---------- 224 (284)
T 2vgo_A 165 PSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRI---------- 224 (284)
T ss_dssp SSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH----------
T ss_pred cccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHH----------
Confidence 4322 23457899999999999999999999999999999999999999743211 111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..... .++......+.+++.+||+.||.+||++.|++++-+.
T Consensus 225 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 225 VNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp HTTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred hcccc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 11111 1222233457899999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=352.89 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=202.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~L 344 (615)
..++|++.+.||+|+||.||++... +|+.||||++..... .+.+|++++.++ +||||+++++++. +....++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD--DGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE--cCCEEEE
Confidence 3567999999999999999999975 689999999975432 345788999888 7999999999987 4568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC----CcEEEEeccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN----FHAKVADFGL 420 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkL~DFGl 420 (615)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+
T Consensus 94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999975 235899999999999999999999999 9999999999998433 3599999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+ ...+....
T Consensus 167 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i~~~~-- 239 (342)
T 2qr7_A 167 AKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARIGSGK-- 239 (342)
T ss_dssp CEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHHHHCC--
T ss_pred cccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHHccCC--
Confidence 987654322 22345789999999999988899999999999999999999999974322211111 11111110
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
..+...........+.+|+.+||+.||++||++.|+++|-+..
T Consensus 240 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 240 ------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp ------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred ------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 0111111122334588999999999999999999999986653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=340.41 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=202.2
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC----CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++...+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999996 468899999997432 2345779999999999999999999999865566689
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||++++ |.+++.... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 777775422 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCc--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
...............||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~--- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKG--- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHC---
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcC---
Confidence 765433222334457999999999987644 4789999999999999999999997432 11111111110
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.. ..+......+.+++.+||+.||++|||+.|++++-+.
T Consensus 229 -----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 229 -----SY----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp -----CC----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred -----CC----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 01 1122233457899999999999999999999987443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.94 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=192.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--------CCchHHHHHHHHHHhhccCCCcceEEEEeec
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--------QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~ 336 (615)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45689999999999999999999964 68999999986432 1112358899999999999999999999852
Q ss_pred CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC---CcE
Q 007160 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHA 413 (615)
Q Consensus 337 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~v 413 (615)
...++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 212 ---~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 212 ---EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp ---SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCE
T ss_pred ---CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceE
Confidence 357999999999999999875 345899999999999999999999999 9999999999999654 459
Q ss_pred EEEeccccccCCCCCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 007160 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 490 (615)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~ 490 (615)
||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+...
T Consensus 282 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~ 356 (419)
T 3i6u_A 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ 356 (419)
T ss_dssp EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH
T ss_pred EEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH
Confidence 999999998765432 234567999999999986 3678899999999999999999999997433221 11111
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.. ...... .+.... .....+.+++.+||+.||++|||+.|+++|-
T Consensus 357 i~---~~~~~~----~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 357 IT---SGKYNF----IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HH---TTCCCC----CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred Hh---cCCCCC----Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 10 000000 000001 1223588999999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=370.07 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=207.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+++|++++||||+++++++. +....+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~l~ 260 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALC 260 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe--eCCEEE
Confidence 467999999999999999999975 6899999998643 2234567899999999999999999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 261 lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 9999999999999997532 234899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+...
T Consensus 336 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~~------ 404 (576)
T 2acx_A 336 VPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEV------ 404 (576)
T ss_dssp CCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHHC------
T ss_pred cccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhcc------
Confidence 754432 23458999999999999999999999999999999999999999754322111 1111111100
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL 546 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L 546 (615)
. ..++......+.+|+.+||+.||.+|| ++.||++|-
T Consensus 405 --~----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 405 --P----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp --C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred --c----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 0 112222334588999999999999999 789998773
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=342.47 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=202.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|.+.+.||+|+||.||+++.. +|+.||+|.+........+.+.+|++++++++||||+++++++. +....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE--STTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc--cCCEEEEEE
Confidence 467999999999999999999975 68999999998665545567999999999999999999999987 455889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE---cCCCcEEEEecccccc
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ 423 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~ 423 (615)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999864 235889999999999999999999999 9999999999999 7889999999999976
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+ ...+.....
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~---~~~i~~~~~---- 224 (304)
T 2jam_A 159 EQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKL---FEKIKEGYY---- 224 (304)
T ss_dssp CCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHHHCCC----
T ss_pred cCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHcCCC----
Confidence 5432 12345699999999999999999999999999999999999999964321 111 111111100
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.............+.+++.+||+.||++||++.|++++-+
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 225 ----EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 0001111222345889999999999999999999998744
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.00 Aligned_cols=197 Identities=25% Similarity=0.388 Sum_probs=155.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecC---CCCc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~---~~~~ 341 (615)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|+||+++++++... +...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999964 6899999999754322 346789999999999999999999998532 2357
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 5799999975 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-------------------------ccceeeccccccCCcccc-ccCcCCchhhHHHHHHHHHHHHhC
Q 007160 422 KQAPEGRTN-------------------------YLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTG 472 (615)
Q Consensus 422 ~~~~~~~~~-------------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDVwS~GvvL~ElltG 472 (615)
+........ ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 876432110 122446789999999976 466799999999999999999994
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.95 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=197.7
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
+|....+||+|+||.||+|.. .+++.||||.+........+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEEe
Confidence 345556999999999999996 4688999999987666666789999999999999999999999874 4588999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEeccccccCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~ 427 (615)
+++++|.+++....+ ...+++..++.++.|+++||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999975322 234678889999999999999999998 999999999999987 899999999999876543
Q ss_pred CccccceeeccccccCCccccccCc--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.. ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ....+... ....
T Consensus 177 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~--------~~~~ 243 (295)
T 2clq_A 177 NP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVG--------MFKV 243 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHHH--------HHCC
T ss_pred CC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhhc--------cccc
Confidence 21 123457899999999987653 789999999999999999999999632211 00000000 0011
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+. .+......+.+++.+||+.||++||++.|++++
T Consensus 244 ~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112 222333458899999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=356.20 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=204.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.. ....++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEEE
Confidence 357999999999999999999975 689999999976532 234678999999999999999999999874 4579999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
|||+++|+|.++++. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp ECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999974 23588999999999999999999985 7 999999999999999999999999999754
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHh--------------
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW-------------- 490 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~-------------- 490 (615)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 183 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 321 12345799999999999999999999999999999999999999975332111000000
Q ss_pred --------hhhh----hccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 491 --------ARPI----LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 491 --------~~~~----~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.... ......+..+................+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 0000 000000111111111111111223458899999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=362.96 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=196.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCC----CC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~ 340 (615)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|++++||||+++++++...+ ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999864 68999999997542 233467889999999999999999999986432 24
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..+|||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999976 57777653 3889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh------
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI------ 494 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~------ 494 (615)
++...... ..+...||+.|+|||++.+..++.++|||||||+||||++|+.||.......+ +.......
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPE 285 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHH
Confidence 98765432 23456899999999999999999999999999999999999999975432111 11000000
Q ss_pred -hcc-chhhhhhcCCccC-CCC-----------------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 495 -LRD-KDRLEELADPRLG-GKY-----------------PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 495 -~~~-~~~l~~i~d~~l~-~~~-----------------~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
+.. ............. ... .......+.+|+.+||+.||++|||++|+++|-
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000 0000011110000 000 011145688999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.52 Aligned_cols=262 Identities=21% Similarity=0.287 Sum_probs=203.9
Q ss_pred HHHHHHHhcCcccc-eeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhcc-CCCcceEEEEee
Q 007160 261 YEELKEATNNFEPA-SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYS 335 (615)
Q Consensus 261 ~~el~~~~~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~ 335 (615)
+...+...+.|.+. +.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34445556678877 89999999999999965 68999999987543 233578999999999994 699999999987
Q ss_pred cCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCc
Q 007160 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFH 412 (615)
Q Consensus 336 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~ 412 (615)
+....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.
T Consensus 100 --~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 100 --NTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp --CSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred --eCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 4558999999999999999996432 346899999999999999999999999 999999999999987 789
Q ss_pred EEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 007160 413 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492 (615)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~ 492 (615)
+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ..
T Consensus 173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---~~ 243 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---T---YL 243 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HH
T ss_pred EEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---H---HH
Confidence 99999999987654322 234579999999999999999999999999999999999999996432111 0 00
Q ss_pred hhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 493 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 493 ~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.+... ...............+.+++.+||+.||++|||++|++++-
T Consensus 244 ~i~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 244 NISQV--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HHHHT--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred HHHhc--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 00000 00011111122234588999999999999999999998763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.79 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=198.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecC--CCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~~~ 343 (615)
+.|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++... +....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788899999999999999964 678999999875432 2346789999999999999999999987642 345689
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc-CCCcEEEEeccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAK 422 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~ 422 (615)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+. +|+||||||+|||++ +++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999974 2458899999999999999999998863 399999999999997 78999999999997
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
...... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||...... ..........
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~----- 245 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSG----- 245 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTT-----
T ss_pred cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhcc-----
Confidence 654332 23457999999999876 45899999999999999999999999643211 1111111110
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... ..+......+.+++.+||+.||.+|||+.|++++
T Consensus 246 -~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 -VKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -CCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCcc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000 1111112358899999999999999999999976
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=354.84 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=203.4
Q ss_pred hcCcccceeeeccCceEEEEEEE----CCCcEEEEEEeccCC----CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 338 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 338 (615)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+++++++ +|+||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 35799999999999999999997 368999999987432 22345678899999999 69999999999874
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||+++|+|.+++.. ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 4578999999999999999974 235899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|+++....... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ..........
T Consensus 204 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~ 280 (355)
T 1vzo_A 204 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK 280 (355)
T ss_dssp SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH
T ss_pred CCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc
Confidence 99987643322 12334579999999999985 3578999999999999999999999975432221 1111111111
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLKM 548 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~L~~ 548 (615)
. .+ .++......+.+|+.+||+.||++|| ++.|++++...
T Consensus 281 ~--------~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 281 S--------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp C--------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred c--------CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 0 11 12233334578999999999999999 99999987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.10 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=194.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc-hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++||||+++++++. +....++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe--eCCEEEEEe
Confidence 57999999999999999999975 68999999997543221 224567999999999999999999987 445889999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp ECCS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 9997 5999998743 235889999999999999999999999 99999999999999999999999999986543
Q ss_pred CCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc--------
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-------- 497 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~-------- 497 (615)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........+..
T Consensus 153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 153 PTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTT
T ss_pred Ccc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchh
Confidence 322 2234578999999999876 568999999999999999999999997543221 11111111000
Q ss_pred ---chhhhhhcCCccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 498 ---KDRLEELADPRLGGK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 498 ---~~~l~~i~d~~l~~~----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
.........+..... ........+.+|+.+||+.||++|||++|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 000000000000000 0011123578999999999999999999999873
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.84 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=205.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|.+.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++. +....+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--DNDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec--cCCEEE
Confidence 367999999999999999999975 578999999875422 23467889999999999999999999987 455889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 92 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 99999999999999864 235899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-------- 228 (294)
T 2rku_A 165 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIK-------- 228 (294)
T ss_dssp CCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH--------
T ss_pred cccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh--------
Confidence 653322 123457999999999999989999999999999999999999999743211 1111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.... ..+......+.+++.+||+.||++|||+.|++++-..
T Consensus 229 --~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 229 --KNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp --TTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred --hccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 1000 1122223457899999999999999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=342.14 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=187.1
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc-h-HHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-D-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~-~-~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||++....... . +.+.++...++.++||||+++++++. +....++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF--REGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee--ccCCEEE
Confidence 46899999999999999999996 478999999997543222 2 23444555688889999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
||||++ |+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999997 588888754222345699999999999999999999998 8 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCcccc----ccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYA----MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
...... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...... ... ......
T Consensus 160 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~--- 228 (290)
T 3fme_A 160 LVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQ-LKQVVE--- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHH-HHHHHH---
T ss_pred cccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHH-HHHHhc---
Confidence 654322 2334799999999996 5667899999999999999999999999643211 111 010111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..............+.+++.+||+.||++|||+.|++++-+.
T Consensus 229 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 229 -------EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp -------SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred -------cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 111011111223458899999999999999999999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.72 Aligned_cols=263 Identities=29% Similarity=0.480 Sum_probs=201.0
Q ss_pred CCHHHHHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeec
Q 007160 259 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS 336 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~ 336 (615)
+.+.++....++|++.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33444555678999999999999999999997 478999999987543 3457899999999999 79999999999875
Q ss_pred CC----CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc
Q 007160 337 RD----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 412 (615)
Q Consensus 337 ~~----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 412 (615)
.. ....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 32 457899999999999999997532 346889999999999999999999999 999999999999999999
Q ss_pred EEEEeccccccCCCCCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchh
Q 007160 413 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 487 (615)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l 487 (615)
+||+|||++........ ......||+.|+|||++. +..++.++||||||+++|||++|+.||....... .+
T Consensus 168 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--AL 243 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH
T ss_pred EEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH
Confidence 99999999986643221 123457999999999987 5678999999999999999999999996432110 00
Q ss_pred hHhhhhhhccchhhhhhcCCcc-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 488 VTWARPILRDKDRLEELADPRL-GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 488 ~~~~~~~~~~~~~l~~i~d~~l-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..... ...+.. ...++ ..+.+++.+||+.||.+||++.+++++-
T Consensus 244 ----~~~~~-------~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 244 ----FLIPR-------NPAPRLKSKKWS----KKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp ----HHHHH-------SCCCCCSCSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred ----HHhhc-------CccccCCccccC----HHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 00000 001111 11222 3588999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.13 Aligned_cols=269 Identities=22% Similarity=0.300 Sum_probs=197.9
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecC-----
Q 007160 264 LKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----- 337 (615)
Q Consensus 264 l~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~----- 337 (615)
+....++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+|++++++++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999996 5789999999975432 234799999999999999999998542
Q ss_pred -------------------------------CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHH
Q 007160 338 -------------------------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386 (615)
Q Consensus 338 -------------------------------~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~y 386 (615)
+....++||||++ |+|.+.+.........+++..++.++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 2334789999998 58887775322224568999999999999999999
Q ss_pred hHhCCCCcEEeccCCCCCeEEc-CCCcEEEEeccccccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHH
Q 007160 387 LHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGV 464 (615)
Q Consensus 387 LH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~Gv 464 (615)
||+.+ |+||||||+|||++ +++.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 99999999999997 689999999999987654332 2345789999999998865 5899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-hhh-------hhhcCCccC-----CCCCHHHHHHHHHHHHHcccc
Q 007160 465 VLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRL-------EELADPRLG-----GKYPKEDFIRVCTIAAACVAP 531 (615)
Q Consensus 465 vL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~l-------~~i~d~~l~-----~~~~~~~~~~l~~Li~~Cl~~ 531 (615)
++|||++|+.||...... ..+.......-... ..+ ....-+... ..++......+.+|+.+||+.
T Consensus 231 il~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999999754321 11111111000000 000 000000000 001222334588999999999
Q ss_pred CCCCCCCHHHHHHH
Q 007160 532 EANQRPTMGEVVQS 545 (615)
Q Consensus 532 dP~~RPsm~eVl~~ 545 (615)
||++|||+.|+++|
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.37 Aligned_cols=268 Identities=15% Similarity=0.191 Sum_probs=207.2
Q ss_pred hcCcccceeeeccCceEEEEEEECC---------CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcce---------
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD---------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK--------- 329 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~--------- 329 (615)
.++|++.+.||+|+||.||+|+... ++.||||.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999753 789999998743 46889999999999999998
Q ss_pred ------EEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCC
Q 007160 330 ------LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS 403 (615)
Q Consensus 330 ------l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~ 403 (615)
+++++.. +....++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 116 ~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred ccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 5666654 346889999999 999999997521 346999999999999999999999998 999999999
Q ss_pred CeEEcCCC--cEEEEeccccccCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCC
Q 007160 404 NILLENNF--HAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 476 (615)
Q Consensus 404 NILl~~~~--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf 476 (615)
|||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 9999999999876532211 1123347999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhHhhhhhhccchhhhhhcCCccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhhhc
Q 007160 477 DMSQPSGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 555 (615)
Q Consensus 477 ~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~~~ 555 (615)
....... ..+.......... ...+.+.... ..++ ..+.+++.+||+.||++||++.+|++.|+.+.+....
T Consensus 269 ~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 269 TNCLPNT-EDIMKQKQKFVDK---PGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GGGTTCH-HHHHHHHHHHHHS---CCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccCCcCH-HHHHHHHHhccCC---hhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 7543221 1111111111110 1111111100 0122 4588999999999999999999999999998776543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=359.35 Aligned_cols=246 Identities=14% Similarity=0.201 Sum_probs=190.9
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC---CCCchHHHHHHH---HHHhhccCCCcceEE-------EE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEV---EMLSRLHHRNLVKLV-------GY 333 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei---~~l~~l~HpnIv~l~-------g~ 333 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.|.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999995 57899999999743 233457899999 455566899999998 55
Q ss_pred eecCCC----------C-----ceeEEEecCCCCChhHhhcCCC---CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcE
Q 007160 334 YSSRDS----------S-----QHLLCYELVPNGSLESWLHGPL---GVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395 (615)
Q Consensus 334 ~~~~~~----------~-----~~~LV~Ey~~~gsL~~~L~~~~---~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 395 (615)
+...+. . ..+|||||+ +|+|.+++.... .....++|..++.++.||++||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 543211 0 378999999 689999997421 11234556889999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccC-----------cCCchhhHHHHHH
Q 007160 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGV 464 (615)
Q Consensus 396 vHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwS~Gv 464 (615)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007160 465 VLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544 (615)
Q Consensus 465 vL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 544 (615)
+||||++|+.||......... ..+... ...++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~----------------~~~~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS----------------EWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS----------------GGGGSS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch----------------hhhhhh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999643322111 001110 01233 34789999999999999999999998
Q ss_pred H
Q 007160 545 S 545 (615)
Q Consensus 545 ~ 545 (615)
+
T Consensus 360 h 360 (377)
T 3byv_A 360 T 360 (377)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=350.36 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=191.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
...++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 108 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRL 108 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEE
Confidence 34578999999999999999999954 7899999999754332 24568899999999999999999999874 4589
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE-----cCCCcEEEEe
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-----ENNFHAKVAD 417 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl-----~~~~~vkL~D 417 (615)
++||||++ |+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|
T Consensus 109 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence 99999997 5999999752 35899999999999999999999999 9999999999999 4556699999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......-.
T Consensus 181 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~ 256 (329)
T 3gbz_A 181 FGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGL 256 (329)
T ss_dssp TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCC
T ss_pred CCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCC
Confidence 999987653322 22345789999999999874 58999999999999999999999997543211 11111100000
Q ss_pred c-ch------hhhhhcC--CccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 D-KD------RLEELAD--PRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~-~~------~l~~i~d--~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. .. ....... +..... .+......+.+|+.+||+.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 00 0000000 000000 000122457899999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=367.12 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=207.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~l~l 262 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE--TKTDLCL 262 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--eCCEEEE
Confidence 67899999999999999999975 68999999996432 233567899999999999999999999987 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999764433456999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+..
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~-------- 407 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE-------- 407 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH--------
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh--------
Confidence 54432 12345899999999999999999999999999999999999999975432211 1111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm-----~eVl~~ 545 (615)
.. ..++......+.+|+.+||+.||++||++ .+|++|
T Consensus 408 --~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 408 --QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 11 11223333458899999999999999975 667654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=340.28 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=196.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+.. +++.||||++....... .+.+.+|++++++++||||+++++++.. ....+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 478999999999999999999965 68899999997543222 3678999999999999999999999874 45889
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++++|.+++.. ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 111 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999974 235899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .............
T Consensus 184 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~- 254 (309)
T 2h34_A 184 TTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRP- 254 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCG-
T ss_pred ccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCc-
Confidence 6543221 223457999999999999999999999999999999999999999743211 1111111100000
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHh
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR 551 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-sm~eVl~~L~~i~~ 551 (615)
......++ ..+.+++.+||+.||++|| +++++++.|+.+..
T Consensus 255 ---~~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 ---STVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp ---GGTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ---cccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 01111223 3478999999999999999 99999998887543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=357.02 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=190.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHH-HhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|..+ ++.++||||+++++++. +....+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~--~~~~~~ 115 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKLY 115 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE--CSSEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--eCCEEE
Confidence 57999999999999999999975 588999999975432 233456777777 57789999999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 116 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999999974 235888999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......++.
T Consensus 189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~------- 253 (373)
T 2r5t_A 189 NIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN------- 253 (373)
T ss_dssp GBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHH-------
T ss_pred cccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-------
Confidence 433221 23456899999999999999999999999999999999999999964321 111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 541 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~e 541 (615)
..+ .++......+.+|+.+||+.||.+||++.+
T Consensus 254 ---~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 254 ---KPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---SCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---ccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 111 112222345789999999999999999853
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.41 Aligned_cols=258 Identities=13% Similarity=0.076 Sum_probs=185.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC---chHHHHHHHHHHhhc--cCCCcceEE-------EEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRL--HHRNLVKLV-------GYY 334 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l--~HpnIv~l~-------g~~ 334 (615)
..+|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346899999999999999999964 7899999999875432 235677886555555 699988755 333
Q ss_pred ecCCC---------------CceeEEEecCCCCChhHhhcCCCCCcccCChhhH------HHHHHHHHHHHHHhHhCCCC
Q 007160 335 SSRDS---------------SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR------MKIALDAARGLAYLHEDSQP 393 (615)
Q Consensus 335 ~~~~~---------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~------~~ia~qia~gL~yLH~~~~~ 393 (615)
..... ...+|||||++ |+|.+++... ...+.+..+ +.++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 32211 34799999998 8999999742 223566667 788899999999999999
Q ss_pred cEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHh
Q 007160 394 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLT 471 (615)
Q Consensus 394 ~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~Ellt 471 (615)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999999876432 124467799999999987 689999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 472 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 472 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
|+.||....+....... .. .....................+.+|+.+||+.||++|||+.|++++-
T Consensus 289 g~~Pf~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWK---RP------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp SSCSTTBCCTTCTTCCC---BC------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCCCCcCcccccchh---hh------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 99999755432211100 00 00000011111111112234588999999999999999999998763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.52 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=204.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|.+.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++|+||+++++++. +....+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--DNDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCCeEE
Confidence 357999999999999999999975 578999999875422 23467899999999999999999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++++|.+++.. ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 118 lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 118 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 99999999999999864 235899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......||..|+|||++.+..++.++||||||+++|||++|+.||..... ..........
T Consensus 191 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~------ 256 (335)
T 2owb_A 191 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKN------ 256 (335)
T ss_dssp CCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHT------
T ss_pred cccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcC------
Confidence 653322 12345799999999999999999999999999999999999999964321 1111111110
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
... .+......+.+++.+||+.||++||++.|++++-+
T Consensus 257 --~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 257 --EYS----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred --CCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 011 12222335789999999999999999999998744
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=345.49 Aligned_cols=271 Identities=21% Similarity=0.299 Sum_probs=200.8
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCC------
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------ 338 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 338 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999997 5789999999865432 23467889999999999999999999987533
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 888877643 235899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCc--cccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh--
Q 007160 419 GLAKQAPEGRT--NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP-- 493 (615)
Q Consensus 419 Gla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~-- 493 (615)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987653221 112244578999999998876 4689999999999999999999999975432211111100000
Q ss_pred ------hhccchhhhhhcCCccCCCCCHHH------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 494 ------ILRDKDRLEELADPRLGGKYPKED------FIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 494 ------~~~~~~~l~~i~d~~l~~~~~~~~------~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..........+...........+. ...+.+|+.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000000000000000011 1347899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=346.37 Aligned_cols=270 Identities=25% Similarity=0.318 Sum_probs=197.1
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc-----hHHHHHHHHHHhhccCCCcceEEEEeecCC
Q 007160 265 KEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG-----DKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 338 (615)
Q Consensus 265 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~-----~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~ 338 (615)
....++|++.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++. +
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~ 83 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--H 83 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--C
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe--e
Confidence 344578999999999999999999964 68999999997543221 346889999999999999999999987 4
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||+++ +|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEec
Confidence 5588999999976 899988753 235899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
|+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+..........
T Consensus 157 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 157 GLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTP 232 (346)
T ss_dssp GGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCC
T ss_pred ccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCC
Confidence 99987654322 22445789999999998764 5899999999999999999999998644311 1111111100000
Q ss_pred c-hh---hhhhcCC---ccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 498 K-DR---LEELADP---RLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 498 ~-~~---l~~i~d~---~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. .. ...+.+. ......+ ......+.+|+.+||+.||++|||+.|++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 0 00 0000000 0000011 112246889999999999999999999998743
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.48 Aligned_cols=273 Identities=23% Similarity=0.299 Sum_probs=201.5
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc-----------hHHHHHHHHHHhhccCCCcc
Q 007160 260 AYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-----------DKEFLVEVEMLSRLHHRNLV 328 (615)
Q Consensus 260 ~~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-----------~~~f~~Ei~~l~~l~HpnIv 328 (615)
...++....++|++.+.||+|+||.||+|...+|+.||||++....... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567888899999999999999999999998889999999986532211 26799999999999999999
Q ss_pred eEEEEeecC---CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 329 KLVGYYSSR---DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 329 ~l~g~~~~~---~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
++++++... .....++||||++ |+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 999998542 3346899999997 6898888742 335899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~ 484 (615)
|++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999998554332 2234578999999999887 6789999999999999999999999975432111
Q ss_pred chhhHhhhhhhcc----------chhhhhhcCCccCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 485 ENLVTWARPILRD----------KDRLEELADPRLGGK-------YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 485 ~~l~~~~~~~~~~----------~~~l~~i~d~~l~~~-------~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.. ....... ...........+... ........+.+|+.+||+.||++|||+.|++++
T Consensus 243 --~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 --LNK-IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp --HHH-HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHH-HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 100 0000000 000001111111000 011122357899999999999999999999976
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=348.37 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=204.1
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc--------hHHHHHHHHHHhhc-cCCCcceEE
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRL-HHRNLVKLV 331 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--------~~~f~~Ei~~l~~l-~HpnIv~l~ 331 (615)
.......++|++.+.||+|+||.||+|++. +|+.||||++....... .+.+.+|+++++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556678999999999999999999975 78999999987543211 34678899999999 799999999
Q ss_pred EEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 332 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 332 g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
+++. .....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 167 ~~~~--~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 167 DSYE--SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEE--BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEe--eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 9987 44589999999999999999974 235899999999999999999999999 99999999999999999
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCcccccc------CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 485 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~ 485 (615)
.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 238 ~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~ 311 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---I 311 (365)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H
T ss_pred CEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---H
Confidence 999999999987654332 234679999999998863 3588999999999999999999999964321 1
Q ss_pred hhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 486 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... ..+........ .+. .... ...+.+++.+||+.||++|||+.|++++
T Consensus 312 ~~~---~~i~~~~~~~~---~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 312 LML---RMIMEGQYQFS---SPE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHH---HHHHHTCCCCC---HHH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH---HHHHhCCCCCC---Ccc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 11111000000 000 0011 2347899999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=341.07 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=200.6
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC--chHHHHHHHHHHhhcc--CCCcceEEEEeecC
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLH--HRNLVKLVGYYSSR 337 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~--HpnIv~l~g~~~~~ 337 (615)
..+....++|++.+.||+|+||.||++...+++.||||++...... ..+.+.+|++++.+++ |+||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-- 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-- 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE--
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee--
Confidence 3344456789999999999999999999888999999999754322 3467899999999997 599999999987
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 417 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 417 (615)
+....++||| +.+++|.+++... ..+++..++.++.|+++||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 4457899999 5688999999752 35889999999999999999999999 999999999999975 7999999
Q ss_pred ccccccCCCCCccccceeeccccccCCcccccc-----------CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~ 486 (615)
||+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 245 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----
Confidence 999987654433323345579999999999875 47889999999999999999999999643211
Q ss_pred hhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 487 l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
. . .+..+.++......+......+.+++.+||+.||++||++.|++++-+.
T Consensus 246 ~-~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 246 I-S----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp H-H----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred H-H----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 0 0 1112222222222333333468899999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.12 Aligned_cols=267 Identities=23% Similarity=0.357 Sum_probs=200.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++. +....++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK--KKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee--cCCEEEE
Confidence 357999999999999999999975 58999999987554332 356889999999999999999999987 4458899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999988764 234899999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh----------h
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR----------P 493 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~----------~ 493 (615)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+..... .
T Consensus 175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHH
T ss_pred cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhh
Confidence 44322 22345789999999998875 78999999999999999999999997543211 1111100 0
Q ss_pred hhccchhhhhhcCCccCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 494 ILRDKDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+...........+.+....+. .....+.+|+.+||+.||++|||+.|++++-+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0000011111111111111111 12346889999999999999999999998743
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=334.04 Aligned_cols=250 Identities=25% Similarity=0.346 Sum_probs=195.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS--TPTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe--cCCeEE
Confidence 368999999999999999999975 78999999986432 233567899999999999999999999987 455899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999999964 235889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
...... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... . .....+...
T Consensus 161 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~~~~~~~~----- 226 (276)
T 2h6d_A 161 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---P---TLFKKIRGG----- 226 (276)
T ss_dssp CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHC-----
T ss_pred cCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---H---HHHHHhhcC-----
Confidence 654321 234578999999999987765 6899999999999999999999964321 1 111111000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.. ..+......+.+++.+||+.||++|||+.|++++-+
T Consensus 227 ---~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 227 ---VF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ---CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ---cc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 00 112222345889999999999999999999998743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=359.58 Aligned_cols=202 Identities=26% Similarity=0.370 Sum_probs=167.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCC---Cc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~---~~ 341 (615)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++|+||+++++++...+. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999964 688999999975432 234678999999999999999999999864322 56
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||++ |+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 699999975 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc--------------------ccceeeccccccCCcccc-ccCcCCchhhHHHHHHHHHHHHhCCCCCC
Q 007160 422 KQAPEGRTN--------------------YLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKPVD 477 (615)
Q Consensus 422 ~~~~~~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDVwS~GvvL~ElltG~~Pf~ 477 (615)
+........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 122456899999999986 56679999999999999999998665553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=339.60 Aligned_cols=265 Identities=28% Similarity=0.416 Sum_probs=185.7
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++||||+++++++.. ....++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES--SSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEE
Confidence 457899999999999999999985 468999999987543 2335678899999999999999999999874 457899
Q ss_pred EEecCCCCChhHhhcCC----CCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 345 CYELVPNGSLESWLHGP----LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~----~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
||||+++|+|.+++... ......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998621 112345899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCc---cccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 421 AKQAPEGRT---NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 421 a~~~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
++....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~---~~~ 242 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLT---LQN 242 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH---HTS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHH---hcc
Confidence 987654321 112234579999999999876 5689999999999999999999999975432211 1000 000
Q ss_pred cchhh-hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRL-EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l-~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... ....++.....++ ..+.+++.+||+.||.+||++.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000 0111111222233 357899999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=358.53 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=196.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecC----CCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~----~~~~~~ 343 (615)
.+|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+|+++|++++|+|||++++++... +....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999975 68999999987432 2345799999999999999999987532 223467
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-CcEEEEeccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAK 422 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~ 422 (615)
+||||+++ +|.+.+.........+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 676665422122346899999999999999999999998 9999999999999955 678999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc-chh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-KDR 500 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~-~~~ 500 (615)
....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||..... ...+.......-.. ...
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence 7654332 2345789999999998765 789999999999999999999999975332 12222221111000 001
Q ss_pred hhhh-------cCCccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 501 LEEL-------ADPRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 501 l~~i-------~d~~l~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
+..+ ..+.+... ++......+.+|+.+||+.||.+||++.|+++|-+
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 1111 00111000 11122346889999999999999999999998743
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.64 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=197.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++. +....++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY--HDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee--eCCeEEEEE
Confidence 468999999999999999999975 58999999998766666788999999999999999999999987 445899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999998642 235899999999999999999999999 99999999999999999999999999764321
Q ss_pred CCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
.. .......||..|+|||++. ...++.++||||||+++|||++|+.||...... ..........
T Consensus 170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--- 238 (302)
T 2j7t_A 170 TL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSD--- 238 (302)
T ss_dssp HH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC---
T ss_pred cc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccC---
Confidence 10 1123356899999999884 567899999999999999999999999743211 1111111100
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+. ...+......+.+++.+||+.||++|||+.+++++
T Consensus 239 ----~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 239 ----PPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ----CCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ----Ccc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 01122233458899999999999999999999865
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=347.96 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=195.5
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCC----C
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~----~ 340 (615)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++++++||||+++++++...+. .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999996 46899999999654322 24678899999999999999999999864321 3
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+ +++|.++++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 569999999 8899999974 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-----
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI----- 494 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~----- 494 (615)
++..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.......
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence 9876432 234578999999999887 6899999999999999999999999975432111 11000000
Q ss_pred -----hccc---hhhhhhc---CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 -----LRDK---DRLEELA---DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 -----~~~~---~~l~~i~---d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+... ..+..+. ...+. .........+.+|+.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 0000000 00000 0111223458899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=350.66 Aligned_cols=266 Identities=21% Similarity=0.262 Sum_probs=202.8
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc--------CCCcceEEEEeecC-
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH--------HRNLVKLVGYYSSR- 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--------HpnIv~l~g~~~~~- 337 (615)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999985 46889999999743 233467899999999986 78899999987632
Q ss_pred -CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCC----
Q 007160 338 -DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNF---- 411 (615)
Q Consensus 338 -~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~---- 411 (615)
+....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 345789999999 667766665321 24589999999999999999999998 8 99999999999998775
Q ss_pred ---------------------------------------------cEEEEeccccccCCCCCccccceeeccccccCCcc
Q 007160 412 ---------------------------------------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446 (615)
Q Consensus 412 ---------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 446 (615)
.+||+|||+++..... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999876533 23457899999999
Q ss_pred ccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh---hcc------------------chhhhhhc
Q 007160 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI---LRD------------------KDRLEELA 505 (615)
Q Consensus 447 ~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~---~~~------------------~~~l~~i~ 505 (615)
++.+..++.++|||||||+||||++|+.||.................+ +.. ...+..+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999755433221111110000 000 00000000
Q ss_pred CCc---------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPR---------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~---------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.. -....+......+.+|+.+||+.||++|||+.|+++|
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 0012355666789999999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=344.97 Aligned_cols=261 Identities=18% Similarity=0.274 Sum_probs=202.4
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc-----------------hHHHHHHHHHHhhccCCCcceE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-----------------DKEFLVEVEMLSRLHHRNLVKL 330 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-----------------~~~f~~Ei~~l~~l~HpnIv~l 330 (615)
.++|++.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999987432111 1789999999999999999999
Q ss_pred EEEeecCCCCceeEEEecCCCCChhHh------hcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCC
Q 007160 331 VGYYSSRDSSQHLLCYELVPNGSLESW------LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKAS 403 (615)
Q Consensus 331 ~g~~~~~~~~~~~LV~Ey~~~gsL~~~------L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~ 403 (615)
++++.. ....++||||+++|+|.++ +.. .....+++..++.++.|++.||.|||+ .+ |+||||||+
T Consensus 109 ~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 109 EGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp SEEEES--SSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred EEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999874 4589999999999999999 543 124569999999999999999999999 88 999999999
Q ss_pred CeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccC-cCCc-hhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007160 404 NILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLV-KSDVYSYGVVLLELLTGRKPVDMSQP 481 (615)
Q Consensus 404 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-ksDVwS~GvvL~ElltG~~Pf~~~~~ 481 (615)
|||++.++.+||+|||+++..... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999876443 22345799999999999877 6666 99999999999999999999975432
Q ss_pred CCcchhhHhhhhhhccchhhh----hhcCCcc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 482 SGQENLVTWARPILRDKDRLE----ELADPRL---GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~~~l~----~i~d~~l---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. ..+... +........ ....+.. ...........+.+++.+||+.||.+|||+.|++++
T Consensus 258 ~--~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 258 L--VELFNN---IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp S--HHHHHH---HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H--HHHHHH---HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 111111 111000000 0000000 000002223458899999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=361.85 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=204.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE--DKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCEEE
Confidence 457999999999999999999975 78999999996543 334678999999999999999999999987 456899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE---cCCCcEEEEeccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGL 420 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGl 420 (615)
+||||+.+|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999975 235899999999999999999999999 9999999999999 5678999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
++....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+ ...+......
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~i~~~~~~ 245 (484)
T 3nyv_A 176 STHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DI---LKKVEKGKYT 245 (484)
T ss_dssp HHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCCCC
T ss_pred eEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHcCCCC
Confidence 987654432 234579999999998865 6899999999999999999999999743211 11 1111111000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
............+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 246 --------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 246 --------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp --------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred --------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 0000011223458899999999999999999999988654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.42 Aligned_cols=254 Identities=28% Similarity=0.389 Sum_probs=199.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
..++|++.+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|++++++++||||+++++++.. ....++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEE
Confidence 4578999999999999999999975 58999999997543 35789999999999999999999999874 4578999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 9999999999998621 235899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ...
T Consensus 177 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-------~~~ 241 (314)
T 3com_A 177 DTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIP-------TNP 241 (314)
T ss_dssp TTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-------HSC
T ss_pred hhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHh-------cCC
Confidence 4321 223457899999999999999999999999999999999999999643211 0000000 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+.. ..+......+.+++.+||+.||++|||+.+++++-+
T Consensus 242 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 242 PPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp CCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred Cccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 0111 112222345889999999999999999999998643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.04 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=202.2
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC---------CchHHHHHHHHHHhhcc-CCCcceEEEEee
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---------QGDKEFLVEVEMLSRLH-HRNLVKLVGYYS 335 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---------~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~ 335 (615)
..++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999975 689999999975431 11356889999999995 999999999987
Q ss_pred cCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEE
Q 007160 336 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 415 (615)
Q Consensus 336 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 415 (615)
+....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 95 --~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 95 --TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp --CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred --cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence 45689999999999999999974 235899999999999999999999999 999999999999999999999
Q ss_pred EeccccccCCCCCccccceeeccccccCCccccc------cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 007160 416 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~ 489 (615)
+|||++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||...... .
T Consensus 166 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~ 236 (298)
T 1phk_A 166 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------L 236 (298)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred ecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------H
Confidence 99999987654332 23457899999999885 456889999999999999999999999643211 1
Q ss_pred hhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....+.... ..............+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 237 MLRMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcCC--------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 111111100 000001112233458899999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.62 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=196.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--------CchHHHHHHHHHHhhccCCCcceEEEEeecC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR 337 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~ 337 (615)
..++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3568999999999999999999964 588999999875321 1224588999999999999999999998632
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc---EE
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AK 414 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vk 414 (615)
..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 88 ---~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 88 ---DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ---SEEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred ---ceEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 48999999999999999975 345899999999999999999999999 999999999999987654 99
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
|+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+....
T Consensus 158 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~ 232 (322)
T 2ycf_A 158 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI 232 (322)
T ss_dssp ECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH
T ss_pred EccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH
Confidence 99999998765432 123457999999999874 5678999999999999999999999997543221 111111
Q ss_pred hhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. ...... .+..... ....+.+++.+||+.||++||++.|++++
T Consensus 233 ~---~~~~~~----~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 T---SGKYNF----IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp H---HTCCCC----CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H---hCcccc----Cchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0 000000 0000011 22358899999999999999999999865
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.78 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=198.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.+.|++.+.||+|+||.||+|+.. ++..||||++.... ......+.+|++++++++||||+++++++. +....++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE--DKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence 457999999999999999999975 68899999997543 333578999999999999999999999997 4568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEEecccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLA 421 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla 421 (615)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999998864 235899999999999999999999999 999999999999976 455999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
+...... ......||+.|+|||++. ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 187 ~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~- 255 (494)
T 3lij_A 187 AVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKYT- 255 (494)
T ss_dssp EECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC-
T ss_pred eECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-
Confidence 8765432 223457999999999876 56899999999999999999999999743311 111111111000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+......+ ...+.+++.+||+.||.+|||+.|+++|-+
T Consensus 256 ---~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 256 ---FDSPEWKNV----SEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp ---CCSGGGTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ---CCchhcccC----CHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 000001112 235789999999999999999999998744
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.58 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=201.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC--CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
..++|++.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++||||+++++++. +....+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--DSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE--cCCEEE
Confidence 3467999999999999999999975 7899999998643 2334578999999999999999999999987 456899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc---CCCcEEEEeccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGL 420 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkL~DFGl 420 (615)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 99999999999998864 235899999999999999999999999 99999999999995 566899999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .....+......
T Consensus 171 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~ 240 (486)
T 3mwu_A 171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYA 240 (486)
T ss_dssp TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC
T ss_pred CeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC
Confidence 98765432 2234579999999999875 5899999999999999999999999643211 111111111000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
............+.+++.+||+.||++|||+.|++++-+.
T Consensus 241 --------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 241 --------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp --------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred --------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 0000011223457899999999999999999999987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.53 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=206.4
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.++||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++|.+.+..+.++.. +....+|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV-EGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEEEEEE
Confidence 46899999999999999999996 5689999998875433 3468899999999987555554444432 445789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE---cCCCcEEEEecccccc
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ 423 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~ 423 (615)
||+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 99999999732 235999999999999999999999999 9999999999999 6889999999999987
Q ss_pred CCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 424 APEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 424 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
....... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.................... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~ 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-A 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-H
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-c
Confidence 6554321 112356799999999999999999999999999999999999999976543322222111110000 0
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
..+..+. ..++ ..+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus 235 ~~~~~l~-----~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 235 TSIEALC-----RGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp SCHHHHH-----TTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccHHHHh-----cCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0111111 1223 35889999999999999999999999999886543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.36 Aligned_cols=267 Identities=24% Similarity=0.322 Sum_probs=201.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCC---CCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~---~~~~ 342 (615)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.... ....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999964 6889999999754322 2367899999999999999999999986432 2468
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+. |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 599999963 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc--
Q 007160 423 QAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-- 498 (615)
Q Consensus 423 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-- 498 (615)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ... ..+...
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~i~-~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN--HIL-GILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH--HHH-HHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH--HHH-HHhCCCCH
Confidence 76543211 11244579999999998754 558999999999999999999999997544322111 100 000000
Q ss_pred hhhh--------hhc-CCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 499 DRLE--------ELA-DPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 499 ~~l~--------~i~-d~~l~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
..+. ... ........+ ......+.+|+.+||+.||++|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000 000 000000011 11123578999999999999999999999873
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=374.47 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=204.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCc
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 341 (615)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..+ +|+||+++++++. +...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCE
Confidence 4578999999999999999999965 6889999998743 223456788999999988 7999999999986 4558
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
++|||||+++|+|.++++. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 9999999999999999974 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
+....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......++
T Consensus 490 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~------ 555 (674)
T 3pfq_A 490 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM------ 555 (674)
T ss_dssp EECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH------
T ss_pred eccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHH------
Confidence 86543322 23456899999999999999999999999999999999999999974321 11111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm-----~eVl~~ 545 (615)
...+ .++......+.+|+.+||+.||++||++ +||++|
T Consensus 556 ----~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 556 ----EHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----SSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----hCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1111 2333344568899999999999999997 777765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.97 Aligned_cols=269 Identities=22% Similarity=0.295 Sum_probs=195.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeec----------
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS---------- 336 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~---------- 336 (615)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 489999999986655556789999999999999999999998742
Q ss_pred --CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc-CCCcE
Q 007160 337 --RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHA 413 (615)
Q Consensus 337 --~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~v 413 (615)
.+....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 23357899999997 699999964 35889999999999999999999999 99999999999997 57799
Q ss_pred EEEeccccccCCCCCc-cccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 414 KVADFGLAKQAPEGRT-NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 414 kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
||+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 9999999987643211 111233467999999998865 6789999999999999999999999975432111 11000
Q ss_pred hhhhc-cchhhhh------------hcCCccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 492 RPILR-DKDRLEE------------LADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 492 ~~~~~-~~~~l~~------------i~d~~l~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
...-. ......+ ...+... ..........+.+++.+||+.||++|||+.|++++-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 00000 0000000 0000000 0000112345889999999999999999999998743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.58 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=199.1
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 264 LKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 264 l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
.....++|++.+.||+|+||.||+|...+ .||+|.+.... ....+.|.+|++++++++|+||+++++++. +...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM--SPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE--CSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe--cCCc
Confidence 33446789999999999999999999854 49999987543 223456889999999999999999999987 4457
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999752 235899999999999999999999999 99999999999998 679999999998
Q ss_pred ccCCCCCc---cccceeeccccccCCcccccc---------CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 007160 422 KQAPEGRT---NYLSTRVMGTFGYVAPEYAMT---------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 422 ~~~~~~~~---~~~~~~~~gt~~y~APE~~~~---------~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~ 489 (615)
+....... ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||...... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~-- 251 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AI-- 251 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HH--
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH--
Confidence 76532111 112233569999999999864 45789999999999999999999999743211 11
Q ss_pred hhhhhhccchhhhhhcCCccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 490 WARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
...... ...+... ..++. .+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 252 -~~~~~~-------~~~~~~~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 252 -IWQMGT-------GMKPNLSQIGMGK----EISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -HHHHHT-------TCCCCCCCSSCCT----THHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -HHHhcc-------CCCCCCCcCCCCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111100 0111111 12222 478999999999999999999999999887654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=359.41 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=200.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-------------CchHHHHHHHHHHhhccCCCcceEEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-------------QGDKEFLVEVEMLSRLHHRNLVKLVG 332 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~~l~~l~HpnIv~l~g 332 (615)
..++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999965 578999999875431 23467899999999999999999999
Q ss_pred EeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-
Q 007160 333 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF- 411 (615)
Q Consensus 333 ~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~- 411 (615)
++. +....++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~--~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 114 VFE--DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEE--CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEE--cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 997 55689999999999999999864 245899999999999999999999999 99999999999998765
Q ss_pred --cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 007160 412 --HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 412 --~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~ 489 (615)
.+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||...... .
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~ 254 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------D 254 (504)
T ss_dssp CSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred CccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence 69999999998775432 223457999999999876 56899999999999999999999999743211 1
Q ss_pred hhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
....+....... +......+ ...+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 255 ~~~~i~~~~~~~----~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 255 IIKKVEKGKYYF----DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp HHHHHHHCCCCC----CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHcCCCCC----CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 111111110000 00000112 2358899999999999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=342.89 Aligned_cols=275 Identities=21% Similarity=0.266 Sum_probs=193.5
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCC--
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD-- 338 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~-- 338 (615)
.......++|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677899999999999999999999974 68999999986543 23456778899999999999999999986422
Q ss_pred ---CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhH--hCCCCcEEeccCCCCCeEEcC-CCc
Q 007160 339 ---SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--EDSQPCVIHRDFKASNILLEN-NFH 412 (615)
Q Consensus 339 ---~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH--~~~~~~ivHrDIkp~NILl~~-~~~ 412 (615)
....++||||+++ +|.+.+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 1237899999976 555444321122345889999999999999999999 888 999999999999996 899
Q ss_pred EEEEeccccccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 413 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 413 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~ 245 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIV 245 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHH
Confidence 99999999987654332 2345789999999998765 4899999999999999999999999754321 1111111
Q ss_pred hhhhccchhhhhhcCCc----------------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 492 RPILRDKDRLEELADPR----------------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~----------------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
+.............++. ............+.+|+.+||+.||.+|||+.|+++|-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 11000000000000000 00111222455789999999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.08 Aligned_cols=261 Identities=21% Similarity=0.312 Sum_probs=201.4
Q ss_pred hcCcccceeeeccCceEEEEEEE--CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCC------cceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL--SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn------Iv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++|+| ++++++++.. .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--H 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--T
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--C
Confidence 46899999999999999999986 368899999997432 23467889999999997665 9999999874 4
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC----------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---------- 409 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---------- 409 (615)
...++||||+ +++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence 5899999999 899999997532 235889999999999999999999999 999999999999987
Q ss_pred ---------CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 410 ---------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 410 ---------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6689999999998754322 34578999999999999999999999999999999999999997543
Q ss_pred CCCcchhhHhhhhhhcc-ch---------------------------hhhhhcCCcc-CCCCCHHHHHHHHHHHHHcccc
Q 007160 481 PSGQENLVTWARPILRD-KD---------------------------RLEELADPRL-GGKYPKEDFIRVCTIAAACVAP 531 (615)
Q Consensus 481 ~~~~~~l~~~~~~~~~~-~~---------------------------~l~~i~d~~l-~~~~~~~~~~~l~~Li~~Cl~~ 531 (615)
....... ....... .. .......+.. ...........+.+|+.+||+.
T Consensus 239 ~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 239 SKEHLAM---MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp HHHHHHH---HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred hHHHHHH---HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 2211111 0000000 00 0000000000 0112334456789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 007160 532 EANQRPTMGEVVQS 545 (615)
Q Consensus 532 dP~~RPsm~eVl~~ 545 (615)
||++|||+.|++++
T Consensus 316 dP~~Rpt~~ell~h 329 (339)
T 1z57_A 316 DPAKRITLREALKH 329 (339)
T ss_dssp STTTSCCHHHHTTS
T ss_pred CcccccCHHHHhcC
Confidence 99999999999876
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.52 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=193.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCC----CC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~ 340 (615)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++...+ ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999964 688999999975432 22457889999999999999999999986433 23
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||++ |+|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 6899999996 578888863 3889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR-------- 492 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~-------- 492 (615)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.....
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPE 248 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 98664322 22346799999999999999999999999999999999999999975432110 000000
Q ss_pred ----------hhhccc-----hhhhhhcCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 493 ----------PILRDK-----DRLEELADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 493 ----------~~~~~~-----~~l~~i~d~~l~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
...... ..+............ .......+.+|+.+||+.||++|||++|+++|-+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 000000 000000000000000 11224568999999999999999999999998543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.30 Aligned_cols=199 Identities=24% Similarity=0.326 Sum_probs=170.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhc------cCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL------HHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l------~HpnIv~l~g~~~~~~~~ 340 (615)
..+|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++++.+ +|+||+++++++.. ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CC
Confidence 457999999999999999999864 5899999999743 22245788899998887 56799999999874 45
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc--EEEEec
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADF 418 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkL~DF 418 (615)
..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeec
Confidence 8999999995 69999997532 234899999999999999999999999 999999999999999887 999999
Q ss_pred cccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 419 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 419 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
|+++...... ....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 247 G~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9997654322 23578999999999999999999999999999999999999997543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.83 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=194.5
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCC----CCcee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~~~ 343 (615)
..+|++.+.||+|+||.||+|+..++..||+|++..... ...+|++++++++||||+++++++.... ....+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 356999999999999999999987777799999864332 2246999999999999999999986432 22378
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc-CCCcEEEEeccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAK 422 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~ 422 (615)
+||||++++.+. .+.........+++..++.++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999875443 33211112345899999999999999999999999 99999999999998 79999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-hh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DR 500 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-~~ 500 (615)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.......-... ..
T Consensus 191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence 7654332 2345789999999998765 5899999999999999999999999754321 11111111000000 00
Q ss_pred hhh----hcC---CccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 501 LEE----LAD---PRLG-----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 501 l~~----i~d---~~l~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.. ... +... ..++......+.+|+.+||+.||++|||+.|+++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 000 0000 00111123468899999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.85 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=194.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecC---------
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--------- 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--------- 337 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999964 7899999999642 23346789999999999999999999987642
Q ss_pred --CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEE
Q 007160 338 --DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 415 (615)
Q Consensus 338 --~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 415 (615)
.....++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 235789999999999999999742 245788999999999999999999999 999999999999999999999
Q ss_pred EeccccccCCCCCc------------cccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 007160 416 ADFGLAKQAPEGRT------------NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 482 (615)
Q Consensus 416 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~ 482 (615)
+|||+++....... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 99999987643210 1112345799999999998864 78999999999999999998 54311
Q ss_pred CcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 483 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 483 ~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
............ ........++......+.+++.+||+.||++|||+.+++++
T Consensus 232 --~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 --MERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111110 01111222333444568899999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=368.50 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=205.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC----CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
...++|++.+.||+|+||.||+|.+. .+..||||++...... ..+.|.+|+.++++++||||+++++++. ..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---cC
Confidence 34577899999999999999999974 2467999998754332 2367999999999999999999999984 24
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+++|+|.++++.. ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 689999999999999999742 235899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ..... +.. .
T Consensus 538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~---i~~-~- 608 (656)
T 2j0j_A 538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---IEN-G- 608 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---HHH-T-
T ss_pred CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH---HHc-C-
Confidence 987654332 22334567889999999999999999999999999999997 99999743211 11111 100 0
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
... ..+......+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 609 -----~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 -----ERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 001 12223334688999999999999999999999999987653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.12 Aligned_cols=272 Identities=21% Similarity=0.274 Sum_probs=186.5
Q ss_pred cCccc-ceeeeccCceEEEEEEEC---CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEP-ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~-~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+.|++ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+++|++++||||+++++++...+....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 458999999999999965 57899999997433 3457899999999999999999999997656678999
Q ss_pred EEecCCCCChhHhhcCCC-----CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE----cCCCcEEE
Q 007160 345 CYELVPNGSLESWLHGPL-----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKV 415 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL 415 (615)
||||++ |+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 58888875211 11234899999999999999999999999 9999999999999 67889999
Q ss_pred EeccccccCCCCCcc-ccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-------ch
Q 007160 416 ADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-------EN 486 (615)
Q Consensus 416 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~-------~~ 486 (615)
+|||+++........ .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999876543211 12344679999999999987 4589999999999999999999999965432110 01
Q ss_pred hhHhhhhhhcc---------------chhhhhhcCCccCCCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHH
Q 007160 487 LVTWARPILRD---------------KDRLEELADPRLGGKYPK---------EDFIRVCTIAAACVAPEANQRPTMGEV 542 (615)
Q Consensus 487 l~~~~~~~~~~---------------~~~l~~i~d~~l~~~~~~---------~~~~~l~~Li~~Cl~~dP~~RPsm~eV 542 (615)
+..... .+.. ......+..... ..... .....+.+|+.+||+.||++|||++|+
T Consensus 254 l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 254 LDRIFN-VMGFPADKDWEDIKKMPEHSTLMKDFRRNTY-TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHH-HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGG-TTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHH-hhCCCChhhcchhhcCcchhhhhhhccccCC-CcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 100000 0000 000000000000 00000 002347899999999999999999999
Q ss_pred HHHHHH
Q 007160 543 VQSLKM 548 (615)
Q Consensus 543 l~~L~~ 548 (615)
++|-+.
T Consensus 332 L~hp~f 337 (405)
T 3rgf_A 332 MQDPYF 337 (405)
T ss_dssp HTSGGG
T ss_pred hcChhh
Confidence 988543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.32 Aligned_cols=266 Identities=24% Similarity=0.292 Sum_probs=198.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecC---CCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~---~~~~~ 342 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++||||+++++++... .....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 6899999999744322 245788999999999999999999987632 23578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+. |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 699999874 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccc--------cceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 007160 423 QAPEGRTNY--------LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 423 ~~~~~~~~~--------~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~ 493 (615)
......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~-~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLL-IFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH-HHH
Confidence 765432110 1123478999999998764 678999999999999999999999997543111 0000 000
Q ss_pred hhcc-----------chhhhhhcCCcc-CCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 494 ILRD-----------KDRLEELADPRL-GGKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 494 ~~~~-----------~~~l~~i~d~~l-~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... .....+...... .... .......+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000000000000 0000 01122457899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=335.52 Aligned_cols=267 Identities=24% Similarity=0.321 Sum_probs=201.2
Q ss_pred HhcCcccceeeeccCceEEEEEEE--CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhc---cCCCcceEEEEeec---
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL--SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL---HHRNLVKLVGYYSS--- 336 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~--- 336 (615)
+.++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++++ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 468899999986432 22234677888888777 89999999999862
Q ss_pred CCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEE
Q 007160 337 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 416 (615)
Q Consensus 337 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 416 (615)
......++||||++ |+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 23457899999997 69999997532 234899999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|||+++...... ......||..|+|||++.+..++.++||||||+++|||++|+.||....... .+..... ...
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~-~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILD-VIG 236 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HcC
Confidence 999998654321 2344678999999999999999999999999999999999999997543211 1111000 000
Q ss_pred cc--hhhh-------hhcCC---ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DK--DRLE-------ELADP---RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~--~~l~-------~i~d~---~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. .... ..... .............+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0000 00000 00001111223457899999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.16 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=183.4
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecC----CCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~----~~~ 340 (615)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++... +..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999995 4689999999975432 2346788999999999999999999998642 224
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++|+||+ +++|.++++. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 7899998864 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK- 498 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~- 498 (615)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.... ..+...
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~-~~~g~p~ 250 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLIL-RLVGTPG 250 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH-HHHCSCC
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCC
Confidence 9875432 234579999999999887 6789999999999999999999999975432111 11100 000000
Q ss_pred ---------hhhhhhcCCccC-CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 ---------DRLEELADPRLG-GKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ---------~~l~~i~d~~l~-~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
............ ...+. .....+.+|+.+||+.||++|||+.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000 00000 112357899999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.54 Aligned_cols=264 Identities=20% Similarity=0.301 Sum_probs=200.4
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-----------CCCcceEEEEee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----------HRNLVKLVGYYS 335 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------HpnIv~l~g~~~ 335 (615)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999996 57899999999742 223467889999999886 899999999987
Q ss_pred cCC--CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEc----
Q 007160 336 SRD--SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLE---- 408 (615)
Q Consensus 336 ~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~---- 408 (615)
..+ ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 432 23689999999 899999997532 23489999999999999999999998 8 99999999999994
Q ss_pred --CCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 007160 409 --NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486 (615)
Q Consensus 409 --~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~ 486 (615)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 44589999999998765422 33478999999999999999999999999999999999999997543221110
Q ss_pred hhHhhhhhhc---------------------cchh-----------hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCC
Q 007160 487 LVTWARPILR---------------------DKDR-----------LEELADPRLGGKYPKEDFIRVCTIAAACVAPEAN 534 (615)
Q Consensus 487 l~~~~~~~~~---------------------~~~~-----------l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~ 534 (615)
.......+.. .... +..+... ...++......+.+|+.+||+.||+
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCcc
Confidence 0000000000 0000 0000000 1134566677899999999999999
Q ss_pred CCCCHHHHHHH
Q 007160 535 QRPTMGEVVQS 545 (615)
Q Consensus 535 ~RPsm~eVl~~ 545 (615)
+|||+.|++++
T Consensus 324 ~Rpt~~ell~h 334 (373)
T 1q8y_A 324 KRADAGGLVNH 334 (373)
T ss_dssp TCBCHHHHHTC
T ss_pred ccCCHHHHhhC
Confidence 99999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=328.21 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=201.8
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 96 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--DSSSF 96 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe--CCCeE
Confidence 44578999999999999999999975 68999999986542 334678999999999999999999999987 45588
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC---CcEEEEecc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFG 419 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFG 419 (615)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999998864 235899999999999999999999999 9999999999999654 479999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
+++....... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... . ....+.....
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~~~~~ 239 (287)
T 2wei_A 170 LSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---D---ILKRVETGKY 239 (287)
T ss_dssp GGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHCCC
T ss_pred cceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---H---HHHHHHcCCC
Confidence 9987654322 233468999999998865 4899999999999999999999999743211 1 1111111100
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. .+......+ ...+.+++.+||+.||++|||+.|++++-+
T Consensus 240 ~----~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 240 A----FDLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp C----CCSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred C----CCchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 0 000000112 235889999999999999999999998743
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=332.42 Aligned_cols=246 Identities=24% Similarity=0.444 Sum_probs=192.3
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC------chHHHHHHHHHHhhc----cCCCcceEE
Q 007160 263 ELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRL----HHRNLVKLV 331 (615)
Q Consensus 263 el~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l----~HpnIv~l~ 331 (615)
+.....++|++.+.||+|+||.||+|+. .+++.||||++...... ....+.+|++++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445568899999999999999999985 46889999999754322 223466799999998 899999999
Q ss_pred EEeecCCCCceeEEEec-CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc-C
Q 007160 332 GYYSSRDSSQHLLCYEL-VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-N 409 (615)
Q Consensus 332 g~~~~~~~~~~~LV~Ey-~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~ 409 (615)
+++.. ....++|||| +.+++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++ +
T Consensus 105 ~~~~~--~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 105 DWFET--QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR 175 (312)
T ss_dssp EEC-------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT
T ss_pred EEEec--CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC
Confidence 99873 4578999999 789999999974 235899999999999999999999999 99999999999999 8
Q ss_pred CCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 007160 410 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 488 (615)
Q Consensus 410 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~ 488 (615)
++.+||+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~- 245 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI- 245 (312)
T ss_dssp TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-
T ss_pred CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH-
Confidence 8999999999998765432 234569999999999887766 459999999999999999999996311 00
Q ss_pred HhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 489 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 489 ~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
... .. ..+......+.+++.+||+.||++|||+.|++++
T Consensus 246 ------~~~--------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 ------LEA--------EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------HHT--------CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------hhh--------cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 1122223457899999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.63 Aligned_cols=259 Identities=21% Similarity=0.238 Sum_probs=176.0
Q ss_pred HhcCcccce-eeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecC--CCCce
Q 007160 267 ATNNFEPAS-ILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQH 342 (615)
Q Consensus 267 ~~~~f~~~~-~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~~ 342 (615)
..++|.+.+ +||+|+||.||+|+.. +|+.||||++... ..........++.++|+||+++++++... +....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356898854 6999999999999975 6899999998632 22222333345667999999999998642 23458
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEEecc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG 419 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFG 419 (615)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 99999999999999998532 246899999999999999999999999 999999999999976 4559999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .......
T Consensus 177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~---- 246 (336)
T 3fhr_A 177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIR---- 246 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhh----
Confidence 998665332 234578999999999999999999999999999999999999996443221100 0000000
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.... .............+.+|+.+||+.||++|||+.|++++-+.
T Consensus 247 -~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 247 -LGQY---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred -cccc---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0000 00000111223458899999999999999999999998654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.83 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=187.9
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
+.|...+.||+|+||+||.+...+|+.||||++.. ...+.+.+|++++.++ +||||+++++++. +....++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSET--TDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCeEEEEEe
Confidence 34556788999999999877777899999999864 2345688999999987 8999999999987 4568999999
Q ss_pred cCCCCChhHhhcCCCCCccc---CChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCC-------------C
Q 007160 348 LVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-------------F 411 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~---l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-------------~ 411 (615)
|+. |+|.+++......... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence 995 6999999764322211 245567889999999999999999 9999999999999654 4
Q ss_pred cEEEEeccccccCCCCCccc--cceeeccccccCCcccccc-------CcCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 007160 412 HAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 481 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~ 481 (615)
.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999999876543211 1234579999999999875 678999999999999999999 9999964321
Q ss_pred CCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 482 ~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ... ...... .+.............+.+++.+||+.||++|||+.||++|
T Consensus 246 ~~----~~i----~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RE----SNI----IRGIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH----HHH----HHTCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hH----HHH----hcCCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11 111 110000 0111112233455678999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=341.22 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=195.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCCC----
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS---- 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~---- 340 (615)
.++|.+.+.||+|+||.||+|... +|+.||||++....... .+.+.+|++++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999964 68999999997643332 46788999999999999999999998743321
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||+. ++|.+++.. .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 2499999997 689988843 3899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-----
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI----- 494 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~----- 494 (615)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.......
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT 263 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcH
Confidence 9865432 234578999999999887 688999999999999999999999997543111 111100000
Q ss_pred -----hccc---hhhhhhcCCccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 -----LRDK---DRLEELADPRLGGK---YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 -----~~~~---~~l~~i~d~~l~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+... .....+... .... ........+.+|+.+||+.||++|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCC-CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCC-cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 000000000 0000 001123458899999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=336.06 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=198.9
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC------chHHHHHHHHHHhhcc--CCCcceEEE
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLH--HRNLVKLVG 332 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l~--HpnIv~l~g 332 (615)
.+.....++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 33444567899999999999999999985 46899999999754322 2245778999999996 599999999
Q ss_pred EeecCCCCceeEEEecCCC-CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc-CC
Q 007160 333 YYSSRDSSQHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NN 410 (615)
Q Consensus 333 ~~~~~~~~~~~LV~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~ 410 (615)
++. +....++||||+.+ ++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++ ++
T Consensus 116 ~~~--~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 116 WFE--RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEE--CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred EEe--cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 987 44588999999986 899999974 345899999999999999999999999 99999999999999 78
Q ss_pred CcEEEEeccccccCCCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 007160 411 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489 (615)
Q Consensus 411 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~ 489 (615)
+.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~--- 254 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E--- 254 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H---
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----h---
Confidence 999999999998765432 234569999999999987765 788999999999999999999996321 0
Q ss_pred hhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 490 ~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... ......++ ..+.+++.+||+.||++|||+.||+++
T Consensus 255 ----~~~~~--------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 ----IIRGQ--------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----HHHCC--------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----hhccc--------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01112223 357899999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=335.03 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=179.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHH-HHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++. +....++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~--~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE--CSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE--eCCceEE
Confidence 368999999999999999999974 689999999975532 22345666666 677789999999999987 4458899
Q ss_pred EEecCCCCChhHhhcCCC-CCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 345 CYELVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~-~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
||||+++ +|.+++.... .....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999975 8888775210 1134589999999999999999999998 8 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCcccc----ccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYA----MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
....... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||....... .........
T Consensus 175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~- 245 (327)
T 3aln_A 175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVVKG- 245 (327)
T ss_dssp C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCS-
T ss_pred ecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHhcC-
Confidence 7654321 2334799999999998 45678999999999999999999999997432110 000001100
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
..+.+...........+.+++.+||+.||++||++.||+++-+.
T Consensus 246 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 246 ------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp ------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred ------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 00111111111223458899999999999999999999987544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.34 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=198.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CC-cEEEEEEeccCCCCchHHHHHHHHHHhhccCCC------cceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn------Iv~l~g~~~~~~~ 339 (615)
.++|++.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|++++++++|++ ++.+.+++.. .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--H 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--T
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--C
Confidence 468999999999999999999964 34 78999999743 233467889999999998766 8999998874 4
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEE------------
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL------------ 407 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl------------ 407 (615)
...++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccc
Confidence 5899999999 667777775422 235899999999999999999999998 9999999999999
Q ss_pred -------cCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007160 408 -------ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ 480 (615)
Q Consensus 408 -------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~ 480 (615)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999999998754332 34579999999999999999999999999999999999999997543
Q ss_pred CCCcchhhHhhhhhhcc-ch---------------------------hhhhhcCCc-cCCCCCHHHHHHHHHHHHHcccc
Q 007160 481 PSGQENLVTWARPILRD-KD---------------------------RLEELADPR-LGGKYPKEDFIRVCTIAAACVAP 531 (615)
Q Consensus 481 ~~~~~~l~~~~~~~~~~-~~---------------------------~l~~i~d~~-l~~~~~~~~~~~l~~Li~~Cl~~ 531 (615)
.... .......... .. .......+. ............+.+|+.+||+.
T Consensus 244 ~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 NREH---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp HHHH---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred HHHH---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 2111 1111100000 00 000000000 00011223345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 007160 532 EANQRPTMGEVVQS 545 (615)
Q Consensus 532 dP~~RPsm~eVl~~ 545 (615)
||++|||+.|++++
T Consensus 321 dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 321 DPAQRITLAEALLH 334 (355)
T ss_dssp STTTSCCHHHHTTS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999876
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=332.95 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=196.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc--hHHHHHHHHHHhhccCCCcceEEEEeecCCC----C
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~----~ 340 (615)
.++|.+.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|+.++++++||||+++++++...+. .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999964 68999999997543322 3578899999999999999999999874332 2
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
..++||||++ |+|.+++.. .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 3599999997 699888753 3889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-----
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI----- 494 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~----- 494 (615)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.......
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT 245 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 9865432 234578999999999887 678999999999999999999999997543211 111000000
Q ss_pred -----hccc---hhhhhhcC---CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 -----LRDK---DRLEELAD---PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 -----~~~~---~~l~~i~d---~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+.+. ..+..+.. +.+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00000000 000 01112234468899999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=336.32 Aligned_cols=199 Identities=25% Similarity=0.314 Sum_probs=168.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CC-----CcceEEEEeecCCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HR-----NLVKLVGYYSSRDS 339 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hp-----nIv~l~g~~~~~~~ 339 (615)
..++|++.+.||+|+||+||+|+.. +++.||||++... .....++.+|+++++.++ |+ +|+++++++.. .
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--R 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--T
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--C
Confidence 4578999999999999999999965 6889999999742 222456788999998885 55 49999999874 4
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh--CCCCcEEeccCCCCCeEEc--CCCcEEE
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE--DSQPCVIHRDFKASNILLE--NNFHAKV 415 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~--~~~~~ivHrDIkp~NILl~--~~~~vkL 415 (615)
...++||||++ |+|.+++.... ...+++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred CceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence 58999999996 59999997532 2358999999999999999999995 45 99999999999994 5788999
Q ss_pred EeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007160 416 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 479 (615)
Q Consensus 416 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~ 479 (615)
+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 203 ~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 203 VDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998765432 3457899999999999999999999999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=324.70 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=178.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc-h-HHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG-D-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~-~-~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
.++|++.+.||+|+||.||+|+.. +|+.||||++....... . +.+..+..+++.++||||+++++++. +....++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI--TNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cCCcEEE
Confidence 467999999999999999999975 68999999997553322 2 23444555678889999999999987 4458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
||||+ ++.+..+.... ...+++..++.++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 102 v~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999 55555555321 23589999999999999999999985 8 99999999999999999999999999976
Q ss_pred CCCCCccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 498 (615)
...... .....||+.|+|||++. ...++.++||||||+++|||++|+.||...... ...........
T Consensus 175 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~ 246 (318)
T 2dyl_A 175 LVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE 246 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC
T ss_pred ccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC
Confidence 644321 23457999999999984 557889999999999999999999999743211 11111111110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+.+.. .......+.+++.+||+.||.+||++.|++++-.
T Consensus 247 -------~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 247 -------PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp -------CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred -------CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 011100 0112235889999999999999999999998743
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=340.79 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=186.7
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
..+|+..++||+|+||+||.....+|+.||||++.... ...+.+|+++|+++ +|||||++++++. +....++||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEK--DRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEE--ETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCEEEEEE
Confidence 45689999999999999766556678999999997433 23467899999999 7999999999987 445789999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-----CCcEEEEecccc
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLA 421 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkL~DFGla 421 (615)
||+. |+|.+++.... ..+.+..++.++.||++||+|||+.+ |+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 69999997532 23556678899999999999999999 999999999999943 346889999999
Q ss_pred ccCCCCCcc-ccceeeccccccCCccccc---cCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 422 KQAPEGRTN-YLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 422 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
+........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... . ......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~----~~~~~~ 243 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---Q----ANILLG 243 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---H----HHHHTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---H----HHHHhc
Confidence 877543221 1234467999999999997 4567889999999999999999 99998532211 0 000000
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... .. ..........+.+|+.+||+.||++|||+.||++|
T Consensus 244 -~~~~-----~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 244 -ACSL-----DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -CCCC-----TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cCCc-----cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 00 01112334457899999999999999999999965
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=353.92 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=192.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCC---c
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS---Q 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~---~ 341 (615)
.++|++.+.||+|+||.||+|.+. +|+.||||++..... .....|.+|++++++++||||+++++++...+.. .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 589999999875432 2345789999999999999999999998754321 1
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.+|||||+++++|.+++.. .++|.+++.++.||++||.|||+.+ |+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999988753 5899999999999999999999999 9999999999999986 8999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
+..... ....||+.|+|||++.+.. +.++|||||||+||||++|..||........ ..
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------~~---- 286 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------PE---- 286 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------CT----
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------cc----
Confidence 876543 3357999999999987654 8999999999999999999888753211100 00
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHhHh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQSLKMVQR 551 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-m~eVl~~L~~i~~ 551 (615)
..........+.+++.+||+.||++||+ ++++.+.|..+.+
T Consensus 287 ---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 ---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000111235789999999999999995 6666666766544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.73 Aligned_cols=254 Identities=14% Similarity=0.172 Sum_probs=186.8
Q ss_pred HhcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC---chHHHHHHHHHHhhccC-CCcce------------
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHH-RNLVK------------ 329 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H-pnIv~------------ 329 (615)
.+.+|...++||+|+||.||+|+. .+|+.||||++...... ..+.|.+|+.+++.++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688889999999999999995 47899999998844322 25789999999999987 32111
Q ss_pred ---------EEEEeecCC---CCceeEEEecCCCCChhHhhcCC---CCCcccCChhhHHHHHHHHHHHHHHhHhCCCCc
Q 007160 330 ---------LVGYYSSRD---SSQHLLCYELVPNGSLESWLHGP---LGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 394 (615)
Q Consensus 330 ---------l~g~~~~~~---~~~~~LV~Ey~~~gsL~~~L~~~---~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ 394 (615)
+..++.... ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 111111111 22456667665 78999988411 122456889999999999999999999999
Q ss_pred EEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCcccc----------ccCcCCchhhHHHHHH
Q 007160 395 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA----------MTGHLLVKSDVYSYGV 464 (615)
Q Consensus 395 ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~ksDVwS~Gv 464 (615)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865432 234567 999999999 5556889999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 007160 465 VLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544 (615)
Q Consensus 465 vL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~ 544 (615)
++|||++|+.||........ ...+.... ..++ ..+.+|+.+||+.||++||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~----------------~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG----------------SEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC----------------SGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhh----------------HHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999974332111 00111100 1233 35889999999999999999999977
Q ss_pred H--HHHhHhh
Q 007160 545 S--LKMVQRV 552 (615)
Q Consensus 545 ~--L~~i~~~ 552 (615)
+ ++.+.+.
T Consensus 364 ~~~~~~~~~~ 373 (413)
T 3dzo_A 364 TPEYEQLRTE 373 (413)
T ss_dssp SHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 6 4444433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=348.64 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC-CCchHHHHHHHHHHhhccCCCcceEEEEeec----CCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS----RDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~~ 342 (615)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.|.+|++++++++||||+++++++.. .+....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999996 468999999987542 2234679999999999999999999998754 225678
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCc---EEEEecc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFG 419 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~DFG 419 (615)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999986332 235899999999999999999999999 999999999999987654 9999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ....|.........
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC----
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccc
Confidence 9987654432 244679999999999999999999999999999999999999996431 11222221111000
Q ss_pred hhhhhcCC------------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 007160 500 RLEELADP------------RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 543 (615)
Q Consensus 500 ~l~~i~d~------------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl 543 (615)
....... .............+.+++.+||+.||++|||+.|++
T Consensus 242 -~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 242 -EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred -hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000000 001223445667899999999999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.50 Aligned_cols=233 Identities=14% Similarity=0.101 Sum_probs=181.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+.. +|+.||||++....... .+.|.+|++++.+++||||+++++++.. ....++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence 57999999999999999999975 48999999998654332 3679999999999999999999999874 457999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++++|.++++.. ....++.+++.|++.||+|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999641 345578899999999999999999 9999999999999999999997443
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
|++| ++.++|||||||++|||++|+.||.......... .+............
T Consensus 175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~- 226 (286)
T 3uqc_A 175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQPIEPA- 226 (286)
T ss_dssp -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSCBCCHH-
T ss_pred -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccCCCChh-
Confidence 4443 6889999999999999999999997554322110 00000000000000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
.....++ ..+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 227 ---~~~~~~~----~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 ---DIDRDIP----FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ---HHCTTSC----HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ---hcccCCC----HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0111222 348899999999999999 9999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.98 Aligned_cols=234 Identities=22% Similarity=0.292 Sum_probs=180.8
Q ss_pred hcCcccc-eeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHH-hhccCCCcceEEEEeec--CCCCce
Q 007160 268 TNNFEPA-SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEML-SRLHHRNLVKLVGYYSS--RDSSQH 342 (615)
Q Consensus 268 ~~~f~~~-~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l-~~l~HpnIv~l~g~~~~--~~~~~~ 342 (615)
.++|.+. +.||+|+||.||++.. .+++.||||++.. ...+.+|++++ +.++||||+++++++.. .+....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567777 7899999999999996 4689999999863 35678899988 55689999999999864 234578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEEecc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG 419 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFG 419 (615)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999997532 235899999999999999999999999 999999999999998 7899999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
++.... +..++.++|||||||++|||++|+.||.......... ...
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~--- 211 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMK--- 211 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSC---
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHH---
Confidence 986532 2346789999999999999999999996433211000 000
Q ss_pred hhhhhcCCccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 500 RLEELADPRLGGKYP----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
..+.... ...+ ......+.+++.+||+.||++|||+.|++++-+..
T Consensus 212 --~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 212 --TRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp --CSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --HHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 0000000 0111 11234588999999999999999999999885543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.66 Aligned_cols=245 Identities=18% Similarity=0.204 Sum_probs=186.0
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCC--------CchHHHHHHHHHHhhcc---------CCCcceE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--------QGDKEFLVEVEMLSRLH---------HRNLVKL 330 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~---------HpnIv~l 330 (615)
.++|++.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|++++++++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45789999999999999999998 689999999986532 22378999999999886 7888877
Q ss_pred EEEeecC----------------------------CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHH
Q 007160 331 VGYYSSR----------------------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382 (615)
Q Consensus 331 ~g~~~~~----------------------------~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~ 382 (615)
.+++... +....+|||||+++|++.+.+.. ..+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 7764211 25689999999999987777743 34899999999999999
Q ss_pred HHHHhH-hCCCCcEEeccCCCCCeEEcCCC--------------------cEEEEeccccccCCCCCccccceeeccccc
Q 007160 383 GLAYLH-EDSQPCVIHRDFKASNILLENNF--------------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441 (615)
Q Consensus 383 gL~yLH-~~~~~~ivHrDIkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 441 (615)
||+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 899 99999999999999887 8999999999876432 3479999
Q ss_pred cCCccccccCcCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc-CCccCCCCCHHHHH
Q 007160 442 YVAPEYAMTGHLLVKSDVYSYGVV-LLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA-DPRLGGKYPKEDFI 519 (615)
Q Consensus 442 y~APE~~~~~~~s~ksDVwS~Gvv-L~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~-d~~l~~~~~~~~~~ 519 (615)
|+|||++.+.. +.++||||+|++ .+++++|..||.. ..|...... ..+.... ..............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTD--KMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHH--HHHHTCCCSSCCCSHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHH--hhhhhhccCcccchhhhhhcCH
Confidence 99999998766 899999998777 7778889998741 111111100 0000000 00111111234556
Q ss_pred HHHHHHHHccccCCCCCCCHHHHH-HH
Q 007160 520 RVCTIAAACVAPEANQRPTMGEVV-QS 545 (615)
Q Consensus 520 ~l~~Li~~Cl~~dP~~RPsm~eVl-~~ 545 (615)
.+.+|+.+||+.| |++|++ +|
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 7899999999976 999988 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=284.51 Aligned_cols=185 Identities=18% Similarity=0.125 Sum_probs=129.2
Q ss_pred eeeccCceEEEEEE-ECCCcEEEEEEeccCCC----------CchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCcee
Q 007160 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ----------QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 276 ~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~----------~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 343 (615)
..+.|++|.+..++ +-.|+.||||.+..... ...++|.+|+++|+++ +|+||++++++++ +....|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--d~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--NAQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--CSSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--ECCEEE
Confidence 45677777777655 33588899999975421 1235799999999999 7999999999987 556899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
|||||++|++|.++|... ..++. .+|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.
T Consensus 319 LVMEyv~G~~L~d~i~~~----~~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAG----EEIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EEEECCCSEEHHHHHHTT----CCCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EEEecCCCCcHHHHHHhC----CCCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCee
Confidence 999999999999999752 34544 358999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCC
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 475 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~P 475 (615)
...... .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 389 ~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 754432 2345689999999998865 467789999999998888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-27 Score=260.72 Aligned_cols=186 Identities=16% Similarity=0.175 Sum_probs=145.2
Q ss_pred ccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCc--------hHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 272 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
...++||+|+||.||+|.. .++.+++|+........ .+.|.+|++++++++||||+++..++.. ....+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTTE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCccE
Confidence 4467899999999999955 46889999875432211 2358999999999999999955555543 34679
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
|||||+++|+|.++++. ++.++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+++.
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999999973 5689999999999999999 999999999999998 999999999998
Q ss_pred CCCCCccc-----cceeeccccccCCcccccc--CcCCchhhHHHHHHHHHHHHhCCCCCC
Q 007160 424 APEGRTNY-----LSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVD 477 (615)
Q Consensus 424 ~~~~~~~~-----~~~~~~gt~~y~APE~~~~--~~~s~ksDVwS~GvvL~ElltG~~Pf~ 477 (615)
........ ......||+.|||||++.. ..|+..+|+|+..+-.++-+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 75532211 1235689999999999986 678889999999999999888877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=216.47 Aligned_cols=154 Identities=16% Similarity=0.117 Sum_probs=123.6
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC------------------chHHHHHHHHHHhhc
Q 007160 261 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ------------------GDKEFLVEVEMLSRL 322 (615)
Q Consensus 261 ~~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~------------------~~~~f~~Ei~~l~~l 322 (615)
...+......|++.+.||+|+||.||+|...+|+.||||.+...... ....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34445556677888999999999999999977999999999643211 235689999999999
Q ss_pred cCCCcceEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCC
Q 007160 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA 402 (615)
Q Consensus 323 ~HpnIv~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp 402 (615)
+ | +++.+++.. ...++||||+++|+|.+ +.. .....++.|+++||.|||+.+ |+||||||
T Consensus 162 ~--~-~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp 221 (282)
T 1zar_A 162 Q--G-LAVPKVYAW---EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQ 221 (282)
T ss_dssp T--T-SSSCCEEEE---ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred c--C-CCcCeEEec---cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCH
Confidence 9 4 666665532 35799999999999998 531 345579999999999999999 99999999
Q ss_pred CCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCcccccc
Q 007160 403 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 450 (615)
Q Consensus 403 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~ 450 (615)
+|||++ ++.+||+|||+++.. ..|+|||++..
T Consensus 222 ~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 222 YNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp TSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred HHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence 999999 999999999999642 34788997743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=181.12 Aligned_cols=137 Identities=19% Similarity=0.144 Sum_probs=108.4
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcE--EEEEEeccCCCCc------------------------hHHHHHHHHHHhhc
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTA--VAIKRLTCGGQQG------------------------DKEFLVEVEMLSRL 322 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~--VAVK~l~~~~~~~------------------------~~~f~~Ei~~l~~l 322 (615)
-|++.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+++|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999997 68888 9999875432110 12578899999999
Q ss_pred cCCCc--ceEEEEeecCCCCceeEEEecCCC-C----ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhH-hCCCCc
Q 007160 323 HHRNL--VKLVGYYSSRDSSQHLLCYELVPN-G----SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH-EDSQPC 394 (615)
Q Consensus 323 ~HpnI--v~l~g~~~~~~~~~~~LV~Ey~~~-g----sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH-~~~~~~ 394 (615)
+|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g--- 191 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE--- 191 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---
Confidence 98864 344432 256899999942 4 66665431 345678899999999999999 888
Q ss_pred EEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 395 VIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 395 ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
|+||||||+|||+++ .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999998 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=9.4e-17 Score=170.52 Aligned_cols=140 Identities=16% Similarity=0.190 Sum_probs=103.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCC--------------CchHHH--------HHHHHHHhhcc
Q 007160 266 EATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--------------QGDKEF--------LVEVEMLSRLH 323 (615)
Q Consensus 266 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------------~~~~~f--------~~Ei~~l~~l~ 323 (615)
....-|++.+.||+|+||.||+|...+|+.||||+++.... .....+ .+|...|.++.
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 33344899999999999999999998999999998753210 011122 24566666665
Q ss_pred CCCcc--eEEEEeecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCC
Q 007160 324 HRNLV--KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 401 (615)
Q Consensus 324 HpnIv--~l~g~~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIk 401 (615)
+.++. ..+++ ...+|||||+++++|.++... .....++.|++.+|.|||+.+ |||||||
T Consensus 172 ~~gv~vp~p~~~------~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLK 232 (397)
T 4gyi_A 172 EEGFPVPEPIAQ------SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFN 232 (397)
T ss_dssp HTTCSCCCEEEE------ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred hcCCCCCeeeec------cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence 44432 22222 134799999999998765431 344678899999999999999 9999999
Q ss_pred CCCeEEcCCC----------cEEEEeccccccC
Q 007160 402 ASNILLENNF----------HAKVADFGLAKQA 424 (615)
Q Consensus 402 p~NILl~~~~----------~vkL~DFGla~~~ 424 (615)
|.|||+++++ .+.|+||+.+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999998776 4899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=6.5e-12 Score=126.11 Aligned_cols=148 Identities=16% Similarity=0.097 Sum_probs=115.7
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCc
Q 007160 263 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 263 el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 341 (615)
.+.....+|++...++.|+++.||+.... ++.+++|+...........+.+|+++++.+. |.++.++++++. +...
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~ 84 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGW 84 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe--cCCc
Confidence 34455678988899999999999998764 6789999987532223446889999999985 677888998876 3457
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-------------------------------
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED------------------------------- 390 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~------------------------------- 390 (615)
.++||||++|.+|.+.+. +......++.+++++|..||+.
T Consensus 85 ~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred eEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 899999999999987642 1233457889999999999981
Q ss_pred -------------------------CCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 391 -------------------------SQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 391 -------------------------~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
.++.++|+|+++.|||++++..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11559999999999999877667899998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.4e-11 Score=122.68 Aligned_cols=139 Identities=19% Similarity=0.120 Sum_probs=101.2
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc--ceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI--v~l~g~~~~~~~~~~~LV 345 (615)
..++.+..+.+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.++ .+++++.. +.+..++|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc--CCCCCEEE
Confidence 3445554444466679999998777888999997643 23567889999999975554 45888765 33468999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC----------------------------------
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS---------------------------------- 391 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~---------------------------------- 391 (615)
|||++|.+|. ... .....++.++++.|..||...
T Consensus 94 ~e~i~G~~l~--~~~----------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH----------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EECCSSEETT--TSC----------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEecCCcccC--cCc----------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 9999998884 221 112356777778888888643
Q ss_pred ---------------------CCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 392 ---------------------QPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 392 ---------------------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++.++|+|+++.|||++++..+.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 23499999999999998876678999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=7.7e-10 Score=116.43 Aligned_cols=145 Identities=14% Similarity=0.162 Sum_probs=107.4
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEEec--cCC-CCchHHHHHHHHHHhhcc--CCCcceEEEEeecCCC-CceeEEE
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGG-QQGDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS-SQHLLCY 346 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~--~~~-~~~~~~f~~Ei~~l~~l~--HpnIv~l~g~~~~~~~-~~~~LV~ 346 (615)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +.++.++++++...+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35779999999999988754 578888775 322 122456888999999997 4567888888764321 4578999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC-----------------------------------
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS----------------------------------- 391 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~----------------------------------- 391 (615)
||++|..+.+... ..++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999988854221 23677888899999999999999731
Q ss_pred --------------------CCcEEeccCCCCCeEEcCCCc--EEEEeccccccC
Q 007160 392 --------------------QPCVIHRDFKASNILLENNFH--AKVADFGLAKQA 424 (615)
Q Consensus 392 --------------------~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~~~ 424 (615)
.+.++|+|+++.|||++.++. +.|.||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 357999999999999987653 689999998653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=5.6e-10 Score=114.76 Aligned_cols=189 Identities=21% Similarity=0.281 Sum_probs=122.5
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCC--cceEEEEeecCCC-CceeEEEecC
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRN--LVKLVGYYSSRDS-SQHLLCYELV 349 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-Hpn--Iv~l~g~~~~~~~-~~~~LV~Ey~ 349 (615)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++......+. ...++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56888986522 23467889999999884 333 3345444322111 2358899999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC---------------------------------------
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED--------------------------------------- 390 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~--------------------------------------- 390 (615)
+|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988875332 1356677778888888888888861
Q ss_pred ----------------CCCcEEeccCCCCCeEEcC--CCcEEEEeccccccCCCCCccc-cc-----------eeecccc
Q 007160 391 ----------------SQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQAPEGRTNY-LS-----------TRVMGTF 440 (615)
Q Consensus 391 ----------------~~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~-~~-----------~~~~gt~ 440 (615)
..+.++|+|+++.||++++ +..+.|+||+.+........-. .. .......
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1356999999999999988 5668899999987543211000 00 0001111
Q ss_pred ccCC-ccccccCcCCchhhHHHHHHHHHHHHhCCCCC
Q 007160 441 GYVA-PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 476 (615)
Q Consensus 441 ~y~A-PE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf 476 (615)
++.. |+.... .....+.|++|.++|++.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1222 222211 122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=7.1e-07 Score=89.45 Aligned_cols=142 Identities=15% Similarity=0.123 Sum_probs=99.6
Q ss_pred hcCcccceeeeccCce-EEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeE
Q 007160 268 TNNFEPASILGEGGFG-RVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG-~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~L 344 (615)
...|+. +.+..|..| .||+.... ++..+++|+-.. ....++.+|...|+.+. +-.+-++++++.. .+..++
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~l 97 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWL 97 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEE
Confidence 334443 445566665 69987754 466789998652 23457888999999885 3346678888764 357899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC---------------------------------
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--------------------------------- 391 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--------------------------------- 391 (615)
|||+++|.++.+.... .......+..++++.|..||...
T Consensus 98 vme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp EEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred EEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 9999999888775531 12334456666677777777531
Q ss_pred ----------------------CCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 392 ----------------------QPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 392 ----------------------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 23589999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.4e-06 Score=89.59 Aligned_cols=138 Identities=22% Similarity=0.184 Sum_probs=93.4
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCC---CcceEEEEeecCCCCceeEEEecCC
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR---NLVKLVGYYSSRDSSQHLLCYELVP 350 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp---nIv~l~g~~~~~~~~~~~LV~Ey~~ 350 (615)
.+.++.|....||+. |..++||+-.. ......+.+|.++|+.+.+. .+.+.+.++.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccC
Confidence 466889999999987 56688888531 12346788999999999753 34566666542 3346789999999
Q ss_pred CCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC----------------------------------------
Q 007160 351 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---------------------------------------- 390 (615)
Q Consensus 351 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~---------------------------------------- 390 (615)
|.+|.+.... .++..++..++.++++.|+.||+.
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9888763211 123334444444444444444432
Q ss_pred -----------------CCCcEEeccCCCCCeEEcC---CCc-EEEEeccccccC
Q 007160 391 -----------------SQPCVIHRDFKASNILLEN---NFH-AKVADFGLAKQA 424 (615)
Q Consensus 391 -----------------~~~~ivHrDIkp~NILl~~---~~~-vkL~DFGla~~~ 424 (615)
.++.++|+|+++.|||++. ++. +.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3456899999999999987 355 589999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.5e-06 Score=90.99 Aligned_cols=83 Identities=6% Similarity=-0.070 Sum_probs=56.8
Q ss_pred ceee-eccCceEEEEEEEC-------CCcEEEEEEeccCC---CCchHHHHHHHHHHhhcc-C--CCcceEEEEeecCC-
Q 007160 274 ASIL-GEGGFGRVFKGVLS-------DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-H--RNLVKLVGYYSSRD- 338 (615)
Q Consensus 274 ~~~L-G~G~fG~Vykg~~~-------~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-H--pnIv~l~g~~~~~~- 338 (615)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+. + -.+.++++++...+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998764 26678888765322 111246788999998885 3 35667887765321
Q ss_pred CCceeEEEecCCCCChhH
Q 007160 339 SSQHLLCYELVPNGSLES 356 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~ 356 (615)
.+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 134689999999877654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.3e-05 Score=81.37 Aligned_cols=80 Identities=20% Similarity=0.211 Sum_probs=60.2
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccC---CCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH---RNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---pnIv~l~g~~~~~~~~~~~LV 345 (615)
..+...+.+|.|..+.||+.++.||+.|.||+-..........|.+|.+.|+.|.. -.+.+.+++. .-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceEE
Confidence 45566788999999999999999999999998765544444568899999998842 2344555542 23789
Q ss_pred EecCCCCCh
Q 007160 346 YELVPNGSL 354 (615)
Q Consensus 346 ~Ey~~~gsL 354 (615)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999988754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.9e-05 Score=83.88 Aligned_cols=75 Identities=17% Similarity=0.123 Sum_probs=49.7
Q ss_pred ceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-------CchHHHHHHHHHHhhccC--CCcc-eEEEEeecCCCCce
Q 007160 274 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-------QGDKEFLVEVEMLSRLHH--RNLV-KLVGYYSSRDSSQH 342 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~H--pnIv-~l~g~~~~~~~~~~ 342 (615)
.+.||.|.++.||++... +++.|+||....... .....+..|.++|+.+.. +..+ +++.+. ....
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d----~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc----CCcc
Confidence 567999999999999754 467899997653211 123457889999988743 3444 555442 2246
Q ss_pred eEEEecCCCC
Q 007160 343 LLCYELVPNG 352 (615)
Q Consensus 343 ~LV~Ey~~~g 352 (615)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.8e-05 Score=81.61 Aligned_cols=143 Identities=22% Similarity=0.279 Sum_probs=80.7
Q ss_pred eeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccC--CCcceEEEEee----cCCCCceeEEEec
Q 007160 275 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYS----SRDSSQHLLCYEL 348 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--pnIv~l~g~~~----~~~~~~~~LV~Ey 348 (615)
+.|+.|..+.||+....+| .+++|+... ....+..|+++++.+.. -.+.+++.... ....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999988655 488998864 23445556666666642 12333332100 0123467899999
Q ss_pred CCCCChh--------------HhhcC----C--C-CC---cccCChhhHH------------------------------
Q 007160 349 VPNGSLE--------------SWLHG----P--L-GV---NCHLDWETRM------------------------------ 374 (615)
Q Consensus 349 ~~~gsL~--------------~~L~~----~--~-~~---~~~l~~~~~~------------------------------ 374 (615)
++|..+. ..+|. . . .. ...-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11121 0 0 00 0011232110
Q ss_pred -HHHHHHHHHHHHhHh----------CCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 375 -KIALDAARGLAYLHE----------DSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 375 -~ia~qia~gL~yLH~----------~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
.+...+.+++.+|+. ..++.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666763 124569999999999999888899999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00016 Score=74.49 Aligned_cols=140 Identities=17% Similarity=0.187 Sum_probs=90.9
Q ss_pred cceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc---CCCcceEEEEeecCCCCceeEEEecC
Q 007160 273 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
..+.|+.|....+|+... ++..+++|+.... ....|..|.+.|+.|. ...+.+.++++.. ....++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEec
Confidence 356799999999999876 4667889987532 3567889999999884 3567788887653 35789999999
Q ss_pred CCCChhH-----------hhcCCCC---Cc---------------ccCChhhHH---HHH--HH--------------HH
Q 007160 350 PNGSLES-----------WLHGPLG---VN---------------CHLDWETRM---KIA--LD--------------AA 381 (615)
Q Consensus 350 ~~gsL~~-----------~L~~~~~---~~---------------~~l~~~~~~---~ia--~q--------------ia 381 (615)
++..+.. .||.... .. ..-+|.... ++. .+ +.
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9986521 2222111 00 011343221 111 11 11
Q ss_pred HH-HHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 382 RG-LAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 382 ~g-L~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
.- ...|.. ..+|.++|+|+.+.|++++.++ +.|.||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 123332 3467899999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00031 Score=75.23 Aligned_cols=78 Identities=14% Similarity=0.135 Sum_probs=49.7
Q ss_pred CCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeec--cccccCCccccccC---cCCchhhHHHHHHH
Q 007160 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM--GTFGYVAPEYAMTG---HLLVKSDVYSYGVV 465 (615)
Q Consensus 391 ~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~---~~s~ksDVwS~Gvv 465 (615)
..+.++|+|+++.|||++.++ ++|+||+.+........- .... -...|++|+..... .-....++......
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 356699999999999998876 999999998754321100 0001 12346666655321 12234566788888
Q ss_pred HHHHHhC
Q 007160 466 LLELLTG 472 (615)
Q Consensus 466 L~ElltG 472 (615)
+|+.+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0004 Score=71.05 Aligned_cols=161 Identities=14% Similarity=0.150 Sum_probs=90.5
Q ss_pred CCHHHHHHHhcCccc-----ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc--ceEE
Q 007160 259 LAYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLV 331 (615)
Q Consensus 259 ~~~~el~~~~~~f~~-----~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI--v~l~ 331 (615)
++.+++......|.+ .+.|+.|....+|+....+| .+++|..... .....+..|++++..+...++ .+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 556677777666754 24567788899999988666 5888988642 123456678888887753232 3333
Q ss_pred EEeec----CCCCceeEEEecCCCCChhH--------------hhcCC-CC--Cc-----ccCChhhHHH----------
Q 007160 332 GYYSS----RDSSQHLLCYELVPNGSLES--------------WLHGP-LG--VN-----CHLDWETRMK---------- 375 (615)
Q Consensus 332 g~~~~----~~~~~~~LV~Ey~~~gsL~~--------------~L~~~-~~--~~-----~~l~~~~~~~---------- 375 (615)
..... ...+..+++++|++|..+.. .+|.. .. .. ....|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21100 01235688999999865421 11110 00 00 0012322111
Q ss_pred --HHHHHHHHHHHhHhC----CCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 376 --IALDAARGLAYLHED----SQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 376 --ia~qia~gL~yLH~~----~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
+...+.+.+++|+.. .++.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234445555532 24569999999999999987666899998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00084 Score=68.24 Aligned_cols=140 Identities=11% Similarity=0.060 Sum_probs=77.6
Q ss_pred ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcc-eEEEEeecCCCCceeEEEecC-CC
Q 007160 274 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELV-PN 351 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~LV~Ey~-~~ 351 (615)
.+.|+.|....+|+. ..+++|+....... ..+..+|+.+++.+...++. ++++++ ...-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~----~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD----PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC----TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE----CCCCEEEEeecCCC
Confidence 678999999999998 45888887643211 12345688888877543343 565543 22347899999 65
Q ss_pred CChhH------------------hhcCCCC-CcccCC-hhhHHHHHHH--------------HHHHH----HHhHh-CCC
Q 007160 352 GSLES------------------WLHGPLG-VNCHLD-WETRMKIALD--------------AARGL----AYLHE-DSQ 392 (615)
Q Consensus 352 gsL~~------------------~L~~~~~-~~~~l~-~~~~~~ia~q--------------ia~gL----~yLH~-~~~ 392 (615)
.+|.. .||.... .....+ +.....+... +.+.+ ..|.. ..+
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 44421 1121110 000011 1111111100 11111 11211 234
Q ss_pred CcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 393 PCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 393 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
+.++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 56999999999999 55667899999987643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00064 Score=73.13 Aligned_cols=73 Identities=23% Similarity=0.279 Sum_probs=51.1
Q ss_pred ceeeeccCceEEEEEEECC--------CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc-ceEEEEeecCCCCceeE
Q 007160 274 ASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~~~L 344 (615)
.+.|+.|....+|+....+ +..+++|+.... .....+.+|..+++.+...++ .++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C----CE
Confidence 3678888899999998753 478899987431 112566789999998864444 56776643 2 38
Q ss_pred EEecCCCCCh
Q 007160 345 CYELVPNGSL 354 (615)
Q Consensus 345 V~Ey~~~gsL 354 (615)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 8999987444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0031 Score=64.58 Aligned_cols=161 Identities=16% Similarity=0.147 Sum_probs=90.6
Q ss_pred CCHHHHHHHhcCccc-----ceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCC--cceEE
Q 007160 259 LAYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLV 331 (615)
Q Consensus 259 ~~~~el~~~~~~f~~-----~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hpn--Iv~l~ 331 (615)
++.+++....+.|.+ ...|+ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 455555555444432 34576 88889999877777789999986332 23567778999888875322 34444
Q ss_pred EEeecC----CCCceeEEEecCCCCChhH-----------h---hcC----CC-CCcccCChhhH----HHH--------
Q 007160 332 GYYSSR----DSSQHLLCYELVPNGSLES-----------W---LHG----PL-GVNCHLDWETR----MKI-------- 376 (615)
Q Consensus 332 g~~~~~----~~~~~~LV~Ey~~~gsL~~-----------~---L~~----~~-~~~~~l~~~~~----~~i-------- 376 (615)
.. ... ..+..+++|+|++|..+.. . +|. .. .....+++... ..+
T Consensus 89 ~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 89 AF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred ec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 32 100 1235578999998854321 0 111 00 00111222111 000
Q ss_pred -------HHHHHHHHHHhHh----CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 377 -------ALDAARGLAYLHE----DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 377 -------a~qia~gL~yLH~----~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
...+.+.++.+.. ..++.++|+|+++.|||++ + .+.|+||+.+...
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1111112222222 1345689999999999999 4 8999999887543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0029 Score=65.04 Aligned_cols=144 Identities=17% Similarity=0.111 Sum_probs=73.9
Q ss_pred eeeeccCceE-EEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCC--CcceEEEEeecCCCCceeEEEecCCC
Q 007160 275 SILGEGGFGR-VFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLVGYYSSRDSSQHLLCYELVPN 351 (615)
Q Consensus 275 ~~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--nIv~l~g~~~~~~~~~~~LV~Ey~~~ 351 (615)
+.|+.|+... +|+....+|..+++|...... ..++..|+.+++.+... .+.+++.+.. +.+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCC--EEEEeeCCC
Confidence 4465555554 667665446677777654321 13345677777776432 3456666532 222 789999987
Q ss_pred CChhHhhcCC---------------------CCC-cccCChhhHH-------H-------------HHHHHHHHHHHhH-
Q 007160 352 GSLESWLHGP---------------------LGV-NCHLDWETRM-------K-------------IALDAARGLAYLH- 388 (615)
Q Consensus 352 gsL~~~L~~~---------------------~~~-~~~l~~~~~~-------~-------------ia~qia~gL~yLH- 388 (615)
..+.+++... ... ...++..... . ....+.+.+..|.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 6665443211 000 0011110000 0 0001111222221
Q ss_pred --hCCCCcEEeccCCCCCeEEcCC----CcEEEEeccccccCC
Q 007160 389 --EDSQPCVIHRDFKASNILLENN----FHAKVADFGLAKQAP 425 (615)
Q Consensus 389 --~~~~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~~~~ 425 (615)
...++.++|+|+.+.||+++.+ ..+.|+||+.+....
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1234579999999999999874 689999999887543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0016 Score=68.93 Aligned_cols=141 Identities=20% Similarity=0.240 Sum_probs=83.0
Q ss_pred eeeeccCceEEEEEEEC--------CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc-ceEEEEeecCCCCceeEE
Q 007160 275 SILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~~~LV 345 (615)
+.|..|-...+|+.... +++.+++|+... .......+.+|.++++.+...++ .++++++. + .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C----ccE
Confidence 56777888889998864 247888988632 22345667799999998853333 45666653 2 289
Q ss_pred EecCCCCChhHh-----------------hcCCC-CCcccC--ChhhHHHHHHHHHH-------------------HHHH
Q 007160 346 YELVPNGSLESW-----------------LHGPL-GVNCHL--DWETRMKIALDAAR-------------------GLAY 386 (615)
Q Consensus 346 ~Ey~~~gsL~~~-----------------L~~~~-~~~~~l--~~~~~~~ia~qia~-------------------gL~y 386 (615)
|||++|.+|..- ||... ...... -|.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998665311 12110 011112 24455555444322 1223
Q ss_pred h----HhC-CCCcEEeccCCCCCeEEcCC----CcEEEEeccccc
Q 007160 387 L----HED-SQPCVIHRDFKASNILLENN----FHAKVADFGLAK 422 (615)
Q Consensus 387 L----H~~-~~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~ 422 (615)
| ... .+..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3 222 23469999999999999876 789999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0029 Score=68.56 Aligned_cols=74 Identities=14% Similarity=0.026 Sum_probs=48.5
Q ss_pred ceeeeccCceEEEEEEECC-CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc-ceEEEEeecCCCCceeEEEecCCC
Q 007160 274 ASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLLCYELVPN 351 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~~~LV~Ey~~~ 351 (615)
.+.|+.|-...+|+....+ +..+++|+..... ...-+..+|..++..|...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C----eEEEEeeCC
Confidence 4678889899999998865 4778888774322 111123579999998875555 46776652 2 259999998
Q ss_pred CCh
Q 007160 352 GSL 354 (615)
Q Consensus 352 gsL 354 (615)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0022 Score=67.09 Aligned_cols=74 Identities=14% Similarity=0.097 Sum_probs=45.1
Q ss_pred ceeeeccCceEEEEEEECC---------CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcc-eEEEEeecCCCCcee
Q 007160 274 ASILGEGGFGRVFKGVLSD---------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHL 343 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~ 343 (615)
.+.|+.|....+|+....+ +..+++|+..... ....+...|.++++.+...+++ ++++.. + -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~---~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF---N---GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---T---TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec---C---Cc
Confidence 3567788889999988754 2678888765321 1112346788888888644443 666543 1 26
Q ss_pred EEEecCCCCCh
Q 007160 344 LCYELVPNGSL 354 (615)
Q Consensus 344 LV~Ey~~~gsL 354 (615)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999998544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.006 Score=63.21 Aligned_cols=33 Identities=24% Similarity=0.317 Sum_probs=28.6
Q ss_pred CCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 392 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
...++|+|+.+.||++++++.+.|.||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 456999999999999998888999999877643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.20 E-value=0.022 Score=55.05 Aligned_cols=101 Identities=20% Similarity=0.147 Sum_probs=66.0
Q ss_pred CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCccc
Q 007160 352 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431 (615)
Q Consensus 352 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 431 (615)
-+|.+.|.. .+.+++++++|.++.|.+.+|.-+-....+ ..+=+-+..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 378898874 346799999999999999998776221111 1333457899999999988764 1111
Q ss_pred cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCC
Q 007160 432 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473 (615)
Q Consensus 432 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~ 473 (615)
.....+.+||... ...+.+.=|||+|++||.-+--.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122356888653 45578999999999999988633
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.67 E-value=0.027 Score=60.32 Aligned_cols=74 Identities=11% Similarity=0.088 Sum_probs=49.4
Q ss_pred ceeeeccCceEEEEEEECC--------CcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc-ceEEEEeecCCCCceeE
Q 007160 274 ASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~~~L 344 (615)
.+.|..|-...+|+....+ +..+++|+..... ...-+..+|.++++.+...++ .++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~------~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP------EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET------TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC------CCE
Confidence 4567778889999998753 5788888864332 222234678888888853334 45555431 278
Q ss_pred EEecCCCCCh
Q 007160 345 CYELVPNGSL 354 (615)
Q Consensus 345 V~Ey~~~gsL 354 (615)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.99 E-value=0.24 Score=52.24 Aligned_cols=29 Identities=28% Similarity=0.430 Sum_probs=24.5
Q ss_pred cEEeccCCCCCeEE------cCCCcEEEEeccccc
Q 007160 394 CVIHRDFKASNILL------ENNFHAKVADFGLAK 422 (615)
Q Consensus 394 ~ivHrDIkp~NILl------~~~~~vkL~DFGla~ 422 (615)
.++|+|+.+.|||+ +++..++++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46899999999999 456679999998775
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.55 E-value=0.057 Score=38.08 Aligned_cols=26 Identities=19% Similarity=0.117 Sum_probs=14.0
Q ss_pred EehhHHHHHHHHHHHHHHHHHHHhcc
Q 007160 200 IFGIGTGLLITAIISVLIICSCAFRG 225 (615)
Q Consensus 200 ii~i~~~~~~~~l~~~~~~~~~~~r~ 225 (615)
+.++++|+++++++++++++++++|+
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 44555556666555555555544443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.99 E-value=0.068 Score=37.62 Aligned_cols=27 Identities=19% Similarity=0.244 Sum_probs=13.8
Q ss_pred EehhHHHHHHHHHHHHHHHHHHHhccC
Q 007160 200 IFGIGTGLLITAIISVLIICSCAFRGR 226 (615)
Q Consensus 200 ii~i~~~~~~~~l~~~~~~~~~~~r~~ 226 (615)
+.++++|+++++++++++++++++|++
T Consensus 13 A~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 13 AAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 344555565555555555555444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.39 E-value=0.092 Score=36.92 Aligned_cols=26 Identities=19% Similarity=0.276 Sum_probs=13.1
Q ss_pred EehhHHHHHHHHHHHHHHHHHHHhcc
Q 007160 200 IFGIGTGLLITAIISVLIICSCAFRG 225 (615)
Q Consensus 200 ii~i~~~~~~~~l~~~~~~~~~~~r~ 225 (615)
+++.++|++++++++++++++.++|+
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhh
Confidence 45555665544444444444444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.89 E-value=0.13 Score=55.70 Aligned_cols=59 Identities=7% Similarity=0.044 Sum_probs=17.0
Q ss_pred ceeeeccCceEEEEEEECC-CcEEEE------EEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEee
Q 007160 274 ASILGEGGFGRVFKGVLSD-GTAVAI------KRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 335 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~-g~~VAV------K~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~ 335 (615)
.+.|| ||.||+|.+.. ..+||| |..+... ......|.+|..+++.++|+|+++..++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 35566 99999999864 367888 7765432 222357889999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 615 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-77 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-69 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 4e-77
Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 24/286 (8%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 328
+G G FG V+KG AV + +T Q + F EV +L + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
+GY + Q + + SL LH + + IA A+G+ YLH
Sbjct: 68 LFMGYS---TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
+IHRD K++NI L + K+ DFGLA ++ ++ G+ ++APE
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 449 MT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
+SDVY++G+VL EL+TG+ P N ++ +L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDL- 231
Query: 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
++ PK + + A C+ + ++RP +++ S++++ R
Sbjct: 232 -SKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 2e-69
Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 28/280 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 328
+ LG G FG V+ G + T VA+K L G FL E ++ +L H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
+L + + E + NGSL +L P G+ L + +A A G+A++
Sbjct: 72 RLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIE 126
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
E IHRD +A+NIL+ + K+ADFGLA+ + + APE
Sbjct: 127 E---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAI 182
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADP 507
G +KSDV+S+G++L E++T + + + + ++R + EEL
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ- 241
Query: 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ C RPT + L+
Sbjct: 242 ----------------LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 2e-68
Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 28/295 (9%)
Query: 277 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 336
+G+G FG V++G G VA+K + ++ E+ L H N++ + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 337 RDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---- 390
+ + Q L + +GSL +L+ + E +K+AL A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 391 -SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEY 447
+P + HRD K+ NIL++ N +AD GLA + +GT Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 448 AMTGHLL------VKSDVYSYGVVLLELLTGRKP----VDMSQPSGQENLVTWARPILRD 497
+ ++D+Y+ G+V E+ D P + +R
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR- 242
Query: 498 KDRLEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
K E+ P + ++ + +R + I C R T + ++L + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 3e-68
Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 26/279 (9%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 328
+ +G G FG V G + VAIK + G +++F+ E E++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
+L G + + L +E + +G L +L ET + + LD G+AYL
Sbjct: 64 QLYGVC--LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLE 118
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
E CVIHRD A N L+ N KV+DFG+ + + + ST + +PE
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVF 174
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508
KSDV+S+GV++ E+ + K ++ + + ++ D L PR
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPR 225
Query: 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
L + + I C RP +++ L
Sbjct: 226 LASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (549), Expect = 8e-66
Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 42/308 (13%)
Query: 261 YEELKEATNNF---------EPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCG-GQ 306
+E+ EA F + ++G G FG V G L VAIK L G +
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 307 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 366
+ ++FL E ++ + H N++ L S+ ++ E + NGSL+S+L G
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHL--EGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 367 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
+ + A G+ YL +HRD A NIL+ +N KV+DFGL++ +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 427 GRTNYLSTRV---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 483
++ T + APE SDV+SYG+V+ E+++ + P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235
Query: 484 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 543
I +D RL P + + + C + N RP G++V
Sbjct: 236 DMTNQDVINAIEQDY-RLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 544 QSL-KMVQ 550
+L KM++
Sbjct: 285 NTLDKMIR 292
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-65
Identities = 62/280 (22%), Positives = 110/280 (39%), Gaps = 28/280 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 328
+ LG G FG V G VAIK + G + EF+ E +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
+L G + + E + NG L ++L + +++ D + YL
Sbjct: 63 QLYGVCT--KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE 117
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
+HRD A N L+ + KV+DFGL++ + S + PE
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVL 173
Query: 449 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507
M KSD++++GV++ E+ + G+ P + S + + R E++
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT- 232
Query: 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
I +C +A++RPT ++ ++
Sbjct: 233 ----------------IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-65
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 42/310 (13%)
Query: 263 ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLS 320
ELK+ ++FE S LG G G VFK G +A K + + + + E+++L
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 380
+ +V G + + +C E + GSL+ L + + K+++
Sbjct: 60 ECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
+GL YL + ++HRD K SNIL+ + K+ DFG++ Q + +GT
Sbjct: 114 IKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTR 167
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD----------------------M 478
Y++PE H V+SD++S G+ L+E+ GR P+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 479 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIA----AACVAPEAN 534
+P ++ R + EL D + PK C+
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 535 QRPTMGEVVQ 544
+R + +++
Sbjct: 288 ERADLKQLMV 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-64
Identities = 67/282 (23%), Positives = 112/282 (39%), Gaps = 28/282 (9%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRN 326
++E +G G +GR K SDG + K L G + + + EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+V+ R ++ + E G L S + +LD E +++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 387 LHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
H D V+HRD K +N+ L+ + K+ DFGLA+ + + +GT Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMS 182
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
PE KSD++S G +L EL P + A I K
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGK------ 230
Query: 505 ADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
R+ +Y E + I + + RP++ E+++
Sbjct: 231 -FRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-63
Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 30/283 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 328
+ +G+G FG V G G VA+K + + FL E ++++L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 329 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 388
+L+G + + E + GSL +L L + +K +LD + YL
Sbjct: 64 QLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 389 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
+HRD A N+L+ + AKV+DFGL K+A + + APE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEAL 172
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508
KSDV+S+G++L E+ + + P + L + +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGY-------KMD 220
Query: 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551
P V + C +A RP+ ++ + L+ ++
Sbjct: 221 APDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-63
Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 33/293 (11%)
Query: 262 EELKEATNNFEPASI-LGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGD-KEFLVEV 316
++L +N A I LG G FG V +GV VAIK L G ++ D +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 317 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 376
+++ +L + +V+L+G + +L E+ G L +L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAEL 114
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTR 435
+ G+ YL + +HRD A N+LL N +AK++DFGL+K + Y +
Sbjct: 115 LHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPI 494
+ APE +SDV+SYGV + E L+ G+KP + + + +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231
Query: 495 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ EL + + C + RP V Q ++
Sbjct: 232 ECPPECPPELYA-----------------LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-62
Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 30/279 (10%)
Query: 276 ILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 330
++G G FG V+ G L D A+K L G+ +FL E ++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 331 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+G R L+ + +G L +++ + + + L A+G+ +L
Sbjct: 94 LGICL-RSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLA-- 147
Query: 391 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP--EGRTNYLSTRVMGTFGYVAPEYA 448
+HRD A N +L+ F KVADFGLA+ E + + T ++A E
Sbjct: 148 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508
T KSDV+S+GV+L EL+T P P N +L+ + L+
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQ------ 255
Query: 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
P+ + + C P+A RP+ E+V +
Sbjct: 256 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-62
Identities = 79/293 (26%), Positives = 120/293 (40%), Gaps = 26/293 (8%)
Query: 255 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 314
T+ LA + + + LG+G FG V+ G + T VAIK L G + FL
Sbjct: 3 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQ 61
Query: 315 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 374
E +++ +L H LV+L S + E + GSL +L G G +
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLR--LPQLV 116
Query: 375 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 434
+A A G+AY+ + +HRD +A+NIL+ N KVADFGLA+ +
Sbjct: 117 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ 172
Query: 435 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 494
+ APE A+ G +KSDV+S+G++L EL T + P +
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQV 227
Query: 495 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
R P E + + C E +RPT + L+
Sbjct: 228 ERGYRM-----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (522), Expect = 6e-62
Identities = 68/314 (21%), Positives = 107/314 (34%), Gaps = 48/314 (15%)
Query: 261 YEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLT-CGGQQGDKEFL 313
L+ NN E +GEG FGRVF+ T VA+K L +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 314 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------------- 360
E +++ + N+VK L +E + G L +L
Sbjct: 65 REAALMAEFDNPNIVK--LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 361 -------PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413
L ++ IA A G+AYL E +HRD N L+ N
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 473
K+ADFGL++ ++ PE +SDV++YGVVL E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 474 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 533
P + RD + L P+ + + + C +
Sbjct: 240 LQ-----PYYGMAHEEVIYYV-RDGNILA----------CPENCPLELYNLMRLCWSKLP 283
Query: 534 NQRPTMGEVVQSLK 547
RP+ + + L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 1e-61
Identities = 71/303 (23%), Positives = 114/303 (37%), Gaps = 46/303 (15%)
Query: 269 NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSR 321
N LG G FG+V + VA+K L ++E + E+++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 322 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH------------- 367
L +H N+V L+G + L+ E G L ++L
Sbjct: 83 LGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 368 -LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
LD E + + A+G+A+L IHRD A NILL + K+ DFGLA+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE- 485
+ ++APE +SDV+SYG+ L EL + P +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 486 -NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
++ +L + E+ D I C + +RPT ++VQ
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPTFKQIVQ 300
Query: 545 SLK 547
++
Sbjct: 301 LIE 303
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-61
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 34/278 (12%)
Query: 277 LGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLV 331
LG G FG V KG VA+K L E L E ++ +L + +V+++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 332 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
G ++ +L E+ G L +L N H+ + +++ + G+ YL
Sbjct: 75 GIC---EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 392 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL-STRVMGTFGYVAPEYAMT 450
+ +HRD A N+LL +AK++DFGL+K Y T + APE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 451 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 509
KSDV+S+GV++ E + G+KP + S ++ + E+ D
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD--- 241
Query: 510 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ C + RP V L+
Sbjct: 242 --------------LMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-61
Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 47/306 (15%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDKE-FLVEVEMLSR 321
N E +LG G FG+V VA+K L ++E + E++M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 322 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG----------------- 363
L H N+V L+G S L +E G L ++L
Sbjct: 97 LGSHENIVNLLGAC--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 364 --VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421
L +E + A A+G+ +L +HRD A N+L+ + K+ DFGLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 481
+ + ++APE G +KSDV+SYG++L E+ + P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----P 266
Query: 482 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 541
+ ++++ +++ P + I +C A ++ +RP+
Sbjct: 267 YPGIPVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 542 VVQSLK 547
+ L
Sbjct: 317 LTSFLG 322
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (516), Expect = 3e-61
Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 26/298 (8%)
Query: 261 YEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEML 319
Y++ + + LG G +G V++GV VA+K L + +EFL E ++
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVM 67
Query: 320 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 379
+ H NLV+L+G + + E + G+L +L + + +A
Sbjct: 68 KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQ 123
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
+ + YL + IHRD A N L+ N KVADFGL++ G T
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179
Query: 440 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499
+ APE +KSDV+++GV+L E+ T D
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLS 223
Query: 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 557
++ EL + + P+ +V + AC + RP+ E+ Q+ + + + D
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-61
Identities = 64/277 (23%), Positives = 113/277 (40%), Gaps = 35/277 (12%)
Query: 276 ILGEGGFGRVFKGVLSD-GTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVG 332
+G G F V+KG+ ++ VA L + + F E EML L H N+V+
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 333 YYSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 390
+ S + + EL+ +G+L+++L + + +GL +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 391 SQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449
+ P +IHRD K NI + K+ D GLA V+GT ++APE
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM-Y 185
Query: 450 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ--ENLVTWARPILRDKDRLEELADP 507
DVY++G+ +LE+ T P Q + Q + + +P DK + E+ +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE- 244
Query: 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
I C+ ++R ++ +++
Sbjct: 245 ----------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 9e-61
Identities = 72/280 (25%), Positives = 111/280 (39%), Gaps = 35/280 (12%)
Query: 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHH 324
+FE LG+G FG V+ +A+K L + + EVE+ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 325 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
N+++L GY+ D+++ L E P G++ L D + + A L
Sbjct: 66 PNILRLYGYF--HDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 119
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
+Y H VIHRD K N+LL + K+ADFG + AP R + GT Y+
Sbjct: 120 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 172
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
PE K D++S GV+ E L G+ P + + I R + +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVEFTFPDF 226
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
D I + +QRP + EV++
Sbjct: 227 VTEGA------RDLIS------RLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-60
Identities = 77/290 (26%), Positives = 113/290 (38%), Gaps = 32/290 (11%)
Query: 269 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSR 321
+ LG+G FG V +G +VA+K L + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
L HRNL++L G + + EL P GSL L G H T + A+ A
Sbjct: 68 LDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVA 121
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTF 440
G+ YL IHRD A N+LL K+ DFGL + P+ +Y + F
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500
+ APE T SD + +GV L E+ T + P N I ++ +R
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGER 233
Query: 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550
L D P++ + + C A + RPT + L Q
Sbjct: 234 LPRPED------CPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-59
Identities = 64/291 (21%), Positives = 118/291 (40%), Gaps = 31/291 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGT-----AVAIKRLTCGGQQGDK-EFLVEVEMLSRL 322
+ ++G G FG V+KG+L + VAIK L G + + +FL E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 323 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
H N+++L G ++ E + NG+L+ +L + + + A
Sbjct: 67 SHHNIIRLEGVI--SKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAA 121
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFG 441
G+ YL +HRD A NIL+ +N KV+DFGL++ + Y ++
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501
+ APE SDV+S+G+V+ E++T + + + +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------V 222
Query: 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552
+ + P + + + C E +RP ++V L + R
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-59
Identities = 82/323 (25%), Positives = 131/323 (40%), Gaps = 42/323 (13%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDG---TAVAIKRL-TCGGQQGDKEFLVEVEMLSRL-H 323
N+ + ++GEG FG+V K + AIKR+ + ++F E+E+L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------------PLGVNCHLDWE 371
H N++ L+G R L E P+G+L +L L +
Sbjct: 70 HPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 372 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 431
+ A D ARG+ YL Q IHRD A NIL+ N+ AK+ADFGL++
Sbjct: 128 QLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-- 182
Query: 432 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491
T ++A E SDV+SYGV+L E+++ P
Sbjct: 183 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY 236
Query: 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ 550
+ + RLE P V + C + +RP+ +++ SL +M++
Sbjct: 237 EKLPQGY-RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
Query: 551 RVIECQDPTLTSSNNRANLRQSS 573
+ TL A + S+
Sbjct: 286 ERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-59
Identities = 65/294 (22%), Positives = 120/294 (40%), Gaps = 36/294 (12%)
Query: 261 YEELKEATN---NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEV 316
YE + N +E LG+G FG+V+K A K + ++ ++++VE+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 317 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 376
++L+ H N+VKL+ + + + E G++++ + L +
Sbjct: 61 DILASCDHPNIVKLLDAF--YYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVV 115
Query: 377 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 436
L YLH++ +IHRD KA NIL + K+ADFG++ +
Sbjct: 116 CKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170
Query: 437 MGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTW 490
+GT ++APE M K+DV+S G+ L+E+ P +++ +
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230
Query: 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
P L R +DF++ C+ + R T +++Q
Sbjct: 231 EPPTLAQPSRWSSNF----------KDFLK------KCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 4e-59
Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 40/282 (14%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRN 326
F +G G FG V+ + + VAIK+++ G+Q + ++ + EV L +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
++ G Y L E + + L + A +GLAY
Sbjct: 77 TIQYRGCY--LREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAY 130
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446
LH + +IHRD KA NILL K+ DFG A + +GT ++APE
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPE 181
Query: 447 YAMT---GHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE 502
+ G K DV+S G+ +EL + P +M+ S ++ P L+ E
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+ +C+ RPT +++
Sbjct: 242 YFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-58
Identities = 64/280 (22%), Positives = 106/280 (37%), Gaps = 29/280 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRN 326
+++ LGEG +G V V AVA+K + + E+ + L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+VK G+ R+ + L E G L + + + + G+ Y
Sbjct: 65 VVKFYGHR--REGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVY 118
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446
LH + HRD K N+LL+ + K++DFGLA L ++ GT YVAPE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 447 YAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKDRLEEL 504
DV+S G+VL +L G P D S QE + + L +++
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+ + + R T+ ++ +
Sbjct: 236 P----------LALLH------KILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 74/333 (22%), Positives = 135/333 (40%), Gaps = 41/333 (12%)
Query: 271 FEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHH 324
F+ +LG G FG V+KG+ VAIK L + +KE L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 325 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
++ +L+G + L +L+P G L ++ ++ + + + A+G+
Sbjct: 71 PHVCRLLGICLTST---VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 124
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
YL ++HRD A N+L++ H K+ DFGLAK Y + ++A
Sbjct: 125 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503
E + +SDV+SYGV + EL+T G KP D S +++ + + +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241
Query: 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR------VIECQD 557
+ I C +A+ RP E++ + R VI+ +
Sbjct: 242 VYM-----------------IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284
Query: 558 PTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPY 590
S +N ++ D + + + Y
Sbjct: 285 RMHLPSPTDSNFYRALM--DEEDMDDVVDADEY 315
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-57
Identities = 69/287 (24%), Positives = 112/287 (39%), Gaps = 33/287 (11%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLH 323
E +GEG FG V +G+ AVAIK +E FL E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
H ++VKL+G + + EL G L S+L LD + + A +
Sbjct: 67 HPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTA 120
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
LAYL +HRD A N+L+ +N K+ DFGL++ + T Y +++ ++
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWM 176
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 502
APE SDV+ +GV + E+L G KP + + + + +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549
L + C A + ++RP E+ L +
Sbjct: 237 TLYS-----------------LMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-56
Identities = 58/279 (20%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 326
+ +G+G G V+ + ++ G VAI+++ Q + + E+ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+V + Y + + E + GSL + +D + + + L +
Sbjct: 79 IVNYLDSY--LVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEF 131
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446
LH + VIHRD K+ NILL + K+ DFG Q ++ + ++GT ++APE
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPE 186
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLEELA 505
K D++S G++ +E++ G P ++ + + T P L++ ++L +
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
DF+ C+ + +R + E++Q
Sbjct: 247 ----------RDFLN------RCLDMDVEKRGSAKELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-55
Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 38/302 (12%)
Query: 269 NNFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSR 321
+ + LG G FG+V + + VA+K L G + + + E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLD 369
+ H V + ++ ++ E G+L ++L L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 370 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
E + + A+G+ +L IHRD A NILL K+ DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 489
++APE ++SDV+S+GV+L E+ + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 490 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KM 548
L++ R+ P + C E +QRPT E+V+ L +
Sbjct: 245 EFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
Query: 549 VQ 550
+Q
Sbjct: 295 LQ 296
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 34/292 (11%)
Query: 269 NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSR 321
+ LG+G FG V++GV T VAIK + + EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH------GPLGVNCHLDWETRMK 375
+ ++V+L+G S L+ EL+ G L+S+L V ++
Sbjct: 80 FNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 376 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 435
+A + A G+AYL+ +HRD A N ++ +F K+ DFG+ + E +
Sbjct: 138 MAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 436 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495
+ +++PE G SDV+S+GVVL E+ T + P + R ++
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLRFVM 249
Query: 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
P + + C RP+ E++ S+K
Sbjct: 250 EGGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 66/282 (23%), Positives = 104/282 (36%), Gaps = 31/282 (10%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLS 320
K+ +F+ ILGEG F V L+ AIK L + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 321 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 380
RL H VKL + +D + NG L ++ D +
Sbjct: 64 RLDHPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEI 117
Query: 381 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 440
L YLH +IHRD K NILL + H ++ DFG AK + +GT
Sbjct: 118 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500
YV+PE SD+++ G ++ +L+ G P N + I++ +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYD 228
Query: 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 542
E P+ D + + +A +R E+
Sbjct: 229 FPEKFFPKA------RDLVE------KLLVLDATKRLGCEEM 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 43/303 (14%)
Query: 269 NNFEPASILGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGD-KEFLVEVEML 319
+ LGEG FG+V + T VA+K L + D + + E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 320 SRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH------------GPLGVNC 366
+ H+N++ L+G + + E G+L +L
Sbjct: 73 KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 367 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426
L + + A ARG+ YL IHRD A N+L+ + K+ADFGLA+
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 427 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486
+T ++APE +SDV+S+GV+L E+ T P
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 242
Query: 487 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546
V +L++ R++ P + + C +QRPT ++V+ L
Sbjct: 243 -VEELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 547 KMV 549
+
Sbjct: 292 DRI 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (459), Expect = 3e-52
Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 32/281 (11%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 327
++++ LG G FG V + + G A K + + + E++ +S L H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
V L + D ++ ++ YE + G L + + + ++ +GL ++
Sbjct: 86 VNLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHM 140
Query: 388 HEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
HE +H D K NI+ + + K+ DFGL ++ GT + AP
Sbjct: 141 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAP 194
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
E A + +D++S GV+ LL+G P EN R + +++ A
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG------GENDDETLRNVKSCDWNMDDSA 248
Query: 506 DPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+ ++ DFIR + + N R T+ + ++
Sbjct: 249 FSGI----SEDGKDFIR------KLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 4e-51
Identities = 65/315 (20%), Positives = 121/315 (38%), Gaps = 34/315 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 327
+ ++ LG G FG V + V + G K + E+ ++++LHH L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
+ L + D + +L E + G L + + + + A GL ++
Sbjct: 89 INLHDAF--EDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHM 143
Query: 388 HEDSQPCVIHRDFKASNILLE--NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
HE ++H D K NI+ E K+ DFGLA + T + AP
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAP 197
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505
E + +D+++ GV+ LL+G P G+++L T + R +E A
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQN-VKRCDWEFDEDA 251
Query: 506 DPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS--LKMVQRVIECQDPTLT 561
+ E DFI+ + E +R T+ + ++ LK + + P+
Sbjct: 252 FSSV----SPEAKDFIK------NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 301
Query: 562 SSNNRANLRQSSTTF 576
+ R +++ +
Sbjct: 302 YNKIRQKIKEKYADW 316
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 173 bits (439), Expect = 3e-50
Identities = 71/294 (24%), Positives = 115/294 (39%), Gaps = 33/294 (11%)
Query: 268 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLH 323
++ +E ILG GG V L VA+K L F E + + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 324 HRNLVKLVGYYSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
H +V + + + L E V +L +H + + +++ DA
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTF 440
+ L + H+ +IHRD K +NI++ KV DFG+A+ A G + + V+GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 441 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500
Y++PE A + +SDVYS G VL E+LTG P ++ V+ A +R+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPI 232
Query: 501 LEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR 551
L + + +A R T E+ L V
Sbjct: 233 PPSARHEGL----SADLDAVVL------KALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (438), Expect = 4e-49
Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 40/283 (14%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLH- 323
N+F I+G GGFG V+ +D G A+K L +QG+ L E MLS +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 324 --HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
+V + + + +L+ G L L + A +
Sbjct: 64 GDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEII 117
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
GL ++H V++RD K +NILL+ + H +++D GLA + + + +GT G
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 170
Query: 442 YVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500
Y+APE G +D +S G +L +LL G P + + + DR
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------DR 219
Query: 501 LEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 541
+ L + E + + + N+R
Sbjct: 220 MTLTMAVELPDSFSPELRSLLE------GLLQRDVNRRLGCLG 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 170 bits (431), Expect = 5e-49
Identities = 66/294 (22%), Positives = 111/294 (37%), Gaps = 47/294 (15%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---------QQGDKEFLVEVEML 319
N+EP ILG G V + + A+K + G Q+ + L EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 320 SRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
++ H N+++L Y ++ L ++L+ G L +L L + KI
Sbjct: 64 RKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMR 117
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
+ LH+ ++HRD K NILL+++ + K+ DFG + Q G V G
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 171
Query: 439 TFGYVAPEYAMTGHLL------VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 492
T Y+APE + D++S GV++ LL G P + R
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLR 225
Query: 493 PILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
I+ + Y D + + + +R T E +
Sbjct: 226 MIMSGNYQFGSPEWD----DYSDTVKDLVS------RFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (430), Expect = 1e-48
Identities = 52/288 (18%), Positives = 103/288 (35%), Gaps = 29/288 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 327
N + +G G FG ++ G ++ G VAIK + + +E ++ +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
+ + + + + +++ EL+ + + + +T + +A + Y+
Sbjct: 65 IPTIRWCGA-EGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYI 119
Query: 388 HEDSQPCVIHRDFKASNIL---LENNFHAKVADFGLAKQAPEGRTN-----YLSTRVMGT 439
H IHRD K N L + + DFGLAK+ + RT+ + + GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 440 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499
Y + + + D+ S G VL+ G P + + + R +
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------YERISE 230
Query: 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
+ L YP E T C + + +P + Q +
Sbjct: 231 KKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-48
Identities = 65/337 (19%), Positives = 117/337 (34%), Gaps = 37/337 (10%)
Query: 265 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH 323
KE + A LG G FG V + V S K + G E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
HRN++ L + S + + ++ +E + + ++ L+ +
Sbjct: 60 HRNILHLHESFESME--ELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEA 114
Query: 384 LAYLHEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
L +LH + H D + NI+ + K+ +FG A+Q G +
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPE 168
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501
Y APE + +D++S G ++ LL+G P E I+ +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL------AETNQQIIENIMNAEYTF 222
Query: 502 EELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPT 559
+E A + E DF+ + E R T E +Q +++ IE
Sbjct: 223 DEEAFKEI----SIEAMDFVD------RLLVKERKSRMTASEALQH-PWLKQKIERVSTK 271
Query: 560 LTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAF 596
+ + R+ T + + S+ S A
Sbjct: 272 VIRTLKH---RRYYHTLIKKDLNMVVSAARISCGGAI 305
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 4e-48
Identities = 59/288 (20%), Positives = 100/288 (34%), Gaps = 29/288 (10%)
Query: 261 YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEM 318
+++ ++ + ++ +LG G F V VAIK + +G + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 319 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 378
L ++ H N+V L Y L +LV G L + ++
Sbjct: 61 LHKIKHPNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIF 114
Query: 379 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
+ YLH+ + L+ + ++DFGL+K G + G
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACG 171
Query: 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498
T GYVAPE D +S GV+ LL G P EN IL+ +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQILKAE 225
Query: 499 DRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+ + DFIR + + +R T + +Q
Sbjct: 226 YEFDSPYWDDI----SDSAKDFIR------HLMEKDPEKRFTCEQALQ 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 67/298 (22%), Positives = 111/298 (37%), Gaps = 27/298 (9%)
Query: 266 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH 323
+ + S +GEG +G V + VAIK+++ Q + L E+++L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 324 HRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
H N++ + + Q Y + L L HL +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQIL 119
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTF 440
RGL Y+H V+HRD K SN+LL K+ DFGLA+ A P+ T + T
Sbjct: 120 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 441 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA--RPILRD 497
Y APE + KS D++S G +L E+L+ R Q N + P D
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAA-----------ACVAPEANQRPTMGEVVQ 544
+ + L P ++ + + + ++R + + +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-47
Identities = 63/276 (22%), Positives = 101/276 (36%), Gaps = 34/276 (12%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSR-LH 323
+F +LG+G FG+VF AIK L D + +VE +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 324 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 383
H L + + +++ E + G L + D A + G
Sbjct: 62 HPFLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILG 115
Query: 384 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
L +LH +++RD K NILL+ + H K+ADFG+ K+ G GT Y+
Sbjct: 116 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYI 170
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503
APE + D +S+GV+L E+L G+ P ++ I D
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPR 224
Query: 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 539
+ +D + E +R +
Sbjct: 225 WLEKEA------KDLLV------KLFVREPEKRLGV 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 22/294 (7%)
Query: 267 ATNNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRL 322
A +E + +GEG +G+VFK + + G VA+KR+ G + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 323 ---HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 379
H N+V+L + + + + + + + + ET +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
RGL +LH V+HRD K NIL+ ++ K+ADFGLA+ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 440 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499
Y APE + D++S G + E+ + S Q + + ++D
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 500 RLEELADPRLG----GKYPKEDFIRVCTIAA-----ACVAPEANQRPTMGEVVQ 544
++A PR P E F+ C+ +R + +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 1e-44
Identities = 67/274 (24%), Positives = 107/274 (39%), Gaps = 36/274 (13%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHH 324
+F+ LG G FGRV +G A+K L + + E MLS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 325 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
++++ G + +D+ Q + + + G L S L + A + L
Sbjct: 64 PFIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLAL 117
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
YLH +I+RD K NILL+ N H K+ DFG AK P+ GT Y+A
Sbjct: 118 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIA 169
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
PE T D +S+G+++ E+L G P N + IL + R
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELRFPPF 223
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT 538
+ + +D + + + +QR
Sbjct: 224 FNEDV------KDLLS------RLITRDLSQRLG 245
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 157 bits (397), Expect = 3e-44
Identities = 58/289 (20%), Positives = 105/289 (36%), Gaps = 23/289 (7%)
Query: 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 326
+ +GEG +G V+K + G A+K RL + + E+ +L L H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+VKL + +L +E + + L+ T L G+AY
Sbjct: 62 IVKLYDVI--HTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAY 115
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446
H+ V+HRD K N+L+ K+ADFGLA+ Y + ++ +
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDV 171
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506
+ D++S G + E++ G + Q + K+
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 507 PRLGGKY------PKEDFIRVCTIAAA-----CVAPEANQRPTMGEVVQ 544
P+ + P E F++ + + + NQR T + ++
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-44
Identities = 66/320 (20%), Positives = 109/320 (34%), Gaps = 35/320 (10%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY 333
+LG G G+V + A+K L Q + EVE+ R ++V++V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 334 YSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 391
Y + + + L E + G L S + + +I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-- 129
Query: 392 QPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 448
+ HRD K N+L N K+ DFG AK+ + T YVAPE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 449 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508
D++S GV++ LL G P G I +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 509 LGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNR 566
+ +E IR + E QR T+ E + + + + L +S
Sbjct: 244 V----SEEVKMLIR------NLLKTEPTQRMTITEFMNH-PWIMQSTKVPQTPLHTSRVL 292
Query: 567 ANLRQSSTTFDSDGTSSMFS 586
++ + TS++ +
Sbjct: 293 KEDKERWEDVKEEMTSALAT 312
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (396), Expect = 5e-44
Identities = 48/290 (16%), Positives = 93/290 (32%), Gaps = 31/290 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 327
+++ +GEG FG +F+G L + VAIK + + E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 328 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 387
+ V Y+ + ++L +L+ + +T A + +
Sbjct: 63 IPNVYYFGQ-EGLHNVLVIDLLGPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSI 117
Query: 388 HEDSQPCVIHRDFKASNILL-----ENNFHAKVADFGLAKQAPEGRTN-----YLSTRVM 437
H + +++RD K N L+ +N V DFG+ K + T +
Sbjct: 118 H---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
GT Y++ + + D+ + G V + L G P + T + R
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA------ATNKQKYERI 228
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547
++ + L +P+E + P +
Sbjct: 229 GEKKQSTPLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-43
Identities = 68/286 (23%), Positives = 105/286 (36%), Gaps = 28/286 (9%)
Query: 276 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLHHRNLVK 329
LGEG F V+K + VAIK++ G + K+ L E+++L L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 389
L+ + S L ++ + + L L +GL YLH+
Sbjct: 65 LLDAF--GHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 390 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 449
++HRD K +N+LL+ N K+ADFGLAK Y T + T Y APE
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLF 173
Query: 450 TGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPILRDKDRLEE 503
+ V D+++ G +L ELL + Q E L T D L +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 504 LADPRLGGKYPKEDFIRVCTIAA-----ACVAPEANQRPTMGEVVQ 544
+ P R T + ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 3e-43
Identities = 60/289 (20%), Positives = 105/289 (36%), Gaps = 23/289 (7%)
Query: 270 NFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 326
NF+ +GEG +G V+K G VA+K RL + + E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
+VKL+ ++ L +E + + L + +GLA+
Sbjct: 63 IVKLLDVI--HTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAF 117
Query: 387 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 446
H V+HRD K N+L+ K+ADFGLA+ Y + V+ +
Sbjct: 118 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEI 173
Query: 447 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506
+ D++S G + E++T R Q + + +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 507 PRLGGKYPK---EDFIRVCTIAAA--------CVAPEANQRPTMGEVVQ 544
P +PK +DF +V + + N+R + +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-43
Identities = 67/292 (22%), Positives = 103/292 (35%), Gaps = 27/292 (9%)
Query: 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 328
++ ++G G FG V++ L G VAIK++ Q + E++++ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 329 KLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
+L ++ S + L + VP H L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSL 135
Query: 385 AYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 443
AY+H + HRD K N+LL + K+ DFG AKQ G N + + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190
Query: 444 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPILRDK 498
DV+S G VL ELL G+ Q + L T R +R+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 499 DRLEELADPRLGGKYPKEDFIRVCTIAAA------CVAPEANQRPTMGEVVQ 544
+ +P R T A + R T E
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-42
Identities = 69/289 (23%), Positives = 108/289 (37%), Gaps = 41/289 (14%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD------KEFLVEVEMLSR 321
+ ++ LG G F V K S G A K + + ++ EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 322 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
+ H N++ L Y + + +L ELV G L +L L E +
Sbjct: 70 IQHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQIL 123
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVM 437
G+ YLH + H D K NI+L K+ DFGLA + G +
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 438 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
GT +VAPE L +++D++S GV+ LL+G P V+ D
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 498 K--DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 544
+ LA +DFIR + + +R T+ + +Q
Sbjct: 238 EYFSNTSALA----------KDFIR------RLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 61/277 (22%), Positives = 96/277 (34%), Gaps = 33/277 (11%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHH 324
N+F+ +LG+G FG+V + G A+K L + + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 325 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
L L Y+ + + E G L L E + L
Sbjct: 65 PFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSAL 118
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
YLH V++RD K N++L+ + H K+ DFGL K+ GT Y+A
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504
PE D + GVV+ E++ GR P ++ IL ++ R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY------NQDHERLFELILMEEIRFPRT 227
Query: 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 541
P + + + + QR G
Sbjct: 228 LSPEA------KSLLA------GLLKKDPKQRLGGGP 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-41
Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 48/302 (15%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL------TCGGQQGDKEFLVEVEMLSR 321
+ ++ +LG GGFG V+ G+ +SD VAIK + G +EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 322 LH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 379
+ +++L+ ++ DS +L E + L E
Sbjct: 64 VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDF---ITERGALQEELARSFFWQ 118
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
+ + H V+HRD K NIL+ N K+ DFG + T G
Sbjct: 119 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDG 171
Query: 439 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
T Y PE+ +S V+S G++L +++ G P + + I+R
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG 219
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 557
+ + + IR C+A + RPT E+ +Q V+ Q+
Sbjct: 220 QVFFRQRVSSEC------QHLIR------WCLALRPSDRPTFEEIQNH-PWMQDVLLPQE 266
Query: 558 PT 559
Sbjct: 267 TA 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 59/302 (19%), Positives = 117/302 (38%), Gaps = 33/302 (10%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHR 325
+ +E + +G+G FG VFK G VA+K++ ++ L E+++L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 326 NLVKLVGYYSSRDSSQH------LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 379
N+V L+ ++ S + L ++ + + V ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQM 125
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS--TRVM 437
GL Y+H ++HRD KA+N+L+ + K+ADFGLA+ + + + T +
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 438 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT------- 489
T Y PE + D++ G ++ E+ T + + Q L++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 490 -WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA------CVAPEANQRPTMGEV 542
P + + + E+L + + K+ A + + QR +
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 543 VQ 544
+
Sbjct: 303 LN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 29/304 (9%)
Query: 261 YEELKEAT----NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFL 313
+E+ + + +G G +G V V G VAIK+L + K
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65
Query: 314 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 373
E+ +L + H N++ L+ ++ ++ + LV G L + L +
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV--MPFMGTDLGKLMKHEKLGEDRI 123
Query: 374 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 433
+ +GL Y+H +IHRD K N+ + + K+ DFGLA+QA T
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---- 176
Query: 434 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV----- 488
V+ + D++S G ++ E++TG+ S Q +
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 489 ----TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAA----ACVAPEANQRPTMG 540
+ + + D+ + P L K +A + +A QR T G
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 541 EVVQ 544
E +
Sbjct: 297 EALA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-39
Identities = 63/291 (21%), Positives = 98/291 (33%), Gaps = 25/291 (8%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 325
+E +GEG +G VFK VA+K RL + L E+ +L L H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 326 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 385
N+V+L S LV + N LD E +GL
Sbjct: 62 NIVRLHDVLHSDK------KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 386 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
+ H V+HRD K N+L+ N K+A+FGLA+ Y S V+ +
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPD 171
Query: 446 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG---QENLVTWARPILRDKDRLE 502
D++S G + EL +P+ + P +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 503 ELADPRLGGKYPKEDFIRVCT---------IAAACVAPEANQRPTMGEVVQ 544
+L D + YP + + + QR + E +Q
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 9e-36
Identities = 53/306 (17%), Positives = 110/306 (35%), Gaps = 52/306 (16%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRN 326
++++ LG G + VF+ + +++ V +K L K+ E+++L L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPN 91
Query: 327 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 386
++ L S L +E V N + L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDY 144
Query: 387 LHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 445
H ++HRD K N+++++ + ++ D+GLA+ G+ + + + P
Sbjct: 145 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP 198
Query: 446 EYAMTGHLL-VKSDVYSYGVVLLELLTGRKP-----------VDMSQPSGQENLVTWARP 493
E + + D++S G +L ++ ++P V +++ G E+L +
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 494 ILRDKD-------------RLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPT 538
+ D R E E DF+ + + R T
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD------KLLRYDHQSRLT 312
Query: 539 MGEVVQ 544
E ++
Sbjct: 313 AREAME 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 1e-35
Identities = 51/234 (21%), Positives = 80/234 (34%), Gaps = 18/234 (7%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHH 324
+ F+ LG G FGRV G A+K L K+ L E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 325 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 384
LVKL + + +V + L A
Sbjct: 101 PFLVKLEFSF------KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 385 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 444
YLH +I+RD K N+L++ + +V DFG AK+ GT +A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALA 206
Query: 445 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 498
PE ++ D ++ GV++ E+ G P QP + +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 65/284 (22%), Positives = 110/284 (38%), Gaps = 35/284 (12%)
Query: 269 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRL----TCGGQQGDKEFLVEVEMLS 320
NFE +LG G +G+VF G A+K L + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 321 RL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 379
+ LV L +Y+ + ++ L + + G L + L +
Sbjct: 84 HIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGE 137
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 439
L +LH+ +I+RD K NILL++N H + DFGL+K+ T + GT
Sbjct: 138 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 193
Query: 440 FGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497
Y+AP+ G D +S GV++ ELLTG P + + + +R IL+
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS 251
Query: 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 541
+ + +D I+ + + +R G
Sbjct: 252 EPPYPQEMSALA------KDLIQ------RLLMKDPKKRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-35
Identities = 65/308 (21%), Positives = 115/308 (37%), Gaps = 25/308 (8%)
Query: 253 PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-- 309
PT R + + E ++ S +G G +G V G VA+K+L+ Q
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 310 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 369
K E+ +L + H N++ L+ ++ S + LV + + + L
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLT 119
Query: 370 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429
+ + RGL Y+H +IHRD K SN+ + + K+ DFGLA+ + T
Sbjct: 120 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 430 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ----- 484
V + H D++S G ++ ELLTGR + Q
Sbjct: 177 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIA--------AACVAPEANQR 536
+ T +L+ + + PK +F V A + ++++R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 537 PTMGEVVQ 544
T + +
Sbjct: 293 ITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-35
Identities = 58/307 (18%), Positives = 113/307 (36%), Gaps = 44/307 (14%)
Query: 269 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 325
++ +G G G V VAIK+L Q K E+ ++ ++H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 326 NLVKLVGYYSSRDSSQH----LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 381
N++ L+ ++ + + + L EL+ + LD E +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQML 129
Query: 382 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 441
G+ +LH +IHRD K SNI+++++ K+ DFGLA+ A T + T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 183
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ----------------E 485
Y APE + D++S G ++ E++ + Q +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA--------CVAPEANQRP 537
L R + ++ + L P+L + A+ + + +R
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 538 TMGEVVQ 544
++ + +Q
Sbjct: 304 SVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 7e-30
Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 15/228 (6%)
Query: 271 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 329
+ LG G F V+ + + T VA+K + G + + E+++L R++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 330 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL----------DWETRMKIALD 379
++ PNG + LG N +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 380 AARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMG 438
GL Y+H + +IH D K N+L+E + + +A + T +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 439 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 486
T Y +PE + +D++S ++ EL+TG + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.8 bits (240), Expect = 1e-23
Identities = 35/207 (16%), Positives = 60/207 (28%), Gaps = 34/207 (16%)
Query: 275 SILGEGGFGRVFKGVLSDGTAVAIKRL----------TCGGQQGDKEFLVEVEMLSRLHH 324
++GEG VF +K GD F V +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 325 RNLVKLVGYYSSR--DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 382
R L KL G + + + EL+ + E ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDA-----------KELYRVRVENPDEVLDMILE 114
Query: 383 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP-EGRTNYLSTRVMGTFG 441
+A + ++H D N+L+ + DF + + EG L V
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 442 YVAPEYAMTGHLLVKSDVYSYGVVLLE 468
Y + Y + D+ S +L+
Sbjct: 171 YFSRTYRT------EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 615 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.39 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-53 Score=429.32 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccC--CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||+++|++.. ...+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEEE
Confidence 467899999999999999999875 35999998754 33445789999999999999999999999752 468999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.++++.. ...++|..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999753 235999999999999999999999998 9999999999999999999999999998776
Q ss_pred CCCccccceeeccccccCCcccccc---CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
............||+.|||||++.+ ..++.++|||||||+||||+||+.||....... .+.. .....
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~----~~~~~---- 225 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIF----MVGRG---- 225 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH----HHHHT----
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHH----HHhcC----
Confidence 5443334456789999999999864 358999999999999999999999997533211 1111 11110
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
...+.+ ...+......+.+|+.+||+.||++||||+||+++|+.+.+.+
T Consensus 226 -~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 226 -YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 111111 0112222345889999999999999999999999999988754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=424.73 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=200.9
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|+|. +....++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceec--cCCceEEEEEe
Confidence 5788999999999999999999888999999997543 44678999999999999999999999997 44578999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.+++... ...++|..++.++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999998753 345899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
.. ......||+.|||||++.+..++.++|||||||+||||+|+..|+..... ...+... +. ..
T Consensus 156 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~---i~-~~---------- 218 (263)
T d1sm2a_ 156 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVED---IS-TG---------- 218 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHH---HH-HT----------
T ss_pred ce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHH---HH-hc----------
Confidence 22 23346799999999999999999999999999999999996544432211 1111111 11 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.....+.....++.+|+.+||+.||++||||+||+++|+++.+.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 01112233345688999999999999999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=422.73 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=210.1
Q ss_pred hcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+++|++++|||||+++|++.. ...++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEEEE
Confidence 46789999999999999999999888999999997543 446789999999999999999999998852 36799999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++.... ...++|..+++|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+|+.....
T Consensus 88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred eCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999886422 335999999999999999999999998 999999999999999999999999999987654
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. .......||+.|||||++.++.++.++|||||||+||||+||..|+..... ...+... +...
T Consensus 163 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~----i~~~--------- 226 (272)
T d1qpca_ 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQN----LERG--------- 226 (272)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTT---------
T ss_pred cc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHH----HHhc---------
Confidence 32 223446799999999999999999999999999999999997666542221 1111111 1110
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.....+......+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 227 -~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1111222333458899999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-51 Score=424.92 Aligned_cols=258 Identities=27% Similarity=0.453 Sum_probs=197.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CC---cEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.++||+|+||+||+|++. +| ..||||++..... ...++|.+|+++|++++|||||+++|+|. +....+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT--KSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe--eCCEEE
Confidence 35667789999999999999974 22 3689999875433 33467999999999999999999999987 445899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
+||||+++|+|.+++... ...++|.+++.++.||++||+|||+.+ |+||||||+||||++++++||+|||+++.
T Consensus 104 iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceE
Confidence 999999999999998753 235999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccc---cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 424 APEGRTNY---LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 424 ~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
........ ......||+.|||||.+.++.++.++|||||||+||||+| |+.||..... ..+...+ ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i----~~-- 248 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI----EQ-- 248 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HT--
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHH----Hc--
Confidence 65433221 1223468999999999999999999999999999999998 8999964321 1111111 11
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
......+.+....+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 249 --------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 249 --------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11112233444568899999999999999999999999988765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=418.91 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=203.6
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||+||+|+.. +|+.||||++..... +..+.+.+|+++|++++|||||++++++.. ....+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEEE
Confidence 57999999999999999999974 689999999975432 234578999999999999999999999884 45899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999974 346999999999999999999999999 99999999999999999999999999997755
Q ss_pred CCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
.......+..+||+.|||||++.+..+ +.++|||||||+||||++|+.||......... ...+ ..
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~----~~--------- 221 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW----KE--------- 221 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH----HT---------
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH----hc---------
Confidence 443334456789999999999988776 67899999999999999999999754322111 1110 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..............+.+|+.+||+.||++|||++|+++|
T Consensus 222 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 222 -KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000001111223457889999999999999999999765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=411.26 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=211.2
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||+||+|++++++.||||+++... ...++|++|++++++++|||||+++|+|. +....++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~--~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC--CSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe--eCCceEEEEEc
Confidence 5889999999999999999999888899999998654 34678999999999999999999999987 44689999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.+++... ...+++..+++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999998642 346899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+. ..+ ...
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~---~~i-~~~--------- 217 (258)
T d1k2pa_ 155 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA---EHI-AQG--------- 217 (258)
T ss_dssp CC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH---HHH-HTT---------
T ss_pred ce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH---HHH-HhC---------
Confidence 22 2344679999999999999999999999999999999998 89999744311 111 111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 548 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~ 548 (615)
.....|......+.+|+.+||+.||++|||++||+++|.+
T Consensus 218 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1112233334568899999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=421.30 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=196.0
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++++|||||++++++.+.....+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999996 46899999999765432 23568999999999999999999999876556678999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCC--CcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ--PCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~--~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
|||+++|+|.+++.........+++..++.++.|++.||+|||+.+. .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999996433334569999999999999999999998652 3499999999999999999999999999998
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ......||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+ ...+...
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~---~~~i~~~------ 229 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL---AGKIREG------ 229 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHT------
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHH---HHHHHcC------
Confidence 754332 23456899999999999999999999999999999999999999964321 111 1111110
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+. .+......+.+|+.+||+.||++|||++|+++|
T Consensus 230 -~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 230 -KFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0111 122233458899999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-51 Score=421.02 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=211.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
..++|++.+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|. +....++|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~iv 91 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 91 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe--eCCeeEEE
Confidence 3467999999999999999999975 58899999997543 44678999999999999999999999987 45588999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+++|+|.+++.... ...++|..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 92 ~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999996422 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
..... ......||+.|||||++.+..++.++|||||||++|||++|..|+..... ...+.. .+
T Consensus 167 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~----~i---------- 229 (287)
T d1opja_ 167 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYE----LL---------- 229 (287)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHH----HH----------
T ss_pred CCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHH----HH----------
Confidence 54322 23345689999999999999999999999999999999998777643221 111111 11
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
........+......+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111112233334456899999999999999999999999887763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=413.22 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=209.9
Q ss_pred hcCccccee-eeccCceEEEEEEEC---CCcEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASI-LGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~-LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|.+.+. ||+|+||+||+|.+. ++..||||+++..... ..++|.+|+++|++++|||||+++|+|.. ...
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeE
Confidence 356777775 999999999999864 3568999999755432 34679999999999999999999999863 358
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
+|||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhh
Confidence 9999999999999998643 245999999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCcc-ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 423 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 423 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
........ .......||+.|||||++.++.++.++|||||||++|||+| |+.||..... ..+.. .+....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~----~i~~~~- 229 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMA----FIEQGK- 229 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHH----HHHTTC-
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCC-
Confidence 87654322 22334568999999999999999999999999999999998 9999974321 11111 111111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
....+......+.+|+.+||+.||++||||.+|++.|+.+...+
T Consensus 230 ---------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 230 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11223333456889999999999999999999999998776544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=415.95 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=207.9
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.. ....+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEEEE
Confidence 4799999999999999999995 5799999999987666667789999999999999999999999884 458999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 98 y~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 9999999998863 35899999999999999999999999 999999999999999999999999999977543
Q ss_pred CccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......||+.|||||++.+..++.++|||||||++|||++|+.||...... .......... .+
T Consensus 170 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~-------~~ 234 (293)
T d1yhwa1 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNG-------TP 234 (293)
T ss_dssp TC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHC-------SC
T ss_pred cc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCC-------CC
Confidence 32 234567999999999999999999999999999999999999999643211 1111111100 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. ...+......+.+|+.+||+.||++|||+.|+++|
T Consensus 235 ~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 E--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp C--CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred C--CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 11223334468899999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=422.03 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=206.8
Q ss_pred hcCcccceeeeccCceEEEEEEECC-C-----cEEEEEEeccCC-CCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD-G-----TAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~-g-----~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.++||+|+||+||+|++.. + ..||||++.... ......|.+|+.+|.++ +|||||++++++. +.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--LS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe--eC
Confidence 4679999999999999999999642 2 369999986543 33456799999999998 8999999999987 44
Q ss_pred CceeEEEecCCCCChhHhhcCCCC-------------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccC
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG-------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF 400 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDI 400 (615)
...+|||||+++|+|.++|+.... ....++|..++.++.||++||+|||+++ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 588999999999999999975432 1235899999999999999999999998 999999
Q ss_pred CCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 007160 401 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMS 479 (615)
Q Consensus 401 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~ 479 (615)
||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987665444333445678999999999999999999999999999999998 89999743
Q ss_pred CCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 480 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 480 ~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
... ..+.. .+... .....+......+.+|+.+||+.||++|||++||+++|.
T Consensus 271 ~~~--~~~~~----~~~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVD--ANFYK----LIQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCS--HHHHH----HHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH--HHHHH----HHhcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 322 11111 11111 111223333456899999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=412.42 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=201.7
Q ss_pred cCcccceeeeccCceEEEEEEECCC-----cEEEEEEeccCCCC-chHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDG-----TAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g-----~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
+.|+..++||+|+||.||+|.++++ ..||||++...... ...+|.+|++++++++|||||+++|++. +....
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~--~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe--cCCce
Confidence 4688899999999999999997532 47999999754332 3457999999999999999999999987 44578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+.+|+|.+++... ...++|.++++++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 85 ~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999988642 245999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCc-cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
....... ........||+.|||||++.++.++.++|||||||+||||++|..|+...... ..+... +
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~----i------ 226 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKA----I------ 226 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH----H------
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHH----H------
Confidence 7654332 22234457899999999999999999999999999999999977666432211 111111 1
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
........+......+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 227 ----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 ----NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11112233344455689999999999999999999999999887764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=409.52 Aligned_cols=247 Identities=29% Similarity=0.428 Sum_probs=206.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++. +....++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE--ECCEEEE
Confidence 57999999999999999999974 6899999998642 2334567899999999999999999999998 4558999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 84 vmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999974 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... .....||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+.+.
T Consensus 157 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~------- 219 (263)
T d2j4za1 157 PSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRV------- 219 (263)
T ss_dssp CCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTT-------
T ss_pred CCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcC-------
Confidence 5432 2456799999999999999999999999999999999999999964321 1111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 546 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L 546 (615)
. ...+......+.+|+.+||+.||++|||++|+++|=
T Consensus 220 ---~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 220 ---E--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp ---C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred ---C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence 1 112223334588999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=407.47 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=198.6
Q ss_pred eeeeccCceEEEEEEECC---CcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEecC
Q 007160 275 SILGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 349 (615)
Q Consensus 275 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey~ 349 (615)
++||+|+||+||+|.+.+ ++.||||+++..... ..++|.+|+++|++++|||||+++|+|.. ...+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 579999999999998643 468999999754322 24679999999999999999999999863 3578999999
Q ss_pred CCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCCc
Q 007160 350 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 429 (615)
Q Consensus 350 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 429 (615)
++|+|.++++. ...++|..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 90 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 90 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999975 345999999999999999999999998 99999999999999999999999999997755433
Q ss_pred cc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 430 NY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 430 ~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
.. ......||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ..+.. .+....
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~----~i~~~~-------- 227 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTA----MLEKGE-------- 227 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHHTTC--------
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHH----HHHcCC--------
Confidence 22 2334579999999999999999999999999999999998 8999974321 11111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
....+......+.+|+.+||+.||++|||+++|++.|+...
T Consensus 228 --~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 228 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11223333456889999999999999999999998887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=409.91 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=203.0
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|+|||+++|+|.. ...++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEEEEe
Confidence 5799999999999999999999888899999997543 456789999999999999999999999852 357999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.+++.... ...++|.+++.++.||++||+|||+.+ |+||||||+||||++++++||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999987421 235999999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCCc
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 508 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~ 508 (615)
. .......||+.|+|||++..+.++.++|||||||+||||++|..|+...... ..+...+. . .
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----~----------~ 230 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----R----------G 230 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----T----------T
T ss_pred c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----h----------c
Confidence 2 2334467999999999999999999999999999999999977776432211 11111111 0 1
Q ss_pred cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 509 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 509 l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
.....+......+.+++.+||+.||++||+|++|++.|+.+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 111223334456889999999999999999999998877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=412.05 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=205.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
+.|++.+.||+|+||+||+|+.. +|+.||||++........+.|.+|+++|++++|||||++++++.. ....+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEEe
Confidence 46899999999999999999964 689999999987766667889999999999999999999999874 458999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 427 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 427 (615)
|+++|+|.+++... ...+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 y~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 90 FCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 99999999998632 235899999999999999999999999 999999999999999999999999999765322
Q ss_pred CccccceeeccccccCCccccc-----cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 428 RTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 428 ~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
. .......||+.|||||++. ...++.++|||||||+||||++|+.||....... . ...+....
T Consensus 164 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~----~~~i~~~~---- 231 (288)
T d2jfla1 164 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--V----LLKIAKSE---- 231 (288)
T ss_dssp H--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--H----HHHHHHSC----
T ss_pred c--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--H----HHHHHcCC----
Confidence 1 1223467999999999984 4568899999999999999999999997543211 1 11111110
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.+. ...+......+.+|+.+||+.||++|||++|+++|
T Consensus 232 ---~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 ---PPT--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---CCC--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCC--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001 11122334468899999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=404.09 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=197.3
Q ss_pred cccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeec--CCCCceeEE
Q 007160 271 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSS--RDSSQHLLC 345 (615)
Q Consensus 271 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~~~LV 345 (615)
|+..+.||+|+||+||+|+.. +++.||+|++..... ...+.|.+|+++|++++|||||++++++.. .+...+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999965 688999999875432 234578999999999999999999999864 234568999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc-CCCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~ 424 (615)
|||+++|+|.++++. ...+++..++.++.||++||+|||+++. +|+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999974 3458999999999999999999998763 399999999999996 5789999999999865
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
... ......||+.|||||++.+ .++.++|||||||+||||++|+.||...... ..+ ...+... .
T Consensus 166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~---~~~i~~~------~ 229 (270)
T d1t4ha_ 166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQI---YRRVTSG------V 229 (270)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHH---HHHHTTT------C
T ss_pred cCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHH---HHHHHcC------C
Confidence 432 2345689999999998865 5999999999999999999999999643211 111 1111110 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..... +......+.+|+.+||+.||++|||++|+++|
T Consensus 230 ~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00111 11122347899999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=419.60 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=204.2
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||+||+|+. .+|+.||+|+++.... ...+.+.+|+++|++++|||||+++++|. +....+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEE
Confidence 57899999999999999999996 4789999999976533 33467999999999999999999999998 45589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
|||+++|+|.+++.. ...+++..+..++.|+++||.|||+ ++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999974 3358999999999999999999997 47 999999999999999999999999999865
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc--------
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR-------- 496 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~-------- 496 (615)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||............ ......
T Consensus 156 ~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPR 229 (322)
T ss_dssp HHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred CCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHhcCCcccCCcc
Confidence 432 224568999999999999999999999999999999999999999754322110000 000000
Q ss_pred --------------------cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 --------------------DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 --------------------~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.......+................+.+|+.+||+.||++|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000001111000000001112457899999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=409.99 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=204.3
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++. +....++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE--CSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE--ECCEEEE
Confidence 5799999999999999999997 46899999998643 2334567999999999999999999999987 4568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 86 vmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999999874 346899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.............||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+...
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~------- 225 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKL------- 225 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTT-------
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcC-------
Confidence 654433334456899999999999999999999999999999999999999974321 1111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
. ..++......+.+|+.+||+.||++|||++|++++.+
T Consensus 226 ---~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 226 ---E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ---C--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ---C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 1 1122233345889999999999999999999876544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-49 Score=410.41 Aligned_cols=266 Identities=26% Similarity=0.394 Sum_probs=211.1
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCCCc-hHHHHHHHHHHhhccCCCcceEEEEee
Q 007160 263 ELKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYS 335 (615)
Q Consensus 263 el~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~ 335 (615)
+++..+++|++.+.||+|+||+||+|++. +++.||||++....... .++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445788999999999999999999964 35789999997654332 467999999999999999999999987
Q ss_pred cCCCCceeEEEecCCCCChhHhhcCCC--------------------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcE
Q 007160 336 SRDSSQHLLCYELVPNGSLESWLHGPL--------------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 395 (615)
Q Consensus 336 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 395 (615)
+....+++|||+++|+|.++++... .....++|..++.++.|++.||+|||+.+ |
T Consensus 87 --~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 87 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred --cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 4558899999999999999996321 11234899999999999999999999999 9
Q ss_pred EeccCCCCCeEEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCC-C
Q 007160 396 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-K 474 (615)
Q Consensus 396 vHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~-~ 474 (615)
+||||||+||||+.++.+||+|||+|+...........+...||+.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998765544333445567999999999999999999999999999999999986 4
Q ss_pred CCCCCCCCCcchhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 007160 475 PVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 550 (615)
Q Consensus 475 Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~ 550 (615)
||..... ..+... +.. .. ....+......+.+|+.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~~~---~e~~~~----v~~---------~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAH---EEVIYY----VRD---------GN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCH---HHHHHH----HHT---------TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCH---HHHHHH----HHc---------CC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6653321 111111 111 11 01223333446889999999999999999999999998763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=410.34 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=205.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCc----EEEEEEeccC-CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.+|++.++||+|+||+||+|++. +|+ .||||++... .....++|.+|++++++++|||||+++|+|.. ...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCe
Confidence 46999999999999999999964 343 6899998754 33456789999999999999999999999973 357
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++++||+.+|+|.+++... ...+++..+++++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 8899999999999988743 346899999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
...............||+.|||||++.++.++.++|||||||+||||+| |+.||+...... +.. .+..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~-- 230 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGE-- 230 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTC--
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCC--
Confidence 8766554444455679999999999999999999999999999999998 788886443211 111 111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
....+......+.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 231 --------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1122333445688999999999999999999999999887653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=408.18 Aligned_cols=266 Identities=25% Similarity=0.401 Sum_probs=202.5
Q ss_pred HhcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhc-cCCCcceEEEEeecCC
Q 007160 267 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD 338 (615)
Q Consensus 267 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 338 (615)
..++|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|..++.++ +|+||+.+++++.. +
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-P 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-T
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-C
Confidence 3468999999999999999999853 346899999975433 2346788899988887 68999999998764 3
Q ss_pred CCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeE
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL 406 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NIL 406 (615)
....++||||+++|+|.++|+.... ....++|..++.++.||++||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 4578999999999999999964321 1235899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcc
Q 007160 407 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQE 485 (615)
Q Consensus 407 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~-~Pf~~~~~~~~~ 485 (615)
|++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+||. .||...... .
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~ 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence 9999999999999998766554444445678999999999999999999999999999999999975 567533221 1
Q ss_pred hhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 486 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
.+ ...+.... .+ ..+......+.+++.+||+.||++|||++||+++|+.+.+.
T Consensus 245 ~~----~~~~~~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 EF----CRRLKEGT------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH----HHHHHHTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHHhcCC------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11 11111111 11 12223334588999999999999999999999999988654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=397.85 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=199.3
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
++|++.+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++|||||+++|+|... ...+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEEEec
Confidence 56888999999999999999985 688999999743 3457899999999999999999999998632 3467999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.++|+.. ....++|..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999999642 1235899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcCC
Q 007160 429 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 507 (615)
Q Consensus 429 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d~ 507 (615)
....+|..|+|||++.++.++.++|||||||++|||+| |+.||..... ..+..++. .
T Consensus 158 -----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~----~---------- 215 (262)
T d1byga_ 158 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE----K---------- 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHT----T----------
T ss_pred -----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----c----------
Confidence 33468999999999999999999999999999999998 6777754321 12222211 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 508 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 508 ~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
......+......+.+|+.+||+.||++||||.||+++|+.+..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11112233334568899999999999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-49 Score=408.25 Aligned_cols=246 Identities=27% Similarity=0.376 Sum_probs=199.8
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
+.|+..+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|+++|++++|||||++++++.. ....++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEE
Confidence 3489999999999999999996 478999999997654433 2568999999999999999999999874 458999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+..
T Consensus 93 v~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999999999877653 245999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCccccceeeccccccCCcccccc---CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
... ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||...... .........
T Consensus 166 ~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~---- 229 (309)
T d1u5ra_ 166 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN---- 229 (309)
T ss_dssp SSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS----
T ss_pred CCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC----
Confidence 432 33579999999999864 46899999999999999999999999643211 111111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+.+. +......+.+|+.+||+.||++|||++|+++|
T Consensus 230 ---~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 ---ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 011111 11223458899999999999999999999876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=397.51 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=198.2
Q ss_pred hcCcccceeeeccCceEEEEEEECC----CcEEEEEEeccCCCCc-hHHHHHHHHHHhhccCCCcceEEEEeecCCCCce
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~ 342 (615)
.++|++.+.||+|+||.||+|++.. +..||||+++...... .+.|.+|+++|++++|||||+++|++. ....
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCeE
Confidence 4679999999999999999998642 3578999987544332 467999999999999999999999985 2468
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
++||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+
T Consensus 83 ~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhe
Confidence 9999999999999987642 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccchhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 501 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l 501 (615)
....... ...+...||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+... + .....
T Consensus 157 ~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~---i-~~~~~- 227 (273)
T d1mp8a_ 157 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---I-ENGER- 227 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---H-HTTCC-
T ss_pred eccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH---H-HcCCC-
Confidence 7654322 23345678999999999999999999999999999999998 89998754322 11111 1 11110
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 502 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 502 ~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
...+......+.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 228 ---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 112333345688999999999999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-48 Score=409.39 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=207.3
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
-++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.. ....+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 35899999999999999999996 4689999999986655556789999999999999999999999884 45899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc--CCCcEEEEeccccccC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE--NNFHAKVADFGLAKQA 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkL~DFGla~~~ 424 (615)
||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 103 E~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 103 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999999999642 235999999999999999999999999 99999999999995 4678999999999877
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... ......||+.|||||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 177 ~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~---- 243 (350)
T d1koaa2 177 DPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWN---- 243 (350)
T ss_dssp CTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC----
T ss_pred cccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC----
Confidence 5543 23456899999999999999999999999999999999999999964321 1111111111100
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
............+.+|+.+||+.||++|||++|+++|
T Consensus 244 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 ----MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011111223457899999999999999999999886
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=404.88 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=189.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
.+.|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++. +....+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE--SGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEE
Confidence 467999999999999999999964 689999999975432 23456889999999999999999999987 45689999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc---CCCcEEEEeccccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAK 422 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~ 422 (615)
|||+++|+|.++|.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+
T Consensus 86 mE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp ECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999975 345999999999999999999999999 99999999999994 57899999999998
Q ss_pred cCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhh
Q 007160 423 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 502 (615)
Q Consensus 423 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~ 502 (615)
...... .....+||+.|||||++.+..++.++|||||||+||||++|+.||...... .+ ...+.....
T Consensus 159 ~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~---~~~i~~~~~--- 226 (307)
T d1a06a_ 159 MEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KL---FEQILKAEY--- 226 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHHHTTCC---
T ss_pred EccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHhccCC---
Confidence 765432 223467999999999999999999999999999999999999999743211 11 111111110
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 503 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 503 ~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.............+.+|+.+||+.||++|||++|+++|
T Consensus 227 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 -----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111112223458899999999999999999999876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=398.07 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=196.7
Q ss_pred cCcccceeeeccCceEEEEEEECC----CcEEEEEEeccCC---CCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
++|++.+.||+|+||.||+|++.. +..||||++.... ....++|.+|+++|++++|||||+++|+|.. ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence 579999999999999999998632 2478999987542 2234689999999999999999999999863 36
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||+++|+|.+++... ...+++..++.++.|+|+||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred hheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 78999999999999988642 346999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccc-cceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 422 KQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 422 ~~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
+......... ......||..|+|||++.+..++.++|||||||++|||+| |+.||..... ... ...+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~---~~~i~~~~- 231 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQI---LHKIDKEG- 231 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH---HHHHHTSC-
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHH---HHHHHhCC-
Confidence 9876554322 2334568899999999999999999999999999999998 8999964321 111 11111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 500 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.....+......+.+|+.+||+.||++||||.||++.|++.
T Consensus 232 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112222334588999999999999999999999888764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=395.46 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=204.2
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC------CchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.+.|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.|.+|+++|++++|||||++++++. +..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECC
Confidence 36799999999999999999997 4789999999865422 23468999999999999999999999987 556
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC----cEEEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA 416 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~ 416 (615)
..+|||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEec
Confidence 89999999999999999974 345999999999999999999999999 99999999999998776 59999
Q ss_pred eccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 417 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 417 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
|||+++....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...... .....+..
T Consensus 160 DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~ 230 (293)
T d1jksa_ 160 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSA 230 (293)
T ss_dssp CCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHT
T ss_pred chhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHHh
Confidence 9999988755432 23457999999999999999999999999999999999999999743211 11111111
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
........ .+......+.+|+.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 231 VNYEFEDE--------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TCCCCCHH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCCCch--------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11000000 001122357899999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.8e-48 Score=406.31 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=207.2
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++. +....+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEEEE
Confidence 5799999999999999999996 479999999998665555667899999999999999999999987 4568999999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc--CCCcEEEEeccccccCC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE--NNFHAKVADFGLAKQAP 425 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkL~DFGla~~~~ 425 (615)
|+++|+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|+...
T Consensus 107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence 99999999988642 335999999999999999999999999 99999999999997 67899999999999876
Q ss_pred CCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhc
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 505 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~ 505 (615)
... ......||+.|||||++.+..++.++|||||||+||||++|+.||...... .....+....
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~------- 244 (352)
T d1koba_ 181 PDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCD------- 244 (352)
T ss_dssp TTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCC-------
T ss_pred CCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------
Confidence 543 234568999999999999999999999999999999999999999643211 1111111111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 506 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 506 d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..............+.+|+.+||+.||.+|||+.|+++|
T Consensus 245 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 -WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111112223457899999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=399.27 Aligned_cols=258 Identities=29% Similarity=0.437 Sum_probs=203.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCc--EEEEEEeccC-CCCchHHHHHHHHHHhhc-cCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGT--AVAIKRLTCG-GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.++||+|+||+||+|++. +|. .||||++... .....++|.+|+++|+++ +|||||+++|+|.. ....+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCeeE
Confidence 57889999999999999999965 444 5788888643 333456899999999999 79999999999984 45899
Q ss_pred EEEecCCCCChhHhhcCCC------------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC
Q 007160 344 LCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 411 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 411 (615)
+||||+++|+|.++|+... .....++|..+++++.|||+||.|||+.+ |+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCC
Confidence 9999999999999997542 22356999999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCCcchhhHh
Q 007160 412 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK-PVDMSQPSGQENLVTW 490 (615)
Q Consensus 412 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~-Pf~~~~~~~~~~l~~~ 490 (615)
.+||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||.... ...+...
T Consensus 165 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~ 238 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEK 238 (309)
T ss_dssp CEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH
T ss_pred ceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHHH
Confidence 999999999986543322 234568999999999999999999999999999999999765 564322 1111111
Q ss_pred hhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 491 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 491 ~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
+ ... .....+......+.+|+.+||+.||++||||+||+++|+.+.+
T Consensus 239 ---i-~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 ---L-PQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ---G-GGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---H-Hhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 111 1112233334568999999999999999999999999988765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=398.28 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=203.8
Q ss_pred ceeeeccCceEEEEEEECCC----cEEEEEEeccC-CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEec
Q 007160 274 ASILGEGGFGRVFKGVLSDG----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 348 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~Ey 348 (615)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++... ....++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEE
Confidence 47899999999999997432 36899999753 333347799999999999999999999998643 3478999999
Q ss_pred CCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCCCC
Q 007160 349 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 428 (615)
Q Consensus 349 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 428 (615)
+++|+|.++++.. ...+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999753 335788999999999999999999999 9999999999999999999999999998765443
Q ss_pred cc--ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhhcC
Q 007160 429 TN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 506 (615)
Q Consensus 429 ~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i~d 506 (615)
.. .......||+.|+|||.+.+..++.++||||||++||||+||+.||...... ..+..+ +... .+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~---i~~g-~~------ 252 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY---LLQG-RR------ 252 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HHTT-CC------
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH---HHcC-CC------
Confidence 22 2233457999999999999999999999999999999999988887643211 111111 1111 10
Q ss_pred CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 507 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 507 ~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
...+......+.+|+.+||+.||++||+|.||+++|+.+.+.
T Consensus 253 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111222334588999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=398.76 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=211.1
Q ss_pred hcCcccceeeeccCceEEEEEEE------CCCcEEEEEEeccCCCC-chHHHHHHHHHHhhc-cCCCcceEEEEeecCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS 339 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 339 (615)
.++|++.++||+|+||.||+|++ .+++.||||+++..... ...+|.+|+.+++++ +|||||+++|+|. +.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~--~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--IG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe--eC
Confidence 46889999999999999999985 24678999999765433 345799999999999 6999999999997 44
Q ss_pred CceeEEEecCCCCChhHhhcCCCC--------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLG--------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
...++||||+++|+|.++++.... ....+++..++.++.||++||+|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 578999999999999999964321 2235899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 485 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~ 485 (615)
|++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|+..|+....... .
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~ 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-S 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-H
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-H
Confidence 999999999999999998776554444456789999999999999999999999999999999999555543222111 1
Q ss_pred hhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 486 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 486 ~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
.+.. .+.. ......+......+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 256 ~~~~----~i~~----------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 256 KFYK----MIKE----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHH----HHHH----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----HHhc----------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111 1111 11112223334568999999999999999999999999987644
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=397.01 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=207.5
Q ss_pred hcCcccceeeeccCceEEEEEEECC--------CcEEEEEEeccCCCC-chHHHHHHHHHHhhc-cCCCcceEEEEeecC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~~ 337 (615)
.++|++.+.||+|+||.||+|+..+ +..||||+++..... ...++.+|...+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence 3578999999999999999998532 347999999765432 346789999999998 7999999999997
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCC------------CcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 405 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NI 405 (615)
+....++||||+++|+|.++|..... ....+++.+++.++.|++.||+|||+.+ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 44589999999999999999975321 1345899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007160 406 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ 484 (615)
Q Consensus 406 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~Ellt-G~~Pf~~~~~~~~ 484 (615)
|++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |+.||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 999999999999999997765544434455679999999999999999999999999999999998 6888763321
Q ss_pred chhhHhhhhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 485 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 485 ~~l~~~~~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
..+.. .+.... ....+......+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 244 ~~~~~----~i~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 EELFK----LLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHH----HHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH----HHHcCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 11111 111111 1122223334689999999999999999999999999888653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=396.33 Aligned_cols=274 Identities=23% Similarity=0.354 Sum_probs=203.2
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHH--HHhhccCCCcceEEEEeecCCC--CceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVE--MLSRLHHRNLVKLVGYYSSRDS--SQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~--~l~~l~HpnIv~l~g~~~~~~~--~~~~L 344 (615)
++|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+++..|.+ .+.+++|||||+++|+|...+. ..+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4678889999999999999997 5789999999643 3344545544 5567899999999999975443 35789
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhC-----CCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-----SQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-----~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
||||+++|+|.++|+. ..++|..+++++.|+|.||+|||+. ..++|+||||||+||||+.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999974 3589999999999999999999974 12349999999999999999999999999
Q ss_pred ccccCCCCCcc--ccceeeccccccCCccccccC------cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 420 LAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 420 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
+++........ .......||+.|||||++.+. .++.++|||||||+||||+||..|+......... .....
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhcc
Confidence 99877543321 223456899999999998754 3678999999999999999999887533221111 00000
Q ss_pred hhhhccchhhhhhcCCccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 007160 492 RPILRDKDRLEELADPRLGGKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 552 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~ 552 (615)
............+.+..+.... +.+....+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0000000011122222222222 223456789999999999999999999999999988754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-47 Score=387.48 Aligned_cols=262 Identities=26% Similarity=0.353 Sum_probs=202.7
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc---hHHHHHHHHHHhhccCCCcceEEEEeecCCC--Cc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--SQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~--~~ 341 (615)
.++|++.+.||+|+||+||+|+. .+|+.||||+++...... .+.|.+|++++++++|||||++++++...+. ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 579999999997654332 3568999999999999999999999875433 34
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.+|||||+++|+|.+++.. ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999999864 346999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCc-cccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 422 KQAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 422 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
+....... ........||+.|||||++.+..++.++|||||||++|||+||+.||..... .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCC
Confidence 76544322 2233456799999999999999999999999999999999999999974321 1111122221111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQ 550 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-sm~eVl~~L~~i~ 550 (615)
... .....++ ..+.+++.+||+.||++|| |++++++.|..++
T Consensus 233 ~~~----~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PPS----ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CGG----GTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCc----hhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 100 1111223 3588999999999999999 8999998887764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=398.53 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=206.1
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++++. +...+++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~i 82 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec--ccccccc
Confidence 5799999999999999999996 57999999999743 2334577899999999999999999999988 5568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 83 v~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999975 345888999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
..... .....+||+.|||||++.+..++.++|||||||+||||++|+.||..... ..........
T Consensus 156 ~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~------- 220 (337)
T d1o6la_ 156 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILME------- 220 (337)
T ss_dssp CCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-------
T ss_pred ccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcC-------
Confidence 54322 23456899999999999999999999999999999999999999975431 1111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 545 (615)
.. .+|......+.+|+.+||+.||++||+ +.|+++|
T Consensus 221 -~~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 -EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CC----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 01 122333345789999999999999995 8888876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=397.04 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=208.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCCC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 340 (615)
.++|++.+.||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++|+|. ...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC--SSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe--cCC
Confidence 468899999999999999999863 357899999975432 23356899999999999999999999987 445
Q ss_pred ceeEEEecCCCCChhHhhcCCC------CCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEE
Q 007160 341 QHLLCYELVPNGSLESWLHGPL------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 414 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~------~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 414 (615)
..++||||+++|+|.++++... .....++|..+.+++.|+|+||.|||+++ |+||||||+|||+++++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 7899999999999999986321 11234789999999999999999999998 99999999999999999999
Q ss_pred EEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcchhhHhhhh
Q 007160 415 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQENLVTWARP 493 (615)
Q Consensus 415 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~-~Pf~~~~~~~~~~l~~~~~~ 493 (615)
|+|||+++...............||+.|+|||.+.+..++.++||||||++||||+||. .||.... ...+..
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~- 246 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLR- 246 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHH-
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHH-
Confidence 99999998776544444445567999999999999999999999999999999999985 5664321 111111
Q ss_pred hhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 007160 494 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 549 (615)
Q Consensus 494 ~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i 549 (615)
.+.+... ...+......+.+|+.+||+.||++||||.+|+++|+..
T Consensus 247 ---------~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 247 ---------FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ---------HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---------HHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111111 112233335689999999999999999999999988765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-47 Score=393.45 Aligned_cols=245 Identities=28% Similarity=0.376 Sum_probs=204.1
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++|||||++++++. +....++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe--eCCeeee
Confidence 5799999999999999999996 46899999998643 2334578999999999999999999999987 5568999
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 82 vmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999999875 335788899999999999999999999 999999999999999999999999999886
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... ....||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+....
T Consensus 155 ~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~------ 217 (316)
T d1fota_ 155 PDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAE------ 217 (316)
T ss_dssp SSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCC------
T ss_pred cccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCC------
Confidence 5432 346899999999999999999999999999999999999999974321 11111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
. .++......+.+++.+||+.||.+|+ |++|+++|
T Consensus 218 --~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 --L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --C----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 12222334588999999999999996 89999886
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-46 Score=382.09 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=203.5
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc---------hHHHHHHHHHHhhcc-CCCcceEEEEeecC
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---------DKEFLVEVEMLSRLH-HRNLVKLVGYYSSR 337 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~---------~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~ 337 (615)
++|++.+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|++++++++ |||||++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 6899999999999999999996 578999999997643221 235889999999997 999999999998
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 417 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 417 (615)
+....+|||||+++|+|.++|+. ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEcc
Confidence 55689999999999999999974 346999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCccccceeeccccccCCcccccc------CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 491 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~ 491 (615)
||+++....... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||...... ...
T Consensus 154 FG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~ 224 (277)
T d1phka_ 154 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LML 224 (277)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred chheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHH
Confidence 999998765432 245679999999998863 35688999999999999999999999743311 111
Q ss_pred hhhhccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 492 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 492 ~~~~~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
..+..... .............+.+|+.+||+.||++|||++||++|
T Consensus 225 ~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMIMSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHhCCC--------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111110 01111112233458899999999999999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=388.96 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=205.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.++|++.+.||+|+||+||+|+.. +|+.||||.++... .....+.+|+++|++++|||||++++++.+ ...+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEE
Confidence 468999999999999999999964 68899999997543 234568899999999999999999999874 45899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC--CCcEEEEeccccccC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA 424 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~ 424 (615)
||+++|+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 81 E~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 81 EFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999999752 235899999999999999999999999 999999999999975 458999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..........
T Consensus 155 ~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 155 KPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCCHH
T ss_pred ccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCChh
Confidence 5433 234567999999999999999999999999999999999999999743311 1111121111100000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
....+ ...+.+|+.+||+.||++|||+.|+++|=+
T Consensus 226 ----~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 226 ----AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp ----HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ----hccCC----CHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 00111 234789999999999999999999998743
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-46 Score=395.14 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=203.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 344 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~L 344 (615)
++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++. +....++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc--ccccccc
Confidence 47999999999999999999964 7999999998642 2234567899999999999999999999987 4558899
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccC
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 424 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 424 (615)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 119 v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999999964 335899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhhh
Q 007160 425 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 504 (615)
Q Consensus 425 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~i 504 (615)
... .....||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+....
T Consensus 192 ~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~------ 254 (350)
T d1rdqe_ 192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGK------ 254 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC------
T ss_pred ccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCC------
Confidence 532 2346799999999999999999999999999999999999999964321 11111111110
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 505 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 505 ~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
. ..+......+.+++.+||+.||.+|+ |++|+++|
T Consensus 255 --~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 --V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1 11222234588999999999999994 89999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-46 Score=396.78 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=198.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCC---CCchHHHHHH---HHHHhhccCCCcceEEEEeecCCCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVE---VEMLSRLHHRNLVKLVGYYSSRDSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~~l~~l~HpnIv~l~g~~~~~~~~~ 341 (615)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+| +++++.++|||||++++++. +...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~--~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE--ECCE
Confidence 68999999999999999999964 68999999986321 1223344444 66677778999999999987 4558
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.++||||+++|+|.++|.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 82 ~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence 9999999999999999974 345889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 500 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 500 (615)
+...... .....||+.|||||++.. ..++.++|||||||+||||+||+.||..........+. +...
T Consensus 155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~----- 222 (364)
T d1omwa3 155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL----- 222 (364)
T ss_dssp EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HHSS-----
T ss_pred eecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhcc-----
Confidence 8775543 234579999999999875 56899999999999999999999999754432211111 1010
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 007160 501 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS 545 (615)
Q Consensus 501 l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-----m~eVl~~ 545 (615)
... ...+......+.+|+.+||+.||++||| ++|+++|
T Consensus 223 -----~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 -----TMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----SCC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----cCC--CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 000 1112222345889999999999999999 6888876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=391.69 Aligned_cols=255 Identities=24% Similarity=0.263 Sum_probs=200.4
Q ss_pred hcCcccce-eeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhc-cCCCcceEEEEeec--CCCCce
Q 007160 268 TNNFEPAS-ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS--RDSSQH 342 (615)
Q Consensus 268 ~~~f~~~~-~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~HpnIv~l~g~~~~--~~~~~~ 342 (615)
.++|++.. +||+|+||+||+|+. .+|+.||||+++. ...+.+|++++.++ +|||||++++++.. .....+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36898875 699999999999996 5789999999863 35678899987665 89999999999864 234578
Q ss_pred eEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC---CCcEEEEecc
Q 007160 343 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG 419 (615)
Q Consensus 343 ~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFG 419 (615)
+||||||+||+|.++|.... ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 99999999999999997532 346999999999999999999999999 999999999999975 5679999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccch
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 499 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 499 (615)
+|+....... .....||+.|||||++.+..++.++|||||||+||||+||+.||.......... ....
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~~~~------- 227 (335)
T d2ozaa1 160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKT------- 227 (335)
T ss_dssp TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred eeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--HHHH-------
Confidence 9987765432 245679999999999999999999999999999999999999996443221110 0000
Q ss_pred hhhhhcCCccCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 007160 500 RLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 547 (615)
Q Consensus 500 ~l~~i~d~~l~~~~~--~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~ 547 (615)
.+......-..+ ......+.+|+.+||+.||++|||+.|+++|=+
T Consensus 228 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 228 ---RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred ---HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 000000000001 122346889999999999999999999998733
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=382.37 Aligned_cols=259 Identities=25% Similarity=0.283 Sum_probs=193.7
Q ss_pred cceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCc-----hHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 273 PASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-----DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 273 ~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~-----~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
.+++||+|+||+||+|+. .+|+.||||++....... .+.+.+|+++|++++|||||++++++. +....+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~--~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec--cCCceeehh
Confidence 468899999999999996 468999999997543221 346899999999999999999999987 445799999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+.++++..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 80 E~~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 80 DFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp ECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred hhhcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCC
Confidence 99998877776653 345899999999999999999999999 99999999999999999999999999987655
Q ss_pred CCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc--------
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-------- 497 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~-------- 497 (615)
... ......||+.|+|||++... .++.++|||||||++|||++|+.||......+. +..... .+..
T Consensus 153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~-~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 153 PNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFE-TLGTPTEEQWPD 227 (299)
T ss_dssp CCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCTTTSSS
T ss_pred Ccc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHHH-hcCCCChhhccc
Confidence 432 22345799999999988754 679999999999999999999999964432111 111000 0000
Q ss_pred chhhhhhcCCccCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.........-......+. .....+.+|+.+||+.||++|||++|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000000000111 112458899999999999999999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=388.59 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccC---CCCchHHHHHHHHHHh-hccCCCcceEEEEeecCCCCcee
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLS-RLHHRNLVKLVGYYSSRDSSQHL 343 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~-~l~HpnIv~l~g~~~~~~~~~~~ 343 (615)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+..|+.++. .++|||||++++++. +....+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc--cCCcee
Confidence 57999999999999999999964 6899999999643 2233456777888766 689999999999988 456899
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
|||||+++|+|.++++. ...+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 80 ivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 99999999999999974 335889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccchhhhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 503 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~l~~ 503 (615)
...... ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~------ 218 (320)
T d1xjda_ 153 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMD------ 218 (320)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC------
T ss_pred cccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHcC------
Confidence 654332 234568999999999999999999999999999999999999999743211 111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 007160 504 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS 545 (615)
Q Consensus 504 i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~-eVl~~ 545 (615)
.+ .++......+.+|+.+||+.||++||++. |+++|
T Consensus 219 --~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 --NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp --CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 11 12222334588999999999999999995 78764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=381.15 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=197.5
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++. +....++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~--~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc--cccceeEE
Confidence 5899999999999999999996 5789999999975432 23578999999999999999999999998 45589999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
|||+.+ ++.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EECCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EeecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceecc
Confidence 999965 455454321 1345999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccccceeeccccccCCccccccCc-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc----hh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK----DR 500 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~----~~ 500 (615)
.... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... .+........... ..
T Consensus 154 ~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 154 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp CCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTT
T ss_pred CCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccc
Confidence 4332 234457999999999877665 5789999999999999999999997443211 1110000000000 00
Q ss_pred hhhhcCCc--cCC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 501 LEELADPR--LGG--KYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 501 l~~i~d~~--l~~--~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.....+.. ... ... ......+.+|+.+||+.||++|||+.|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 000 000 0112457899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=376.36 Aligned_cols=240 Identities=23% Similarity=0.389 Sum_probs=195.5
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC------chHHHHHHHHHHhhcc--CCCcceEEEEeecCCC
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS 339 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l~--HpnIv~l~g~~~~~~~ 339 (615)
++|++.++||+|+||+||+|+. .+|+.||||++...... ....+.+|+++|++++ |||||++++++. +.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--eC
Confidence 5799999999999999999996 47899999998753211 1234778999999996 899999999987 45
Q ss_pred CceeEEEecCCC-CChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-CCcEEEEe
Q 007160 340 SQHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVAD 417 (615)
Q Consensus 340 ~~~~LV~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~D 417 (615)
...++||||+.+ +++.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence 589999999976 678888764 345899999999999999999999999 999999999999985 57999999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccCcC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhc
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 496 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~ 496 (615)
||+|+...... .+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... . ..+
T Consensus 155 FG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~~ 218 (273)
T d1xwsa_ 155 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------IIR 218 (273)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HHH
T ss_pred cccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------Hhh
Confidence 99998765432 245679999999999987765 678999999999999999999996321 1 111
Q ss_pred cchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 497 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 497 ~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ......++ ..+.+|+.+||+.||++|||++|+++|
T Consensus 219 ~~--------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 GQ--------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CC--------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc--------cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 10 01112233 357899999999999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-45 Score=375.40 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=199.0
Q ss_pred cCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.+.||+|+||+||+|+.++|+.||||++..... ...+.+.+|+.+|++++|||||++++++. +....++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc--cCCceeEEE
Confidence 58999999999999999999999999999999975432 23578999999999999999999999988 455899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 426 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 426 (615)
||+.++.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp ECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EeehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 99988777766653 346999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-------hccc
Q 007160 427 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI-------LRDK 498 (615)
Q Consensus 427 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~-------~~~~ 498 (615)
... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....... .+....... +...
T Consensus 153 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTG
T ss_pred Ccc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhccch
Confidence 332 23345689999999998754 56899999999999999999999997433211 111100000 0000
Q ss_pred hhhhhhc------CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 DRLEELA------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 ~~l~~i~------d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
....... .+.............+.+|+.+||+.||++|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0000000111123457899999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=376.38 Aligned_cols=267 Identities=25% Similarity=0.309 Sum_probs=199.0
Q ss_pred hcCcccceeeeccCceEEEEEEE-CC-CcEEEEEEeccCC--CCchHHHHHHHHHHhhc---cCCCcceEEEEeec---C
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SD-GTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL---HHRNLVKLVGYYSS---R 337 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~HpnIv~l~g~~~~---~ 337 (615)
.++|++.+.||+|+||+||+|+. .+ ++.||||++.... ......+.+|+++|+.+ +||||++++++|.. .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 6789999986432 22344677888887766 79999999998853 2
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEe
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD 417 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 417 (615)
.....+++|||++++++....... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 335689999999988776555432 345889999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh---
Q 007160 418 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI--- 494 (615)
Q Consensus 418 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~--- 494 (615)
||+++...... ......||+.|||||++.+..++.++||||+||++|||++|+.||........ +.......
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCC
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCC
Confidence 99998654332 23456899999999999999999999999999999999999999975432111 11100000
Q ss_pred ----hccchhh-hhhcCCc---cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 ----LRDKDRL-EELADPR---LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 ----~~~~~~l-~~i~d~~---l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
+...... ....... ............+.+|+.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0000000 0001111223457889999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-43 Score=360.77 Aligned_cols=262 Identities=20% Similarity=0.302 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEEEe
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE 347 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV~E 347 (615)
++|++.+.||+|+||.||+|+. .+|+.||||++..... .+++..|++++++++|+|++..++.+.. +....++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe-cCCEEEEEEE
Confidence 5799999999999999999996 4689999999875433 3468899999999988877766665543 4457899999
Q ss_pred cCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEc---CCCcEEEEeccccccC
Q 007160 348 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQA 424 (615)
Q Consensus 348 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~~~ 424 (615)
|+ +|+|.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+..
T Consensus 84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 56777666532 345899999999999999999999999 99999999999985 4567999999999987
Q ss_pred CCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhhhhccc
Q 007160 425 PEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDK 498 (615)
Q Consensus 425 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~-~~~~~~~~~~ 498 (615)
...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||............ .+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH--
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC--
Confidence 554321 1224467999999999999999999999999999999999999999754432221111 11111000
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 007160 499 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 551 (615)
Q Consensus 499 ~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~ 551 (615)
...+.+...++. .+.+++..||+.||++||+++++.+.|+.+..
T Consensus 235 -----~~~~~~~~~~p~----~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 -----TPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----SCHHHHTTTSCH----HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----CChhHhccCCCH----HHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000111223333 47899999999999999999999988887654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-43 Score=367.59 Aligned_cols=261 Identities=17% Similarity=0.268 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCCceeEEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY 346 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~~~LV~ 346 (615)
++|++.++||+|+||+||+|+. .+|+.||||+++. ...+.+.+|+++|++++ ||||+++++++........++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 5789999999974 33578899999999995 99999999998866667899999
Q ss_pred ecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEEeccccccCC
Q 007160 347 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP 425 (615)
Q Consensus 347 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 425 (615)
||+.+|+|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999987653 4889999999999999999999999 99999999999998654 69999999998775
Q ss_pred CCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch--hh---------Hhhhh
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN--LV---------TWARP 493 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~--l~---------~~~~~ 493 (615)
.... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... +. .|...
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5432 2445789999999998765 57999999999999999999999997543221110 00 00000
Q ss_pred h-hccchhhhhhcCCc--------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 494 I-LRDKDRLEELADPR--------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 494 ~-~~~~~~l~~i~d~~--------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. .............. ............+.+|+.+||+.||++|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000000000 0000111123457899999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=363.25 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=195.6
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCC--CCchHHHHHHHHHHhhccCCCcceEEEEeecCC------
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------ 338 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 338 (615)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|+||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 579999999986542 334577999999999999999999999875422
Q ss_pred CCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEec
Q 007160 339 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 418 (615)
Q Consensus 339 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 418 (615)
....++||||+.++.+..+... ...++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 3468999999988777655543 335788999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCcc--ccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 419 GLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 419 Gla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
|+++........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||............ ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i---~~~~ 238 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLC 238 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH---HHhc
Confidence 999876543321 122335799999999998765 6899999999999999999999999743321111111 0000
Q ss_pred cc-c-hh--------hhhhcCCccCCCCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 496 RD-K-DR--------LEELADPRLGGKYPK-ED------FIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 496 ~~-~-~~--------l~~i~d~~l~~~~~~-~~------~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. . .. ............... +. ...+.+|+.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 0 00 000000000000011 11 2246789999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=368.83 Aligned_cols=269 Identities=23% Similarity=0.291 Sum_probs=197.4
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC-CchHHHHHHHHHHhhccCCCcceEEEEeecCCC--Ccee
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--SQHL 343 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~--~~~~ 343 (615)
+.+|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+++|+++|++++||||+++++++..... ...+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999986 5799999999975432 234678999999999999999999999864321 2334
Q ss_pred EEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 344 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 344 LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55667779999999963 35899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCc-cccceeeccccccCCccccc-cCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc----
Q 007160 424 APEGRT-NYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD---- 497 (615)
Q Consensus 424 ~~~~~~-~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~---- 497 (615)
...... .......+||+.|+|||++. ...++.++||||+||++|||++|+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 644322 12234567999999999985 456789999999999999999999999754422211111000000000
Q ss_pred -----chhhhhhcCCccCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 498 -----KDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 498 -----~~~l~~i~d~~l~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.........+.. ...+. ....++.+|+.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 01111 111357899999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=369.57 Aligned_cols=261 Identities=24% Similarity=0.346 Sum_probs=193.9
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecCC----CC
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS 340 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~ 340 (615)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999996 46999999999754332 2457899999999999999999999987533 23
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccc
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 420 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 420 (615)
.+++||||+ +.+|..+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 6678887753 35999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-----
Q 007160 421 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI----- 494 (615)
Q Consensus 421 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~----- 494 (615)
|+...... +...||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ +.......
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPA 240 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcH
Confidence 98765432 345799999999998764 568999999999999999999999975432111 11000000
Q ss_pred -----hccc--hhhhhhcCCccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 495 -----LRDK--DRLEELADPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 495 -----~~~~--~~l~~i~d~~l~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.... ....... +.... .........+.+|+.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000000 00000 0111122347899999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=371.36 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=193.5
Q ss_pred CcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcceEEEEeec----CCCCceeE
Q 007160 270 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS----RDSSQHLL 344 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~~~L 344 (615)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|+||+++++++.. .+...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999974 689999999975432 23479999999999999999999853 23345789
Q ss_pred EEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCC-cEEEEecccccc
Q 007160 345 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQ 423 (615)
Q Consensus 345 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~ 423 (615)
||||++++.+..+.+ .......+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998764443332 1112346999999999999999999999999 99999999999999765 899999999987
Q ss_pred CCCCCccccceeeccccccCCcccccc-CcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc-chhh
Q 007160 424 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-KDRL 501 (615)
Q Consensus 424 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~-~~~l 501 (615)
...... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+....+..-.. ....
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhh
Confidence 754432 234579999999998775 578999999999999999999999997543211 111111000000 0000
Q ss_pred hh----hcC---CccC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 502 EE----LAD---PRLG-----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 502 ~~----i~d---~~l~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
.. ..+ +... ..........+.+|+.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000 0000 00111223357899999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-42 Score=355.53 Aligned_cols=265 Identities=18% Similarity=0.223 Sum_probs=206.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCCchHHHHHHHHHHhhccC-CCcceEEEEeecCCCCceeEE
Q 007160 268 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~~~LV 345 (615)
.++|++.+.||+|+||+||+|+.. +|+.||||.+.... ....+.+|++.++.++| +|++.+++++. +....++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCccEEE
Confidence 368999999999999999999964 68999999886543 23467889999999975 89999999887 45588999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcC-----CCcEEEEeccc
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGL 420 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkL~DFGl 420 (615)
|||+ +|+|.++++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 80 me~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccce
Confidence 9999 78999998643 235899999999999999999999999 999999999999964 57899999999
Q ss_pred cccCCCCCcc-----ccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 007160 421 AKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 495 (615)
Q Consensus 421 a~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~ 495 (615)
|+........ .......||+.|||||.+.+..++.++|||||||++|||++|+.||..................
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~- 231 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK- 231 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-
Confidence 9876543221 1223467999999999999999999999999999999999999999754433222111111000
Q ss_pred ccchhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhh
Q 007160 496 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 553 (615)
Q Consensus 496 ~~~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~L~~i~~~~ 553 (615)
....... .+...+|. .+.+++..|++.+|++||+++.+.+.|+.+.+..
T Consensus 232 ~~~~~~~-----~l~~~~p~----~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 232 KQSTPLR-----ELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHSCHH-----HHTTTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCCChH-----HhcCCCCH----HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0000111 11223343 4788999999999999999999999888876544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=356.91 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=202.7
Q ss_pred cCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCC--CchHHHHHHHHHHhhccCCCcceEEEEeecCCCCceeEE
Q 007160 269 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 345 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~~~LV 345 (615)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++||||+++++++. +....+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc--cccceeEE
Confidence 5799999999999999999996 5789999999975433 33578999999999999999999999998 45588999
Q ss_pred EecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEeccccccCC
Q 007160 346 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 425 (615)
Q Consensus 346 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 425 (615)
+|++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...
T Consensus 80 ~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 80 FEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhccc
Confidence 999999999888864 345889999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCccccceeeccccccCCccccccCc-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc-----h
Q 007160 426 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-----D 499 (615)
Q Consensus 426 ~~~~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-----~ 499 (615)
..... .....++..|+|||.+.... ++.++|||||||++|||++|+.||....... ....-........ .
T Consensus 153 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 153 IPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCT
T ss_pred CCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhh
Confidence 54322 23446788999999887665 6899999999999999999999975432211 1111000000000 0
Q ss_pred hhhhhcCC---------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 500 RLEELADP---------RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 500 ~l~~i~d~---------~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
......+. .............+.+|+.+||+.||++|||++||++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00011112223457899999999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=362.15 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEE----CCCcEEEEEEeccCC----CCchHHHHHHHHHHhhccC-CCcceEEEEeecCCC
Q 007160 269 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDS 339 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H-pnIv~l~g~~~~~~~ 339 (615)
++|++.+.||+|+||+||+|+. .+|+.||||.+.... ....+.+.+|+++|++++| |||+++++++.. .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--C
Confidence 5799999999999999999985 247899999986432 2334678899999999976 899999999874 4
Q ss_pred CceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecc
Q 007160 340 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 419 (615)
Q Consensus 340 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 419 (615)
...+++|||+.+|+|.+++.. ...+....+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred CceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence 589999999999999999974 234677889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccccceeeccccccCCccccccC--cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhcc
Q 007160 420 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 497 (615)
Q Consensus 420 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 497 (615)
+++........ ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... ........
T Consensus 175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~~~ 251 (322)
T d1vzoa_ 175 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKS 251 (322)
T ss_dssp EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHHC
T ss_pred chhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcccC
Confidence 99876543322 23446799999999998754 468899999999999999999999975543322111 11111100
Q ss_pred chhhhhhcCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 007160 498 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS 545 (615)
Q Consensus 498 ~~~l~~i~d~~l~~~~~~~~~~~l~~Li~~Cl~~dP~~RP-----sm~eVl~~ 545 (615)
.+ ..+......+.+++.+||+.||++|| |++|+++|
T Consensus 252 --------~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 --------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11 12333445688999999999999999 47888875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=361.52 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=190.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-CCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecC----CCCc
Q 007160 269 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQ 341 (615)
Q Consensus 269 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~----~~~~ 341 (615)
++|++.++||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.+|++++|||||++++++... +...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999965 6999999999755332 235688999999999999999999998643 3367
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 89999999665 445553 24889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhh---------Hhhh
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV---------TWAR 492 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~---------~~~~ 492 (615)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||............ .+..
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8765433 234567999999999999999999999999999999999999999644311110000 0000
Q ss_pred h-------hhccc-----hhhhhhcCCccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 493 P-------ILRDK-----DRLEELADPRLGGK---YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 493 ~-------~~~~~-----~~l~~i~d~~l~~~---~~~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
. ..... .............. ........+.+|+.+||+.||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000 00000111111000 112234568899999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=359.89 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=195.2
Q ss_pred hcCcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCC--chHHHHHHHHHHhhccCCCcceEEEEeecC---CCCc
Q 007160 268 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQ 341 (615)
Q Consensus 268 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~HpnIv~l~g~~~~~---~~~~ 341 (615)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++++|+|||++++++... +...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999995 57999999999765432 235788999999999999999999988632 2234
Q ss_pred eeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcEEEEecccc
Q 007160 342 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 421 (615)
Q Consensus 342 ~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 421 (615)
.+++++|+.+|+|.++++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 5677888889999999964 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccccceeeccccccCCccccccC-cCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhccc--
Q 007160 422 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-- 498 (615)
Q Consensus 422 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-- 498 (615)
..... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+ ........
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i--~~~~~~~~~~ 241 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI--LRLVGTPGAE 241 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCHH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCChH
Confidence 76532 22345799999999987765 4689999999999999999999999754321111100 00000000
Q ss_pred -------hhhhhhcCCccC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 007160 499 -------DRLEELADPRLG-GKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS 545 (615)
Q Consensus 499 -------~~l~~i~d~~l~-~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPsm~eVl~~ 545 (615)
............ .... ......+.+|+.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000 0000 0112347899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-38 Score=332.48 Aligned_cols=266 Identities=20% Similarity=0.234 Sum_probs=191.9
Q ss_pred CcccceeeeccCceEEEEEEE-CCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-----------CCCcceEEEEeecC
Q 007160 270 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----------HRNLVKLVGYYSSR 337 (615)
Q Consensus 270 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------HpnIv~l~g~~~~~ 337 (615)
+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 499999999999999999996 579999999997432 22457788999998875 57899999988765
Q ss_pred CCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-CCCCcEEeccCCCCCeEEcCCC-----
Q 007160 338 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNF----- 411 (615)
Q Consensus 338 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~----- 411 (615)
.....+++++++..+........ ......+++..+..++.||++||+|||+ .+ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 55567777777766543333221 1123457889999999999999999998 77 99999999999997654
Q ss_pred -cEEEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch----
Q 007160 412 -HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN---- 486 (615)
Q Consensus 412 -~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL~ElltG~~Pf~~~~~~~~~~---- 486 (615)
.+|++|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||..........
T Consensus 169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 49999999998654322 34579999999999999999999999999999999999999996433221111
Q ss_pred hhHhhhhh-------hccchhhhhhcCC-----c--------------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 007160 487 LVTWARPI-------LRDKDRLEELADP-----R--------------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 540 (615)
Q Consensus 487 l~~~~~~~-------~~~~~~l~~i~d~-----~--------------l~~~~~~~~~~~l~~Li~~Cl~~dP~~RPsm~ 540 (615)
+......+ ...........+. . ............+.+|+.+||..||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11111000 0000000000000 0 01123455667899999999999999999999
Q ss_pred HHHHH
Q 007160 541 EVVQS 545 (615)
Q Consensus 541 eVl~~ 545 (615)
|+++|
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=9.4e-24 Score=201.60 Aligned_cols=169 Identities=15% Similarity=0.137 Sum_probs=123.0
Q ss_pred ccceeeeccCceEEEEEEECCCcEEEEEEeccCCCC------------------chHHHHHHHHHHhhccCCCcceEEEE
Q 007160 272 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ------------------GDKEFLVEVEMLSRLHHRNLVKLVGY 333 (615)
Q Consensus 272 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~------------------~~~~f~~Ei~~l~~l~HpnIv~l~g~ 333 (615)
.+.++||+|+||+||+|+..+|+.||||+++..... ......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999989999999987532110 01234568889999999999998876
Q ss_pred eecCCCCceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCCCCcEEeccCCCCCeEEcCCCcE
Q 007160 334 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 413 (615)
Q Consensus 334 ~~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 413 (615)
. ..+++|||++++.+.+ +++.....++.|++++|+|||+.+ |+||||||+|||++++ .+
T Consensus 83 ~------~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 83 E------GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp E------TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred c------CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 3 2379999998765533 445667789999999999999999 9999999999999965 58
Q ss_pred EEEeccccccCCCCCccccceeeccccccCCccccccCcCCchhhHHHHHHHH
Q 007160 414 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVL 466 (615)
Q Consensus 414 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwS~GvvL 466 (615)
+|+|||+|+............+.+. .+ .| +..+.|+.++|+||..--+
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~rd~~---~~-~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILERDVR---NI-IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHHHHH---HH-HH-HHHHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHHHHH---HH-HH-HHcCCCCCcccHHHHHHHH
Confidence 9999999987653322110000000 00 01 1245678899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=8.8e-08 Score=93.20 Aligned_cols=149 Identities=15% Similarity=0.091 Sum_probs=104.3
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhcc-CCCcceEEEEeecCCCC
Q 007160 262 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSS 340 (615)
Q Consensus 262 ~el~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~ 340 (615)
.++...-+.|+..+..+-+..+.||+... +++.+.||+...........+.+|..++..+. +--+-+++.+.. +.+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCC
Confidence 46777778888766655555678999765 45667888886554444556788999988774 433566777665 345
Q ss_pred ceeEEEecCCCCChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHhCC-----------------------------
Q 007160 341 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS----------------------------- 391 (615)
Q Consensus 341 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~----------------------------- 391 (615)
..++||+++++.++.+.... ......++.++++.|+.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred ceEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 78999999999888665421 1223345555666666666421
Q ss_pred ---------------------------CCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 392 ---------------------------QPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 392 ---------------------------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
.+.++|+|+.+.|||++++...-|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 2348999999999999987777799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.21 E-value=3e-06 Score=81.55 Aligned_cols=130 Identities=21% Similarity=0.154 Sum_probs=84.4
Q ss_pred eeeccCc-eEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCC--CcceEEEEeecCCCCceeEEEecCCCC
Q 007160 276 ILGEGGF-GRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLVGYYSSRDSSQHLLCYELVPNG 352 (615)
Q Consensus 276 ~LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~Hp--nIv~l~g~~~~~~~~~~~LV~Ey~~~g 352 (615)
.+..|.. ..||+...+++..+++|...... ...+..|...++.+... .+.+++++.. +....++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEEEeeecc
Confidence 4455553 68999988888888999865432 33567788888877533 3456677655 445789999999987
Q ss_pred ChhHhhcCCCCCcccCChhhHHHHHHHHHHHHHHhHh-------------------------------------------
Q 007160 353 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE------------------------------------------- 389 (615)
Q Consensus 353 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~------------------------------------------- 389 (615)
++.+... ....++.++++.|.-||.
T Consensus 92 ~~~~~~~------------~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 92 DLLSSHL------------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp ETTTSCC------------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccccccc------------cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 6643210 001112222222333332
Q ss_pred ------------CCCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 390 ------------DSQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 390 ------------~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
..++.++|+|+.+.|||++++..+-|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 113458999999999999988777899998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=0.00024 Score=72.92 Aligned_cols=76 Identities=16% Similarity=0.097 Sum_probs=47.9
Q ss_pred ceeeeccCceEEEEEEEC-CCcEEEEEEecc----C--C-CCchHHHHHHHHHHhhcc-C--CCcceEEEEeecCCCCce
Q 007160 274 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTC----G--G-QQGDKEFLVEVEMLSRLH-H--RNLVKLVGYYSSRDSSQH 342 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~----~--~-~~~~~~f~~Ei~~l~~l~-H--pnIv~l~g~~~~~~~~~~ 342 (615)
.+.||.|....||+.... +++.|+||.-.. . + .........|.+.|+.+. + ..+.+++.+. ....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d----~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc----CCCC
Confidence 356899999999999864 467899996431 1 1 112234556888887663 2 3455566553 2356
Q ss_pred eEEEecCCCCC
Q 007160 343 LLCYELVPNGS 353 (615)
Q Consensus 343 ~LV~Ey~~~gs 353 (615)
++|||++++..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 89999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.00029 Score=70.30 Aligned_cols=139 Identities=14% Similarity=0.120 Sum_probs=78.3
Q ss_pred ceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc--ceEEEE---eecCCCCceeEEEecCCCCChhH
Q 007160 282 FGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGY---YSSRDSSQHLLCYELVPNGSLES 356 (615)
Q Consensus 282 fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI--v~l~g~---~~~~~~~~~~LV~Ey~~~gsL~~ 356 (615)
--.||+++.++|+.|++|....+ ....+++..|...+..|...++ +..+.. .........+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 45899999999999999987643 3346778889999888853322 111111 00012345778899998744321
Q ss_pred ----hh--------------cCC-CCCcccCChh-------------------hHHHHHHHHHHHHHHhHh----CCCCc
Q 007160 357 ----WL--------------HGP-LGVNCHLDWE-------------------TRMKIALDAARGLAYLHE----DSQPC 394 (615)
Q Consensus 357 ----~L--------------~~~-~~~~~~l~~~-------------------~~~~ia~qia~gL~yLH~----~~~~~ 394 (615)
.+ ... ......+++. .+..+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 110 0001111111 111122222223333322 23456
Q ss_pred EEeccCCCCCeEEcCCCcEEEEecccccc
Q 007160 395 VIHRDFKASNILLENNFHAKVADFGLAKQ 423 (615)
Q Consensus 395 ivHrDIkp~NILl~~~~~vkL~DFGla~~ 423 (615)
++|+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45889998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.90 E-value=0.0021 Score=65.52 Aligned_cols=73 Identities=23% Similarity=0.281 Sum_probs=50.2
Q ss_pred ceeeeccCceEEEEEEECCC--------cEEEEEEeccCCCCchHHHHHHHHHHhhccCCCcc-eEEEEeecCCCCceeE
Q 007160 274 ASILGEGGFGRVFKGVLSDG--------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLL 344 (615)
Q Consensus 274 ~~~LG~G~fG~Vykg~~~~g--------~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~~~L 344 (615)
.+.|+.|-.-.+|+....++ ..|.+++.. . ........+|..+++.+.-.++. ++++++. + .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C----ce
Confidence 36788899999999987543 456666554 2 23345667899999988644554 6777653 2 68
Q ss_pred EEecCCCCCh
Q 007160 345 CYELVPNGSL 354 (615)
Q Consensus 345 V~Ey~~~gsL 354 (615)
|+||+++.+|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.39 E-value=0.012 Score=57.37 Aligned_cols=161 Identities=14% Similarity=0.064 Sum_probs=84.9
Q ss_pred CCHHHHHHHhcCcccceee-----eccCceEEEEEEECCCcEEEEEEeccCCCCchHHHHHHHHHHhhccCCCc--ceEE
Q 007160 259 LAYEELKEATNNFEPASIL-----GEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLV 331 (615)
Q Consensus 259 ~~~~el~~~~~~f~~~~~L-----G~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~HpnI--v~l~ 331 (615)
++.+|+.....+|.+.+.. ..|---+.|+...++|+ +++|+..... ..++...|++++..+.+.++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 5678888888899775443 45666889999887665 8899876432 23455567777777743222 1111
Q ss_pred EE----eecCCCCceeEEEecCCCCChhHh--------------hc----CC--CCCccc-----------------CCh
Q 007160 332 GY----YSSRDSSQHLLCYELVPNGSLESW--------------LH----GP--LGVNCH-----------------LDW 370 (615)
Q Consensus 332 g~----~~~~~~~~~~LV~Ey~~~gsL~~~--------------L~----~~--~~~~~~-----------------l~~ 370 (615)
.. ....-......++.+..+...... ++ .. ...... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 10 000011234556666665433210 00 00 000000 001
Q ss_pred hhHHHHHHHHHHHHHHhHhC-CCCcEEeccCCCCCeEEcCCCcEEEEeccccc
Q 007160 371 ETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAK 422 (615)
Q Consensus 371 ~~~~~ia~qia~gL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 422 (615)
......+..+...+.-.+.. -+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222222223332221 13359999999999999998777899999875
|